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Thirty-seven pupils attending a special school for children and adolescents with autism were 
observed for the presence of motor and vocal tics. Subsequent family interviews confirmed 
the diagnosis of comorbid Gilles de la Tourette's Syndrome (GTS) in three children with 
autism, giving a minimum prevalence rate of 8.1 %. Family history data also suggested this 
was heritable. The presence of GTS was not associated with superior intellectual, language, 
or social development. Results suggest that the rate of GTS in autism may exceed that 
expected by chance. The limited sample size constrains this conclusion. A large-scale 
epidemiological study testing this association study would appear merited. 
Keywords: Autism, Tourette syndrome, comorbidity, pervasive developmental disorder. 
Abbreviations: GTS: Gilles de la Tourette's Syndrome; PDD: pervasive developmental 
disorder; TROG: Test for Reception of Grammar. 
Introduction 
Gilles de la Tourette's Syndrome (GTS) is a neuro­
developmental disorder defined by the presence of 
chronic, mUltiple motor and vocal tics ofchildhood onset 
(DSM-IV: American Psychiatric Association, 1994). 
Typically, tics develop at 6-7 years of age, show a 
fluctuating course, and decrease in severity during adult­
hood. The precise aetiology of GTS is unknown. In most 
cases, GTS appears to be genetically transmitted (Curtis, 
Ro bertson, & Gurling, 1992; Eapen, Pauls, & Robertson, 
1993). Implicated neurological abnormalities include 
functional abnormalities of the basal ganglia and pre­
frontal cortex (reviewed in Chase, Geoffrey, Gillespie, & 
Burrows, 1986), and biochemical abnormalities of the 
dopamine and serotonin neurotransmitter systems (re­
viewed in Baker, Chokka, & Bornstein, 1995). GTS is 
often accompanied by obsessive-compulsive behaviours 
(Frankel et aI., 1986), which may be an alternative 
expression of the putative GTS gene(s) (Pauls, Towbin, 
Leckman, Zahner, & Cohen, 1986). 
Requests for reprints to: Dr Simon Baron-Cohen, Departments 
of Experimental Psychology and Psychiatry, University of 
Cambridge, Downing Street, Cambridge CB2 3EB, U.K. 
Autism is also a neurodevelopmental disorder, itself 
defined by abnormal social and communication devel­
opment, with a pattern of restricted and repetitive 
interests and activities (DSM -IV: American Psychiatric 
Association, 1994). Autism has an earlier age of onset 
than GTS, and shows a chronic and unfiuctuating course. 
The aetiology of autism is unknown, although possible 
factors include genetic (Bailey et aL, 1995; Folstein & 
Rutter, 1977), neurobiological (Bauman & Kemper, 
1994), and cognitive (Baron-Cohen, 1995; Frith, 1989) 
abnormalities. 
Although distinct disorders, autism and GTS share 
several behavioural features. Here we list some of these 
shared features, whilst pointing out how these may differ 
in the two syndromes: (1) Echolalia and palilalia are 
common in both GTS and autism, although in autism, 
unlike GTS, these behaviours may be appropriate to the 
level of speech development. (2) Types of obsessive­
compUlsive behaviours are frequently seen in both autism 
and GTS, although in autism these may be better 
described as rigid and ritualistic behaviour, such as an 
insistence upon sameness and resistance to change. (3) 
Like GTS, autism is associated with abnormal motor 
behaviours, although in autism these often take the form 
of stereotypies, such as spinning, rocking, and hand 
flapping. 
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Recently, a growing number of case reports have 
documented the co-occurrence of autism and GTS in the 
same individuals. Early reports described the develop­
ment of motor and vocal tics in adults with autism 
following withdrawal from long-term neuroleptic treat­
ment (Mueller & Aminoff, 1982; Stahl, 1980). Owing to 
the adult onset, Stahl interpreted the development of tics 
as secondary to neuroleptic withdrawal, although 
Mueller and Aminoff also discussed the possibility that 
long-term neuroleptic use may have masked or delayed 
the appearance of tics that may otherwise have developed 
spontaneously. Later case reports of childhood-onset 
motor and vocal tics in autism or Asperger syndrome 
have also interpreted their development as secondary to 
neuroleptic withdrawal (Littlejohns, Clarke, & Corbett, 
1990; Perry, Nobler, & Campbell, 1989). 
Realmuto and Main (1982) were the first to report the 
development of GTS in a drug-naive child with autism. 
These authors interpreted this co-occurrence as a chance 
association, as did a subsequent report of childhood­
onset GTS in autism (Barabas & Matthews, 1983). 
However, Barabas and Matthews also discussed the 
possibility of a common neurochemical abnormality. 
A number of case reports of GTS comorbid with 
autism or Asperger syndrome have since been published. 
Most of these later reports have speculated on possible 
aetiological relationships between autism spectrum dis­
orders and GTS, including common chromosomal and 
genetic abnormalities (Hebebrand et aI., 1994; Ker­
beshian, Burd, & Martsolf, 1984a, b; Sverd, Montero, & 
Gurevich, 1993). This recent discussion of common 
aetiological factors implies a higher rate of comorbid 
autism and GTS than would be expected by chance. 
However, although the growing number of case reports 
suggests this higher rate, there have been few studies of 
the prevalence of comorbid autism and GTS. 
The estimated general population prevalence of autism 
is 2.5 per 10,000 (DSM-IV: American Psychiatric As­
sociation, 1994). The estimated general population preva­
lence of GTS is 2 per 10,000 (Robertson, 1994). Hence, if 
autism and GTS are truly independent, the rate of co­
occurrence expected by chance would be roughly 5 per 
100 million. 
A few studies have documented the prevalence of GTS 
in populations of individuals with autism spectrum 
disorders. Kerbeshian and Burd (1986) reported a clinical 
series of six individuals with Asperger Syndrome, of 
whom three (50 %) had comorbid GTS. The same group 
(Burd, Fisher, Kerbeshian, & Arnold, 1987) reported a 
rate of 20.3 % of GTS in an ascertained sample of 59 
individuals meeting DSM-III criteria for infantile autism 
or pervasive developmental disorder (PDD). Of the 12 
children with comorbid GTS, 10 had an atypical PDD, 
whereas only 2 had autism. Kano's group (Kano, Ohta, & 
Nagai, 1987; Kano, Ohta, Nagai, Yokota, & Shimizu, 
1988) described 2 children with autism and GTS, drawn 
from a sample of 76 children with autism, suggesting a 
much lower prevalence rate of 2.6 %. 
Autism spectrum disorders may be considerably more 
common than autism itself. Ehlers and Gilberg (1993) 
estimate their prevalence to be as high as 0.74%. Fewer 
studies have documented the rate of autism spectrum 
disorders in populations of individuals with GTS. 
Comings and Comings (1991) reported 16 individuals 
with autism, Asperger syndrome, or PDD, among a 
clinical series of 1400 children and adults with GTS, 
suggesting a rate of 1.1 % ofautism spectrum disorders in 
GTS. Berthier's group (Berthier, Bayes, & Tolosa, 1993) 
reported 9 individuals with Asperger Syndrome among a 
clinical series of 100 patients with GTS, giving a preva­
lence rate of 9.0 %. 
We are not aware of any studies reporting the rate of 
comorbid autism and GTS in the general population. 
However, Sverd (1991) reported 10 children with autism 
or PDD and comorbid GTS. Given the population 
statistics for the geographical regions from which these 
children were clinically ascertained, Sverd argues that 
these children represent a rate of comorbidity exceeding 
that of chance. 
It is clear that all reported prevalence rates exceed that 
expected by chance. However, two inconsistencies in the 
research to date require explanation. First, reported rates 
of GTS in autism spectrum disorders (2.6 %, 20.3 %, 
50.0 %) tend (with the exception of Kano and colleagues' 
statistic of 2.6 %) to exceed, by far, reported rates of 
autism spectrum disorders in GTS (1.1 %,9.0%). These 
results suggest a sampling bias. One source of bias may be 
that studies reporting the rate of autism spectrum 
disorders in GTS have sampled clinic outpatient atten­
ders. The difficulties of most children with autism are 
likely to be identified during the preschool years, and 
these children are likely to attend special schools. Unusual 
behaviours that develop subsequently will tend to be 
considered in the context of the child's autism, and as the 
key management of these children's needs will be met in 
special school placements, the need for further assessment 
for a subset of unusual behaviours is unlikely to be 
recognised or felt. Hence, outpatient samples of children 
with tic disorders probably under-represent children with 
autism, and staff at special schools for children with 
autism are unlikely to look for the presence of tics. 
Second, the rate ofAsperger syndrome in GTS appears 
to exceed by far that of autism in GTS (9.0 % vs. 1.1 %), 
and the rate of GTS in Asperger syndrome appears to 
exceed by far the rate of GTS in autism (50.0 % vs. 
2.6 %-20.3 %). (Note that Comings and Comings' figure 
of l.l % includes individuals with Asperger syndrome 
and PDD, and that Burd and colleagues' figure of 20.3 % 
includes individuals with atypical PDD.) This may again 
reflect a sampling bias. Children with Asperger syndrome, 
or high-functioning forms of autism, are more likely than 
children with autism to receive a late diagnosis and to 
receive mainstream schooling, and these factors may 
render the identification of tics, and so referral to 
outpatient GTS clinics, more likely. 
This is important as Kerbeshian and Burd's group 
(Burd et aI., 1987; Kerbeshian et aI., 1984a, b) has 
suggested that the development of GTS in children with 
autism is a marker for improved developmental outcome. 
In their study (Burd et aJ., 1987), the comorbid group had 
a higher mean IQ (70.4 vs. 45.5), and superior receptive 
and expressive language skills, than the group with 
infantile autism or PDD alone. Similarly, Sverd (1988) 
reported two children with GTS comorbid with a mild 
form ofPDD, and suggested that in some cases ofPDD, 
the co-occurrence of GTS may be an indication of a less 
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severe variant of PDD. Contrary to these reports, Kano 
and colleagues (Kano et aI., 1987, 1988) have reported 
two young adults with comorbid autism and GTS, 
followed since early childhood, neither of whom showed 
improved intellectual, language, or social functioning 
following the development of GTS. 
The study presented here aimed to establish the rate of 
GTS in a special school population of children and 
adolescents with autism. This population was chosen in 
order to avoid possible sampling biases created by relying 
solely on outpatient clinics. In addition, the present study 
employed a prospective, multi-stage design, using both 
direct observation and family interview methods. 
Method 
Participants 
All pupils attending a special school for children and 
adolescents with autism were invited to take part in the study. 
The total school population was 61 pupils, with a mean age of 
14:2 (years:months; range 10: 10 to 18:9), and a sex ratio of 
3.7: I (male:female). The parents of 41 (67.2%) children 
responded. Of responders, the parents of 39 (95.1 %) children 
consented and the paren ts of 2 (4.9 %) children declined to take 
part in the study. Two children for whom parental consent was 
given were unavailable for observation at the time of the study. 
Hence, the total number of children participating was 37, with 
a mean age of 14: 2 (range 10: 10 to 18: 9), and a sex ratio of 
4.3: I (male: female). 
Procedure 
Stage 1: Case-note identification. The case-notes of all 
participating children were reviewed to identify any children 
who had previously been assessed for a tic disorder, or had 
previously received a diagnosis of GTS. 
Stage 2: Teacher identification. The symptoms of GTS were 
discussed with teaching staff with the aid of a video showing 
motor and vocal tics in a child and adult with GTS. Teachers 
were subsequently asked to identify any child who had ever 
displayed similar behaviours at school. 
Stage 3: Observation. Two observers (CM & 1M) carried 
out independent observations of all participating children 
during a 2-day period. Both observers are experienced in the 
assessment and diagnosis of GTS. Children were observed at 
school, in their classrooms, and during their usual school 
activities. An attempt was made for each child to be observed at 
different times of the day (morning and afternoon) by the two 
observers, although this was not possible for all children. Each 
child was observed for at least 20 minutes (10 minutes by each 
observer), using a time-interval sampling observational pro­
cedure. The presence of motor and vocal tics, and of other 
abnomlal movements, was recorded. Each child was sub­
sequently classified by each observer independently as having 
motor tics, vocal tics, motor and vocal tics, or not tics, on 
observation. Children c1assifieQ as having motor and vocal tics, 
when both observers' observations were pooled, were entered 
directly into Stage 5. Children classified as having only motor or 
vocal tics, when both observers' observations were pooled, were 
entered into Stage 4. 
Stage 4: Re-observation. All children classified as having 
motor or vocal tics (but not motor and vocal tics) at Stage 3 were 
re-observed at their school by one observer (CM), for a further 
20 minutes each, 4 weeks later. Children for whom both motor 
and vocal tics had been observed, when all observations (Stages 
3 and 4) were pooled, were also entered into Stage 5. 
Stage 5: Family interviews. The parents of the children 
classified as showing both motor and vocal tics on observation 
were invited to discuss their child's possible GTS. Interviews 
were conducted at the children's school, by a neuropsychiatrist 
(MMR) and psychologist (SBC) experienced in the specialist 
assessment and diagnosis of GTS and autism, respectively. 
DSM-JII-R (American Psychiatric Association, 1987) criteria 
for GTS were used in preference to DSM-JV (American 
Psychiatric Association, 1994) criteria, as DSM-IV requires the 
additional criterion that tic symptoms must cause marked 
distress or significant impairment. The adoption of this sub­
jective criterion is inappropriate for many research purposes 
(Comings, 1995; Erenberg & Fahn, 1996; Freeman, Fast, & 
Kent, 1995). Particular issues for this study are that personal 
distress may not be experienced by young children, and may be 
difficult to establish in children with limited communication and 
in some children with learning disability. The interviewers also 
observed each (Stage 5) child on the same day as the family 
interviews, either as part of the interview, or during the child's 
usual school activities. 
Subsequently, previously obtained results on the Test for 
Reception of Grammar (TROG) measure of vocabulary and 
syntax comprehension (Bishop, 1983) were made available to 
the research team for each Stage 5 child. 
Results 
The numbers of children identified at each stage of the 
study are shown in Table I. 
At Stage 2, the teachers of 29 of the 37 participating 
children were available for discussion at the time of the 
study. Nine of these 29 children (31.0%) were identified 
by their teachers as having shown a history of tic-like 
behaviours. This information was not used to classify 
children, as teachers reported some difficulty in differ­
entiating between voluntary and involuntary movements 
and noises. (However, five of the nine teacher-identified 
children were also identified by the trained observers as 
showing motor and/or vocal tics, and two of these nine 
were later diagnosed with GTS.) 
Four children entered Stage 5 of the study. The parents 
of one child declined to be interviewed. For the remaining 
three children, at least one parent was interviewed. For 
two of the children, a second parent or other relatives also 
took part in the interview. The diagnosis of GTS was 
confirmed after family interview for all three children. 
Family history data confirmed a family history ofGTS in 
all three cases. A brief description ofeach diagnosed child 
is given below. 
Table I 
Numbers ofChildren Identified at Each Stage ofthe Study' 
Motor 
Motor Vocal and 
tics only tics only vocal tics Total N 
Stage I 0 0 0 0 37 
Stage 2 4 I 4 9 29 
Stage 3" 8 0 2 10 37 
Stage 40 6 0 2 (8) 8 
Stage 5 0 0 3 (3) 3 
• Non-cumulative. 

"When both observers' data were pooled. 

o When all observations (Stages 3 and 4) were pooled. 
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Child 1 
Child I was aged 16: 6 at the start of the study. He 
displayed multiple motor and vocal tics on observation. 
Simple motor tics included blinking, mouth movements, 
head-jerking, finger-flexing, and arm extensions. Simple 
vocal tics included throat-clearing and high-pitched 
noises. More complex motor tics included lip-smacking, 
face-rubbing, body-tapping, head-clasping, clapping, 
stamping, and whole-body jumping. Complex vocal tics 
included exaggerated laughing and bird-like noises. 
Echolalia and palilalia were also observed. He did not 
show any other abnormal movements, such as stereo­
typies, on observation. 
The following history was obtained on family in­
terview. Child I was born by forceps delivery, and was 
mildly jaundiced. He had developed tics between the ages 
of 7 and 12 years old, and had a wide repertoire of simple 
and complex motor and vocal tics. He had a positive 
history of both echolalia and palilalia, but a negative 
history of coprophenomena, echopraxia, and palipraxia. 
His tics had shown a fluctuating course, were exacerbated 
in crowds, and had decreased in severity with age. The tics 
did not appear to cause any distress. He also showed 
obsessive-compulsive behaviours, including checking and 
forced-touching. He had a history of mild self-injurious 
behaviour, in the form of hand-biting. He had a positive 
maternal family history of both motor and vocal tics, and 
a positive paternal family history of tics. He fulfilled 
DSM-III-R criteria for GTS, of moderate severity. 
Child I was assessed on the TROG measure of 
receptive language (Bishop, 1983) at age 15: 0 (18 months 
preceding entry into the study). He performed with an age 
equivalent of 5: 3, giving a discrepancy of 9: 9. 
Child 2 
Child 2 was aged 14: 10 at the start of the study. On 
observation, he displayed several simple motor tics, such 
as blinking, arm-extensions and abductions, and whole­
body jerking, and a simple vocal tic, in the form of a loud 
guttural noise. He did not show any complex tics on 
observation, although his tics were of marked intensity. 
He did not show any other abnormal movements, such as 
stereotypies, on observation. 
The following history was obtained on family in­
terview. Child 2 had been born by forceps delivery, and 
had been mildly jaundiced. He had suffered several febrile 
convulsions between the ages of 5 and 7 years of age. He 
had developed motor tics at the age of 5 years in the form 
of blinking, and vocal tics at the age of9 years. He had a 
positive history of echopraxia, but a negative history of 
coprophenomena, paliphenomena, and echolalia. Typi­
cally, his tics had shown a fluctuating course, had 
increased in severity at adolescence, and were exacerbated 
by excitement and distress. At times, the tics disrupted his 
activities and caused distress to himselfand his family. He 
also had marked compUlsive behaviours, including 
checking, a concern for objects to be positioned in exactly 
the "right" place, and forced touching. These compulsive 
behaviours had warranted a trial of behaviour therapy. 
He also had a history of self-injurious behaviours, such as 
smacking himself. He had a positive maternal history of 
motor and vocal tics. He satisfied DSM-III-R (and DSM­
IV) criteria for GTS, of moderate severity. Although he 
had received a low dose of chlorpromazine for I year 
during adolescence, the onset of tics had preceded this 
treatment. 
Child 2 was assessed on the TROG measure of 
receptive language (Bishop, 1983) at age 14: 5 (5 months 
preceding entry into the study). He performed with an age 
equivalent of < 4: 0, giving a discrepancy of > 10:5. 
Child 3 
Child 3 was aged 13:9 at the start of the study. On 
observation, he showed several simple motor tics, such as 
blinking, blowing-out, and whole-body jerking, and some 
simple vocal tics, such as whooping noises. He also 
displayed palilalia on observation. He showed additional 
stereotypical behaviours on observation, as well as over­
activity, jumping, and a variety of noises which were not 
considered tic-related. 
The following history was obtained on family in­
terview. Child 3 was born by caesarean section, at 10 days 
post-maturity. He had developed facial grimacing be­
tween 3 and 4 years ofage, and grunting at 7-8 years, and 
ticks had shown a fluctuating course. He had a positive 
history ofecholalia and palilalia, but a negative history of 
coprophenomena, echopraxia, and palipraxia. The tics 
did not appear to cause any personal distress, although 
the onset of excessive blinking at age II had caused some 
concern to his family. He also showed compulsive 
behaviours, such as flicking light switches on and off, and 
forced touching, including a ritual of touching the corners 
of objects with his foot before leaving a room. He had a 
history of self-injurious behaviours, including head­
banging. He had a positive maternal family history of 
vocal tics and obsessive-compulsive behaviours. He 
satisfied DSM-IIJ-R criteria for GTS, of mild severity. 
Motor and vocal tics had preceded a small dose of 
thioridazine at 8 years of age. 
Child 3 was assessed on the TROG measure of 
receptive language (Bishop, 1983) at age 13:4 (5 months 
preceding entry into the study). He performed with an age 
equivalent of < 4:0, giving a discrepancy of> 9:4. 
Discussion 
The observed rate of 8.1 % of GTS in this special 
school population of children with autism far exceeds 
that expected by chance. This observed rate may currently 
be the most accurate estimate of the prevalence of GTS in 
autism, as previous studies have retrospectively assessed 
the rate of GTS in clinical series of individuals with 
autism, and have not used prospective multi-stage studies, 
using combined observational and family interview 
methods. 
This study supports the use of prospective multi-stage 
designs, using independent observation and direct family 
interview methods to assess the prevalence of GTS in 
children with autism. It is important to use populations of 
children with autism who are not selected for the presence 
of GTS. That no participating child had previously 
received a diagnosis of GTS, or an assessment for a tic 
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disorder, supports the suitability of special school popu­
lations for future prevalence studies. 
In accordance with Kano and colleagues, this study 
does not lend support to earlier suggestions that the 
development of GTS in children with autism is a marker 
for improved developmental outcome, or indicates a less 
severe variant of PDD. On clinical impression, the three 
comorbid children did not show superior intellectual, 
language, or social development to their non-comorbid 
peers. On the TROG measure of receptive language 
(Bishop, 1983), our children showed a developmental 
delay of at least 9-10 years. At the time of the study, 
expressive speech had not developed in one child (who 
used sign language), and the remaining two children used 
largely single words and stereotyped phrases. Given that 
these children had already reached adolescence, and that 
the onset of GTS was at 7-12 years,S years, and 3-4 
years, respectively, these results suggest that these chil­
dren's development was not significantly accelerated with 
the onset of GTS. However, a longitudinal group design 
using repeated quantitative measures would be necessary 
to compare accurately the rate ofdevelopment ofchildren 
with autism who develop GTS with those who do not. 
We consider the rate of 8.1 % of GTS in autism as a 
minimum prevalence estimate for several reasons. First, 
that a significant proportion of children not identified as 
having GTS did, however, show motor or vocal tics (but 
not both) on observation. Children with GTS show a 
fluctuating course of tic expression, and so it is plausible 
that those children showing only motor or vocal tics, if 
observed for a longer period, would have shown both 
motor and vocal tics, and so entered the final stage of the 
study. Indeed, this is demonstrated by the two children 
who were identified as showing both motor and vocal tics 
only after re-observation at Stage 4. Second, children 
identified by their teachers as showing tic-like behaviours, 
but not identified by the researchers as showing motor or 
vocal tics on observation, may have been identified by the 
researchers as showing tics if they had been observed at a 
different time, or for a longer period. For both of these 
reasons, the observed rate of 8.1 % of GTS in children 
with autism may be an underestimate. 
In the final section of this paper we consider some 
methodological issues important to future research. First, 
it is possible that children with autism also appeared to 
show a higher prevalence ofalternative tic disorders (such 
as transient tic disorder, chronic motor tic disorder, and 
chronic vocal tic disorder). The possibility ofan increased 
rate of other tic disorders in autism has relevance for 
genetic studies. This merits full investigation. 
Second, we should be aware of the possibility that the 
high observed rate of tics in children with autism may 
simply reflect the difficulty in distinguishing tics from 
other abnormal movements and noises in this population. 
In particular, complex motor tics can be difficult to dis­
tinguish from stereotypies in the absence of self-reported 
subjective experiential information, particularly regard­
ing the volitional nature of behaviour. Such self-report 
data is not easily available in children with autism. 
However, tics, in contrast to stereotypies, are typically 
short-lived, contextually inappropriate, and interrupt the 
flow of behaviour or speech. Future studies might develop 
quantitative measures using these observable parameters 
with which to distinguish tics and other abnormal 
movements in children with autism. 
Third, the method used here was only tested in one 
(medium-sized) school for children with autism. The 
sample size is not sufficiently large to enable robust 
conclusions, but given the apparent link between autism 
and GTS re-emerging even in a study of this size, we 
would advocate that a large-scale prevalence study of 
such comorbidity is merited. 
Fourth, there is the possibility that despite the elevated 
rates found here, the link between these two conditions 
may 110t reflect any genetic factor. Rather, the observed 
elevated rate ofGTS in children with autism could simply 
be due to some other common aetiological factor such as 
a neurochemical and/or a frontostriatal abnormality. 
What we can conclude is that the elevated rate of GTS in 
au tism support neither a chance co-occurrence, and nor is 
it a neuroleptic-induced artefact. Future work addressing 
the genetic vs. other biological explanations of the link 
between these two conditio s will be important in 
furthering our understanding of their respective patho­
geneses. 
Acknowledgements-We are grateful to the staff and pupils of 
the participating National Autistic Society school for their help 
with this study, to Patrick Bolton for discussions, and to 
Michael Trimble for his support and his comments on an earlier 
draft of this paper. Simon Baron-Cohen was supported by the 
Tourette Syndrome Association (U.S.A.) and the NHS Anglia 
and Oxford Region during the period of this work. 
References 
American Psychiatric Association. (1987). Diagnostic and stat­
istical manual of mental disorders (3rd ed., revised; DSM­
IlI-R). Washington, DC: Author. 
American Psychiatric Association. (1994). Diagnostic and stat­
istical manual ofmental disorders (4th ed.; DSM-IV). Wash­
ington, DC: Author. 
Bailey, A., Le Couteur, A., Gottesman, I., Bolton, P., Simonoff, 
E., Yuzda, E., & Rutter, M. (1995). Autism as a strongly 
genetic disorder: Evidence from a British twin study. Psycho­
logical Medicine, 25, 63-77. 
Baker, G. B., Chokka, P. R., & Bornstein, R. A. (1995). 
Neurochemical and some related psychophannacological 
aspects of Tourelle's Syndrome: An update. Journal of 
Psychopharmacology, 9, 273-280. 
Barabas, G., & Matthews, W. S. (1983). Coincident infantile 
autism and Tourelle Syndrome: A case report. Developmental 
and Behavioural Pediatrics, 4, 280-281. 
Baron-Cohen, S. (1995). Mindblindness. London: MIT Press. 
Bauman, M. L., & Kemper, T. L. (1994). The neurobiology of 
autism. Baltimore, MD: 10hns Hopkins University Press. 
Berthier, M. L., Bayes, A., & Tolosa, E. S. (1993). Magnetic 
Resonance Imaging in patients with concurrent Tourette's 
disorder and Asperger Syndrome. Journal of the American 
Academy of Child and Adolescent Psychiatry, 32, 633-639. 
Bishop, D. V. M. (1983). Test for Reception of Grammar 
(TROG). Published by the author and available from the Age 
and Cognitive Perfonnance Research Centre, University of 
Manchester. 
Burd, L., Fisher, W. W., Kerbeshian, 1., & Arnold, M. E. 
(1987). Is development of Tourette disorder a marker for 
improvement in patients with autism and other pervasive 
developmental disorders? Journal of the American Academy 
of Child and Adolescent Psychiatry, 26, 162-165. 
-
-
 
"'''," .... Jl''''"
I 
 
 
-
-
.... VJ" .... U~'VH~,
 
-
-
I
VU1Im s{,u: -
 -
a, . ; l'
-
i J
"Ulnf'T""T Vlnrlr·O"',. 
J  
j
Un
ive
rsi
ty 
of 
Ca
pe
 T
ow
n
218 S. BARON-COHEN et al. 
Chase, T. N., Geoffrey, V., Gillespie, M., & Burrows, G. H. 
(1986). Structural and functional studies of Gilles de la 
Tourette Syndrome. Revue Neurologique, 142, 851-855. 
Comings, D. E. (1995). DSM-IV criteria for Tourette's (Letter 
to the editor). Journal ofthe American Academy of Child and 
Adolescent Psychiatry, 34, 401-402. 
Comings, D. E., & Comings, B. G. (1991). Clinical and genetic 
relationships between autism-pervasive developmental dis­
order and Tourette Syndrome: A study of 19 cases. American 
Journal ofMedical Genetics, 39, 180-191. 
Curtis, D., Robertson, M. M., & Gurling, H. M. D. (1992). 
Autosomal dominant gene transmission in a large kindred 
with Gilles de la TOUl'ette Syndrome. British Joul'llal of 
Psychiatry, 160, 845-849. 
Eapen, V., Pauls, D. L., & Robertson, M. M. (1993). Evidence 
for autosomal dominant transmission in Tourette's Syn­
drome: United Kingdom Cohort Study. British Joumal of 
Psychiatry, 162, 593-596. 
Ehlers, S., & Gilberg, C. (1993). The epidemiology of Asperger 
syndrome. A total population study. Joumal of Child 
Psychology and Psychiatry, 34, 1327-1350. 
Erenberg, G., & Fahn, F. (1996). Tourette Syndrome (Letter to 
the editor). Archives ofNeurology, 53, 588. 
Fo1stein, S., & Rutter, M. (1977). Genetic influences and 
infantile autism. Nature, 265, 726-728. 
Frankel, M., Cummings, J. L., Robertson, M. M., Trimble, 
M. R., Hill, M. A., & Benson, D. F. (1986). Obsessions and 
compulsions in the Gilles de la Tourette Syndrome. New'o­
logy, 36, 378-382. 
Freeman, 	R. D., Fast, D. K., & Kent, M. (1995). DSM-IV 
criteria for Tourette's (Letter to the editor). Journal (Jf 
the American Academy of Child and Adolescent Psychiatry, 
34,400-401. 
Frith, U. (1989). Autism: Explaining the enigma. Oxford: Basil 
Blackwell. 
Hebebrand, J., Martin, M., Komer, J., Roitzheim, B., de 
Braganca, K., Werner, W., & Remschmidt, H. (1994). Partial 
trisomy 16p in an adolescent with autistic disorder and 
Tourette's Syndrome. American Journal ofMedical Genetics 
(Neuropsychiatric Genetics), 54, 268-270. 
Kano, Y., Ohta, M., & Nagai, Y. (1987). Two case reports of 
autistic boys developing Tourette's disorder: Indications of 
improvement? (Letter to the editor). Journal ofthe American 
Academy of Child and Adolescent Psychiatry, 26, 937-938. 
Kano, Y., Ohta, M., Nagai, Y., Yokota, K., & Shimizu, Y. 
(1988). Tourette's disorder coupled with infantile autism: A 
prospective study of two boys. Japanese Journal ofPsychiatry 
and Neurology, 42, 49-57. 
Kerbeshian, J., & Burd, L. (1986). Asperger syndrome and 
Tourette syndrome: The case of the pinball wizard. British 
Journal of Psychiatry, 148, 731~736. 
Kerbeshian, J., Burd, L., & Martsolf, J. (I 984a). A family with 
fragile X syndrome. Journal ofNervous and Mental Disease, 
172, 549-551. 
Kerbeshian, J., Burd, L, & Martsolf, J. T. (I984b). Fragile X 
syndrome associated with Tourette symptomatology in a 
male with moderate retardation and autism. Developmental 
and Behavioural Paediatrics, 5, 201-203. 
Littlejohns, C. S., Clarke, D.1., & Corbett, J. A. (1990). 
Tourette-Iike disorder in Asperger syndrome. British Journal 
of Psychiatry, 156,430-433. 
Mueller, J., & Aminoff, M. J. (1982). Tourette-like syndrome 
after long-term neuroleptic drug treatment. British Journal of 
Psychiatry, 141,191-193. 
Pauls, D. L., Towbin, K. E., Leckman, 1. F., Zahner, G., & 
Cohen, D. J. (1986). Gilles de la Tourette's syndrome and 
obsessive-compulsive disorder: Evidence supporting a gen­
etic relationship. Archives of General Psychiatry, 43, 1180­
1182. 
Perry, R., Nobler, M. S., & Campbell, M. (1989). Tourette-Iike 
symptoms associated with neuroleptic therapy in an autistic 
child. Journal of the American Academy of Child and 
Adolescent Psychiatry, 28, 93~96. 
Realmuto, G. M., & Main, B. (1982). Coincidence ofTourette's 
disorder and infantile autism. Journal of Autism and De­
velopmental Disorders, 12,367-372. 
Robertson, M. M. (1994). Annotation: Gilles de la Tourette 
Syndrome: An update. Journal of Child Psychology and 
Psychiatry, 35, 597-611. 
Stahl, S. M. (I980). Tardive Tourette syndrome in an autistic 
patient after long-term neuroleptic administration. American 
Journal of Psychiatry, 137, 1267-1269. 
Sverd, 1. (1988). Tourette syndrome associated with pervasive 
developmental disorder: Is there an aetiological relationship? 
Journal of the Multi-handicapped Person, 1,281-291. 
Sverd, J. (1991). Tourette syndrome and autistic disorder: A 
significant relationship. American Journal of Medical Gen­
etics,39,173-179. 
Sverd, J., Montero, G., & Gurevich, N. (1993). Brief report: 
Cases for an association between Tourette syndrome, autistic 
disorder, and schizophrenia-like disorder. Journal of Autism 
and Developmental Disorders, 23, 407-413. 
Manuscript accepted 28 April 1998 
%gi ~ 5.
/'l1  ica/1
J ~ 2.
-
r l.
~f ~ 1.
ourett rn
,
-
.l
rn
 
lst
/w·
ur -
·
- 0l
£X(Jl lnllJ.I:
 ll
,2
 
lll
 
· .. 
1,  
m ,7 - .
1,.
l'I1  i
1 l
el1
l  .... 
i
l
(J  , 0--
,
1 U
rt. -
l -
U l
()
 
-
I 'f
(l
 J 
1 nmri"'n-I 
J 
1 ] c
-
Un
ive
rsi
ty 
of 
Ca
pe
 T
ow
n
Psychological Medicine, 1999, 29, 1151-1159. Printed in the United Kingdom 
© 1999 Cambridge University Press 
.The prevalence of Gilles de la Tourette syndrome In 

children and adolescents with autism: 

a large scale study 

S. BARON-COHEN,' V. L. SCAHILL, 1. IZAGUIRRE, H. HORNSEY 

AND M. M. ROBERTSON 

From the DepartmenL of Experimental Psychology and Psychiatry, University of Cambridge; Children's 
Centre, Southport; and Department of Psychiatry and Behavioural Sciences, University College London and 
the National Hospital for Neurology and Neurosurgery, London 
ABSTRACT 

Background. An earlier small-scale study of children with autism revealed that 8·1 % of such 

patients were co-morbid for Gilles de la Tourette syndrome (GTS). The present study is a large scale 

test of whether this result replicates. 

Method. Four hundred and forty-seven pupils from nine schools for children and adolescents with 

autism were screened for the presence of motor and vocal tics. 

Results. Subsequent family interviews confirmed the co-morbid diagnosis of definite GTS in 19 

children, giving a prevalence rate of 4·3 %. A further 10 children were diagnosed with probable GTS 

(2'2 %). 

Conclusions. These results indicate that the rate of GTS in autism exceeds that expected by chance, 

and the combined rate (6'5 %) is similar to the rates found in the smaller-scale study. Methodological 

considerations and alternative explanations for an increased prevalence are discussed. 

INTRODUCTION 
Gilles de la Tourette syndrome, or Tourette 
syndrome (GTS) is a neurodevelopmental 
disorder defined by the presence of chronic, 
multiple motor and vocal tics of childhood onset 
(American Psychiatric Association, 1987). The 
average age of onset is reported to be 5 years of 
age (Leckman et al. 1998). The tics show a 
fluctuating course and may decrease in severity 
during adulthood. The precise aetiology of GTS 
is unknown. In most cases however, GTS 
appears to be genetically transmitted (Curtis et 
al. 1992), although the exact pattern of in­
heritance is still unknown. Implicated neuro­
logical abnormalities include dysfunction of the 
basal ganglia and/or the prefrontal cortex 
(reviewed in Chase et al. 1986), and biochemical 
abnormalities of the dopamine and serotonin 
Address for correspondence: Dr Simon Baron-Cohen. Depart­
ments of Experimental Psychology and Psychiatry, University of 
Cambridge, Downing Street, Cambridge CB2 3EB. 
neurotransmitter systems (reviewed in Baker et 
al. 1995). GTS is often accompanied by 
·obsessive-compulsive behaviours (Frankel et al. 
1986; Eapen et al. 1997a). These may be an 
alternative expression of the putative GTS 
gene(s) (Pauls et al. 1986). 
Autism is also a neurodevelopmental dis­
order, itself defined by abnormal social and 
communication development, with a pattern of 
restricted and repetitive interests and activities 
(American Psychiatric Association, 1994). 
Autism has an earlier age of onset than GTS 
(usually by 18 months of age) and often shows a 
chronic course. The precise aetiology of autism 
is also unknown, although possible aetiological 
factors include genetic (Foistein & Rutter, 1977; 
Bailey et al. 1995), neurobiological (Bauman & 
Kemper, 1994) and cognitive (Frith, 1989; 
Baron-Cohen, 1995) abnormalities. 
Recently, a growing number of case-reports 
have documented the co-occurrence of autism 
and GTS in the same individuals. Realmuto & 
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Main 1982) were the first to report the de­
velopment of GTS in a child with autism. These 
authors interpreted this as a chance association, 
as did a subsequent report of GTS in autism 
(Barabas & Matthews, 1983). However, Barabas 
& Matthews also discussed the possibility of a 
common neurochemical abnormality. 
The estimated general population prevalence 
of autism is I per 1000 (Baron-Cohen et al. 
1996) and the estimated general population 
prevalence of GTS is 2 per 10000 (Robertson, 
1994). This is likely to be an underestimate, as 
GTS may go undetected. Hence, if autism and 
GTS are truly independent, the rate of co­
occurrence expected by chance would be 2 per 
10 million of the general population, I per 1000 
individuals with GTS, and 2 per 10000 indi­
viduals with autism. 
A few studies have documented the prevalence 
ofGTS in populations of individuals with autism 
spectrum disorders. Kerbeshian & Burd (1986) 
reported a clinical series of six individuals with 
Asperger's syndrome, of whom 3 (50'0 %) had 
co-morbid GTS. The same group (Burd et al. 
1987) reported a rate of 20'3 % of GTS in an 
ascertained sample of 59 individuals meeting 
DSM-III cri teria for infantile autism or pervasive 
developmental disorder (PDD). Of the 12 chil­
dren with co-morbid GTS, 10 had an atypical 
PDD, while only two had autism. This group 
also showed significantly higher IQ than the 
group with PDD without GTS, and significantly 
higher measures of receptive and expressive 
language. Burd et al. believed this to be an 
indication that co-morbid GTS in children with 
autism provided a marker for improved de­
velopmental outcome. Kano et al. (1987, 1988) 
described two children with autism and GTS, 
drawn from a sample of76 children with autism, 
suggesting a much lower prevalence of 2·6 %. 
We are not aware of any studies reporting the 
rate of co-morbid autism and GTS in the general 
population. However, Sverd (1991) reported 10 
children with autism or PDD and co-morbid 
GTS. Given the population statistics for the 
geographical regions from which these children 
were clinically ascertained, Sverd argues that 
these children represent a rate of co-morbidity 
exceeding that of chance. 
Although distinct disorders, autism and GTS 
share several behavioural features. Here we Jist 
some of these shared features, while pointing out 
how these may differ in the two syndromes: (I) 
echolalia and palilalia are common in both GTS 
and autism, although in autism, unlike GTS, 
these behaviours may be appropriate to the level 
of speech development; (2) types of obsessive­
compulsive behaviours are frequently seen in 
both autism and GTS, although in autism these 
may be better described as rigid and ritualistic 
behaviours, such as an insistence upon sameness 
and resistance to change; (3) like GTS, autism is 
associated with abnormal motor behaviours, 
although in autism these often take the form of 
stereotypies, such as spinning, rocking and hand 
flapping. 
A study carried out in a special school for 
children with autism (Baron-Cohen, et at. 1999), 
found that three out of the 37 pupils (8'1 %) had 
co-morbid GTS. Previous studies had generated 
prevalence rates retrospectively from clinical 
series. A special school population of children 
and adolescents with autism was used, with a 
prospective, multi-stage design, using direct 
observation in the classroom, and, later, both 
pupil and family interviews. This may have 
produced a more accurate estimate of the 
prevalence of GTS in children with autism than 
previous studies. However, the sample size was 
small. The current study aimed to replicate the 
earlier study, to establish the rate of GTS in a 
special school population, but this time with a 
much larger sample. 
METHOD 
Participants 
Thirty-three schools for children with autism 
from around England were invited to take part 
in the study. Of these, nine schools agreed to 
participate within the timescale of the study. We 
have no reason to suspect these were not 
representative of children with autism spectrum 
conditions more generally, as three schools were 
in the north, four were in the midlands, and two 
were in the Greater London area. The schools 
catered for a mixture of day and residential 
students. The total number of children with 
autism within these schools was 458, with a 
mean age of II : 1 (years: months; range 3: 6 to 
19:8) and a sex ratio of 4,9:1 (male: female). 
The children's parents were contacted, via the 
schools, to request their consent for them to take 
part in the study. The parents of two children 
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(0·4 %) declined to take part. Nine children for 
whom parental consent was given were 
unavailable for observation at the time of the 
study. Hence the total number of children 
participating was 447, with a mean age of 11: 1 
(years:months; range 4:2 to 19:8), and a sex 
ratio of 5: 1. The children's diagnoses showed 
varying degrees of autism: 280 were diagnosed 
as having autism; 141 received a diagnosis of 
autism spectrum condition; and 26 were diag­
nosed as having Asperger's syndrome. These 
diagnoses were not made by our team but were 
taken from the school notes, in all cases from 
reports by a child psychiatrist or paediatrician. 
Procedure 
Stage 1 
The records of all children included in the study 
were reviewed to identify any children who had 
previously been assessed for a tic disorder, or 
had previously received a diagnosis of GTS. 
Stage 2 
Where possible, the symptoms of GTS were 
discussed with teaching staff, using an advisory 
leaflet adapted from the Tourette Syndrome 
Association, UK. Some teachers were then asked 
to comment on the habits and movements of 
children in their classes. 
Stage 3 
An observer (V.S., a psychologist) carried out 
observations of all participating children. Chil­
dren were 0 bserved at school, in their classrooms 
and during their usual school activities. Class 
sizes ranged from three children to nine, with an 
average class size of six. Each child was observed 
for at least 10 min, using a time-interval sampling 
observational procedure. The presence of motor 
and vocal tics was recorded. Each child was 
subsequently classified as having motor tics, 
motor and vocal tics, or no tics, on observation. 
Children classified as having motor and vocal 
tics were entered directly into Stage 6. Children 
classified as having only motor or vocal tics were 
entered into Stage 4. 
Stage 4 
Children classified as having motor or vocal tics 
(but not motor and vocal tics) at Stage 3 were re­
observed at their school by the observer, for a 
further 10 mins each, a few days later. Children 
for whom both motor and vocal tics had been 
observed, when all observations (Stages 3, 4 and 
5) were pooled, were also entered into Stage 6. 
Stage 5 
Some children (N = 55) were later observed by 
an independant observer (RH., also a psy­
chologist) for 10 mins each. Of these children, 23 
had been classified by the first observer as 
showing tics, and 32 had been classified as 
showing no tics. The names given to this observer 
were presented in a random order, with no 
indication of their initial tic classification. 
Stage 6 
The parents of the children classified as showing 
both motor and vocal tics on observation were 
invited to meet a psychiatrist (M. M. R. or J. I.) 
to discuss their child's possible diagnosis of 
GTS, and to obtain a family history. Children 
and parents were interviewed using a short 
version of the National Hospital Interview 
Schedule (NHIS) (Robertson & Eapen, 1996). 
The Yale Global Tic Severity Scale (YGTSS) 
(Leckman et al. 1989) was also used. The 
diagnostic interviews were conducted at the 
children's schools, or at University College 
London Middlesex Hospital (N 1). Interviews 
were conducted at the child's school as far as 
was possible, to reduce anxiety. Each child 
was also observed for 30-45 min, as part of the 
interview. DSM-II1-R (APA, 1987) criteria for 
GTS were used in preference to DSM-IV (APA, 
1994) criteria, as DSM -IV requires the additional 
criterion that tic symptoms must cause marked 
distress or significant impairment. The adoption 
of this subjective criterion is inappropriate for 
many research purposes (Freeman et al. 1995; 
Erenberg & Fahn, 1996; Kurian et al. 1997). A 
particular issue for this study is that impairment 
and distress may be difficult to establish in 
children with limited communication and in 
some children with learning disability. 
If the parents were unable to attend the 
interview, but wished their child to be included 
in this stage of the study, the child was 
accompanied by his or her keyworker from the 
school, and a phone interview with the parents 
was conducted later by a psychiatrist. It should 
be noted that in a study of this kind there is a 
risk that stereotypies will be confused as tics. 
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The distinction between these is hard to draw, 
but if either of the raters or clinicians thought a 
behaviour could be a stereotypy, this was 
discounted as a tic, in order to err on the side of 
being conservative. 
RESULTS 
Stage 1 - review of notes 
No evidence for previous assessments or diag­
noses of GTS or alternative tic disorders was 
found in the records of any of the participating 
children. 
Stage 2 - teacher discussion 
Our previous study (Baron-Cohen et al. 1999) 
showed teachers' reports to be fairly reliable. 
Therefore, the children identified by their 
teachers as showing tic-like behaviours were 
noted and this data was used to help classify 
children. 
Stage 3 - initial observation (V. S.) 
Thirty children were identified as having motor 
and vocal tics by the first observer (V. S.) after 
Stage 3. These children were entered directly 
into Stage 6. A further 114 children were 
identified for whom motor or vocal tics were 
observed by the first observer. These children 
were entered into Stage 4. 
Stage 4 - re-observation (V.S.) 
Of the 114 children who were entered into Stage 
4, 18 were unavailable for re-observation by the 
first observer. Their classification therefore 
remained the same. From the remaining 96 
children, a further 10 were identified for whom 
both motor and vocal tics had been observed, 
when both Stage 3 and 4 observations were 
pooled. These children were also entered into 
Stage 6. 
Stage 5 - re-observation (H.H) 
Fifty-five children were seen by the second 
observer (H. H.), 1 to 2 weeks after the initial 
observations. All observations, from Stages 3, 4 
and 5, were pooled (for example, if one observer 
saw motor tics and the other vocal tics, that 
child was classified as showing motor and vocal 
tics). Agreement on tics v. no tics between the 
two observers was 70·4 %. The two observers 
agreed that 12 out of the 55 children were 
showing tic-like behaviours, 26 showed no tic­
like behaviours. They disagreed on the classi­
fication of 16 children. Both observers were 
trained in the identification of tics by MMR at 
the Tourette Clinic, at the National Hospital for 
Neurology and Neurosurgery, Queen Square, 
London. The implications of this result are 
discussed below. When the observations of both 
observers were combined, the final results were 
as follows: out of the 447 children entered into 
the study, 43 children were identified as showing 
both motor and vocal tics, 98 were identified as 
showing motor tics only, and 11 were identified 
as showing vocal tics only. 
Stage 6 
Forty-three children entered Stage 6 of the 
study. The parents of 10 children declined to be 
interviewed. One child was unavailable at the 
time of the appointment. For the remaining 
children, at least one parent was interviewed. 
Twenty-three children were accompanied by 
their parents to interview, nine were accom­
panied by their keyworker or teacher, and the 
parents later interviewed by phone. The di­
agnosis of definite GTS was confirmed after 
family interview for 19 of the 32 children. A 
further 10 children were diagnosed as having 
probable GTS. lfthe child showed symptoms at 
interview and there was a personal history of 
symptoms, a diagnosis of definite GTS was 
made. If one of these two criteria was met, but 
not the other, a diagnosis of probable GTS was 
made. For the remaining children, two were 
diagnosed with chronic motor tic disorder, and 
one was diagnosed as having Rett syndrome. 
This is a pervasive developmental disorder, 
characterized by the development of autism, 
dementia, apraxia of gait and stereotyped use of 
the hands, following a period of at least 5 
months of normal functioning after birth 
(Hagberg et al. 1983). 
For definite cases, the rate of true positives 
was 59·38 %, although if we include probable 
GTS cases, the true positive rate rises to 90·63 %. 
The rate of false positives was 9·38 %. The 
method employed in this study does not allow 
the calculation of true and false negatives. 
Medication information was provided by the 
parents, and six of the 32 children were taking 
psychotropic medication (four definite, two 
probable GTS), three were taking anti­
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Table 1. Diagnosis, severity of tics, and family history 

Fam. history Yale score 
Child Diagnosis I TS/Tics/OCB (%) Diagnosis 2 
I Autism M 6 Mild GTS 
2 Autism x 15 Probable GTS 
3 Autism P 15 Mild GTS 
4 Spectrum x 17 Probable GTS· 
5 Autism M 18 Definite CMT 
6 Autism P 48 Mild GTS 
7 Spectrum M 17 Definite GTS 
8 Autism 40 Probable GTS 
9 Spectrum x 26 Probable GTS 
10 Autism P 41 Severe GTS 
II Autism M 54 Mild GTS 
12 Autism ?M 40 Severe GTS 
13 Autism M 24 Mild GTS 
14 Autism P 49 Mild GTS 
15 Spectrum M 62 Mild GTS 
16 Autism 12 Mild GTS 
17 Autism x 35 Probable GTS 
18 Autism PM 7 Prob. CMT* 
19 Spectrum x 16 Mild GTS 
20 Autism P 30 Mild GTS 
21 Spectrum M 21 Mild GTS 
22 Autism PM 4 Probable GTS· 
23 AS P 56 Moderate GTS 
24 Autism PM 7 Definite CMT 
25 Autism P 33 Mild GTS 
26 Autism M 37 Mild GTS 
27 Spectrum M 25 Probable GTS 
28 Autism M 25 Mild GTS 
29 Autism P 32 Probable GTS 
30 Autism M 15 Mild GTS 
31 Autism PM 63 Probable GTS 
32 AS M 18 Mild GTS 
• Child 4, probable GTS, definite chronic motor tic disorder (CMT); Child 18, probable CMT, definite Rett's syndrome; Child 22, probable 
GTS, definite chronic vocal tic disorder. 
Family history: Tourette syndrome/tics/obsessive-<ompulsive behaviours; M, history on maternal side of family; P, history on paternal 
side of family; x, no family history. 
AS, Asperger's syndrome. 
convulsants (two probable GTS, one Rett 
syndrome plus probable chronic motor tic 
disorder) and one was taking ritalin (definite 
GTS). The onset of tics in this child predated the 
commencement of medication. 
YGTSS scores were calculated for all 32 
children. The scores ranged from 4 % to 63 %, 
with a mean of 28 % (S.D. = 16'7). 
For the children found to have co-morbid 
GTS and autism; 20 had been diagnosed with 
autism (7'1 % of children with autism had co­
morbid GTS), seven had been diagnosed with an 
autism spectrum condition (5·0 % of children 
with an autism spectrum condition had 
co-morbid GTS) and two had been diagnosed 
with Asperger's syndrome (7'7 % of children 
with Asperger syndrome had co-morbid GTS). 
When the frequencies of co-morbid GTS in 
children with autism, autism spectrum 
conditions and Asperger's syndrome were com­
pared, there were no significant differences (X 2 
= 0-43, df = 2, NS). 
Family histories were collected for all 32 
children. For 25 of the 32 children (78 %), there 
was found to be a paternal and/or maternal 
family history of tics and/or obsessive­
compulsive behaviours. These results are shown 
in Table 1. 
DISCUSSION 
The observed rate of 6·5 % of GTS (including 
'probable' GTS cases) in this special school 
population of children with autism far exceeds 
that expected by chance. This study, with its 
prospective, multi-stage design, using combined 
observational and family interview/history 
methods, and large sample size, is likely to have 
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yielded the most accurate estimate yet of the 

prevalence of GTS in children with autism. 

Previous studies have retrospectively assessed 

the rate of GTS in clinical series of individuals 

. with autism, and the earlier study carried out by 

this team (Baron-Cohen et al. 1999) had a much 

smaller sample size, although it used a similar 

method. The rates found in these two studies are 

also similar (X = 0'43, df I, NS). Thus, the 

current study supports the findings of the smaller 
study, and the methods used. 
It was suggested (Burd et al. 1987) that co­
morbid GTS in children with autistic-type 
conditions provides a marker for improved 
developmental outcome. The present study was 
unable to collect data on IQ, and measures of 
receptive and expressive language, and so cannot 
be directly compared with Burd et al.'s study. 
However, the fact that GTS was found to be 
equally common in children with autism, chil­
dren with autistic spectrum conditions and 
children with Asperger's syndrome shows that 
GTS is not related to the severity of autism in 
the child. 
It is also notable that a significant proportion 
of children not identified as having GTS did, 
however, show motor or vocal tics (but not both 
motor and vocal tics) on observation. One 
hundred and nine children (24-4 %) were show­
ing tics on observation, but did not show full 
GTS symptoms. Children with GTS show a 
fluctuating course of tic expression, and so it is 
plausible that some of those children showing 
only motor or vocal tics, if observed for a longer 
period, would have shown both motor and vocal 
tics, and so would have entered the final stage of 
the study. Indeed, this is demonstrated by the 10 
children who were identified as having both 
motor and vocal tics only after re-observation at 
Stage 4. This is also evident in the four children 
who were identified as having only motor or 
vocal tics, or even no tics in one case, by one 
observer, but as having both motor and vocal 
tics by the other, either a week later or a week 
earlier, and the one child who was observed as 
having motor tics only by one observer, and 
vocal tics only by the other. This may point to 
the need for a longer period of observation, to 
increase the chances of identifying those children 
with GTS. The observed rate of 6· 5% of GTS 
in children with autism may, therefore, be an 
underestimate. 
The high rate of tics observed in these children 
(34'0 % of children were classified as showing 
tics)l is interesting, as no children had previously 
been diagnosed as having a tic disorder. This 
may indicate that children with autism also 
show a higher prevalence of alternative tic 
disorder, chronic motor tic disorder and chronic 
vocal tic disorder, but that this is being over­
looked, possibly since they are occurring in the 
context of the other problems associated with 
autism. The possibility of an increased rate of 
other tic disorders in autism has relevance for 
genetic studies. 
Is it also possible that the high observed rate 
of tics in children with autism reflects the 
difficulty in distinguishing tics from other ab­
normal movements and noises in this popu­
lation? This differential diagnosis problem has 
been previously documented (Burd et ai. 1987). 
In particular, complex motor tics can be difficult 
to distinguish from stereotypies in the absence 
of self-reported subjective experiential infor­
mation, particularly regarding the volitional 
nature of behaviours. Differentiating vocal tics 
from the wide range of vocal productions in 
children with autism may be even more prob­
lematical. Apart from the clear-cut tics and 
stereotypies, there are quite a number of 
behaviours that can only be understood through 
careful enquiry about the nature of the move­
ment or noise, its longitudinal course, and 
possible alternative explanation for the symp­
tom. For example, a vocalization, which was 
initially noted as a sniffing tic, was later 
discovered, after questioning, to be a repetitive 
imitation of a TV character with which the child 
was currently obsessed. However, as mentioned 
in the Burd et ai. study, tics, in contrast to 
stereotypies, are typically short-lived, con­
textually inappropriate and interrupt the flow of 
behaviour or speech. It was also attempted 
to systematize the difference between motor 
tics and stereotypies by their topography 
(tics tend to be clearer in the face, neck 
shoulders and arms, compared with hands 
and fingers), their nature (spasmodic versus 
, This prevalence includes those children: diagnosed with probable 
or definite, GTS (29) and CMT (3); with parents who declined to be 
interviewed in Stage 6 (J 0) and one child unavailable for diagnosis 
(these 11 children were classified as either motor or vocal, as their tics 
had not been verified by a psychiatrist); who were showing motor or 
vocal tics on observation by V.S. and/or H.M. (109). Therefore, the 
total number of children showing tics was 152. 
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rhythmic) and also by the quality of the 
subjective experience and their response to 
psychosocial factors (Kano et al. 1988). These 
factors were taken into account when the 
observations were made, and we are therefore 
confident that the result obtained represents true 
co-morbidity. 
It is well-known that the tics encountered in 
GTS wax and wane in severity and fluctuate 
with time. Stress or anxiety may increase tics, 
whereas concentrating on a task may reduce 
tics. Thus, if the raters observed the children 
with autism at different times, for up to 10 min, 
and on different days (sometimes more than a 
week apart), it is quite conceivable that different 
tics occurred at different times. The levels of 
stress and anxiety may also have been different, 
and the children may also have been observed at 
different times during different tasks (e.g. con­
centrating). The raters were trained at the 
Tourette clinic at the National Hospital Queen 
Square during both new-patient and follow-up 
clinics. Inter-rater reliability was assessed on the 
tic observation section of the NHIS. Training 
was carried out for approximately 6 weeks, 
seeing about 40 GTS patients (V. S.), while the 
other psychologist (H. H.) sat in on the clinic 
and rated many more GTS patients over a year's 
duration. Agreement between the two raters was 
only modest, and this may well have been due to 
factors described above. 
A study by Eapen et al. (J997b) found that 
children in a special school population had an 
increased prevalence of GTS. Fifty-five per cent 
of emotionally/behaviourally disturbed children 
(EBD) and 20 % of children classed as learning 
disabled (LD) were diagnosed as having GTS. 
Whereas the EBD result could indicate that 
children with EBD have such problems due to 
the disruptive effects that GTS can have on the 
individual, the LD result could point to a larger 
picture - that children with learning difficulties 
are more prone to GTS. IQ data were not 
available for the children in the current study, 
thus we cannot say whether the results we 
obtained, of 6· 5% GTS in children with autism, 
can be attributed to their more general learning 
difficulties. Further research in this area is 
necessary to better clarify the links between 
these conditions. 
The generally accepted prevalence figure for 
GTS is around 0·5 per 1000 (Bruun, 1984); this 
figure has also been reached in a careful 
epidemiological study (Apter et al. 1993). A 
more recent pilot study by Banerjee el al. (1998) 
in the UK yielded higher results and found the 
rate of GTS in a mainstream school population 
to be around 3 %. This study, however, had a 
small sample size (N 166), and the identified 
cases were not re-assessed and formally diag­
nosed by an expert. It has been criticized 
(Traverse, 1998) and stirred debate (Banerjee et 
al. 1998). The actual prevalence rate ofGTS has, 
therefore, yet to be determined, but the currently 
accepted figure remains around 0·5 per 1000. We 
await the results of our larger definitive study in 
a UK school population. 
The YGTSS scores in our GTS individuals 
ranged from 4 % to 63 % with a mean of 29 % 
(see Table 1). The majority of the scores indicate 
mild to moderate severity. The scale range is 
0-100%. In the only UK GTS clinic study 
published using the scale (a modified version 
with the total range being 0-55) the GTS cases 
scored a mean of 26·2 (range 11-55) (Robertson 
et al. 1997). This would be between 45 % and 
55% using the currently used version of the 
scale. In another study (Robertson et al. 1999), 
on 280 consecutive GTS clinic cases, the YGTSS 
scores ranged from I to 100% (mean 49%; S.D. 
= 23). Both these studies indicate that the 
GTS/autism individuals are not nearly as severe 
as clinic patients. In the present study, some of 
the YGTSS global tic severity scores may have 
been higher than expected in this population due 
to the presence of, for example, echophenomena, 
which occur in both GTS and autism and which 
symptom receives a separate score on the 
YGTSS. 
The short version of the NHIS (Robertson & 
Eapen, 1996) was used in this study. This goes 
into detail with regard to individual tics, and the 
interviewer records whether specific tics have 
taken place in the past (ever), in the past week 
(which allows the YGTSS to be completed), as 
weJl as those observed at interview. Tics include 
simple ones such as frowning, raising eyebrows, 
blinking, winking, eye movements, nasal 
twitches, mouth twitching, pouting and opening, 
tongue protrusion, facial grimacing, platysma 
tightening, head nodding and shaking, shoulder 
shrugging and flicking the hair out of the eyes; 
simple vocalizations include grunting throat 
clearing, sniffing, snorting, grunting and 
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coughing. These were the majority of tics noted 
in the study. Complex tics (motor and vocal) 
and stereotypies may, however, be difficult to 
differentiate from each other, and include, for 
example, hand-flapping (common in people with 
autism; rare in people with GTS, and not 
regarded as a tic in this study), twirling (also not 
encountered in this study), vocalizations, in­
appropriate fluctuations in pitch of the voice, 
and squealing. Of course, some symptoms such 
as echolalia and echopraxia, are common in 
both autism and GTS, and may be in­
distinguishable from each other phenomeno­
logically in each condition. It is acknowledged 
that the relatively higher scores in the complexity 
score of the YGTSS may well have been partly 
due to the presence of symptoms such as 
ecophenomena; one author (M.M.R.) rated the 
pupils on the YGTSS and included only what 
she considered to be tics, apart from the 
ecophenomena. It must be noted that 18 pupils 
had echolalia, while 12 had echophraxia (10 of 
these had echolalia as well). We acknowledge 
the difficulties in differentiating between the two. 
Our new screening method suggests that a 
larger scale cognitive study of the effects of co­
morbidity would now be possible. These effects 
were investigated in the Baron-Cohen and 
Robertson (1995) case studies. A child with 
autism, a child with GTS and a child with both 
conditions were tested for theory of mind, 
intention-editing and executive function deficits. 
The predictions, that the child with autism 
would show a deficit in theory of mind tests, that 
the child with GTS would show a deficit in 
intention-editing tests, and that the child with 
both conditions would show deficits in both 
these areas, were supported. A larger scale 
study, with similar methods, may help to confirm 
these results, which have the natural limitations 
of single case studies. 
One of the purposes of this study was to find 
children who were being overlooked for treat­
ment. In co-morbid cases of autism and GTS, 
the latter is often overlooked (as in 100 % of our 
cases) and the symptoms are, therefore, left 
untreated. Finding these co-morbid cases allows 
the children's pharmacological management to 
be reviewed, and alleviation of tics can help to 
improve their quality of life. Three such cases 
were found in this study. By themselves, these 
cases provide a clinical justification for such 
screening. For the other children, diagnosed 
with mild GTS, and not needing medication, 
knowledge of their condition can help parents 
and teachers in their continuing support for the 
child. 
The observed elevated rate of GTS in children 
with autism is consistent with the operation of 
common aetiological factors, and does not 
support a chance co-occurrence. Possible com­
mon aetiological factors include neurochemical 
and frontal lobe abnormalities. That there is a 
substantial family history of GTS or GTS 
spectrum disorders suggests that there may also 
be independent genetic mechanisms at play. 
Future work addressing these possibilities will 
be important in furthering our understanding of 
the respective pathogeneses of these two neur­
odevelopmental disorders. 
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Diagnosing Tourette syndrome 
Is it a common disorder? 
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Abstract 
Objectives: The evaluate the prevalence of Tourette. youngsters in mainstream schools between the ages of 5. 
syndrome (TS). Methods: A review of the literature on TS and 16 years. It is even more common in youngsters with 
was undertaken to examine the prevalence of TS in mainstream special educational needs. Conclusions: TS is more common 
children as well as those in special education. Results: Recent than was previously documented. 
studies have indicated that TS occurs in around 1 % of © 2003 Elsevier Inc. All rights reserved. 
Introduction 
Tourette syndrome (TS) is an inherited neuropsychi­
atric disorder characterised by the presence of both 
multiple motor tics and one or more vocal tics that last 
for longer than a year and begin in childhood or early 
adolescence [1,2]. 
Diagnostic criteria 
The diagnostic criteria for diagnosing TS will be briefly 
considqed in the article, and it will be shown how the 
systems· for diagnosing TS have evolved and indeed been 
controversial at times. For instance, the WHO system has 
remained fairly static and has had no age limit, while the 
DSM criteria of the APA have stipulated upper age limits 
that have, in fact, changed with time. In the DSM-IV-TR [1] 
current diagnostic criteria, the onset must be before the age 
of 18 years. In addition, DSM-IV [3] was controversial, as 
evidenced by several letters to the editor challenging, inter 
alia, the stipulations of impairment and distress in order to 
make the diagnosis [4-7]. In addition, the Tourette Syn­
drome Classification Study Group [8] suggested that, by and 
.. Fax: +44-207-226-9979. 
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large, the DSM-ill-R criteria [9] were those seen as accept­
able in TS research. 
It is worth remembering, at this juncture and from an 
historical perspective, that the syndrome that was named 
after Georges Gilles de la Tourette [10], consisted of 
multiple motor tics, coprolalia, echolalia, and motor inco­
ordination. How many TS cases seen in general and expert 
clinics and also especially epidemiological, prevalence, and 
genetic studies today do actually fill these particular criteria? 
It is suggested that it is the small minority. 
Epidemiology and demography 
TS used to be considered a very rare condition, with only 
case reports documented in the literature [11,12] and a small 
international registry published [13]. Throughout the 1980s 
and the 1990s, however, the medical literature on TS 
mushroomed, and many large cohorts of TS patients were 
described, including several dedicated prevalence studies. 
The prevalence of tic disorders has been the subject of 
study for some time, and the generally agreed prevalence 
figures range from 4% to 18%, with the majority of studies 
finding that about 10% of youngsters have tics (for full 
review, see Ref [14]). 
TS is a category with in the tic spectrum and is one of the 
manifestations of childhood tics. The generally accepted 
prevalence for TS has always been much less common than 
0022-3999/03/$ - see front matter 10 2003 Elsevier Inc. All rights reserved. 
doi: 10.1016/80022-3999(02)00580-9 
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for tics and for some time was thought to be 5110,000 [15]. 
Recently, it has peen demonstrated that TS is much more 
common than previously suggested as evidenced by two 
pilot studies [16,17] and four definitive investigations 
embracing a relatively large number of youngsters [18­
21]. For a summary of the prevalence studies in mainstream 
school populations, see Table 1. It should be noted that the 
senior authors in all these studies all have a special interest 
in TS, and that the methods used included direct observa­
tions of the youngsters under study. It is thus suggested that 
a more realistic figure for the prevalence ofTS is around 1 % 
of school children between the ages of 6 and 17 years old. 
The prevalence of TS in children. with special edu­
cational needs [16,22,23] and autistic spectrum disorders 
[24,25] is, however, even higher than that in normal 
mainstream children. 
AI:, psychopathology and comorbid disorders are com­
monly associated with TS [11 ,26], it was decided to 
assess the prevalence of tics and TS in a psychiatric 
inpatient population in a cross-sectional study using semi­
structured interviews [27]. None of the 200 patients 
examined had definite TS, but two were observed to have 
motor tics at interview and 10 had a history of tics 
(present for less than a year). The results did not support 
the theory that TS is overrepresented among adult rnpa­
tients with psychiatric illness. 
18 is found in all cultures, countries, and racial groups 
and occurs three to four times more commonly in males 
[11,12,26]. 
Clinical phenomenology 
It may be clinically useful to subdivide TS into three 
groups [28]. (i) The first is "simple" TS (with motor and 
vocal tics being the predominant and almost the only 
symptoms). (ii) Secondly, there may be "full blown TS" 
(with coprophenomena, echophenomena, and palipheno­
mena. (iii) Thirdly, there may be "TS plus" in which the 
TS patients may also have attention deficit hyperactivity 
disorder (ADHD), obsessive-compulsive behaviours 
(OCB), self-injurious behaviours (SIB), and a variety of 
kinds of complex psychopathologies. 
Table 1 

Prevalence of TS in mainstream school (after Lanzi et aI. 

In the majority of studies, TS seems to start at the mean 
age of 6.7 years (range 1-17), with motor tics (such as eye 
blinking), followed by the vocal tics around the age of 9 
(such as throat clearing and sniffing) [29]. Coprolalia 
(which is seen in about 30% of clinic TS patients and 
10% of all 18 individuals) begins at around the age of 15 
[12]. Goetz et a1. [30] studied 58 adult TS patients who 
had been diagnosed during childhood. It was reported that 
tics persisted in all patients but were moderate/severe in 
only 24% when compared to 60% at the lifetime point of 
worst function. Coprolalia persisted in 4% compared with 
22% during the period of worst function. For most TS 
patients, worst function had occurred during adolescence 
(mode =13 years). Of importance is that despite a high 
frequency of school and behavioural problems during 
development, the vast majority (90-98%) had completed 
high school and were either full-time students or in 
employment [30]. A similar and more recent study has 
suggested a slightly earlier age of onset of TS (5.6 years), 
severe tics at around 10 years, and the majority of 
symptoms disappearing in half of the patients by the age 
of 18 years [31]. Thus, the prognosis of TS is better than 
previously thought. 
Investigations have also demonstrated that TS clinic 
patients also have significant nonobscene complex socially 
inappropriate behaviours (NOSI) [32], plus a variety of 
psychopathologies [33], but it is unclear whether or not 
these behaviours and psychopathologies would be found in 
TS cases identified in the community. In one large multi­
country study [26], only 12% of TS patients had no other 
psychopathology or comorbidity. 
Psychopathology and comorhid disorders 
Suggested common associations in clinical TS cohorts 
include ADHD and obsessive-compulsive disorder (OCO). 
The prevalence of ADHD is about 5% in the general 
population and that of OCD is between 1.9% and 3.2% 
[14]. In this context, there has been a suggestion [34] that if 
one were to examine the suggested TS spectrum, i.e., tics, 
TS, ADHD, and OeD, the prevalence would be about 10% 
of the population, which is clearly far from uncommon. 
Author Year Country Age (years) Sample size Procedure Prevalence (%) 
Kurian et al. (16) 1994 USA 7-14 35 observation + interview 3.0 
Mason et al. [17] 1998 UK 13-14 166 self-report, parents' Q, 2.9 
teachers' Q, and observation 
K.adesjo and 2000 Sweden 11 435 clinical examination 0.15-1.1 
Gillberg [19) 
HQmsey et al. [18] 2001 UK 13-14 918 self-report, parents' 9, 0.76-1.85 
teachers' Q, and two interviews 
Kurian et aI. [20) 2001 USA 8.5-17.5 1255 interviews 3.8 
Lanzi et al. [21] 2002 Italy 6-11 2347 classroom and observation 0.68 
After Lanzi et al. 2002 [21). 
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Aetiology 
It is now generally recognised that TS is a genetic 
disorder with most evidence suggesting a single major 
gene locus with suggestions of autosomal dominant 
inheritance, although more recently other mechanisms of 
inheritance have been suggested' [33], but to date no 
single gene has been identified. There may be several 
reasons for this nondetection of gene(s), including clinical 
heterogeneity, consequent incorrect definition of the 
phenotype and genetic heterogeneity (i.e., different 
gene(s) in different families). The recent first genome 
scan [35] identified areas of interest on chromosomes 4 
and 8. However, other factors have been very recently 
invoked in the aetiopathogenesis of TS and have included 
streptococcal infections in some patients [36-38] and pre­
or perinatal events [39]. 
It is suggested that only when the TS gene(s) are found, 
will it be clearer as to which of the above aetiological and 
genetic explanations are correct, and in fact, what consti­
tutes the precise TS phenotype. Whether or not this pheno­
type includes only tic phenomena, or whether it includes 
behaviours and psychopathology as well will be clearer. 
Only then will the true prevalence of both tics and TS 
be known. 
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Familial Tourette's Syndrome in a Large British Pedigree 

Associated Psychopathology, Severity, and 

Potential for Linkage Analysis 

MARY M. ROBERTSON and ALISON GOURDIE 
A British pedigree multiply affected by the Gilles de la Tourette syndrome and spanning six 
generations is described. Of 122 members identified, 85 were individually interviewed. 
and 50 were diagnosed as ·cases·. 'Cases' consisted of 29 with definite or probable Gilles 
de la Tourette syndrome, 17 with definite or probable chronic multiple tics, and four with 
definite or probable obsessive-compulsive behaviour. Only eight of the 50 'cases' had 
consulted a doctor for their symptoms. 'Cases' and 'non-<:ases' could be distinguished on 
the basis of echo-phenomena, obsessive-compulsive features, self-injurious behaviour, and 
the trait score of the Leyton Obsessional Inventory, but did not differ significantly on any 
other psychopathological variables. The pattern of inheritance of the Gilles de la Tourette 
syndrome in this pedigree is consistent with autosomal dominant transmission. 
The precise aetiology of the Gilles de la Tourette 
syndrome (GTS) is still unknown. In 1885, George 
Gilles de la Tourette postulated the hereditary 
nature of the disorder. Many investigators have 
subsequently demonstrated that GTS and chronic 
multiple tics (CMT) show a familial pattern (Eldridge 
et ai, 1977; Golden, 1978; Guggenheim, 1979; Kidd 
et ai, 1980; Nee et ai, 1980; Pauls et ai, 1981; Jagger 
et aI, 1982; Erenberg et ai, 1986; Lacey, 1986). 
Moreover, data from studies involving 11 concordant 
monozygotic GTS sets of twins suggest a genetic 
influence in GTS (Escalar et ai, 1972; Wasman 
et ai, 1978; Shapiro et ai, 1978; Jenkins & Ashby, 
1983; Waserman et ai, 1983; Vieregge, 1987) and 
CMT (price et ai, 1985)_ In the latter study 43 pairs 
of same-sex twins were studied in which at least one 
co-twin had GTS. Concordance rates for GTS were 
53070 for monozygotic pairs and 8OJo for dizygotic 
pairs, but when diagnostic criteria were broadened 
to include tics in a co-twin, concordance rates'rose 
to 77f1Jo and 23f1Jo for monozygotic and dizygotic 
twins respectively. It has been suggested that in 
families with GTS, CMT may be a milder mani­
festation of the disease (pauls et ai, 1981). A 
study of one large Mennonite extended family, 
of whom 159 were interviewed, suggests the trans­
mission of GTS and CMT is autosomal dominant 
(Kurian el aI, 1986, 1987). 
Recent psychopathological studies suggest that 
obsessive-compulsive behaviour (OCB) is not only 
severe in many patients with GTS (Frankel el ai, 
1986), but may be an integral part of the disorder, 
as it is significantly associated with central features 
of the syndrome such as copra- and echo-phenomena 
(Robertson et ai, 1988). This link between GTS and 
OCB does not appear to be culturally determined, 
as OCB has been reported as occurring in significant 
proportions of American GTS cohorts (Comings & 
Comings, 1987a,b), and in equivalent cross-cultural 
American-British cohorts (Frankel et ai, 1986), and 
in both British (Robertson et ai, 1988) and Dutch 
(van der Wetering et ai, 1988) GTS populations. 
Moreover, recent studies have suggested that GTS 
and OCB may be aetiologicaliy and even genetically 
related (pauls el ai, 1986a,b). 
Initially identified through the index case who 
presented at the clinic at the National Hospital for 
Nervous Diseases, Queen Square, we have identified 
and studied a large British kindred spanning 
six generations, and induding 122 members plus 
spouses. In trus paper we report the clinical and 
psychopathological features in the members of this 
extended family. 
Method 
We evaluated individuals in the pedigree over a two-year 
period. Initially. me subjects were interviewed to assess 
'caseness', using a shon, semistructured interview. lasting 
approximately 15-20 minutes, and devised by one of us 
(MMR) who is well acquainted with the clinical presentation 
and diagnosis of GTS. 'Caseness' was defined as the 
presence of symptoms or history sufficient to fulfil the 
criteria of one of me five diagnostic categories (see below). 
In addition. each individual over 18 years-of-age was 
assessed using the Schedule for Affective Disorders and 
Schizophrenia, Lifetime version (SADS-L; Endicott, 1978). 
The adult members of the pedigree (over 18 years) 
were also asked to complete the following standardised 
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psychiatric rating scales to assess specific -aspects of 
psychopathology: the questionnaire form of the Leyton 
Obsessional Inventory (Snowdon, 1980); the Crown-Crisp 
Experiential Index (CCEI) , previously known as the 
Middlesex Hospital Questionnaire (Crown & Crisp, 1966); 
the Hostility and Direction of Hostility Questionnaire 
(HDHQ; Caine et ai, 1967); and the 3()..item version of the 
General Health Questionnaire (GHQ; Goldberg, 1972). 
These particular rating scales were chosen as it has been 
reported that patients with GTS referred to a clinic not 
only have high general psychopathology, but that both 
obsessionality and hostility are intimately linked to central 
features of GTS (Robertson et ai, 1988). 
Fifty-eight pedigree members were reinterviewed, using 
a more detailed questionnaire (taking one to two hours to 
complete) about symptoms and behaviour recognised in 
patients with GTS including the following: the presence and 
types of motor and vocal tics; the age of onset of symptoms; 
the severity of the tics; suppressibility and duration of the 
symptoms. The presence of associated behaviour such as 
coprolalia, copropraxia, echolalia, echopraxia, palilalia, 
palipraxia, stammering, stuttering, self-injurious impulses, 
the urge of feeling forced to touch, aggressive behaviour, 
and sleep disturbances were also inquired after. In addition 
obsessional thoughts, compulsions and rituals, and other 
behaviour which may be considered to be obsessional. such 
as arithmomania and 'evening up', were assessed. Further 
historical information was obtained by direct interview with 
reliable informants. 
Individuals were assigned to diagnostic categories as 
follows: 
(a) definite 	 GTS: satisfying DSM-1II (American 
Psychiatric Association, 1980) criteria on history and 
examination 
(b) 	probable GTS: symptoms observed but no history 
obtained, or history obtained but no symptoms 
observed 
(c) 	 definite CMT: DSM-III diagnosis on history and 
examination 
(d) probable CMT: 	as for probable GTS but without 
vocalisations 
(e) 	Obsessive-compulsive behaviour: obtained on history 
and, in the case ofchildren, corroborated by parents, 
Global illness severity was rated according to the 
following: 
(a) mild: present but not requiring medication and not 
interfering with social life 
(b) moderate: present and requiring medication 
(c) 	severe: as for (b) but severely socially disabling. 
Severely socially disabling in this context means that 
an individual is unable to live a normal life with 
respect to employment, interpersonal relationships 
and living independently, 
Statistical analysis 
The data were analysed using the x! test and Fisher's exact 
probability test for contingency tables, The Mann-Whitney 
U-lest was used for examining the relationships between 
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discrete and continuous variables. Non-parametric tests 
were employed because the continuous variables were not 
normally distributed. The data were analysed on the 
EUCLID computer at University College London, using 
the MINITAB and EASISTAT statistical packages. 
Results 
Of 122 members of a family multiply affected by GTS, 85 
were interviewed at least once. Fifty-eight were interviewed 
twice. Six were seen and diagnosed as 'non-cases': five of 
these were too young for meaningful diagnosis, and one 
adult, while happy to be seen, was unwilling to answer 
detailed questions. The family, including members who 
were not interviewed. are shown in Fig. I. Information 
about 31 of these was obtained from other family members, 
and considered to be sufficient for diagnosis (hence the fact 
that there are more than the 50 'cases' in the genogram), 
but not for the analysis of detailed psychopathological data. 
Information about the remaining six was considered 
unreliable for the purpose of this communication. 
Statistical analysis was therefore performed on 79 
individuals about whom there was adequate information. 
Of the 85 subjects interviewed, 50 were diagnosed as 'cases', 
as shown in Table 1. Cases 21 and 28 were dizygotic twins 
concordant for GTS. The mean age of the 'cases' was 31.9 
years (range 5-84) and that of 'non-<:ases' was 36 years 
(range 6-81). Age at onset of symptoms (tics or obsessive­
compulsive symptoms) was 8.6±4.6 years (mean+s.d.). 
For the 50 'cases' (24 men, 26 women), eight had cortsulted 
a doctor for an opinion about their symptoms: two for tics; 
two for a cough; three for behavioural problems, and the 
index case for GTS at the clinic at the National Hospital 
for Nervous Diseases, Queen Square. Of these eight, three 
received treatment from psychiatrists; only one was given 
drug treatment, following a diagnosis of schizophrenia. Of 
the 50 'cases' graded for severity, one was graded as severe, 
one was moderate (index case), and the remaining 48 were 
mild. For these 50 subjects, associated behaviour was 
elicited (fable II). Twenty-nine subjects were diagnosed as 
TABLE I 
Diagnoses oJ aJJected members 
Diagnosis No. oJ individuals 
Definite GTS without OCB 18 
Definite GTS with OCB 1 
Probable GTS without OCB 9 
Probable GTS with OCB 1 
Definite CMT without OCB 7 
Definite CMT with OCB 2 
Probable CMT without OCB 6 
Probable CMT with OCB 2 
OCB 3 
Probable OCB 1 
Total 50 
OTS. OWes de la Tourene Syndrome, CMT, chronic motor tic, 
OCB, obsessive-compulsive behaviour. 
TOURETIE'S SYNDROME IN A LARGE BRlTISH PEDIGREE 
having definite or probable GTS (fable I). The asso­
ciated behaviour of these 29 GTS patients is shown in 
Table III. 
The results of the standardised rating scales are 
presented in Table IV. No significant differences were 
found in scores between 'cases' and 'non-cases', with 
the exception of the trait score of the Leyton Obsessional 
Inventory, which was signficantly higher for the 
'cases'. When the scores for the 29 GTS 'cases' only 
were compared v.;th 'non-cases', no significant differences 
emerged. 
Fifty-two subjects were assessed using the SADS-L, and 
diagnoses are shown in Table V. Seven subjects received 
more than one diagnosis. Of the 21 subjects to whom 
TABLE II 
Associated behaviours and Jeatures oJ 50 'cases' 
Associated 
behaviourl 
Jeature 
No. oJ No. oJ Significance 
'cases' 'non- between 'cases' 
cases' and 'non-cases" 
Sleep disturbance 32 
'Evening up' 16 
Forced to louch II 
Echolalia 10 
Aggressive behaviour 10 
Arithmomania 8 
Echopnvda 8 
Self-injurious behaviour 6 
History of stuttering 4 
Mental coprolalia 3 
Coprolalia I 
Copropraxia I 
Palipraxia I 
Palilalia 0 
II NS 
o P=O.OOOI 
o P=O.OO35 
o P=0.OO55 
I NS 
o P=0.019 
o P=0.0174 
o NS 

I NS 

o NS 
o NS 
o NS 
o NS 
o NS 
I. P"" Fisher's exact probability test. 
TABLE III 

Associated behaviour and Jeatures oJ29definite or probabl 

GTS 'cases' 

Associated No. oJ Significance 
behaviour/ 'non­between 'cases 
feature cases' and 'non-cases' 
Sleep disturbance 17 II NS 
'Evening up' 6 o P=0.012 
Forced to louch 7 o P=0.0065 
Echolalia 7 o P=0.OO54 
Aggressive behaviour 6 I NS 
Arithmomania 3 o NS 
Echopraxia 7 o P=0.OO54 
Self-injurious behaviour 5 o P=0.038 
History of stuttering 4 I NS 
Mental coprolalia 1 o NS 
Coprolalia I o NS 
Copropraxia I o NS 
Palipraxia I o NS 
Palilalia 0 o NS 
1. P= Fisher's e;<ao probability test. 
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TABLE IV 
Psychopathology assessed by rating scales 
Rating scale 'Cases' 'Non-cases' Significance I 
mean s.d. mean s.d. 
Leyton Obsessional inventory 
Symptom 13.13 8.1 9.86 7.3 NS Trait 
8.90 3.2 7.00 4.1 U= 1216. P=O.04 
Total 22.03 10.4 16.86 10.6 NS 
Crown Crisp Experiential index 
Free floating anxiety 5.14 4.2 5.65 4.6 NS 
Phobic anxiety 4.62 3.8 4.80 2.7 NS 
Somatic anxiety 4.95 3.5 4.25 3.0 NS 
Depression 4.41 3.3 4.40 3.7 NS 
Hysteria 5.08 3.4 5.15 2.8 NS 
Obsessional 5.68 3.2 5.40 2.5 NS 
Total 29.86 16.9 29.65 14.3 NS 
General Health Questionnaire 4.28 5.9 3.45 5.9 NS 
Hostility and Direction 0/ Hostility Questionnaire 
Total 16.61 8.7 14.95 6.4 NS 
Direction -1.03 6.02 -0.84 4.6 NS 
1. Mann-Whitney lj-test. 
TABLE V 
Psychopathology assessed by SADS-L 
Diagnosis No.o/cases 
Major depressive disorder 10 
Alcohol abuse 4 
Hypomania episode 3 
Generalised anxiety disorder 2 
Cyclothymic personality disorder 2 
Labile personality disorder 2 
Schizophrenia 2 
Phobic disorder I 
SADS-L diagnoses were assigned. 15 were 'cases', while 
six were 'non~es' (i!=0.59; 1 d.f; NS). As there are so 
few case reports on GTS and schizophrenia coexisting, we 
briefly present our two cases, though the association may 
be a chance finding. 
Case reports 
Casel 
Miss A is 23 years old and single, living with her parents. 
She was first seen by a psychiatrist in 1986. aged 22. with 
a presenting complaint of disturbed behaviour, particularly 
violence. At the time it was noted that she experienced visual 
and auditory haJlucinatioll5, the latter in the second person. 
Also noted ,were obsessive-compulsive phenomena, with 
repeating of the middle letters of words. The initial 
formulation was that she had a severe personality disorder 
with "intense ambivalent feelings". A psychotic illness 
could not be. excluded. She was therefore treated initially 
with oral neuroleptics, then depot long-acting neuroleptics. 
At interview in late 1987, however, there was evidence 
of Schneiderian first-rank symptoms, namely auditory 
hallucinatiOIl5 in the third person, and passivity, with made 
actioll5. At that time, when we interviewed her. she 
admitted to marked obsessive-compulsive phenomena 
(arithmomania. 'evening-up', intrusive thoughts, and 
compulsions to move objects), in addition to severe motor 
and vocal tics (including animal noises), together with 
coprolalia, copropraxia, echolalia, echopraxia, and pali­
lalia. Her nuclear family corroborated the history of 
GTS dating back to 12 years of age. This combination of 
symptoms resulted in severe social disability. She lived at 
home with her parents, was unemployed, and had no 
friends. 
Case 2 
Mrs B, a 58-year-{lld, separated woman, has had a long 
history of psychiatric illness since the early 19605, following 
the birth of her eighth child. She has warranted at least six 
in-patient admissioll5 and prolonged attendance at a day 
hospital, necessitating trearment for many years for 
schizophrenia with intramuscular flupenthixol decanoate, 
and oral neuroleptics when required. She currently resides 
in a community-based psychiatric residential hostel. When 
interviewed by us for the study she spoke of "Mr Clock". 
who has spoken to her since 1962, commenting on her 
actioll5 in the third person. She has also experienced other 
auditory hallucinations; for example when the traffic is busy 
she hears a certain man and his associates gossiping about 
her. These voices are usually intrusive and derogatory. 
In addition, she experiences thought broadcasting and 
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passivity. There was also evidence of several- negative 
symptoms of schizophrenia such as blunted affect, 
avolition, and apatby. On direct questioning Mrs B 
admined to the following: finger drumming, looking at her 
watch constantly without wanting to know the time, and 
looking in mirrors all as 'habits'. At interview she cleared 
her throat several times, and admitted to that and coughing, 
both as 'habits'. She admitted to arithmomania, in that she 
had many counting obsessions and had done so since the 
age of 16. She also admitted to obsessional rituals embracing 
dressing and undressing, bathing and 'evening-up', in that 
she felt the need to have symmetry and order. This had 
begun in her lOs and has continued to date. She was unsure 
of the age of onset of other GTS symptoms, but they had 
been present as long as she could remember. It must be 
noted that she has been on dopamine antagonists for many 
years for her schizophrenia. which may have masked other 
motor or vocal tics. 
Of note is that three of the bipolar affectives (type II, 
DSM-llI-R; American Psychiatric Association, 1987) are 
her children: we suggest this is probably as a consequence 
of assonative mating. Attempts were made to contact the 
fatbers of the children, but letters and telephone calls were 
consistently unanswered. 
Blood samples 
Blood samples were collected from 77 family members for 
DNA extraction. Analysis of linkage with a large series 
of restriction fragment-length polymorphisms (RFLPs) 
markers and mini-satellite mapping is in progress. Segre­
gation analysis is also in progress and will be reported 
in a future communication. 
Discussion 
Our findings in a large pedigree of many affected 
individuals. the majority of whom have never 
sought or received medical attention, would support 
previous suggestions from both pedigree (Kurian et 
al. 1987) and epidemiological (Caine et ai, 1988). 
data that GTS in the community is more common 
than previously estimated. usually mild and thus 
often undiagnosed. Moreover, the frequency of 
'caseness' in our pedigree is strikingly similar to that 
found by Kurian et af (1987), with 54 'cases' in their 
pedigree of 159 members. The only difference from 
the Kurian study is that we included as 'cases' 
subjects with OCB, but as can be seen from Table 
I. there were only four such individuals with OCB 
as a sole diagnosis. We would point out that our 
number of 'cases' may be an underestimate. as nine 
who were under the age of 21 were interviewed and 
labelled 'non-cases', but some of these individuals 
may well develop GTS at a later age. 
Sleep disturbance. which has been documented 
widely in GTS (Robertson. 1989), was the most 
common of the associated behaviours, occurring in 
32 of our 'cases', but this was not significantly more 
common than in 'non-cases'. It is noteworthy that 
'evening-up' was not only the next most common 
associated behaviour. but also a significant 
discriminator between 'cases' and 'non-cases'. 
Arithmomania, another obsessional characteristic, 
was also significantly commoner in 'cases' than 'non­
cases'. as was the feeling or compulsion of being 
forced to touch. The only other behaviours dis­
criminating between 'cases' and 'non-cases' were 
echolalia and echopraxia, known to occur in roughly 
30-40010 of GTS populations (Robertson, 1989) and 
widely recognised as being integral parts of the 
syndrome in the initial paper by George Gilles de la 
Tourette himself in 1885. When the associated 
behaviours of only GTS and probably GTS 'cases' 
were compared with 'non-cases'. arithmomania 
failed to reach significance, but self-injurious 
behaviour was found to discriminate significantly 
between the tWo groups. This is particularly note­
worthy as we (Robertson et al. 1989) have reported 
self-injury as occurring in one-third of a cohort 
of 90 GTS patients, suggesting that self-injury 
in the GTS population has been under-reported to 
date. 
It is important to address the issue as to how 
typical our 'cases' were in their GTS symptomatology 
when compared with GTS subjects in other investi­
gations. Our patients exhibited most commonly 
a variety of OCB. such as 'evening up', arithmo­
mania, and the feeling of being forced to touch. 
which discriminated between 'cases' and 'non­
cases'. This is typical of a substantial proportion of 
GTS individuals encountered in a wide variety of 
settings, including clinical (Frankel et ai, 1986; 
Robertson et aI, 1988) and epidemiological (Caine 
et aI, 1988) cohorts. as well as pedigree/family studies 
(Kurian et aI, 1986). Thus, our findings suggest our 
cases are typical and in keeping with the literature, 
which adds to the argument that OCB is an integral 
part of the syndrome (Robertson, 1989). irrespective 
of the severity of GTS symptoms. Sleep disturbance 
has been reported to be common in GTS subjects, 
independent of cohort setting. namely epidemio­
logical (Caine et ai, 1988) or clinical (Robertson 
et al. 1988); it is of importance in this context 
that it has been argued that GTS is a disorder 
of arousal (Glaze et aI, 1982; Barabas et al. 1984a,b, 
1985). although there have been opponents to this 
view (Erenberg, 1985). Other associated behaviours 
seen in smaller numbers of our pedigree cases were 
aggression, self-injurious behaviour and, in only one 
case. copro-phenomena. It would seem that our cases 
are not unusual in that relatively small numbers of 
sufferers exhibited these behaviours, and although 
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such behaviours are documented in patients with 
GTS, they are more common in those patients who 
have been referred to physicians and may well be a 
reflection of the severity of the disorder, and thus 
a result of ascertainment or referral bias; for the 
majority of GTS subjects in the community, it 
is a mild disorder and thus often undiagnosed 
(Robertson, 1989), and this was the situation with 
the majority of our cases. 
The trait scores of the Leyton Obsessional Inventory 
were the only ones to discriminate between 'cases' 
and 'non-<:aSes', thus arguing again for an intimate 
association between OCB and GTS. Thus, although 
a significant association between obsessive-compul­
sive phenomena and core features such as copro­
phenomena and echo-phenomena has only been 
documented once (Robertson et ai, 1988), there 
is a growing literature on obsessive-compulsive 
disorder and GTS (Frankel et ai, 1986; Comings & 
Comings, 1985; Hagin et ai, 1982; Montgomery et 
ai, 1982; Nee et ai, 1980; Green & Pitman, 1986). 
With regard to the general psychopathology, it can 
be seen from Table IV that there are no differences 
in the scores of the rating scales between 'cases' and 
'non-cases'. Moreover, the results of the SADS-L 
show 21 family members had had a psychiatric illness 
during their lifetime. When doing a breakdown of 
the specific diagnoses, these are not in excess of 
the lifetime risks for schizophrenia (I 070), major 
depressive disorder (20%), alcohol abuse (13070), and 
the others, which could be subsumed under the 
diagnosis 'neurosis', which has a lifetime risk of 13% 
(American Psychiatric Association, 1980; Kendell & 
Zealley, 1983). Moreover, two schizophrenics in a 
cohort of 122 people is not above the ex ected 
(Kendell & Zealley, 1983) and hence our findings 
suppOrt the assertion that there is no connection 
between schizophrenia and GTS (Robertson, 1989), 
as has been reflected by only a few case reports in 
the literature (Caine et ai, 1978). Our data of 
depressive disorders, schizophrenia, phobic states, 
and generalised anxiety not being more common in 
the GTS population than in the general popu­
lation does not support the suggestion that these 
pathologies and GTS are genetically related (Comings 
et ai, 1984). 
The pattern of inheritance of GTS and CMT in 
our pedigree supportS an autosomal dominant 
pattern of inheritance, as suggested by previous 
authors (Devor, 1984; Price et ai, 1984; Pauls & 
Leckman, 1986; KurIan et ai, 1986, 1987) but this 
is only eyjdent when the presumed phenotype is 
broadened to include CMT and OCB. Even when 
this is done, penetrance is apparently incomplete, as 
there are two unaffected individuals who, if paternity 
has been correctly detemined, are obligate carrie 
of the disease gene (nos 116 and 96). However, proc 
that GTS, CMT, and OCB are genetically related w 
have to await the demonstration of linkage betwef 
GTS and polymorphic genetic markers. The pedigrl 
is a suitable one for linkage analysis because it 
unlikely that heterogeneity of linkage is presen 
However, due account for the presence of the tvI 
inbreeding loops (cases 18 married to 15, and all 
96 to 50) will have to be taken into account in tl 
calculation of lod scores. 
Conclusions 
Our pedigree data confmn those of preyjOl 
investigators suggesting that the majority of G1 
cases in the community are mild and go undetectel 
thus the true prevalence of GTS remains unknoWJ 
Our data also support the notion that GTS ar 
obsessionality are intimately related. Likewise, ech. 
phenomena are an integral part of the syndrome. " 
further suggest that self-injurious behaviour occu 
in a clinically significant proportion of GTS patient 
that it often goes undetected, and that it can OCC1 
in those individuals who have mild GTS symptom 
Finally, inspection of the pattern of affect( 
indiyjduals within the family suggests autosom 
dominant inheritance when the presumed phenotYl 
is broadened to include CMT and OCB. 
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Gilles de la T ourette Syndrome in the Middle East 

Report of a Cohort and a Multiply Affected Large Pedigree 

MARY M, ROBERTSON and M, R, TRIMBLE 
In a cohort of five patients from the Middle East with 
the Gilles de la Tourette syndrome, family history of a 
tic disorder or the Gilles de la Tourette syndrome was 
positive in three cases, In one of these there was a 
multiply affected pedigree spanning six generations. The 
phenomenology of the syndrome is the same as that 
described in Western reports. The familial pattern 
of inheritance and cross-cultural similarity empha­
sise the biological factors in the aetiology of the 
syndrome. 
British Journal of Psychiatry (1991), IS8, 416-419 
The Gilles de la Tourette syndrome (GTS) is no 
longer the bizarre rarity that it was once thought to 
be. Substantial cohorts of GTS patients have been 
reported from North America, the United Kingdom 
and Europe, but from most other parts of the world, 
to date, only case reports exist (Robertson, 1989). 
The syndrome is diagnosed by the presence of both 
motor and vocal tics; however, associated features 
such as echophenomena, coprophenomena, and more 
recently obsessional thoughts and lor behaviour, 
are recognised as being integral parts of the syndrome 
(Lees et ai, 1984; Robertson et ai, 1988). 
There has only been one report from the Middle 
East, namely from Saudi Arabia (EI-Assra, 1987). 
This report not only stated that it is the first known 
documentation from the Middle East, but 'confmned' 
supposedly correct previous suggestions that a 
"disturbed parent-child relationship underlies the 
psychogenesis of the syndrome", as the' 'results of 
the psychotherapeutic sessions and the family 
meetings ... showed the patient's inability to grow 
up psychologically at home, and her use of the GTS 
symptoms to seek the attention of her parents". 
Further arguments for the underlying psychogenesis 
of GTS were advanced by the author who stated that 
"the early and remarkable response of our patient 
to haloperidol is doubtful", "because of the small 
dose of haloperidol administered" (0.5 mg), and 
"furthermore there was no evidence of organic 
dysfunction, as indicated by the patient's good health 
and normal IQ". No mention was made of family 
history and the only references to cultural factors 
were that the patient was one of 12 children and that 
the reason she sought the attention of her parents 
was because they had always been more attentive to 
male children - a 'cultural phenomenon'. 
While it is acknowledged that sporadic cases of 
GTS do occur, it is becoming increasingly accepted 
that in the majority of cases there is a genetic basis 
to the disorder (Robertson, 1989). In addition, it has 
been suggested that the anticipated gene for GTS 
may manifest as GTS or chronic multiple motor 
or vocal tics only (Pauls et ai, 1981; Kurian et ai, 
1986; Robertson & Gourdie, 1990), or obsessional 
behaviour (Pauls & Leckman, 1986; Pauls et ai, 
1986 a, b; Comings & Comings, 1987), with 
obsessional behaviour as opposed to tics being 
particularly evident in the female relatives of affected 
families. 
A cohort of patients from the Middle East is 
presented. In addition, a large pedigree with multiply 
affected members is discussed. We emphasise not 
only the cross-cultural similarities of GTS patients, 
in that our patients are not substantially different 
from those documented in the United States, the 
United Kingdom or Europe, but note also the similar 
familial pattern of GTS andlor obsessional disorder 
in the families of our cohort. 
Case reports 
Patient no. 1 
Miss eM, born in the Sudan, and of Armenian background, 
presented to the National Hospital, Queen Square, at the 
age of 22 years. Her first symptom, blinking of the eyes, 
began at the age of six years. Subsequently, she exhibited 
shaking of the hands, flexing of various muscles, especially 
of the hands, nodding of the head, stretching of the neck 
muscles, shrugging of the shoulders and a complex jumping 
movement of the whole body. At the age of 15 years she 
began to have vocalisations such as snorting, coughing and 
a deep throaty noise. Typically, the symptoms would wax 
and wane and were made worse by stress and anxiety. She 
was able to suppress them at the expense of inner tension. 
She had both echolalia and echopraxia when young 
(especially if someone made a strange noise or bodily 
movements), felt forced to touch objects (especially if 
hot or cold), but exhibited no coprolalia nor obsessive­
compUlsive behaviour. 
The patient was 91b (4 kg) at birth and there was no 
evidence of birth injury. As a child she bit her nails but 
otherwise her development was unremarkable. Her early 
life was spent in Africa and she came to England at the 
age of 10 years. She settled well at school, obtained a degree 
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417 TOURETTE SYNDROME IN THE MIDDLE EAST 
equivalent at college and took up a post as assistant to a 
solicitor with a view to becoming a solicitor. She was 
single and despite her illness, of which she has always 
been conscious, she adapted well to life in England. 
Family history of note is that her father snorted throughout 
his life and that her brother continually blinked his eyes. 
On examination, no neurological nor abnormalities of the 
mental state were detected, She did, however, exhibit several 
facial and lower limb movements, in addition to the 
occasional snort. An electroencephalogram (EEG) was 
normal. She was successfully treated with c10nidine (0.2 mg 
daily), with a marked reduction of all her symptoms 
resulting in a better quality of life. 
Patient no. 2 
Miss MA presented to the National Hospital, Queen Square, 
at the age of 21 years. She was born in the Lebanon. 
Her symptoms had begun at the age of 10 years with a 
vocalisation similar to the yelping of a puppy. Since then 
she exhibited a wide repertoire of motor tics including 
raising of the eyebrows, blinking, winking, a nasal twitch, 
sniffing, a movement similar to flicking hair out of her eyes, 
abdominal contractions, a twisting movement of the torso 
and leg extension. Subsequent vocalisations have included 
throat clearing and persistent yelping. She never exhibited 
copro- nor echophenomena, signs of attention-deficit 
disorder nor hyperactivity. The only obsessional behaviour 
she exhibited was t he repeated and unnecessary shutting 
of doors. Typically, the symptoms were increased with 
anxiety and decreased while playing sport. 
Her birth and early childhood were unremarkable. She 
went to secondary school in Belgium and subsequently 
attended university in London where she integrated well 
and achieved well academically. Family history of note is 
that a paternal aunt was reported to have winked and 
blinked excessively. Neurological and mental state 
examinations were normal, apart from facial tics and 
vocalisations. An EEG and magnetic resonance imaging 
(MRI) were normal, as were serum copper and caerulo· 
plasmin. As her condition was considered to be mild, no 
pharmacological treatment was indicated. Reassurance, 
especially to the family and patient who felt both genetic 
endowment and the war in Lebanon were responsible for 
her symptoms, was given, as was supportive psychotherapy. 
Patient no. 3 
Miss ZA was born in Kuwait of an Arabic background. 
She presented to the National Hospital, Queen Square, at 
the age of 22 years. Her first tic was excessive blinking of 
the eyes at the age of eight years. Since then she has 
had many motor tics including frowning, raising of the 
eyebrows, winking, blinking, rolling of the eyes upwards, 
nasal twitching and flaring, sniffing, several movements 
of the mouth including pouting, tongue protrusion, facial 
grimacing, spitting, licking of the lips, head nodding. 
platysma tightening, shoulder shrugging, pelvic movements, 
kicking, an abnormal gait interrupted by hopping, complex 
jumping, jerks of both arms and legs and a complex 
movement involving hitting of both her head and abdomen. 
Vocalisations began at the age of nine years and have 
included yelping, squeaking, coughing, throat clearing and 
gulping as well as sounds simulating words but which are 
not recognised as belonging to any particular language. 
Coprolalia began at the age of 15 years and literal 
translations of the Arabic words were arse, bitch and pimp. 
She also had echolalia, echopraxia, palilalia and an urge 
to touch things. In addition she indulged in self·injurious 
behaviour such as slapping of her face, punching her 
head and abdomen and stabbing her hand or face with a 
pen with resultant bruising. She had exhibited sexual 
disinhibition in public, exposing her breasts at school and 
uncovering her thighs in public (this was unacceptable in 
Moslem culture). She also had obsessional thoughts 
associated with avoidance behaviour. Her symptoms were 
worse in public and other stressful situations, and were 
improved when she concentrated, for example playing the 
piano. When asleep, the vocalisations disappeared but the 
tics continued in an irregular fashion. Neurological 
and mental state examinations were unremarkable. The 
following investigations were normal: EEG, computerised 
tomography scan, copper and caeruloplasmin, full blood 
count and blood chemistry. 
The patient's birth and development were unremarkable. 
Despite interruptions in her schooling because of medical 
consultations abroad, she was able to attain good grades 
in high school. She was the ninth of 14 siblings, her mother 
having had two miscarriages. The family denied any family 
history of tic or psychiatric disorder. She failed to respond 
to haloperidol and was successfully treated for a period with 
melOclopramide although she discontinued this because of 
an acute dystonic reaction. She was then commenced on 
sulpiride with some success. 
Patient no. 4 
Mr MA presented to the National Hospital, Queen Square, 
at the age of 16 years. He was born in Dubai to Arabic 
parents. His first symptoms were at the age of 15 years when 
he had noticed a ticking movement of his right arm. He 
subsequently had developed frowning, eyebrow raising, 
rolling of the eyes upwards, a nasal twitch, movements of 
the upper lip, mouth pouting, a gripping movement of the 
lips, spitting, licking of the lips, platysma tightening, turning 
of the head sideways, flicking his hair out of his eyes, a 
shoulder shrug, extension of the arms, movement of the 
toes, a whole body jump, looking at his watch as a habit, 
putting his fingers in his mouth, and although several of 
these were observed at interview, they were denied by the 
patient. He admitted to vocalisations including sniffing, 
gulping and hiccuping, which were evident at the interview. 
These had developed after the motor tics. He had no 
coprolalia, copropraxia, self-injurious behaviour, aggression, 
attention-deficit disorder nor hyperactivity. Of particular 
interest is that he had many obsessional actions in that 
he would check a door at least three times even if he 
knew it was closed, he would tidy his room meticulously 
to an extent that would worry his family, and he had a 
bathing ritual in that he had to wash himself in a particular 
order, Typically, his symptoms were made worse by stress, 
increased with concentration and since the onset of his 
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418 ROBERTSON AND TRIMBLE 
Fig. I Arab pedigree multiply affected with the Gilles de la Tourette syndrome chronic tics/habits ( ~ ) and obsessional disorder ( till. ) 
(0 = dead, (Pl = ( • ), the palient). 
illness he had only been free from all tics for hours at 
the most. 
He had a normal birth, and apart from walking late, had 
average milestones. He was brought up by a paternal aunt, 
but lived only two houses away from the parental home 
and therefore was in close contact with the family. He was 
a sensitive child but otherwise no abnormalities were noted. 
He began school at the age of five years and was still al 
school at the time of the clinic interview; he got on well 
with both teachers and peers and apparently had no 
problems at school. He had several hobbies including 
playing with model aeroplanes, and he had no trouble 
making friends. 
Family history was obtained by interviewing the patient, 
his brother and a paternal aunt, and the information 
obtained revealed a pedigree spanning six generations as 
shown in Fig. I. Of note is that his maternal great-aunt 
was reported to be an obsessive-compulsive hand-washer, 
as was his maternal aunt. His maternal grandfather blinked 
his eyes for many years, while his maternal uncle was 
described as being excessively meticulous as well as a 
compulsive cleaner. In addition, he was meticulous with 
regard to the order in his room. The proband's mother, 
aged 43 years, had motor tics such as jerking of the arms 
and vocal tics such as clearing of the throat, as well as 
obsessive-compulsive behaviour in that she would spend 
two to three hours in the bath; she was a compulsive hand­
washer, and if she washed a shirt, she had to do it at least 
20 times. He has two brothers who possibly have 'habits'. 
The unmarried brother had a habit of pinching his body, 
grinding his teeth, pinching his triceps, pulling the hairs 
out of his beard, and cutting his nails very deep. His married 
brother (who was interviewed) admitted to having a 
'nervouS habit' as a child. His nephew, aged seven years, 
apparently has started to blink his eyes, stretch his neck, 
have facial grimaces, look both up and down involuntarily, 
and also to smell things as a 'habit' (see Fig. 1). 
Patient no. 5 
Miss NA was born in Iran and presented to the National 
Hospital, Queen Square, at the age of 12 years. At the age 
of four years she began to have invol'untary movements of 
the face, head and neck, including excessive eye blinking, 
which spread to the upper limbs at the age of II years, 
She also had vocalisations including grunting, and her 
movements would characteristically increase with anxiety. 
She had had febrile convulsions between the ages of one 
and five years. She also had a nocturnal convulsion at the 
age of II which was not associated with a fever and was 
therefore treated with various anticonvulsants including 
mysoline and tegretol. 
The patient was born normally, walked somewhat late, 
althe age of two, talked at two and was enuretic until aged 
eight. She was described as a 'nervous child' and had 
problems at school in that she underachieved and had 
difficulty in making friends. She was, however, able to read 
and write. Both her father (aged 40 years) and her mother 
(aged 30 years), who were unrelated, were well. Her sisler 
(aged II years) and her brother (aged four years) were also 
well. There was no known relevant family history. On 
examination there were obvious involuntary movements of 
her face, head and neck, especially excessive blinking. 
Neurological examination revealed a fine tremor of both 
hands. There were no Kayser-Fleischer rings. The following 
special investigations weIe normal: serology (WR), serum 
copper, caeruloplasmin and uric acid, skull X-ray and EEG. 
As she was young and her symptoms were not severe, no 
medication was given at the time. 
Discussion 
We present five cases of GTS and a multiply affected 
pedigree from the Middle East, and suggest therefore 
that the disorder is probably more common in the 
Middle East than has so far been recognised to date 
there has only been one case documented (EI-Assra, 
1987). What is perhaps more important, however, is 
that the phenomenology of the GTS in our cohort is 
the same as that documented in Western populations, 
with both motor and vocal tics, obsessive-compulsive 
behaviour, coprolalia, self-injurious behaviour, 
echophenomena and the feeling of being forced to 
touch things (Robertson, 1989). In addition, the 
familial pattern as documented in case number four 
is very similar to that encountered in the West 
(Kurian et ai, 1986; Robertson & Gourdie, 1990), and 
the expression of an anticipated GTS gene seems to 
have shown itself in our Arab pedigree, presenting 
as obsessive-compulsive behaviour, GTS or chronic 
tics, not dissimilar to the pattern found in other large 
pedigrees (KurIan et ai, 1986; Robertson & Gourdie, 
1990). This cross-cultural similarity shown by our 
pedigree when compared with a large variety of 
world-wide case reports and documentations of large 
cohorts (for review see Robertson, 1989) emphasises 
the biological factors in the aetiology of the GTS. 
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419 TOURETTE SYNDROME IN THE MIDDLE EAST 
In contrast to cohorts from the West (Robertson 
et aI, 1988, 1989), however, none of our patients had 
associated psychiatric dysfunction (apart from the 
obsessional symptoms), nor attention-deficit disorder 
nor hyperactivity. It is also of interest that three of 
the five cases were female, whereas in most cohorts 
from the West there is a male to female ratio of 
3-4 : I (Robertson, 1989). Further studies on patients 
should resolve these issues. 
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Catatonia: Harbinger of the Neuroleptic Malignant Syndrome 
DENISE A. C. WHITE and ASHLEY H. ROBINS 
Five consecutive cases of the NMS are presented, in all 
of which a catatonic state preceded the onset of the 
condition. Catatonia would appear to represent a highly 
significant risk factor for the NMS and a possiblle causal 
link between the two disorders is suggested. 
British Journal oj Psychiatry (1991),158,419-421 
The neuroleptic malignant syndrome (NMS) is a well 
documented complication of neuroleptic treatment. 
Its major manifestations are muscular rigidity, 
altered consciousness, hyperthermia and autonomic 
instability, often accompanied by raised serum 
creatine phosphokinase (CPK) levels and leucocytosis. 
Owing to the potential lethality of the NMS, the 
search for risk factors is urgent. We describe five 
consecutive patients with the NMS in whom a 
catatonic state of acute onset appeared to herald the 
emergence of the syndrome. 
Case reports 
All five patients were admitted to the psychiatric emergency 
unit of Groote Schuur Hospital, Cape Town. Table I briefly 
describes the clinical state of each patient before and after 
the administration of a neuroleptic. None of the patients 
had received neuroleptics before admission and none had 
a previous history of psychiatric illness. To exclude another 
aetiology, the following additional investigations were done ­
and found to be negative - in every patient after the onset of 
the NMS: blood culture, toxicology screen, chest X-ray, 
lumbar puncture, electroencephalography and computerised 
tomography. In each case the NMS was managed by 
supportive treatment and without the use of pharmacological 
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Normal chromosomal findings in Gilles de la 

Tourette syndrome 

M.M. Robertson1 and M.R. Trimble2 
1Academic Department of Psychiatry, University College and Middlesex School 
of Medicine, Riding House Street, London W1 P 7PN, and 2Department of Psychological 
Medicine, Institute ofNeurology, University of London, Queen Square, London W1, UK 
Correspondence to: M.M. Robertson at above address 
Sixty-eight consecutive patients (51 male, 17 female) who satisfied OSl\1-111 criteria for Gilles de la Touretle syndrome had 
blood taken for chromosomal analysis. Three individuals exhibited abnormalities or variatioJ]s: an XY\, chromosome, a 
heterochromatin of chromosome), and heterochromatin of chromosome 9, respectively. The remaining 65 patients showed 
apparently normal karyotypes without any striking heteromorphisms. The literature on chromosomal abnormalities in Gilles 
de la Tourelle syndrome and associated disorders is re\'iewed. 
Keywords: Chromosomes - Genetics - Gilles de la Tourelle Obsessive compulsive disorder Tics 
INTRODUCTION CASE REPORTS 
Prompted by the report of a patient with Gilles de Ia Tou­ Patient 1 
rene syndrome (GTS) from the National Hospital for Ner­ Mr T allended NHN D al the age of 15. He was born 
vous Diseases, Queen Square, London (NHND), who also normally weighing 7 lb. and although his motor develop­
had an XYY chromosomal (Merskey, 1974). we under­ ment was nomlill, by two and a half he was only saying it 
took a prospective investigation, perfonning chromoso­ few words. He was hyperactive as a child. often screaming 
mal studies on 68 consecutive patients with GTS who and prone to rage allacks. lie was phobic of the dark. and 
_satisfied DSM-JIl (American Psychiatric Association. h~IS always billen his nails. Since early childhood, his 
1980) crileria for GTS. parellls IHlled tiial he was "always twit,hing", with the 
Three individuals exhibited karyotype deviiltinns: (I) a Illovelllents .. n-':cling his faee; the ...e included mouth open­
sex chromosome anomaly (an extra Y chromosome in it ing. head eXlen,ion and a moderate mnge or simple move­
male); (2) a heteromorphism of chromosome I (Iqh+); ments affecting his shoulder, trunk. proximal ann and 
nnd (3) a heteromorphism of chromosome 9 (inv 9) legs. He also exhibited sounds sllch a~ throat clearing, 
(p 11 q 13). The remaining 65 patients showed apparently sniffing. snorting and coprolalia (the involuntary inappro­
nonnal karyotypes without major heteromorphisms. priate ullering of obscenities). AI the age of j I he develop­
The diagnostic chromosomal studies were carried out ed obsessional behaviour. for example unnecessilrily 
on G-banded chromosomes (method of Seabright. 1971) folding his clothes neatly into piles. pUlling records in files 
karyotyped according to International Nomenclature and, during interview. he tidied the examination room. and 
(ISCN, 1981) and perfornled by Dr D.T. Hughes. folded his clolhes before he could lie down on the couch. 
The three patients described here were notewoI1hy in He a!lendcd a normal school until the age of7. but made 
that they had striking heterochromatic chromosomal fea­ lillie progress. and was therefore sent to a special school. 
tures through duplication of a band (I qh+), structural where he coped for 8 years. He then over a year became 
rearrangement (inv 9gh) or an extra chromosome. C-band­ uncontrollable with violent outbursts of behilviour. 
ing (method of Arrighi and Hsu, 1971) confirnled the usually triggerl!d by provocation. He became destructive 
expected constitutive heterochromatic nalme of these 10 propeI1y and was only rarely violent h) people. There 
G-banded polymorphic variants. was no relevanl known family history. 
The significance of these findings is discussed follow­ E>.umination of his menIal state was nonnaL He exhi­
ing the brief presentation of the clinical fealures of these bited Illultiple motor and vocallic~. Psychometric testing 
patients. revealed that his verballQ was 52 and performance IQ 48: 
© 1993 Rapid Communicalions of Oxford Ltd PsyrhiJlrk (;"nclics . Vol 3 . 1<)<)3 95 
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his Schondl word reading test was managed at the 7.7 year 
level and Schonell spelling was commensurate with this. 
A CT scan and both chest and skull X-rays were nomlal. 
An EEG was abnonllal with excess of slow activity. Rou­
tine haematological investigalions were nOnlwl. Chromo­
somal investigalions revealed a 47.XYY karyotype. 
Patient 2 
Miss S preselllcd to the NIIND at the age of 17. Her GTS 
symptoms began at the age of 8 with throat clearing. Since 
then her repertoire of mOlor tics has included eye blinking. 
eyes rolling upwards, twisting of the upper lip, head nod­
ding, a pulling in of the abdominal muscles. and foot tap­
ping. She has several vocalizations including a loud 
hooting noise, snorts, sniffs and throat clearing. ller symp­
toms chamcteristically wax and wane in severity, are wor­
sened by anxiety and improved by concentration, and she 
is able to suppress them volulltarily at the expense of inner 
tension. She feels the urge to touch things, but has never 
exhibited copro- nor echophenomena. 
She denied any relevant family history of tics, psychi­
atric or neurological disorder. She was born nOnllally, 
weighing 7 lb. 14 oz after a normal pregnancy, but labour 
was induced. She had average milestones and coped with 
life until she was 10 years old. when it became necessary 
for her to attend a special school: she nevertheless 
obtained two CSEs, leaving school at 16 years. after which 
she allended a college for further education. 
Neurological and mental status examinations were nor­
mal. Neuropsychological testing showed a verballQ of79 
and a performance IQ of87. CT scan was normal. An EEG 
was abnonnal. with brief episodes of generalized slow 
activity with components at 3 cyclesls as well as theta 
activity, which lasted up to 2 s, although during over­
breathing more protracted episodes occurred when, at 
times. the slow waves were associated with sharp compo­
nents. full blood cOUll1. urea and electrolytes, liver func­
tion tests, copper and caeruloplasmin were all within 
normal limits. Chromosomal analysis revealed 46,XX 
Iqh+ female karyotype (G-banded) with a heteromorphic 
chromosome l. having extra heterochromatin next to the 
centromere in the long ann, which was considered to be a 
familial polymorphism. 
Patient 3 
Miss W presented to thc NIIND at the age 01'20. Since the 
<lge of 8. she displayed GTS symptoms, beginning with 
excessive blinking of the eyes and also exhibiting head 
nodding, rotation and tilting back, shoulder shrugging, 
movements of the upper and lower limbs, sniffing and 
coughing. She had no history of copro- nor echopheno­
mena. Family history infomlation was unremarkable. 
She was born nonnally weighing 5 lb. 4 oz. As a teenager 
she was diagnosed as having anorexia nervosa. She sub­
se4uently described depressive mood swings and panic 
96 Psychialric Gcnclics . Vol J . 1993 
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attacks. Apart from multiple tics and vocalizations, exam­
ination of her mental state was normal, as was her neuro­
logical examination. Neuropsychological assessment 
gave a verballQ of 103 and performance IQ of 100. ACT 
scan and EEG were normal. All routine blood tests includ­
ing serum copper and caeruloplasmin were within normal 
limits. Chromosomal analysis revealed 46,XX.inv(9) 
(p II:q 13) normal female karyotype, with a heteromorphic 
chromosome 9 which had a pericentric inversion involv­
ing transfer oflhe heterochromatic long arm band (9qh) to 
the short arm (p) (G-banded): this feature was considered 
likely to be a familial polymorphism. 
DISCUSSION 
Gilles de la Tourelle syndrome (GTS) is a disorder con­
sisting of multiple motor and one or more vocal (phonic) 
tics (American Psychiatric Association, 1987) and is no 
longer considered to be rare (Robertson, 1989). GTS is 
currently thought to be genetic and inherited as an auto­
somal dominant gene, with variable expression and sex­
specific penetrance (Comings et al., 1984; Devor. 1984; 
Price et al., 1984; Pauls and Leckman, 1986; Pauls et al., 
1990; Curtis el al., 1992). Pauls and Leckman (1986), 
moreover, pointed out that the phenotypic spectrum of 
GTS subdivided into three distinct diagnostic groups: 
GTS, chronic multiple tic syndrome (CMT) and obsessive 
compUlsive disorder (OCD), all being regarded as alterna­
tive phenotypic expressions of the putative GTS gene. 
Other family, clinical and epidemiological studies also 
suggest that GTS and OCD or obsessional compUlsive be­
haviours (OCB) are related (Montgomery el al., 1982; 
Pauls el al., 1986a, b; Kurian el al., 1986; Caine el al., 
1988; Robertson el al.• 1988; Robertson and Gourdie, 
1990). 
A range or chromosomal anomalies in GTS has been 
reported. Thus Merskey (1974) described a man with an 
XYY karyotype pattern. Singh el al. (1982) reported a 
Black woman with GTS with triple X and 9p mosaicism. 
Robertson et al. (1989) documented a patient with GTS 
and a 3/8 balanced translocation, but on examination of 
family members, GTS was not found to co-segregate with 
the chromosomal abnormality (Breit et al., in preparation). 
Taylor (1990) reported the case of a 16-year-old male 
with GTS ;Jnd a 9p terminal deletion (9)(qter p2J04). The 
patient had negative family history (father 46,xy and 
mother 46,XX), was born 3 weeks prematurely. a breech 
presentation by Caesarean section. He was developmen­
tally retarded and had the dysmorphic features of the 9p 
monosomy deletion syndrome, in addition to many classic 
features diagnostic of GTS. Kerbeshian et al. (1984) 
described two patients with GTS with the fragile X-syn­
drome. Six patients with GTS and Down's syndrome (tri­
somy 21) have also been reported (Sacks, 1982; Barabas 
lle II l
;1I1 ~r w
n -
l lO t orma cim)fl1 ~ 
t
clH l
l l !
ot ,
l l -
l -
. -
mi v. -
ncentrati(~ ,
n
r ( -
w
l
ll
I O l ,
:m
I l   -
l R ml !
l l  /
-
, -
F l oun! II -
L
rm
l e <lt il
~g X,
)(
-
l
rm
· 
l mi
(i t e etics. i 
  I  
~lIa~ . -
m ll l -
l
: -
r~lg .s l
I HTli I ,
 ! l
-
I sfer t 10
10
-
.isti l
IICS
l -
-
l
U -
I l -
t
I ! t
, [
yy
l
!
t l J
a l 3(
, V
-
I l 
-
-
Un
ive
rsi
ty 
of 
Ca
pe
 T
ow
n
CIfROMOSOMAL FINDINGS IN GILLES DE LA TOURETTE SYNDROME 
el af., 1986; Karlinsky el af., 1986 Collacoll and Ismail, 
19RR). 
Comings et af. (1986) reponed a family in which six 
members with "varying manifestations" of GTS all had a 
7q22: 18q22.1 balanced translocation. Bearing in mind the 
recent suggestions that obsessional illness and GTS are 
closely related. stemming from psychopathological, 
family and pedigree studies (see above), it is of added 
interest, therefore, that cytogenetical analysis of a woman 
presenting with OCB, some hyperactivity, panic attacks 
and visual hallucinations, in addition to other behavioural 
problems revealed a deletion of the long arm of chromo­
some 18 at 18q22.2 breakpoint (Donnai, 1987). 
There are several explanations for the occun'ence of the 
chromosomal abnormality (XYY) and variations in our 
GTS patients, and indeed those in the literature. 
As GTS is quite common, the possibility must exist that 
the chromosomal abnormalities found could have 
occurred by chance alone. The polymorphisms may also 
be regarded as variations of nonna!. As familial polymor­
phisms do occur, the variations in the second and third 
patients in our study could very easily have been due to 
this, and indeed this was suggested in the cytogenetic 
repons. A limitation of the present study is that no detailed 
family investigations (interviews or blood samples) were 
performed. However, as in the vast majority of patients in 
clinical studies there is a positive family history (Roben­
son et af., 1988; Robenson and Gourdie, 1990), the 
absence of a positive family in these patients (and many in 
the literature on GTS and chromosomal abnormalities) is 
suppon that the chromosomal anomalies may be relevant. 
None of the patients who had chromosomal abnornHlli­
ties in our study were absolutely typical ofGTS, The third 
patient had a history of anorexia nervosa, mood swings 
and panic allacks. Despite classical GTS manifestations, 
(he first patient in our study is, however, severely learning 
disabled (mentally retarded) and the second patient is 
moderately disabled. In these (WO laller patients, the chro­
mosomal abnormality and variation could have been 
related to this disability rather than to the GTS. Patients in 
other repons of chromosomal abnormalities and GTS 
have been learning disabled, supponing the argument that 
the learning disability and the chromosomal abnormalities 
may be related. Ahhough GTS has been reponed in learn­
ing disabled patients (Golden and Greenhi II, 1981; Reid, 
1984) it is uncommon: this is possibly due to underdiagno­
sis, as learning disability has been reponed in 10% of one 
GTS cohon (Golden and Hood, 1982). 
It has been postulated by Comings el al. (1986) that 
GTS is due to a deletion of chromosome 18. However, in 
(he present study of 68 GTS patients we did not find an 
J8q- deletion in standard G-banded chromosome prep­
arations, analysed in the banding range of368 to 529 bands 
per haploid karyotype of the International Nomenclature 
as used in rouline cylOgenelical diagnosis (ISCN, 1981). 
Such a large deletion as the I Hq~~,2 In ISqter should not 
have been overlooked in our standard G·handing at the 
minimal level of 368 hands per haploid karyotype. This 
suppons the data of Heutink III af. (1990) who found no 
evidence for genetic linkage on chromosome f8 and chro­
mosome 7 in six extended families, Data from Ihe markers 
tested made it possihle 10 exclude the Whole of chromo­
some 18 and the chromosome 7421.3-qter region as a sile 
for the GTS gene C1lcutink l'I al., 1990). However, il is 
possihle thaI smaller deletions of IXI( could be octecll:d by 
further studies employing higher resolution banding. Fur­
them1Ore, application or techniques of molecular genetics 
employing gene prohes could <1(: I(:t:1 suhmicroscopic 
microdeletions and also microduplit:alions such as Ihose 
recenlly reponed in three patients wilh Down's syndrome 
lacking apparent trisomy Welabar el (J/., 1987). 
All three of the GTS palients in our conseclltive series 
presented here have a chromosomal anomaly involving a 
deviant amount or lot:ation ofhetefOchromatin. This is any 
chromalin charal"lerized by an excessive amount of des­
oxyribose-type nucleoprotein. with a looser structure, and 
functiorially more generalized Ihan the more specific 
action of genes in the euchromatin which gives the fam­
iliar Mendelian ratio. Thus, palient nurnberone (47,XYY) 
in having anextra Y thereby has a striking increase in hete­
rochromatin because a large pan of the long arm of the Y is 
nomlally heicrochrolllatic. Both our patients with a variant 
chromosome have either an extra amount of hetero­
chromalin, as in the I qh+ (Patient ~), or a rearrangemcnl of 
heterochromatin, as in the pericentric inversion of chro­
mosome 9 (Patient 3). Although we were unable to carry 
out family studies, it is believeJ Ihal these features are 
familial polymorphisms because variants or this kind arc 
known tooccur in olher families (Hook and Poncr, IY77). 
Although these polymnrphisms could oCCur by chance, il 
is sufficiently noteworthy in our sample (i,e, )ftc) to war­
rant further sruJy bel'all~e Ihey have previow,ly heen 
reponed to occur at Itm er frequencies in popuhllion 
stuJies. for example in White ElIIopeans Iqh+ 0.1)\)%, 
inv9 O.73'1c (Hsu el af.. 19H7). 
CONCLUSIONS 
In conclusion, althollgh no one chromosomal abnormalily 
can be said to be characterislic or GTS, it is notewonhy 
that an XYY ahnonnality has been documented twice; 
chromosome 9 has heen repoT1ed as abnol1lJal three times; 
chromosome J11 has been implicalcd in six cases in one 
family in one centre, and in a patient with obsessional dis­
order in another centre, An ahnormal ity orchromosomes 3 
and 8 has been documented once. Very many of these 
chromosomal abnonlJulities and variations could be 
chance association, except wllere there is co-segregation 
of the cytogenetic ahnonnality and GTS in the family. 
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The present rim.lings raise questions about the role or 
constitutive heterochromatin and familial polymor­
phisms. which may well merit rurther altcntion in GTS as 
possible predisposing factors arfecting the expression of 
genes causing GTS. 
Finally. us more than 50% of the genome has now been 
excluded (pakstis et aI., 1991), the definition of the GTS 
phenotype must also he audresscd in future investigations. 
From the point of the clinician. when a GTS patient is not 
typical, and specifically when the individual is learning 
uisabled, chromosomal analysis is suggested, as this nwy 
shed further light on the genetics of GTS. 
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Autosomal Dominant Gene Transmission in a Large Kindred 
with Gilles de 1a Tourette Syndrome 
DAVID CURTIS, MARY M. ROBERTSON and HUGH M. D. GURLING 
A multiplex kindred ascertained through a single proband with GTS has been systematically 
investigated with standardised diagnostic instruments for other cases of GTS and related 
disorders. Complex segregation analysis supported the hypothesis that a single major gene 
inherited in autosomal dominant fashion but with incomplete penetrance contributed most 
of the variance in the liability to develop GTS and related disorders. This result is consistent 
with previous segregation analyses which have employed different methods of ascertainment, 
and tends to confirm that a proportion of GTS is due to a dominant gene and is suitable for 
investigation with genetic markers for linkage analysis. 
The first clear medical description of the Gilles de 
la Tourette syndrome (GTS) was made by Hard in 
1825. In 1885 Georges Gilles de la Tourette described 
nine cases of the syndrome. He emphasised the triad 
of multiple tics, coprolalia and echolalia, noted the 
association with obsessive-compulsive behaviour 
(OCB), and considered the condition to have a 
hereditary component. 
There have been many investigations of genetic 
predisposition to GTS, but such studies did not, until 
recently, employ modern methods of segregation 
analysis. Some researchers have commented that 
GTS is often sporadic (Baraitser, 1982; Zausmer & 
Dewey, 1987) suggesting incomplete penetrance, the 
existence of non-genetic phenocopies, or cases caused 
by new mutations. Evidence for a genetic factor can 
be inferred from twin data if it can be assumed that 
the twin method is valid for studying GTS. 
Robertson (1989) has reported 11 concordant 
monozygotic (MZ) twin pairs, and Price et al (1985) 
reported a concordance of 0.533 for MZ twins but 
only 0.077 for dizygotic twins. In addition, numerous 
family studies indicate that the relatives of probands 
with GTS may present with either GTS or motor or 
vocal tics only, and some studies provide evidence 
that within these families chronic multiple tics (CMT) 
and GTS are related genetically (Robertson, 1989). 
Two large pedigrees have been reported previously. 
In the first, 17 out of 43 members were affected 
(Guggenheim, 1979). In the second (Kurian e/ ai, 
1986,1987; Pauls et aI, 1990), 159 family members 
were evaluated and 54 subjects were diagnosed as 
definite or probable GTS or CMT. 
The mode of transmission for GTS and CMT can 
be investigated using segregation analysis on the 
relatives of affected probands. Four such studies 
(Comings et aI, 1984; Devor, J984; Price et aI, 1984; 
Pauls & Leckman, 1986), on independent samples, 
have suggested that a dominant autosomal gene 
contributes to liability. Comings et af (1984) found 
penetrance to be low but Pauls & Leckman (1986) 
found it to be high. The discrepancy may have arisen 
because Pauls & Leckman used fairly stringent 
criteria, whereas Comings et al included many 
other disorders such as agoraphobia, panic attacks, 
mania, depression and schizoid behaviour within the 
GTS spectrum (Robertson, 1989). Pauls et af (1990) 
carried out a complex segregation analysis on one 
large multiply affected pedigree, and concluded that 
cases of GTS and CMT within the pedigree were 
likely to be due to an autosomal dominant gene with 
penetrance similar to that reported by Pauls & 
Leckman (1986). The estimates for penetrance of 
GTS were 0.81 for males and 0.31 for females, 
whereas if cases of CMT were also included as 
affected the penetrance estimates rose to 0.99 and 
0.60 respectively. 
We have identified, through the index case who 
presented at the Neuropsychiatric Clinic at the 
National Hospital for Nervous Diseases, Queen 
Square, a British pedigree of six generations and 122 
members. We report our findings from segregation 
analysis, testing several genetic hypotheses for the 
transmission of GTS including single gene transmission, 
multifactorial transmission, and the mixed model. 
Method 
The index patient with GTS presented with his mother, who 
told the doctor that she knew of a few relatives with similar 
symptoms. These were interviewed, and it became clear that 
the family would be of interest for the study of the genetics 
of the illness, and in particular for linkage analysis. The 
pedigree was originally selected for study on the basis that 
it contained multiple cases, and as such could not be 
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considered ideal for segregalion analysis. Nevertheless, 
subsequently subjects Were included regardless of Iheir 
affection status, and there did seem 10 be a uniformly high 
density of cases throughout the pedigree ralher Ihan only 
in those branches which had led to its seIeL'lion. 
As many as possible of the pedigree members were 
interviewed personally. Those who were not available for 
interview but about whom information cOHld be gained 
from relatives were assigned a 'best guess' diagnosis. 
In accordance with the procedure described by Morton 
el al (1983), the pedigree was divided up into nuclear 
families before analysis. Each nuclear family which did not 
have the original proband as a member was assigned a 
'pointer', this being defined as the affecled person who 
had led to that family being included in the analysis. Because 
of the failure to use a systematic method for extending the 
pedigree, the concept of a pointer was notional only. The 
proband was taken to be the pointer for the family of the 
most closely related affected case, and then affected members 
of the latter's family were used as pointers to other families, 
and so on until all cases had been included. Nuclear 
families were included in the analysis if there was an affected 
child or parent, but not if no members were affected. 
Once the pedigree was divided into nuclear families, the 
data were analysed according to the mixed model of Morton 
& MacLean (1974) as modified in the computer program 
POINTER (Laloue! & Morton, 1981; Morton ef aI, 1983). The 
mixed model proposes that affection results from the additive 
contribution of three factors: a random environmental 
component, multifactorial transmission (not necessarily 
genetic), and a single major locus effect. Each factor mayor 
may not contribute to the liability to a particular disease. 
Multifaciorial transmission may be due 10 a large number 
of independent factors, which may be polygenic or cultural, 
or both, and results in a general tendency for the child to 
resemble the parent. Single major locus tran~mission occurs 
as a result of the inheritance of alleles at one particular 
locus. It is assumed that there are two aJleles, a normal aJlele 
and a disease allele, and that the three possible genotypes 
at this locus (AA, Aa or aa) lead to significantly different 
liabilities to develop the disease. 
Single major locus transmission thus depends on the 
discrete phenomenon of whether or not a particular allele 
is inherited from the parent, and as such it behaves 
somewhat differently from multifactorial transmission. For 
example, there is a tendency for single-locus effects to be 
'better preserved' than multifactorial effects as an extended 
pedigree is traversed if a rare disease is due to multi­
factorial transmission then the risk to the relatives of 
secondary cases (those ascertained through a proband) is 
less than the risk to relatives of the proband, but if the 
disease is due to a single susceptibility allele then the risk 
to the relatives of all cases is the same. 
POINTER allows constraints to be applied 10 the mixed 
model so that the likelihoods of different modes of 
transmission can be compared. If this is done with extended 
pedigrees (slIch as the one reported here) it is.possible to 
test whether there is evidence for familial transmission, 
whether there is evidence for a multifactorial component, 
and whether there is evidence for a single major locus 
component. 
Diagnosis 
One of us (MMR) evaluated lite pedigree over two year 
Subjects were interviewed to assess 'caseness' using 
semistructured interview (Robertson & Gourdie, J990) all 
were assigned to diagnostic categories as follows: 
(a) definite 	 GTS - satisfying DSM-lIl (America 
Psychiatric Associalion, 1980) criteria on history an 
examination 
(b) probable GTS -	 symptoms observed but no histol 
obtained, or history obtained but no sympton 
observed 
(c) 	 definite CMT - DSM-III diagnosis on history an 
examination 
(d) probable CMT - as for probable GTS but withol 
vocalisations 
(e) obsessive-compulsive behaviour -	 obtained on histo! 
and, in the case of children, corroborated t 
parents. 
Method of analysis 
The pedigree was inspected and affection rates and s( 
distribution of the different syndromes were studied. 01 
of us (DC) used POINTER to investigate different models I 
aetiology. Each analysis was performed taking either G1 
or probable GTS as indicating affection, then was repeat! 
taking GTS, probable GTS, CMT, and probable CMT; 
indicating affection. The analyses were repeated using 
wide range of different population prevalences and of SI 
ratios (male prevalence for GTS ranging from 10070 
0.05070 and male:female ratio ranging from I: I to 5:1). C 
each occasion the prevalence for children of age seven, 
under was taken to be half the corresponding ad. 
prevalence. To compare competing pairs of hypothese 
iteration was performed for each hypothesis and the I( 
of the ratio of the maximum-likelihood estimates of tI 
two hypotheses was obtained. This was taken to appro) 
mate to a i statistic with the number of degrees f 
freedom equal to the number of conSTraints remov, 
between one hypothesis and the next. The following pai 
of hypotheses were compared: 
(a) 	no parent-child transmission against multifactori 
transmission 
(b) multifactorial transmission against the mixed mod 
(including a major locus effect and multifactori 
factors) 
(c) single gene (major locus) transmission against 	tl 
mixed model 
(d) single gene recessive transmission against single gel 
dominant transmission. 
The following pairs of hypotheses were compared ush 
realistic values for population prevalence and sex ratio, aJ 
using the maximum-likelihood estimates of other par 
meters derived from the earlier analyses: 
(a) different gene frequencies producing either 	Gl 
alone on the one hand, or GTS and CMT on tl 
other, against equal gene frequencies (i.e. possib 
the same gene producing both illnesses) 
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(b) Mendelian transmission probabilities against 	nOI)­
Mendelian probabilities. 
The results of the former of these two analyses wcre also 
used to derive maximum-likelihood estimates of gene 
penetrance. The second of the above analyses was 
performed as a test of goodness of fil. 
Results 
The pedigree comprised 122 people, of whom 85 were 
interviewed, and information about a further 22 members 
was obtained and was considered to be sufficient for 
diagnosis. Information about the remaining IS was 
considered unreliable. Clinical and psychopathological 
features of the pedigree, including a genogram, have 
been presented previously (Robertson & Gourdie, 
1990). 
Table I shows that the male:female ratios for both GTS 
and CMT in our sample were approximately equal, with 
only a slight male excess. Using a modified i test it was 
possible to assign a 9S!I!o upper confidence limit for the true 
male:female ratio for the prevalence of GTS of slightly less 
than 2:1 (that it could be as high as 3:1 was rejected at 
P<O.Ol). 
Table I shows that there was a slight, non-significant 
excess of women with obsessive-compulsive symptoms. All 
five subjects who had a diagnosis of OCB or probable OCB 
without GTS or CMT were female. Since this is in line with 
previous work suggesting that OCB alone is more common 
in female than male relatives of patients with GTS, this 
finding has a one-tailed significance of P~0.031. 
Inspection of the pedigree suggested a dominant gene 
with partial penetrance, although in fact there are more 
affected individuals in the pedigree than would be expected 
under these conditions. Using POINTER for formal segrega­
tion analysis, the hypothesis that there was no transmission 
of a liability to affection from parent to child was rejected 
at P< 0.001 for both GTS and CMT at all sex ratios and 
all population frequencies. 
Table 1 

Numbers of cases of Gilles de la Tourette syndrome 

(GTS)', definite and probable chronic multiple tics (CMT)', 

and definite and probable obsessive-compulsive behaViour 

(OCB)', by sex 

Male Female Total 
GTS 16115%1 13 (12%) 29 (27%) 
No GTS 44 (41%) 34 (32%) 78 (73%) 
GTS+CMT 26 (24%) 23 (22%) 49 (46%) 
Neither 34 (32%) 24 (22'7'0) 58 (54%) 
OCB 10 (9%) 13 (12%) 23 (21%) 
No OCB 50 (47%) 34 (32%) B4 (79%) 
60 (56%) 47 (44%) 107 
1 x';0.030. d.I.;1, NS. 
2. x'.OA07.d.f.=l,NS. 
3. x' = 1.973. d.f. = 1. NS. 
The hypothesis that there is no single major locus could 
be rejected at P<O.OJ for all sex ratios if Ihe true prevalence 
of GTS among males is I "/0 or less. This hypothesis could 
be rejected at P< 0.001 if the true male prevalence of GTS 
is 0.5"lo or less, or if the male prevalence of CMT is 5"10 
or less. In other words, there is good evidence in favour 
of transmission by a single major locus, and this evidence 
is nOI particularly dependent on the population prevalence 
nor the male:female ratio specified. 
When the model was unconstrained (i.e. the mixed model 
of transmission was specified) the maximum-likelihood 
parameters obtained favoured a single-locus mode of 
transmission, without any additional multifactorial trans­
mission. In addition, for all male prevalence values for GTS 
of less than S!I!o, a fully dominant mode of transmission 
was preferred, and when fully dominant transmission was 
compared with fully recessive transmission, the latter could 
be rejected at P<O.OOI. 
Wilh the exception of unrealistically high prevalences, 
the evidence for major locus dominant transmission was 
not contingent on the population prevalence or the 
male:female ratio specified. However, the same cannot be 
said about the estimates obtained for the frequency of the 
disease allele, which were highly dependent on these 
parameters. In fact, once the disease prevalence is set to 
be l!I!o or less, the maximum-likelihood estimate for the 
allele frequency is directly proportional to the male 
prevalence supplied. The value obtained for the constant 
linking the two is set out in Table 2 for the different 
male:female ratios and different disease models used. 
The data were analysed in more detail using what we 
believe to be close to the true values for population 
prevalence: a prevalence among adult males and females 
of O.OOOS for GTS, and twice that for the combmed 
syndromes of GTS or CMT. This yielded maximum­
likelihood estimates for the disease allele frequency of 
0.0004 if GTS only was studied, or 0.0006 if GTS and CMT 
cases were included. Since logically if both diseases represent 
different expressions of the same disease allele, the allele 
frequencies must be equal in each case, the allele frequency 
was constrained to be 0.0005 and the analysis was repeated. 
The Ii kelihoods of the models did not change appreciably, 
and so the data could be said to be consistent with the 
hypothesis that the different diseases represent variam 
expressions of a single dominant gene. The penetrance of 
this gene was estimated to be 0.50 if GTS is taken to indicate 
affection, or 0.88 if either GTS or CMT is indicative 
of affection. The estimates for the probability of affection 
in the absence of the disease allele (the normal homozygote 
Table 2 

Value of constant, c, relating estimated gene frequency, 

q, to male population prevalence specified, Kp (for all male 

prevalences of 1 % or less) (q cKp) 

Sex ratio GTS GTS+CMT 
(male:female) 
1:1 0.85 0.58 
2:1 0.63 0.39 
5:1 0.52 0.14 
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penetrance) and for the probability of an affected individual 
not having the disease allele (the proportion of phenocopies) 
were both very low (less than 0.001). However, these last 
two results do not refer to the population in general but 
only to individuals within the pedigree, and so little reliance 
should be placed upon them when compared with the results 
of studies that have taken a wider sample of cases. 
Finally, the constraints on transmission probabilities were 
removed to allow for non-Mendelian transmission. The 
models using the realistic values for prevalence as described 
above were tested under these conditions. In each case the 
unconstrained model was significantly more likely than 
the model constrained to Mendelian transmission, suggesting 
that the mixed model did not fit well with our data. 
Discussion 
Previous workers have suggested that GTS is a 
genetically heterogeneous disease, with some cases 
being clearly familial and apparently having a 
significant single-locus effect, but with a substantial 
fraction of cases being sporadic and of unknown 
aetiology. Since GTS is rare it seems reasonable 
to regard the pedigree presented here as being 
representative of a single genetic subtype, and 
therefore offering a particularly valuable opportunity 
to study a genetically homogeneous form of the 
disease. 
There are strong theoretical objections to per­
forming genetic studies, and particularly segregation 
analysis, on a pedigree which has been selected on 
the basis of containing multiple affected cases, since 
this introduces an obvious ascertainment bias. The 
likely effects of such a bias are impossible to quantify 
because the pedigree was not sampled or extended 
in a systematic manner, and so it is not possible to 
be certain of the extent to which some of our results 
may be artef actual. However, we believe that there 
are benefits in being able to study the characteristics 
of a genetically 'pure' form of the disease such as 
this pedigree seems to represent, and that these 
benefits outweigh the disadvantages of having to use 
a method which is not strictly appropriate. It is 
perhaps also important to realise that if there 
is genetic heterogeneity then the application of 
segregation analysis to a series of systematically 
ascertained probands would also be inappropriate. 
In such a case the parameters obtained would 
represent a compromise between subtypes rather than 
representing a true picture of the mode of trans­
mission in anyone family. In the present case we 
do not think it is feasible that the results we have 
obtained could be solely due to the methodological 
weaknesses outlined. 
The results of our analysis are similar to those 
obtained by other workers who have analysed a 
systematic series of families (Pauls & Leckman, 1986 
and one large pedigree (Pauls el aI, 1990). The onl: 
slight anomaly in our data was that we did not detee 
the excess of male cases of GTS that is commonl: 
described. This may represent a genuine differenc, 
between the form of the disease in this pedigree ant 
other forms in the population, or may be due tl 
chance or some other cause. The subsequen 
specification of equal prevalences for both sexe 
meant that the penetrances we derived for males ani 
females were also equal. 
There was strong evidence for the action of a majo 
autosomal dominant locus, and this was not sensitiv· 
to the disease prevalence specified. It is not clear wh: 
this model was shown to fit poorly when the constraint 
on Mendelian transmission were removed, althougJ 
this may possibly be due to the rather high frequenc: 
of cases commented on earlier. In general our result 
provide further support for the theory that some case 
of GTS are due to an autosomal dominant gene tha 
can also be expressed as CMT, which seems, there 
fore, to be a milder form of the same illness. 
Because there were only five cases of OCB in th, 
absence of GTS or CMT, it was not possible formall: 
to investigate a genetic relationship between th, 
syndromes. Nevertheless, the occurrence of five case 
in a sample of this size represents a 5ignifican 
increase over the normal prevalence. It is noteworth: 
that under the assumption of autosomal dominan 
transmission four of these five cases were 'obligat­
carriers' for CMT and GTS that is, people whl 
while not having tics themselves had affected parent 
and siblings, and appeared to pass the syndrome tl 
their children. These observations add weight to th 
suggestion that OCB alone can occur as a varian 
expression of the genetic abnormality which gives ris 
to GTS and CMT. There is also some evidence fo 
the hypothesis that such expression occurs mor· 
frequently in females than males, as all five sucl 
cases in our sample were female. 
It is not possible to determine the extent to whicJ 
the results from the study of one multiply affecte! 
pedigree can be generalised. Nevertheless, there wer· 
no obvious phenomenological differences betweel 
these cases and those described in the literature 0 
encountered by MMR in other circumstances, ant 
the genetic parameters derived from this pedigre. 
conformed reassuringly closely to the results 0 . 
similar segregation analyses which have employel 
different ascertainment procedures. It may, therefore 
be the case that a substantial majority of GTS is duo 
to the same genetic mechanism as that which i 
operating in this pedigree. 
The indication that a single-gene predisposition t( 
GTS is operative in this large pedigree means tha 
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it is feasible to find genetic markers linked to GTS_ 
The parameters that have been estimated in the 
segregation analysis can be employed in the models 
to be used for linkage analysis. Ifmarkers linked to 
GTS can be found, this may lead to the cloning and 
sequencing of the responsible mutation. New preven­
tive strategies and more effective treatments for this 
distressing disorder might then become possible 
(Gurling, J985, J986). 
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Evidence for Autosomal Dominant Transmission 

in T ourette's Syndrome 

United Kingdom Cohort Study 

V. EAPEN, D. L. PAULS and M. M. ROBERTSON 
Complex segregation analyses were performed on families ascertained through 40 unselected 
consecutive patients with Tourette's syndrome to examine the hypothesis that its transmission 
is consistent with genetic inheritance. Analyses were done using several diagnostic 
classifications. All results were consistent with an autosomal dominant gene with high 
penetrance. The penetrances ranged from 0.882 to 1.000 for males and 0.452 to 0.980 for 
females. depending upon the specific classification scheme incorporated into the analyses. 
Tourette's syndrome (TS) is characterised by multiple 
motor and one or more vocal tics of more than a 
year's duration and an age of onset before 21 years 
(American Psychiatric Assocjation, 1987). Early 
family studies suggested that a single major gene 
confers susceptibility for TS (Baron et aI, 1981; Kidd 
& Pauls, 1982; Comings et aI, 1984; Devor et aI, 
1984; Price et aI, 1984; Curtis et aI, 1992). However, 
findings from these studies were inconsistent as to the 
precise mode of inheritance. Some suggested auto­
somal dominant inheritance with reduced penetrance, 
others were consistent with polygenic inheritance, 
while others suggested that the genetic model was 
additive. Pauls & Leckman (1986l performed 
complex segregation analysis on a sample of 27 
families with TS sufferers in which all available 
relatives were personally interviewed. These investi­
gators reponed that an autosomal dominant model 
best described the transmission. Subsequent analyses 
of large kindreds with TS (Pauls et aI, 1990; Curtis 
et aI, 1992) also supported the hypothesis of a major 
dominant gene with high penetrance. 
However, studies of large kindreds need to be 
interpreted with the knowledge that the bias 
introduced by the ascertainment of such multiplex 
families cannot be easily incorporated into the 
analyses. A much b tter test of genetic transmission 
can be accomplished with a larger sample of smaller 
families that have been ascertained without regard to 
familial loading. The present study was undertaken 
to examine the inheritance pattern of TS in a UK 
cohort ascertained through consecutive admissions 
to a TS clinic. 
Method 
Families included in this study were ascertained through 
40 consecutive new cases of TS registered at the National 
Hospital for Neurology and Neurosurgery (NHNN), Queen 
Square, London, over eight months. Two additional 
patients were seen in this time, but their families were not 
included in this study as information was not available on 
the biological relatives. In all 40 families, direct clinical 
interviews were conducted with the index case (by MMR) 
and aIlli'ling relatives eVE). Data were obtained about all 
first-degree relatives from each proband (and parents/other 
relatives) during the initial interview at the clinic. These data 
were included in the final diagnostic estimates for each 
relative, All subjects were interviewed to assess 'caseness' 
using a semistructured interview by one of the authors (VE) 
who is well acquainted with the interview schedule widely 
used (Robertson el aI, J988; Robertson & Gourdie, 1990). 
Complex segregation analyses were completed using the 
unified model as implemented in the computer program 
POINTER (Lalouel el aI, 1983). The unit of analysis in 
POINTER is the nuclear family. Thus, multigenerational 
families were broken down into smaller units. The 40 
ascertained families comprised 49 nuclear families. Pointers 
(I.e. affected probands) to nuclear families indicate how 
each family is related to the proband's nuclear family 
(Lalouel & Morton, 1981). The unified model as incorporated 
in POINTER has five main parameters: q, the frequency of 
the putative major gene; d, the degree of dominance of the 
putative major gene; h2, the heritability of the polygenic 
component important for the expression of the disorder; 
I, the major-gene effect measured as the distance between 
two homozygotes; and lau, the probability that the risk 
allele will be transmined by the heterozygous genotype. 
Segregation analyses were carried out for five different 
diagnostic schemes: 
(a) TS only 
(b) TS or chronic multiple tics (CMT) 
(c) TS, CMT or transient tic disorder (TID) 
(d) TS or obsessive-compulsive behaviour (OCB) 
(e) TS, CMT, TID or OCB. 
OCB was included in the diagnoslic scheme as previous 
studies have suggested an association between it and TS 
(Fernando, 1967; Yaryura Tobias el aI, J981, Montgomery 
e( ai, 1982; Nee el ai, J982; Frankel el ai, 1986; Pauls el 
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Table 1 
Rates of TS, tics and OCB among first-degree relatives of probands 
-----------------------­
Diagnosis 
TS CMT Tics OCB TSfTics/OCB 
Male relatives In = 90) 
Female relatives (n 78) 
Total In = 1:68) 
no. 
19 
11 
30 
(%J no. 
121.1) 13 
(14.1) 8 
117.9) 21 
01, 1986; Robertson el 01, 1988; Robertson & Gourdie, 
1990). 
The prevalences ofTS, CMT and OCB differ with both 
age and sex, To incorporate these differences into the 
analyses, separate estimates of prevalence were made. For 
the first three diagnostic schemes, four fairly narrow age 
classes (0-5, 6-10, 11-15, and over ]5 years) were 
incorporated. For the analysis that included OCB, four 
somewhat broader age classes (0-15, 16-25, 26-35, and 
over 35 years) were used. Furthermore, analyses were 
carried out using a wide range of age-specific and sex­
specific prevalences. Overall popUlation prevalences ranged 
from 0.00032 to 0.001 for TS only; from 0.005 to 0,030 for 
TS or CMT; and from 0.008 to 0.05 for TS or CMTI1TD; 
when OCB was included in the analyses, the overall preva­
lences ranged from 0.003 to 0.05. The penetrance results 
are reported only for the accepted prevalence rate (0.5 per 
1000; Bruun, 1984), because parameter estimates with the 
other values proved very similar. Because ascertainment was 
through consecutive cases, it is likely that the probability 
of any person with TS in the UK being a proband was quite 
small. Thus, an ascertainment probability of 'If 0.01 was 
incorporated into the analyses. 
Results 
Of 168 relatives included in the study (Table 1),30 (17.90/0) 
had TS, 21 (12.5%) CMT, and 10 (6070) OCB. Consistent 
with other reports (Pauls el 01,1991), males were more likely 
to have TS or CMT, while females were more likely to 
receive a diagnosis of OCB. 
A wide range of genetic models was examined in a 
hierarchical fashion. Firstly, the model of no transmission 
1%1 no. (%J no. 1%) no. 1%) 
[14.4) 2 (2.2) 3 13.31 141.11 
(10.3) 1 (1.3) 7 (9.01 [35.9) 
(12,5) 3 /1.91 10 
was compared with the mixed model. The mixed model 
postulates that there is a gene of major effect against a 
polygenic background that contributes to the manifestation 
of the disorder. Since there was evidence for vertical 
transmission in these families (i.e. the model of no trans­
mission could be rejected), additional analyses were done 
to test specific genetic hypotheses (Table 2). For all 
the five diagnostic schemes there was evidence that the 
transmission was consistent with a hypothesis of single-locus 
transmission. Furthermore, the generalised single-locus model 
converged to the dominant model for all diagnostic hier­
archies. The mixed model converged at the boundary with 
polygenic heritability (h2 ) being zero, and the parameter 
estimates were essentially identical to the best-fitting 
Mendelian major-locus model (d= I, t= 5.36, q= 0.0002, 
h2= 0; and 0% phenocopies for males and females). 
Furthermore, the mixed model resulted in a significantly 
better likelihood when compared with the polygenic 
hypothesis, which therefore could be rejected. There 
was no evidence to suggest non-Mendelian transmission 
probabilities. The most parsimonious Mendelian single-locus 
model was the autosomal dominant model; the estimates 
of penetrance for this model were 0.966 males and 0.452 
for females. 
The analyses with the other diagnostic schemes also 
suggest autosomal dominant transmission_ The analysis 
when subjects with TS or CMT were included gave higher 
penetrance figures for males (0.999) and females (0.554). 
When the definition of 'affected' status induded those with 
TS or OCB, the penetrance estimated was 0.882 for males 
and females. When relatives with TS, tics (CMT ITTD) or 
OCB were included, the penetrance rate was 0.980 for both 
sexes (Table 3). 
Table 2 
Complex segregation analysis on 49 nuclear families lTourette's syndrome only) 
------------------­ -----------­
Model of nansmission Diagnostic scheme 
TS TS/Tics TS/OCB TSlTics/OCB 
No transmission Rejected" • Rejected'" Rejected'" Rejected' •• 
Polygenic Rejected' , Rejected' Rejected" • Rejected' • 
Mendelian Consistent Consistent Consistent Consistent 
Autosomal dominant Consistent Consistent Consistent Consistent 
Additive Consistent Rejected' Consistent Consistent 
A utosomal recessive Rejected' , Rejected' Rejected" • Rejected' • 
·P<0.005, "P<O.Ol, '''P< 0.001 
Consisten1 indica1es that model of transmission cannot be rejected at P< 0.05. 
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Table 3 

Genetic model estimates for male and female subjects according to diagnostic schemes 

Prevalence1 IKpmlKpfl p2 pl pO q 
TS only 
male 0.0005 0.9658 0.9658 0.0000 0.0002 
female 0.00015 0.4518 0.4518 0.0000 
TS/CMT 
male 0.0029 0.9996 0.9996 0.0001 0.0009 
female 0.0010 0.5540 0.5540 0.0000 
TS/tics 
male 0.0030 1.0000 1.0000 0.0001 0.0009 
female 0.0010 0.5816 0.5816 0.0000 
TSIOC8 
male 0.0030 0.8818 0.8818 0.0020 0.0009 
female 0.0010 0.8818 0.8818 0.0020 
TS/ticsIOCB 
male 0.0250 0.9806 0.9806 0.0210 0.0021 
female 0.0250 0.9806 0.9806 0.0210 
p2, pl and pO denote the penetrance for genotype with two susceptibility alleles (aa). one susceptibility allele IAa), and no susceptibility 
allele (AM. respectively. and q the frequency of the susceptibility allele 'a'. 
1. Values from Bruun (1984). 
Goodness-of-fit tests (x2) were carried out for all solutions 
obtained for all diagnostic schemes_ First-degree relatives 
were grouped according to sex of the proband, sex of the 
relative, and relationship to the proband (parents v. 
siblings). Expected risks of being affected with TS, tics or 
OCB were calculated using the parameters of the autosomal 
dominant model (the best-fitting model) and compared 
with the observed rates for all first-degree relatives. 
For the TS-only scheme, the predicted and the observed 
frequencies were not significantly different (X2 12.4, 
doL =6, 0.05<P<0.1O). For the TS or CMT group, the 
predicted rates were significantly different from the 
observed (X' = 20.33, d.L = 6, P<0.005). Similar findings 
were obtained when TTD was included with TS and CMT 
(X' 21.60, d.f.=6, P<0.005), indicating a poor fit for 
the data. In the TS/OCB scheme, X2 for goodness-of-fit 
was not statistically significant (X' = 3.7934, d. f. = 6, 
0.990 <P<0.9995). suggesting that OCB is an integral part 
of the spectrum of expression of TS. Finally, the goodness­
of-fit test for TS, CMT/TTD or OCB gave statistically 
significant values (i= 119.465, d.L =6, P<0.0005), again 
indicating a poor fit for the data. These results suggest that, 
within these families, motor tics (chronic or transient) may 
not always be aetiologically or genetically related to TS. 
Discussion 
We found 17.9070 of first-degree relatives to have TS. 
This is higher than previously reported figures. This 
may be due in part to referral bias, in that NHNN 
is a tertiary centre, and families with more than one 
affected member may be more likely to be referred. 
It may also be a ref1ection of a change in trend in the 
diagnOSis ofTS over time. It should be noted, however, 
that even though the rates among first-degree relatives 
are higher. the distribution of diagnoses is similar 
to that in other reports (Pauls et ai, 1991): males are 
more likely to exhibit TS or tics, and females 
are more likely to manifest OCB_ 
The results of the study support the hypothesis that 
TS is inherited as an autosomal dominant trait 
with high penetrance. Furthermore, the results 
are consistent with the hypothesis that OCB is 
part of the spectrum of the syndrome. The best 
fit for the data was obtained when OCB was also 
included. 
In order to allow comparison with previous studies, 
data were analysed using the higher prevalence rates 
as assumed by Comings et at (1984) and Devor 
(1984). This did not alter the inferences; all results 
remained consistent with autosomal dominant trans­
mission. Although segregation analysis suggested an 
autosomal dominant mode of transmission for all 
diagnostic schemes, the estimated values did not 
correspond with the observed rates in the relatives 
for those schemes including tic disorders. The 
difference was most marked in the rates for mothers 
of male probands, where the observed rate was much 
higher than that expected. The rate for fathers showed 
a more slight but similar trend. This should be viewed 
in the context of the fact that the sex ratio distribution 
of affected relatives in our data is different from that 
in other published studies, with more females being 
affected than expected. Thus the rates do not conform 
with the sex ratio of population prevalences used 
in the analyses, which may be contributing to the 
goodness~of-fit results. However, a more recent 
epidemiological study (Apter el aI, 1992) has shown 
a male: female ratio of approximately 1.6: 1, which 
is similar to our findings. 
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It is interesting to note that the estimated values 
compared best with the observed values for the TS 
and OCB group. This is consistent with a report by 
Pauls & Leckman (1986) on an independent US 
sample suggesting that obsessive-compulsive disorder 
(OCD) is aetiologi{:ally and genetically related to TS. 
On the other hand, our results suggest that not all 
chronic tics may be related to TS. When goodness­
of-fit X2 were calculated, the analyses that included 
CMT category resulted in the most significant 
differences between observed and expected, This 
suggests that either CMT is related to TS and the 
genetic model is wrong, or that some individuals with 
CMT do not have a disorder that is related to TS, 
and that, within these families, motor tics (chronic 
and transient) are phenocopies. 
To help understand the relationship between OCB, 
CMT and TS, phenomenological studies using 
personal interview to assess different expressions 
of the syndrome are indicated. It also emerges 
that sound epidemiological studies are of crucial 
importance at this juncture to examine some of the 
issues raised here, particularly that of true estimates 
of the prevalence of TS in the general population, 
sex ratio, and sex-dependent differences in the 
expression of the disorder. 
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A microsatellite 
polymorphism at the THRB 
locus 
Peter M.BreW. Georg Melmer. Mary M.Aobertson and 
Hugh M.D.Gurling 
Molecular Psycrllarry LaOoralory. Oepanmenr of Acaaem.c Psychlarry. UnlverSlly 
College ana M.ocrlesex SchOOl of MeolclI'e. The Wolfson 3U1ldln9. Hiding House 
Street. Lon(lon W1N 8AA. UK 
Source/Description: A human genomic library in EMBL3 
(Clomech) was screened with a human repeat free fragmem probe 
of pBH302 at locus THRB (l). Chromosome walkingidemified 
a done. lambda THRB-5. One AluI fragment of lambda THRB-5, 
subdoned in NT 13, hybridised to poly(dC-dA). Sequencing of 
this subdone identified a (OT)n repeat which detects 5 alleles. 
The subdone was designated THRB-5GT. Flanking sequences 
were used to design PCR primers (0 amplify the repeat sequence. 
PCR Primers: 
THRB·) I S··AACTGACTCTACTGACACCTG·Y 
THRB-5 ~ 5' ·..HGGT.-\CCCTC-\nCCTI.-\GG·}, 
Frequency: Estimated from 42 chromosomes of unrelated 
European Caucasians. 
THRB·5GT 
Allele Size (Ol) Frequency 
Ai 201 0.D7 
A.2 195 008 
AJ !93 OJ) 
A4 191 0,42 
A5 189 0.10 
H<:terolygosicy = 0.66 
Chromosomal Localisarion: THRB formerly the ERBA2 locus. 
Douglas er al. (2), has been mapped 1O chromosome 3 by Drabkin 
e( al. (3) to 3p21.33 -p22. Microsatellite probe localised to 
THRB by linkage to the RFLP. 
Mendelian Inheritance: Co-dominant segregation was observed 
in 6 two or three generation families. 
PCR Conditions: PCR is performed in 12.5 p.1 containing: 50 
ng DNA, 12.5 pmoles of each primer, LQ rru\1 MgCI2• 10 mM 
Tris-C1 pH 8.3, 50 rruv[ KCl. 25 p.M dATP and 200 p.M of other 
dNTPs. I unit Taq polymerase (Perkin-Elmer/Cetus), 0.01 % 
gelatin and 0.5 p.l of J5S-dATP at 500 Ci/mmol (Dupom). 
Amplification is for 35 cycles with denaturation at 94"C, 
annealing at 57°C and extension at neC, all for 1 minute each. 
The dinucleotide repeat sequenced was (GT)4 (A) (GT)6 (0)13 
(GTh, and is different from the sequence reported by Sakurai 
et af. (4). 
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Research and Development Committee (Middlesex Hospital). 
Medical Research Council and Merck. Sharpe & Dohme. 
References: I) Gareau,J.-L.P. et al. (1988) NAR 16, 1223. 2) 
Douglas,J.B. et al. (991) Genomics 9.398. 3) Drabkin,H. et 
al. (1987) Am. I. Hum. Genet. 41. A25: 4) Sakurai.A. et ai. 
(1991) NAR 19, 6661. 
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Genomic cloning and localization by FISH and linkage analysis of the 
human gene encoding the primary subunit NMDARl (GRINl) of the 
NMDA receptor channel 
P. M. BRETT,I B. LE BOlTRDELLES,2 C. G. SEE.:J P ..J. WHI'ITXG,2 J. ATTWOOD,~ 
K. WOOD\VAHD,4 M. 1\1. ROBERTSOi\,1 G. KALSLI S. PO\'EY4 . 
AND H. i\I. D. GPRLli\Gl 
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SFMMARY 
A cDi\A clone of the XlVIDARl (iSOfOl'lll E) has been used to screen both lambda and cosmid 
genomic libraries, A genomic phage done was identified and sequenced and was found to 
contain some of the 3' coding regions of the GRIX1 gene. This clone was used to localize the 
gene using fluorescent. in si:lu h~'bridization (FISH) to normal chromosomes, and also to a 
lymphoblast-oid cell line eontaining a translocation im'oh'ing chromosomes 9 and 15. FISH 
localized the gene to chromosome 9q:H, 3. The elone ",as used to sC'J'f'en a panel of genomk 
DXAs cut. with 20 restriction enz~·mes. A \"XTR sequenee 5' to the gene. which was 
polymorphic for a number of I'estrietion enzymes. was detec·ted. A Pnlll fragnwnt of the 
genomiC' clone was found to dete('t the \';';TH 011 Nouthf'l'I1 hybridizatioll, Thf' polymoJ'phie 
VXTR markf'r \\'a::\ mapped clgainst chromosome H4:3-J. markers using linkagf' allal.n;iR in tIlt' 
CEPH families, The GRE\' J gene was linkf>cl to l)flSi' with a maximum lod s('ore of 20'09 at zero 
recombination fradion in males and O{13 % recombination in females. 
Thf' gIut<'lma te l'f'ceptol's consist of two main e1as,.;f''';. ionot l'opi(' Hnd met a hotropiC'. The 
Ilwtnbotropic receptors are coupled to .intnH'elIulHI' ;.;ignHl tl'Hnsdudion through G-j}rotl·in;.; 
:f (Schoepp et at. 1990). The ionotropie J'E'C'E'ptors ('ontain illtegral c:ation-speeifk ion ('hannels and 
! are didcled into: X:\lDA (X-methyl D-aspartHte) I'P('('ptor:s; Al\IPA (alpllH):3-h."dJ'ox~'I-;')-
t 
. methyl-4-isoxazoleproprionicacid) I'P('pptOl's. and kainatt:' l'E'ceptol's (:.Ionaghnn el al. J989). The 
XMDA (X-methyl-D-aspartate) 1'E'('eptol' iF; im·oln·d in memOl'Y and the lIlediation of 
exeitotoxicity. There are 5 ('Ioned subunits of the ::\?llDA receptor: X:\IDAR 1 (whiC'h hM.; i' 
isofol'ms A-G) and is designated GHIXI. and X:\] ])AR2A. 2B. 2C. 2]). TIlt' fUlldion<'l1 reeepfol' 
is a heteromer eonsisting of Xl\JDAR L \\'hie:h tonfers the ::\l\lDA propertieR of the receptor 
combined with the Xl\1DAR2 subunits. 
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Moriyoshi et al. (1991) demonstrated that XMDARI is the key subunit of the receptor as it 
exhibits the pharmacological and electrophysiological properties of the NMDA receptor. In the 
rat there are seven isofonns of NMDAR1 (A-G) formed by altemative splicing. The other 
constitutive subunits NJiDAR2 (A-D) do not exhibit the intrinsic NMDA receptor properties, 
but have the ability to potentiate NMDARI activity (Kutsuwada el at. 1992). Functional 
NMDA receptors are generated by the co-expression in transfected cells 01' Xenopus oocytes of 
the NMDAR1 subunit with specific members of the NMDAR2 subunit. family confelTing 
functional variability in the electrophysiological and pharmacological properties of the 
receptors (Moriyoshi ef al. 1991; Kutsuwada et ai. 1992). It is thought that in d1'o t.he different 
spatial and temporal expression of these subunit genes results in the generation of NR 1 and 
NR2 heteromeric receptor subtypes (Kutsuwada et al. 1992). 
The NMDA receptor mediates many of the excitatory functions of glutamate, including long­
t.erm potentiation and long-term depression; these long-t.erm changes in neurol1HI responsi,-e­
ness could explain certain aspects of leaming and memory (Collingridge et al. 1990; Monaghan 
et al. 1989). Additionally, in pathological situations, the excessi,-e activation of excitatory 
synapses has been hypothesized to cause neuronal death in neurodegenerati,-e disorders due to 
excitotoxicity (Choi, 1991). The excitotoxic effect is mediated by abnormal increases in intra­
neuronal calcium ions. In order to study this gene in human disorders it is helpful to identi(y 
polymorphic genetic markers within or near the NMDAR1 gene. 
A cDNA clone of the NMDARI (Le Bourdelles et a,t. 1993) gene was therefore used to screen 
a. genomic phage library and 3 different genomic cos mid libraries in order to find a polymorphic 
marker for the locus. This screening yielded only 1 positive clone from the phage library, 
supporting the obsen'ations of others about the inherent cloning difficulties of this gene 
(Henneberry, 1992). The clone (ADl) ~vas used for FISH on both normal chromosomes and also 
on the Iymphoblastoid ceUline B00015 (described in Povey et al. 1992 and obtained from the 
European Cell Culture Repositol'Y, Wilts) which has the karyotype 46XXt(9; 15) (q3-!. 3; q24). 
The breakpoint on chromosome 9 has previously been shown t.o be distal to D9S14 and RXRA 
(Zhou et al. 19~2) and we have recently determined that. it is distal to D9S114 (K. \Vood,vard, 
personal communication, 1993, data not shown). AD1 was screened for simple dinucleotide 
repeats using poly( de. dA) . (dG. dT) (Pharmacia), and for restriction length polymorphisl11s 
(RFLPs) using the radiolabeUed AD 1 on Southern blots restrict.ed with 20 different enzymes. 
PCR sequencing was performed on a 2'3 kb subclone cHlled Pl\iB3. 
MATERlALS AND METHODS 
Hybridization of genomic lambda libran:es 
The library ,vas titred in a suit.able host (LE392 for Clontech EMBL3 Sau3Al partial 
HL1067j genomic library). 30000 phage wet'e plated out per 15 em petri dish, and a total of 20 
plates were prepared such that. 4-5 genomes were screened (Clarke & Carbon. 1976). The phage 
were then screened using the method described by Sambrook el al. (1989). 
Hybridization of cosmid genomic libmries 
Three human coslllid libraries were screened using the protoC'ol described by Kiousis et al. 
(1987). 
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Fig. 1. Hybridization of a genolllic N.MDAR 1 clone by Flf:)H on t.he IYll1phohlastoid ('ell line BOOO15 
(karyotype 46XXt(9; 1;)) (q34. 3; qU)). showing the presence of the cloned sequence on tht~ 
translocated chromosome 15 a)ld normal chromosome H. 
" 
DNA preparation, digestion and Southern hybridization 
DNA was isolated from peripheral lymphocytes (Sambrook et ai. 1989). Five to 10 pg DNA 
was digested with 20 to 30 units of restriction enzymes ovel'llight. in buffers recommended by 
. the manufacturer (Boehringer l\Iannbeim or Amersham). The UNA was electrophoretically 
separated on 0·8.% agarose gels and transferred to a nylon membrane (HybondN , Amersham) 
according t.o t.he manufacturers' protocols. The DNA was fixed to the membrane by VV 
irradiation. Prior to hybridization the blots \\'ere prehybl'idized in 0·9 M-Xa.Cl, 1% SDS with 
sheared salmon sperm DNA at a final concentrat.ion of 50 mg/ml for at least 4 hours. Plasmid 
DNA from the probes was isolated a.ceording to t.he alkaline lysate procedure of Birnboim & 
Doly (1979). Insert DNA was prepared by electroellltion or by separation in low-melting 
aga.rose (Sam brook et al. 1989). The insert DNA was labelled by random priming (Feinberg & 
Vogelstein, 1983) with 32P-dCTP (Amersham) to a speeifie aeth'ity of 2-10 x 108 cpm/fl.g and, 
after denaturat.ion, was incubated for 1 hour at 65 or with ('01'1 D:\A (Gibeo BRL Cat no. 
5279SA) to compete-out t.he C0111mon repeat sequence befol'e being added to the hybridization 
buffer (0'9 !If-NaCJ, 1 % SDS, 10% dextran sulphate, 50 mg/mJ sheared salmon sperm DNA). 
Hybridization was at 65°C oyernight.. The bJots were washed 011<::e in 1 x SSC, 0-1 % SDS for 
: 	20 min at 6.5 °C, followed by two washe;,; at 6,~ or in 0,25-0'1 SSC, 0'1 % SDS for 20 min each. 
The hybridized filters were aut.oracliograpllf'd using Fuji X-ray fiJm at -70°C. 
Subclolling and PC'I' sequencing 
The Pvu II 2·3 kb fragment PMB3 was subdoned llsing the pC'R-Seript SK( +) cloning kit 
from Stratagene Cat no. 211190. The seq uencing "'1:\,,> performed using the fmol DNA sequencing 
s~'stel11 from Promega Cat no. Tl\1024. 
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(b) 
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Fig. 2. (a) Southern hybridizat.ion oft.he PMB3 subelone eont.aining the VNTR sequence on a Pvu It 
filter of a small nuclear family showing 7 alleles. (b) The genot.ypes are shown on the pedigree diagram. 
Pluorescent in sitn hybridiza.tion 
The FISH was performed on both normal chromosomes and the 1ymphoblastoid cell line 
B00015 using the method described by Fitzgibbon et al. (1993). 
Link:age 
Linkage was performed using the eRI-MAP (Donis-Kener et al. 1987) computer programme. 
RESULTS 
Figure 1 shows that GRIN! maps to the derintti,-e ehromosome [5, distal to the breakpoint 
and therefore lies distal to D9S1l4. A variable numbered tandem repeat (VNTR) was identified 
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calue oj Z max 
Genomic cloning oj NMDARI (GRIN1) 
Table 1. Two poinllodscore table (jellwle above and male below)jor NMDARl and chronwsorne.9q 
markers. (b) 21Ja.;rimwn likelihood estimates oj rccombinationjraction (theta) and the corresponding 
(The order of mal'kt'rs shown in both tables is centromere t.o qtel'. D9Sli is the most distal mal'ker in 
the c,hromosome 9 eOllsol'tium Illap (Attwood ef al. 1994). Those' maTl;;ers "hown on U1C same line do not 
reeombine ill the CEPH data and were treakd a.'l aile during the analysis.) 
(a) 
Theta: 0'001 0'05 0'10 0·20 0'30 0'40 
DBHjD9S66 1'94 
-9-44 
6'87 
4-67 
7'60 
6'14 
6'95 
6'09 
5'15 
4-53 
2-65 
2,21 
D9S14jD9S67 4'97 
5·72 
6·78 
8-21 
,6-61 
7-82 
5'40 
6'27 
%2 
4·20 
1'.'50 
1'80 
D9S17 4'28 
1'24 
5'49 
2'73 
5'27 
2-7.5 
4'33 
2·29 
3'03 
1'54 
l'48 
0'66 
D9S7 5'11 
13'8:1 
6'20 
12'78 
5-84 
11'6.') 
4'71 
9'19 
3·27 
6-42 
1'61 
3'29 
D9S11 3'i'i:l 
11{)2 
7'61 
10·30 
7-53 
~H4 
6'31 
7-49' 
4'47 
5'14 
2,20 
2-52 
(h) 
DBHjD9S66 
D9S14jD9S67 
D9S17 
OJ 
0-11 
0·06 
0-04 
Om 
0'14 
0-05 
0·07 
Z max 
14'01 
15'00 
8'28 
D9S7 
D9S11 
{}o3 
0'07 
0'00 
0·00 
20·09 
18-69 
with over 12 alleles (Figure 2) ranging in size from 2'1 kb to 4-5 kb, which were difficult to read 
due to the presence of non-specific repeat sequences. The VNTR was not found in the cDNA 
clone, demonstrating t.hat the polymorphic sequence is locat.ed in an intl'on 01' at the 3' or .5' 
ends of the gene. A 2·3 kb Pvu II fragment of ADl was found to contain the VNTR sequence 
and was used to hybridize against the CEPH reference family Pvu II filters. Linkage ana.Jysis 
was performed; the polymorphism gave a maximum lod seoJ'(~ of 20-09 at the-tam. f (0-00 and 
0-03) with D9S7 (Table 1). It could not be precisely positioned on the CEPH chromosome 9 
consortium map (Att,,;'ood el al. 1994) at odds of 1000: 1 but eould be confidently placed dist.al 
to D9S67. The 2·3 kb Pvu II fragment containing the VNTR was subcloned into the pCR­
Script@) SK (+) phagemid (Stratagene) and called PMB3 in an attempt to remove the non­
specific repeat sequences and make hybridization more specific, hO'wever, this did not make the 
signals from Southern hybridizations easier to read. Some of the sequence was determined and 
analysed using the BLAST program (Altschul et al. 1990)_ 60 bases of the sequence obtained 
showed 100%, homology to the 3' end of the published mRNA sequence for the hunian 
NMDARl subunit (Karp et al. 1993),94 % with rat (Moriyoshi et'a.l.1991) and 93 % with mouse 
(Yamazaki cl. al. 1992). 
DISCUSSION 
While this work was in progress, two other groups have reported assignment of GRINl to 
9q34_3 (Collins et al. 1993; Karp et al_ 1993) using FISH, mentioning the possibility that 
GRIN1 might be a candidate locus either for Tuberous sclerosis (TSC1) or for Idiopathic 
Torsion Dystonia, both mapping to 9q34. However, we have shown both by physical mapping 
and by genetic means, that GRIN1 lies distal to the distal flanking markers for these diseases 
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(Kwiatkowski et al. 1993) and can therefore be excluded as a candidate gene. The distal position 
of GRIN 1 makes it a valuable genet,ic marker for 9qter and we are eurI'entlyattempting to 
format. the marker for use with peR. 
This work was !Supported by l\1RC project grant G9023197X and also grants from the GSA Tourette 
Syndrome Association, the GK Touret.te Syndrome As;;ociation and the Clinical Re»earch and Development 
Committee ofthe Middle"ex Hospital, J. A. and S. P. acknowledge the support of the MRC a» pal·t ofihe Human 
Genome 1\fapping Project. The BLAST search was done u~ing the fa(,i1itie~ at the l'IIRC HGl\lP Resource Centre. 
We acknowledge the support of Eurogem and of CEPH. K. W. is supported by an HGMP MRC student~hip. 
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Exclusion of the 5 -HTlA Serotonin N euroreceptor 

and Tryptophan Oxygenase Genes in a Large British Kindred 

Multiply Affected With Tourette's Syndrome, 

Chronic Motor Tics, and Obsessive-Compulsive Behavior 

Peter M. Brett, B.Sc., David Curtis, M.D., M.R.C.Psych., 
Mary M. Robe~son, M.D., F.R.C.Psych., and Hugh M.D. Gurling, M.D., M.R.C.Psych. 
Objective: Previous studies have demonstrated a relationship between obsessive-compulsive 
disorder or behavior and Gilles de la Tourette syndrome. it has been hypothesized that the 
serotonergic system is implicated in the etiology ofobsessive-compulsive disorder. Therefore, 
the authors investigated whether genetic variation in a serotonergic receptor and a modifying 
enzyme were associated with Tourette's syndrome. Method: A linkage analysis using DNA 
and blood group markers was carried out in a large British kindred multiply affected with 
Tourette's syndrome, chronic motor tics, and obsessive-compulsive behavior. Results: There 
was no evidence to support the hypothesis that genetic variation in the serotonin 5-HT1A 
receptor and tryptophan oxygenase genes causes susceptibility to Tourette's syndrome and 
chronic multiple tics. Conclusions: The results eliminate two possible candidate genes from 
having a role in the pathophysiology of Tourette's syndrome. 
(Am 1995; 152:437-440) 
T he association between Gilles de la Tourerre syndrome and obsessive-compulsive disorder is 
well established, with evidence from historical, epi­
demiological, phenomenological, and genetic re­
search. This association h2s been fully reviewed by 
Robertson and Yakeley (1). Neuroendocrine studies 
suggest that the function of serotOnin 5-HT1 receptors 
(particularly, 5-I-IT1A ) may be disturbed in obsessive­
compulsi ve disorder (2); however, the exact na ture of 
Rf{;eived S<:pr. 20, 1993; revisions received Feb. 7 and May 24, 
1994; accepted July 22, 1994. From the Molecular Psychiacry Labo· 
ratory, Academic Psyduacry Depamnent, University College London 
Medical School. Address reprint requests to Dr. Brerr, Academic Psy· 
chiatry Department, University College London Medical School, 
Wolfson Bldg., Riding House St., London W1N 8AA, England. 
Supported by Medical Research Council projeCt grant G9023197N 
and previously by grams from the U.S. Tourene Syndrome Associa· 
tion, the U.K. Tourene Syndrome Associaoon, and the Clinical Re­
search and Deveiopmem Commirree of the Middlesex Hospital. 
The aumors thank clinicians Alison Gourdie, Gary Jackson, and 
Viviene Schneiden for help in collecring family data and blood samples 
and Len Dodson for blood grouping. 
the alterations in seroronergic function is uncertain. 
There have also been descriptions of abnormalities in 
serotonin metabolism in Tourerte's syndrome in which 
CSF levels of 5-hydroxyindoleacetic acid are decreased 
after probenecid loading (3). It has been suggested 
that these changes in patients with Tourene's syn­
drome are due to a mutation in the tryptophan oxy­
genase gene (4). 
METHOD 
The pedigree we srud~ed consists of 116 members (figure 1), 85 of 
whom were individually interviewed. Of the 85 interviewed, 29 had 
Tourcrre's syndrome, a further 20 had chronic mulriple tics without 
Tourene's syndrome, and five had obsessive-compulsive behavior 
alone; these clinical findings have been fully documented (5). The 
structure and paternity of the kindred were confirmed with the u~e of 
DNA fingerprinring. 
Patients were assigned to diagnostic categories 2S follows: 1) defi· 
nite or probable Tourene's syndrome, diagnosis according IO the 
DSM·I1l criteria by history andior examination; 2) definite Or prob­
able chronic multiple rics, diagnosis according to DSM-J11 by history 
Am J Psychiatry 152:3, March 1995 437 
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BRlEF REPORTS 
FIGURE 1. A Large Kindred, Multiply Affected With Tourette's Syndrome, Chronic Multiple Tics, and Obsessive-Compulsive Behavior, Used 
for linkage Analysis, Showing the Genotypes Analyzed' 
• Gilles de la Tourette syndrome 
a-.ronlc multiple Ilcs 
lID Obsesslve-<:ompulslve behavior 
35 33 
"" 
u; n 
AD AB AA 
1"11 II.. MI1 
S. 
"" 
n 
M AA 
MPI MPI
... 
23 Sf. 26 ~6 
u ..% ..% 
All DB AA AB 
PIli "PI .... MPI 
S. ..
• .. 26 22... n 
AA A. 
MPI MPI 
S. s. 
26 25 2(' 1.1. 5&
.. ww ... ... 
.." All AA AA All All AA AA AA All 
Mil MPI M.. MPI .... tv! rn MI1 MI1 
s. S. s. ss SS
•26 ~(, 
.." ..% AA RA 
PlPI "PI
.. 
'A square indicates a male; a circle indicates a female. Alldes are shown in the following order: PS99GT1n) (topmost marker), L599Ha, G·21, 
and MN and 5s blood groups. 
TABLE 1. Linkage Markers, Their Locations, and Allele Frequencies 
Used in a Study of Members of a Kindred With Tourette's Syndrome 
and Chronic Multiple Tics 
Chromosomal 
Probe Locus Locarion Allele Frequency 
G·21 HTRIA Scen-q1l A] 0.78 
A2. 0.22 
L599Ha DSS76 5qlL2 A1 0.32 
A2 0.16 
A3 O.SO 
A4 0.02 
PS99GT1nl D5576 Sql1.2 A1 0.021 
A2 0.213 
A3 0.213 
A4 0.127 
A5 0.064 
A6 0.362 
M.l'J and 5s MNS 4q31 M 0.S3 
blood groups N 0.47 
Restriction fragment length polymorphism (RFLP) and microsatel­
lite polymorphism were determined with the use of the protocols set 
out by Melmer et a!. (6) and Sherrington et aL (7). On the basis of the 
results of a previous segregation analysis {8),-aulOsomal transmission 
was assumed with a gene frequency of 0.0005 and heterozygote pene­
trances of 0.50 for Tourene's syndrome and 0.88 for Tourene's syn­
drome and chronic multiple tics. To allow for occasional pheno­
copies, the normal homozygote penetrance was set at 0.001. Two 
diagnostic categories were used to indic3,e affected status: Tourette's 
syndrome only and Tourerre's syndrome and chronic multiple Dcs. 
No separate analysis was carried out in which the cases of obsessive­
compulsive behavior were included as affected because four of the 
five individuals with obsessive-compulsive behavior were obligate 
carriers under the assumption of dominant transmission. The 
MLINK program of the LINKAGE package of programs (9) was used 
to carry out linkage analysis between markers and different affection 
classes. 
From published linkage data (6) the S-HT", locus (HTR1A) maps 
ro within 2 cM of the locus D5S79 on chromosome 5. Therefore, 
markers at [his locus can be used to exclude S-HTIJ. if sufficient ex­
5 0.3] 
0.69 
andlor examination; and 3) obsessive-compulsive behavior without 
Tourette's syndrome Or chronic multiple tics, diagnosis by histOry 
and, in the case of children, corroboration by parents. 
438 

clusion data are obtained from the linkage analysis. Two markers 
were used, an RFLP (L599Ha) and a microsatellite polymorphism 
(PS99GT1nll (6, 7). The tryptophan oxygenase gene is less than 1 eM 
in distance from the MNS blood group (4); therefore, this locus was 
used as a marker for the rryprophan o:qgenase gene itself. For the 
MN5 blood group, two allelic systems (MN and 55) were defined with 
zero recombination between them. The locations and allele frequen­
cies of the markers that were used are listed in table 1. When linkage 
Am J Psychiatry 152:3, March 1995 
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XX 'Xx 
AA AA A~ AA A8 
tI1 "1"1 "" SS 
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•• 
""So 
~. 
AA AA AS AA AA 
on 
S. 
MI1 
S5 
TABLE 2. Two-Point and Three·Point Lod Scores Between Affection Class and Genetic Markers for Diagnostic Models of Tourette's Syndrome 
Alone and Tourette's Syndrome and Chronic Multiple Tics 
--~---~----~~-~-~--.--~.--.----.-
Lod Score for Each Recombination Fracrion (9) 
---~~-
Markers and 9=0.000 e=O.OOl e=0.010 9=0.050 9=0.100 e=0.200 9=0.300 9=00400 
Two-point lod score: G-21 Taql RFLP' 
Tourene's syndrome 0.908 0.905 0.884 0.793 0.685 00492 0.320 0.159 
Tourene's syndrome and chronic multiple tics -2.000 -1.751 -1.057 -D.398 --D.l11 0.133 0.200 0.153 
Three-poim lod scores 
L599Ha RFLP and P599GT1n ) rnicrosatellite at 
D5S76 
Tourerte's syndrome -3.904 -3.596 -2.531 -1.522 --D.999 -DA13 0.Q25 0.131 
Tourene's syndrome and chronic multiple tics -14.980 -13.591 -10.160 -5.646 -2.835 -DA21 0.341 0.365 
Blood groups MN and 5s on chromosome 4 
Tourene's -12.365 -11.975 -9.855 -6.152 -4.086 -1.958 --D.938 -D.385 
Tourene's and cruonic tics -22.059 -19.349 -14.323 -9.208 -6.798 -3.986 -2.147 -D.864 
'RflP=resrricrion fragment length polymorphism. 
analysis was carried our berween the RJ1.P and the microsateiLire RESULTS 
polymorphism at D5S76, rhe maximum lod score of 8.660 was at a 
recombination fracrion of zero. The rwo-point lod scores for D5S76 The 5·HT1A probe G-21 gave results that were o'nly(RFLP and rrucrosaceUitc) and G·l] were combined intO an overall 
weakly informative and detected no recombinants withmap 'mch the use of FASTlv1AP, a program that combines lod scores 
on a fixed map, raking inro account the number of informative meio­ Tourette's syndrome. However, when cases of chronic 
ses for each marker (10). multiple tics were also included as affected, a lod score 
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FIGURE 2. Estimated Multipoint Lod Scores Produced by the FAST· 
MAP Program on the Basis of Two-Point Lod Scores at 05S76 and 
5-HTR 1A Loci of Members of a Kindred for Tourette's Syndrome 
Alone and Tourette's Syndrome and Chronic Multiple Tics' 
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'The solid line represents lod scores for the Tourene's syndrome di­
agnostic model, and the dotted line the scores for Tourette's syn­
drome and chronic multiple tics. D5S76 has been placed 2.[ a map 
position of 0 cM, and 5-HTR1A at 2 eM. 
of -2.000 at zero recombination was obtained (table 2). 
Counting only cases of T ourette's syndrome as affected 
resulted in an exclusion (lod less than -2.000) up to a 
recombination fraction of 1 % with D5S76, and when 
cases of chronic multiple tics were also included, an ex­
clusion of over 10% was achieved (table 2). FASTMAP 
(figure 2) produced good exclusions for bOth models. 
This certainly excludes all of the region to which the 
5-HT1A gene has been mapped. With the MNS blood 
group, an exclusion of nearly 20% was obtained for 
Tourette's syndrome, and an exclusion of over 30% for 
chronic multiple tics (table 2). 
DISCUSSION 
Our analysis eliminates one possible hypothesis 
about the pathophysiology of Tourette's syndrome in 
one very large multiplex kindred when an autosomal 
dominant mode of transmission is assumed. The fact 
that considerable effort has been made in linkage analy­
sis of Tourette's syndrome and that currently about 
85% of the genome has been excluded implies either 
that a susceptibility locus will shortly be identified or 
that there is genetic heterogeneity for the syndrome. If 
heterogeneity is present, then clearly, single large kin­
dreds such as ours and those reported in Canada, Ore­
gon, and Utah (5, 11) should be studied independently. 
Data across studies should not necessarily be used to 
produce combined exclusion maps. 
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The Genetic Susceptibility to Gilles de la Tourette 
Syndrome in a Large Multiple Affected British 
Kindred: Linkage Analysis Excludes a Role for the 
Genes Coding for Dopamine Dl, D2, D3, D4, D5 
Receptors, Dopamine Beta Hydroxylase, Tyrosinase, 
and Tyrosine Hydroxylase 
Peter M. Brett, David Curtis, Mary M. Robertson, and Hugh M. D. Gurling 
Segregalion analyses have shown that Gilles de la Tourette Syndrome (GTS) is transmitted as 
an autosomal dominant gene disorder indicating that classical linkage analysis should be able 
10 identify susceptibility loci. Previous studies ofGTS 1wve included investigations ofneurore­
ceptor function, neurotransmitters, and their metabolites as well as neurotransmitter-related 
enzymes in an attempt to determine the pathophysiology ofGTS. The neurotransmitter systems 
most often thought to be involved in GTS include those involving adrenaline, noradrenaline, 
and dopamine. We have carried out research to test the hypothesis that genes encoding proteins 
in the catecholamine pathways Inay contribute to the genetic etiology of GTS. Polymorphic 
markers at or near the Dl, D2, D3, D4, D5 neuroreceptor gene loci as well as at the genes 
encoding dopamine beta hydroxylase (DBH), tyrosinase (TY) and tyrosine hydroxylase (TH) 
were studied in one large multiple affected pedigree. The linkage results of this investigation 
exclude a major role ofthese candidate genes in the etiology ofGTS in the pedigree. 
Key Words: Touretle syndrome, linkage analysis. dopamine receptor 
Introduction 	 vocal tics (American Psychiatric Association 1987; World 
Health Organization 1992). The syndrome, as originally Gilles de la Tourette Syndrome (GTS). first described in described, was thought to be rare but more recent work has 1825 by Itard and later in 1885 by Georges Gilles de la 
shown that GTS and the genetically related disorder chronic Tourette is characterized by multiple motor and one or more 
motor tics (CMT) may have a life time prevalance of at least 
0.5 per thousand (Robertson 1989). GTS is thought to be 
genetically determined with the mode of transmission being From the Academic Departmenl of Psychiatry, Molecular Psychiatr), Laboratory. 
University College London Medical School. London WIN KAA. UK autosomal dominant with incomplete penettance as shown 
Address reprint requesl' to Dr. Peter M. Breit. InstitUie of Psychiatry. De Crespigny by segregation analyses carried out on independent GTS Park. Denmark Hill. London SES 8AF. U.K. 
Received March 7. 1994; revised lune I. 1994. samples (Comings et a11984; Devor 1984; Price et a11984; 
© 1995 $ociety of Biological Psychiatry 0006·32231951$09. SO 
SSDI 0006·3223(94)OOI61·U 
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Pauls and Leckmann 1986; Curtis et al 1992; Eapen et al 
1993). Several twin studies have given evidence of variable 
phenotypic expression (pleiotropy) forthc genetic suscepti­
bility to GTS (Shapiro and Shapiro 1980; Jcnkins and 
Ashby 1983; Wasennan etal 1983;Prieeetal 1985). 
A possible link between the catecholamine system and 
GTS has been reviewed by Caine (1985). Observations on 
the treatment of GTS patients have provided the most evi­
dence in favor of a role for the dopamine system in the 
etiology of GTS, Successful treatments used to ameliorate 
the symptoms of GTS employ predominantly D2 receptor 
antagonists such as haloperidol (Shapiro and Shapiro 1982). 
pimozide (Golden 1984) and sulpiride (Robertson et al 
1990). There are now five recognized dopamine receptor 
genes that have been cloned and localized, It has been 
shown that commonly used dopamine antagonists have af­
finity for all five dopamine receptors (van Tol et al 1992), 
but that affinity for SUbtypes varies considerably. In addi­
tion, it is known that dopamine antagonists have mUltiple 
actions on other brain transmission systems (Gilman et al 
1992; Baldessarini 1980), 
The effects of dopaminergic agonists, such as L-DOPA 
(Sacks 1982), and central nervous system (CNS) stimulants, 
such as methylphenidate (Golden 1984; Robertson and 
Eapen 1992). are deleterious and increase the number and 
severity of the symptoms shown by GTS patients, whereas 
the dopamine depletors, such as tetrabenazine (Jankovic et 
al 1984), do induce somc improvement in the symptoms. 
These drugs provide evidence of the possible involvement 
of the enzymes controlling the synthesis and breakdown of 
dopamine. Dopamine beta hydroxylase (DBH) catalyses 
the conversion ofdopamine to norepinephrine in the adrenal 
medulla (Kirshner 1957). Tyrosine hydroxylase (TH) is the 
first enzyme in the catecholamine biosynthetic pathway and 
is responsible for the conversion of L-tyrosine to 3,4-dihy­
drophenylalanine (DOPA) (Cooper et aI1991). Tyrosinase 
is involved in the conversion of tyrosine to DOPA to be used 
in thc synthesis of melanin (Cooper et al 1991), These genes 
are, therefore, essential in the functioning of the catechol a­
mincrgic pathways and a mutation in anyone ofthem could 
have an impact on overall catecholamine metabolism. 
It is however not clear from the evidence whether the 
catecholaminergic system itself is in some way etiOlogically 
responsible for GTS, or whether the changes observed are 
the effect of another brain system dysfunction. Bomstein 
and Baker (l990) measured changes in several aminergic 
systems in a controlled study. Significant decreases in beta­
phenylethylamine (PEA), 5-hydroxytryptamine, p-tyra­
mine and 3-methoxy-4-hydroxyphenylglycol were found in 
patients' urine. After control for the effects of drugs the 
most pronounced change was found in PEA. PEA is pro­
duced by the decarboxylation of phenylalanine and has a 
mescaline-related psychotogenic action (Cooper et al 
P.M. Brett et al 
1991). It is known that PEA has effects on brain dopamine, 
5-HT and norepinephrine (Jackson and Smythe 1973; 
Sloviter et al 1980), 
Methods 
Family Collection and Diagnosis 
The pedigree wa~ identified when the proband presented at a 
specialist GTS clinic. The pedigree studied consists of 116 
members (Figure 1), 85 of whom were individually inter­
viewed. The structure and paternity of the kindred was 
confirmed using deox.yribose nucleic acid (DNA) finger­
printing. 
One of us (MMR) evaluated individuals in the pedigree. 
Subjects were interviewed to assess "caseness" using a 
semistructured diagnostic interview to obtain DSM III cri­
teria for GTS and chronic multiple tic syndrome (CMT), 
which has been developed by MMR (Robertson et aI1988). 
The protocol used is highly comparable with other workers 
in the field. Other psychiatric diagnoses were made using 
the SADS-L standardized interview (Spitzer and Endicott 
1977) and Research Diagnostic Criteria (RDC) (Spitzeret al 
1978). 
Patients were assigned to diagnostic categories as follows: 
I. Definite or probable GTS; satisfying DSM III (Amer­
ican Psychiatric Association 1980) criteria on history 
andlor examination. 
2. 	 Definite or probable CMT; DSM III diagnosis on 
history andlor examination. 
3. 	 Obsessive compulsive behaviors (OCB) without 
GTS or CMT; obtained on history and, in the case of 
children, corroborated by parents. 
Of the 85 interviewed 29 had GTS, a further 20 had CMT 
without GTS and 5 had OC behaviors alone (Robertson and 
Gourdie 1990). 
RFLPand Microsatellite Polymorphism 
Detennination 
DNA was isolated from peripheral lymphocytes (Sambrook 
et al 1989). Five to 10 fJ..g DNA was digested with 20 to 30 
units of restriction enzymes overnight to buffers recom­
mended by the manufacturer (Boehringer Mannheim or 
Amersham). The DNA was electrophoretically separated 
on 0,8% agarose gels and transferred to a nylon membrane 
(Hybond N, Amersham, U.K.) according to the manufactur­
ers' protocols. The DNA was fix.ed to the membrane by UV 
irradiation. Prior to hybridization the blots were prehybri­
dized in O.9M NaCI, 1 % SDS with sheared salmon spenn 
DNA at a final concentration of 50 mg/ml for at least 4 hr. 
Plasmid DNA from the probes was isolated according to the 
alkaline lysate procedure of Bimboim and Doly (1979). 
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Figure I. Multiplex GTS/CMT Kindred (F24) studi.ed by linkage analysis. 
Insert DNA was prepared by electroelution or by separation 
in low-melting agarose (Sambrook et al 1989). The insert 
DNA was labelled by random priming (Feinberg and Vogel­
stein 1983) with JZP-dCTP (Amersham, U.K.) to a specific 
activity of 2-10 x 108 cpmlJ.Lg and, after denaturation, added 
to the hybridization buffer (O.9M NaCI, 1% SDS, 10% Dex­
tran Sulfate, 50 mg/ml sheared salmon sperm DNA). Hybridi­
zation was at 6SO C ovemight. The blots were washed once in 
I xSSC. 0.1 % SDS for 20 min at 65° C. followed by two 
washes at 65° C in 0.5 to 0.1 SSC, 0.1 % SDS (the stringeney 
varied depending on the probe being used) for 20 min each. 
The hybridized filters were autoradiographed for up to J4 
days using Fuji X-ray film at -70° C. 
Polymerase chain reaction (PCR) was performed in 
12.5 J.LI containing: 50 ng DNA, 12.5 pmoles of each primer, 
1.0 mmollL MgC h, 10 mmollL Tris-CI pH 8.3, 50 mmoIIL 
KCI, 25 J.LmollL dATP and 200 J.LmoIIL of other dNTPs, I 
unit Taq polymerase (Perkin-Elmer/Cetus), 0.01% gelatin 
and 0.5 J.LI of lSS-dATP at 500 Ci/mmol (Dupont. St. Louis, 
MO). End-labeled primers were also used for some microsa­
tellite amplifications (100 pmoles of primer labeled in IOJ.LI 
with I J.LI gamma- J2p A TP at 3000 Cilmmol, 0.1 J.LI ofthis was 
used per reaction). Amplification was for 35 cycles with den­
aturation at 94° C, annealing at the appropriate temperature 
for the primers and 20 sec extension at 72° C. The amplified 
product was separated by polyacrylamide gel electrophoresis 
using a urea denaturing gel. The gels were fixed in 10% acetic 
acidllO% methanol and vacuum dried onto 3 mm paper. The 
gels were autoradiographed using Fuji X-ray film at -700 C 
for 1 hr to 2 days depending on the primers used. 
Linkage Analysis 
Based on the results of a previous segregation analysis 
(Curtis et al 1992) autosomal transmission was assumed 
with a gene frequency of 0.0005, and heterozygote pene­
trances of 0.5 for GTS and 0.88 for GTS and eMT. To 
allow for occasional phenocopies, the normal homo­
z.ygote penetrance was set to 0.00 I. Two diagnostic cate­
gories were used to indicate positive affection status, GTS 
only and GTS and CMT. No separate analysis was earried 
out including the aCB cases as affected, because four out 
of fi ve of the aCB cases were obligate carriers under the 
assumption of dominant transmission. Six of the nine 
markers used had six or more alleles, these were con­
densed to just five alleles for the purpose of the linkage 
analysis. This may lead to a slight loss of information in 
some cases and so may result in some reduction of the 
overa.11 magnitude of the lad scores obtained. The effect, 
however, is likely to be smalL In the present case this theo­
retical disadvantage was outweighed by the benefits of re­
duced computational demands for this extremely complex 
pedigree. Two-point and mUltipoint lod scores were calcu­
lated with the LINKAGE package of programs (Lathrop et 
al 1984) for the polymorphic markers listed in Table 1. 
Three three-point analyses were performed between 
affection status, HRAS and TH to examine 04 (Gelemter 
et al 1992); affection status, ORD2 and 011S97 to ex­
clude tyrosinase (Barton et al 1988) and between affec­
tion status, OROI and 05S211 to examine the role in 
susceptibility for the DI gene (Wasmuth et aI1991). 
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Table I. Linkage Markers. Their Location and Allele 
Frequencies Used in the Study 
Chromosomal 
Probe name Locus location References 
c·Ha·RASI HRAS llplS.S (Gelemter et aI1992) 
THCA TH IlpIS.S (Gelemtcretall992l 
pMSS! D1IS97 Ilql3 (Barton et a11988) 
D2·S/D2·6 DRD2 Ilq22'q23 (Barton et a11988) 
DBH·CA OBH 9q34.3 (Poneret aI1992) 
HGR2 13· I DROl Sq34-35 (WasmulhetaI1991) 
Mfdl54CA D5S211 5q33.3·qter (Wasmuth et a11991) 
OSCA DRD5 4pl6 (Sherrington et al 1993) 
L214 DRD3 3q 13.3 (LannfeltetaI1992) 
Probe Alleles Frequency 
HGR213·1 EcoRI AI 0.90 
A2 0.10 
L214 Mscl AI 0.72 
A2 0.28 
D2·51D2·6 peR AI 0.15 
A2 0.47 
A3 0.22 
A4 0.16 
All the other markers were condon.cd to Ii.e alleles wilitequal fequencies for the 
100 score calculations. 
Results 
The two-point lod scores for each marker used are shown in 
Table 2. The genetic information from the probe for the Dl 
receptor gene was largely uninformative, but by using a 
tightly linked microsatellite at D5S211 we were able to 
exclude the region around the DRDI locus over a distance 
of 20 cenlimorgans with a two-point analysis and over 40 
centimorgans using a three-point lod ana1ysis (Figure 2). 
The gene for the enzyme tyrosinase is 10ca1ized on chromo­
some llq between the DRD2 and Dl1S97 loci and is ex­
cluded using a three-point analysis, (Figure 3). A three­
point analysis using markers at the HRAS and tyrosine 
hydroxylase loci was used to exclude the role of the D4 
receptor in GTS (Figure 4). All the other loci of interest, 
DRD2, DRD3, DRD5, DBH, and TH were excluded with 
two-point ana1yses using their associated polymorphisms 
(Table 2). 
Discussion 
There have been severa1 previous linkage analyses reported 
in GTS. examining various candidate loci or general exclu­
sions of specific chromosomes. Devor et al (1990) and 
Gelcmter et al (1990) both previously excluded a role for the 
D2 dopamine receptor in GTS. Comings et al (1993) re­
ported increased homozygosity for the D3 receptor gene, 
but Brett et al (1993) failed to replicate this finding. Heutink 
et al (1990) excluded chromosomes 7 and 18, and Pakstis et 
al (1991) combined the exclusion data from several groups 
to exclude more than 50% of the genome. Brett et a1 (1989, 
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Table 2. Two-Point Lod Scores for Linkage between Affection Status and Nine Markers for Two Diagnostic Models 
Theta 0.000 0.001 0.010 0.050 0.100 0.200 0.300 0.400 
Two-point lod scores for HRAS 
GTS -6.946 -6.201 --4.281 -2.541 -1.860 -1.117 -0.574 -0.201 
GTS&CMT -16.199 -14.280 -10.219 -5.835 -3.912 -1.993 -0.815 -0.194 
Two-point lod scores for D I I S97 
GTS -9.443 -8260 -6.232 -4.142 -2.925 -1.523 -0.776 ' -0.394 
GTS&CMT -21,255 -19,568 -14,169 
-7.693 -4.791 -1.984 -0.723 -0.235 
Two-point lad scores forTH 
GTS -10.909 -10.006 -7.289 -4.243 -2.561 -0.967 -0.208 0,074 
GTS&CMT -23.638 -22.435 -16.944 -9.437 -6.036 -2.760 -1.078 -0.239 
Two-point lod scores for DRD2 
GTS -12.201 -11.777 -9,280 
-5.529 -3.595 -1.748 -0.889 -0.396 
GTS&CMT -13,600 -13.029 -10.175 -5,576 -3.185 -1.048 -0.255 -0.048 
Two-pointlod scores for DBH 
GTS -8,903 -7.726 -5.455 -3.145 -1.946 -0.692 -0.173 -0.013 
GTS&CMT -8.539 -0.614 -3.554 -1.104 -0.241 0.439 0.636 0.445 
Two-point lod scores for DRD I 
GTS 0.800 0.804 0.784 0,698 0.591 0.387 0.213 0.083 
GTS&CMT 0.016 0.023 0.085 0.271 0.383 0.408 0.312 0,169 
Two-pointlod scores for D5S211 
GTS -10.655 10443 -8.914 
-5.782 -3.951 -1.985 -0.954 -0.358 
GTS&CMT -14.928 -14.087 -11.419 -6,917 -4.246 -1.777 -0.697 -0.202 
Two-point lod scores for DRD5 
GTS -12858 -11.914 -9.427 -5.769 -3.862 -1.908 -0.784 -0.183 
GTS&CMT -22,1)39 -20.703 -16.289 -10.531 -7.102 :"3.598 -1.610 -0.481 
Two-point lod scores for DRD3 
GTS -3.204 -~.O71 -2.516 -1.659 -1.126 -0.567 -0.264 -0.088 
GTS&CMT -6.263 -S.720 --4.195 -2.267 -1.345 -0.601 -0.300 -0.128 
1990. 1991) examined in detail the association of a recipro­
cal translocation, between chromosomes 3p and Sq, found 
in a rare case ofGTS and excluded most ofchromosomes 3p 
and 8q from being involved in the etiology ofGTS. 
Given the difficulty experienced so far in localizing a 
susceptibility gene for GTS and related disorders, methods 
to overcome the possibility that there is heterogeneity of 
linkage in the genetic predisposition to GTS must be con­
sidered. We have chosen the approach used by Gelemter et 
al (1990, 1993). of primarily studying a single large kindred. 
in which it may be assumed a single locus is responsible. We 
routinely follow-up weakly positive lod scores in the main 
kindred by studying a number of smaller families. Our 
results suggest that abnonnalities in the cloned human do­
pamine receptors and the catecholamine metabolizing en­
zymes studied do not have a major effect in the etiology of 
GTS in the family studied by us, assuming that the mode of 
transmission is approximately correct, which is that the 
cases of GTS in this family are due to the action of a single 
autosomal dominant gene with fairly high penetrance. It 
does of course remain a possibility that abnonnalities of 
these genes may cause GTS in other families, 
In excluding these genes we have only investigated a 
small number of the potential candidate genes of neurologi­
cal relevance that have recently been cloned. The involve­
ment of serotonergic system genes has been proposed 
(Crosley 1979). In addition there are many second messen­
ger systems that might be involved in the etiology of GTS 
(Singer and Walkup 1991). Genes encoding proteins in­
volved in the gammaaminobutyric acid (GABA)ergic. sero­
tonergic, adrenergic, and cholinergic systems should also be 
studied using linkage methods. 
This work was supported by MRC project grant G9023I 97N and also by 
granL~ from the USA Tourette Syndrome Association. the UK Tourette 
Syndrome Association and the Clinical Research and Developrnem Com­
mittee of the Middlesex Hospital. 
Thanks go to all the families who have participated in our study and to 
the clinicians Alison Gourdie. Gary Jackson and Viviene Schneidcn for 
their help in collecting family data and blood samples. 
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Figure 2. Multipoint lod scores on chromosome 5 between GTS/CMT and 05S21 I and ORD I to exclude the dopamine D I receptor gene. 
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Figure 3. Multipoint lod scores on chromosome II bel ween GTS/CMT and D1IS97 and DRD2 to exclude the gene for tyrosinase. 
DllS97 isal OeM and DRD2 is at 40cM. with the tyrosinase gene lying al25 cM from DllS97 and 15cM from DRD2. 
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Figure 4. Muhipoiot [00 scores on chromosome 11 between GTS/CMT and TH and H RAS to exclude the gene for D4 dopamine receptor. 
TH is at OcM and HRAS-I is at 3.8cM, with the DRD4 gene lying 2cM_ either proximal or distal, ofHRAS-I. 
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Psychiatric Genetics (1996), 6, 99-105 
Linkage analysis· and exclusion of regions of 
chromosomes 3 and 8 in Gilles de la Tourette 
syndrome following the identification of a balanced 
reciprocal translocation 46 XV, t(3:8)(p21.3 q24.1) 
in a case of Tourette syndrome 
P.M. Brett, D. Curtis1 , M.M. Robertson, M. Dahlitz and H.M.D. Gurling 
Molecular Psychiatry Laboratory, Academic Department of Psychiatry, University College 
London Medical School, The WOIfSOR Building, Riding House Street, London W1 N BAA, UK 
1Present address: Academic Dept. of Psychological Medicine, London Hospital Medical 
College, 3rd floor, Alexandra Wing, Turner Street, London E1 2AD, UK 
Correspondence to: H.M.D. Gurling at above address 
Gilles de la ToureUe syndrome (GTS) and related disorders such as chronic multiple tics and obsessive compulsive behav­
iour are likely to be ger.etically transmitted with a Mendelian autosomal dominant mode of transmission. Following our 
discovery of a patient with GTS who also carried a balanced translocation 46 XV, t(3:8) (p21.3 q24.1), a linkage study 
of several families was performed covering the areas on chromosomes 3 and 8 implicated by the cytogenetic abnormality· 
in this unique GTS patient. A positive multipoint lod score of 2.9 was obtained on chromosome 3 with markers at the 
loci RAFl, THRB, and D3S11. Subsequently, the genetic map of this region was imlJrOved and new polymorphic markers 
close to our original three markers were identified. With the new map the maximum two-point lod with any marker was 
reduced to 1.77 at RAFl, and the FASTMAP approximate multipoint Iud excluded the likely region of the breakpoint. 
After constructung a somatic cell hybrid, the original three mal"kers were mapped relative to the break point of the 
translocation and to other new markers. It was confirmed tbat the original mal'ken were al least 20 eM away from the 
position of the break point. In addition, we traced further family memhers or onr translocation GTS proband, and iden­
tified affected individuals who did not possess the translocation. We concluded that the translocation was not responsible 
for the GTS symptoms in our arrected proband. 
Keywords: Linkage anlllysis - Chromosome 3 - Chromosome 8 Cilles de la Tourelle Syndrome Translocation 46 XY 
t(3:8) (pit.3 q24.1) - Cytogenetic abnormality 
INTRODUCTION 
We report on a linkage study of a large family 
multiply affected with Gilles de la Tourette syndrome 
(GTS), chronic multiple tics (CMT) and obsessive 
compulsive behaviour (OCB) covering areas on 
chromosomes 3 and 8 following our discovery of a 
patient with GTS who also carried a balanced trans­
location 46 XY, t(3:8) (p2 L3 q24.1). GTS is thought 
to be a genetically detelmined disease which some­
times has a dominant mode of inheritance with in­
complete penetrance and expression as shown by 
segregation analyses carried out on several indepen­
dent GTS samples (Devor, 1984; Pauls and 
Leckmann, 1986; Curtis et 01., 1992; Eapen et al., 
1993). Because of the hereditary nature of GTS 
and the discovery of the translocation, markers on 
chromosome 3 and chromosome 8 were used on an 
unrelated large British kindred multiply affected 
with GTS, CMT and OCB (Robertson and Gourdie, 
1990) to lest the hypothesis that there would be 
linkage at the loci implicated by the cytogenetic 
abnormality. Three markers on chromosome 3 
(THRB, E41 and RAF I) produced positive lod scores 
(Brett et 01., 1990), so the area surrounding these 
markers was examined by using a further 16 linked 
markers. Cells were fused IIsing the PEG method as 
descrihed by Carriu and Povey (1979). A cell hybrid 
which conlaineli the abnormal chromosome 8 was 
found and used to map the break points relative to 
the markl:rs used. Chromosome 8 was investigated 
using 19 markers covering part of the p-ann and all 
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of the q-arm including the area around the break­
point. 
METHODS 
Family collection and diagnosis 
The pedigree (F24) lIsed for the linkage analysis was 
identified when the proband presented at a GTS clinic 
at the National Hospital for Neurology and Neuro­
surgery, Queen Square. The pedigree studied consists 
of 116 members, 85 ofwhol11 were individually inter­
viewed. The structure and paternity were confirmed 
using DNA fingerprinting. 
One of us (M.M.R.) evaluated individuals in the 
pedigree. Subjects were interviewed to assess 'case­
ness' using a semi-structured diagnostic interview to 
obtain DSM III criteria for GTS and CMT which has 
been developed by M.M.R. (Robertson et al., 1988). 
The protocol used is highly comparable with that used 
by other workers in the field. Other psychiatric diag­
noses were made using the SADS-L standardized 
interview (Spitzer et al., 1977) and Research 
Diagnostic Criteria (ROC) (Spitzer et al., 1978). 
Patients were assigned to diagnostic categories as 
follows: 
(J) 	Definite or probable GTS; satisfying DSM III 
(APA, 1980) criteria on history and/or exam­
ination. 
(2) 	Definite or probable CMT; DSM IIJ diagnosis 
on history and/or examination. 
(3) Obsessive 	 compulsive behaviours (OCB) 
without GTS or CMT; obtained on history 
and, in the case of children, corroborated by 
parents. 
Of the 85 interviewed 29 had GTS, a further 20 
had CMT without GTS and live had OCB alone 
(Robertson and Gourdie, 1990). 
RFLP and microsatellite polymorphism 
determination 
DNA was isolated from peripheral lymphocytes 
(Sam brook et al., 1989). Five to 10 p"g DNA was 
digested with 20-30 units of restriction enzymes 
overnight in buffers recommended by the manu­
facturer (Boehringer Manllhcilll or Amcrsham). The 
DNA was electrophoretically separated on 0.8% 
agarose gels and transferred to a nylon membrane 
(HybondN, Amersham) according to the manu­
facturers' protocols. The DNA was fixed to the 
membrane by UV irradiation. Prior to hybridization 
the blots were prehybridized in 0.9 M NaCi, 1% SDS 
with sheared salmon sperm DNA at a final concen­
] 00 Psychiatric Genetics . Vol 6 . 1996 
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tratiol1 of 50 mg ml- I for at least 4 h. Plasmid DNA 
from the probes was isolated according to the alka­
line lysate procedure of Birnboim and Doly (1979). 
Insert DNA was prepared by electroelution or by 
separation in low-melting agarose (Sambrook et aI., 
1989). The insert DNA was labelled by random 
priming (Feinberg and Vogelstein, 1983) with 32p_ 
dCTP (Amersham) to a specific activity of 2-10 x 108 
cpm ILg-1 and, after denaturation, added' to the 
hybridization buffer (0.9 M NaCI, 1% SDS, 10% 
dextran sulfate, 50 mg ml- I .sheared salmon sperm 
DNA). Hybridization was at 65°C overnight. The blots 
were washed once in I x SSC, 0.1 % SDS for 20 min 
at 65°C, followed by two washes at 65°C in 0.5-0.1 
SSC, 0.1% SDS for 20 min each. The hybridized 
filters were autoradiographed for up to 14 days using 
Fuji X-ray film at -70°e. 
PCR was performed in 12.5 ILl containing 50 ng 
DNA, 12.5 pmol of each primer, 1.0 mM MgCI2, 10 
mM Tris-Cl pH 8.3, 50 mM KCI, 25 !JM dATP and 
200 ILM of other dNTPs, 1 unit Taq polymerase 
(Perkin-Elmer/Cetus), 0.01% gelatin and 0.5 ILL End 
labelled primers were used for the microsatellite 
amplifications (100 pmol of primer labelled in 10 ILl 
with I ILl gamma-32p ATP at 3000 Ci mrnol-1, 0.1 ILl 
of this was used per reaction). Amplification was for 
35 cycles with denaturation at 94°C, annealing at the 
appropriate temperature for the primers and 20 s 
extension at n°e. The amplified product was sepa­
rated by polyacrylamide gel electrophoresis using a 
urea denaturing gel. The gels were fixed in 10% acetic 
acid! 10% methanol and vacuum dried on to 3 mm 
paper. The gels were autoradiographed using Fuji X­
ray film at -70°C for 1 h to 2 days depending on the 
primers used. 
Genetic analysi~ 
Two diagnostic categories were used to indicate posi­
tive affection status, GTS only and GTS and CMT. 
Based on the results ofa previous segregation analysis 
(Curtis et al., 1992), autosomal transmission was 
assumed with a gene frequency of 0.0005, and 
heterozygote penetrances of 0.5 for GTS and 0.88 for 
GTS and CMT. To allow for occasional phenocopies, 
the nOlmal homozygote penetrance was set to 0.00 I. 
No separate analysis was carried out including the 
OCB cases as affected, because four out of five of 
the OCB cases were obligate carriers under the 
assumption of dominant transmission. Two-point lod 
scores were calculated with F ASTLINK (Cottingham 
et al., 1993; Schaffer et al., 1994) for the polymor­
phic markers listed in Tables I and II. Markers used 
and their allele frequencies are shown in Tables I and 
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LINKAGE ANALYSIS IN GILLES DE LA TOURETIE SYNDROME 
TABLE I. Two-point lod scores for linkage between the two models of affection status and the markers 
used on chromosome 3 
Theta 0.000 0.010 0.050 0.100 0.200 0.300 
THRB microsatellite and RFLP 
GTS -2.095 
GTS and GMT -4.669 
-1.059 
-2.315 
-0.498 
-1.063 
-0.325 
-0.553 
-0.218 
-0.136 
-0.146 
0.018 
RAF 
GTS 
GTS and GMT 
1.768 
-3.291 
1.907 
-1.363 
2.338 
0.265 
2.365 
1.107 
1.865 
1.398 
1.131 
0.998 
R59 
GTS 
GTS and GMT 
-2.673 
-5.269 
-2.560 
-4.187 
-1.914 
-2.697 
-1.338 
-1.788 
-0.705 
-0.938 
-0.354 
-0.495 
03F15S2E 
GTS 
GTS and GMT 
0.246 
-3.831 
0.493 
-2.164 
0.784 
-0.850 
0.821 
-0.306 
0.661 
0.072 
0.423 
0.139 
03S196 
GTS 
GTS and GMT 
-10.351 
-16.025 
-7.958 
-10.438 
-5.013 
-5.995 
-3.429 
-4.072 
-1.759 
-2.203 
-0.827 
-1.192 
03S17 
GTS 
GTS and GMT 
-8.784 
-14.237 
-5.351 
-8.151 
-2.702 
-4.337 
-1.515 
-2.494 
- -0.372 
-0.688 
0.154 
0.013 
03S11 
GTS 
GTS and GMT 
0.399 
0.591 
0.667 
1.534 
1.012 
2.020 
1.100 
2.065 
0.997 
1.785 
0.733 
1.298 
03S5 
GTS 
GTS and GMT 
1.344 
-1.219 
1.319 
-0.075 
1.212 
0.539 
1.069 
0.719 
0.766 
0.690 
0.461 
0.468 
GP 
GTS 
GTS and GMT 
-4.020 
-5.998 
-3.186 
-4.003 
-2.241 
-1.967 
-1.605 
-0,851 
0.755 
-0.056 
-0.300 
0.078 
03S18 
GTS 
GTS and GMT 
-2.554 
-5.199 
-1.596 
-3.867 
-0.648 
-2.172 
-0.294 
-1.219 
-0.080 
-0.387 
-0.027 
-0.061 
03S1312 
GTS 
GTS and GMT 
-7.768 
-12.280 
-6.019 
-7.365 
-3.743 
-3.779 
-2.601 
-2.053 
-1.351 
-0.486 
-0.638 
-0.010 
03S1284 
GTS 
GTS and GMT 
-6.467 
-11.685 
-4.059 
-7.339 
-1.773 
-3.553 
-0.755 
-1.543 
-0.066 
0.031 
0.033 
0.422 
03S1281 
GTS 
GTS and GMT 
-6.421 
-16.675 
-4.894 
-10.200 
-2.531 
-5.473 
-1.206 
-3.062 
-0.172 
-1.003 
0.124 
-0.216 
LlB12-37 
GTS 
GTS and GMT 
-7.758 
-9.191 
-6.189 
-6.791 
-3.726 
-4.100 
-2.386 
-2.707 
-1.122 
-1.216 
-0.504 
-0.508 
03S1100 
GTS 
GTS and GMT 
-9.217 
-17.725 
-6.734 
-10.912 
-3.894 
-5.796 
-2.557 
-3.679 
-1.155 
-1.6"75 
-0.435 
-0.627 
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TABLE II. Two-point lod scores for linkage between affection status and the markers used on chromo­
some 8 
Theta 0.000 0.010 0.050 0.100 0.200 0.300 
TG 
GTS 
GTS and GMT 
-0.881 
-1.819 
-0.879 
-1.095 
-0.833 
-0.451 
-0.622 
-0.133 
-0.171 
0.179 
0.008 
0.206 
GA2 
GTS 
GTS and GMT 
-2.838 
-1.261 
-2.207 
-0.514 
-1.570 
0.061 
-1.170 
0.277 
-0.616 
0.411 
-0.282 
0.378 
GA3 
GTS 
GTS and GMT 
-3.852 
-4.333 
-3.199 
-4.061 
-2.144 
-2.880 
-1.441 
-2.012 
-0.734 
-.1.082 
-0.371 
-0.570 
NEFL 
GTS 
GTS and GMT 
-2.070 
-2.371 
-1.872 
-1.692 
-0.989 
-1.053 
-0.453 
-0.559 
0.011 
0.080 
0.153 
0.283 
PLAT 
GTS 
GTS and GMT 
0.333 
1.375 
0,324 
1.339 
0.285 
1.197 
0.233 
1.020 
0.129 
0.689 
0.048 
0.408 
08S39 
GTS 
GTS and GMT 
-10.130 
-9.577 
-7.724 
-6.776 
-4.653 
-3.453 
-2.935 
-1.644 
-1.260 
-0.130 
-0.484 
0.353 
08S38 
GMT 
GMT and GMT 
-0.906 
-2.935 
0.027 
-1.809 
0.875 
-0,244 
1.183 
0.380 
1.253 
0.748 
0.962 
0.654 
08S11 
GTS 
GTS and GMT 
-0.880 
-1.119 
-0.347 
-0.562 
0.163 
-0.017 
0.344 
0.192 
0.414 
0.301 
0.343 
0.266 
08S7 
GTS 
GTS and GMT 
0.663 
-0.383 
0.665 
-0.371 
0.656 
-0.307 
0.620 
-0.166 
0.512 
0.087 
0.385 
0.156 
08S8 
GTS 
GTS and GMT 
-0.377 
-4.797 
0.351 
-2.670 
0.809 
-0.932 
0.886 
-0.253 
0.765 
(1.216 
0.541 
0.294 
PENK 
GTS 
GTS and GMT 
-1.877 
-4.536 
-0.862 
-2.901 
0.075 
-1.069 
0.384 
-0.274 
0.474 
0.299 
0.360 
0.383 
08S556 
GTS 
GTS and GMT 
-5.411 
-16,521 
-4.079 
-10,862 
-2.550 
-6,251 
-1.480 
-3,854 
-0.390 
-1.613 
0.075 
-0.494 
08S284 
GTS 
GTS and GMT 
-5.392 
-13.358 
-3.770 
-8.015 
-1.700 
-3.751 
-0.779 
-2.027 
0.040 
-0.474 
0.316 
0.161 
08S554 
GTS 
GTS and GMT 
-8.539 
-14.038 
-5,649 
-9.446 
-2.778 
-5.697 
-1.112 
-3,128 
0.144 
-0.662 
0.405 
0.217 
D8S272 
GTS 
GTS and GMT 
-7.477 
-10.264 
-5.140 
-3.617 
-2.111 
-0.075 
-0.715 
1.212 
0.346 
1.898 
0.563 
1.677 
D8S373 
GTS 
GTS and GMT 
-10,097 
-15.047 
-7.998 
-9.430 
-4.636 
-4.646 
-2.834 
-2.632 
-1.218 
-0.941 
-0.510 
-2.222 
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FIG. 1. Approximate multipoint lod scores on chromosome 3 obtained from FA8TMAP by combining results from two-point 
analyses. (Map order and distances from the Genome database and Gyapay et al.. 1994.) 03817 is at 0 cM; 03818 at 
3cM; RAF1 at 6cM; THRB (RFlP and microsatellite) at 26cM; 03812 at 30cM; 03F1582 at 42cM; 0381312 at 57cM; 
0381284 at 77 cM; 0381281 at 97 cM; and 038196 at 137 cM. The break point is located between 0381312 and 0381100, 
which is at approximately 32 cM on this map. The dashed line indicates the GT8 affection model. while the dotted line 
includes both GT8 and CMT cases as affected. 
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FIG 2. Approximate multipoint lod scores on chromosome 8 obtained trom FA8TMAP by combining results from two-point 
analyses. (Map order and distances trom the Genome database and Gyapay et al .• 1994.) NEFL is at 0 cM; PLAT at 8 
cM; PENK at 17 cM; 0888 at 30 cM; CA3 at 39 cM; CA2 at 43 cM; 088556 at 59 cM; 088284 at 85 cM; 088554 at 97 
cM; 088272 at 98 cM; and 088373 is at 121 cM. The break point is located between markers 088556 and 088284. The 
dashed line indicates the GT8 affection model. while the dotted line includes both GT8 and CMT cases as affected. 
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II. Multiple two-point lod scores were combined 
into approximate multipoint maps using FASTMAP 
(CUliis and Gurling, 1993). 
RESULTS 
Investigation of the GTS family with 
translocation 
The mother was a definite case of GTS and a blood 
sample was found to be positive for the 3:8 translo­
cation. Of the other family members on the maternal 
side, about whom information was obtained, nine out 
of 14 had a diagnosis of GTS. Further blood samples 
were taken from the maternal grand f'ather, uncle ami 
aunt, who all had a diagnosis of GTS, to see if 
the translocation co-segregated with the GTS found 
in this family. The cytogenetic screens carried out 
showed that the proband (A B) and his mother were 
the only carriers of the translocation and therefore no 
fUliher cytogenetic screcns were underta ken on the 
other maternal relatives. From this we drew the 
conclusion thai the translocal ion was 11111 ikely to be 
involved in the aetiology or the tiTS and related dis­
orders in this family. 
Linkage analyses 
The markers E41, p627 and pBH302 produced a 
maximum lod score of 2.998 in an earlier multipoint 
analysis (Brett et al., 1990) using the map order 
THRB-D3SII-RAFI. This map order, however, 
proved to be inaccui'ate (Cl-ILC, 1993). Following this 
report many more markers in this region of chromo­
some 3 were typed and lod scores calculated 
(Table 111). Eleven of the markers were used for a 
FASTMAP analysis. The position of one of the orig­
inal three markers (D3SII) was omitted due to lack 
of certainty concerning the actual distances from 
flanking markers as was D3S J 100, for the same 
reason. The break point found in AB was mapped 
relative to the new markcrs and was found to be 
flanked by D3S I 100 and D3S 1312 in a gap of 25 
cM, which places the break point at least 20 cM prox­
imal to the positive lod score. With the new markers 
the region from D3S 17 to D3S IYCl was excluded (Iod 
< -2.00) using thc FASTMAP program as shown in 
Fig. I. 
On chromosome 8 a rew small, non-significant 
positive lod scores (Table IV) werc observed due 
mainly to a lack or heterozygosity in many of the 
older RFLP markers. These were investigated further 
by performing a FASTMAP analysis across some of 
the p-arm and all of the q-arm of chromosome 8 with 
I J linked markers. This proved to be negative (Iod < 
] 04 Psychiarric Generics . Vul () . 1996 
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-2.00) for the whole map (Fig. 2), and therefore the 
whole region was excluded from NEFL at 8p21 to 
D8S373 at the telomere of 8q. The break point on 
chromosome 8 was found to be in a 26 cM gap 
llanked by the markers D8S55Cl and D8S284, both of 
which were used in the F ASTMAP analysis. 
DISCUSSION 
From the results obtained using improved map data 
and further markers in the region surrounding the 
original positive lod score it was concluded that the 
original lod score did not reflect any involvement of 
the relevant chromosomes 3 and 8 in the aetiology 
of GTS in the family studied. The cytogenetic screens 
carried out showed that the proband and his mother 
were the only carriers of the translocation. From this 
the conclusion drawn was that the translocation was 
not likely to be involved in the aetiology of the GTS 
and related disorders in this family. Furthell11Ore, from 
work carried out on the cell hybrids from the proband 
we found that the actual clu·omosome 3 break point 
was localized proximal to the region producing the 
positive lod score. 
The results must, however, be interpreted with the 
possibility of heterogeneity in mind. This means 
that these exclusions may not apply to all GTS fami­
lies being studied by linkage methods. To date 
approximately 85% of the genome has been covered 
in the search for the predisposing gene in GTS 
(Pakstis et at., 1991; USA Tourette Syndrome 
Association Collaborative Group, personal communi­
cation) assuming homogeneity. Considerably less has 
been excluded assuming heterogeneity. 
The approach of examining candidate genes and 
regions implicated by cytogenetic abnonnalities is a 
potentially fruitful one in the current situation where 
a confirmed linkage has yet to be found. There have 
been a few other instances of reported associations 
between GTS and cytogenetic abnonnalities but these 
have not resulted in the localization of the predis­
posing gene, for example on chromosome 9p (Singh, 
1982; Taylor, 1990). With much of the genome 
already screened, furthcr randomly chosen markcrs 
should soon localize a susceptibility gene for GTS 
but this is likely to reault from work carried out in a 
single large kindred. 
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Neuroreceptor Subunit Genes and the Genetic 
Susceptibility to Gilles de la Tourette Syndrome 
Peter M. Brett, David Curtis, Mary M. Robertson, and Hugh M.D. Gurling 
Segregation studies have shown that Gilles de la Tourette Syndrome (GTS) is probably 
transmitted as an autosomal dominant gene disorder and can therefore be studied by classical 
linkage analysis to identify susceptibility loci. Many neurotransmitter systems have been 
implicated in the etiology of GTS. Most recently the alpha-l subunit of the glycine receptor 
etiologically responsible for hyperekplexia has been hypothesized as the cause of the 
susceptibility to GTS. Because of this and the high concentration ofother neuroreceptor genes 
at 5q33-35, it was decided to study this region and the associated gene cluster on chromosome 
4p12-16 in a large British kindred multiply clflected with GTS and chronic motor tics. The 
genotypes of the microsalellite markers at these loci were detennined by polymerase chain 
reaction. The allele data were ano.lyzed using both parametric and non parametric methotls. 
Approximate multipoint maps were constructed across the regions of interest using 
FAS'ILINK. All of the lod scores produced were negative. showing no evidence of linkage to 
GTS in the family studied. The multipoint maps showed good exclusion across tht'se regions. 
The glycine receptor gene responsible for hyperekplexia and the other neuroreceptor genes 
examined in this paper are not involved in the ~tiology ofGTS in this large pedigree. © 1997 
Society ofBiological Psychiatry 
Key Words: Gilles de la Tourette Syndr me, hyperekplexia, glycine receptor GABA 
receptors. linkage 
BIOL PSYCHIATRY 1997;42:941-947 
1992). When first described GTS was thought to be rare, Introduction 
bUl the currently accepted lifetime prevalence is of at least 
Gilles de la Tourette syndrome (GTS), first described in 0.5 per thousand (Robertson 1989). Segregation analyses 
1825 by hard and later in 1885 by Georges Gilles de la carried out on independent GTS samples have shown GTS 
Tourette (1899), is a neurological disorder characterized to be genetically detennined, with an autosomal dominant 
by multiple motor and one or more vocal tics (American mode of transmission with incomplete penetrance (Com' 
Psychiatric Association 1980; World Health Organization ings et al 1984; Devor 1984; Price et al J984; Pauls and 
Leckrnann 1986; Curtis et al 1992; Eapen el al 1993). 
From 'he Molecular Psychiauy Laboratory. Academic Depanmen' of Psythiarry. There have been several twin studies that have given 
University College London Medical School. London, United Kingdom. 
Address reprinl requests 10 Dr. Pelet M. Brett. Coeliac Research. The Rayne concordance data showing pleiotropy for the genetic 
Institute. S .. Thomas Hospital. Lambeth Palace Road, Londoo SEI 7EH. susceptibility for GTS (Shapiro and Shapiro 1980; Jenkins 
United Kingdom. 
Received March 13, 1996; revised October 24. 1996. et al 1983; Waserman et aJ 1983; Price et al 1984). 
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Hereditary startle disease or hyperekplexia (STIlE) is 
an autosomal dominant neurologic disorder that is caused 
by a base change in exon 6 of the alpha-l subunit of the 
glycine receptor (Shiang et al 1993). As such it is the first 
neurologic disorder found to be caused by a mutation in a 
neuroreceptor gene. It has been hypothesized that GTS 
may be caused by a mutation in the same gene, since GTS 
has exaggerated startle responses as a part of the symp­
tomatology (Floeter and Hallen 1993). The gene encoding 
for the glycine alpha) subunit (GLRA1) is located on 
chromosome 5q in an area rich with genes encoding for 
neuroreceptors. This region contains the genes for: gam­
ma-aminobutyric acid (GABA)A receptor alpha-I, a1­
pha-6. and gamma-2 subunits (GABRA), GABRA6. and 
GABRG2); dopamine 01 receptor; glutamate receptor 
GLUR I; the alpha ·adrenergic receptor ADRA t B; the beta 
adrenergic receptor ADRB2, and the glucocorticoid recep­
tor GRL (Hicks et al 1994; Shiang et al 1993; Warrington 
et aI 1991, 1992; Ryan et al 1992; Johnson et a11992). 
Due to this high concentration of neuroreceptor genes, it 
was decided to perfonn a linkage study of the whole 
region in a large British kindred multiply affected with 
GTS and chronic motor tics (CMT). We have chosen to 
study this large kindred as it may be assumed that a single 
locus is responsible for the susceptibility to GTS. CMT 
and obsessive-compulsive behaviors are thought to be 
variant phenotypes of the GTS susceptibility gene (Kurian 
1989; Eapen et al 1993). The GABAA receptor beta-l and 
a1pha-2 subunits (GABARBI and GABARA2).whichlie 
within 6 cM of each other on chromosome 4p (Dean et al 
1991; Wilcox et al 1992; Gregeret al 1995; Genome 
Database of Johns Hopkins University). and the gene 
encoding for dopamine transporter (DATI) on chromo­
some 5p (Vandenbergh et al (992) have been suggested to 
be involved in the etiology of GTS (Caine 1985; Cook et 
al 1995) and are, therefore. also good candidates for stUdy 
by linkage analysis. The linkage study was perfonned 
using microsatellite markers linked to the genes that werc 
hypothesized to have a role in the susceptibility to GTS. 
Methods 
Family Collection and Diagnosis 
The pedigree was identified when the proband presented at 
. a GTS clinic at the National Hospital for Neurology and 
Neurosurgery. Queen Square. The pedigree studied COll­
sists of 	116 members. 85 of whom were individually 
interviewed. The structure and paternity of the kindred 
were confinned using DNA fingerprinting. 
One of us (MMR) evaluated individuals in the pedigree. 
Subjects were interviewed to assess "caseitess" using a 
semistructured diagnostic interview to, obtain DSM-llJ 
P.M. Brea et al 
criteria for GTS and chronic multiple tic syndrome (CMT) 
that has been developed by MMR and used regularly at the 
National Hospital Queen Square (Robertson et al 1988). 
The protocol used is high1y comparable with other work­
ers in the field. Other psychiatric diagnoses were made 
using the Schedule for Affective Disorders and Schizo­
phrenia-Lifetime (SADS-L) standardized interview 
(Spitzer and Endicott 1977) and research diagnostic crite­
na (RDe) (Spitzer et al 1978). 
Patients were assigned to diagnostic categories as fol­
lows: 
I. Defmite 	or probable GTS; satisfying DSM-III 
(American Psychiatric Association 1980) criteria 
on history and/or examination. 
2. 	Definite or probable CMT; DSM-III diagnosis on 
history and/or examination. . 
3. Obsessive-compulsive 	 (OC)behaviors without 
GTS or CMT; SADS-L and ROC diagnoses ob­
tained on history and. in the case of children, 
corrobOrated by parents. 
Of the 85 interviewed. 35 had GTS. a further 14 had CMT 
without GTS. and 5 had OC behaviors alone (Robertson 
and Goutdie 1990). 
'Microsaullite Polymorphism Determination . 
Polymerase chain reaction (PCR) was perfonned in 12.5 
p..L containing: 50 ng DNA. J2.5 pmol of each primer. 1.0 
mmoJIL MgClz 10 mmoVL Tris-CI pH 8.3. 50 mmoVL 
KCI. 200 p..moVLof 2' -deoxynuc1eoside 5 t -triphosphate. 
1 unit Taq polymerase (Perkin-Elmer/Cetus), 0.01% gel­
atin. End-labeled primers were used for visua1ization of 
microsatellite amplification products (100 pmol of primer 
labeled in 10 p..L with) p..L gamma-32p adenosine triphos­
phate at 3000 Cilmmol; 0.1 p..L of this was used per 
reaction). Amplification ,was for 35 cycles with denatur­
ation at 94°C. annealing at the appropriate temperature for 
the primers and 20 sec extension at n°e. The amplified 
.product was separated by polyacrylamide gel electro­
phoresis using a urea denaturing gel. The gels were not 
fixed or vacuum dried. and 1Nere autoradiographed using 
Fuji X-ray film at -70°C for 1 hour to 2 days, depending 
on the primers used. 
LinI«1ge Analysis 
Two diagnostic categories were.used to indicate pOsitive 
affection. statuS, GTS only and GTS and CMT. Based on 
the results of a previous segregation analysis (Curtis et al 
1992), autosomal transmission was assumed with agene 
frequency of .0005. and heterozygote penetrances of .5 for 
G1'8 and .88 for GTS and CMT. To allow for occasional 
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Figure 2. Approximate multipoint lod scores obtained from FASTMAP by combining result~ from two-point analyses, with O4S174 
at -12 eM, GABRB I at 0 cM, D4S398 at 5 cM. and D4S1558 at 17 eM. GABRA2 maps between O4S 174 and GABRB I at 6 eM 
from D4S174. The dashed line indicates the GTS affection model; the dotted line includes both GTS and CMT cases as affected. 
match the patterns of inheritance found in GTS pedigrees, 
and that this may account for the lack of positive linkage 
in GTS. To exclude the possibility of model misspecifi­
cation, we also used nonparametric analyses. which make 
no assumption about the mode of transmission and con­
Imned our findings. 
The chromosomal regions excluded in the present study 
contain the genes GABRAl, GABRA6, GABRG2. 
GABRB1, GABRA2, GRL, GLURl, GLRA1, AORAl, 
AORB2, and ORO 1. These have all been mapped to these 
regions by radiation hybrid mapping andlor linkage anal­
ysis (Hicks et al 1994; Shiang et al 1993; Warrington et al 
1991, 1992; Ryan et al 1992; Johnson et al 1992). The 
exclusion of these genes has added to the number of 
potential candidate genes of neurological relevance that 
have recently been investigated. It does of course remain 
a possibility that if there is locus heterogeneity present in 
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Genome scan of Tourette syndrome in a single large pedigree 
shows some support for linkage to regions of chromosomes 
5,10 and 13 
D. Curtisa , P. Brettb, A.M. Dearlovec , A. McOuiliind, G. Kalsid, M.M. Robertsond 
and H.M.D. Gurlingd 
Objectives To localize genes influencing the susceptibility 
to Gilles de la Tourette syndrome (GT5) and associated 
chronic multiple tics (CMf). 
Method A single, large, multiple affected pedigree con­
taining 35 subjects diagnosed with GT5 and a further 14 
with CMT was genotyped for markers spanning the 
autosomes. linkage analysis was carried out using 
classical lad score analysis and model-free lod score 
analysis. All markers were subjected to two-point analysis, 
and markers producing a two-point result significant at 
P< 0.005 were subjected to three-point analysis using 
adjacent markers. 
Results The following markers produced at least one result 
significant at 0.005 using two-point analysis: 0551981, 
0552050, 0105591, 01 05189, 0135217, and 0145288. 
Three-point analysis with 0552050 and 055400 produced 
a lod of 2.9 with CMT. Three-point analysis of 01 05591 and 
0105189 produced lods of 1.9 with GT5 and CMT. Three­
point analysis of 0135217 and 0135171 produced a lad of 
2.7 with GT5. No single haplotype appeared to account for 
the majority of cases within the pedigree. 
Conclusions It seems likely that more than one suscept­
ibility allele is present in the pedigree. Although none of the 
Introduction 
Although there is good evidence that the familial 
aggregation of Tourette syndrome is at least in part due 
to the effects of single major loci (Pauls and Leckman, 
1986; Curtis et al, 1992; Hasstedt et aI., 1995; Walkup 
et al, 1996), attempts to date to localize the genes 
concerned have not been definitively successful. A 
number of linkage and association studies that were 
claimed to be posi rive have not been convincingly 
replicated. A genome screen of 76 families containing 
110 affected sib-pairs produced multipoint maximum­
likelihood scores (MLSs) greater than 2 at 4q and 8p, and 
MLSs greater than 1 in four other regions (Tourette 
Syndrome Association International Consortium for 
Genetics, 1999). Another genome scan in multigenera­
tional families did not produce any notable evidence for 
linkage using lod score analyses (Barr et al., 1999). Some 
0955·8829 © 2004 Lippincott Williams & Wilkins 
three positive regions is conclusively implicated, 
it seems probable that at least one contains a susceptibility 
locus. We recommend that association-based studies 
be carried out in these three regions to produce 
further evidence for a localization and to carry out fine­
mapping. Psychiatr Genet 14:83-87 © 2004 lippincott 
Williams & Wilkins. 
Psychiatric Genetics 2004, 14:83-87 
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positive results were obtained using the affected pedigree 
method, but the authors cautioned that this approach was 
prone to produce false positives. Perhaps the most 
promising finding is that a linkage study of a single large 
French Canadian pedigree that focused on a number of 
regions previously claimed to demonstrate association did 
in fact produce support for linkage to markers at llq23 
(Merette et aI., 2000). The implicated region included 
the marker 011S1277, which had demonstrated associa­
tion in a study of an Afrikaner population (Simonic et aI., 
1998): Several other loci have been claimed to demon­
strate association in single studies, including a number of 
so-called 'candidate genes', but such results have not 
been replicated in independent samples. 
Overall, although Tourette syndrome appears to have a 
major genetic contribution to aetiology that in at least 
001: 1O.1097/01.ypg,00001 07927.32051.15 
Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited. 
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some pedigrees appears to be due to single gene effects, 
attempts to map susceptibility genes have to date proved 
disappointingly unsuccessful. It is clear that at very least 
locus heterogeneity must exist, with more than one gene 
contributing to susceptibility. It may also be that the 
mode of inheritance is not as straightforward as initially 
hoped and, for example, that oligogenic effects char­
acterized by the combined action of two or more loci 
might be important. 
We report here on the linkage analysis of a large British 
pedigree containing multiple cases of Tourette syndrome 
and related disorders using markers covering the auto­
somal genome. Previously we have used this pedigree to 
carry out linkage analyses of particular genetic regions 
(Brett et aI., 1991, 1993, 1995a, 1995b, 1996) but this is 
the first account of a complete genome scan. The 
previous studies produced negative results for regions of 
chromosomes 3 and 8, and around genes coding for 
neuroreceptors and proteins involved in neurotransmitter 
metabolism. 
Methods 
Family collection and diagnosis 
The pedigree was identified when the proband presented 
at a Tourette syndrome clinic at the national Hospital for 
Neurology and Neurosurgery, Queen Square. The pedi­
gree studied consists of 116 members, 85 of whom were 
individually interviewed. The structure and paternity of 
the pedigree were confirmed using DNA fingerprinting. 
One of us (M.M.R.) evaluated individuals in the 
pedigree. Subjects were interviewed to assess 'case ness' 
using a semi-structured diagnostic interview to obtain 
DSM-III criteria (American Psychiatric Association, 
1980) for Gilles de la Tourette syndrome (GTS) and 
chronic multiple tic syndrome (CMT) that has been 
developed and used regularly at the National Hospital 
Queen Square (Robertson et al., 1988). Other psychiatric 
diagnoses were made using the Schedule for Affective 
Disorders and Schizophrenia-Lifetime standardized in­
terview (Spitzer and End icott, 1977) and research 
diagnostic criteria (Spitzer et 01., 1978). 
Patients were assigned to diagnostic categories and were 
counted as affected if they had definite or probable GTS 
or CMTon history and/or examination according to DSM­
III criteria. Of the 85 interviewed, 35 had GTS and a 
further 14 had CMT (Robertson and Gourdie, 1990). The 
pedigree extends over six generations, contains two in­
breeding loops and has been presented previously in a 
report which showed that the segregation of GTS and 
CMTwas consistent with the action of a single autosomal 
dominant gene with incomplete penetrance (Curtis et 01., 
1992). The pattern of segregation is consistent with one 
mutation derived from a single founder segregating 
throughout the entire pedigree, but we cannot exclude 
the possibility that susceptibility genes might enter the 
pedigree from more than one source. For the purposes of 
linkage analysis, two hierarchical affection definitions 
were used. In the first, denoted GTS, only subjects with 
GTS were classed as affected while all other subjects 
were classed as unaffected. In the second, denoted CMT, 
subjects with GTS or CMTwere classed as affected and 
others as unaffected. 
Genotyping 
DNA was isolated from whole frozen blood.. Subjects 
were typed using 393 microsatellite polymorphic markers 
spanning the genome from the ABI LMS2 (MDlO) 
mapping set. The average distance between these 
markers is 10 eM. Polymerase chain reaction (peR) 
reactions were carried out for each marker individually 
in a 5 III reaction volume, containing approximately 50 ng 
DNA, 2.5 mM Tris-HCI (pH 8.3), 50 mM KCI, 250 fJ.M 
dNTPs, 0.625 pmol each primer and 0.25 U Ampli taq 
Gold (Applied Biosystems, Foster City, California, USA). 
Reactions were carried out on a Applied Biosystems 9600 
thermal cycler or using an ABI 877 integrated thermal 
cycler robot. A standard thermocycling profile was used 
for all markers, and consisted of an initial denaturation of 
12 min at 95°C, followed by lO cycles with denaturation 
at 95°C for 15 s, annealing at 55°C for 15 s and synthesis 
at noc for 30s. This was followed by 20 cycles with 
denaturation at 89°C for 15 s, annealing at 55°C for 15 s 
and synthesis at noc for 30 s, finishing with an extension 
step of noc for 10 min. PCR products for selected sets of 
markers were pooled, ethanol precipi tated, and size­
fractionated on a 5% denaturing polyacrylamide gel 
(Amresco, Ohio, USA) by electrophoresis on an ABI 
377XL sequencer. PCR products were sized using the 
GeneScan® version 2.1 programme, and scored using the 
Genotyper® version 2.0 programme. Tests for Mendelian 
inheritance of marker data were carried out and incon­
sistent genotypes were repeated or omitted. 
Linkage analysis 
Linkage analysis was carried out using standard lod score 
methods and using 'model-free' likelihood-based analysis. 
For lod score analyses, the FASTLINK program was used 
(Cottingham et 01., 1993; Schaffer, 1996). Separate 
analyses were performed for the GTS and CMT models 
with penetrances of 0.5 and 0.8 and phenocopy risks of 
0.01 and 0.05, respectively. A dominant mode of 
transmission was assumed, with susceptibility allele 
frequency of 0.0005. 
The 'model-free' analyses were carried out using the 
MFLINK program (Curtis and Sham, 1995; Curtis et al, 
1999) and the accompanying MFMAP utility. MFLINK 
calculates the likelihood of the data with the disease 
locus at a given map position using a range of different 
Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited . 
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dominant and recessive transmission models having 
different penetrance values and phenocopy probabilities, 
but all yielding the same disease prevalence (Kp) and 
parameterized using a single variable, the heterozygote 
penetrance ifl, which is varied from 0 to 1). The MLOD 
is the maximum lod score obtained for any of these 
transmission models (maximized over Id. The MFLOD 
is the difference between the log-likelihood maximized 
over both II and alpha, the proportion of linked families, 
and the log-likelihood maximized over II but with alpha 
constrained to O. Since in the present analysis there is 
only one pedigree, the likelihoods are maximized with 
alpha set either to 1 or to 0; that is, under the 
assumptions that the pedigree does or does not harbour 
a susceptibility locus at the test position. MFLINK 
analyses were carried out using both the GTS and CMT 
affection models, with the population prevalence being 
set to 0.01 or 0.05, respectively, to match the prevalences 
used for the lod score analyses. Two-point analyses were 
carried out with each marker using a test position at a 
recombination fraction of 0.05 with the marker, and when 
three-point analyses were carried outthe position midway 
between a pair of adjacent markers was tested. 
An initial screen of all the markers using two-point 
analyses was performed. Each marker yielded two lod 
scores and four lod scores from the MFLINK analyses 
(MLOD and MFLOD for the GTS and CMT). Each type 
of lod score was converted to a likelihood ratio statistic by 
multiplying by 2In(10) = 4.6. The statistic derived from 
the conventional lod score was taken to be distributed as 
a 50:50 mixture of xi and xg. As originally described 
(Curtis and Sham, 1995), the likelihood ratio statistic 
from the MFLOD was taken to be distributed as a 50:50 
mixture of xi and xg. However, since there is only one 
pedigree this interpretation is likely to be somewhat 
conservative because MFLOD is not maximized over a 
range of different values of alpha, and alpha can only take 
values of 1 or O. Subsequently (Curtis et ai, 1999), it has 
been shown that 2In(lO)*MLOD can be taken to be 
distributed as xi. Using these distributions allows P 
values to be derived so that the different types of lod 
score can be compared more easily. All regions that 
yielded a result significant at P < 0.005 using any of the 
methods of analysis were selected for further study. 
Additional analyses from regions highlighted by the 
screening analyses consisted of computing three-point 
linkage analyses using pairs of adjacent markers. Because 
of the size of the pedigree and the fact that it included 
two loops, it proved impossible to carry out these analyses 
before first downcoding the genotype data so that each 
marker was recoded as having only five alleles. This was 
accomplished au tomatically using the DOLINK program 
(Cooketai, 1993), which carries out the recoding in such 
a way as to minimize loss of linkage information. Even 
when this had been done, it was not possible to 
incorporate more than two markers at a time in multi­
point analysis. Regardless of which method of analysis had 
produced the significant results, the three-point analyses 
were carried out using both GTS and CMT models, and 
obtaining conventional lod scores as well as MLOD and 
MFLOD statistics. 
Results 
The following markers produced at least one result 
significant at 0.005 using two-point analysis: D5S1981, 
D5S2050, DI0S591, DI0S189, D13S217, and D14S288. 
Results for these markers, along wi th nearby markers 
showing some support for linkage, are detailed in Table 1, 
where distances are shown according to those given in the 
ABI Prism V2 sex-averaged maps (http://gai.nci.nih.gov/ 
Table 1 Markers showing support for linkage with Gilles de la Tourette syndrome (GTS) and/or associated chronic multiple tics (CMT) 
using two-point analysis 
Map Name Lad MLOO MFLOO 
GTS GMT GTS GMT GTS GMT 
0.0 05S1981 1.785" 0.023 1.538' 0.210 1.538" 0.000 
173.3 05S2050 0.692t 1.083t 1.099t 1.781" 1.01Ot 1.781" 
177.2 05S400 0.465 1.008t 0.301 1.482' 0.000 1.396' 
13.0 010S591 1.425' 0.998t 1.738" 0.883t 1.321 0.442 
18.3 010S189 0.729 1.130t 1.619' 2.399" 1.214' 2.249" 
16.0 013S217 1.579" 0.209 1.319t 0.000 1.225' 0.000 
25.0 013S171 0.084 0.070 0.679 0.094 0.000 0.000 
33.1 013S218 0.744t 1.073t 1.704' 0.707 0.585 0.171 
33.3 014S70 0.533 0.893t 0.732 1.459' 0.000 0.000 
40.2 014S288 1.528" 1.014t 0.660 0.476 0.000 0.000 
MLOO, maximum lad score obtained for any Iransmission model (maximized over ',); MFLOO, difference between the log-likelihood maximized over both', and alpha, the 
proportion of linked families, and the log·likelihood maximized over " but with alpha constrained to O. 
·P<O.Ol; 
··P<0.005; 
tp<0.05. 
Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited. 
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ABI/index.html). The full set of results can be inspected 
online (http://www.mds.qmul.ac.uk!statgen/dcurtis/gtsscan. 
html). These markers were incorporated in three-point 
analyses with flanking markers. 
The results from three-point analysis provided increased 
support for linkage for the regions around D5S2050, 
DI0S591 and D13S217, but not around D5S1981 or 
D14S288. Three-point analysis between D5S2050 and 
D5S400 using the CMT model produced conventional 
lod scores of 2.9 (P = 0.0001) 10 cM proximal to 
D5S2050 and 2.0 (P = 0.001) between these markers, 
and also an MLOD between the markers of 2.9 
(P 0.0003) using a dominant model with penetrance 
of 0.6 and phenocopy probability of 0.02. The GTS model 
produced a lod of 1.9 (P = 0.002) proximal to DSS2040 
and an MLOD of 1.8 (P := 0.004). Three-point analysis 
of DlOSS91 and DlOS189 produced lods of 1.9 
(P 0.002) 10-20 cM proximal to the markers with both 
models and an MLOD between the markers of 1.8 
(P 0.004) with GTS and 1.6 (P 0.007) with CMT. 
Three-point analysis using the GTS model with D13S217 
and D13S171 produced a lod of 2.7 (P = 0.0002) 
proximal to the markers and of 2.0 (P 0.001) between 
the markers, while the MLOD midway between 
D13S171 and D13S218 was 2.5 (P = 0.0007). The 
CMT model produced lods of 1.1 (P 0.01) and 1.7 
(P = 0.003) with these pairs of markers. 
When the pedigree was inspected visually it did seem at 
least possible that affection with GTS and CMT 
might be related to the combined effects of susceptibility 
loci present in these three separate regions. 
Some genotypes were missing, especially in all the 
early generations and patterns of inheritance were 
often not clear. However, it did appear that many 
affected subjects in the major part of the pedigree shared 
a haplotype consisting of allele 1 at 010S591 and allele 2 
at 01OS189, while in the remaining small part of the 
pedigree affected subjects often received the 1-5 
haplotype. In this same small part affected subjects 
often shared the 2-5 haplotype of OSS20S0 and D5S400, 
but linkage to these markers was not apparent in most of 
the pedigree. Finally, the 3-4 haplotype of markers 
013S171 and D13S218 was present in many affected 
subjects scattered throughout the whole pedigree. At 
least one subject affected with GTS did not have 
any of these four haplotypes, although did have risk 
alleles from two of them, and could only be consistent 
with linkage if recombination had occurred. We regard 
such observations as quite subjective and not really 
adding to the evidence for linkage obtained from the 
formal statistical methods. Nevertheless, it did seem 
clear that there was not one single haplotype that could 
definitely be said to account for all or most of the cases of 
disease in the pedigree, and it seems very possible that 
more than one susceptibility allele is present, perhaps at 
more than one locus. 
Discussion 
The genome scan of this pedigree highlights three 
regions, on chromosomes 5, 10 and 13. The weight of 
evidence is about equal for each of these regions, and 
constitutes fairly strong support for linkage while failing 
to convincingly implicate any region conclusively. None of 
the regions overlaps with any demonstrating linkage to 
Tourette syndrome in previous studies, although the 
chromosome 5 region may coincide with that which 
appeared linked to the trait of hoarding in samples of sib 
pairs affected with Tourette syndrome (Zhang et ol, 
2002). This finding may well simply be a coincidence. 
Large pedigrees offer substantially greater power to 
detect linkage than samples of smaller families and sib­
pairs unless the susceptibility allele is very common and 
especially if locus heterogeneity is present. Tourette 
syndrome is fairly rare and there is good evidence for a 
major gene effect, while the failure to produce replicated 
evidence for linkage to date makes it probable that more 
than one locus is involved. These considerations imply 
that large pedigrees should be useful in detecting linkage. 
However, as the present case illustrates, large pedigrees 
can bring problems of their own. Multipoint and two­
locus analysis become problematic and patterns of 
inheritance are ambiguous in the early, untyped genera­
tions. This is especially so when the pedigree is not only 
large, but also complex, as with this one that contains two 
in-breeding loops. Perhaps more seriously, the larger the 
pedigree is the greater is the chance that it will contain 
twO or more susceptibility alleles segregating indepen­
dently, possibly at different loci. The probability of 
independent sources of disease occurring in the same 
pedigree is increased when, as is the case for Tourette 
syndrome, assortative mating is likely to take place 
(Kurian et ol, 1994; Hasstedt et oL, 1995). If alleles from 
different loci segregate within the same pedigree then 
simple methods of linkage analysis that assume a major 
gene effect is due to the actions of a single locus will have 
substantially reduced power to detect linkage. 
The results we have obtained seem to illustrate these 
problems. We do not find the kind of strongly convincing 
lod scores that we would expect were only a single locus 
to be influencing susceptibility, and we are severely 
limited in terms of the complexity of the analyses we can 
carry out. Nevertheless, we do find some evidence for 
linkage in each of the three regions highlighted and it 
does seem likely that at least one of them contains a 
susceptibility locus. 
Another disadvantage of single large pedigrees is that 
although they can provide strong evidence for linkage to a 
Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited. 
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region they are not helpful for fine-mapping, and indeed 
once one identifies a chromosomal segment that co­
segregates with disease it becomes impossible to 
demonstrate genetically which of many polymorphisms 
within that segment may be relevant. In order to fine­
map susceptibility loci and eventually to identify 
pathogenic allelic variants association-based methods 
must be used. It is possible that mutations present in 
the pedigree we have studied are rare, or even unique, 
and that they may not be found in many other cases of 
Tourette syndrome. Nevertheless, given the weight of 
evidence we have obtained for the three highlighted 
regions, we would recommend carrying out association 
studies of these regions using finely spaced (0.5 eM) 
markers. Such studies may provide more convincing 
evidence for a localization and can then be followed up by 
more intensive studies aimed at determining polymorph­
isms that contribute to the genetic susceptibility to 
Tourette syndrome. 
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Gilles de la Tourette Syndrome and Attention Deficit 

Hyperactivity Disorder: No Evidence 

for a Genetic Relationship 

Valsamma Eapen and *Mary M. Robertson 
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National Hosplla/for Neurology and Neurosurgery. London, England 
Summary: Previous studies have suggested a relation between Gilles de la Tourette 
syndrome (GTS) and attention deficit hyperactivity Disorder (ADHD). However, 
the findings are inconsistent as to the exact nature of the relation. Whether the 
disparate findings are due to ascertainment and referral bias, the use of high-den­
sity multiply affected kindreds, and family history data is a matter of debate. We 
studied 40 consecutive GTS probands and their 168 first-degree relatives (FDRs) 
to test whether the two disorders share a common genetic mechanism. All subjects 
included in the study were directly interviewed. Although the rate of ADHD in 
the GTS probailds was 40%, the rate ofADHD in the FDRs was 6%. Furthennore, 
the data were analyzed in two groups: relatives of probands with both GTS and 
ADHD and relatives of probands with GTS only. The rate ofADHD among rela­
tives of GTS+ADHD probands was 10.3%, and the rate in the GTS-ADHD 
group was 4.5%. In these families of GTS+ADHD probands, no evidence sug­
gested cosegregation of the two disorders. Our data do not support the view that 
ADHD may be an alternative expression of the putative GTS gene. Key Words: 
Gilles de la Tourette syndrome-Attention deficit hyperactivity disorder-Ge­
netic mechanism-Cosegregation. NNBN 9:192-196,1996 
Gilles de la Tourette syndrome (GTS) is a neuro­
psychiatric condition characterized by mUltiple mo­
tor and one or more vocal tics of> I-year duration 
and age of onset before age 21 years (I). The most 
widely used current definition of attention deficit dis­
order is that of the Diagnostic and Statistical Manual 
ofMental Disorders (DSM I IIR) (I), which has two 
diagnostic categories: attention deficit hyperactivity 
disorder (ADHD) and undifferentiated attention 
deficit disorder (UADD). 
ADHD has been reported to occur in a substantial 
proportion of GTS patients, with rates ranging from 
21 to 90% (2). However, the exact relation between 
the two disorders remains unclear and has been the 
Address corn:spondence and rcprin! requcsts to Dr. Valsamma 
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subject of much controversy. Researchers have sug­
gested that male GTS patients are more likely to have 
ADHD, that these symptoms often precede the devel­
opment of tics, andjhat they are more pronounced 
in those with a severe form of GTS (3-6). Sverd and 
colleagues (7) suggested that increased severity ofGTS 
symptoms is associated with an earlier age ofonset of 
behavioral problems such as ADHD. Furthermore, in 
clinic samples, there may be an overrepresentation of 
associated problems, in particular ADHD, because of 
referral and ascertainment bias (8). However, the de­
velopmental course of the two disorders differs 
slightly. In ADHD, by definition, age of onset is <7 
years. Although the subjects continue to have some 
attentional impairment into adult life, the symptoms 
mostly disappear after the early childhood years. In 
GTS, on the othcr hand, age at onset is -7 years and 
thc symptoms persisl into adult lire. 
The observation that stimulants used in the tre<1t­
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ment of ADHD cause, provoke, or exacerbate tics/ 
GTS has led to several possible explanations regarding 
the biochemical relation between the two disorders. 
Stimulants release dopamine (DA) and norepineph­
rine (NE) from the presynaptic nerve terminals (9). If 
indeed the hypothesis of increased dopaminergic ac­
tivity in GTS is correct, it is not surprising that the 
stimulant-induced increase in dopaminergic activity 
can precipitate the onset or cause exacerbation of 
GTS symptoms. Other evidence for such a relation 
derives from amphetamine-induced stereotypic be­
haviors in animals as well as from the occurrence 
of tremulousness and tics in patients taking toxic 
doses (10). 
At a neuroanatomic level, thalamocortical path­
ways and frontal lobe caudate nucleus pathways have 
been suggested to be related to hyperkinetic symp­
tomatology. Furthermore, a dysfunction in the dopa­
minergic pathways in the frontal lobe has been postu­
lated in hyperkinesis (II). Comings and Comings (12) 
postulated an imbalance of mesencephalic-mesolim­
bic DA pathways fort he pathogenesis ofGTS. 
Increasing evidence therefore suggests a consider­
able symptomatic, neuroanatomic, and biochemical 
overlap between GTS and ADHD. However, whether 
the association between the two disorders is due to 
such overlaps in neuroanatomically or biochemically 
mediated intermediate or final pathways in the gene­
sis of clinical symptoms, or indeed is the result of a 
shared primary etiology, is not clear. If a genetic rela­
tion does exist between GTS and ADHD and ADHD 
represents an alternative phenotypic expression of the 
same gene, it would be that a significantly greater 
number of relatives of GTS patients would be ex­
pected to have ADHD. In addition, the morbid risk of 
ADHD should be the same in relatives of GTS+­
ADHD probands, as compared with that in relatives 
of GTS-ADHD probands. However, if those with 
GTS and ADHD represent a distinct genetic subentity 
of the syndrome, the two conditions would cosegreg­
ate within families and both GTS and ADHD would 
coexist in a given individual much more often than is 
expected by chance alone (8). 
It bas also been suggested that the two disorders 
may share the same underlying genetic mechanism 
and that ADHD may represent a different manifesta­
tion of the GTS diathesis ( \3, 14). Other investigators 
have refuted such an association (6,8,15). There may 
be several explanations for this disparity in findings. 
Issues relating to ascertainment and referral bias have 
already been discussed. In addition, studies using fam­
ily history data have an inherent problem of misdiag­
nosis and undcrdiagnosis. Therefore, the true rates of 
illnesses among relatives may be ditIerent; conse­
quently, the pattern of illnesses within families can be 
affected by such reporting bias (16,17). This is partic­
ularly relevant in the case of ADHD with an early age 
of onset, and most subjects reporting about lheir rela­
tives may be relying on their memories or other peo­
ple's accounts oftheir behaviorduringchildhood. The 
use of multiply affected families in some studies and 
the fact that most probands had a severe form of the 
disorder are other important factors that may have in­
fluenced the findings of these studies. A much better 
test of genetic relation between ADHD and GTS can 
be accomplished with a large sample of small families 
that have been ascertained without regard to familial 
loading. 
SUBJECTS AND MEnlODS 
This study was performed with data obtained from 
direct clinical examination of families ascertained 
through 40 consecutive new cases of GTS (DSM 
II 1 R), registered at the National Hospital for Neurol­
ogy and Neurosurgery (NHNN), London, England, in 
an 8-month period. Two other patients were exam­
ined during this time, but their families were not in­
cluded in this study because infonnation was not 
available about the biological relatives. Of the 40 pro­
bands, 21 were aged < 16 years. 
All subjects underwent direct clinical examination 
by the National Hospital Interview Shedule (NHIS) 
for the assessment of GTS and related behaviors, 
which has been used in previous phenomenological 
and genetic studies (18, I 9). The NHIS is a semistruc­
tured interview schedule designed for use by specially 
trained clinicians. Subjects were interviewed in the 
company of other infonnants (typically parents or 
spouses). For subjects aged < 16 years, a parent in­
terview was always obtained and was combined with 
a clinical observation at the time of the interview. All 
168 FDRs included in the study were personally in­
terviewed by the same investigator (V.E.); 132 FDRs 
were interviewed at the NHNN clinic and 36 were in­
teNiewed at home. For those interviewed at the clinic, 
diagnosis was assigned by an independent clinician 
(M.M.R.) and consensus was obtained. After comple­
tion of the interview, family history data were col­
lected in a semistructured interview from each infor­
mant about all his or her FDRs. 
For a diagnosis of ADHD, information was gath­
ered from the parent on problems relating to inatten­
tion, hyperactivity, and impulsivity according to the 
DSM 11 I R crileria. The criteria items as given in the 
NH IS were used as a guide; in addition, Ihe data from 
Family Psychialric History (questions adapted from 
the Schedule ror Ancctive Disorders and Schizophrc­
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nia for school age children) were used to make a diag­
nosis of ADHD. Thus, questions regarding inatten­
tion included information about whether the child 
had difficulty finishing chores, listening, and paying 
attention and whether the child was distractable in 
several different settings. For impulsivity, informa­
tion was collected about the ability of the child to 
complete tasks, to wait his or her turn in group activi­
ties, or to think about the consequences of something 
before acting on it. For hyperactivity, questions were 
asked about whether the child "often" had trouble sit­
ting still, and whether the child could be considered 
"always on the go." The term often was interpreted 
to the parent as behaviors occurring in > 50% of the 
situations, and this was taken as an indication of the 
"pervasive" nature of the problem. The age of onset 
was specified as before age 7 years and duration as >6 
months. Whenever possible, while interviewing adult 
subjects whose parents were not part of the study pop­
ulation, we obtained information by a telephone in­
terview with the parent, using the Family Psychiatric 
History. School and teacher reports were not ob­
tained. 
These family history data were included in the final 
diagnostic estimates of the relatives. After interviews 
in a given family were completed, all available infor­
mation (personal interview and family history de­
scriptions) for each person were collated and diagnos­
tic ratings were completed using DSM III R criteria. 
Independent diagnostic estimates were performed by 
the two clinicians (V.E. and M.M.R.) based on all the 
collated information. Disagreements were resolved by 
a joint interview, and consensus using a "best esti­
mate" method ofdiagnosis was adopted (20). Ifsymp­
toms were present both on history and examination, 
a "definite" diagnosis was assigned. Ifsymptoms were 
present on examination but supporting information 
from personal history and family reports was lacking, 
a "probable" diagnosis was given. Finally, if symp­
toms were present on history but were not sufficient 
to satisfy either a definite or a probable diagnosis, a 
"possible" diagnosis was given. Only definite and 
probable diagnoses were used in the analysis reported. 
Goodness of Fit Test 
FDRs were grouped according to sex of the pro­
band, sex of the relative, and the relation to the pro­
band (e.g., fathers of male probands, brothers of fe­
male probands). Using the goodness of fit test as in­
corporated in the program POINTER (21), one can 
calculate the expected risk ofoccurrence of individual 
and combined diagnosis ofGTS and ADHD based on 
[he best fitting genetic model [for this family data set. 
TABLE I. Rates oftics and ADHD amant; relatives of 

GTS probands 

Tics ADHD 
Group (%) (%) 
Relatives orGTS+ADHO 
probands (n = 58) 
ReiativesorGTS-ADHD 
probands (n = 110) 
19 (32.8) 
32 (29.1) 
6 (IO.]) 
5 (4.5) 
Total In = 168) 51 (30.6) II (6.5) 
GTS. Gilles de la Tourette syndrome; AOHD. attention deficit 
hyperactivity syndrome. 
segregation analysis had shown that an autosomal do­
minant model gave the best fit (19)] and compare this 
with the observed rates of illnesses in the families. A 
statistically significant difference evident between the 
predicted and observed rates could be regarded as an 
indication to suggest poor fit for the data. If, on the 
other hand, for any particular clinical behavior in 
question, the expected and observed rates were not 
statistically different, this would indicate an integral 
part of the expression of the syndrome and hence sug­
gesting a clinical phenotype. 
To examine whether GTS and ADHD share a com­
mon genetic mechanism and whether indeed ADHD 
is a clinical phenotype of GTS, we analyzed the data 
from probands and FDRs who fulfilled the diagnostic 
criteria for ADHD accord{ng to DSM III R criteria. 
The data were analyzed in two groups: the relatives of 
pro bands with both GTS and ADHD and the relatives 
of probands \\rith GTS only. Goodness of fit test was 
performed with expected and observed rates as al­
ready detailed. 
RESULTS 
Ofthe 40 GTS prObands, 16 subjects (40%) fulfilled 
the diagnostic criteria for ADHD. The M/F ratio of 
the probands was 3: I. In ali, 168 relatives (M 90, F 78) 
were studied: 30 (17.9%) had GTS, 21 (12.5%) had 
chronic multiple tics (CMT), and II (6.5%) had 
ADHD. When we divided the data into two groups 
(relatives of GTS+ADHD probands and relatives of 
GTS-ADHD probands) we noted that the occur­
rence of ADHD was more than double in the former 
group as compared with the latter (10.3 vs. 4.5%), al­
though this did not reach statistical significance, 
whereas the occurrence of tics did not differ (32.8 vs. 
29.J%) greatly between the two groups (Table I). 
Males comprised 81 % of the GTS+ADH 0 probands 
and 70% of tile GTS-ADHD probands. 
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TABLE 2. FrcqucncyofGTS. CMT. andADHDamonl: TABLE 4. J-:xpec/cd and ohservcd numher o{re/allve.\" in 
relativcs olGTSprobands families ofpro hands willi GTS+ADI1D 
Diagnosis n Frequency 
GTSonly 23 0.137 ± 0.034 
CMTonly 20 0.119 ± 0.031 
ADHDonly 3 0.012±0.014 
GTS+ADHD 7 0.041 ± 0.023 
CMT-ADHD 0.006 ± 0.003 
CMT, chronic multiple tics; Olher abbreviations as in Table I. 
Table 2 shows the frequency of GTS, CMT, and 
ADHD among all 168 FDRs; Table 3 shows the fre­
quency separately for GTS+ADHD probands and 
GTS-ADHD probands. The frequencies were calcu­
lated with the computer programme POINTER (21), 
Only three individuals had ADHD without some tic 
disorder. Furthermore, although most probands diag­
nosed as having GTS+ADHD were rated as moderate 
to severe (mild == 12.5%, moderate 56%, severe == 
31.5%) on the clinician's rating (based on the impair­
ment of functioning and need for medication) and the 
Yale Global Tic Severity Scale (22), those with 
GTS-ADHD more often received a mild to moderate 
rating (mild 40%, moderate = 31 %, severe 29%). 
To test whether GTS and ADHD were cosegregat­
ing within families, we studied the association ofGTS 
and ADHD in the affected relatives of GTS+ADHD 
probands. If cosegregation exists, there should be a 
nonrandom association different from that predicted. 
The observed and expected risks ofbeing affected with 
individual (GTS, CMT, ADHD) and combined diag­
nosis (GTS+ADHD and CMT+ADHD) are shown 
in Table 4. Goodness offit chi-square test showed that 
the expected and observed rates were not significantly 
different, suggesting that the association is in no way 
different from that expected by chance alone. 
DISCUSSION 
Our results support the fact that the rate of occur­
rence of ADHD is increased in GTS probands (40%), 
which is in keeping with results of earlier studies. AI­
TABLE 3. FrequencyofGTS. CMT. and ADHDamong 
relatives ofGTS+ADHD probands as compared with 
GTS-ADHD probands 
Relatives orCTS+ADHD Relatives or GTS-ADHD 
Diagnosis probands probands 
GTS 13/58 (0.224) 17/110(0.154) 
CMT 6/58 (0.103) J5/ J J 0 (0. 136) 
ADHD 6/58 (0.103) 5/110 (0.045) 
Ahbrcyiations as in Tablcs I and 2. 
Diagnosis Expecled Observcd 
GTS 6.02 9 
CMT 4.20 6 
ADHD 2.18 2 
GTS+ADHD 2.38 4 
CMT+ADHD 0.32 0 
None 42.89 37 
Abbrevialions as in Tables I and 2. 

Chi-square ~ 4.502. 

though the M/F ratio of the total sample of probands 
was J: I, there were proportionately more males in the 
GTS+ADHD group, as expected. However, only 
6.5% of the FDRs qualified for a diagnosis of ADHD. 
Because there were no control subjects in the study, it 
is difficult to compare this percentage with the avail­
able general population prevalence, estimated to be 
3-\0% (23). 
Between-group comparisons showed a much higher 
occurrence of ADHD among relatives of GTS+­
ADHD probands. There are different ways of explain­
ing this finding. First, the two disorders are not genet­
ically related. Second, GTS+ADHD represent a dis­
tinct genetic subtype, and they cosegregate within 
families. However, our findings from the goodness of 
fit test suggest that the two disorders appear to segre­
gate independently. Third, GTS+ADHD may be a 
clinically separate group representing a more severe 
form of the disorder with more extensive invoLvement 
of neurochemicals and neuroanatomic structures and 
thus possibly causes greater risk of exhibiting ADHD 
symptoms. Our finding that the GTS+ADHD sub­
jects had a more severe form of the disorder tends to 
support this view. Age and sex may be other modify­
ing factors. Very few of our probands in the GTS+­
ADHD group were females, thus precluding any 
meaningful comparisons between groups based on the 
sex of the proba-nd~ !findeed an association exists be­
tween age of onset, sex, and severity, the referral bias 
in clinic samples may be further compounded. 
The finding that only three relatives had ADHD in 
the absence of tics is of interest. If ADHD were an 
alternative expression of the same gene, one would ex­
pect more relatives to have ADHD, in the absence of 
any tics. However. ADHD may well be one aspect of 
the GTS phenotype, mediated by an overlap in the 
intermediate or final pathways of expression, rather 
than an alternative expression. The overlap could ex­
ist at a biochemical (common neurotransmitter in­
volvement such as DA and NE), neuroanatomic (both 
basal ganglia and rronlallobc have been implicated in 
both the di~ordcrs). or symptomatic level. For exam-
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pIe, children with GTS, because of their involuntary 
movements, may appear fidgety and overactive. In 
addition, if they try to suppress their tics, they may 
experience mounting inner tension. which in turn 
may affect their ability to attend to and concentrate in 
tasks. Therefore ADHD occurring in the context of 
GTS may be the result of different mechanisms. vary­
ing from being a clinical aspect of GTS itself, being 
secondary to the GTS symptoms; being a behavior 
that forms a final common pathway for a variety of 
conditions in which frontal lobe and basal ganglia are 
involved, of which GTS is one; or being a comorbid 
condition exaggerated by referral and ascertainment 
bias. This may also be the result ofBerkson effect (24), 
by which, for statistical reasons separate from referral 
bias, the comorbidity rate in clinical samples will al­
ways be greater than that in .the general population 
whenever only a small proportion of the condition.s 
constituting the comorbidity pattern are referred to 
the clinics. Other explanations include shared and 
overlapping risk factors and diagnostic considera­
tions. 
Our failure to detect cosegregation will have to be 
interpreted cautiously because of the small sample 
size. However, because our findings are not signifi,. 
cant, the power of the analysis is estimated to be 0.78 
(dJ = 5; ex =: .33; (J = .22). Other limitations of our 
study include lack of a control group to allow calcula­
tion of the base rates of ADHD. Furthermore, there 
was no ADHD proband group with which to compare 
the rate of GTS in the FDRs. In addition, the in­
terviewer was not blind to the GTS diagnosis of the 
proband. However, we do believe this has not biased 
our findings because the main focus was the difference 
in rates between relatives of GTS+ADHD and 
GTS-ADHD probands, and although not blind as to 
the GTS status of the proband, the investigator was 
not aware at the time ofinterviewing the family mem­
bers of whether the proband also had a diagnosis of 
ADHD. 
Further studies are indicated with a larger sample 
size, using normal subjects and ADHD probands as 
controls, and taking into account some of the relevant 
patien t characteristics such as the age of onset of tics 
and ADHD, sex of the proband, and severity of the 
disorder.. 
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~d may represent one critical period when ge­
information is "tagged" or marked, and methyl­
may be the molecular mechanism involved in 
orarily changing the genetic information to per­
:lifferential expression.2 This is contrary to the 
:lelian tenet that the parental source of genetic 
'mation does not influence gene expression. 
lmic imprinting, however, appears to be a form 
gulation allowing another level of flexibility in 
:ontrol of expression of the human genome. 
~nomic imprinting is found in several genetic 
-ders, including Prader-Willi and Angelman syn­
les,3 bilateral retinoblastoma,4 myotonic dystro­
and Huntington's disease.6 Other examples 
~re the sex of the transmitting parent is shown to 
lence the severity or nature of the clinical ex­
,sion include neurofibromatosis types 1 and 2,7.8 
-bellar ataxia,9 seizures,1() spinocerebellar atax­
and Fragile X syndrome. 12 Furthermore, if there 
-two loci for a disorder, there may be two different 
lS of imprinting, as might be found with tuberous 
rosis and adult polycystic kidney.2 However, for 
-IY genetic disorders, there are no data on the 
>rential expression of specific genes when inher­
from the father versus the mother. The role of 
er in parental origin is particularly relevant in 
case of Tourette's syndrome (TS), because there 
known sex effects observed in this disorder; for 
pIe, females more often have an obsessive com­
ive expression of the disorder and there are more 
14cted males than females. 13•
hods. The families for this study were identified 
ugh the TS clinic at the National Hospital for Neurol­
and Neurosurgery, Queen Square, London, U.K. In 
ition to the 168 First Degree Relatives (FDRs) ascer­
ed through 40 consecutive TS probands for whom seg­
tion analysis had indicated an autosomal dominant 
smission,15 the study also included 229 family mem­
from 17 multigenerational TS pedigrees (where there 
'e more than five affected family members) chosen for 
purpose of linkage analyses.16 Direct clinical examina­
was carried out in all the subjects using the National 
'pital Interview schedule for the assessment of TS and 
ted behaviors. This is a semi-structured interview 
edule that has been used in previous genetic studiesl 4-l6 
uses the best estimate diagnosis methodP The reli­
lity and validity of this instrument are established. 18 
Subjects were interviewed in the company of other in­
ants, typically parents or spouses. For those subjects 
er age 16, a parent interview was always obtained, and 
s was combined with the clinical observation at the time 
the interview. For those subjects above age 16 whose 
ents were not part of the study population, information 
ut childhood was obtained by a telephone interview. 
mily history data were collected from each informant 
ut all FDRs, and were included in the final diagnostic 
imates of each of the relatives. Thus, following the com­
tion of all interviews within a given family, all available 
.ormation (personal interview and family history de­
iptions) for each individual was conated and diagnostic 
tings were completed using DSM IIIR criteria,19 When 
Table Rate of occurrence of TS, CMT and aCB in offspring of 
transmitting males and females 
---~--~-
TS 
N (%) 
CMT 
N (%) 
--~-
aCB 
N (%) 
-.-.~.--
Paternal transmission 50177 (50%) 70177 (90.9%) 26177 (33.6%) 
Maternal 
transmission 
60/80 (75%) 77/80 (96.2%) 29/80 (36.2%) 
p with 1 df 0.168 0.172 0.744 
TS >= Tourette's syndrome; CMT '" chronic motor tics; aCB '" 
obsessive compulsive behavior; df degree offreedom. 
symptoms were present both on history and on examina­
tion, a "definite" diagnosis was assigned. If symptoms were 
present on examination but there was lack of supporting 
information from personal history and family reports, a 
"probable" diagnosis was given. Finally, if some symptoms 
were present on history but not enough to satisfy either a 
probable or definite diagnosis, a "possible" diagnosis was 
given. Only definite and probable diagnoses were used in 
the analyses reported here. 
Age at onset was defined in terms of the onset of first 
symptom (motor tic, vocal tic, or obsessive compulsive be­
havior) and where possible, this was corroborated by the 
parent or relatives. The phenotypic definitions used in the 
analyses were TS, chronic motor tic, and obsessive compul­
sive behavior (based on the consensus from available liter­
ature). The age at onset, age at diagnosis, and phenotypic 
expressions in the offspring of affected males were com­
pared with that of the offspring of affected females. Data 
were verified after entry into a database and t test and 
chi-square analyses were done using SPSSIPC (SPSS Inc., 
Chicago, IL).20 
Results. Of the total 437 subjects, 73 f:ases (16.7%) dem­
onstrated evidence of maternal transmission and 61 cases 
(13.9%) demonstrated paternal transmission. The offspring 
showing evidence of maternal transmission showed earlier 
age at onset (mean 7.04; SD = 3.05) when compared 
with offspring showing evidence of paternal transmission 
(mean 8.50; SD 3.79), which was statistically signifi­
cant (t = ~2.43; df = 132; two-tailed p < 0.017). We 
performed the Mann-Whitney U test on~the age at inter­
view to check whether this finding ,,;jas due to a bias 
through sampling younger or older people in either of the 
two groups. The age distribution was not significantly dif­
ferent (two-tailed p "" 0.3379) between the two groups. 
Chi-square analyses (chi-square for heterogeneity) of the 
different phenotypic definitions and sex of the transmit­
ting parent failed to provide evidence of significant group 
differences (table). In addition, there were no significant 
differences between the two groups regarding the age at 
diagnosis. 
Discussion. If the age at onset of symptoms in TS 
is determined by an age-dependent methylation of 
the putative TS gene or some other chronogenetic 
mechanism,21 then the effect must stem from early 
embryogenesis. In adult polycystic kidney disease22 
some linkage data suggest that there are two or 
more linkage groups, and th~t there is an earlier age 
at onset of the disease with maternal transmission 
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for one group, and with paternal transmission for the 
other. If a similar mechanism is in operation in TS, 
perhaps there is more than one locus involved in 
causing distinct subtypes. This could be considered 
as one of the reasons for the failure so far to estab­
lish linkage in TS. Another plausible explanation of 
the finding may be that intrauterine environmental 
influences may act to produce the early onset of TS 
symptoms in those individuals carrying the putative 
gene. Such a mechanism is shown to be in operation 
in myotonic dystrophy.23 Possible candidates for such 
an influence in TS include perinatal events, exposure 
to chronic intermittent psychosocial stress, exposure 
to thermal stress, exposure to androgenic steroids, 
and exposure to cocaine or other stimulants.24 
In this study, there were no between-group differ­
ences with regard to age at diagnosis or phenotypic 
expressions. The latter finding is in keeping with the 
study by Furtado and Suchowersky,25 who failed to 
find any significant differences in the age at onset or 
the frequency of occurrence of various TS-related 
symptoms between maternally and paternally trans­
mitted cases. However, that study was limited be­
cause of the small sample size, and the use of a 
retrospective mediS9-1 ch~rt ~fview meth?d; we sus­
pect that the informatIon 111 the medIcal charts 
would be particularly unreliable for the age at onset. 
In our study, we believe that a more accurate esti­
mate of the age at onset and diagnostic status of the 
relatives has been achieved by using the direct inter­
view method coupled with the family history data. 
The variable expressivity of TS could camouflage 
mild cases if they( are not clinically examined. There­
fore, we included in the analysis only those subjects 
who were available for examination. To overcome 
any bias due to a child's knowledge of minor symp­
toms in a mother compared to a father, we used 
multiple informants, and the information given by 
all other family members about a given subject was 
used in arriving at the best estimated diagnosis. Al­
though the clinical rater was not blind to the family 
history, thus adding an element of bias in the rat­
ings, this is unlikely to influence the information 
about the age at onset, which is the main positive 
finding in this study. However, the sex of the af­
fected parent could be a confounding factor in the 
reporting of age at onset. For example, a mother who 
is affected and hence familiar with TS symptoms 
may identify early manifestations of the condition in 
her offspring, compared with an affected father, who 
may not notice manifestations in offspring as early. 
Lichter et aL,26 using family history methodology, 
found that maternal transmission was associated 
with greater motor tic complexity and more frequent 
non-interfering rituals, while paternal transmission 
was associated with increased vocal tic frequency 
and more prominent attention-deficit hyperactivity 
disorder (ADHD) behaviors. In our study, we did not 
use ADHD as a possible phenotypic expression, given 
31the controversy sun'ounding this issue.27. 
The pedigree of a disease gene, and its mutation 
936 NEUROLOGY 48 April 1997 
that is imprintable, can appear to show autosomal 
dominant, autosomal recessive, or multifactorial in­
heritance, depending on which part of the family is 
being observed.32 Thus, the findings from this stUdy 
indicate that there is a need to re-examine family 
data separately for maternally versus paternally 
transmitted cases. 
If this finding can be replicated consistently, the 
earlier age at onset found in maternally transmitted 
cases offers a new dimension for further investiga­
tions, as it suggests a new level of control in the 
nature and expression of the putative TS gene. At 
present, however, only a small percentage of families 
seems to manifest this differential effect, suggesting 
that if these are imprinting effects, they do not Occur 
in all families or between all chromosome parts. Nev­
ertheless, the trend towards differential expression 
when inherited primarily from the male or female 
parent poses a new challenge and raises the possibil­
ity of imprinting as one of the modifying factors in 
the genesis and expression of TS. 
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Bilineal transDlission in 

Tourette's. syndro1lle falDilies 

R. KurIan, MD; V. Espen, MD; J. Stem, MD; M.P. McDermott, PhD; and M.M. Robertson, MD 
Article abstract-We assessed the frequency of biIineal (from maternal and paternal sides) transmission of 
Tourette's syndrome (1'8) in two groups of pedigrees: (1) 39 high-density families in which five or more relatives were 
reported w have 1'8. and (2) the families of 39 consecutively ascertained probands referred for evaluation of 1'8. We 
used two designations for the TS phenotype (tics, tics or obsessive-compulsive behavior lOCB)), and we attempW to 
verity bilineal transmission with direct examinations. For the high-density pedigrees, biIineal traMmission was evi­
dent in 33% (considering tics) and 41% (considering tics or OCB) offamilies. which was confirmed by examination in 
77% of the kindreds. For the consecutive pedigrees, bilineal transmission was seen in 15% (tics) and 26% (tics or OCB) 
of families, which was verified by examination in 66% of the kindreds. Both parents ofthe proband were atre<':ted (tics 
or OCB) in 38% of the high·density pedigrees and 10% of the consecutive pedigrees. For the high-density families only, 
the frequency of bilineal transmission appeared to be related to the proband's severity of 1'8, and for both pedigree 
groups, the frequency of both parents being affected was higher in families in which the proband's symptoms were 
most severe. Our findings suppvrt the contention that bilineal transmission and homozygosity are common in TS. 
These genetic phenomena might playa role in determining severity of illness and may explain current difficulties in lo­
calizing the gene defect by linkage analysis. 
NEUROLOGY 1994;44:2336-2342 
Although Gilles de la Tourette described the famil­
ial nature of the condition he reported in 1885, it 
was not until the Jate 19705 that studies demon­
strated an increased frequency of tics in the fami­
lies of Tourette's syndrome (TS) patients.)'" Analy­
sis of family history data by Pauls et a14 supported 
vertical transmission of tics, thereby suggesting a 
heredit.a..Qt etiology for the disorder. Five separate 
studies used family hlstory information to test spe­
cific genetic hypotheses regarding the hereditary 
transmission pattern of TS.f>.9 An studies reported 
that the pattern of inheritance was consistent with 
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8 single gene of major effect; three of the studies 
supported an autosomal dominant model,5,7.' and 
two could not reject a hypothesis of multifactorial­
polygenic transmission.6.? Data obtained from di­
rect examinations of the first-degree relatives ofTS 
probands were subsequently used for segregation 
analyses, which supported autosomal dominant in­
heritance and indicated that chronic tic disorder 
and obsessive-compulsive disorder are variant ex­
pressions of the syndrome. to The most recently per­
formed segregation analysis studies continue to 
support an autosomal dominant transmission pat­
tern in studied families. ll•12 . 
In 1989, Coml'ngs et aP3 reviewed 170 TS pedi­
grees and found that in 8.2% of the families there 
was a history of tics on both the maternal and pa­
ternal sides. In addition, behaviors potentially as­
sociated with TS, including obsessive-compulsive 
behavior (DeB), panic attacks, attention deficit hy­
peractivity disorder, and severe alcohol or drug 
abuse, were present on both sides for 34.7% of the 
families. Based on these observations, the authors 
suggested that many individuals with TS may be 
homozygous for the disease gene defect. Further­
more, they proposed that the hereditary transmis­
sion pattern for 1'8 can be best described as ·semi­
dominant, semi-recessive," whereby clinical expres­
sion is determined by whether an individual inher­
its one or two doses of the TS gene (ie, 1'8 is a dom­
inant trait with a dosage effect). This work has not 
received wide acceptance since the data was based 
on patient self-report questionnaires rather than 
direct clinical interviews, and since the authors in· 
duded wide-ranging psychopathology as part of the 
TS clinical spectrum, for which there is currently 
insufficient support. Ie 
In the course of evaluating and caring for several 

hundred patients with '1'8, it has been our clinical 

impression that the symptoms of TS are indeed 

commonly reported on both the maternal and pater­

nal sides in affected families. In order to investigate 

the frequency of such biJineal transmission, we 

studied two groups of TS pedigrees collected at the 

National Hospital for Neurology and Neurosurgery 

(NHNN), Queen Square. London. The first group in­

duded a series of high-density pedigrees in which 

five or more family members were reported to be af· 

fected. The second group consisted of the famiJies of 

probands consecutively evaluated at NHNN in 

1991. The nudear families of these probands had 

been pre"\-'"1ously examined as part of a segregation 
analysis study.11 For both family groups, we em­
ployed a definition of disease phenotype that in· 
duded as affected only individuals with tics or OCB. 
In addition, we attempted to verify the presence of 
symptoms on both parental sides through direct 
clinical examination offamily members. 
Methods. We included 39 high-density pedigrees in 
which five or more relatives within three generations of 
the proband were reported to have tics or OCB (Lifetime 
history). 'The probands of these families were evaluated 
at NHNN between 1989 and 1993. We also 8tudied 39 
pedigrees of probands consecutively evaluated at the 
NHNN during an 8-month period in 1991. For all fami· 
lies, historic information was obtained from the proband 
and relatives (parents of children, spouses of adults) who 
were present at the time of the clinical interview. Data 
were collected in a standardized format using the Na­
tional Hospital Tourette Questionnaire. This instrument 
includes specific questions regarding the presence of tics 
and OCB (as well as other symptoms associated with 1'5) 
in family members. In each family, we attempted to doc. 
ument the presence of tics by direct clinical examination 
for at least one member of the maternal side and one 
member of the paternal side. If subjects reported to have 
tics were unavailable, we then earried out direct clinical 
interviews ·for the presence of OCB using the Leyton Ob­
sessional InventoryU in relatives reported to have these 
symptoms. In some families, such targeted relatives were 
unavailable or unwilling to participate for such direct as­
sessments. For each of the consecutive pedigrees, the 
proband and available siblings and parents had previ. 
ously been assessed with direct clinical evaluations as 
part of a segregation analysis study. In these families, 
we carried out additional clinical interviews for pertinent 
family members in order to verify biJineal transmission. 
For both pedigree groups, our definition of bilineal trans· 
mission was restricted to include relatives within three 
generations of the proband. No consanguinity was evi­
dent in any of the families. For each family, we rated the 
severity of 1S in the proband as mild (not interfering 
with daily functioning, not requiring medications), mod­
erate (some functional impairment, requiring medica­
tions), or severe (substantial functional impairment, reo 
quiring medications). 
A two-sided Fisher's exact test, modified using the 
mid-p value,16 was used to compare Ole high-density and 
consecutive families regarding the proportion of families 
having bilineal transmission. The same test was used to 
compare the high-density and consecutive fami1ies reo 
garding the proportion of probands baving both parents 
affected. These analyses were performed using two dif­
ferent definitions of phenotype: tics alone, and either tics 
orOCB. 
The C«hra,n.Armitage testlf was used to examine the 

hypothesis that the proportion of families haVing bi1ineal 

transmission (tics or oeS) increases with the severity of 

the proband. This was done separately for the high­

density and the consecutive families. The same test was 

used to examine the hypothesis that the proportion of 

probands baving both parents affected (tics or OeB) in­

creases with the severity of the proband. The exact per­

mutation distribution of the test statistic was used for 

computingp values. 

All tests were performed using the StstXact statistical 

software package. 11 

Results. High-density pedigrees. The clinical fea­
tures of the 39 high-density pedigrees are summa­
rized in table 1. For this group, 44 of the siblings or 
children of the probands were reported to be af­
fected by tics or OCB. Since these individuals could 
not be assigned to either maternal or paternal 
sides, they were excluded from the analysis ofbilin­
eal transmission. On the probands' maternal side 
51 relatives were reported to have tics, 33 OCB: 
and 18
. 
both tics and OCB. For these subjects, 15 
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Table 1. Clinical features of 39 biib-denslty ped1e-rees 
Severity 01 UnHineaJ 01' bltlneaJ Maternal Paternal 
No. proband (materna1lpaterna1) Tic. OCB Both Tic. OCB Both 
1 
2 
3 
4 
6 
6 
1 
Severe 
Moderate 
Mild 
Severe 
Mild 
Severe 
Moderate 
B* (BIB) 
U 
B (TIB) 
B (TIB)t 
B" (M) 
B" (BIB) 
S (BIB) 
210 
0 
411 
0 
110 
313 
0 
W 
0 
0 
0 
111 
414 
0 
111 
0 
0 
0 
0 
0 
111 
110 
:w 
110 
714 
111 
313 
W 
1M 
0 
W 
0 
0 
2t.2 
0 
111 
211 
311 
111 
0 
0 
W 
8 Moderate S (BIB) W W 0 0 0 110 
9 
10 
Severe 
Severe 
B' {BIB) 
B (()IB) 
W 
0 
210 
. lID 
111 
0 
111 
0 
W 
flO 
0 
lJO 
11 Moderate U 616 313 0 0 0 0 
12 Mild U 0 0 0 210 111 211 
13 Mild U W W 2'1 0 0 0 
14 Severe B* <BIB) 4/1 .W 0 0 0 111 
15 Severe B* (BIT) 0 0 111 211 0 0 
16 Mild U 110 0 W 0 0 0 
17 Mild U :w 0 w 0 0 0 
18 Mild U .w 0 110 0 0 0 
19 Mild U 210 0 0 0 0 0 
20 Mild U :w 0 110 0 0 0 
21 Mild U 0 210 111 0 0 0 
22 Moderate B* (BIB) 110 :w 111 W 210 111 
23 Severe U 0 0 0 311 0 110 
24 Moderate U 0 0 0 W 0 0 
25 Mild U 311 110 111 0 0 0 
26 Mild B(OIB) 0 110 0 110 W 111. 
27 Moderate U 0 0 0 110 111 211 
28 Moderate S* (BIB) 211 2ft) 0 812 lID JI1 
29 Mild U W M> 311 0 0 0 
30 Moderate B· (Otr) 0 0 111 211 0 0 
31 Mild U 0 210 111 O. 0 0 
32 Moderate U 0 0 0 410 0 0 
33 Severe U 0 0 0 111 W lJO 
34 . Severe S* (TIB) 211 0 0 0 0 211 
35 Severe U 210 0 0 0 0 0 
36 Mild U 4/1, 0 0 0 0 0 
37 MHd U 0 0 0 W W 0 
38 Moderate U 0 0 0 ' 110 2ft) 0 
39 Mild U 0 0 0 110 W 111 
Totala Mild:o 17 S", 16 (41~) 51116 3318 1&'11 47115 2414 23112 
Moderate = 11 U=23(5~) (~) (24~) (61~) (32'1» (17'1» (sn.) 
Severe =11 
OCB Obsessive...:ornpu1sive behavior. 
t Marned-in 5poUR a1fect.ed. 
For unilineaJ (U) or bilineal (B) expreuion, l!.D asterisk indiute! o.at biUneality wu venned by di..rect examination. In pareno.eses, we Uldicau 
the dinical phenot)'poi IT '" tics, 0 =OCB. B '" both tics and OCB) observed 00 the maternalfpaterual .ide$. For the maternal udpaternal.idea, 
tbe oumeratDr indica.!.e:: the number of relatives reported to be afl'ected by tics, OCB. or both, l!.Dd the denominator indicates bow many of theM 
lubjec\JI were examined.. 
(29%) with tics, eight (24%) with OCB, and 11 
(61%) with both tics and OCB were directly exam­
ined by the investigators. On the paternal side, 47 
subjects were reported to have tics, 24 OCB, and 23 
both tics and OCB. For these subjects, 15 (32%) 
with tics, four (17%) with OeB, and 12 (52%) with 
both tics and OCB were examined. In total, 65 of 
the 196 relatives (33%) reported to have tics or 
OeB were examined. In these 39 high-density fam­
ilies, bilineal transmission was found in 13 kin­
2.S38 NEUROLOGY « ~ernber 1994 
dreds (33%) when tics alone was considered the af­
fected phenotype. The number with bilineal trans­
mission increased to 16 (41%) when the phenotype 
was extended to include tics or OCB. The presence 
of tics in at least one member of the maternal and 
paternal sides was confirmed by direct examination 
in 10 (77%) of the families with reported bilineal 
transmission of tics: In the high-density pedigrees, 
both parents were affected in 12k:indreds (31%) 
when tics alone was considered and in 15 kindreds 
Un
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Table 2. eUnlcal feature. of 39 consecutive pedfarree• 
PaternalMaurnalUnlUneaJ or bilinealSeverity of OCB BothTi~ OCB Both Ti~(maternallpllternal)No. proband 
U 0 0 0 111 0 0 1 Severe 0 VO 0B· (BlO) 111 110 0 2 Mild 0 110B (TIB) 110 0 0 111 3 Mild 0 0 1.A) 0 00 
.. Mild 0U 1/1 0 0 0 0U6 Moderate 1f1 0 1.A) 1.A) 111 B* (OIB) 0Severe 1116 0 0 0 110B (TIB) 110 1 Severe 1.A) 110 0 311 0 0 B(BIl'lSevere M) 110 ~8 0 0 0USevere 0 09 111 0 0 0UMild· 0 0 010 111 0 0UModerate 011 111 0 0 0 0UModerate 0 11112 M) 110 0 VOB (BIB) 13 Mild 0 0 0 0 110 0 U14 Severe VO 0 110 0 110 211 B (BIB) 
16 Moderate 0 0 0 111 0 0 USevere 0 110 016 0 0 111B (BlO)Mild 0 11117 0 0 0 410U18 Mild 0 111 0 000UMild 1.A) 111 019 0 0 VIU20 Severe 111 0 0 0 1110B* (OIB)21 Severe 0 0 00 0 0N22 Severe 111 0 0211 0 110B·(Btl')23 Mild 0 0 0lJO 0 0U24 Severe 0 U1 0 00 0U25 Mild 0 00 03fl 0U26 Severe 0 0 0 0111 0U27 Moderate 0 01/1 110 0 0U28 Moderate 0 0M) 111 0 0U29 Mild 0 00 0'111 0UModerate 030 0 110 0U 0 0Moderate31 0 0 0U 111 0 0Moderate32 0 0 0 0U U1 0 33 Severe 0 0 0 0VIU 0SevereM 0 0U 1/1 0 0 0 85, Moderate U 1/1 0 0 0 0 0 SevereS6 0 210 0 0U 0 0Moderate37 0 0 0 111 0 0USeveresa 0 0 0111 0 0UModerate 
B", 10 (26%) 39116 HY4 ~ 2&'8 911 1016
39 
Totall Mild = 11 (50'1» (29'\\) (11%) (60%)(41%) (40%)U =28(72%)Moderate = 12 
N = 1 (2%)Severe =16 
oeB Ob&eSsive-coropulsive behavior. 

N No II.ffed.ed relauvea. 

For w:u1lneal tID or biline.aJ CBl expression, an ast.erisk indic.atee that biline.aJit1 WIIa ve.rifled by direct UAmination. In p&renthe&a, we indicate 
the ellruc:al phenotype (T .. tics, 0 • OCB. B = both t;iC'lS And OCB) observed on the materoslfpaternal aide •. For the mat.eroal and paternal aide&, 
the numerator iDdic.atee the number of relatives 'reported to be ail'ected by tics, OCB. or booth, and the denorcin.ator iDdir..ateto bow mlI.ll1 or theM 
l'Ubj«1..l ,.,ere e.umit>ed. 
(38%) when the TS phenotype included tics or 
OCB. Such mating of two affected individuals was 
also observed in the grandparents of probands in 
11 instances. In addition, in two cases, individuals 
who married into the family were reported to have 
TS. including tics (one case) and OCB (one case). 
Consecutive pedigrees. The clinical features of 
the 39 consecutive families are summarized in 
tab1e 2. As expected. the numbers of relatives re­
ported to be affected by TS were lower than in the 
high-density pedigrees. Twenty-four siblings or 
children of probands were reported to be affected 
by tics or OCB, and they were not included in our 
analysis of bilineal transmission. On the maternal 
side of the probands, 39 relatives were reported to 
have tics, 10 OCB, and four both tics and OCB. On 
the paternal side, 28 were reported to have tics 
nine OeB, and 10 both tics and OCB. Of these su~ 
jects, 16 (41%) with tics, four (40%) with OCB. and 
two (50%) with both tics and OCB on the maternal 
December 1994 NEUROLOGY « 233t 
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Table 3. Frequency ot bill neal transmission and 
frequency ot both parents hein, af'Cected 
according to severity ot proband 
Hie d .. "lltl IN • Sf' Con""c"Uve IN • n,_ 
Do" Bolla 
smnu' p.....,,,ta Bm".... p"""'''U 
tra..n.ml•• iOll- ..!f..,~. ....n.ml..loaf alfrt~t 
Mild 3111 On) 3I1711S'l ) 5I11l45'1 , 1111 19'1) 
Mod."."" Y1114~'1 ) Soil! f4$'lJ 1I12(N) QI1210'l) 
~.... &Ill 173'1, 1111164'1) 41lfiCZ5'11 3116 Illl'J) 
".. " .. ",be, lperttntl 0( r • ..ulies with !>ilinn) .......mi••i... Of both J>&renla 
be'n, .1'fe<1.e<! lind..din, llca or oeDI i••howl! ror nch (11/ thrH l~v~l. or 
T""ret""·••ynd"""" ~.rit,r Imild. mndeuta. "",ere) rOt thr~. 
• p c 0.003 ror Codlran·Armi!.t&' tHt for trend. 

f P • not .i""ificaIlL 

" .0.25. 

side underv.·ent direct clinical examinations. Eight 
subjects (29%) with tics, one (11%) with OCB. and 
six (60%) with both tics and OCB on the paternal 
side were examined. In total, 37 of the 100 rela­
tives (37%) reported to have tics or OCB were ex­
amined. In the 39 consecutive pedigrees, biJineal 
transmission was Jess evident (p < 0.07) than in the 
high-density pedigrees, being observed in six kin­
dreds (15%) when tics was considered to be the dis­
ease phenotype and in 10 kindreds (26%) when the 
phenotype was extended to include tics or OCB (p < 
0.16). The presence of tics in at least one member 
on each side was confirmed by direct examination 
in four of the six families (66%) reporting biHneal 
expression of tics. We found that both parents were 
affected by tics in only one (3%) of the consecutive 
families and by tics or OCB in four families (10%). 
These rates were significantly lower than those ob­
served in the high-density pedigrees (p = 0.0008 for 
tics, 0.007 for tics or OCB). 
Severity of TS. For the high-density pedigrees, 
we found a trend (p < 0.003) indicating that the fre­
quency of bilineal transmission is related to the 
severity of TS in the proband <table 3). Bilineal 
transmission was found in 18% of families with 
mild severity. 45% with moderate severity, and 
73% with severe symptoms. This relationship was 
not evident for the consecutive pedigrees. For both 
groups of pedigrees, we identified a trend (p = 
0.003 for high-density families, 0.25 for consecutive 
families) suggesting that the frequency of both par­
ents being affected is also related to the severity of 
TS in the proband, with the higher frequency assO­
ciated with more severe symptoms (table 3). 
Discussion. Our initial infoonation regarding bi­
lineal transmission of TS was generated by the 
family history method, which depends on historic 
information provided by relatives. It has been our 
experience in studying large TS kindreds for link­
age analysis that when family members indicate a 
certain relative is affected, their assessment is usu­
ally correct. In fact, family members tend to signifi­
cantly underestimate the number of affected rela­
23-40 NEUROLOGY « De-eem~r 1994 
tives when compared with diagnoses established by 
investigator examinations. I. Using the family study 
approach, we were able to verify the presence of 
tics in at least one member of the maternal and pa­
ternal sides by direct examination in 77% of the 
high-density pedigrees and 66% of the consecutive 
families. Our study is limited, however, by the fact 
that we did not examine all relatives in the pedi­
grees of interest. In this case, there may have been 
some false-positive diagnoses based on family re­
ports as well as false-negative diagnoses for rela­
tives whose symptoms ofTS were overlooked by the 
histOrians. Pauls et a]20 have shown that when rel­
atives are examined directly, the recurrence risks 
and patterns within families can change when com­
pared with family history data. Our study also in­
cludes other potential shortcomings. First, for some 
subjects, sufficient historic and examination data 
were not obtained in order to make assignments to 
specific tic disorder diagnostic categories (eg, 1'8, 
chronic multiple tic disorder). Most studies do, 
however, indicate that the range of primary tic dis­
orders does fall within the TS clinical spec­
trum.10.21.22 Second, for many subjects, the diagnosis 
of OCB was made on clinical grounds and not sub­
stantiated with standardized rating scales or for­
malized structured psychiatric interviews. There is 
currently no substantial inform~tion regarding the 
issue ofwhether the diagnosis ofTS is more or Jess 
secure for subjects who have both tics and OCB 
versus those with one type of symptom only.23 
Third, due to ascertainment bias, our analysis may 
overestimate the frequency of biJineal transmission 
in TS families in general since our probands con­
sisted of patients with TS whose symptoms were 
severe enough that medical attention was sought. 
Fourth, our study did Dot include a control group to 
clarify the unknown probability that any given per­
son, regardless of their own h'istory of tics, may 
have a family history of tics. Finally. we did not in­
clude any kind of age correction in our analyses; it 
is possibJe that for families with more young (child) 
subjects. tics or OCB might not yet have been ex­
pressed and this situation could therefore have af­
fected our assessment of bilineal transmission. 
Given these limitations. our study is viewed as a 
pilot, preliminary investigation of biJineal trans­
mission in TS families. 
Our study does represent the first one to exam­
ine the bilineaJ transmission of TS using a strict 
definition of disease phenotype and that attempted 
to confion affected status using direct clinical ex:­
aminations. We found evidence of biJineal trans­
mission in 33% of the high-density famiHes and 
15% of the consecutive pedigrees when including 
tics only. thus yielding figures significantly higher 
than the 8.2% observed by Comings et al.13 When 
expanding the phenotype to include tics or OCB, 
we found that 41% of the high-density families and 
26% of the consecutive families showed biJineal 
transmission. These figures, which are based on a 
conservative designation for the behavioral compo­
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· of the TS spectrum (OCB only), compare with 
~4.7% Tate of bilineal transmission observed by 
tings et al IS when a wider range of psy­
lathology was included. We found that both 
!nts were affected by tics in 31% of the high­
iity families and 3% of the consecutive families 
by tics or OCB in 38% of the high-density pedi­
s and 10% of the consecutive pedigrees. These 
res compare with the rates of both parents 
g affected by tics in 4.7% and tics or associated 
lviors in 19.4% as reported by Comings et aVs 
~. our findings support the contention of Com­
let aps that bilineal transmission is common in 
amilies, even when a narrower definition of 
~se phenotype is used, and that since both par­
lare often affected, many cases ofTS are proba­
lomozygous for the genetic trait. However, .it is 
~ble that some affected relatives manifested 
ptoms on a nongenetic basis (ie, as pheno­
~s). Our observations indicating that the fre­
ICY of biJineal transmission and of both parents 
g affected are higher in ramilies with the most 
rely affected probands also supports the by­
~sis of Comings et allS that a genetic dosage ef­
;may be important in influencing the clinical 
~ssion of1'8. . 
ur observed rates of biJineal transmission in 
high-density pedigrees of 33% (for tics) and 
;(for tics or OCB) are higher than the rates for 
~(msecutive families (15% for tics, 26% for tics 
CB). This finding suggests that the bilineal oc­
~Dce ofTS contributes to the high density of af­
~ cases observed in m~y famil!es. Thi~ notion 
IPported by the large high.<Jenslty TS 1cindreds 
!have been employed for international efforts tolze the 1'8 genetic defect by linkage analysis. 
a.r own Canadian Mennonite pedigree, for ex­
Ie. both parents of the proband have clinical 
~nce of lics. Z4 In the same pedigree, there is one 
~ documented instance of mating between two 
ted family members. Evidence for such mating 
:ected individuals has been found in eight of 17 
1S in a large fundamentalist Monnon pedigree 
~ investigated by McMahon et al.25 Five in­
~es of matings of affected individuals have 
identified by Sandor et al (personal communi­
11) in a group of TS kindreds under study in 
)1.0. The selection of lcindreds known to have a 
,density of affected members, which are typi­
~ou~ht for linkage analysis studies, may make 
re likely to encounter bilineal transmission. 
e use of bilineal (intercross) families for link­
inalysis is satisfactory as long as the mode of 
itance is clear and the disease is not charac­
d by genetic heterogeneity within families.2S.27 
i~eHhood ?f ~enetic heterogeneity s~ould be 
, 10 genetic Isolates, such as the Canadian 
onile kindred. and a two-locus model can be 
for the analysis of bilineaJ families. 28 Never­
s. J.i.nkage studies are critically dependent on 
correct parameters of gene frequency, mode 
eritance. and penetrance. The existence of bi­
lineal transmission in TS kindreds with frequent 
homozygosity could have a major deleterious im­
pact on linkage analysis, particularly if genetic het­
erogeneity is present. Such bilineal pedigrees vio­
late the assumptions of standard one-trait-Iocus 
models and complicate the analysis. This situation 
represents one possible explanation ror the unsuc­
cessful localization of the TS genetic derect to 
date.29 Under these circumstances, sib-pair analy­
sis may be a better technique for studying linkage 
in TS, but even the power of this approach would 
be reduced if, in a number of families, one of the 
parents was homozygous for the TS gene.u 
If rnost TS patients are homozygotes and there is 
a single major locus, then the gene frequency can 
be calcuJated as the square root of the frequency of 
1'8 in the population.I' Recent epidemiologic stud­
ies have suggested that the prevalence of TS is 
much higher than previous estimates.30.l1 High ear­
rier frequencies raise the possibility that there may 
be a variety of genetic mechanisms that can pro­
duce the same phenotype. Thus, genetic hetero­
geneity is expected that would preclude the com­
bining of linkage exclusion data across different 
families, as has been done.n and that would predict 
major difficulties for tbe linkage analysis approach 
to localizing the gene defect or defects. A very high 
gene (disease) frequency might explain the fre­
quent mating of affected individua.ls seen in TS 
families, but there may be other currently uniden­
tified reasons for tbis observation. The phe­
nomenon of assortative mating (nonrandom mating 
in which spouses choose ODe another based on some 
characteristics associated with a particular geno­
type) may be at play. For example, two individuals 
with OCB may be attracted to each other, or 8. per­
son with tics may find this symptom less unappeal­
ing in a potential mate. 
Our findings suggest that bilineal transmission 
with frequent homozygosity likely explains the 
high density of TS observed in many families, 
might be an important determinant of disease 
severity, and may explain the failure of current at­
tempts using high-density kindreds to localize tbe 
gene defect or defects by linkage analysis. 
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Abstract 
This is the first case description in the published literature of the association of definite 
Gilles de la Tourette syndrome (GTS) and the chromosome 22q11.2 deletion syndrome, 
previously referred to as CATCH-22 syndrome. The co occurrence of GTS, 22q11DS and 
their behavioural/neuropsychiatric abnormalities may be due to the common 
endophenotypic mechanisms shared by these disorders, rather than being specific for 
GTS. Research into this genomic region may lead to advancement in 
neurobehavioural/neuropsychiatric genetics that will help us in further explicating the 
broader perspective of gene-brain-behaviour inter-relationship and genetic underpinnings 
of various developmental psychopathologies, neuropsychiatric and behavioural disorders 
that are common to both GTS and 22q11 DS. Our report should warrant further genetiC 
investigation ofchromosome 22q11.2 deletion site using alternative strategies of 
quantitative trait loci - endophenotype based approach which would be useful for 
establishing the biological and molecular underpinning of OeD, ADHD and GTS. 
Keywords: Gilles de la Tourette syndrome, CATCH 22 syndrome, microdeletion 
syndrome, chromosome 22q11.2 deletion syndrome, endophenotype, genetics. 
Introduction 
Gilles de la Tourette syndrome (GTS) is a complex neuropsychiatric developmental 
disorder with high comorbidity rates with other neurobehavioural disorders and 
psychopathologies [1]. This includes attention deficit hyperactivity disorder (ADHD), 
, 
obsessive-compulsive behaviours (OCB) or disorder (OCD), self injurious behaviour (SIB), 
depression, anxiety, bipolar affective disorder, personality disorder, drug abuse, rage attacks, 
and increased irritability and cognitive abnormalities such as executive dysfunction [2,3,4]. It 
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seems likely that these disorders share a common or overlapping neurobiological basis. The 
aetiopathogenesis of GTS spectrum phenotype is multifactorial contributed by the interaction 
of genetic susceptibility, epigenetic factors, environmental factors, and neurobiological 
systems active in the developing brain. GTS is both genetically and phenotypically 
heterogeneous with many areas of chromosomal loci having been identified [3, 4,5]. The 
interested reader is referred to updates on the genetics of GTS reviewed by Pauls [6, 7]. 
The chromosome 22q11.2 deletion syndrome (22q11 DS) is also known as the 
CATCH-22 syndrome which is an acronym for Cardiac defect, Abnormal facies, Thymic 
hypoplasia/aplasia, and T-cell deficiency, Cleft palate, Hypoparathyroidism. and 
Hypocalcemia and is aSSOCiated with chromosomal microdeletion in the q11 band of 22 
[8]. DiGeorge syndrome (DGS). Velocardiofacial syndrome (VCFS) and Conotruncal 
anomaly face syndrome (CTAFS) are part of 22q11 DS reflecting various outcomes of the 
same underlying genetic defect. About 60% of patients with 22q11 DS will manifest 
neuropsychiatric. neurobehavioural and developmental psychopathologies [9]. The 
comorbid behavioural/psychiatric disorders include leaming disabilities, ADHD. attention 
deficit without hyperactivity. early onset OCD/OCS. early onset bipolar spectrum 
disorders, schizophrenia and schizoaffective disorder, anxiety disorder. and oppositional 
defiant disorder [10,11]. 
Of importance is that there now appears to be considerable overlap between 
22q11 DS and both OCD [12] and ADHD [13]. Behavioural abnormalities associated with 
VCFS and ADHD have been correlated with corpus callosum morphology abnormalities 
[14]. Similar observations have been made in GTS [15. 16]. Further research on 
psychopathology of 22q11 DS may provide a model of how a specific genetic defect could 
lead to the development of neuropsychiatric/behavioural disorders. Both these complex 
neuropsychiatric genetic disordelS are the result ofgenetic probabilism, where the 
phenotypic output is the product ofactive interaction ofgenotype, environmental, and 
epigenetic factOIS. The genetiCS and genomics ofsuch complex behavioural and 
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neuropsychiatric disorders can be studied by using multifaceted approaches such as 
quantitative trait loci-endophenotype approach [17, 18]. 
Case-report 
A 28 year-old female presented to the GTS Clinic for assessment of a tic disorder. 
She was born one month premature at 36 weeks gestation, with cyanosis at birth, and 
was floppy with a birth weight 3 Ibs 120z. She required an incubator for 6 weeks. In 
childhood, she was found to have developmental motor delays and expressive language 
delays, as she only walked and talked at the age of 15 months. She had insomnia and 
rage attacks as a youngster. She had moderate learning disabilities and 
comorbid ADHD. She was also diagnosed with oppositional defiant disorder (ODD) and 
has some symptoms suggestive of Asperger's syndrome or autistic spectrum disorder. 
Later, she was also found to have unexplained persistent hypocalcaemia and attributed to 
as idiopathic hypoparathyroidism. As a youngster she was investigated and found to have 
a heart murmur, but with no obvious cardiac abnormalities. Her learning difficulties were 
noticed eariy, and she attended a special nursery school at the age of three. She received 
a Statement of SpeCial Educational Needs at the age of 6 years and attended a special 
boarding school between the ages of 6 and 19 years. She thereafter lived with her mother 
and other carers, with respite with grandmother and other individuals/agencies. 
Her motor tics began at the age of 2 and a half to 3 years with a shoulder shrug 
and arm movements and excessive blinking beginning at 4 years. Vocalisations began at 
the age of 4-5 years. She also developed coprolalia, copropraxia, echopraxia, 
suggestibility, premonitory sensations, SIB and OCB (arithmomania, rearranging), but not 
OCD. Her tics were suppressible (with rebound afterwards), suggestible and 
characteristically waxed and waned in intenSity. The tics had remained much the same 
after the age of 18 years. 
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Significant family history included confirmed proven 22q11 deletion in her mother 
(fluorescent in situ hybridization [FISH] analysis) who also suffered from repetitive sniffing 
(a phonic tic), in addition to the 22q11 DS multi-system anomalies (hypoparathyroidism, 
hypothyroidism, osteoporosis and kyphoscoliosis). The patient's maternal grandmother 
had kyphoscoliosis, and two deceased maternal great aunts apparently had motor tics. 
Her maternal grandfather was anxious and depressed all his life, necessitating ECT. 
Maternal great aunt was diagnosed with schizophrenia. There was also a history of 
autistic spectrum disorders and epilepsy in the family. These latter family members were 
not available for the cytogenetic study for chromosome 22q11 microdeletion as they were 
deceased. 
Examination revealed typical dysmorphic craniofacial abnormalities including 
prominent epicanthic folds, up-slanting palpebral fissures and marked epicanthic folds. 
She was impulsive and disinhibited ~nd took no notice of obvious social cues. She fulfilled 
DSM IV-TR criteria for GTS. She had a history of 27 motor tics, 17 of which were 
observed at interview, and 8 vocal/phonic tics, 3 of which were heard during the interview. 
On the Yale Global Tic Severity Scale she scored 50% (moderate) and on the Diagnostic 
Confidence Index, she scored 82%. She used several words as substitutes for swear 
word such as "janus". She had a low mood and persecutory delusions. Special 
investigations included fluorescent in situ hybridization (FISH) which confirmed 22q 11 
deletion, a borderline IQ (V= 73; P = 68) and a spot of calcification of the right globus 
pallidus on CT scan. 
Discussion 
We describe a young woman of 28 years with DSM-IV- TR GTS who also presented 
with another complex genetic disorder with craniofacial and neuropsychiatric phenotype of 
22q11 DS confirmed by fluorescent in situ hybridization (FISH). Interestingly, her mother who 
had chronic phonic tics also had the interstitial microdeletion of chromosome 22q11.2 and 
many of the associated mUlti-system anomalies. At present, the scientific community is at 
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the threshold of identifying the regions harbouring the genes for the expression of the 
GTS phenotype, and the association of GTS with 22q110S may be another step in our 
understanding of the geneticlbiologic risk factors important for the expression of these 
'genetically driven' behaviours. Given that there is almost certainly genetic and dinical 
heterogeneity in GTS, and yet undetermined phenotypiC variations, it is important to 
document interstitial microdeletion syndromes co-occuning with GTS, particularly when two 
generations of individuals have both ticlGTS spectrum disorder and the chromosome 
22q11.2 microdeletion as in our case reported here. The earlier study by Gothelf did 
document the presence of stereotypy, and motor tics in addition to comorbid 
psychopathology in 22q11 OS that included OCO/OCS [12], and AOHO [13]. 
Some of the specific genes within the 22q11.2 deletion site that are implicated to 
central nervous system structure or functioning indude GSCL gene, the ES2 gene, the 
UFOIL gene, PROOH gene, and the COMT gene [11,19]. COMT gene functional 
polymorphism has attracted intense interest because of the association of chromosome 
22q and disorders at the mind-brain interface. A functional polymorphism of this gene 
results in the dysregulation of the dopaminergic system that underpin various dopamine­
related neuropsychiatric disorders such as schizophrenia, bipolar disorder [20, 21, 22, 23], 
OCO [24, 25, 26], AOHO [27] and the 22q11 OS neuropsychiatric phenotype [28] COMT 
therefore does represent one of the excellent susceptibility or candidate genes for several 
neuropsychiatric, behavioural and developmental psychopathologies as exemplified by 
the model of 22q11 OS. 
We acknowledge that as both GTS and the 22q11 OS are now recognised to be 
\ 
quite common, the association of our index patient with both could be chance. However 
the fact that her mother has the microdeletion and phenotypiC features of 22q11 OS, as 
well and that she also has a chronic phoniC tic (GTS spectrum), we would suggest that the 
association is not chance. We suggest that the co occurrence of GTS and 22q11 OS as 
illustrated by our case report might reflect common endophenotypic mechanisms 
underpinning both these complex genetic disorders. Thus, endophenotype research and 
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'quantitative trait loci' approach are excellent strategies that may have greater potential 
than the conventional multiple genetic linkage/association studies to assist in the genetic 
dissection of these complex behavioural/neuropsychiatric disorders. 
Conclusion 
We believe that ours is the first report in literature of the association of the 
22q 11 DS with DSM-IV definite GTS. We suggest that research of 22q11 DS critical 
deletion region and the genes contained within may well be regions of interest for future 
genetic dissection using cytogenetic studies, genetic linkage studies, and quantitative trait 
loci - endophenotype based approach. This would be useful for establishing the biological 
and molecular underpinning of OCD, ADHD and GTS. Such studies will help us in further 
explicating the broader relationship between gene-brain and behaviour, the domain of 
neu robehavioural-neuropsychiatric genetiCS. 
Human behaviour results from the interactions between complex genetic and 
epigenetic factors, cellular, anatomical and functional networks with environmental 
influences. Hence genetiC approaches to dissect the gene-behavioural/psychiatric trait 
equation are challenging. Forward genetiC approaches, reverse genetiC approaches, 
quantitative trait loci (QTL) mapping and mouse models represent current genetiC 
approaches for investigating the genetic basis of behaviour. 
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Summary 
Gilles de la Tourette syndrome is a neuropsychiatric dis­
order characterized by waxing and waning multiple mo­
tor and phonic tics with a complex mode of inheritance. 
Previous attempts, which used large multi generational 
families to localize susceptibility loci, have been unsuc­
cessful. In this report, the results of the first systematic 
genome scan, using 76 affected-sib-pair families with a 
total of 110 sib pairs, are summarized. While no results 
reached acceptable statistical significance, the multipoint 
maximum-likelihood scores (MLS) for two regions (4q 
and 8p) were suggestive (MLS > 2.0). Four additional 
genomic regions also gave multipoint MLS scores be­
tween 1.0 and 2.0. 
Introduction 
Gilles de la Tourette syndrome (GTS) (MIM 137580) is 
a chronic neuropsychiatric disorder with onset in child­
hood. It is characterized by multiple, fluctuating motor 
and vocal tics of variable severity. Prevalence estimates 
are higher in males than in females, and range from 11 
20,000 to 112,000, depending on the age group studied 
and on the diagnostic inclusion criteria (Apter et al. 
1993). More recent studies in school-age populations 
suggest that the prevalence may be somewhat higher 
(e.g., 1 % in males) (Robertson and Stern 1998). Support 
for a genetic component in the etiology of GTS comes 
from several lines of evidence, including twin studies 
(Price et al. 1985; Hyde et al. 1992) and family studies 
(Pauls et al. 1991). Family studies also provide support 
for a common genetic basis for GTS, chronic tic disorder 
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(CT), and obsessive-compulsive disorder (OCD) (Pauls 
et al. 1986). In addition, a relationship with other psy­
chiatric disorders has been suggested (Comings and 
Comings 1985). While the relationship between GTS 
and other conditions has been somewhat controversial, 
the recurrence risk for GTS among first-degree relatives 
appears to be quite consistent among studies. Pauls et 
al. (1991) reported a recurrence risk for GTS of 7/61 
(11.5%) in brothers and 4/83 (4.8%) in sisters of pro­
bands. Walkup et al. (1996) and Hebebrand et al. (1997) 
observed recurrence risks that were not significantly dif­
ferent from those reported by Pauls and colleagues. 
Segregation analysis generally supports the presence 
of a major locus, but the characteristics for this predis­
posing gene vary. Pauls et al. (1990) reported that the 
pattern of transmission was consistent with autosomal 
dominant inheritance with incomplete penetrance, 
whereas Hasstedt and colleagues (1995) found the pat­
tern in large multigenerational families in which there 
was bilineal transmission to be consistent with a genetic 
model in which the penetrance of the heterozygote was 
between the penetrance of the two homozygotes. 
Walkup et al. (1996) reported a similar solution but with 
a significant multifactorial background. Several studies 
have reported the frequent occurrence of bilineal fami­
lies, in which either GTS, CT, or OCD occurs in both 
parents of a proband or in one of the parents' first-degree 
relatives (McMahon et al. 1992; Kurian et al. J994; 
McMahon et al. 1996; Walkup et al. 1996). 
Attempts to localize the responsible gene(s) have not 
yielded consistent results thus far. Linkage analysis of 
data from a series of multiply affected families resulted 
in the exclusion of ~80% of the genome (for review, see 
Barr and Sandor 1998). These analyses were completed 
assuming a dominant mode of inheritance and locus ho­
mogeneity for GTS and spectrum disorders. This data 
set included several very large families, which, on their 
own, could yield significant evidence for linkage (Heu­
tink et al. 1995). It is possible that incorrect specification 
of genetic parameters (e.g., penetrance and gene fre­
quency) of the GTS susceptibility gene could have led 
to false exclusion of one or more relevant genomic 
regIOns. 
More recently a genome scan was completed on a 
series of multigenerational families (Barr et al. [1999]) 
that included two families that had also been examined 
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by Heutink et al. (1995). This genome scan used more 
informative markers that were evenly spaced throughout 
the genome. The data were analyzed using both para­
metric (autosomal dominant with reduced penetrance) 
and nonparametric methods. LOD scores >1.0, calcu­
lated with the parametric method, were observed for 24 
of the markers in at least one of the families. No LOD 
scores >2.0 were observed. When the Affected Pedigree 
Method (APM; Weeks and Lange 1988) modified by 
Ward (1993) was used, eight markers were observed 
with a P < .00005 in at least one of the families. APM 
has been shown to be more likely to give false positive 
results (Field and Kaplan 1998), so these results should 
be interpreted with caution. 
Other approaches have also been employed in the 
search for GTS-susceptibility loci. Several families have 
been reported with apparent cosegregation of balanced 
translocations with GTS (for a review, see Robertson 
and Boardman 1996), but these candidate regions have 
not been supported by positive linkage findings in other 
families (Heutink et aL 1990). In addition, a number of 
association studies have been published examining a va­
riety of candidate genes in GTS patients and controls 
(Comings et al. 1991; Comings et al. 1993; Nothen et 
al. 1994a, 1994b; Grice et al. 1996). Finally, Simonic 
and colleagues (1998) performed a genomewide search 
(with genetic markers at an average spacing of 3 eM) 
. using a case-control strategy in a sample of unrelated 
patients with GTS from an Afrikaner population. These 
investigators reported positive associations between GTS 
and markers on chromosomes 11, 14,20, and 21 that 
were highly significant before correction for multiple 
testing. While these are potentially interesting leads, as­
sociation studies should be interpreted with caution. It 
has been demonstrated that false positive findings can 
occur when controls are not perfectly matched with re­
spect to their genetic background (Kidd 1993). It should 
be noted that none of the positive reports from associ­
ation studies have been replicated. 
Analysis of affected sib pairs has been proposed as an 
alternative to parametric linkage analysis and associa­
tion studies. The sib-pair approach is suited for diseases 
with an unclear mode of inheritance and has been used 
successfully in studies of other complex disorders. Thus, 
given the lack of conclusive results from more traditional 
linkage and association studies, an affected-sib-pair 
study appears to be an appropriate strategy to identify 
chromosomal regions linked to GTS. 
The overall contribution of genetic factors to disease 
susceptibility can be measured conveniently by compar­
ing the risks for various types of relatives of probands 
with the risk of the disease in the general population 
(Risch 1990a). When calculated in this way, the relative 
risk for sibs of GTS probands is sufficiently high ()\ib > 
10.0) to suggest that affected sib-pair analysis is a viable 
alternative to traditional parametric linkage analysis for 
GTS. In this report, the results of a complete genome 
screen using 370 highly polymorphic DNA markers is 
reported. The sample for this genome scan consisted of 
76 affected-sib-pair families with at least one parent 
available for clinical evaluation and genotyping. These 
76 families yielded a total of 110 sib pairs. Correcting 
for nonindependence resulted in a sample that was 
equivalent to 91 independent pairs. 
Material and Methods 
Sample 
All affected-sib-pair families consisted of at least two 
sibs affected with GTS. Furthermore, in the ascertain­
ment of families, if both parents were affected with GTS 
or if one parent had GTS, CT, OCD, and/or subclinical 
OCD and the other parent also received a diagnosis of 
CT, OCD, and/or subclinical OCD the family was not 
included in the analyses reported here. All diagnoses 
were made using DSM-III-R criteria. The criteria for 
subclinical OCD were the same as those used to make 
a diagnosis of OCD, with the exception that the indi­
vidual did not perform the compulsions or obsessions 
for at least an hour, did not experience them as ego­
dystonic, or did not report any impairment. These were 
the same criteria used in the family study of OCD re­
ported by Pauls et aL (1995). The final sample included 
in the genome scan consisted of 76 families with at least 
two sibs affected with GTS. Both parents were included 
in the tests for 72 families. Among these 72 families, 
there were 19 in which neither parent was affected with 
GTS, tics, or OCD; 32 in which the father was affected 
and the mother was unaffected; and 21 in which the 
mother was affected and the father was unaffected. In 
the remaining four families, only one parent was tested; 
in every case that parent was unaffected. Of the 76 fam­
ilies, 64 had only two children who were affected, 10 
had three affected sibs, and the remaining 2 had four 
and five affected sibs, respectively. 
Phenotypic Evaluation 
When a family entered the study, information con­
cerning both affected siblings and their parents was col­
lected in a two-stage process. The initial stage consisted 
of the collection of information concerning symptoms 
associated with GTS and OCD using a self-and-family 
report based on the tic inventory and ordinal severity 
scales of the Yale Global Tic Severity Scale (Leckman et 
aJ. 1989) and the symptom checklist and ordinal scales 
of the Yale-Brown Obsessive-Compulsive Scale (Good­
man et aJ. 1989). Earlier versions of these instruments 
have been used in prior studies of individuals with GTS 
and OCD and have been shown to have a high level of 
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agreement with expert clinician ratings of tic and ob­
sessive-compulsive symptom severity (Leckman et al. 
1993, 1994, 1997). In a second stage, the validity of 
these symptom ratings were reviewed by an experienced 
clinician to insure their accuracy and validity. These in­
struments are currently being used in family studies of 
both GTS and OCD. Earlier versions have been shown 
to be both valid, when compared to clinician diagnoses 
(the rates of agreement between interview derived di­
agnoses and clinical diagnoses were .98 for GTS and .97 
for OCD), and reliable, for the diagnoses of GTS (I{ 
1.00) and OCD (I{::; .97) (Pauls et al. 1995). For the 
assessment of other psychopathology, the Kiddie Sched­
ule for Affective Disorders and Schizophrenia (Cham­
bers et al. 1985; Kaufman et al. 1995) was used for 
children aged <18 years and the Structured Clinical In­
terview for DSM-III-R (Spitzer et al. 1992) was used for 
adults. Both interviews have established reliability. For 
this report, only sibs with a diagnosis of GTS were con­
sidered to be affected. Future analyses will include in­
formation about chronic tics, OCD, attention deficit hy­
peractivity disorder, and other comorbid conditions. 
Best-Estimate Diagnoses 
All diagnoses were made using the best-estimate ap­
proach (Leckman et aL 1982). The best-estimate pro­
cedure used in the present study followed a standard 
protocol. Before the initial diagnostic estimate was 
made, separate files for each individual were prepared. 
These files contained all available information about the 
individual, including the completed interview packet and 
medical records, when available. All of this information 
was reviewed by three clinicians (E. v.d.W., Rotterdam 
site; W. M., Utah site; R. A. K., Yale site) who indepen­
dently made diagnostic assessments. All three diagnos­
ticians were blind to the prior diagnosis of the individual 
and to hislher relationship to the proband. Each inter­
view was evaluated by two raters. The best estimates of 
the two diagnosticians were then compared. The rate of 
agreement between any two diagnosticians was very 
high (K .97) for the diagnosis of GTS. When there was 
disagreement between the two raters, the individual files 
were reviewed by the third diagnostician and a final 
consensus diagnosis was assigned. These consensus di­
agnoses were then compared with the diagnosis assigned 
by the clinician at the site where the family was recruited. 
If there were differences, the clinical materials were re­
viewed via a conference call and consensus was reached 
if possible. If there was still disagreement, more data 
were requested to help resolve the differences. If there 
was still disagreement, the family was removed from the 
sample. For the current report, only diagnoses of GTS, 
chronic tics, OCD, and ADHD were made. 
Am. J. Hum. Genet. 65:1428-1436, 1999 
DNA Markers 
Short tandem-repeat polymorphisms (STRPs) from 
Marshfield Screening Set 8 (Yuan et al. 1997) were gen­
otyped in Marshfield. The markers chosen were at a 10­
cM average density. 
Data Analysis 
Allele frequencies for the genetic markers were estab­
lished by gene counting in genotyped parents. Tests for 
linkage were done under the direction of LS (Rotterdam 
site) and were performed following the maximum-like­
lihood-score (MLS) approach (Risch 1990b). In general, 
the MLS does not depend on marker allele frequencies 
when the parents' genotypes are available, which was 
the case for almost all families in the present study. For 
each pair of affected sibs, the identity-by-descent (IBD) 
distribution was estimated by single-point and multi­
point analysis. In the single-point analysis, the IBD dis­
tribution was estimated given the marker genotypes for 
each marker individually. In the multipoint analysis, 
MLS values were computed for >4,000 different loca­
tions relative to the markers (average step size <1 cM). 
For all calculations the MAPMAKER-SIBS program 
(Kruglyak and Lander 1995) was used. In the estimation 
of the IBDdistribution, this program only considers IBD 
vectors that are biologically consistent, lying within the 
"possible triangle" as described by Holmans (1993). All 
MLS calculations allowed for dominance variance. In 
addition to these MLS calculations, the information con­
tent of the marker map was evaluated, and likelihoods 
were calculated for a fixed value of As of 2.0 under the 
assumption of no dominance variance, which leads to 
an IBD vector of (zo, Zl, zz) ::; (.125, .5, .375). A com­
parison of these likelihoods with the likelihoods ob­
tained for the Mendelian expectation (zo, ZJ' zz) = 
(.25, .5, .25) yields exclusion LOD scores for a GTS­
predisposing gene with a Asib ::; 2 (Kruglyak and Lander 
1995). 
For families with more than two affected siblings, all 
possible pairs were evaluated, and the results were 
weighted by a factor equal to 21n, where n indicates the 
number of affected children in the sibship. 
Results 
As noted above, the 76 families yielded a total of 110 
sib pairs. Weighting by a factor of 21n resulted in a 
sample equivalent to 91 independent sib pairs. The 
power of this sample is sufficient to detect linkage when 
Asib is ;'34. When equations published by Risch and Mer­
ikangas (1996) are used, this sample of 91 sib pairs has 
power of 59% to map a given locus with Asib 2, and 
99.9% when Asib =4. 
The panel of markers genotyped included 370 DNA 
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markers with an average spacing of 9.1 cM in the male 
meiotic map. The observed average heterozygosity of 
this set of markers was .77. Single-point analyses with 
dominance variance yielded MLS values of 2.38 and 
2.09, respectively, for markers D4S1625 and D8S1106. 
Twelve additional markers (DlS1728, D4S403, 
D4S2623, D4S1644, D6S1053, D8S1130, D8S1145, 
D8S136, DI0S1213, DllS912, D14S592, and 
DI7S1298) yielded MLS values between 1.0 and 2.0. 
Two of these markers (D4S2623 and D4S1644) are lo­
cated in the vicinity of D4S1625, and three (D8S1130, 
D8S1145, and D8S136) are in the vicinity of D8S1106. 
Graphs of multipoint MLS values are shown infigure 1. 
Two regions show suggestive MLS values ~2.0. On 
chromosome 4, MLS values exceeded 2.0 over a region 
. of -12 cM, including markers D4S1644 and D4S1625, 
with a peak MLS value of 2.3 at -3 cM telomeric of 
D4S1625. The estimated IBD values at this location were 
(zo, Z» zz) =(.185, .370, ,445). On chromosome 8, 
MLS values reached 2.0 in two adjacent intervals, 
bounded by markers D8S1106, D8S1145, and D8S136, 
respectively. Here the estimated IBD values were 
(ZO, Zj) zz) =(.146, .442, ,412). As can be seen in figure 
1, four additional regions show multipoint MLS values 
>1.0. These regions are on chromosomes 1, 10, 13, and 
19. Finally, summing over all regions for which the LOD 
score was <-2.0 suggests that -35% of the genome has 
been excluded, assuming "'sib 2. 
Discussion 
When judged purely on the basis of twin and family 
studies (Price et al. 1985; Pauls et at. 1991; Hyde et a1. 
1992; Hebebrand et al. 1997), the evidence for a sub­
stantial genetic contribution to the etiology of GTS is 
convincing. Even when the highest estimates for the pop­
ulation prevalence of GTS are considered, the risk for 
first-degree relatives of pro bands is increased by at least 
a factor of 10. Thus, it is surprising that genetic linkage 
studies have so far been unsuccessful. It is possible that 
such an increased risk in close relatives of pro bands 
could be due to shared environmental factors. If such 
factors exist, the outlook for their detection is much 
better than that for the detection of similar factors in 
some late-onset diseases, such as multiple sclerosis, be­
cause the time window, between birth and onset of dis­
ease, for such factors to act would be quite small. That 
no clear risk factors have yet been identified in the fa­
milial shared environment is in agreement with the re­
sults of segregation analysis. To date, all segregation 
analyses for GTS consistently yield evidence that the risk 
for GTS is transmitted in a Mendelian fashion and that 
there are genes of major effect that contribute to its 
manifestation (Pauls et a1. 1990; Hasstedt et a1. 1995; 
Walkup et al. 1996). 
The results of segregation analysis are also consistent 
with the observed high relative risks for close relatives 
of probands. Given these high relative risks, many in­
vestigators believed that it should be relatively simple to 
map the gene(s) responsible for GTS in one or a few 
large multiply affected families. These efforts have not 
resulted in convincing linkage findings, even when the 
existing large families were considered separately (Heu­
tink et a1. 1995; Barr et aL [1999]). It is conceivable that 
extensive locus heterogeneity might preclude one from 
detecting linkage in a series of unrelated families. In that 
case, however, one would expect to find suggestions for 
linkage in the existing large families, albeit for each fam­
ily in a different location. It is noteworthy that Barr and 
colleagues (1999) did observe suggestive evidence for 
regions on chromosomes 5 and 19p. 
One potential pitfall in the study of large families has 
been discussed (Pauls 1993): the very unpredictable and 
highly biased ascertainment procedure that leads to the 
identification of large multiply affected families may lead 
to identification of families segregating for more than a 
single disease gene, even when those disease genes are 
rare in the general population. A general problem in the 
early statistical analyses of linkage in family data was 
the choice of genetic model parameters-most impor­
tantly, the gene frequency and the penetrances for the 
different genotypes. Serious misspecification of these pa­
rameters may lead to false exclusion of the region of 
interest (Heutink et a1. 1995). Furthermore, it is not 
appropriate to rely completely on the results of segre­
gation analysis for this purpose. When locus heteroge­
neity exists, and some loci act recessively while others 
act dominantly, the joint segregation analysis of these 
families may yield intermediate results that are inade­
quate for analysis of linkage in each individual family. 
The models chosen in earlier mapping efforts were 
broadly in agreement with the results of segregation 
analysis and family studies: dominant, with a low gene 
frequency and a relatively low phenocopy frequency, 
leading to a high recurrence risk in families. 
Given that the early mapping studies were inconclu­
sive, a new series of families with sib pairs affected with 
GTS were ascertained for a complete genome scan. It 
should be emphasized that all affected sibs met diag­
nostic criteria for GTS. That is, in contrast to linkage 
studies in large families, no relatives with CT or OCD 
were considered as affected in the sib pairs. Furthermore, 
all linkage analyses were done using nonparametric 
methods. 
Two areas, one on chromosome 4q and another on 
chromosome 8p, are suggestive of linkage. When viewed 
from a pessimistic standpoint, the results are disappoint­
ing, in that no single area of the genome showed sig­
nificantly increased lBD sharing in the affected siblings. 
It is possible that the increased allele sharing in either 
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of these regions is only due to chance. On the other hand, 
these peaks in the MLS curve may reveal the true lo­
cation of genetic risk factors for GTS. Certainly, these 
results suggest that additional typings are needed in these 
areas, as well as in the other regions of the genome in 
which there are suggestive MLS scores (i.e., 1.0 < 
MLS < 2.0). At present, additional genotyping is under 
way in the available multigenerational families and will 
be completed in new affected-sib-pair families that are 
currently being evaluated. It should be recognized that 
if these peaks represent real genetic risk factors, it is 
likely that they only convey mildly increased risks. 
It is clear that for further analysis of these regions in 
the available extended families, nonparametric methods 
should be employed. Given the relative risks of these 
loci, it is unlikely that the appropriate genetic mechanism 
could be adequately modeled. In this respect, it is im­
portant to observe that the sharing pattern observed for 
4q is most consistent with a recessive contribution in 
this region: the increased sharing is exclusively based on 
an excess of affected sib pairs sharing two parental al­
leles. On the basis of the ascertainment procedures fol­
lowed in the collection of the existing series of extended 
families, it is unlikely that a recessively acting gene 
would playa prominent role in those families, although 
in several of the large families there is evidence for bil­
ineal inheritance of milder forms of the syndrome (i.e., 
CT andlor OCD). At the present time, there is no way 
of knowing whether the locus on 4q contributes to the 
expression of CT andlor OCD. Therefore, further anal­
ysis of this region should be mostly based on findings 
in additional sib pairs affected with GTS. 
It is important to note that the sharing pattern for 8p 
is most consistent with a dominant contribution in this 
region. That is, the increased sharing comes from sib 
pairs sharing just one parental allele. This is also gen­
erally true for the other four genomic regions that have 
multipoint MLS scores greater than 1.0. Thus, the ex­
isting large families should be helpful in understanding 
more completely the genetic mechanisms in these areas. 
Nevertheless, more affected sib pairs are needed to fol­
low up these results as well. 
It is somewhat disappointing that none of the several 
chromosomal regions (e.g., 3 (3p21.3], 8 [8q21.4], 9 
[9pter), and 18 [18q22.3]) in which there were cyto­
genetic abnormalities cosegregating with GTS and re­
lated conditions showed any strong evidence for linkage 
in these families. Furthermore, none of the regions in 
which associations had been reported with candidate 
genes are supported by these results (e.g., DRD2 [llq22) 
and D RD4 [11 P 15]). It is still possi ble that there are 
genetic loci in the regions identified by the cytogenetic 
abnormalities that confer some risk for GTS and related 
conditions and that the reason that they were not seen 
in the current study is that only GTS was examined. If 
Am.]' Hum. Gel1et. 65:1428-1436, 1999 
that is the case, then it could be concluded that the 
cytogenetic abnormalities are more likely to be associ­
ated with the related conditions and that the GTS seen 
in these families could be etiologically different than that 
observed in these sib-pair families. 
It is noteworthy that one region that has been sug­
gested from a genome scan of multigenerational families 
(chromosome 19p; Barr et al. [1999]) is also positive in 
the current study. Clearly, this and the other positive 
regions need to be explored more thoroughly to deter­
mine whether these findings represent true linkages. 
In sum, the results of the first systematic genomewide 
scan for GTS suggest that there are several genes of 
moderate effect that increase susceptibility to GTS. Fur­
ther work is needed to confirm and extend these findings. 
While it is possible that the current results are false pos­
itives, they represent the best available data as to the 
location of susceptibility loci for this complex neuro­
psychiatric disorder of children and adults. 
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Genomewide Scan of Hoarding in Sib Pairs in Which Both Sibs Have 
Gilles de la Tourette Syndrome 
Heping Zhang,l,2 James F. Leckman,l David L. Pauls/ Chin-Pei Tsai/ Kenneth K. Kidd,l 
M. Rosario Campos,l and The Tourette Syndrome Association International Consortium 
for Genetics' 
'Yale Child Study Center and 'Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT; and 
'Massachusetts General Hospital and Harvard Medical School, Boston 
A genome scan of the hoarding phenotype (a component of obsessive-compulsive disorder) was conducted on 
77 sib pairs collected by the Tourette Syndrome Association International Consortium for Genetics (TSAICG). 
All sib pairs were concordant for a diagnosis of GiIles de la Tourette syndrome (GTS). However, the analyses 
reported here were conducted for hoarding as both a dichotomous trait and a quantitative trait. Not all sib paits 
in the sample were concordant for hoarding. Standard linkage analyses were performed using GENEHUNTER 
and Haseman-Elston methods. In addition, novel analyses with a recursive-partitioning technique were employed. 
Significant allele sharing was observed for both the dichotomous and the quantitative hoarding phenotypes for 
markers at 4q34-35 (P = .0007), by use of GENEHUNTER, and at 5q3S.2-3S.3 (P .000002) and 17q2S 
(P = .00002), by use of the revisited Haseman-Elston method. The 4q site is in proximity to D4S162S, which 
was identified by the TSAlCG as a region linked to the GTS phenotype. The recursive-partitioning technique 
examined multiple markers simultaneously. Results suggest joint effects of specific loci on 5q and 4q, with an 
overall P value of .000003. Although P values were not adjusted for multiple comparison, nearly all were much 
smaller than the customary significance level of .0001 for genomewide scans. 
Introduction 
In his original description of Gilles de la Tourette syn­
drome (GTS [MIM "137580]) in 1885, Gilles de la Tour­
ette noted the presence of obsessive-compulsive symp­
toms in several of the patients he studied. Subsequent 
studies have shown prevalences of obsessive-compulsive 
symptoms of 11 %-80% among individuals with GTS 
(King et al. 1998). This wide range in prevalence likely 
reflects differences not only in the sample composition 
but also in the assessment instrument and criteria used. 
Although obsessive and compulsive features are com­
mon in individuals with GTS, the proportion whose 
symptoms are sufficiently severe to warrant a diagnosis 
of obsessive-compulsive disorder (OCD [MIM 164230]) 
is considerably smaller, with only ~30% of adults with 
GTS meeting the full criteria for obsessive-compulsive 
disorder. These elev~ted prevalences of obsessive-com-
Received October 30, 2001; accepted for publication January 11, 
2002; electronically published February 11, 2002. 
Address for correspondence and reprints; Dr. Heping Zhang, De­
partment of Epidemiology and Public Health, Yale University School 
of Medicine, 60 College Street, New Haven, cr 06520-8034. E-mail: 
heping.zhang@yale.edu 
• A complete list of members can be found in the "Acknowledg­
ments" section. 
© 2002 by The American Society of Human Genetics. All rights reserved. 
0002-92971200217004-0008$15.00 
pulsive symptoms are found not only in clinical samples 
composed of patients with GTS but also in nonreferred 
individuals with tics who were identified in community 
samples (Apter et al. 1993), as well as in first-degree 
relatives of individuals with tics (Pauls et al. 1991). The 
obsessions and compulsions found in individuals with 
GTS cover a broad range in terms of content, intensity, 
persistence, impairment, degree of perceived ego­
syntonicity; and relationship to the individual's tic 
symptoms. A growing number of studies examining 
symptom type, natural history, sex ratio, family-ge­
netic data, neurobiological correlates, and treatment 
response lend increasing support to the hypothesis 
that tic-related obsessive-compulsive disorder consti­
tutes a distinctive obsessive-compulsive disorder phe­
notype (Leckman et al. 2000a). 
OCD, considered separately from GTS, is a chronic 
disability affecting 1 %-3% of the general population 
(Horwath and Weissman 2000). Patients with OCD 
describe the sudden intrusion into consciousness of 
unwanted' worries or unpleasant images, as well as 
repeated urges to perform seemingly senseless acts. 
Standard nomenclatures designate OCD as a unitary 
nosological entity (American Psychiatric Association 
1994). Although this parsimony has a certain appeal, 
it is misleading. The symptoms used to define OCD 
are diverse and include various intrusive thoughts, pre­
896 
,
l
I
i l l V i
l l
l
r
5 5 5
5
I
t
-
 -
-
COlmpOSJ:tlo
-
~.~", .. ,/V.u
-30
""SC;""lVC LUlIIU 
· 
ideITl l':>
L lJ.r ;t- le lre
11U';":>"Y,
an"""n".
-
-
1
I IS
-
Un
ive
rsi
ty 
of 
Ca
pe
 T
ow
n
l.n 
1.0 
·2.0 
Chrorn<l<ome 4 fOT Original Hoarding Factor Chromosome 4(or Residual Hoarding raClOr 
4.0 
l.O 
20 
1.0 ~ 
·1.0 
·2.0 
l.O 
1.0 
1.0 
·1.0 
Chromosome SforOrigioal Hoarding Factor OJromosome S(or Residual Hoarding FBdor 
'.0 
3.0 
1.0 
o .. 
R~g !j; i !j;~~~ - 'I!<l:" §~ ~<! 
191,,,. 
lHlaEi as! ; a!&11 1(:!2&l!2 !2~ !2!2~ ~ ~H_ ~ ;; & i*~ \: 
,3.i)R &EiS!~ EiS!~ ~ I 11 ~ !':i=!1~!'! ~a~O::I~ l3 
Chromosome 17 (or Residual Hoanliog FatlorOuomosome 17 for 'Original Hoanling Factor 
10 
\ 202.0 (,0 
·2.0 
mcMmoM 
0 0 00 
'" g 0" 0 S?~ E 0 E !!" ii ii ~~ " il " ~ " a '" i'!~ " a a~ ~ !~ ~ '~ x ~ ~ !8S: ~ ¢ I i ~ -s ~ ~ ~ ~ 9js: ~ ¢ i ~ 
>: ~ I< 
Figure 1 Nonparametric Z scores produced by GENEHUNTER for original and residual hoarding factor scores on chromosomes 
4q (top), 5q (middle), and 17q (bottom). 
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Overall P value = 2.65E·6 
IBD Sharing at 
D5SMfdl54 
/
>1.16 P = .007S 
Figure 2 Tree-based genome scan for linkage to hoarding. Nodes 
are labeled "1"-"7." Inside each node, the numbers of sib pairs in 
which both members are affected (top number), only one member is 
affected (middle number), and neither member is affected (bottom 
number) are given. Thus, the three numbers indicate, from top to 
bottom, the numbers of bOth affected, discordant, and both unaffected 
pairs in any given node. IBD sharing is used to split nodes. Selected 
markers and cut-off values are below and to the bottom right of the 
node, respectively. P values calculated using Fisher's exact test are 
presented for each node split and for the distribution among all ter· 
minal nodes (boxes). 
occupations, rituals, and compulsions, many of which 
are found at lower frequencies in unaffected 
populations. 
Although the subtyping of patients with OCD on the 
basis of specific proband characteristics (e.g., age at on­
set or absence of motor or vocal tics) may lead to in­
creased biological homogeneity, other quantitative ap­
proaches may prove to be of greater value in the 
identification of the relevant genetic risk factors. Factor 
analyses of patients with OCD have identified several 
obsessive-compulsive symptom dimensions (Baer 1994; 
Leckman et al. 1997; Mataix-Cols et al. 1999; Sum­
merfeldt et al. 1999), including the following factors: 
1. 	Obsessions about harm, sex, religion, and the body, 
as well as checking compulsions; 
2. 	 Obsessions about a need for symmetry or exactness, 
repeating rituals, counting compulsions, and order­
ing/arranging compulsions; 
3. Contamination 	 obsessions and cleaning/washing 
compulsions; 
4. 	Hoarding obsessions and compulsions. 
Data supporting the validity of these obsessive­
compulsive symptom dimensions have been provided 
by studies of psychiatric comorbidity, functional brain 
imaging, treatment response, and studies of normal 
Am. J. Hum. Genet. 70:896-904, 2002 
development (Leckman et al. 2001). Hoarding symp­
toms, in particular, appear to be associated with in­
creased psychiatric comorbidity (Mataix-Cols et al. 
1999; Frost et al. 2000), as well as poor response to 
standard pharmacotherapies and cognitive-behavioral 
treatments (Black et al. 1998; Mataix-Cols et al. 1999). 
Although these studies suggest that the presence of hoard­
ing symptoms is useful for prognosis, there has been little 
examination of the familial or genetic factors that may 
contribute to their expression. 
The mode of inheritance of OCD has been investi­
gated by means of segregation analysis in five studies. 
Evidence of a gene of major effect was found in each 
of the studies that classified relatives according to the 
presence or absence of OCD as a binary outcome (Ni­
colini et a!. 1991; Cavallini et al. 1999; Nestadt et al. 
2000a). For example, Nestadt et al. (2000a) conducted 
complex segregation analyses of OCD in 153 families 
(80 case and 73 control families) that were ascertained 
in the Johns Hopkins OCD Family Study, and they re­
ported strong evidence for a major autosomal dominant 
gene with significant sex effects. 
Alsobrook et al. (1999) and J. F. Leckman, D. L. 
Pauls, H. Zhang, M. C. Rosario-Campos, L. Katsovich, 
K. K. Kidd, A. J. Pakstis, J. P. Alsobrook, M. M. Rob­
ertson, W. M. McMahon, J. T. Walkup, B. J. M. van 
de Wetering, R. A. King, D. J. Cohen, and the Tourette 
Syndrome Association International Consortium for 
Genetics (TSAICG) (unpublished data) have reported 
similar results by use of symptom-based factor scores. 
Thus far, only the aforementioned study by Leckman 
et al., which was undertaken as part of the TSAICG, 
has specifically focused on the role that genetic factors 
play in the transmission and expression of hoarding 
symptoms. They found evidence in support of a reces­
sive mode of transmission for the hoarding symptom 
dimension in families with two affected siblings with 
GTS (J. F. Leckman, D. L Pauls, H. Zhang, M. C. 
Rosario-Campos, L Katsovich, K. K. Kidd, A. J. Pak­
stis, J. P. Alsobrook, M. M. Robertson, W. M. Mc­
Mahon, J. T. Walkup, B. J. M. van de Wetering, R. A. 
King, D. J. Cohen, and the TSAICG, unpublished data). 
The same segregation analyses also indicated that the 
transmission of factors 1 and 2 was consistent with 
dominant major gene effects, whereas the pattern of 
transmission for factor 3 was consistent with recessive 
inheritance. Unlike factor 4 (i.e., the hoarding factor), 
the other three factors comprise more than one symp­
tom. Thus, the understanding of the linkage analysis 
is more challenging, and the results will be published 
separately. The goal of the present study was to conduct 
a genome analysis focused on hoarding symptoms, 
treated as both a quantitative trait and a dichotomous 
variable. 
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Table 1 
Results of Genomewide Scan Significance of the Hoarding Factor Score by Use of a 
Nonparametric likelihood Method and Haseman-Elston Methods 
P VALUE IN ANALYSIS OF 
Original Hoarding Factor Residual Hoarding FactorREGION AND 
NEAREST MARKER SIBPAIR' SIBPAL2h GH-NPL' SIBPAIR' SIBPAL2' GH-NPL' 
4q34-35: 
D4S2431 .092 .006 .003 .171 .011 7E-4 
04S2417 .111 .005 .012 .153 .005 .003 
D4S408 .264 .034 .232 .216 .040 .092 
04S1652 .012 .031 .090 .005 .047 .016 
5q35.2-35.3: 
05S1471 .036 .031 .023 .022 .029 .009 
0551456 .003 .005 .002 .002 .004 6E-4 
055Mfd154 2E4 .001 .001 3E·4 .002 9E4 
055408 2E-5 2E-6 .001 6E-5 3E-6 .001 
17q25: 
D17S1301 .005 lE-4 .147 .007 2E4 .189 
017S784 3E·4 2E-5 .019 8E-4 6E·5 .047 
, Traditional Haseman-Elston method by use of S.A.G.E. (version 6 beta). 
h Revisited Haseman-Elston method by use of S.A.G.E. (version 6 beta). 
, Nonparametric-likelihood method in GENEHUNTER. 
Subjects, Material, and Methods 
Sample 
All families include at least two siblings with GTS. In 
the original ascertainment, families were excluded if both 
parents were affected with GTS or if one parent had GTS, 
CT (chronic tics), OCD, and/or subclinical OCD and the 
other parent also had CT, OCD, and/or subclinical OCD. 
All diagnoses were made by use of Diagnostic and Sta­
tistical Manual-llI-R criteria (American Psychiatric As­
sociation 1994). The criteria for subclinical OCD were 
the same as those used to make a diagnosis of OCD, 
except that the individual did not perform the compul­
sions or obsessions for at least an hour, did not experience 
them as ego-dystonic, or did not report any impairment. 
These were the same criteria used in the family study of 
OCD reported by Pauls et al. (1995). The final sample 
included in the genome scan consisted of 51 families with 
a total of 77 sib pairs and 223 individuals (including 
parents). Of the 77 pairs, 26 are concordant for hoarding, 
28 are discordant for hoarding, and 23 are concordant 
for being unaffected with hoarding. This is a subset of 
the families that were included in the original genome 
scan of GTS reported by the TSAICG (1999), and the 
rest of the families are no longer available to the TSAICG. 
J. F. Leckman, D. 1. Pauls, H. Zhang, M. C. Rosario­
Campos, 1. Katsovich, K. K. Kidd, A. ]. Pakstis, J. P. 
Alsobrook, M. M. Robertson, W. M. McMahon, J. T. 
Walkup, B. J. M. van de Wetering, R. A. King, D. J. 
Cohen, and the TSAICG (unpublished data) present de­
tailed demographic and clinical information for sample 
that we studied. 
Phenotypic Evaluation 
When a family entered the study, information con­
cerning both affected siblings and their parents was 
collected in a two-stage process. The initial stage con­
sisted of (1) the collection of information concerning 
symptoms associated with GTS, (2) diagnosis of OCD 
through an interview developed specifically for the 
TSAICG (i.e., a self-and-family report [TSAICG 1999] 
; based on the tic inventory and ordinal severity scales 
Table 2 
Alleles Shared by Sib Pairs for Selected Markers 
SHARED ALLELES, BY TYPE' 
SIB PAIR 1 2 3 4 5 6 7 9 
Node 3:' 
AA 1 1 0 0 8 3 1 
AU 0 0 0 0 o o o 
UU 1 2 3 6 3 1 o 
Node 5:< 
AA 4 0 0 12 2 o o 
AU 3 1 1 9 4 o 1 
UU 4 0 2 8 6 2 o 
Node 7:· 
AA 4 8 7 0 1 
AU 1 2 1 2 o 
UU 4 3 1 0 o 
NOTE.-Selected mar kers are shown in figure 2. AA both affected; 
AU discordant; UU = both unaffected. 
, Allele types at the selected markers were numbered consecutively 
from 1­
h IBD at 055Mfd154:> 1.9. 
, IBO at D5SMfd154 '" 1.9, and IBO at 055408:> O. 
• IBD at D5SMfd154 '" 1.9, IBD at D5S408 :> 0, and IBO at 
0451652:> 1.16. 
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of the Yale global tic severity scale [Leckman et al. 
1989]), and (3) the review of the symptom checklist 
and ordinal scales of the Yale-Brown obsessive-com­
pulsive scale (Y-BOCS) (Goodman et al. 1989). Earlier 
versions have been shown to be both valid (K = 0.98 
for GTS; K = 0.97 for OCD) and reliable (K = 1.00 for 
GTS; K 0.97 for OCD) (Leckman et al. 1993, 1994, 
1997; Pauls et al. 1995). In the second stage, these 
symptom ratings were reviewed by an experienced cli­
nician during a face-to-face interview with the inform­
ant, to insure their accuracy and validity. These instru­
ments are currently being used in family studies of both 
GTS and OCD. 
AU diagnoses were made by use of the best-estimate 
approach (Leckman et al. 1982) according to our stan­
dard protocol. Before the initial diagnostic estimate was 
made, separate files for each individual were prepared. 
These files contained all available information about the 
individual, including the completed interview packet and 
medical records, when available. All of this information 
was reviewed by three clinicians who independently 
made diagnostic assessments. All three diagnosticians 
were blind to prior diagnoses and individuals' relation­
ships to the probands. Each interview was evaluated by 
two raters. The best estimates of the two diagnosticians 
were then compared. The rate of agreement between any 
two diagnosticians was very high (K = 0.97) for the di­
agnosis of GTS. When there was disagreement between 
the two raters who had evaluated the same person, the 
individual files were reviewed by the third diagnostician, 
and a final consensus diagnosis was assigned. These con­
sensus diagnoses were then compared with the diagnosis 
assigned by the clinician at the site where the family was 
recruited. If there were differences, the clinical materials 
were reviewed via a conference caU, and an attempt was 
made to reach consensus. If there was still disagreement, 
more data were requested to help resolve the differences. 
If there was still disagreement after more data were ob­
tained, the family was removed from the sample. 
To make the dichotomous rating of the presence of 
significant hoarding symptoms, we judged hoarding 
symptoms to be present when one or both of the hoard­
ing items on the Y-BOCS symptom checklist were rated 
as present by the experienced clinician. In addition to 
treating hoarding as a dichotomous outcome, we also 
considered it as a quantitative trait that was derived from 
a factor analysis, on the basis of an earlier study of 292 
individuals with OCD diagnosed by use of item en­
dorsements from the Y-BOCS symptom checklist (Leck­
man et al. 1997). The factor loadings and algorithm 
derived by Leckman et al. (1997) were used to calculate 
the hoarding-factor scores for the present sample. 
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DNA Markers 
The panel of markers genotyped included 370 DNA 
markers with an average spacing of 9.1 eM in the male 
meiotic map on 22 autosomal chromosomes. A detailed 
description of the markers and map is given by TSAICG 
(1999). 
Data Analysis 
Allele frequencies for the genetic markers were es­
tablished by gene counting in genotyped parents. For 
each sib pair, the identity-by-descent (IBD) distribution 
was estimated by single-point and multipoint analyses 
by use of the MAPMAKER-SIBS and GENEHUNTER 
programs (Kruglyak and Lander 1995). In the single­
point analysis, the IBD distribution was estimated on 
the basis of the marker genotypes for each marker in­
dividually. In the multipoint analysis, maximum-like­
lihood scores (Risch 1990) were computed for 4,000 
different locations relative to the markers (average step 
size <1 eM). In the estimation of the IBD distribution, 
only inheritance vectors that were consistent with Men­
delian inheritance were considered. 
Several analytic approaches have been applied to the 
sib-pair analyses, as well as the analyses of nuclear fam­
ilies. The main results reported here are from the analysis 
of the quantitative hoarding-factor score. As mentioned 
in the "Introduction" section, Leckman et al. (1997) 
reported four OCD factors, the last of which is the 
hoarding factor. To examine the unique variability of the 
hoarding factor, we obtained a residual factor by re­
gressing the original hoarding factor on the other three 
factor scores. Using the computer program POINTER 
(Lalouel 1983),]. F. Leckman, D. L. Pauls, H. Zhang, 
M. C. Rosario-Campos, L. Katsovich, K. K. Kidd, A. ]. 
Pakstis, ]. P. Alsobrook, M. M. Robertson, W. M. Mc­
Mahon, J. T. Walkup, B. J. M. van de Wetering, R. A. 
King, D.]. Cohen, and the TSAICG (unpublished data) 
performed a complex segregation analysis for the hoard­
ing-factor score, as a part of an effort to examine the 
hypothesis that there is transmission of these OCD fac­
tors in families and that that transmission is consistent 
with genetic modes of inheritance. Significant evidence 
for genetic transmission was obtained for the original 
hoarding factor, with a possibly recessive inheritance, 
although the segregation analyses did not suggest evi­
dence for any kind of genetic transmission of the residual 
hoarding factor. 
Linkage analyses of the quantitative hoarding-factor 
score were completed using the variance-component 
model for the nuclear families in GENEHUNTER and 
the traditional and revisited Haseman-Elston sib-pair 
methods (Haseman and Elston 1972; Elston et al. 2000). 
In the traditional Haseman-Elston method, the squared 
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difference between the phenotypes of the twO siblings is 
regressed against their IBD sharing. In the revisited 
method, the mean corrected cross-product of the sibling 
traits is used as the dependent variable. Elston et al. 
(2000) indicate that the newer method is based on a test 
statistic that has better-understood asymptotic proper­
ties and yields better power. Furthermore, as has been 
noted in the literature, analysis by use of a quantitative 
phenotype is potentially more powerful than are anal­
yses by use of qualitative phenotypes (Risch and Zhang 
1995; Zhang and Risch 1996). 
Because the status of hoarding is the chief contributor 
to the hoarding factor, this phenotype was also examined 
as a dichotomous trait. Analyses were done with both 
GENEHUNTER and the RTREE program, which was 
developed by one of the authors (H.Z.) and is available 
to the public from his Web site (Zhang Lab of Statistics 
and Bioinformatics). The RTREE program is based on 
a recursive-partitioning procedure described by Breiman 
et al. (1984) and Zhang and Singer (1999). Zhang and 
Bonney (2000) and Zhang et al. (2001a) have explored 
the potential use of this method in genetic linkage and 
association studies. Others have also noted the great 
promise of these techniques in genetic studies (Rao 1998; 
Shannon et al. 2001). The most attractive features of 
this method are (1) the ability to accommodate a prac­
tically arbitrary number of markers together with en­
vironmental factors and (2) the ability to identify po­
tential epistatic (i.e., gene-gene) and gene-environment 
interactions. Although the method is well established in 
the statistical literature and the field of machine learning, 
it is still a novel approach in genetic studies. The key 
idea is that, in sib-pair analyses, genetic sharing between 
sib pairs is used to predict the distribution of the num­
bers of the concordant (both unaffected or both affected 
are treated as two different concordances) and discor­
dant sib pairs. If a marker is linked to a disease locus, 
a high-level IBD sharing is expected to result in more 
concordant sib pairs. Unlike the Haseman-Elston model, 
the relationship can be simply monotonic, rather than 
having to be linear (Zhang et al. 2001a). In association 
studies, if some particular alleles are associated with an 
increased likelihood of a certain condition, the excess 
level of those allele frequencies should have predictive 
power to discriminate between the normal condition and 
the abnormal condition (Zhang and Bonney 2000). In 
both linkage and association analyses, the recursive-par­
titioning process stratifies the study sample, on the basis 
of the information (as well as environmental var­
iables when included in the analyses), into a number of 
smaller subsamples, in each of which the condition of 
interest for all observational units is similar (or, ideally, 
the same). The similarity is usually measured by an en­
tropy function of the distribution of the condition (Brei­
man et al. 1984; Zhang and Singer 1999; Zhang and 
Bonney 2000; Zhang et al. 2001a). No ascertainment 
correction was employed for these analyses, since the 
ascertainment was based on the presence of GTS and 
not hoarding or OeD. 
Results 
Results of the analyses of these data suggested linkage to 
three regions on three chromosomes (4q, 5q, and 17q). 
Among different analytic methods, the significance levels 
are largely consistent, regardless of whether the original 
or the residual hoarding-factor scores were used. Specif­
ically, in the region of 4q34-35, the best significance levels 
are .003, for the original factor score, and .0007, for the 
residual score, both of which are based on the nonpara­
metric Z score computed by GENEHUNTER. In the re­
gion of 5q35.2-35.3, the best significance levels are 
.000002, for the original factor score, and .000003, for 
the residual score, both of which are calculated by the 
revisited Haseman-Elston method. In the region of17q25, 
the best significance levels are .00002, for the original 
factor score, and .00006, for the residual score, both of 
which are calculated by the revisited Haseman-Elston 
method. A graphical presentation of the nonparametric 
Z scores of these results is provided in figure 1. 
As noted above, the status of hoarding as a binary­
outcome variable was also examined. Analyses with 
GENEHUNTER did not reveal any evidence of linkage 
for this binary trait. The power of GENEHUNTER is 
markedly reduced by the use of this dichotomized trait. 
However, by use of the R TREE program, some consistent 
evidence emerged from both linkage and association 
analyses on chromosomes 4q and Sq. The tree structure 
produced from the genomewide scan is shown in figure 
2. In the top circle, the so-called "root node" (labeled 
"I") includes all 77 sib pairs (26 concordant for hoard­
ing, 28 discordant for hoarding, and 23 concordant for 
being unaffected with hoarding). The IBD sharing from 
marker D5SMfd154 is first used to partition the sib pairs 
into two sets. As shown in table 1, this marker is in the 
region where other methods identified significance evi­
dence of linkage to the quantitative hoarding score. The 
62 sib pairs with IBD <1.9 at this marker are assigned 
to the left circle, the so-called "left daughter node" (la­
beled "2"). The remaining 15 sib pairs are assigned to 
the right box, the so-called "right daughter node" (la­
beled "3"). When IBD can be uniquely defined, the sib 
pairs in node 3 share exactly the same alleles at this 
marker. The alleles that are shared by the sib pairs in 
node 3 are shown in table 2. The first four alleles are 
shared most among seven unaffected sib pairs, and the 
last three alleles are mostly shared among eight affected 
sib pairs. The second split, which applies to the 65 sib 
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pairs in node 2, uses the IBD sharing at D5S408, which 
is next to D5SMfd154. This reaffirms the evidence of 
linkage in the same region. The eight sib pairs in node 
4 do not share any allele at this marker, suggesting that 
it could be either a vulnerability allele or a protective 
allele. The 54 sib pairs in node 5 share one or both alleles. 
Finally, node 5 is further divided into nodes 6 and 7 
through D4S1652, which is also within the vicinity where 
linkage to the quantitative-trait locus is suggested. The 
overall disparities in alleles that are shared among dif­
ferent types of sib pairs for the three selected markers 
are shown in table 2. 
Discussion 
Hoarding is likely to be an evolutionarily conserved trait 
that, in times of adversity, was associated with increased 
survival and reproductive fitness. However, extreme 
forms of this trait are associated with marked disability 
and poor treatment response (Black et al. 1998; Mataix­
Cols et al. 1999). 
The current analyses provide evidence that alleles 
shared at specific loci on 4q, 5q, and 17q are asso­
ciated with this trait. The 4q site is in proximity to 
D4S1625, which was identified by the TSAICG (1999) 
as a region linked to the GTS phenotype. The other two 
regions, 5q and 17q, show the strongest evidence for 
linkage and have not been previously identified as 
showing promise in kindreds with GTS or OCD. Fu­
ture studies will need to evaluate this and other ob­
sessive-compulsive-related quantitative traits in large 
families segregating for GTS and/or early-onset OCD, 
by use of highly informative marker sets in these regions 
of the genome. High-density mapping within these 
regions and replication studies with the additional GTS­
affected sib pairs may also be promising endeavors. 
Thus far, only one genome scan of early-onset OCD 
has been reported. This preliminary report found a pos­
sible vulnerability locus on 9p (G. L. Hanna,]. Veenstra­
VanderWeele, N. J. Cox, M. Boehnke, J. A. Himle, and 
G. C. Curtis, personal communication); however, a sub­
sequent study failed to find evidence of linkage dise­
quilibrium at a well-characterized locus in that chro­
mosomal region (Veenstra-VanderWeele et al. 2001). 
Although virtually all of the siblings with OCD in this 
sample had an age at onset <10 years (J. F. Leckman, 
D. L. Pauls, H. Zhang, M. C. Rosario-Campos, L. Kat­
sovich, K. K. Kidd, A. J. Pakstis, ]. P. Alsobrook, M. 
M. Robertson, W. M. McMahon, J. T. Walkup, B. J. 
M. van de Wetering, R. A. King, D. J. Cohen, and the 
TSAICG, unpublished data), we found no evidence of 
linkage to the hoarding trait of OCD in that 9p region. 
The one weakness of this study is the small number 
of sib pairs. As Risch (1990) has noted, very large sam­
ples of sib pairs may be necessary to detect linkage when 
Am. J. Hum. Genet. 70:896-904, 2002 
the relative risk is ~2. In the current study, it is not 
possible to accurately estimate the relative risk, since 
the population prevalence for hoarding is not known 
and since no family studies have been reported in which 
the recurrence risk for hoarding was reported. The best 
estimate for the relative risk for OCD that is available 
comes from two family studies of OCD (Pauls et al. 
1995; Nestadt et al. 2000b). The population prevalence 
of OCD has been estimated to be -2% (Karno et al. 
1988). The recurrence risk for OCD is -11 %-12% 
(Pauls et al. 1995; Nestadt et al. 2000b). Thus, the best 
estimate of the relative risk for OCD is -5.5-6.0. If it 
is assumed that the proportion of individuals with OCD 
who have hoarding is constant, then the relative risk 
for hoarding would also be -5.5-6.0. 
Another limitation is the small number of hoarding 
items on the Y-BOCS symptom checklist. A dimensional 
version of Y-BOCS (i.e., DY-BOCS), which should en­
hance the phenotypic characterization of this trait, is 
currently under development (Leckman et al. 2000b). 
Alternatively, the Questionnaire for Saving Things, de­
veloped by Frost et al. (1995), could be used for this 
purpose. 
The recursive-partitioning methods in genomic scans 
have lately emerged as flexible and potentially powerful 
alternatives to the standard approaches (Rao 1998; 
Zhang and Bonney 2000; Shannon et al. 2001; Zhang 
et al. 200tb). In addition, the success of these methods 
in the classification of distinct colon-cancer tissues and 
the methods' potential for the identification of other­
wise-obscure epistatic interactions suggest that such 
techniques may be especially valuable in efforts to iden­
tify the risk and protective factors that underlie genet­
ically complex neuropsychiatric disorders (Zhang et al. 
2001b). Furthermore, the identification of specific allele 
sharing in specific sib pairs may provide a direct ap­
proach to the confirmation of these findings in family­
based association studies (Simonic et al. 2001). 
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Obsessive-compulsive disorder (OCD) is an 
etiologically heterogeneous disorder. Recent 
factor analyses have consistently identified 
several symptom dimensions, two of which 
are associated with increased familial risk 
for OCD; aggressive, sexual, and religious 
obsessions and checking compulsions (FAC­
TOR 1) and symmetry and ordering obses­
sions and compulsions (FACTOR 2). Both 
of these symptom dimensions are also fre­
quently seen in association with Gilles de 
la Tourette syndrome (GTS). The purpose of 
this study was to determine whether these 
obsessive-compulsive (OC) symptom dimen­
sionsare correlatedwithin families (between 
sibs and between parent-child pairs). Using 
data collected by the Tourette Syndrome 
Association International Consortium for 
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Genetics Affected Sibling Pair Study, the 
authors selected all available GTS sib pairs 
and their parents for which these OC symp­
tom dimensions (factor scores) could be 
generated. This group included 128 full sibs 
and their mothers (54) and fathers (54). Four 
OC symptom dimension scores were com­
puted for each family member using an 
algorithm derived from item endorsements 
from the Yale-Brown Obsessive·Compulsive 
Scale (Y·BOCS) symptom checklist. In ad­
dition to a series of univariate analyses, 
complex segregation analyseswere also com· 
pleted using these quantitative OC symptom 
dimension scores. FACTOR 1 and FACTOR 2 
scores were significantly correlated in sib 
pairs concordant for GTS. The mother-child 
correlations, but not father-child correla­
tions, were also significant for these two 
factors. Segregation analyses were consis­
tent with dominant major gene effects for 
both FACTOR 1 and FACTOR 2. We conclude 
that familial factors contribute significantly 
to OC symptom dimension phenotypes in 
GTS families. This familial contribution 
could be genetic or environmental. 
© 2003 Wiley·Liss, Inc. 
KEY WORDS: 	 Gilles de la Tourette synd­
rome; obsessive-compulsive 
disorder; quantitative traits; 
segregation analyses 
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INTRODUCTION 
Substantial recent advances in molecular genetics 
have greatly increased the capacity to localize disease 
genes on the human genome. These methods are now 
being applied to complex disorders, including Gilles de la 
Tourette syndrome (GTS) [Tourette Syndrome Interna­
tional Consortium for Genetics, 1999]. One of the major 
difficulties in the application of these approaches is the 
likely etiologic heterogeneity of GTS and related pheno­
types. Heterogeneity reduces the power of gene-locali­
zation methods, such as linkage analysis [Zhang and 
Risch, 1996; Gu et al., 1998; Alcais and Abel, 1999]. 
Etiologic heterogeneity may be reflected in phenotypic 
variability, thus it would be highly desirable to dissect 
the syndrome, at the level of the phenotype, into valid 
quantitative heritable components. 
Obsessive-compulsive (OC) symptomatology is ob­
served frequently in patients with GTS [Pauls and 
Leekman, 1986; Pauls et al., 1991; Swerdlowetal., 1999; 
Robertson, 2000]. Factor analytic studies of OCD 
patients have identified at least four OC symptom 
dimensions [Baer, 1994; Leckman et al., 1997, 2001; 
Mataix-Cols et al., 1999; Summerfeldt et al., 1999; 
Cavallini et al., 2002]. One dimension (FACTOR 1) is 
characterized by aggressive, sexual, and religious ob­
sessions and checking compulsions. FACTOR 2 is 
characterized by symmetry and ordering obsessions 
and compulsions. FACTOR 3 includes contamination 
obsessions and cleaning/washing compulsions, and the 
fourth factor (FACTOR 4) includes hoarding obses­
sions and compulsions. Preliminary data supporting the 
validity of these dimensions come from longitudinal 
studies [Mataix-Cols et al., 2002] as well as functional 
brain imaging [Rauch et aI., 1998; Phillips et al., 2000] 
and treatment studies [Black et al., 1998; Mataix-Cols 
et al., 1999]. Preliminary studies also provide evidence 
for the orderly emergence ofsimilar compulsive traits in 
normally developing children [Evans et al., 1997; Zohar 
and Felz, 2001]. 
Although these studies suggest that these dimensions 
are stable over time and may have biological validity, 
there has been little examination of their familial or 
genetic nature. At the present time, we are aware of only 
one study that has examined the relationship of these 
factors to familial risk [Alsobrook et al., 1999]. In that 
study, the relatives of OCD probands who had high 
scores on FACTOR lor FACTOR 2 were at greater risk 
for OCD than were relatives of probands who had low 
scores on those factors. To date there have been no 
published studies done that examine whether the OC 
symptom dimensions are themselves familial. 
Families of affected sib pairs diagnosed with GTS 
are ideally suited for efforts to identify the genetic loci 
responsible for these quantitative OC phenotypes. First, 
the early-onset OCD observed in these families is likely 
to be etiologically more homogenous [Pauls et al., 1995; 
Nestadt et al., 2000]. Second, the two symptom dimen­
sions associated with higher familial risk of OCD 
(FACTORS 1 and 2) are also frequently observed in 
patients with GTS [Leckman et al., 1997; Swerdlow 
et al., 1999; Robertson, 2000]. Third, the use of quan-
OC Traits Among Tourette Family Members 
titative traits that are familial provides a more powerful 
approach than analyses using categorical diagnostic 
(qualitative) outcomes [Zhang and Risch, 1996; Alcais 
and Abel, 1999; Elston et al., 2000]. 
We addressed the question of familial factors under­
lying the OC symptom dimensions commonly seen in 
GTS by examining affected sib pairs and their parents 
ascertained in the Tourette Syndrome Association 
International Consortium for Genetics Affected Sibling 
Pair Study [Tourette Syndrome International Consor­
tium for Genetics, 1999]. The purpose of the current 
study was to test the hypothesis that pairs of GTS 
relatives resemble one another for each of the four 
quantitative OC symptom dimensions at greater 
than chance expectations. To investigate the possible 
transmission of these quantitative OC symptom dimen­
sions, complex segregation analyses were also carried 
out. 
MATERIALS AND METHODS 

Sample 

All families consisted of at least two sibs affected 
with GTS. Families were not included in the analyses 
reported here ifboth parentswere affected with GTS orif 
one parent had GTS, chronic motor or vocal tic disorder 
(CT), OCD, or subclinical OCD and the other parent also 
reeeived a diagnosis of CT, OCD, or subclinical OCD. 
All diagnoses were made using DSM-III-R criteria. The 
criteria for subclinical OCD were the same as those used 
to make a diagnosis of OCD, except that the individual 
did not perform the compulsions or obsessions for at 
least an hour, or did not experience them as ego dystonic, 
or did not report any impairment. These were the same 
criteria used in the family study of OCD reported by 
Pauls et al. [1995]. Written informed consent was 
obtained for all participants after the procedures had 
been fully explained. Children were also asked to assent 
to participate in the study in the presence of their 
parents after the purpose of the study, the nature of the 
interviews, and the blood collection procedures were 
described in age-appropriate language. 
Phenotypic Evaluation 
When a family entered the study, information con­
cerning both affected sibs and their parents was col­
lected in a two-stage process. The initial stage consisted 
of the collection of information concerning symptoms 
associated with GTS and OCD using a self-and-family 
report based on the tic inventory and ordinal severity 
scales of the Yale Global Tic Severity Scale [Leckman 
et al., 1989] and the symptom checklist and ordinal 
scales of the Yale-Brown Obsessive-Compulsive Scale 
[Y-BOCS, Goodman et al., 1989]. Earlier versions of 
these instruments have been used in prior studies of 
individuals with GTS and OCD and have been shown to 
have good agreement with expert clinician ratings of tic 
and OC symptom severity [Leckman et al., 1993, 1994; 
Swerdlowet al., 1999]. In a second stage, an experienced 
clinician reviewed these symptom ratings with each 
family member to insure their accuracy and validity. 
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These instruments are currently being used in family 
studies of both GTS and OCD. 
Factor scores were computed using an algorithm 
derived from an earlier study of 292 individuals with 
OCD and based on item endorsements from theY -BOCS 
Symptom Checklist. This factor analysis is described 
more fully in Leckman et a1. [1997]. Briefly, a principal 
components factor analysis with a Varimax rotation was 
carried out on symptom counts from the 13 a priori 
categories in the Y-BOCS symptom checklist in two 
independent groups of patients with OCD (N = 208 and 
N =98) [Leckman et aI., 1993, 1994, 1995; Pauls et aI., 
1995]. The two data sets yielded nearly identical results. 
Four factors, obsessions and checking, symmetry and 
ordering, cleanliness and washing, and hoarding, 
emerged in each data set, in total accounting for more 
than 60% of the variance. The algorithm used to 
generate the factor scores in this study was based on 
the category-specific coefficients, derived from the total 
sample ofOCD subjects, and reported in Table II ofthat 
earlier study [Leckman et al., 1997]. Specifically, the 
number of items endorsed for each of the 13 symptom 
categories by each participant in this study was multi­
plied by the respective category-specific coefficients 
from the earlier study to generate the four factor scores. 
Best-Estimate Diagnoses 
All diagnoses were made using the best-estimate 
approach [Leckman et aI., 1982]. The best-estimate 
procedure used in the present study followed a standard 
protocol. Before the initial diagnostic estimate was 
made, separate files for each individual were prepared. 
These files contained all available information about the 
individual, including the completed interview packet 
and medical records, when available. Three clinicians 
(Bv dW, Rotterdam site; WM, Utah site; and RAK, Yale 
site) reviewed all available information and indepen­
dently made diagnostic assessments. All three diagnos­
ticians were blind to the prior diagnosis of the individual 
and to his/her relationship to the proband. Two raters 
evaluated each interview. If they judged DSM-IV 
criteria to be satisfied, then they rated that diagnosis 
as "definite." If they judged DSM-IV criteria to be sati­
sfied save one criterion, then they rated that diag­
nosis as "probable." The best estimates of the two 
diagnosticians were then compared. When there was 
disagreement between the two raters, the third diag­
nostician reviewed the individual files and a final 
consensus diagnosis was assigned. These consensus 
diagnoses were then compared to the diagnosis assign­
ed by the clinician at the site where the family was 
recruited. Ifthere were differences, the clinical materi­
als were reviewed via a conference call and consensus 
was reached if possible. If there was still disagreement, 
more data were requested to help resolve the differ­
ences. If there was still disagreement, the family was 
removed from the sample. 
Statistical Analyses 
Because the original factor scores were normally 
distributed [Leckman et a1., 1997), resemblance in sib 
and relative pairs for quantitative traits was examined 
by standard parametric analyses of association and 
analyses of covariance. Because this analysis contain­
ed non-independent sib pairs from sibships containing 
three or more affected individuals, we repeated all 
analyses, using just the two oldest sibs from sibships 
with three or more affected members. Age was included 
as a covariate in the univariate models. 
Complex segregation analyses were carried out to 
examine the hypothesis that there is transmission of 
OCD within families and if that transmission is con­
sistentwith genetic modes of inheritance. Analyses were 
carried out using the unified model as implemented in 
the computer program POINTER [Lalouel et a1., 1983]. 
The unified model allows for the possible contributions 
of both major genetic and polygenic loci (the so-called 
mixed model). Specific genetic models are hierarchical 
and were examined by comparing the maximum like­
lihood estimates using a X2 test. In these analyses four 
parameters were estimated: 1) Q, the frequency of the 
putative major susceptibility allele; 2) D, the degree of 
dominance of that allele; 3) H, the heritability of the 
polygenic component contributing to the expression of 
OeD; and 4) T, the effect of the major susceptibility 
allele in the population. In addition, V, stands for 
the variance of the quantitative trait and, U, the mean 
value of the quantitative trait given the phenotype. For 
the factor scores the variance should be 1.0 and the mean 
should be 0.0. No ascertainment correction was em­
ployed for these analyses because the ascertainment 
was based on the presence of GTS and not the value of 
these factors. 
By taking twice the difference between the maximum 
log likelihood estimates for each model we compared 
competing genetic models. This difference in log like­
lihoods is distributed as a X2 statistic with degrees of 
freedom equal to the difference in the number of esti­
mated parameters in the two models. For example, four 
parameters are estimated when fitting the Mendelian 
mixed model and only one is estimated when fitting the 
polygenic modeL Twice the difference between the log 
likelihoods for the mixed and polygenic model is distri­
buted as a X2 with 3 degrees offreedom. 
First, we compared the model of "No Transmission" 
with the mixed model assessed evidence for transmis­
sion. If twice the difference in log likelihoods did not 
yield a significant X2 statistic, we concluded that there 
was no evidence for vertical transmission and no further 
comparisons were made. If the difference in log like­
lihood yielded a significant X2 statistic, it is taken as 
evidence for possible vertical transmission and further 
comparisons were made. The next two comparisons 
examined: 1) if models of a major gene alone (no poly­
genic background) were sufficient to account for the 
presumed vertical transmission; and 2) if models of 
polygenic inheritance (no major locus) were consistent 
with the pattern of transmission. 
Evidence for a major locus component in transmission 
was assessed by comparing the likelihood of this model 
to that of the likelihood of the mixed modeL If the dif­
ference in twice the log likelihood was not significant, 
the major locus hypothesis was not rejected. If at the 
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63 OC Traits Among Tourette Family Members 
TABLE 1. Gilles de la Tourette Syndrome Sibships Studied for 
Obsessive-Compulsive Symptoms 
Number Number of Number Number of Number 
of siblings sibships of siblings mothers offathers 
withGTS (n 54) n=128 n=54 n=54 
Two 38 76 38 38 
Three 12 36 12 12 
Four 4 16 4 4 
same time, then similar comparison between the poly­
genic hypothesis and the mixed model hypothesis could 
be rejected, then a mode of inheritance that includes a 
major locus with no polygenic background would be the 
most parsimonious. If both major locus and polygenic 
hypotheses can be rejected, then a mode of transmission 
with both a major locus and polygenic background (Le., 
the mixed model) would be the most parsimonious. 
RESULTS 
Sample 
The 236 subjects came from 54 families (Table I). 
Thirty-eight of the families contained two sibs affected 
with GTS. Twelve families contained three sibs affected 
with GTS. Four families had four affected sibs. One 
hundred and sixty-two subjects (68.6%) were judged to 
have probable or definite GTS. Ninety-seven subjects 
(41%) were judged to have probable or definite OCD. 
Table II presents the clinical characteristics of GTS­
affected sib pairs and their parents. 
Sib and Parental ReselIlblance for Obsessive 
Compulsive Symptom Dimensions 
We were able to compute four OC symptom dimen­
sions (FACTORS 1-4) for all 236 subj cts. The sibs 
resembled each other significantly with respect to 
FACTOR 1 and FACTOR 2 scores (Table III). We repe­
ated this analysis after removing non-independent 
sib pairs. The results were similar, with a significant 
correspondence between sib pairs with respect to 
FACTOR 1 and FACTOR 2 (Table III). Partial correla­
tions were also significant such that sib 1's FACTOR 1 
score was significantly related to sib 2's FACTOR 1 score 
even after controlling for the effects of sib 1's and sib 2's 
FACTOR 2 scores (data not shown). Similarly, the 
partial correlations for FACTOR 2 were also significant 
even after controlling for the effects of sib l's and sib 2's 
FACTOR 1 scores (data not shown). 
The mothers, but not fathers, resembled their affect­
ed children with respect to FACTOR 1 and FACTOR 2 
scores (Table III). When we repeated this analysis 
after removing non-independent sib pairs, the results 
were similar, with a significant mother-child corre­
spondence with respect to just FACTOR 1 and FACTOR 
2 (Table III). Partial correlations were also significant 
such that both sib l's and sib 2's FACTOR 1 scores were 
significantly related to the mother's FACTOR 1 score 
even after controlling for the effects of sib l's or sib 2's 
and the mothers' FACTOR 2 scores (data not shown). 
Similarly, the partial correlations for FACTOR 2 were 
also significant even after controlling for the effects of 
either sib's and the mother's FACTOR 1 scores (data not 
shown). 
Because the mother served as the primary informant 
for the prepubertal subjects, these correlations were 
computed again using only the data from 17 sibs pairs 
where both were above the age of 15 years. The sib-sib 
correlations for FACTOR 1 and FACTOR 2 scores were 
in same range as for the entire set of sib pairs (0.38 and 
0.39, respectively, P < 0.10). Interestingly, the FACTOR 
4 scores also approached significance (0.42, P = 0.09). 
The mother-child correlations for these older sibs were 
also comparable to those found in the entire set of 
TABLE II. Clinical Characteristics of Gilles de la Tourette Syndrome Affected Sibling Pairs and 

Their Parents 

Eldest sibling 
(N=54) 
2nd Eldest 
sibling (N =54) 
Mother 
(N =54) 
Father 
(N=54) 
Male, n (%) 38 (70) 42 (78) 0(0) 54 (100) 
Mean age, years (SD) 14.8 (7.1) 13.6 (7.7) 42.8 (7.5) 44.3 (7.6) 
GTS diagnosis: n (%) 
Definite 43 (80) 46 (85) 14 (26) 11 (20) 
Probable 11 (20) 8 (15) 3(7) 6 (3) 
Age of tic onset, years (SD) 5.7 (2.3) 5.6 (2.6) 7.6 (3.3) 7.6 (2.0) 
OCD diagnosis: n (%) 
Definite 23 (43) 22 (41) 14 (26) 4 (7) 
Probable 8 (15) 7 (13) 4 (7) 3 (6) 
OCD age of onset, years (SD) 6.7 (3.5) 6.7 (3.4) 10.3 (3.6) 11.5 (9.6) 
SSRI medication history: n (%) 
Ever 19 (35) 21 (39) 17 (31) 13 (24) 
Current 13 (24) 15 (28) 10 (19) 8 (15) 
YGTSS-total tic score 
Current (SD) 16.2 (10.7)" 16.2 (1O.0)b 
Y-BOCS-total score 
Current (SD) 17.6 (7.9)" 17.4 (5.9}d 
"n =41. 
bn =40. 
'n=22. 
d,,=18. 
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TABLE III. Pearson Correlations Between Obsessive-Compulsive Symptom Factor Seorest 

OCfactora Sib1-Sib2 Sib I-mother Sib I-father Sib2-mother Sib2-father 
Factor 1 0041*,0041* 0.64*,0046* 0.13,0.11 0.36*,0.24 0_01,0.15 
Factor 2 0.38*,0.33*** 0041*, 0_25*'" 0.00,0.20 0.31**,0.35** -0.01,0.03 
Factor 3 0.11,0.08 0.26***, 0.08 0.04,0.09 0.26***,0.25**'­ -0.11, -0.22 
Factor 4 0.16,0.15 0.12, -0.06 0.05,0.08 0.18,012 -0.06,0.15 
tIn each cell the first coefficient is for all sib-pairs and all parent-sib pairs. The second coefficient is for the oldest two sibs and their parent-sib correlations. 

DC, obsessive-compulsive. 

·OC Factors scores were generated based on an algorithm developed in a study of 292 patients with DC disorder [Leckman et a1., 1997]. Factor 1 includes 

aggressive, sexual, religious and somatic obsessions and checking compulsions. Factor 2 includes obsessions of symmetry and exactness and ordering, 

counting, doing and redoing compulsions. Factor 3 includes obsessions of cleanliness and washing compulsions. Factor 4 includes obsessions and compulsions 

related to hoarding. 

'p< O.OOOL 

"p< 0.0l. 

"'p< 0.05. 

""p< 0.10. 

mother-child pairs (FACTOR 1 [mother-sib 1: 0.84, FACTOR 2 scores were the most robust predictors of the 

P < 0.0001; mother-sib 2: 0.53, P =0.031, FACTOR 2 sib's scores for FACTORS 1 and 2. 

[mother-sib 1: 0.63, P < 0.007; mother-sib 2: 0.00, NS] 

and FACTOR 4 [mother-sib 1: 0.57, P < 0.02; mother­
 Factor Analysis
sib 2: 0.43, P =0.09]). 
In a further effort to examine the relative effect of UsingaprincipalcomponentsfactoranalysiswithVari­
parent-child vs. sib associations a series of univariate max rotation, we examined the results when we specifi­
analyses were carried out in which sib l's factors scores ed a four-factor model. The four factors that emerged 
were related to sib 2's factor scores as well as the closely resembled the results froni the earlier analyses 
mother's and father's factor scores while simultane­ that relied solely on individuals with OCD. This solution 
ously controlling for the effects of age. As presented in also accounted for more than 70% of the variance 
Table IV, the effects of the mother's FACTOR 1 and (Table V). 
TABLE IV. Analyses of Variance of Sib1 OC Factor 1 and Factor 2 Scores' 
Dependent measure Independent variables F (1, 83), P-value" F (1, 43), P-valueb 
Sl Factor 1 Sib1 age 8.71, .004 2.15, NS 
Sib2 age 0.128, NS 0.000, NS 
Mother's age 0.618, NS 0.01, NS 
Father's age 3.60, .06 0.39, NS 
Sib2 Factor 1 5.44, .02 3.31, .08 
Mother Factor 1 35.89, .0001 9.50, .004 
Father Factor 1 0.05, NS 0.00, NS 
Sl Factor 2 Sib1 age 1.98, NS 2.59, NS 
Sib2 age 0.303, NS 0.79, NS 
Mother's age 5.90, .017 0.05, NS 
Father's age 6.91, .01 0.14, NS 
Sib2 Factor 2 5.31, .02 2.28, NS 
Mother Factor 2 11.32, .001 2.72, .10 
Father Factor 2 1.08, NS 2.22, NS 
Sl Factor 3 Sib1 age 0.002, NS 0.84, NS 
Sib2 age 3.56, .06 0.07, NS 
Mother's age 5.14, .03 0.89, NS 
Father's age 8.78, .004 1.81, NS 
Sib2 Factor 3 0.007, NS 0.37, NS 
Mother Factor 3 2.12, .15 0.26, NS 
Father Factor 3 1.42, NS 1.16, NS 
Sl Factor 4 Sib1 age 2.91, .09 4.79, .04 
Sib2 age 0.01, NS 0.80, NS 
Mother's age 0.18, NS 0.03, NS 
Father's age 1.42, NS 0.52, NS 
Sib2 Factor 4 0.13, NS 016, NS 
Mother Factor 4 0040, NS 0.17, NS 
Father Factor 4 0.33, NS 0.22, NS 
•ANCOVAs in which we evaluated the effect of the Sib2's and the parents' Factor scores on Sibl's Factor scores 

while simultaneously controlling for age. 

"This analysis was performed using all available Sl pairs (N = 91). 

~his analysis was performed using just the eldest two siblings IN = 51). 
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TABLE V. Varimax Rot ated Factor Structure for Yale-Brown Obsessive Compulsive Scale 
SVlmo,toln Checklist Scores 
Factor loading" 
Obsessions Symmetry Cleanliness 
Symptom category and checking and ordering and washing Hoarding 
Aggressive obsessions 0.62 0.18 0.49 0.18 
Contamination obsessions 0.43 0.27 0.70 0.05 
Sexual obsessions 0.83 0.18 0.18 0.11 
Hoarding obsessions 0.09 0.19 0.19 0.87 
Religious obsessions 0.66 0.22 0.21 0.22 
Obsessions of symmetry 0.23 0.76 0.19 0.23 
Somatic obsessions 0.58 0.18 0.49 0.15 
Cleaning compulsions 0.02 0.08 0.70 -0.03 
Checking compulsions 0.22 0.45 0.68 0.29 
Repeating rituals 0.05 0.33 0.68 0.30 
Counting compulsions 0.41 0.56 0.18 0.21 
Ordering and arranging 0.12 0.83 0.29 0.13 
Hoarding and collecting 0.33 0.23 0.06 0.78 
% of variance explained 21.5 16.7 21.3 13.6 Sum = 72.1% 
"Robust loadings (greater than 0.50) are printed in bold. 
Segregation Analyses 
Results of segregation analyses using the four factors 
as quantitative phenotypes are presented in Table VI. 
Significant evidence for genetic transmission was ob­
tained for all factors. Of interest is that the specific mode 
of transmission differed for specific factors. The most 
parsimonious solution for each factor suggests genes of 
major effect. For FACTORS 1 and 2 the transmission 
was consistent with dominant inheritance whereas for 
FACTORS 3 and 4 the most parsimonious solution was 
consistent with recessive inheritance. 
DISCUSSION 
The findings in this study suggest that at least some 
of the OC symptom dimensions are heritable. First, for 
FACTORS 1 and 2, there was a significant correlation 
both between sib pairs and mother-child pairs. To our 
knowledge, this is the first report of familial resem­
blance for these quantitative phenotypes in patients 
with GTS, OCD, and closely related disorders. Second, 
these correlational findings are strengthened by the 
results of segregation analyses that suggest that the 
patterns within families are consistent with genetic 
TABLE VI. Segregation Analyses of Yale-Brown Obsessive Scale Factor Scores* 
V U D T Q H -2Ln(L) 
OC Factor I" 
No transmission 0.70±0.07 -0.53±0.01 0.00· 0.00· 0.00· 0.00· 283.563 
Mixed model 0.94±0.09 -0.04±0.10 l.OOf 1.57 ±0.10 0.29±0.OB 0.06±0.06 246.950 
Single locus model 0.94±0.09 -0.04±0.19 l.OOf l.57±0.11 0.29±0.OB 0.00· 24B.029 
Polygenic model 
OC Factor2b 
0.67±0.07 -0.50±0.02 0.00· 0.00· 0.00· 0.44±0.OB 264.975 
No transmission 0.BB±0.08 -0.36±0.02 0.00· 0.00" 0.00· 0.00· 30B.599 
Mixed model 0.84±0.08 -0.13±0.1O l.OOf 1.49±0.08 0.39±0.07 0.04±0.05 275.565 
Single locus model 0.84±0.08 -0.14±0.09 l.OOf l.49±0.08 0.39±0.07 0.00· 275.818 
Polygenic model 0.90±0.1O -0.17±0.10 0.00· 0.00· 0.00· 0.54±0.10 291.243 
OC Factor 3· 
No transmission 0.39±0.04 -0.56±0.Q7 0.00· 0.00· 0.00· 0.00· 217.3B1 
Mixed model 0.56±0.09 -0.37±0.03 0.01±0.07 1.51±0.10 0.50±0.07 0.04±0.04 169.891 
Single locus model 0.55±0.OB -0.37 ±0.03 0.03±0.06 1.50±0.10 0.52±0.Q7 0.00· 170.617 
Polygenic model 
OC Factor 4d 
0.41±0.04 -0.52 ±0.01 0.00· 0.00· 0.00· 0.24±0.05 217.362 
No transmission l.09 ±0.10 0.37±0.07 0.00· 0.00· 0.00· 0.00· 333.097 
Mixed model 0.97±0.18 1.03±0.22 O.OOf 1.91±0.07 0.85±0.06 0.01±0.01 287.290 
Single locus model 0.97±0.19 1.03 ±0.23 O.OOf 1.91 ±0.07 0.B5±0.07 0.00· 287.294 
Polygenic model 1.09±0.10 0.38±0.08 0.00· 0.00· 0.00· 0.OB±0.08 332.643 
·V, variance ofthe quantitative trait; U, mean value ofthe quantitative trait; D, the degree of dominance ofthat allele; T, the effect of the major susceptibility 
allele in the population; Q, the frequency of the putative mejor susceptibility allele; H, the heritability of the polygenic component; NS, not significant.
2
"No transmission vs. mixed, X2(4) = 36.613 (P < 0.000001); Mixed vs. single locus, X m =1.079, NS; Mixed vs. polygenic, X'(3) = 18.025 (p < 0.0005). 

"No transmission va. mixed, X2(4) = 33.034 (p < 0.000001); Mixed va. single locus, X'(l) =0.253, NS; Mixed va. polygenic, X'(3) =15.678 (P < 0.002). 

"No transmission vs. mixed, X2(4) = 47.490 (P < 0.000001); Mixed vs. single locus, X2m = 0.726, NS; Mixed vs. polygenic, X2(3) = 47.471 (P < 0.000001). 

dNo transmission vs. mixed, X2(4) = 45.807 (p < 0.000001); Mixed vs. single locus, X'm = 0.004, NS; Mixed vs. polygenic, X2(3) = 45.353 (P < 0.0001). 

'Parameter fixed for the analysis. 

rparameter converged at the boundary, no standard error estimated. 
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transmission. The most parsimonious results were con­
sistent with the hypothesis that there are genes of major 
effect underlying each of these OC symptom dimensions. 
It is important to note that although FACTORS 3 and 4 
that did not show a significant correlation between sibs 
or parents, their transmission patterns within families 
were consistent with recessive inheritance. For reces­
sive inheritance, the expected correlation between sibs 
would be 0.25 and between parents and children itwould 
approach zero. Consequently, it is not surprising that 
the correlations observed for those factors were small 
and, given the size of our current sample, not statisti­
cally significant. 
Limits 
Although much of the available data are promising, 
there are many questions yet unanswered concerning 
the value of a dimensional approach in OCD and related 
disorders. Principal among these is how best to measure 
these dimensional traits in patients and populations. 
Among patient populations the factor structure for these 
OC symptom dimensions has been remarkably consis­
tent across at least six large studies [Leckman et al., 
1997, 2001; Mataix-Cols et al., 1999; Summerfeldt et al., 
1999; Cavallini et al., 2002]. The results of the present 
study offer additional support for the validity of these 
symptom dimensions. These symptom dimensions ap­
pear to be relatively stable over 2-year intervals in 
adults [Mataix-Cols et al., 2002], but similar studies 
have yet to be carried out in younger OCD patient 
groups. Studies of normal popUlations have yet to be 
completed although data from normally developing chil­
dren are consistent with the orderly emergence of these 
traits [Evans et al., 1997; Zohar and Felz, 2001]. 
It is also possible that the observ d associations 
between the sib pairs and the mother-child dyads is 
due in part to a measurement bias in that the mothers 
typically served as the primary informant in the study. 
We believe, however, that this may not be a major factor. 
First, these associations were generally stronger when 
the analyses were confined to the older sib pairs. Second, 
the observed associations were generally not presentfor 
FACTOR 3, contamination obsessions and cleaning 
compulsions, traits that would likely be subject to the 
same biases. Third, the requirement that an experi­
enced clinician validate each symptom also insured the 
highest standard of accuracy. Finally, the possibility 
that these findings are the result of non-genetic trans­
mission cannot be excluded given the design of this 
study. 
Other issues include the accuracy of the four-factor 
solution with some investigators suggesting that FAC­
TOR 1 is divisible within two separate domains: aggres­
sive obsessions and related checking compulsions vs. 
obsessions with either sexual or religious content 
[Mataix-Cols et al., 1999]. 
Future studies using a larger collection of sib pairs 
will also need to examine gender-specific associations 
(mother-son, mother-daughter, father-son, father­
daughter) in an effort to replicate these findings as well 
as evaluate possible parent-of-origin effects (genetic 
imprinting) vs. gender-specific effects. It may also be 
important to use analytic strategies that would permit 
the use of data from all sibs and thatwould also take into 
account the correlation of observations within families 
[Hudson et al., 2001]. The selection ofthe oldest two sibs 
in this analysis was not wholly an arbitrary decision, 
however, because their inclusion should provide the 
best lifetime data regarding the development of DC 
symptoms. 
The results of the segregation analyses should be 
viewed with caution. For example, because FACTORS 1 
and 2 are known to be associated with tic disorders, 
the ascertainment of the sib pairs was not comple­
tely unbiased with regard to two of these quantitative 
phenotypes. In addition, the estimates of allele fre­
quencies are uniformly high (0.29-0.85) and may re­
flect some aspect of the unique ascertainment of this 
sample. In addition, given that the factor scores for 
FACTORS 1, 2, and 3 were inter-correlated, future 
analyses should endeavor to estimate the unique vari­
ance for each factor as well as the common variance 
for all four. These residual variances and the common 
variance could then be used as quantitative phenotypes 
in future segregation and linkage analyses using larger 
data sets. 
CONCLUSIONS 
Common disorders with genetic susceptibilities are 
likely to involve the action of multiple genes interact­
ing with each other and with environmental factors, 
making it difficult to localize the specific genetic loci 
responsible. An important route to the disentangling of 
this complex inheritance may be through the study of 
normal variation in quantitative psychological traits. 
Studies of the symptoms ofOCD have led to the identi­
fication of at least four such traits. A preliminary study 
of OCD probands has found evidence that at least two 
of these factors may be useful in family aggregation 
studies. This study confirms the promise of these 
factors, particularly in patients at high risk for GTS. 
Genome scans are currently underway to utilize these 
quantitative OC phenotypes in multipoint linkage ana­
lyses [Zhang et al., 2002]. Further, ifOCD proves to be a 
multidimensional and etiologically heterogeneous con­
dition, it may be used to develop "state" as well as "trait" 
assessment instruments based on these symptom 
dimensions [Leckman et al., 2000]. Such scales could 
then be used in clinical trials to quantity more precisely 
the patterns of treatment response. The factors asso­
ciated with an unfavorable treatment response remain 
largely unknown. Although global ratings of pretre­
atment symptom severity appear not to be a useful 
predictor of response [Steketee, 1993; Ackerman et al., 
1994], the differential patterns of response for OCD 
patients with hoarding symptoms emphasize the po­
tential value of separate severity scales for separate 
symptom dimensions. 
With regard to GTS, these results are consistent 
with the high rate of OC symptoms reported in GTS 
families [Pauls and Leckman, 1986; Pauls et al., 1991; 
Leckman et al., 1997; Swerdlow et al., 1999; Robertson, 
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2000] and may aid in the identification of autosomal 
genes that predispose individuals to both GTS and 
specific forms of OCD [Pauls and Leckman, 1986; 
Robertson and Gourdie, 1990; Eapenetal., 1993; Gardos 
et al., 2001]. 
These dimensions may also be of heuristic value in 
the context of evolutionary perspectives on psycho­
pathology and the emergence of related behaviors across 
the OCD spectrum including eating disorders, body 
dysmorphic disorder, autism, and Prader-Willi syn­
drome as well as during the course of normal develop­
ment [Evans et al., 1997; Leckman and Mayes, 1998; 
Bienvenu et al., 2000; Zohar and Felz, 2001; Halmi et al., 
in press]. 
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a2A and ale and Gilles de la Tourette Syndrome 
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Gilles de la Tourette Syndrome (GTS) has 
longbeen known to be familial, and evidence 
from twin studies indicates that it has a 
substantial genetic component. Our genome 
scan of sibling pair families with GTS found 
evidence suggestive of linkage to several 
chromosomal locations. On the basis of these 
findings, we have begun to study additional 
markers in these regions, with some of the 
markers located in candidate genes. Two 
candidate genes stand out in these regions: 
the adrenergic receptor alC(1A) (ADRA1C) 
located on chromosome 8p and the adrener­
gic re.ceptor a2A (ADRA2A) located on chro­
mosome 10q. The adrenergic system has been 
suggested to playa role i  GTS based on the 
reduction of symptoms with the adrenergic 
receptor agonists, clonidine and guanfacine. 
We examined the inheritance of polymorph­
isms in the ADRA2A and ADRA1C genes in 
113 nuclear families identified through a 
GTS proband. We found no significant evi­
dence for linkage using the transmission 
disequilibrium test for these two genes. 
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Based on our 	families, we conclude that 
these genes are not major genetic factors 
contributing to the susceptibility to GTS. 
© 2003 Wiley-Liss, Inc. 
KEY WORDS: 	 Gilles de la Tourette syn­
drome; genetics; adrenergic 
receptor alC (ala); adrener­
gic receptor a2A; linkage 
INTRODUCTION 
Gilles de la Tourette syndrome (GTS) is a familial 
disorder characterizedby the presence of both motor and 
phonic tics. Other disorders are commonly observed in 
affected individuals and in family members of GTS 
probands and segregation studies have supported that 
some ofthese phenotypes, in particular chronic multiple 
tics (CMT) and obsessive compulsive disorder, may 
share a common genetic susceptibility in GTS families 
[Pauls et aI., 1986, 1990, 1991; Walkup et al., 1996J. 
Symptoms of attention-deficit hyperactivity disorder 
(ADHD) are common in individuals with GTS and their 
family members and have been suggested to be an 
alternative phenotype of GTS susceptibility genes. The 
genetic link between GTS and ADHD, however, has not 
been clarified based on segregation studies [Barr and 
Sandor, 1998J. 
The search for genetic factors contributing to the 
susceptibility ofGTS has been investigated by a number 
of groups using linkage and association studies [Barr 
and Sandor, 1998]. These studies include genome scans 
for GTS, using multi-generational families [Pakstis 
et al., 1991; Barr et aI., 1999J, nuclear families with 
affected sibling pairs [The Tourette Syndrome Associa­
tion International Consortium for Genetics, 1999], and 
studies using pools of DNA from individuals with GTS 
from the Afrikaner population compared with those of 
control subjects [Simonic et aI., 1998]. 
Our recent genome scan o~ 119 affected sibling pairs, 
carried out as part of an mternational consortium, 
© 2003 Wiley-Liss, Inc. 
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identified several regions that provided some evidence 
for linkage although the findings did not reach genome­
wide significance levels [The Tourette Syndrome Asso­
ciation International Consortium for Genetics, 1999]. 
One region identified was located on the short arm of 
chromosome 8 in the region of D8S1106. Additional 
markers in the region <D8S1130, D8S1145, and D8S136) 
also provided support for linkage. Another of the re­
gions with a LOD score greater than 1 was located on 
chromosome lOq in the region of marker D10S1213. 
Within these two regions, two genes stand out as 
promising candidates-the adrenergic receptor cdC 
(ADRAIC) and the adrenergic receptor tx2A (ADRA2A). 
The adrenergic system has always been a particularly 
attractive candidate for the genetic susceptibility to 
GTS, considering the efficacy of treatment of tics with 
clonidine and guanfacine [Leckman et al., 1991; Chap­
pell et al., 1995; Lichter and Jackson, 1996]. Clonidine 
and guanfacine are tx-adrenergic agonists that prefer­
entially stimulate the tx2 adrenergic receptors. Stimula­
tion of the presynaptic cd receptors decreases the 
amount of norepinephrine released into the synapse, 
suggesting that dysregulation of the adrenergic system 
may be causally involved in GTS. 
The <x-adrenergic receptors function in a many physio­
logical processes, including control of blood pressure and 
flow, digestion, reproduction, pupil diameter, endocrine 
and metabolic processes, and most importantly for 
this study, neural modulation and behavior [Docherty, 
1998]. The activation of tx1-adrenergic receptor pro­
motes vigilance (sustained attention), and selective 
attention and influences working memory and beha­
vioral activation [reviewed in Sirvio and MacDonald, 
1999]. Stimulation ofthetx2 receptors has been shown to 
improve cognitive function and distractability and this 
receptor has been suggested to be involved ADHD 
[Arnsten et al., 1996]. 
The ADRA2A gene has previously been tested as 
a susceptibility factor in ADHD using a quantitative 
approach andADHD symptom scores in a sample of274 
individuals diagnosed with GTS and 62 controls [Com­
ings et a1., 1999]. Of the individuals with GTS, 144 also 
met DSM-IV criteria for ADHD. That study reported a 
correlation between scores for ADHD (P 0.043) using 
regression analysis. However, it did not specifically 
analyze the ADRA2A gene as a susceptibility factor for 
GTS, so it is not possible to determine whether this 
finding relates to the susceptibility to GTS or only to the 
susceptibility to the symptoms of ADHD in the sample. 
Studies oftheADRA2A andADRAlCgenes in an ADHD 
sample without GTS or chronic tics did not find any 
evidence for linkage of these two genes to the ADHD 
phenotype [Barr et al., 2001; Xu et al., 2001]. 
BecauseADRA1C and ADRA2Aare located in regions 
with some support for linkage, and because the phar­
macological and physiological evidence shows adrener­
gic receptors to be involved in attentional processes and 
reduction in tic symptoms in some individuals, we 
explored the possibility that these genes contribute to 
the genetic susceptibility to GTS. We genotyped a total 
?f113 probands with 89 affected siblings for polymorph­
Isms at the ADRA1C and ADRA2A loci and tested for 
linkage using the transmission disequilibrium test 
[Spielman et al., 1993]. 
MATERIALS AND METHODS 
Subjects 
We genotyped in total 113 small nuclear families 
(probands, parents and affected siblings) collected 
through a GTS proband. Seventy-two of the families 
had more than one affected child with a total of 202 
affected children in the analysis (Table n. The majority 
of these families were collected as part of a multi-site 
consortium study that was used for the genome scan of 
affected sib pairs [The Tourette Syndrome Association 
International Consortium for Genetics, 1999]. Addi­
tional families were collected from Canada and Turkey 
for this study. 
Diagnostic Assessment 
Canada and international consortium sample. 
The diagnostic assessment of subjects for this study 
(probands, siblings, and parents of the affected sibling 
pair families) has been previously described [The 
Tourette Syndrome Association International Consor­
tium for G netics, 1999]. Briefly, information about 
symptoms associated with GTS and obsessive compul­
sive disorder was collected using a self- and family­
report based on the tic inventory and ordinal severity 
scales of the Yale Global Tic Severity Scale [Leckman 
et a1., 1989] and the symptom checklist and ordinal 
scales of the Yale-Brown Obsessive-compulsive scale 
[Goodman et al., 1989]. Other psychopathology was 
assessed using the K-SADS [Chambers et a1., 1985] 
for children under 18 and the scm [Spitzer et a1., 1992] 
for adults. The information was checked by an ex­
perienced neuropsychiatrist and complemented by the 
direct examination of symptoms using the Yale Global 
Tic Severity Scale and the Yale-Brown Obsessive-
Compulsive Scale. .~ 
Turkish sample. Children were assessed at the 
Marmara University Medical School, Development and 
Neuropsychiatry Unit, Istanbul. A definite diagnosis 
of GTS and other comorbidities was established by a 
child psychiatrist according to DSM-IV criteria, using a 
semistructured interview with child and parents based 
on the K-SADS. The diagnosis was confirmed by ano­
ther child psychiatrist blind to the original diagnosis. 
Turkish versions of the Yale-Global Tic Severity Scale 
and the Yale-Brown Obsessive Compulsive Scale (child 
or adult, when appropriate) were also administered for 
severity ratings. 
TABLE 1. Summary of Families 
Canadian Turkish Consortium 
Total families 42 29 42 
One affected child 15 26 o 
Two affected children 20 3 34 
Three affected children 6 o 7 
Four affected children 1 o 1 
Total children with GTS 77 32 93 
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Isolation of DNA and Marker Typing 
DNA was extracted from blood lymphocytes using 
a standard high salt extraction method [Miller et aI., 
1988]. To genotype the Cys492Arg polymorphism of 
ADRAIC, we amplified a 502 bp fragment a 
reaction mixture oflOO ng ofgenomic DNA, the primers 
ADRAIC-Pstl (5' atg ctc cag cca aga gtt ca 3') and 
ADRAIC-Pst2 (5' tcc aag aag agc tgg cct tc 3'), 1.5 mM 
MgCI2, and 1 U of Taq polymerase [Shibata et a1., 
1996]. The polymerase chain reaction (PCR) reaction 
consisted of an initial denaturation stage of 4 min at 
94°C followed by 35 cycles of denaturing at 94°C for 
30 sec, annealing at 58°C for 30 sec, and an extension of 
72°C for 30 sec. A final extension step of 72°C was added 
for 10 min after the last cycle. To detect the polymorph­
ism, 10 III of the PCR product was digested with 8 U of 
PstI restriction enzyme (New England Biolabs, Beverly 
MA) for approximately 2 h at 37°C. The alleles were 
separated on a 2% agarose gel. Allele 1 (C, Cys492) was 
not cut with the restriction enzyme and was seen as a 
501 bp band. Allele 2 (T, Arg492) was cut into two bands 
of 477 and,,25 bp. 
To genotype the -1291 promoter region polymorph­
ism for ADRA2A, we amplified a 522 bp fragment by 
PCR with the primers ADRA2A-MspI F (5' tca cac cgg 
agg tta ctt ccc tcg) located at position -1417 and 
ADRA2A-MspI R (5' tcc gac gac agc gcg agt t) located 
at position -913 [Lario et al., 1997]. The modified PCR 
conditions consisted of 35 cycles of denaturation at 94°C 
for 40 sec, annealing at 58°C for 40 sec and extension at 
72° C for 1 min. PCR products (8 Ill) was digested with 
5 U of MspI (New England Biolabs, Mississauga, ON, 
Canada) at 37°C for 2 h. The fragments were separated 
on a 4.8% polyacrylamide gel followed by silver staining 
to detect the alleles. The allele designated 1, is detected 
by a polymorphic band of 174 bp and several constant 
bands of 165, 116, 62, and 5 bp. The change of C to G 
reduces the 174 bp fragment into two bands of 121 and 
53 bp (designated allele 2). 
Statistical Analysis 
To test these two genes for linkage, we examined 
the inheritance of a common polymorphism at each 
locus using the transmission disequilibrium test (TDT) 
[Spielman et a1., 1993] calculated with the extended 
transmission disequilibrium test (ETDT) program 
[Sham and Curtis, 1995]. This test considers parents 
who are heterozygous for an allele and evaluates the 
frequency with which an allele is transmitted to an 
affected offspring compared to the alternative alleles. 
Under the null hypothesis each allele has an equal 
chance of being transmitted and deviation from equal 
transmissions indicates evidence for linkage. We chose 
the TDT as the statistical test for this study because it 
allows the use ofgenotypes from affected siblings. Since 
we were using the genotypes from the siblings in the 
analysis the test is more accurately described as a test 
for linkage as opposed to association. We therefore use 
the term linkage throughout this paper to describe our 
results. 
For the analysis, the families from Canada and 
Turkey were analyzed separately to determine if there 
were site-specific differences. The families from the 
multi-site consortium were not analyzed individually by 
collection site because there were not sufficient families 
collected from anyone site to be informative. 
RESULTS 
We have chosen for this analysis, two single nucleo­
tide polymorphisms (SNPs). Although microsatellite 
markers are potentially more informative for linkage 
studies, polymorphisms located within the gene are 
more likely to have remained in linkage disequilibrium. 
with DNA sequence changes contributing to the pheno­
type, and therefore may be more useful for studies 
based on linkage disequilibrium. Further, DNAchanges 
that alter the function or the expression of the protein 
may potentially be a change contributing to GTS and 
therefore are ofprimary interest for testing in our study. 
For the ADRAIC gene, we used a PstI polymorphism 
identified first by traditional restriction fragment length 
polymorphism methods [Hoehe et al., 1995] and later as 
a C to T change located in codon 492 resulting in a 
change of cysteine to arginine [Shibata et aI., 1996]. This 
amino acid variation is unlikely to cause a change in 
phenotype, since no differences in receptor function 
were observed between the two protein variants [Shi­
bata et al. , 1996]. The pharmacological characteristics 
and the receptor-mediated [Ca2+]i response were found 
to be desensitized in a similar manner for either ofthese 
receptor variants. For theADRA2A gene, we genotyped 
the C to G polymorphism located at position -1291 
upstream from the putative origin of transcription of the 
ADRA2A gene [Lario et al., 1997]. 
We examined the frequencies of the alleles in the 
chromosomes of the parents for each sample. The allele 
frequencies for the MspI polymorphism in ADRA2A are 
shown in Table II, those for the PstI polymorphism of 
ADRAIC in Table III. 
We calculated the TDT for the samples collected in 
Canada, Turkey, and the consortium sample individu­
ally and then combined the results. For the ADRA2A 
polymorphism, we found no significant evidence for 
biased transmission of either allele in any of the 
samples; however, there was a trend for the biased, 
transmission ofthe 1 allele in the multi-site consortium 
sample (Table IV). For the ADRA1C polymorphism, the 
results for the sample collected in Canada showed a 
trend for biased transmission (see Table V). The number 
of informative transmissions totaled 76. The Cys492 
allele was transmitted 44 times to the probands and 
affected siblings vs. 32 times that it was not transmitted. 
For the sample collected in Turkey, there was also a 
TABLE II. Allele Frequencies of the 

ADRA2A·MspI Polymorphism 

Canadian Turkish Consortium 
Allele 1 0.709 0.798 0.722 

Allele 2 0.291 0.202 0.278 
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TABLE III. Allele Frequencies of the 
ADRAIC-PstI Polymorphism 
-~.~-.-----------------­
Canadian Turkish Consortium 
Allele 1 0.466 0.617 0.580 

Allele 2 0.534 0.383 0.420 

trend for the transmission of the Cys492 allele. Of 27 
informative transmissions, the Cys492 allele was trans­
mitted 18 times compared to 9 times that it was not 
transmitted. No evidence for biased transmission was 
found in the international consortium sample (Cys492 
allele transmitted 33 times vs. 32 times that it was not 
transmitted). For the combined sample, the number of 
informative transmissions totaled 162 with the Cys492 
transmitted 91 times vs. 71 times that it was not 
transmitted (X2 = 2.469, 1 d.f., p= 0.116). 
DISCUSSION 
For both theADRA2A andADRA1C genes, we did not 
find significant evidence for linkage in this sample. 
However, we did note a trend for the Cys492 allele of the 
ADRAlC gene to be transmitted to the affected offspring 
in the Canadian and Turkish samples. This trend may 
indicate that a portion ofthe sample is linked to this gene 
but our sample lacked sufficient power to identify 
linkage. The results from our genome scans suggest 
that there may be substantial locus heterogeneity in 
GTS [Barr et aL, 1999; The Tourette Syndrome Asso­
ciation International Consortium for (knetics, 1999]. 
If only a few of the families in our sample are linked 
to these genes, or if the relative risk of the gene to 
the development of the phenotype is small, a larger 
sample would be required to identify linkage for anyone 
gene contributing to GTS. However given that the TSA 
consortium sample used in this study did provide evid­
ence for linkage to this region using an affected sibling 
pair analysis that is less powerful than methods that 
rely on linkage disequilibrium, it would be expected that 
if the marker is in linkage disequilibrium with the 
susceptibility allele then the TDT analysis would have 
sufficient power to detect these genes. While it is not 
possible to precisely determine the power of a sample 
to detect a particular susceptibility gene because the 
contribution of each gene to the risk for the development 
of the phenotype and the mode of inheritance of each 
gene is unknown, we can estimate that this particular 
sample of families could detect a susceptibility gene 
using TDT analysis with a genotypic relative risk of 15 
given an autosomal dominant mode of inheritance and 
disease allele frequency of 0.003 [Chen and Deng, 2001]. 
It is possible that theADRA1C gene is linked to GTS 
but the polymorphism that we tested is not in strong 
linkage disequilibrium with the DNA variant respon­
sible for the phenotype. We screened the coding region 
of the ADRA1C gene in our GTS probands by direct 
sequencing and single stranded conformational poly­
morphisms analysis but we found no additional common 
polymorphism that could be used for linkage analysis. 
We have not at this time screened the promoter region or 
the single intron of this gene. 
In light of our genome scan on part ofthis sample, then 
the criteria needed to accept linkage must be stringent 
and this trend would fall far short of a genome wide 
significance level. Therefore, the most likely explana­
tion is that this trend for biased transmission is a chance 
finding. It is still possible that the 8p and 1Oq regions are 
linked to GTS but that these two adrenergic receptors 
are not the susceptibility genes. The suspected role of 
the adrenergic system in GTS made these genes logical 
choices as candidates in these two regions. Further, the 
previous linkage report oftheADRA2A gene and ADHD 
symptoms in a sample ascertained through a GTS pro­
band support d this gene as a strong candidate in the 
10q region. The study of these two genes was therefore 
our first step in the search for susceptibility genes in 
these regions and we will continue to study genes in 
these two regions. 
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Abstract 
Gilles de la Tourette syndrome (GTS) is a sporadic or inherited complex neuropsychiatric disorder characterized by involuntary motor 
and vocal tics. There is comorbidity with disorders like obsessive compulsive disorder and attention deficit hyperactivity disorder. Until now 
linkage analysis has pointed to a number ofchromosomal locations, but has failed to identifY a clear candidate gene( s). We have investigated 
a GTS fantily with a complex chromosomal insertion/translocation involving chromosomes 2 and 7. The affected father [46,xy,inv(2) 
(p23q22),ins(7;2) (q35-q36;p2Ip23)J and two affected children [46,xx,der(7)ins(7;2)(q35-q36;p2Ip23) and 46,xy,der(7)ins(7;2)(q35­
q36;p213p23)] share a chromosome 2p21-p23 insertion on chromosome 7q35-q36, thereby interrupting the contactin-associated protein 2 
gene (CNTNAP2). This gene encodes a membrane protein located in a specific compartment at the nodes of Ranvier ofaxons. We 
hypothesize that disruption or decreased expression of CNTNAP2 could lead to a disturbed distribution of the K+ channels in the nervous 
system, thereby influencing conduction and/or repolarization of action potentials, causing unwanted actions or movements in GTS. 
© 2003 Elsevier Science (USA). All rights reserved. 
Keywords: Gilles de Ia Tourette syndrome; Contactin-associated protein; Potassium channel; Node of Ranvier; Translocation breakpoint; Chromosome 7; 
Chromosome 2 
Gilles de la Tourette syndrome (GTS) (OMIM 137580) 
is an inherited neuropsychiatric disorder characterized by 
repeated simple or complex involuntary motor and vocal 
tics that begin in childhood and fullow a waxing and waning 
course [1-4]. 
GTS is also often accompanied by features associated 
with obsessive compulsive disorder (OeD), attention deficit 
hyperactivity disorder (ADHD), poor impulse control, and 
other behavioral problems [1,2]. However, the relationships 
between both ADHD and GTS and OeD and GTS are 
complex and not yet clear [5]. Evidence is accumulating that 
an association exists between OeD and GTS [6,7]. Specific 
.. Corresponding author. Fax: +31 !O 4089489. 
E-mail address:b.oostra@erasmusmc.nl (B.A. Doma). 
I A complete list ofmembers can be found tmder Acknowledgments in 
Am. J. Hum. Genet. 65 (1999) 1428-1436. 
symptoms of obsessive-compulsive disorder are found to 
be similar in GTS with and without OeD and differ from 
tic-free OeD [8]. These studies suggest that GTS with oeD 
constitutes a fonn of GTS, and not of OeD, and reinforce 
the ideas that at least some forms of OeD are etiologically 
related to GTS and that GTS + OeD represents a variant 
phenotype or maybe a more severe fonn of GTS. At the 
same time OeD alone in individuals ofGTS families might 
be considered an alternative phenotype or could be due to 
reduced penetrance of the autosomal dominant mode of 
inheritance of the disease [9]. 
Although the cause ofGTS is unknown, there is evidence 
that genetic factors are involved [10,11]. An obvious first 
approach to search for responsible genes is linkage studies, 
but due to the complexity of the disorder, until now, results 
have remained elusive [12]. Several genomic regions have 
been identified using linkage and association studies point­
0888-7543/03/$ - see front matter © 2003 Elsevier Science (USA). All rights reserved. 
doi:l0.1016/80888-7543(03)00097-1 
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ing to susceptibility loci for GTS, although no clear candi­
date genes have yet emerged [13-16]. Other regions have 
been excluded [17,18] . Another approach is the identifica­
tion and cloning of breakpoints in GTS patients with chro­
mosomal abnormalities. The advantage of this method is 
that when the interrupted region harbors a specific gene, this 
may give a direct entry into a biological pathway involved 
in the etiology of GTS. There is also always the possibility 
that the breakpoint is coincidental and has no relation to the 
GTS phenotype. A number of candidate genes have been 
proposed [19,20], but none of them has yet led to the 
long-awaited breakthrough. The only gene reported that was 
interrupted by a breakpoint is IMMP2L [20], the human 
homologue of the yeast mitochondrial inner membrane pep­
tidase subunit 2; however, its role in the etiology ofGTS has 
not been demonstrated. Candidate regions that have been 
indicated by chromosomal aberrations include chromo­
somes 9p [21], 7q22, 18q22 [22], 8q22 [19], and 7q22-q31 
[23]. 
In this paper we describe a family with a complex trans­
location/insertion/inversion involving chromosomes 2 and 
7. The father as well as his two children has GTS charac­
teristics. With karyotyping and fluorescence in situ hybrid­
ization (fISH) analysis this complex chromosomal rear­
rangement has been resolved. All breakpoints have been 
determined with bacterial artificial chromosome (HAC) 
clones identifying these sites. The insertion of chromosome 
2p22-p23 in chromosome 7q35-q36 interrupts a recently 
described gene, contactin-associated protein 2 [24], in all 
three patients. 
Results 
Clinical and cytogenetic evaluation of the family 
In fig. lA the pedigree of the family is shown. This 
family was referred to one of us (C.M.) via the Tourette 
Syndrome Association. A full case report is presented under 
Materials and methods. In short, the mother is unaffected, 
the father has OCD. The daughter has Tourette syndrome, 
OCD, mental retardation, and speech abnormalities. The 
son has Tourette syndrome, OCD, mental retardation, and 
A 

normal OGD 
no history or motorphenotype 
or vocal tics 
1 normal chr. 2normal 
1 der (2)karyotype 
1 normal chr. 7 
1 der(7) 
OGDOCD 
TSTS 
MR MR 
GR GR 
2 normal chr. 2 2 normal chr. 2 
1 normal chr. 7 1 normal chr. 7 
1 der(7) 1 der(7) 
B 
-+ 
2 der(2) der(7) 7 
Fig. I. Family with chromosome 217 rearrangement. (A) Pedigree with 
description of phenotype. (B) Normal and derivative chromosomes 2 and 
7 as seen in the karyotype of the father. The children inherited the der(7) 
from the father. Arrows indicate abnormalities. OCD, obsessive compul­
sive disorder; TS, Tourette syndrome; MS, mental retardation; GR, growth 
retardation. 
some speech abnormalities, but less severe than his sister. In 
addition both children have growth retardation. The karyo­
type of the mother was normal, the karyotype of the father 
showed abnormalities involving one chromosome 2 and one 
chromosome 7, the children showed two normal chromo­
somes 2 and one abnormal chromosome 7. The cytogenetic 
reports derived from the karyotype are for the father 46,X Y, 
inv(2)(p23q22),ins(7;2)(q35-q36;p21p23) and for the 
daughter 46,xx,der(7)ins(7;2)(q35-q36;p21p23) and son 
46,xY,der(7)ins(7;2)(q35-q36;p213p23). fig. IB shows 
the normal and derivative chromosomes 2 and 7 as seen in 
the karyotype of the father. The children both inherited the 
normal chromosome 2 and the derivative chromosome 7 
from the father. 
Fig. 2. Fluorescence in situ hybridization. (A) Chromosomal paint with chromosome 2 in red and chromosome 7 in green. The metaphase shown is of the 
son's chromosomes. For the lather and daughter the same results were obtained, indicating an insertion of part of chromosome 2 into chromosome 7 for aU 
three Toure11e patients in the family . (B) Comparative genomic hybridization with DNA from both children. A gain of chromosome band 2p21-p23 is seen. 
(C) BAC 64IE23 (green) crosses the breakpoint of chromosome 7 where the chromosome 2 region (red) is inserted into chromosome 7q35- q36. 
Chromosome 2 is painted in red. The metaphase shown is of the son's chromosomes. (D) BAC 490M8 (red) indicates the proximal breakpoint of the 
chromosome 2 deletion/insertion. Signal is present on der2q22 and der7q35 (red arrows) and on the nonnal chromosome 2p23. In addition a homologous 
signal is present on chromosome 7qll-q21 (white arrows). The metaphase shown is of the father's chromosomes. (E) The upper breakpoint of the inversion, 
on the short arm of chromosome 2, is represented by BAC clone 3420 I, localized on chromosome 2p23 of the normal chromosome 2 and on chromosome 
2p23 and 2q22 of the abnormal chromosome 2. The metaphase shown is of the father's chromosomes. (F) The lower breakpoint of the inversion, on the long 
arm of chromosome 2, is represented by BAC clone 432012. This clone is localized on chromosome 2q22 of the normal chromosome 2 and on chromosomes 
2q22 and 2p23 of the abnormal chromosome 2. The metaphase shown is of the father's chromosomes. (G) FISH to show the order of BAC clones on 
chromosome 2p using BAC 560C7 (in green) and BAC 742MIO (in red). The metaphase shown is of the father's chromosomes. On der(7) SAC 742M 10 
is inserted, on der(2) BAC 56OC7 is inverted. 
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To detennine the precise breakpoints at the DNA level 
and identify possible genes interrupted by the breakpoints, 
further analysis by fluorescence in situ hybridization was 
undertaken. 
Determination of involvement of chromosomes 2 and 7 by 
chromosomal paint and comparative genomic 
hybridization 
As the cytogenetic rearrangement seemed very complex, 
and could not be resolved in detail by standard cytogenetic 
studies, a chromosomal paint with chromosomes 2 and 7 
was performed on metaphase chromosomes of the affected 
individuals. This showed an insertion of part of chromo­
some 2 into chromosome 7q35-q36 of the father as well as 
of the children (Fig. 2A). To detennine the region of chro­
mosome 2 that was inserted into chromosome 7, we used the 
comparative genomic hybridization technique with DNA of 
the son. This showed a peak of the chromosome 2 region 
p2l-p23 (Fig . 2B), indicating a trisomy for this region in 
the children. FISH analysis using telomere probes for chro­
mosomes 2 and 7 showed that the telomeres were not 
involved in the rearrangement (data not shown). 
Fine mapping of the involved regions using FlSH analysis 
with BAC clones 
Breakpoint on chromosome 7 
The rearrangement was further resolved in more detail 
by FISH analysis using BAC clones that mapped to chro­
mosomes 2 and 7. A number of BAC contigs were chosen 
from the National Center for Biotechnology information 
(NCBI) in the chromosome 7q35-q36, 2p21-p23, and 
2q2l-q23 regions and BAC clones were selected to deter­
mine the different breakpoints. An overview of BACs cross­
ing the breakpoints is indicated in Fig. 3. FISH analyses of 
these BACs are shown in Fig. 2. A breakpoint for the three 
patients was seen on chromosome 7q35-q36 using BAC 
641E23 (Fig. 2C and black circle in Fig. 3A). It is clearly 
visible that the chromosome 7 sequence is interrupted by the 
chromosome 2p2l-p23 insertion. 
Breakpoints on chromosome 2 
Deleted/inserted region 2p21-p23. The distal breakpoint of 
the chromosome 2p21-p23 region (white circle in Fig. 3A) 
could not be determined precisely due to a gap between two 
contigs [NT_005053 (distal contig) and NT_005204 (prox­
imal contig»). This breakpoint is located between the two 
BACs on either end of these contigs (BAC 596A4, the most 
distal clone on NT _005204, and BAC 398J 17, the most 
proximal clone on NT_005053) or on the far end of one of 
these clones, which would make the result invisible with the 
FISH technique (see inset I, Fig. 3B). The gap between 
these two BACs could be covered by designing primers on 
either end of each BAC (see Materials and methods) and by 
performing a PCR on genomic DNA. The resulting I.6-kb 
PCR product was sequenced and contained the end se­
quences of both BACs contiguously, indicating that the 
BACs mentioned do not overlap but are perfectly con­
nected. This sequence is represented in AC 110925, a linear 
genomic fragment of 3994 bp. The proximal breakpoint of 
the chromosome 2p21-p23 region is represented by BAC 
490M8 (Fig. 2D and blue circle in Fig. 3A). 
inverted region 2p23-q22. The breakpoints of the inversion 
are visualized in Figs. 2E and 2F. The upper breakpoint on 
the short arm of chromosome 2 is represented by BAC clone 
342D I, localized on chromosome 2p23 (Fig. 2E and yellow 
circle in Fig. 3A) and the lower breakpoint on the long arm 
is represented by BAC clone 432012, localized on chro­
mosome 2q22 (Fig. 2F and red circle in Fig. 3A). 
Complexity of the rearrangement 
The inversion/deletion has not been a simple event, and 
the result is schematically shown in Fig. 3. The region of 
chromosome 2 (2p21 - p23) that is deleted from the abnor­
mal chromosome 2 was not located at the upper border of 
the inversion on chromosome 2, but somewhat farther 
down. This is shown by the fact that BAC 342D I gives two 
signals on der2 and not one on chromosome 2p and one on 
chromosome 7q. In addition BAC clones distal to BAC 
342Dl mapped to their normal position on the 2p arm of the 
abnormal chromosome. BAC clones localized proximal to 
BAC 342D I mapped to the 2q arm of the abnormal chro­
mosome 2. The order of the BAC clones has been confirmed 
with FISH experiments on metaphase chromosomes of the 
father, one ofwhich is shown in Fig. 2G, using BAC clones 
56OC7 and 742MlO (little green circles in Fig. 3A). For the 
deletion to have taken place, two extra breaks must have 
occurred (white and blue circles in Fig. 3A). The green 
block is the chromosome 2p21-p23 region that is deleted 
from the abnormal chromosome 2 and inserted in chromo­
some 7q35-q36. The size of this block is estimated to be at 
least 12 Mb, based on the NCBI BAC contigs (build 29) that 
are now located in this region. This chromosomal region is 
present in triplicate in the affected children and 152 genes 
are placed within this region. Of these, 29 are confirmed 
genes, based on a clean alignment ofmRNA (with or with­
out EST evidence) to the genomic sequence. Of the remain­
ing loci, 12 are based on EST evidence only, 35 are pre­
dicted with EST evidence, 26 are predicted only, 40 have 
some discrepancy between the mRNA sequence and the 
gene model, and for 10 there is no unambiguous solution as 
to what they should be. An imbalance in the expression of 
one or more genes in this region could explain the mental 
and growth retardation in the children (see Discussion). 
The purple block is the upper border of the inverted 
region of chromosome 2. Based on the contig lengths given 
by NCBJ we have estimated the size of this block to be 
around 6.5 Mb. 
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normal chr. 2 abnormal chr. 2 abnormal chr. 7 normal chr. 7 
34201 
---. p23
q22398J17-596A4 
490M8 
n 
Vp-arm q11 .2 
ce p11 .2 
r 
S 
0 
n 
--. p23432012 q22 
q-arm 
A 
r0050~ 

~ BAC 398J17 
rAC59~ 
NT_OO5204 
B inset 1 
P 
q 
p 
• 
q35q35 641E23 q36Inq 
q36 
1c,,~exon 1-8 
r­
' BAC 490M8 
~ BAC 596A4 
. BAC 398J17 
1c","exon 9-25 
inset 2 
Fig. 3. Rearrangement as fOWld in the father. BACs are indicated with colored circles. Breakpoints are indicated as half circles. The children have the same 
aberrant chromosome 7 and inherited two normal chromosomes 2. The green block is the chromosome 2p21 - p23 region that is deleted in the abnonnal 
chromosome 2 and inserted in chromosome 7q35-q36. The purple block is the upper border of the inversion. BAC 641£23 (black) is part of NCBI 
chromosome 7q contig NT_007194, BAC 342Dl (yellow) is part of NCBl chromosome 2p contig NT_0222275, BAC 49OM8 (blue) is part of NCBI 
chromosome 2p contig NT_005367, BAC 432012 (red) is part of NCBl chromosome 2q contig NT_022 135, BAC 398117 is the most proximal clone of 
contig NT_005053, and BAC 596A4 is the most distal clone on NT _005204. Insets are details of different breakpoints. 
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F.,her. OCD Children: OCD • TS • MR +GR 
2 der 2 der 7 7 2 2 der 7 
~ i · 
deletion 
2p21-23 
Insertion 
2p21-23 
balanced complex cOr. aberration unbalanced aberration 
breakpoints in chr. 2p, 2Q and 7Q partial trisomy Chr. 2p 
breakpoint in 7Q 
Fig. 4. Overview of the chromosomal rearrangements and clinical pheno­
type in the affected persons. OCD, obsessive compulsive disorder; TS, 
Tourette syndrome; MS, mental re1ardation; GR, growth retardation. 
Contactin-associated protein 2 
Because the common denominator in all three patients of 
the family is the breakpoint on chromosome 7q35-q36 with 
the chromosome 2p21- p23 insertion (Fig. 4), we initially 
concentrated on this region to search for intenupted genes. 
To find genes crossing the breakpoints, the BAC sequences 
were screened for genes using the NCB] Blast database. 
BAC 64IE23, crossing the breakpoint on chromosome 
7q35-q36 and similarly present in the three patients, 
showed homology to the contact in-associated protein 2 gene 
(CNTNAP2) (GenBank Accession No. AFI9045). The 
CNTNAP2 gene consists of 25 exons, has a genomic size of 
over 2.0 Mb [25], and is one of the largest genes in the 
human genome. It is predominantly expressed in the ner­
vous system, at the juxtaparanodal region next to the nodes 
of Ranvier, and localized to the axonal membranes of large 
myelinated nerves [24]. CNTNAP2 is colocalized and as­
sociated with Shaker-type voltage-activated K + channels, 
which play a role in repolarization of the action potential 
[24,26]. 
Blast analysis with and alignment of the complete 
mRNA of CNTNAP2 (AF3] 9045, 8107 bp) showed the 
presence of exons 6, 7, and 8 on BAC 64IE23. This was 
confirmed by PCR experiments, using primers in and 
around these exons on the BAC clone (data not shown). The 
orientation of CNTNAP2 [25] was confirmed by FISH to be 
5' to 3' from 7q centromere to 7q telomere, using different 
BAC clones containing exon ] and exons 24 and 25 on the 
aberrant chromosome 7, so that clones could be distin­
guished above and below the chromosome 2 insertion (data 
not shown). Sequence data (NCBI, AC092676) showed that 
exons 6, 7, and 8 are present in the first 23 kb of the BAC 
clone 641E23. As the FISH signals of this BAC seem 
equally divided above and below the insertion on chromo­
some 7q35-q36 (Fig. 2) we concluded that the breakpoint 
must be localized in intron 8. Based on BAC sequence data 
from BAC clone 64IE23 (containing exons 6, 7, and 8) and 
the overlapping SAC clone 643A21 (containing ex on 9) the 
size of intron 8 is 167,632 bp. 
Discussion 
Chromosomal karyotypes in Gilles de la Tourette pa­
tients mostly are found to be normal [27], so in general there 
is no reason for standard chromosomal examination. When, 
however, in addition to GTS other clinical abnormalities are 
observed, chromosomal analysis is often called for. In the 
family described above, the father is the most mildly af­
fected, with only obsessive-compulsive disorder; the chil­
dren suffer from tics and OCD and in addition have growth 
and mental retardation. Comparing the chromosomal pic­
ture to the phenotype of the patients, the father has a bal­
anced chromosomal abnormality. This includes an inversion 
of chromosome 2p23- q22 and a deletion of 2p21- p23, 
which has inserted into chromosome 7q35- q36, in addition 
creating a breakpoint in this region on chromosome 7. It is 
surprising that, despite this complex rearrangement, the 
only clinical feature in the father is OCD. The children each 
have an unbalanced situation with a partial trisomy for 
chromosome 2p21 - p23 and the breakpoint on chromosome 
7q35-q36. The children have OCD, GTS, and mental and 
growth retardation. For an overview, see Fig. 4. 
A common feature in the three affected persons is the 
insertion of chromosome 2p21-p23 into chromosome 
7q35- q36 with the breakpoints that accompany it. This 
suggests the presence of a gene for OCD/GTS on the break­
point of chromosome 7q35-q36, which is shared by the 
three patients. The mental and growth retardation in the 
children could be accounted for by the presence of the 
trisomy of the chromosome 2p21-p23 region. The size of 
the chromosome 2 insertion into chromosome 7q35-q36 is 
estimated to be around 12 Mb, based on the current NCB] 
BAC contig data (build 29). An imbalance in the expression 
of one or more genes in this region could well account for 
the mental and growth retardation. 
Partial trisomy 2p syndrome 
Of interest in this regard are cases with rare partial 
trisomy 2p syndrome, involving different chromosomal re­
gions between 2p 12 and 2p24 [28]. Although in these pa­
tients the phenotype is variable, most likely due to different 
sizes of the trisomic region, mental retardation is present in 
all cases with involvement of 2p21-p24. Tourette-like 
symptoms have never been described in trisomy 2p syn­
drome patients, suggesting that Tourette symptoms are not 
caused by the trisomic region. 
Possible fusion genes 
in addition, there is also the possibility of interrupted 
genes on the chromosome 2 breakpoints. in principle only 
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the chromosome 2p21-p23 breakpoints of the insertion into 
chromosome 7q are of interest, as these are shared by the 
three patients. In this case, only fusion products of genes on 
chromosome 2 with one or both interrupted ends of 
CNTNAP2 would be significant, possibly causing aberrant 
protein function. Therefor BACs 490M8, 397Jl7, and 
596A4 were tested for the presence of genes by running 
them through the NiX analysis of the UK HGMP Resource 
Centre computing facilities and comparing with contig 
maps of the NCBt. Genes on BAC clones 398J 17 and 
596A4 would contain possible candidates to form fusion 
genes with the 3' part of CNTNAP2 (exon 9-25) (see insets 
I and 2, Fig. 3B). On BAC 398J 17 three predicted genes 
were detected, of which only the hypothetical gene 
LOC 130219 would be in the right orientation to be able to 
form a fusion product. On BAC 596A4 five predicted genes 
are placed, two of which would be in the same transcrip­
tional orientation with CNTNAP: LOC165316, which is 
similar to mitochondrial capsule selenoprotein (a gene that 
is expressed in sperm [29]), and LOC165318, of which 
nothing is known. Genes on BAC clone 490M8 were in­
vestigated as possible candidates to form fusion genes with 
the 5' part of CNTNAP2 (exons 1-8) (inset 2, Fig. 3B). Two 
predicted genes are present on this BAC, the hypothetical 
gene (LOCI30741) with unknown function and without 
conserved domains and one gene (LOC 165443) that has 
similarity to 60S ribosomal protein L21 [30]. On the aber­
rant chromosome 7, either gene, when interrupted, would be 
in the same transcriptional orientation as CNTNAP2. For all 
possible fusion genes between genes present on the break­
point BACs and CNTNAP2, at the moment, the effect would 
not be predictable. 
CNTNAP2, potassium channels, and Tourette syndrome 
Because of the insertion, and assuming that no functional 
fusion genes have formed, the CNTNAP2 gene on chromo­
some 7q is interrupted on one copy. The implication of a 
lower expression of this gene during development is hard to 
predict, also because the function of this gene is not yet fully 
elucidated. CNTNAP2 belongs to the superfamily of the 
neurexins, a group of transmembrane proteins that mediate 
cell- cell interactions in the nervous system [24,31,32]. 
CNTNAP2 and CNTNAP I, another member of this family, 
are localized to the axonal nodes of Ranvier, but to differ­
ent, distinct, compartments [24,31,33,34]. CNTNAP2 is 
located in the juxtaparanodal region and is associated 
with Shaker-like, Voltage-gated, K+ channels [24,34]. 
CNTNAP2 has a structure similar to that of CNTNAP I, 
containing various domains in the extracellular region, but 
they differ in their cytoplasmic tails [24,35]. 
Based on what is known of the movement of Na+ chan­
nels during myelinogenesis and their subsequent clustering 
at each (para)node of Ranvier through the physical pushing 
activity of CNTNAP I [34], it is speculated that CNTNAP2, 
possibly in association with other proteins, has a similar 
function in the localization of the K + channels to the jux­
taparanode [24]. Tourette syndrome is a complex disorder, 
and its cause is unknown. It is hypothesized that symptoms 
of GTS are caused by the absence of inhibition of unwanted 
actions, movements as well as behaviors, regulated by the 
basal ganglia [36,37]. We hypothesize that disruption or 
decreased expression of CNTNAP2 could lead to a dis­
turbed distribution of the juxtaparanodal Shaker-like K + 
channels in the nervous system, having an influence on 
conduction and/or the repolarization of the action potential 
in certain parts of the brain that are sensitive to these kinds 
of changes. Mutations in the K + channel in Drosophila 
leads to a hyperexcitable, leg-shaking phenotype (Shaker 
phenotype) [38]. In addition mutations in the K v I.l K + 
channel subunit are present in patients with episodic ataxia, 
a disease in which patients suffer from episodes of invol­
untary movements [39]. Deletion of K v 1.1 causes epilepsy 
in mice [40] and repetitive discharge from the nerve endings 
at neuromuscular junctions [41]. 
Future molecular studies like creating knockout mice for 
CNTNAP2 or the K + -channel subunits might shed some 
light on involvement of these genes in Tourette syndrome. 
in summary, we have identified a gene, CNTNAP2, that is 
interrupted in a family with Gilles de la Tourette syndrome/ 
OCD. This gene is a candidate gene for GTS/OCD, as it is 
likely to be involved in signal transduction, a feature that is 
obviously disturbed in this disorder. 
Materials and methods 
Case reports 
The father has no history of motor or vocal tics. He does 
have OCD, including some excessive handwashing, con­
tamination fears, a need for strict timetables, and frequent 
checking and rewriting rituals. He also has evidence of 
recurrent major depressive disorder. The mother is unaf­
fected, but stutters. 
The daughter at age 5 years was found to have general­
ized developmental delay with specifically language delay, 
with an iQ of about 65, small stature, and microcephaly. She 
was noted to have inappropriate behaviors with other chil­
dren, with unprovoked behaviors as well as ritualistic be­
haviors and significant perseveration. At the age of 8, she 
had multiple motor tics (which began at age 3) and vocal 
tics (which began around the age of 5) and continued to 
have ritualistic behaviors. At age II she continued to have 
motor and vocal tics as well as repetitive and ritualistic 
behaviors. She read at a second-grade level and wrote at a 
first-grade leveL 
The son was also found to be globally developmentally 
delayed, with small stature, esotropia, and a chronic derma­
titis. At the age of 2 years and 2 months he had essentially 
no expressive language. At the age of 3V2 he was found to 
have multiple motor tics but no vocal tics and had devel­
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oped a sign language vocabulary of over 200 words. Like 
his sister he had multiple ritualistic behaviors, including a 
very involved bathing ritual. He was very perseverative 
about lining things up and tearing and cutting things, in­
cluding paper, books, and clothes. At the age of 5 he 
spontaneously developed verbal language. IQ assessment 
gave him a full-scale IQ of 54. He was found to be reading 
at age level, although his verbal skills continue to be very 
low. 
Clinical diagnosis of Tourette syndrome was made ac­
cording to specific criteria described in the Diagnostic and 
Statistical Manual ofMental Disorders, 4th ed. [4,42]. Ap­
propriate informed consent was obtained from human sub­
jects. 
Karyotyping 
Karyotyping was done on metaphase chromosomes iso­
lated from cultured blood samples and Epstein-Barr virus 
(EBV)-derived cell lines. The results were the same in both 
cases. 
FiSH analysis 
FISH analyses were performed on metaphase chromo­
somes derived from EBV-transformed peripheral blood 
lymphocytes according to the protocols of Pinkel et al. [43] 
with minor modifications. Whole-chromosome-specific 
paints were obtained commercially (Eurodiagnostica). 
Probes were labeled with either biotin (Bio) or digoxigenin 
(Dig) using the Nick Labeling Kit (Roche). Bio/Dig were 
detected with a one-layer amplification step using strepta­
vidin Alexa 594 (Molecular Probes) and anti-Dig-fluores­
cence (Roche). Chromosomes were counterstained with 
Vectashield (Vector) containing 4,6-diamidino-2-phenylin­
dole (Sigma) (blue) . Slides were analyzed with a Zeiss 
Axioskop II imaging fluorescence microscope and images 
were captured using a Genetiscan Power Gene System (Ap­
plied Imaging). 
BAC clones 
BAC clones were ordered from Dr. Pieter de Jong at 
BAC/P AC Resources (http://www.chori.orgiBACPAC). All 
BACs (641 E23, 342D 1, 490M8, 4320 I 2, 398J 17, 596A4, 
560C7, 742MIO) were from the RPCl-l 1 library. For the 
isolation of DNA, BAC clones were grown overnight at 
37°C in 350 ml LB medium with the relevant antibiotics. 
DNA was isolated using the Nucleobond AX Kit (Mach­
erey-NageJ). Yields varied between 15 and 30 ILg. 
PCR 
Primers used on genomic DNA to cover the gap between 
BACs 398J17 and 596A4 were 12IE2-2R, 5' GAGGCTT­
GGTGACCAGTATC 3', and 121E2-1F, 5' AGACG­
GAGATGTCCCA TGAC 3'. Standard conditions were 
used, with 1.5 mM MgCI2 and 35 cycles of 1.5 min at 55°C. 
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Tourette' s syndrome: a cross sectional study to exam i ne 
the PANDAS hypothesis 
A J Church, R C Dale, A J Lees, G Giovannoni, M M Robertson 
J Neural Neurosurg Psychialry 2003;74:602-607 
Background: The classical neurological disorder after group A ~ haemolytic streptococcal infection is 
Sydenham's chorea. Recently a tic disorder occurring after group A streptococcal infection has been 
described and termed PANDAS (paediatric autoimmune neuropsychiatric disorders associated with 
streptococcal infection). It is proposed that antibodies induced after group A streptococcal infection 
react with basal ganglia neuranes in Sydenham's chorea and PANDAS. Anti-basal ganglia antibodies 
(ABGA) ore present in mast cases of acute Sydenham's chorea, but rarely in controls . 
Objective: To investigate the hypothesis that Taurette's syndrome may be associated with group A 
streptococcal infection and ABGA. 
Methods: 100 patients with Tourette's syndrome (DSM-IV-TR) were enrolled in a cross sectional study. 
Children with neurological disease (n = 50) and recent uncomplicated streptococcal infection (n = 40). 
adults with neurological disease (n =50). and healthy adults (n =50) were studied as controls. Recent 
See end of artide for group A streptococcal infection was defined using antistreptolysin 0 titre (ASOT). ABGA were detected 
authors' affiliations 
using western immunoblotting and indirect immunofluorescence. 

Results: ASOT was raised in 64% of children with Tourette's syndrome compared with 15% of paedi­

Correspondence to: atric neurological disease controls (p < 0.0001). and in 68% of adults with Tourette's syndrome com­
Mr Andrew Church, pared with 12% of adult neurological controls and 8% of adult healthy controls (p < 0.05). WesternNeuraimmunolagy Unit, 

Room 917, Institute of immunoblotting showed positive binding in 20% of children and 27% of adults with Tourette's 

Neurology, Queen Square, syndrome, compared with 2-4% of control groups (p < 0.05) . The most common basal ganglia bind­
london WC1N 3BG, UK; ing was to a 60 kDa antigen, similar to the proposed antigen in Sydenham's chorea. Indirect immuno­
a.church@ian.ud.ac.uk fluorescence revealed autoantibody binding to bas l ganglia neurones. Serological evidence of recent 
Received group A streptococcal infection, assessed by a raised ASOT, was detected in 91 % (21/23) of 
21 October 2002 Tourette's syndrome patients with positive ABGA compared with 57% (44/77) with negative ABGA 
In revised form (p < 0.01).
1 3 January 2003 Conclusions: The results sUFport a role of group A streptococcal infection and basal ganglia autoim­Accepted 
20 January 2003 munity in a subgroup of patients with Tourette's syndrome and suggest a pathogenic similarity between 
Sydenham's chorea and some patients with Tourette's syndrome. 
Gilles de la Touretle's syndrome is characterised by mul­tiple motor and vocal tics which wax and war.e over time.' Epidemiological studies have shown that 
Touretle's syndrome is relatively common (occurring in up to 
I% of children)'-' and is more prevalent in boys." The mean 
age of onset is seven years.' Comorbid neuropsychiatric symp­
toms are a common feature, and include obsessive-compulsive 
disorder, atlention deficit hyperactivity disorder (ADHD), 
anxiety, and depression. Indeed, Tourette's syndrome and 
obsessive-compulsive disorder may be part of the same disease 
spectrum.' , 
The results from large family studies have suggested that 
Tourette's syndrome is at least partly genetically determined, 
although no common single genetic locus has yet been 
demonstrated.' A multifactorial aetiology has therefore been 
proposed, with genetic predisposition and environmental 
factors (such as trauma and infection) playing roles in disease 
expression.' It is also conceivable that Touretle's syndrome is a 
heterogeneous disorder, which would confound genetic studies. 
It has recently been suggested that group A ~ haemolytic 
streptococcal infections are an important factor in acute onset 
neuropsychiatric and movement disorders.' The classic post­
streptococcal neurological disorder is Sydenham's chorea, 
which occurs weeks to months after group A streptococcal 
infection and is one of the major diagnostic criteria of 
rheumatic fever. In addition to chorea, patients with 
Sydenham's chorea also have characteristic behaviour dis tur­
bances, particularly emotional lability.' Follow up studies have 
also shown a high prevalence of obsessive-compulsive 
disorder in Sydenham's chorea.' Although half the patients 
with Sydenham's chorea have a self limiting illness, the 
remaining 50% will have a chronic course with relapses or 
persistence' 
Until the 1990s, Sydenham's chorea was considered 10 be 
the only neurological sequel of streptococcal infection. 
However, during an outbreak of group A streptococcal 
infection in Rhode Island, there were many reports of affected 
children developing sudden onset tics and psychiatric 
disorders ." Subsequently, the clinical phenotype of post­
s treptococcal tics and obsessive-compulsive disorder was 
described, and the term PANDAS (paediatric autoimmune 
neuropsychiatric disorders associated with streptococcal in­
fections) was coined.' Patients with PANDAS characteristically 
have exacerbations of characteristic symptoms after further 
group A streptococcal infections but othelWise have a clinical 
phenotype similar to Touretle's syndrome. This has led to the 
hypotheSis that Touretle's syndrome may also be related to 
streptococcal infections, although this association remains 
Abbreviations: ABGA, anti-basal ganglia antibodies; ADHD, a~entian 
deficit hyperactivity disorder; ASOT, antistreptolysin 0 titre; DSM, 
Diagnostic and Statistical Manual of Mental Disorders; lCD, International 
ClassiFication of Diseases; PANDAS, paediatric autoimmune 
neuropsychiatric disorders associared with streptococcal infection 
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Toure~e's syndrome ond infection 
Table 1 Demographics of the sample 
Mean age (years) 
Group n (range) Sex (M/F) 
Child ToureMe syndrome 56 · 12.8 (810 17) 40/16 
Aduh ToureHe syndrome 44 37.8 (18 10 (1) . 32/12 
Child slreplococcol infeclion 40 9.8 (210 15) 25/ 15 
Child neurological disease 50 7.610.51018) 24/26 
Adull·heallhy conlrol, 50 35.6 )1910 57) 25/25 
Aduh neurological disease conlrols 50 4 I. 1 (19 1070) 30/20 
F, female; M,.male. 
controversial." The proposed disease mechanism in Syden­
ham's chorea and PANDAS is cross reactive antibodies induced 
by group A streptococcal infection that bind specifically to 
basal ganglia antigens." The presence of anti-basal ganglia 
antibodies (ABGA) in Sydenham's chorea"-" and PANDAS" 
supports this hypothesis. 
We aimed to examine the association of streptococcal infec­
tion and basal ganglia autoinununity in Tourelle's syndrome 
by screening for recent streptococcal infection and ABGA in a 
large cohort of children and adults with this syndrome. 
METHODS 
Patients 
Permission for the study was obtained from the local e thics 
committee of the National Hospital for Neurology and Neuro­
surgery. Index patients were interviewed by one of us (MMR) 
using standardised instruments including the National 
Hospital interview schedule," the diagnostic interview 
schedule," and the Yale global tic severity rating scale." To be 
diagnosed as having Tourette's syndrome, patients had to sat­
isfy DSM-IV-TR (APA, 2000) and ICD-IO (WHO, 1992) criteria. 
Thus they had to have multiple motor and one or more vocal 
tics, with symptoms lasting longer than a year. Comorbid 
diagnosis of obsessive-compulsive disorder and ADHD con­
formed to DSM-IV and ICD-I 0 criteria. 
Controls 
To determine the significance of both streptococcal serology 
and anti-basal ganglia antibodies, we enrolled controls for 
comparison (table I), as follows: 
• 	Children with neurological disease (n = 50). This group 
contained patients with dystonia (n = 30) of inflammatory 
(n = 12), vascular (n = 6), metabolic (n = 6), and genetic 
(n = 2) aetiology. Additional dystonic aetiologies included 
variant Creutzfeldt-Jakob disease, basal ganglia tumour, 
athetoid cerebral palsy, and juvenile Parkinson's disease 
(n = I each). Also within the neurology control group were 
patients with invasive viral encephalitis (n = 20). 
• 	Children with recent uncomplicated streptococcal injection 
(n = 40). 
• 	Adults with neurological disease (n = 50), including multiple 
sclerosis (n = 12), dementia (n = 7), paraneoplastic syn­
dromes (n = 3), autoimmune neuropathy (n = 3), acute 
cerebellitis (n = 3), and other mixed neurological disease. 
• 	 Healthy adults Jrom laboratory staff and paediatric hospital work· 
ers (n = 50). 
The Tourelle's syndrome patients and controls were recruited 
during the same time period and blood samples were stored at 
-80°C with identification data coded. 
Streptococcal serology 

Evidence of recent streptococcal infection was examined using 

antistreptolysin 0 titres (ASOT). All patient and control sam­

ples were analysed using standardised Dade Behring II neph ­

elometry; an ASOT above 200 JU/m! is considered to indicate 

recent infection (WHO guidelines). 

Basal ganglia homogenate 
Caudate, putamen, and globus pallidus from a patient with no 
evidence of neurological disease was kindly provided by the 
Queen Square brain bank for neurological disorders, Institute 
of Neurology, London. The block of tissue was homogenised 
with a small volume of saline containing protease inhibitors 
(Sigma Chemicals, Poole, Dorset, UK) and centrifuged for 30 
minutes at 7500 x g. Equal volumes of supernatant and 
Di-isopropyl ether were mixed and centrifuged at 600 x g for 
10 minutes 10 remove lipid from the supernatant. The protein 
fraction was then collected and stored at-80°C until required. 
Basal ganglia antibody western immunablalling 
As previously described" the basal ganglia homogenate was 
mixed with lithium dodecyl sulphate sample buffer (Invitro­
gen, USA), containing 0.05 M dithiOlhreitol and heated at 
65°C for 15 minutes. A total of 30 J.lg of protein was loaded 
onto a 4-12% bis-tris gel (Invitrogen, Paisley, Scotland, UK) 
and electrophoresed. The proteins were blotted onto nitrocel­
lulose (Sartorius, Epsom, Surrey, UK) and blocked with 2% 
milk proteins for two hours. Samples were diluted 1/300, 
applied to the blot, and incubated overnight at 4°C. The nitro­
cellulose was washed with 10 changes of 0.9% saline contain­
ing 0.2% milk proteins and 0.025% meen. The blot was incu­
bated for two hours with rabbit anti-human IgG conjugated 
with horseradish peroxide diluted 1/1000 (Dako, Cambridge, 
UK). After washing, the substrate 4-chloro-I-naphthol 
(Sigma) was added and the blot was allowed to develop for 15 
minutes. Western immunoblotting was done in all patients 
and controls. 
Basal ganglia antibody indirect immunofluorescence 
IndireCl immunofluorescence was undertaken in 10 western 
immunoblot positive Tourelle's syndrome patients and 10 
controls from each group. Using previously described 
methods,"" 10 J.lm seClions of norma) human basal ganglia 
were cut from a snap frozen tissue block of caudate and puta­
men. Control and patient sera were diluted 1:10 in phosphate 
buffered saline (PBS), overlaid onto prepared slides, and incu­
bated for 30 minutes. A control slide was also prepared and 
incubated with PBS alone for 30 minutes to assess back­
ground fluorescence. All slides were washed in PBS and incu­
bated with anti-human IgG conjugated with fluorescein 
isothiocyanate (Dako) and analysed using a fluorescence 
microscope. 
Statistical analysis 
All statistical analyses were done using SAS software (SAS 
Institute Inc. Cary, North Carolina, USA). Streptococcal serol­
ogy was compared using the non-parametric two sample exact 
Wilcoxon rank-sum test. Positive ABGA Western immunoblot­
ting was compared in each subgroup using X' tests. Ninety five 
per cent confidence intervals (CI) are given. 
RESULTS 
Demographics 
Demographic data on the patients are summarised in table I. 
The serology results were analysed in paediatric and adult 
www.jnnp.com 
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98 kDa ~ 
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mw 2°Ab GTS GTS GTS SC GTS GTS GTS GTS 
Figure 1 Western immunoblot against homogenate of human basal ganglia. An IgG band is present in lanes from both patients and controls 
and is Irom the human basal ganglia donar. Toure"e syndrom'3 patients have an IgG response against a 60 kDa basal ganglia antigen which 
is similar to the pa"ern seen in Sydenham's chorea. Other IgG binding is to a 40 kDa and a 45 kDa basal ganglia antigen. mw, molecular 
weight marker; GTS, Gilles de 10 Toure"e syndrome patients; SC, Sydenham's chorea; 2°Ab, secondary antibody only. 
groups separately, because of the higher incidence of streplo­
coccal infection in childhood. The Tourette's syndrome cohort 
had a mean (SD) diagnostic confidence index of 64 (20)%, 
range 14% to 100%. The prevalences of obsessive-compulsive 
disorder and ADHD in the total cohort were 31 % and 43%, 
respectively. The paediatric Tourette's syndrome patients had a 
diagnostic confidence index of 64 (21 )%, range 14% to 100%, 
a 17% incidence of obsessive-compulsive disorder, and a 49% 
incidence of ADHD. The adult Tourette's syndrome p3tients 
had a diagnostic confidence index of 63 (20)%, range 16% to 
100%, a 51 % incidence of obsessive-compulsive disorder, and a 
31% incidence of ADHD in childhood. 
Streptococcal serology 
Paedialric 
As predicted, ASOT was raised in 80% of the children with 
recent streptococcal infection (mean 349 IU/ml (95% CI, 270 
to 427». ASOT was also raised in 64% of the children wilh 
Tourette's syndrome (299 IU/ml (262 to 335» and in 18% of 
the children with neurological disease (151 IU/ml (101 to 
201». ASOT was raised in the paediatric Tourette's syndrome 
cohort compared with the neurological controls (p < 0.0001), 
but not with the streptococcal controls (p = 0.4) . 
Adult 
ASOT was raised in 68% of the adults with Tourette's 
syndrome (mean 298 I U/ml (95% CI, 243 to 353 ), in 12% of I he 
adults with neurological disease (140 IUlml (92 to 188», and 
in 8% of the healthy adults (122 IUlml (101 10 143)). ASOT 
was statistically raised in the adult Tourette's syndrome cohort 
compared with the neurological controls (p < 0.05) c.nd the 
healthy controls (p < 0.05). 
ABGA western immunoblolting 
Paediatric 
lWenty per cent of the paediatric Tourette's syndrome group 
( 12/56) had positive western immunoblotting, compared with 
4% of the neurological controls (1/50) and 2% of the strepto­
coccal controls (1140). The difference between the Tourette's 
syndrome group and both control groups was significant 
(p < 0.05 and p < 0.05, respectively). Common bands of reac­
tivity were seen in the Tourette's syndrome group, rather than 
polyspecific binding. The most common responses were to 60 
kDa (n = 6),40kDa (n = 4),45 kDa (n = 3),67kDa (n = 2), 
80kDa (n = 2), and 95 kDa antigens (n = I) (fig 1).Theposi­
tive neurological controls bound to a 40 kDa (n = I) and 
43 kDa (n = I) antigen. The positive streptococcal conlroJ 
bound to a 60 kDa anligen. 
Adult 
Twenty seven per cent of Ihe adull Tourette's syndrome group 
(12/44) had posilive western imlllunobiotting, compared with 
2% of the neurological controls (1/50) and 4% of the healthy 
controls (2/50) (p < 0.005 and p < 0.005, respectively). The 
common antibody binding was also to 60 kDa (n = 7),40 kDa 
(n = 5),45 kDa (n = 2),80kDa (n = 2),67 kDa (n = I),and 
98 kDa antigens (n = I). The positive neurological control 
bound to a 40 kDa antigen. The positive healthy controls both 
bound to a 55 kDa antigen. In all paediatric and adult 
Tourette's syndrome patients the most common basal ganglia 
autoantigen detected was to a 60 kDa protein (n = 13) and 
then to a 40 kDa protein (n = 9). 
ABGA indirect immunofluorescence 
To define the localisation of antibody binding, we carried out 
indirect immunofluorescence on 10 Tourette's syndrome 
patients (five paediatric and five adult) with positive western 
immunoblotting. All patients had the same binding pattern, 
with IgG binding to large basal ganglia neurones (fig 2). The 
Figure 2 (A) Basal ganglia immunonuorescence revealing 
ontibody binding to basal ganglia neurones in a patient with 
Tourelte's syndrome. (B) Negative binding in control. 
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Table 2 Clinical comparisons between ABGA positive and ABGA negotive 
Tourette's syndrome patients' 
Finding ABGA positive (n =24) ABGA negative (ri= 77) .p Vatue 
Age 01 firsllic Iyearsl lrange) 6.56 12 10 13) .6.81 121016) . NS 
Diagnostic confidence index 62 120)% [36% 10 96%) 64121)% [14% 10100%) ..NS 
Imeon (SD), [range]) 
Obsessive-compulsive behaviour 27% 33% NS 
~isorder 
Atteniion:.deficil hype(Q~I~viry 22% 50,),. <0.05 
disorder 
History of neuropsychiatric 69.6% 753% NS 
disease in I sl degree family 
membert 
ASOT >200 IU/ml 91.3% 584% <0.01 
.- ... By weslern immunoblotting. . 
' lFomily history of neuropsychiatric disease includes lie disorders, laureNe's syndr-orne, eod' 
obsessive-compulsive disorder. 
ABGA, onli·bosol ganglia onlibodies; ASO-, onlislreplolysin Olilre. 
Table 3 Follow up studies 
Time,a.lter lsUest 
Case Tesl lsi Tesl result 2nd Test result (months) 
Case 1 ASOT 500lU/mi 1331U/mI , 3 
ABGA Negol;ve 60 kDo 
Case 2 ASOT 260lU/mi Ui51U/mi 3.5 
ABGA ' Negalive 45 and 60 kDo 
Case 3 ASOT 7101U/ml ' ·220IU/ml 4 
.' ABGA Negative '4o kDa 
Case 4 ASOT 315tU/mi <50 lU/mt 
ABGA .. Negative 40 and 95kDo 
ABGA, onli-bosal go."gli.o onlibodies; ASOT, onlislreplolysin 0 lilre. 
immunofluorescence staining pattern seen using these 

Tourette's syndrome patients was identical to that previously 

described in Sydenham's chorea." None of the controls tested 

had reactivity against any cellular component of the basal 

ganglia. 

Raised streptococcal serology and positive ABGA 

Ninety one per cent of Tourette's syndrome patient, with 

positive ABGA western immunoblotting (21/23) had a positive 

ASOT. compared with 57% of Touretle's syndrome patients 

with negative ABGA western immunoblotting (44/77) 

(p < 0.01). 

Clinical comparison between ABGA positive and ABGA 

negative groups 

The clinical characteristics (obses sive-compul sive disorder/ 

ADHD and family history of neuropsychia tric disease) d id not 

differ between patients who were ABGA positive or ABGA 

negative (table 2). The numbers of patients with a signifi­

cantly raised ASOT were greater in the ABGA positive group 

(91.3%) than in the ABGA negative group (58.4%). We were 

able to retest the blood of four of the Tourette's syndrome 

patients who had negative ABGA and positive ASOT 3.5 

months after first testing. This showed that ASOT levels had 

decreased to normal in three cases but ABGA had become 

positive in all four (tab)e 3). 

DISCUSSION 

The Tourette's syndrome patients were recruited from a dedi­

cated clinic with all patients fulfilling strict diagnostic criteria. 

The mean age of onset (6.75 years) and the male predomi­

nance were consistent with previously published data ." Simi­

larly, 100% of the patients in this study presented in childhood 

« 18 years), which is characteristic of Tourme's 
syndrome.' , As longitudinal studies have shown that 50% of 
patients will be free of tics by 18 years of age, and tic severity 
gradually diminishes in adulthood,' it is Ukely that this cohort 
of adult patients with Tourette's syndrome represents a severe 
form of the disease. 
The pathogenesis of Tourette's syndrome remains obscure 
but it is considered to be an inherited neurodevelopmental 
disorder resulting in disinhibition of the cortico-striatal­
thalamic-cortical circuitry.' Although various neurotransmi t­
ters have been implicated in the pathogenesis of the 
syndrome, the most favoured hypothesis is that there are sub­
tle abnormalities of the dopaminergic system." Tourette's 
syndrome appears to be a familial disorder, with early report s 
supporting an autosomal dominant inheritance."''' A system­
atic whole genome screen revealed two regiOns, 4q and 8p, 
with increased lod scores, and these loci might yet reveal sus­
ceptibility genes for Tourette's syndrome." As a genetic basis 
for Tourette's syndrome has yet to be uncovered, alternative 
pathological models are being considered, and Touretle's syn­
drome may turn out to be a heterogeneous disorder." 
The recognition that PANDAS may be pathologically related 
to Sydenham's chorea, along with the clinical Similarity of 
PANDAS and Tourette's syndrome, has led to the notion that 
Tourette's syndrome may occur as a result of basal ganglia 
dysfunction secondary to post-streptococcal autoimmunity." 
The observation that patients with tic disorders or Tourette's 
syndrome are more Ukely to have positive streptococcal serol­
ogy than control subjects"-17 supports this hypothesis, though 
not all studies have replicated such an association."" Prelimi­
nary analysis of antibody reactivity to streptococcal M 
proteins has shown raised titres to M 12 and M 19-but no! to 
M I, M4, and M6-in 25 adult patients with Tourette's 
www·innp.com 
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syndrome compared with 25 control subjects." This may sug­
gest that only certain strains of group A streptococcal 
infection could be linked to Tourette's syndrome. This is com­
patible with observations that other post-streptococcal im­
mune mediated disorders, such as acute rheumatic fever and 
glomerulonephritis, are also strain specific" 
The proposal that Sydenham's chorea and PANDAS occur as 
the result of an immune mediated insult is supported by the 
presence of ABGA which bind to basal ganglia neurones."-" In 
a study of patients with Sydenham's chorea, we have recently 
shown that ABGA were present in all 20 patients (100%) with 
acute disease and in 11/16 patients (69%) with persistent dis­
ease, but in none of a group of II healthy controls." Increased 
antibody binding to putamen in Tourette's syndrome, and 
identification of basal ganglia antigens of molecular weights 
60,67, and 83 kDa, have been reported." A further study also 
suggested that 60 kDa was the most prevalent basal ganglia 
autoantigen in Tourette's syndrome, although a complex mul­
tivariate analysis is required to establish this association." 
Preliminary results from another group also suggested that a 
60 kDa and an 83 kDa antigen represented the dominant 
response in patients with tics, Tourette's syndrome, or 
obsessive-compulsive disorder," and the same investigators 
suggested that these antibodies recognised a calpain­
calpastatin complex." In Sydenham's chorea, we have 
described three dominant basal ganglia autoantigens of 
molecular weights 40, 45, and 60 kDa." The consistent finding 
of a 60 kDa antigen from this study may suggest that the anti­
gen could be important in Sydenham's chorea, PANDAS, and 
Tourette's syndrome. 
Not all of the studies reported have had similar findings to 
ours. Two studies using a neuroblastoma cell line rather than 
basal ganglia as the antigen source found no discriminate 
antibody responses in Tourette's syndrome."" It would appear 
from these studies that human or mammalian brain homoge­
nates should be the preferential source of antigen. The meth­
ods for detecling antibodies may also influence the results 
from different studies; enhanced chemiluminescence i~ a very 
sensitive method but produces a multitude of responses in 
western inununoblotting of patients and controls, most of 
which are of doubtful significance."-"" We propose that 
colorimetric analysis of western blots in this setting is 
preferable" and improves specificity, although arguably at the 
cost of reduced sensitivity. 
Using the methods described we found a correlation 
between ABGA and positive ASOT. Serological evidence of 
recent group A streptococcal infection was detected in 91 % of 
patients with positive ABGA and in 57% with negative ABGA. 
This may suggest that ABGA and recent streptococcal 
infection are related in some patients. Interestingly the preva­
lence of raised ASOT in the ABGA negative patients was 
significantly more common than in the control groups. This 
finding suggests that post-streptococcal autoimmunity could 
be important in a larger proportion of patients with Tourette's 
syndrome. It is possible that ABGA reactivity is be a phenom­
enon that waxes and wanes with the clinical course. lndeed 
three of four patients whom we followed up with positive 
ASOT but negative ABGA had positive ABGA and decreased 
ASOT three months after the initial sample was taken. A lon­
gitudinal study is required to investigate the temporal associ­
ation between ABGA, streptococcal serology, and clinical 
course . 
An alternative explanation for ABGA in Sydenham's 
chorea, PANDAS, and Tourette's syndrome is that it occurs as 
an epiphenomenonon secondary to basal ganglia damage. We 
believe this is unlikely, for three reasons. First, control patients 
with inflammatory, metabolic, and ischaemic basal ganglia 
diseases uncommonly develop these antibodies. Second, in a 
provocative study by Hallett and coworkers, the microinfusion 
of sera or IgG from patients with Tourette's syndrome into the 
striatum of rats induced stereorypes analogous to the 
www.jnnp.cam 
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involuntary movements seen in Tourette's syndrome," sug­
gesting that ABGA may playa pathogenic role. Finally, a ran­
domised trial of therapeutic plasma exchange and intravenous 
immunoglobulin for PANDAS showed a therapeutic response 
in favour of the treated patients ." 
Conclusions 
We have shown that a significant proportion of patients with 
Tourette's syndrome have evidence of recent streptococcal 
infection and anti -basal ganglia antibodies. The studies 
published so far on these antibodies have used immuno­
fluorescence, western immunoblotting, and enzyme linked 
immunosorbent assay methods, which have different sensi­
tivities and speCifiCities. This may help explain the differences 
between studies in the reported associations between ABGA 
and disease . Many investigators have proposed that the pres­
ence a 60 kDa autoantigen in Sydenham's chorea, PANDAS, 
and Tourette's syndrome is significant. The identification of 
this antigen is ctucial in determining the pathogenicity of 
ABGA in post-streptococcal eNS syndromes. 
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Abstract 
To investigate the immune-mediated response in TS, and its relationship with streptococcal infection, we measured serum levels of 
soluble intercellular adhesion molecule-l (ICAM-I), vascular cell adhesion molecule-I (VCAM-I) and E-selectin in patients with TS, 
compared to healthy and diseased controls. Soluble VCAM-I and sE-selectin were significantly elevated in children and adults with TS, and 
sVCAM-l was higher among anti-basal ganglia antibodies (ABGA)-positive adults with TS. No correlation of adhesion molecule levels to 
clinical severity or anti-streptococcal antibodies was observed. Children with Sydenham's chorea and paediatric autoimmune 
neuropsychiatric disorders associated with streptococcal infections (PANDAS) showed an increased level of sICAM-I, but not sVCAM- J 
and sE-selectin. These results provide initial evidence for a role of adhesion molecules and systemic inflammation in TS, and support the 
hypothesis of an ongoing immune-mediated process in this condition. 
© 2005 Elsevier BV All rights reserved. 
Keywords: Tourette's syndrome; sICAM-I; s VCAIvI- I; sE-selectin; Adhesion molecules; Streptococcal infection; Anti-basal ganglia antibodies 
1. Introduction 
Gilles de la Tourette's syndrome (TS) is characterised by 
the presence of multiple chronic motor and phonic tics [I]. 
The aetiology of TS is still undefined, although several 
different genetic and envirorunental factors might playa role 
[2 - 5]. A relationship between the occurrence of tic 
disorders and Group A f)-hemolytic streptococcal (GABHS) 
infections bas been proposed [4] and intensely debated [6­
8], leading to the description of the PANDAS (Paediatric 
Autoirrunune Neuropsychiatric Disorders Associated with 
• Corresponding author. Department of Neurological and Psycbianic 
Sciences, University of Ban, Piazza Giulio Cesare, II 70124 Ban, Italy. 
Tel. : +39 080 5478511; fax: +39 080 5478532. 
E-mail address: da videmartino@virgilio.it (D . Manino). 
0022-5 JOXiS - see from matter © 2005 Elsevier BV All rigl:ts reserved. 
doi: 10.1016/j .jns. 2005.03.032 
Streptococcal Infections) syndrome [9]. Interestingly, PAN­
DAS show similarities to TS, mainly the predominance of 
tics in both syndromes, a high frequency of psychiatric 
comorbidity, such as obsessive-compulsive disorder (OCD) 
and anxiety disorders, and the waxing and waning of 
symptoms [1,9,lD]. 
On the model of Sydenham's chorea (SC), a neuro­
psychiatric disorder related to rheumatic fever (RF) , 
PANDAS are hypothesized to be an autoaggressive disorder 
triggered by molecular mimicry between surface GABHS 
antigens and neuronal antigens, enriched in the basal 
ganglia [11,12]. Cross-reacting autoantibodies were pro­
posed to playa role in this process [11,13], and serum anti­
basal ganglia antibodies (ABGA) were suggested as a 
potential diagnostic marker in post-streptococcal neuro­
logical and psychiatric disorders [14,15]. 
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Several reports showed elevated titers of anti-streptococ­
cal antibodies in TS [16-18], and a cross-sectional study 
reported a higher frequency of ABGA in the serum of 100 
patients with TS, compared to healthy and diseased controls 
[18]. This preliminary evidence led to the hypothesis that 
autoimmunity directed against the basal ganglia, triggered 
by GABHS infection, is involved in a subgroup of patients 
with TS. However, reports on markers related to systemic 
autoimmune diseases have been rare in TS. 
Cellular adhesion molecules (intercellular adhesion 
molecule-I, ICAM-l; vascular cell adhesion molecule-I, 
VCAM-I; selectins) are glycoproteins belonging to the 
immunoglobulin superfamily, which mediate cell-cell and 
cell-extracellular matrix interactions [19]. Their expression 
is increased in a large number of inflammatory and immune­
mediated conditions, including multiple sclerosis (MS) and 
experimental autoimmune encephalomyelitis (EAE) [20]. 
When expressed by endothelial cells in their membrane­
bound fonn, these molecules act as ligands for leukocytes to 
facilitate their entry into the sites of inflammation [19]. 
Serum levels of soluble ICAM-I are raised also in patients 
with RF, and such increase is maintained over time, until 
clinical remission [21]. 
To explore the concurrence of an immune-mediated 
inflanunatory response in TS, we measured serum levels of 
the soluble fonns of three adhesion molecules in children 
and adults with TS, and analysed their relationship to 
serological markers of recent streptococcal infection and the 
presence of ABGA. 
2. Materials and methods 
2.1. Subjects 
Pennission for the study was obtained from the ethics 
committee of the National Hospital for Neurology and 
Neurosurgery and the Institute of Neurology. Thirty-three 
children and 51 adults diagnosed with TS were consecutively 
recruited from a tertiary referral centre of the same 
institution. Patients diagnosed with TS fulfilled DSM-IV­
TR (APA, 2000) and ICD-10 (WHO, 1992) criteria, and 
were not preselected on the basis of a preceding strepto­
coccal infection. Diagnostic interviews were perfonned by 
two specialists in TS (MO and MMR), using standardised 
instruments, including the National Hospital interview 
schedule [22], the Diagnostic Confidence Index (DCI) [23] 
and the Yale global tic severity rating scale (YGTSS) [24]. 
To detennine the significance of serum levels of soluble 
ICAM-I (sICAM-I), soluble VCAM-I (sVCAM-1) and 
solubleE-selectin (sE-se1ectin), we studied several controls 
for comparison: 
Children with non-inflammatory neurological diseases 
(NNID, n = 35). This group contained 10 children with 
developmental delay, 14 children with epilepsy and 11 
children with diagl1os~d CNS metabolic disorders. 
Healthy children (n=34). 
Children with post-streptococcal neuropsychiatric dis­
eases (SC or PANDAS, n 19). Nine patients were 
diagnosed with acute SC: they all presented with an acute 
onset of chorea, met the modified Jones criteria for RF (25], 
and other causes of chorea were excluded. Ten patients 
fulfilled the working criteria for PANDAS (9). All children 
in this group entered the study within 2 weeks from the 
onset of the acute illness. 
Adults with non-inflammatory neurological diseases 
(NNID, n =40). This group contained 28 patients with 
primary adult-onset dystonia, 7 patients with primary 
hemifacial spasm, 3 patients with dopa-responsive dystonia, 
I with paroxysmal kinesigenic choreoathetosis and I with 
DYT-l dystonia. 
Healthy adults (n=30). 
Subjects with NNID and children with SC or PANDAS 
were consecutively recruited from other tertiary referral 
centres of the same institution. Healthy controls were 
recruited from laboratory staff and hospital workers, and 
from their.. relatives. Diseased and healthy controls were 
matched to TS patients by age (i5 years), recruiting each 
suitable subject in a consecutive fashion. No subject, other 
than SCIPANDAS patients, had had RF, SC or an auto­
immune disease. Case or control subjects affected by a 
clinically evident infectious or inflammatory disorder at the 
time of recruitment were excluded from the study. All 
subjects were recruited during the same period. A blood 
sample was taken from each subject, and aliquots of serum 
specimens were frozen within 30 min of collection and 
stored at -80°C with identification data coded until 
analysis. 
2.2. Adhesion molecules 
Soluble adhesion molecules .(sICAM-I, sVCAM-l and 
sE-selectin) were quantified from patient sera using a 
quantitative sandwich enzyme-linked immunosorbent assay 
(ELISA) (R&D Systems Europe, Abingdon, Oxon, UK), 
following the protocol of the manufacturer. A monoclonal 
antibody specific for sICAM-I had been pre-coated onto a 
96 well microplate. Antibody to recombinant human 
sICAM-1 conjugated to horseradish peroxidase was then 
added to the wens. Standards, positive controls and sera 
were then incubated for 90 min at room temperature, at a 
1 :20 dilution. After washing, a colorimetric reading of the 
microplate by measurement of the absorbance at 450 nm 
was perfonned, using a tetramethy1benzidine solution as 
substrate. The same protocol was used for sVCAM-1 and 
sE-selectin quantitative measurements, using a 1 :50 dilution 
for sVCAM-1 and a 1 :20 dilution for sE-selectin. 
2.3. Streptococcal serology 
Evidence of recent streptococcal infection was examined 
using antistreptolysin 0 (ASOT) and anti-DNAse B titers. 
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For the ASOT measurements, samples were analysed using 
standardised Dade Behring II nephelometry; an ASOT 
above 200 ill/ml was considered to iridicate recent infection 
(WHO guidelines). For the anti-DNAse B measurements, 
samples were analysed by a semiquantitative neutral ising 
assay (Ph Plate, Stockholm, Sweden). The assay measures 
neutralisation of· streptococcal DNAse enzyme B by 
colorimetric visual reading, using DNA-methyl green as 
the substrate; an anti-DNAse B titer above 300 IVlml was 
considered to indicate recent infection. 
2.4. Anti-basal ganglia antibodies in patients with TS 
The Western immunoblotting method to detect ABGA 
has been previously described [26]. The antigen used was 
derived from human basal ganglia (caudate and putamen) 
and came from a donor with no history or evidence of 
neurological disease. The basal ganglia homogenate was 
mixed with lithium dodecyl sulphate sample buffer (Invi­
trogen, USA), containing 0.05 M dithiothreitol and heated at 
65°C for 15 min. A total of30 ig of protein was loaded onto 
a 4-12% Bis-Tris gel (Invitrogen, Paisley, Scotland, UK) 
and electrophoresed. The proteins were blotted onto nitro­
cellulose (Sartorius, Epsom, Surrey, UK) and blocked with 
2% milk proteins for 2 h. Samples were diluted 11300, 
applied to the blot and incubated overnight at 4 0c. The 
nitrocellulose was washed with 10 changes of 0.9% saline 
containing 0.2% milk proteins and 0.025% Tween. The blot 
was incubated for 2 h with rabbit anti-human IgG 
conjugated with horseradish peroxidase diluted 111000 
(Dako, Cambridge, UK). After washing, the substrate 4­
chloro-I-naphthol (Sigma) was added and the blot was 
allowed to develop for 15 min. The test was considered 
positive when reactivity to at least one of three previously 
reported [26] common basal ganglia antigens (40, 45 and 60 
lilla) was detected. ." 
2.5. Statistics 
SPSS (SPSS Inc., U.S.A.) was used for all statistical· 
analyses. Serum soluble adhesion molecules levels from the 
different groups were compared using a one-way analysis of 
variance (ANOVA), when data from the compared groups 
passed the nonnality assumption test, or a Kruskal-Wallis 
one-way ANOVA, when data did not pass the nonnality 
assumption test or the difference between their standard 
deviation (SD) was significant. Assumption of nonnality . 
was tested using the method of Kolmogorov and Smimov. 
Scheffe test was used for multiple comparisons between 
groups. Correlation between soluble adhesion molecule 
values and ASOT values, YTSS score and DCI, expressed 
as continuous variables, was assessed by logistic linear 
regression analysis. ASOT values, YTSS and DCI scores 
were further categorized in a binomial fashion (011 scores), 
in the following ways: lower than/higher or equal to 200 ill 
for ASOT, lower thanfhigher or equal to median value for 
YTSS and DCI. Due to the semiquantitative type of 
detennination, anti-DNAse B antibody titer was analysed 
only as a binomially categorized variable. Subsequently, 
frequency distribution of elevated soluble adhesion mole­
cules values and ASOT (nonnal or elevated), anti-DNAse B 
(nonnal or elevated), YTSS (0 or 1), DCI (0 or I) and ABGA 
status (negative or positive), was assessed by Fisher's Exact 
Test, categorizing the soluble adhesion molecules values of 
patients in lower thanfhigher or equal to the mean value of 
the healthy+2 S.D. Differences between proportions were 
assessed using two-sample t-test for proportions. 
3. Results 
3.1. Demographics 
Patients' demographic data are summarised in Table I. 
The mean (S.D.) duration of disease in patients with TS was 
6.04 (2.5) years in children and 24 (7.2) years in adults. The 
median (25th-75th percentile range, rounded to the nearest 
integer) value of DCI was 55 (46-74) in children and 62 
(55-75) in adults. The median (25th-75th percentile range) 
value ofYTSS was 47 (23-56) in children and 49 (39-63) 
in adults. 
3.2. Soluble adhesion molecules . 
Fig. I presents the distribution of adhesion molecules 
levels in the different groups, p values for differences 
between groups using the one-way ANOVA in all groups 
and the results of Scheffe test for multiple comparisons 
between groups. 
3.3. Correlation between clinical scores and soluble 
adhesion molecules 
In both paediatric and adult groups of TS patients, 
soluble adhesion molecule levels did not correlate to age 
and duration of disease (p > 0.05 for all linear regression 
analyses). In the adult TS group, only sE-selectin values 
positively correlated to DCI (r=0.56; p=O.04). In both 
paediatric and adult TS groups, sICAM-l and sVCAM-I 
values did not significantly correlate to YTSS and DCI 
(p>0.05 for all correlation analyses, all Fisher's Exact 
Table I 
Demographic features of participating subjects 
Age mean (range) Sex (M/F) 
Children with TS 12.8 (4-17) 26n 
Children with NNlD 8.6 (4-17) 23112 
Healthy children 9.6 (3-16) 24110 
Children with SCIPANDAS II (6-22) 11/8 
Adults with TS 32.9 (18-66) 39/16 
Adults with NNlD 38.5 (19-56) 15125 
adults 36.8 20110 
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Fig. I. (a) Soluble ICAM-I levels in paediatric groups. One-way ANOVA: F=6.51, p=0.0004. Scheffe test for multiple comparisons between groups: 
TS > healthy, NS; TS>NNID, NS; SCIPANDAS > TS, NS; SCIPANDAS > healthy,p =0.01; SCIPANDAS> NNID, p =0.02. (b) Soluble ICAM-l levels in adult 
groups. One-way ANOVA: F=2.37,p=0.09. Scheffe test for multiple comparisons between groups: TS>healthy, NS; TS>NNID, NS. (c) Soluble VCAM-J 
levels in Pllediatric groups. One-way ANOVA: F=4.76, p=0.004. Scheffe test for multiple comparisons between groups: TS> healthy, p = 0.017; TS>}''NID, 
p=0.016; TS>SCIPANDAS, NS; SCIPANDAS>healthy, NS; SCIPANDAS>NNID, NS. (d) Soluble VCAM-l levels in adult groups. One-way ANOVA: 
F= 15.62, p< 0.0001. Scheffe test for multiple comparisons between groups: TS> healthy, p <0.001; TS> NNID, p =0.001. (e) Soluble E-seleclin levels in 
paediatric groups. One-way ANOVA: F=8.8, p < 0.0001. Scheffe test for multiple comparisons between groups: TS> healthy, p < 0.0001; TS> NNID, NS; 
TS>SCIPANDAS, NS; SCIPANDAS>healtby, NS; SCIPANDAS>NNlD, NS. (f) Soluble E-selectin levels in adult groups. One-way ANOVA: F=5.87, 
p=0.004. Scheffe test for multiple comparisons between groups: TS>healthy,p=0.034; TS>NNID,p=O.OlL 
Tests>0.05), when analysed both as continuous and binary 3.4. Correlation and frequency distribution ofstreptococcal 
variables. Likewise, serum sE-selectin levels did not serology and soluble adhesion molecules 
correlate to YTSS score in children and in adults with TS, 
when analysed both as continuous and binary variables ASOTwas raised in 23 (69%) of the 33 children with TS, 
(p >0.05 for all correlation analyses, all Fisher's Exact and in 33 (65%) of the 51 adults with TS.ln both paediatric 
Tests> 0.05). and adult groups with TS, there was no significant 
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aSSOCIatIOn between serum levels of the three adhesion 
molecules and ASOT, when analysed both as continuous 
(p > 0.05 for all linear regression apalyses) and binary (all 
Fisher's Exact Tests>0.05) variables. 
Anti-DNAse B antibody titers were rnised in 10 (30.3%) 
of the 33 children with TS, and in 9 (17.6%) of the 51 adults 
. with TS. When compared to children with TS, anti-DNAse 
B antibody titers were significantly lower in healthy 
children (4/34 positive results, 11.8%, p=0.03), whereas 
there was no significant difference between TS children and 
paediatric non-inflammatory neurological controls (8/35 
positive results, 22.6%, p=0.23). When compared to TS 
adults, anti-DNAse B antibody titers were significantly 
lower in healthy adults (0/30 positive results, p =0.0 1) and 
in adult non-inflammatory neurological controls (1/40 
positive results, p =0.02). 
In both paediatric and adult groups with TS, there was no 
significant association between serum levels 9f the three 
adhesion molecules and anti-DNAse B aI!tibody titers (all 
Fisher's Exact Tests> 0.05). 
3.5. Frequency distribution ofABGA and soluble adhesion 
molecules 
ABGA against three previously reported common basal 
ganglia antigens (40, 45, 60 kDa) were detected by Western 
immunoblotting in 10 (30%) of the 33 children with TS, and 
in 15 (29%) of the 51 adults with TS. There was no 
significant association between elevated sI CAM -1 serum 
level and ABGA, both in children (Fisher's Exact 
Test=0.07) and in adults (Fisher's Exact Test=0.76). 
Elevated serum levels of sVCAM-l were associated with 
ABGA in adults with TS (Fisher's Exact Test = 0.046), 
whereas there was no association in children (Fisher's Exact 
Test= 1.000). There was no significant associa~n between 
elevated sE-selectin serum levels and ABGA, both in 
children and in adults with TS (Fisher's Exact Test=0.46 
and 1.000, respectively). 
4. Discussion 
We report significantly increased titers of sVCAM-l 
and sE-selectin in the serum of children and adults with 
TS, compared to healthy and NNID controls; this increase 
was less striking for sE-selectin in children, in whom 
there was no significant difference between patients and 
NNID controls. Conversely, sICAM-l levels did not differ 
between patients with TS and controls. Children with SCI 
PANDAS had elevated titers of sICAM-l, when com­
pared to healthy and NNID controls, but their sVCAM-l 
and sE-selectin titers did not differ from those of the 
other groups. There was no association between anti­
streptococcal antibodies titers and adhesion molecules in 
the two groups of patients with TS. Interestingly, 
sVCAM-l levels were significantly higher among 
ABGA-positive than among ABGA-negative adults with 
TS. 
Adhesion molecules are expressed by endothelial cells 
and peripheral blood mononuclear cells. An increased titer 
of their soluble forms may either be related to an' increased 
expression of their membrane-bound counterparts, or be due 
to enhanced proteolytic degradation from the cell surface 
following endothelial damage [20,27]. Overnll, they are 
considered markers of a systemic inflammatory response, as 
well as of endothelial activation and damage. 
Our findings support a concurrent inflammatory response 
in patients with TS of different age groups and duration of 
disease. These fmdings might be explained in different 
ways. First of all, it has been observed that anti-strepto­
coccal antibody titers are significantly elevated in children 
and adults with TS [16-18], even though an ongoing 
GABHS infection or colonisation was never definitely 
confirmed by culture or polymerase chain reaction analyses 
from throat specimens or skin biopsies. Our findings could 
therefore be due to a bystander effect of an inflammatory 
microenvironment created by recurrent or persistent 
GABHS infection. Indeed, soluble adhesion molecules have 
been reported as persistently elevated in recurrent paediatric 
upper respiratory tract infections of viral origin [28], and the 
possibility of a subclinical GABHS pharyngeal carriage has 
been thoroughly documented [29]. However, if this was the 
case, one would expect adhesion molecule titers to correlate 
with ASOT or anti-DNAse B titers, both highly specific 
markers of an ongoing immune response to this agent. 
Consistent with previous reports, serum anti-streptococcal 
antibodies were raised in our TS patients, but did not covary 
with adhesion molecules, suggesting that the elevated levels 
of adhesion molecules may not be a mere epiphenomenon 
of a concomitant GABHS infection. 
An alternative explanation for our fmdings is that TS is 
associated with an immune-mediated systemic inflamma­
tory response. Adhesion molecules are increased in severnl 
immune-mediated diseases, such as rheumatoid arthritis [30] 
and systemic lupus erythematosus (SLE) [31], but also in 
inflammatory diseases primarily of the CNS, like MS or 
EAE [32-34]. In SLE, upregulation of adhesion molecules 
was linked to acute disease activity and chronic multi-organ 
damage, as well as to abnormal titers of antiphospholipid 
antibodies in SLE-related antiphospholipid syndrome [35]. 
Interestingly, serum sICAM-} levels were reported as 
significantly elevated in children with RF, both during the 
acute and the remitting phases of the disease [21]. During 
remission, sICAM-l titers remained high, while other acute 
phase reactants (erythrocyte sedimentation rnte and fibri­
nogen) had already returned to normal [21]. Another group 
reported elevated levels of sICAM-I, sVCAM-I and sE­
selectin in the serum of patients with rheumatic mitral 
stenosis [36]. ABGA, a potential biological marker of post­
streptococcal neuropsychiatric disease, are highly sensitive 
in discriminating children with SC,· the neuropsychiatric 
manifestation of RF, from children with uncomplicated 
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streptococcal infections [26,37]. Moreover, ABGA were 
shown to be more frequent in a subgroup ofpatients with TS 
than in normal and pathological controls [18,38,39}. In our 
new cohort, we replicated the finding of a 25-30% 
proportion of ABGA positivity in patients with TS 
previously reported by our group [18]. Importantly, 
sVCAM-l levels were significantly higher in ABGA­
positive than in ABGA-negative adult patients with TS, 
although it was not possibl!! to detect a quantitative 
correlation between the two markers, since Western 
immunoblotting, currently the most accurate technique in 
detecting ABGA [26], is not a quantitative assay. A possible 
conclusion is that adhesion molecules and ABGA are both 
markers of the same immune-mediated process, potentially 
triggered by a preceding GABBS infection, which might be 
relevant in a proportion ofpatients with TS. Consistent with 
this hypothesis, our SCIPANDAS cohort, similarly to the 
RF cohorts reported by other groups [21,36], showed 
significantly elevated levels of sICAM-I. . 
CNS inflammatory disorders are characterised by an 
increased expression of adhesion molecules on brain 
microvessel endothelial cells and glial cells within active 
lesions [20). When expressed by endothelial cells in their 
membrane-bound form, these molecules act as ligands for 
leukocytes to facilitate their passage through the blood­
brain barrier (BBB). Soluble forms of adhesion molecules 
are detectable in the serum and CSF of MS patients, and 
seem to correlate with the degree of activity of the 
inflammatory response in the CNS [32-34]. ABGA have 
recently been documented in the CSF of patients with' SC 
[40] or a post-streptococcal encephalitis lethargica-like 
syndrome [41], suggesting the possibility of intrathecal 
synthesis of these antibodies. To the best of our knowledge, 
in serum ABGA-positive patients with TS, a condition in 
which the BBB is known to be intact, a similar finding has 
not been confirmed, due to the poor availability of CSF 
specimens from these patients. The increased levels of 
soluble adhesion molecules found in our patients might be 
related to brain microvessel endothelial activation, thereby 
facilitating lymphocytic extravasation in the brain, even in 
the absence of a major disruption of the BBB. Analysis of 
soluble adhesion molecules and ABGA in the CSF of 
patients with TS is warranted to verify this hypothesis. 
The lack ofcorrelation between adhesion molecules titers 
and disease severity in TS patients does not exclude the 
contribution of an underlying immune-mediated process to 
the pathophysiology of the disease. In fact, a similar 
mismatch was already reported in patients with RF [21] or 
in a group of 57 patients with neuropsychiatric SLE [35]. In 
addition, it has to be pointed out that severity scales for 
neurobehavioural disorders, such as TS, provide ordinal 
data which are only approximately continuous, and there­
fore not ideal for correlation analyses with biological 
measures. However, even after categorization of YTSS 
scores, the most used and reproducible severity scale for tics 
in TS, we failed to detect a significant association with our 
biological markers. A single-point-in-time study design, as 
is ours, does not detect possible covariations over time of 
clinical features and biological measures. A longitudinal 
type of study would be necessary for this purpose, and it is 
currently being performed by our group. 
The observed differential involvement of adhesion 
molecules between TS and SC/PANDAS might result from 
differences in the immune-mediated processes underpinning 
the two conditions. There is evidence for a variable 
regulation in the expression of these molecules, which 
might account for different serum levels according to the 
temporal stage of the inflammatory process [42,43]. ICAM­
1 and E-selectin are mainly stimulated by T-helper-l 
lymphocyte-secreted cytokines (IL-I, TNF(x' IFN-'Y) [42], 
whereas antiinflammatory cytokines, such as ILA, IL-J 0 
and IL-13, secreted by T-helper-2 lymphocytes, have been . 
shown to downregulate ICAM-l and E-selectin synthesis 
and facilitate VCAM-l expression [44). Our SCIPANDAS 
patients were all characterised by a recent acute onset of 
neurop~hiatric symptoms, suggesting that blood samples 
were collected during the acute phase of inflammation; 
conversely, all TS patients had a chronic illness. In the 
present study, we did not perform cytokine measurements; 
therefore, additional comments on the different pattern of 
expression of adhesion molecules in TS and SCIPANDAS 
are merely speculative. The question of a differential 
cytokine expression dUring the course of TS should be 
addressed in future studies. 
In conclusion, our study gives preliminary evidence for 
the involvement of adhesion molecules in IS, thereby 
suggesting the presence of a chronic systemic immune­
mediated response in this condition. Further work is 
warranted to investigate the contribution of other systemic 
immunological markers in TS, as well as the involvement of 
the intrathecal district in such immune response. Moreover, 
longitudinal surveys are Currently ongoing, in order to 
evaluate the extent of temporal covariation of clinical 
features and immunological measures in patients with TS. 
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Original Article Proof 
Increased Antistreptococcal Antibody Titers and 
Anti-Basal Ganglia Antibodies in Patients With 
Tourette Syndrome: Controlled Cross-Sectional 
Study 
Renata Rizzo, MD, PhD; Mariangela Gulisano, . MD; Piero Pavone, MD; Fabia Fogliani, MDj 
Mary M. Robertson, MD, MRCPCH, Ii'RCP, FRCPsych 
ABSTRACT 
The association between Tourette syndrome, attention-deficit hyperactivity disorder (ADHD), and obsessive-compulsive 
disorder following streptococcal infections has been documented,but with conflicting reports. We thus felt it was 
important to investigate this association in a group of Italian patients not previously documented. We took blood on 69 
patients with Tourette syndrome and 72 age- and sex-matched tic-free controls. Laboratory staff were blind to the 
diagnostic status of the subjects. Evidence of recent streptococcal infection was dermed using antistreptolysin titers. . 
Anti-basal ganglia antibodies were determined using human basal ganglia sections. StatiStical analysis was conducted 
using analysis of variance and chi-square tests. Raised antistreptolysin titers were found in 41 of 69 (59%) patients with 
Tourette syndrome and 14 of 72 (19%) controls (P = .000). Positive anti-basal ganglia antibodies were found in 22 of 69 
(32%) subjects with Tourette syndrome compared with 7 of 72 (10%) controls, which was also significant (P = .002). 
Raised antistreptolysin titers were detected in IS of 22 (S2%) patients with Tourette syndrome with positive anti-basal 
ganglia antibodies and 22 of 47 (47%) patients with negative anti-basal ganglia antibodies (P = .01). These results 
support the reported association between streptococcal infection and anti-basal ganglia antibodies and some patients 
with Tourette syndrome. (J Child Neurol 2006;21:000-000; DOl 10.2310nOlO.2006.00l7S). 
Gilles de la Tourette syndrome or Tourette syndrome is 
characterized by the presence of chronic multiple motor 
abnonnalities and one or more vocal tics, which must be present 
for at least a ye~,2 and characteristically wax and wane over 
time. Comorbid neuropsychiatric symptoms include obsessive­
compulsive behaviors and disorder and attention-<ieficit hyper­
activity disorder (ADHD).3.4 
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Epidemiologic studies have shown that Tourette syndrome 
is relatively common, occurring in between 0.4% and 1.76% of 
children between the ages of 5 and 18 years.5-11 The prevalence is 
even higher in individuals with autistic spectrum disorde~2 and 
individuais with learning disability and/or mental retardation. 13 
The etiology of Tourette syndrome remains unclear, 
although a combination of genetic and environmental (nonge­
netic) factors has been suggested14-17 Not only was Tourette 
syndrome found to be genetic, but autosomal dominant with a 
single major gene with incomplete penetrance was documented. 
However, much of the genome was then excluded, and 
subsequent genome scans and investigations have suggested 
[j]regions of interest on chromosomes 2, 4, 5, 7, 8, 10, 11, 13, and 17, 
as well as the DRD4 and MAOA genes. 1B,19 For thorough reviews 
on the genetics of 'l'ourette syndrome, the reader is referred to 
paulS. 14,lS It has also been proposed that although Tourette 
syndrome is an inherited disorder, environmental factors either 
have an etiolOgic role or mediate the severity of the phenotype.20 
Therefore, other etiologic theories were proposed and investi­
gated. 
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It was suggested that group A j}-hemolytic streptococcal 
infections might be important factors in acute-onset neuropsy­
chiatric and movement disorders.21 Sydenham chorea is con­
sidered the prototype of an autoimmune disorder triggered by an 
infectious agent. Thus, Sydenham chorea is documented as 
having a clearly defined association with rheumatic fever with a 
23preceding group A j}-hemolytic streptococcal infection.22• In 
addition to the chorea that typically involves the face and 
extremities, affected individuals can also presentwith behavioral 
or emotional difficulties, which can predate the motor abnorm­
alities by weeks to months;24.2-5 Then in 1998, Swedo et al 
proposed that Sydenham chorea was not the only immlIDe­
mediated central nervous system manifestation of group A beta­
hemolytic streptococcal infection.."! and proposed diagnostic 
criteria for a group of patients with the acronym PANDAS 
(pediatric autoimmune neuropsychiatric disorders associated 
with streptococcal infections).21 
The proposed mechanism in Sydenham chorea and 
PANDAS is the presence of cross-reactive antibodies induced 
by group A j}-hemolytic streptococcal infections that bind 
specifically to basal ganglia antigens.26 The presence of anti­
basal ganglia antibodies in patients with Sydenham chorea27 
supports this hypothesis. 
In a study ofnine patients with Sydenham chorea (acute and 
matched convalescent individuals), monoclonal antibodies 
showed specificity for mammalian lysoganglioside and N­
acetyl-beta-o-glucosamine, the dominant epitope of the group A 
streptococcal carbohydrate.23 Sydenham chorea antibodies 
targeted the surface of human neuronal cells, with specific 
induction of calciumlcalmodulin-dependent protein kinase IT 
activity by monoclonal antibody 24.3.1 and sera from patients 
with active chorea. Convalescent sera, as well as sera from other 
streptococcal diseases in the absence of chorea (acute rheumatic 
fever), did not activate the kinase. This evidence implicates 
antibody-mediated neuronal cell signaling in the immunopatho­
genesis of Sydenham chorea, which might improve our lIDder­
standing of antibody-mediated neurologic disorders.28 
We decided to investigate the hypothesis that Tourette 
syndrome might be associated with group A j}-hemolytic 
streptococcal infections and anti-basal ganglia antibodies in a 
cohort of children and adolescents with Tourette syndrome and 
compare them with a group of healthy control children from 
similar sociodemographic backgrounds. Neither group had been 
previously documented. 
MATERIALS AND METHODS 
Etlrical pernLission for the bwdy was given by the University of Catania 
Hospital Ethics Conrmittee. The parents of each child gave written 
informed consent. Sixty-nine consecutive outpatients with Tourette 
syndrome attending a .referrnJ-based clinic in OUT department (64 boys, 
5 girls; age range 7-15 years) participated in the study. Seventy-two 
healthy control subjects also participated. The patients were interviewed 
by OIle of us (R.R.), who used the following standardized instruments 
after training with another (M.M.R.): The National Hospitsl Interview 
Scbedule20 and the Yale Global Tic Severity ScaIeM All patients fulfi1]ed 
the diagnostic criteria for Tourette syndrome (defined bY the Tourette 
Syndrome Classification Study Groupi and the Diagrwsti.c and
' 
Sta.tistica! Mamlfll ofMenllJI DiSOTderS. Fourth Bditi.oTt, T=t Revisiun 
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(DSM-JV-TR).' Comorbid diagnosis of obsessive-compulsive disorder and 
ADHD was made according to the DSM-JV-TR criteria. Obsessive­
compulsive disorder was also diagnosed using the National Hospital 
Interview Scbedule,29 as well ~ the child version of the Yale-Brown 
Obsessive Compulsive ScaIe.82 
Subject Selection 
No subject had a histoI)' of meumatic fever, Sydenham chorea, or known 
autoinunune disease. All patients with Tourette syndrome had nonnal 
neurologic examinations, normal cognitive flIDct:ioning, and no. evidence 
of psychosis. Patients were not selected as to whether they had had a 
clinical course consistent with infection-triggered eJ<.aCerbations. Patients 
bad not suffered an upper respiratoI)' infection for at least a month prior 
to tlle study. Patients were medication free for at least 2 weeks prior to 
the study, which was IIDdertaken in autumn and winter. 
The tic-free control group consisted of 72 children (65 boys, 7 girls; 
age range 7-15 years) recruited from the same hospital clinics (with 
similar sociodemographic characteristics), including 34 neurologic 
patients (n = 19 patients with epilepsy; n 15 patients with mental 
retardation [learning disability]) and sa nonnaI healthy controls, that is, 
youngsters presenting for minor ailments to the walk-in clinic who 
received no relevant or m&ior medical or neuropsychiatric diagnosis, 
such as psychosis. No throat or streptococcal infections were documen­
ted in the control subjects for at least 1 month before the study. 
Laboratory Investigations 
Blood was obtained from subjects and controls and was analyzed by 
personnel blind to their diagnostic status. Statistical comparisons were 
not perfonned Imtil al1 of the investigations had been completed. Owing 
to the high incidence of both false-positive throat cultures in subjects 
who are not acutely infected and false-negative findings in subjects 
acutely infected with streptococcus,33 throat cultures were not obtained. 
Recent group A fl-hemolytic streptococcal infections were defined 
using antistreptolysin 0 titers. Indirect inununofluorescence34 revcaled 
antibody binding to anti-basal ganglia antibodies. Anti-basal ganglia 
antibodies were determined using human basal ganglia sections accord­
ing to Husby et al and scored using the criteria described therein?7 An 
antistreptolysin titer cutoff limit of > 400 lUlL was used in our study.as 
Statistical Analysis 
Statistical analysis was performed as follows: sex distribution was 
analyzed U&ing the chi-square test and analysis ofvariance to compare the 
age differences between the clinical group and the control group. To 
compare the antistreptolysin titers between patients with Tourette 
syndrome and the healthy cOfltrol grouP. different distributions of 
increased values between the groups were analyzed using chi-square, 
as weD as for comparisons between patients with Tourette syndrome and 
the control group positive for anti-basal ganglia antibodies. The PRIMER 
Statistical Package for Biomedical &iences was employed.36 [±] 
RESULTS 
There were 69 patients with Tourette syndrome (64 male) and 72 
healthy controls (65 male) (not significantly different; P = .822). 
The mean age of the patients was 9.36 years (SD 3.18 years) and 
that of the normal controls was 8.75 years (SD 2.75 years) (not 
significantly different; P .225). The mean age at onset of tics 
was 6.6 years (range 2-15 years), and 65% had a positive family 
history of tics. The mean severity score of the tic symptolllS, 
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measured using the Yale Global Tic Severity Scale, was 26.3% 
(range 0-79%). Eleven patients reported that their symptoms 
were worse with fever; the symptoms of 27 patients (37%) 
improved during sununer months. 
In 23 of 69 (33%) children with Tourette syndrome, a 
comorbid diagnosis of ADHD was made. Obsessive-compulsive 
disorder was diagnosed in 10 of 69 (14%) patients with,Tourette 
syndrome. 
Raised antistreptolysin titers (> 400 nJlmL) were found in 
41 of 69 (59%) children with Tourette syndrome but in only 14 of 
72 (19%) subjects in the control group (significant; P = .000). 
Positive anti-basal ganglia antibodies were found in 22 of 69 
(32%) children with Tourette syndrome compared with 7 of 72 
(10%) subjects in the control group (significant;P = .002). Raised 
antistreptolysin titers were detected in 18 of 22 (82%) patients 
with positive anti-basal ganglia antibodies and 22 of 47 (47%) of 
those with negative anti-basal ganglia antibodies (significant; 
P .01). 
DISCUSSION 
The mean age at onset ofgymptoms in our patients was 6.6 years, 
and there was a male predominance, consistent with published 
data.3,20 
As mentioned, the etiology of Tourette syndrome is 
complex, with genetics and pre- and perinatal theories invoked 
but no conclusive evidence being documented. New evidence 
was thus sought, and the role of infections and neuroimmuno­
logic factors in the etiopathogenesis of Tourette syndrome was 
proposed.21,37 
Swedo and colleagues were the fITSt to describe PANDAS in 
a group of 50 patients.21 They proposed specific diagnostic 
criteria: (1) the presence of obsessive-compulsive disorder andl 
or tic disorder; (2) pediatric onset (symptoms evident between 3 
years and puberty; (3) episodic course of symptom severity and 
clinical course characterized by an abrupt onset or dramatic 
exacerbation of symptoms; (4) gymptoms bearing a temporal 
relationship to group A I>-hemolytic streptococcal infection; and 
(5) an association of neurologic abnonnalities, for example, 
motor hyperactivity and "adventitious" movements. Kurian 
discussed the suggestion that tic disorders and associated 
behavioral disturbances (eg, obsessive-compulsive disorder) 
might develop following streptococcal infections by the process 
of molecular mimicry, whereby antibodies are directed against 
bacterial antigens cross-reacting with brain targets.38 
Dale et al proposed that neuronal membrane glycolytic 
enzymes might be putative autoantigens in post-streptococcal 
neuropsychiatric disease, demonstrating that autoantibodies can 
affect neuronal metabolism.39 They noted that these enzymes 
exist on streptococcal surfaces, sharing about 25%. to 50% 
homology with human glycolytic enzymes, therefore represent­
ing a theoretic model of molecular mimicry.39 
Our results give further support to a role for group A I>­
hemolytic streptococcal infections in a subgroup of patients with 
Tourette syndrome. The diagnoses of Tourette syndrome were 
made by an expert, using standardized assessment procedures 
and internationally accepted diagnostic criteria.1 
However, it is important to note that the validity of PANDAS 
and the relationships between tic disorders, Tourette syndrome, 
Journal of Child Neurology JCN_2006_00178.3d 216/06 17:56:41 
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andlor obsessive-compulsive disorders and group A fl-hemolytic 
streptococcal infections have become controversiaL Thus, 
some scientific groups have reported results broadly in favor 
of the neuroimmunologic hypothesis, showing that in some 
patients with Tourette syndrome, there is evidence of group A 
~-hemolytic streptococcal infections andlor some patients 
with Tourette syndrome have increased anti-basal ganglia 
antibodies in case reports,4() cohort studies,4l and controlled 
studies.33,34.41-45 
Peterson et al documented antistreptolysin titers and basal 
ganglia volumes in 105 individuals (7-55 years) with DSM-W 
chronic tic disorder and obsessive-compulsive disorder and 
compared them with 37 age-, sex- and socioeconomic status­
matched controls.46 A DSM-W diagnosis of ADHD was ass0­
ciated significantly with titers of two distinct antistreptococcal 
antibodies: antistreptolysin 0 and antideoxyribonuclease B, 
which was significant after controlling for the effects of chronic 
tic disorder and obsessive-compulsive disorder. No significant 
association was seen between antibody titers and a diagnosis of 
chronic tic disorder or obsessive-compulsive disorder. They 
suggested that previous reports of an association between 
antistreptococcal antibodies and chronic tic disorder and 
obsessive-compulsive disorder might have been confounded by 
the presence of ADHD. 
Thus, in studies to date, 522 patients previously reported 
(Tourette syndrome 242; tics 150; tics or obsessive 
compulsive disorder 25; tics, obsessive-compulsive disorder, 
and ADHD = 105) and our 69 patients with Tourette syndrome 
(591 patients from six independent groups in eight studies) have 
all shown evidence of streptococcal infections in patients with 
Tourette syndrome, tics, obsessive-compulsive disorder, and 
ADHD (Table 2). It is acknowledged that the cutoff points used lID 
in studies have varied41.43.44,46; nevertheless, the results obtained 
are reasonably consistent. 
In our study. 23 of 69 (33%) subjects had ADHD and 10 of 69 
(14%) subjects had obsessive-compulsive disorder. As these 
numbers were too small for meaningful analysis of subgroups 
within the patients, we undertook no further analysis. Whereas 
some studies reported fewer streptococcal infections in patients 
with tics and/or Tourette syndrome and obsessive-compulsive 
disorder compared with those with ADHD,41,46 others found no 
relationship between streptococcal infections and these comor­
bidities.33,34,45 Other centers failed to compare the Tourette 
syndrome-alone group with those with comorbid disorders.43,44 
The simultaneous obtaining of throat cultures is possibly 
desirable, although some studies suggest that this is not S033; 
Table 1. Comparison BStwe&n Antt-8asal Ganglia 
. Antibody-Positive and Anti-Basal Ganglia 
Antibody-Negative Patients With Tour&tte 
Syndrome and the Control Group 
Antineural Absence of 
Antibody Antineural 
Positivity Antibodies Total 
Tourette syndrome 22 (31.88) 47 69 (100) 
patients. n (%) 
Control group, n (%) 7 (9.72) 65 72 (100) 
Pvalue .002 151 
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Table 2. Studies Reporting Neuroimmunologic 

Influences in Neuropsychiatric Disorders. 

Excluding PANDAS 

Number of Patients' 
Study Year Patients Diagnoses 
Peterson et al46 2000 105 Tic, obsessive-
compulsive 
disorder, 
attention-deficit 
hyperactivity 
disorder {ADHD} 
Muller et al43 2000 36 Tourette 
syndrome 
Muller et al33 2001 25 Tourette 
syndrome 
Cardona and 2001 150 Tics 
Orefici 44 
Morshed et al45 2001 SO Tourette 
syndrome 
Church et al34 2003 100 Tourette 
syndrome 
Murphy at al41 2004 25 Tics, obsessive­
compulsive 
disorder 
Rizzo et al 2004 69 Tourette 
(present stud y) syndrome 
Total 591 
PANDAS pediatric autoimmune neuropsychiatric disorders associated with 
streptococcal infections. 
therefore, we did not obtain them. This was also not undertaken 
in several investigations.34,46 
There are, however, conflicting results as to the association 
between group A ~-hemolytic streptococcal infections and 
Tourette syndrome. Data from two other groups including 
reviewing medical records47 and controlled studies48•49 failed 
to show any significant relationship between group A fl­
hemolytic streptococcal infections and/or the presence of anti­
basal ganglia antibodies in patients with Tourette syndrome. As 
in two of the studies, tile numbers are identical and originate 
from the sante laboratory; it is unclear as to whether the 41 
children in the two studies are the sante or independent cohorts. 
More recently, the sante group failed to demonstrate anti-basal 
ganglia antibodies in 15 children with PANDAS when comparing 
them with 15 controls,50 Furthermore, the opinions of others in 
editorials and/or commentaries do not support the relationship 
between group A J3-hemolytic streptococcal infections and/or 
neuronal anti-basal ganglia antibodies or the PANDAS/autoim­
mune hypothesis.51,52 
Moreover, even within laboratories, somewhat differing 
results have been documented. Thus, Singer et al studied 41 
children with Tourette syndrome and 39 controls and reported 
tllat the patients had significantly higher serum levels of 
antineuronal antibodies against the putamen but not the caudate 
or globus paUidus; nevertheless, they concluded tllat their results 
were not in support of the hypothesis and suggested tllat a 
relationship between tile antineuronal antibodies, clinical char­
acteristics, and markers for streptococcal infections remained 
equivocal.fi..1 Further, Singer et al reported tllat 11% of children 
with tic disorders described abrupt changes in tic behavior soon 
after streptococcal infections.54 Similarly. Wendlandt et al 
studied antineuronal antibodies from 20 children witil Tourette 
syndrome and 21 controls using Western blot techniques.55 There 
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were significant differences between patients' and controls' 
blots, and tllese were identified using striatal epitopes. This was 
in contrast to similar patterns found in the groups for the globus 
pallidus, muscle, and HTB-I0 tissue. Thus, these results appear, 
in our opinion, to support striatal autoimmune involvement in 
Tourette syndrome patilophysiology5-5 in some patients and tllus 
are broadly in agreement with tlle hypothesis suggesting a 
relationship between group A J3-hemolytic streptococcal infec­
tions and an autoimmune factor, altilOUgh, as mentioned, three 
earlier documentations from the Singer et al group are not in lID 
favor of and/or do not support the hypothesis. Thus, the five 
studies that do not support the role of group A [l-hemolytic 
streptococcal infections in various relevant patients include four 
from Singer et al's group (three cohorts of 41 patients and tlle 
Wendlandt et al study including 20 patients~ and one other 
study (Betancourt et al47), documenting 38 patients, but some of 
these appear to be inconsistent. 
What are the possible reasons for tlle differing results? 
These might be explained by at least four differences in 
laboratory techniques.56 Pavone et al documented significant 
differences in antibrain antibodies in 22 patients who met the 
strict criteria for PANDAS (mean age 10.1 years) when compared 
with 22 patients (mean age 9.1 years) with clinical evidence of 
active group A ~-hemolytic streptococcal infection, confirmed by 
throat culture and elevated antistreptolysin titers, but without a 
history or clinical evidence of tics or obsessive-compulsive 
disorder.57 These r sults suggest that antibrain antibodies that 
are present in children with PANDAS cannot be explained 
merely by a history of group A J3-hemolytic streptococcal 
infection. 
Further, most studies have not commented on tlle pre­
valence of group A streptococcal carrier status in the commu­
nities or countries where the studies were undertaken34,43-45 or 
taken into account geographic or seasonal variations. For 
example, in tlle Morshed et al study, patients witil Tourette 
syndrome were recrnited from the United States, SC patients IlJ 
from Brazil, tllose with autoimmune disorders from Japan, and 
controls from the United States.45 Some studies have included 
season as a covariate and found no significant effect, 46 whereas 
otllers did not mention the season of study.34,42-44 
In this context, studies on group A streptococcus could 
shed light on tilese difficulties. In an urban longitudinal study of 
between 48 and 100 children, 5658 throat cultures were 
performed and 878 (15.5%) were positive for group A strepto­
coccus.58 Kaplan et al documented tllat between 29% and 45% of 
500 chilruen in a semi closed community had group A strepto­
coccus yielded on throat cultures; seasonal variations were 
reported.59 In anotller study, botil geographic and seasonal 
variations in group A streptococcus were demonstrated.60 In 
Italy, in 1982, D'Arca et al investigated 1535 primary school 
children in Rome over 2 years, demonstrating that group A 
streptococcal carrier status was between 11.7% and 19.6%.61 A 
recent study in Italy documented that 620 of 321,612 hospitalized 
children (0.19%) had severe streptococcal diseases.62 It is 
acknowledged that tlle former figures are old and tlle latter are 
of hospitalized children. Nevertheless, they give some indication 
that the true prevalence of group A streptococcal carrier states 
and infections was not known in Italy at the time of our study. 
No otller PANDAS studies to date have given prevalence rates of 
Un
ive
rsi
ty 
of 
Ca
pe
 T
ow
n
5 Anti··Basal Ganglia Antibodies and Antistreptococcal Antibody Titers in Tourette Syndrome I Rizzo el a./ 
group A streptococcal carrier states in the geographic area of the 
study at the time of the investigations, which might have a 
bearing on conflicting results. 
Thus, the PANDAS hypothesis or t.he role of the group A f:\­
hemolytic streptococcal hypothesis in patients with Tourette 
syndrome and tics is far from simple, and further controlled and 
longitudinal studies witl:J larger numbers of patients supporting 
or refuting the hypothesis are important to examine more 
precisely the role of group A ~hemolytic streptococcal infections 
in neuropsychiatric disorders. Studies as to the precise epide­
miology of group A streptococcal carrier status would also be 
helpful in understanding the hypothesis and published results. 
Possible limitations to our studY include the following: (1) 
our nonselection of patients who had a Tourette syndrome 
course consistent with infection-triggered exacerbations, (2) 
blood was taken without relevance to onset or exacerbation of 
neuropsychiatric symptoms, (3) we employed no throat cultures, 
and (4) we did not analyze the different diagnostic groups 
(ADHD, obsessive-£ompulsive disorder) because we felt that 
with the small numbers (obsessive-£ompulsive disorder = 10), it 
would be inappropriate. Nevertheless, our data add to the further 
understanding of the relationship between group A ~-hemoJytic 
streptococcal infections and Tourette syndrome. 
CONCLUSIONS 
In conclusion, our results on 69 patients with Tourette syndrome 
are in broad agreement with the majority of laboratories (using 
522 patients), suggesting a relationship between a group A f:\­
hemolytic streptococcal infection and some patients with 
Tourette syndrome. We have also documented that some 
patients with Tourette syndrome have anti-basal ganglia anti­
bodies. We do not suggest that group A f:\-hemolytic streptococ­
cal infections cause Tourette syndrome. It is conceivable that an 
individual inherits susceptibility to Tourette syndrome and also 
to the way that the individual reacts to group A ~-hemolytic 
streptococcal infections_ To our knowledge, many genetic 
studies, as well as prospective studies evaluating the role of 
environmental factors (pre- and perinatal) in the etiopathology of 
Tourette syndrome, are under way to explore further the 
etiopathogenesis of Tourette syndrome. Only when the results 
of these studies, as well as further studies investigating the role 
of streptococcal infections and indeed PANDAS, are available 
will the actual role of group A ~-hemolytic streptococcal 
infections in the etiopathology of Tourette syndrome be clarified 
further. 
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D2 be or not to be? 
Neuroimaging of monozygotic twins with Tourette syndrome suggests that increased 
binding by dopamine D2 receptors contributes to the disease phenotype. 
Tourette syndrome (TS), a chronic tic dis­
order, has been known for more than 150 
years. Although it remains under­
recognized, literature on TS has mush­
roomed as scientists continue to explore 
the plethora of symptoms and their 
underlying pathophysiology. Mainly on 
the basis of empirical evidence, it has 
been postulated that altered dopamine 
function contributes to the Tourette phe­
notype. Dopamine antagonists have ben­
eficial effects whereas dopamimetic 
agents exacerbate symptoms; dopamine 
metabolites in cerebrospinal fluid are de­
creased in some TS patients' . However, 
there is little hard evidence supporting 
the involvement of dopamine and func­
tional neuroimaging (FNJ) studies have so 
far been unable to resolve the debate. [n a 
recent issue of Science, Wolf and col­
leagues' have made a timely contribution 
to understanding the etiology of TS by 
combining genetiC, neuroimaging and 
neurobiochemical approaches to the 
study of five sets of monozygotic (Ml) 
twins, concordant for TS but discordant 
for symptom severity. 
TS, characterized by multiple motor 
and one or more vocal tics, is genetically 
determined, although the precise inheri­
tance pattern is unknown . Studies have 
suggested autosomal dominance, but 
more than 80 percent of the genome (in­
cluding loci for dopamine D1 and D2 re­
sceptors) has so far been excluded3­
Prenatal environmental factors such as 
lower birth weight have also been in­
voked as determinants of phenotype6 TS 
prevalence is 0.5 per 1000 live births, and 
it occurs three to four times more often in 
males than females. Symptoms, including 
coprophenomena (inappropriate invol­
untary swearing), echophenomena (copy­
ing behaviors) and palilalia (repeating 
oneself), are heterogeneous. Many tics are 
clearly involuntary, and TS patients with 
mild disorder are often unaware that they 
are "ticcing." Some patients with pre­
monitory sensatiOns, "have to" perform 
tics to relieve local physical tensions (pre­
viously likened to a sneeze). Yet other TS 
subjects perform tics such as forced 
touching in a compulsive way, and with 
this group, the boundary with compul­
sive behavior is indistinct. [t is generally 
recognized that chronic multiple tic dis-
MARY M. ROBERTSON 
order and obsessive-compulsive behav­
iors are part of TS and probably both phe­
notypes of the putative TS gene(s). A 
disease as curious as "full-blown" TS will 
always find important individuals with 
the disorder to give it credibility and raise 
Time-averaged SPECT images of IBlM 
binding in a single Tourette p tient (top 
row). Regions of interest (red) created on 
the MRI scans (bottom row) for the caudate 
nucleus (left), putamen (middle) and 
cerebellum (right), are shown transposed 
(white) onto the SPECT images. 
(Reprinted with permission from ref. 2. 
©1996 American Association for the 
Advancement of Science.) 
awareness of it. In this context, Samuel 
Johnson (correctly) and Mozart (in my 
opinion, incorrectly) have both been sug­
gested to have suffered from TS. 
In their study, Wolf and co-workers 
used Single-photon emission computed 
tomography (SPEeT) combined with 
magnetiC resonance imaging (MRJ) to 
measure binding of the radioligand 
iodobenzamide (IBlM), a potent dopa­
mine D2 receptor antagonist, in the stri­
atal dopaminergic pathway. Their 
technique measures, inter alia, the avail­
ability of D2 receptors in different regions 
of the striatum. lBlM binding in the cau­
date nucleus (eN) was significantly 
greater (1 7%) in all five of the more af­
fected twins. Ml twin intra pair differ­
ences in D2 receptor binding in the eN 
correlated significantly with clinical 
severity ratings; in contrast, no signifi­
cant differences in binding were found 
for the putamen (the region adjacent to 
the eN). The authors also analyzed all 
subjects with brain perfusion SPEeT and 
found no significant intrapair differences, 
demonstrating that their findings were 
not attributable to regional cerebral blood 
tlow effects. They postulate that their re­
sults support the notion that D2 receptor 
"supersensitivity" explains the pheno­
typic variations observed in TS patients. 
Although the basis for increased D2 re­
ceptor binding is unclear, they speculate 
that it might reflect "increased receptor 
density, receptor-ligand affinity, e.ndoge­
nous dopamine concentratiOns, or any 
combination of these." 
This group is not the first to study the 
D2 receptor or the striatal pathway in TS 
subjects; many others have done so, but 
with conflicting results. Although studies 
have demonstrated hypoperfusion of the 
left eN and cingulate, as well as the left 
medial temporal region, to be related to 
tic severity, perfusion patterns were not 
characteristic of any behavioral sub­
groups' . Some"" but not others'o have 
found increases in presynaptic dopamine 
transporters in TS patients. The same in­
consistency is apparent at the level of the 
D2 receptor, with some groupS'O.1I show­
ing no difference from controls and the 
Wolf study' demonstrating intrapair dif­
ferences among Ml twins. The latter 
finding seems to complement post­
mortem studies showing significantly 
greater radioligand binding by striatal 
presynaptic D2 receptors in three TS 
cases"; neuronal dopamine uptake car­
rier sites were significantly increased in 
number over control values by 37 per­
cent in the eN and 50 percent in the 
putamen. Levels of dopamine and its pri­
mary metabolites were normal and only 
slight alterations in D1 and D2 receptor 
binding were observed", probably due to 
medication. 
Many clinical scientists view FNI as a 
computing "black box, " the science of 
which may be hard to validate. In this 
context, there are problems with the 
Wolf et al. study. The TS patients were 
heterogeneous regarding medication; 
ideally, the patients should have been 
neuroleptic-naive. As it is, five were 
neuroleptic-naive, three were drug-free 
for three or more years, and two were re­
ceiving neuroleptics just six weeks be-
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fore the study. Effects of acute neurolep­
tic treatment on the dopaminergic 
presynaptic projections are well estab­
lished, but the effects of chronic treat­
ment are uncertain'o. Because individual 
CN binding values varied substantially 
between more and less affected pairs, it 
would have been informative to know 
the relation, if any, between binding val­
ues and medication status. If medication 
status could affect the 02 receptor bind­
ing data, then the entire result might be 
explained on the basis of the medication 
history rather than symptom severity. In 
addition, IBZM binding is age-related in 
normal controls'3, yet only two pairs 
were matched for age (31 years); the 
other three pairs were in three different 
decades. However, the intra pair 02 re­
ceptor binding differences and their cor­
relation to symptom severity answer this 
question to some extent. Surprisingly, 
no mention is made in the article of the 
volumes of the CN or the putamen. 
Several studies using volumetric MRI 
show abnormalities in CN size among 
Tourette patients" and also between MZ 
twins with TS (ref. 15). Neither is refer­
ence made to possible differences be­
tween right and left hemispheres. These 
last two concerns are all the more sur­
prising as the same group has previously 
shown that, in a similar cohort of twins 
(concordant for TS, discordant for sever­
ity), right CN volume was slightly but 
significantly reduced in more severely af­
fected tWins". Inclusion of age- and sex­
matched healthy controls in the Wolf 
study would have helped to put previous 
conflicting results into context, which is 
always important given the small num­
bers of patients studied and the clinical 
heterogeneity of the condition. 
What then distinguishes the investiga­
tion by Wolf and colleagues? They must 
be congratulated on their deSign, using 
MZ twins (who share identical genetic 
material and an almost identical pre- and 
perinatal environment) and using three 
independent neuroimaging techniques, 
making this twin cohort study unique. It 
is also noteworthy that the male:female 
ratio in the study is similar to that en­
countered in the general population. 
Future investigations should also include 
FNI analyses of unaffected twins together 
with normal controls. If the findings of 
Wolf et al. can be replicated, then they 
will have important implications beyond 
TS. This studyZ and that of Hyde et al." 
(although pOSSibly using some of the 
same twin pairs) highlight the brain's 
structural and functional plastidty in re­
sponse to environmental influences, 
which results in different clinical presen­
tations (phenotypes). 
The findings of the Wolf study pose 
many questions. If biological differences 
accompany variation in symptom sever­
ity, then is there any hope of accurately 
studying other phenotypes when many 
arise at different times in the course of 
the disorder and some may be more diffi­
cult to measure than severity? Are the 
observed differences in 02 receptor bind­
ing a result of a bystander phenomenon 
or or do they tell us something about the 
primary lesion? How will the Wolf data 
compare with previous conflicting norm­
referenced studies7.!1? In addition, one 
should not forget the role of other neuro­
transmitters in the dopaminergic striatal 
circuits implicated in TS - what role 
might, for example, serotonin or 
y-aminobutyric acid play? 
Kinnear Wilson dubbed the compo­
nents of the basal ganglia (a region that 
includes the CN and putamen) "those 
dark basements of the brain." FNI ap­
pears to be casting light on the physiol­
ogy and pathology of certain of these 
dark basements. If indeed the compo­
nents of the basal ganglia do constitute 
"the orchestra of movement disorders," 
is CN the conductor of Gilles de la 
Tourette's neuropsychiatric symphony? 
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Estrogen and bone: 

New pieces to the puzzle 

Recent studies on osteoclast apoptosis and TGF-13 gene regulation 
provide new insights into the mechanisms by which estrogens and 
their analogues inhibit bone resorption (pages 1132-1136). 
.................................................. preparations"', which sug­
Although it has long been 
known that estrogen with­ LAWRENCE G. RAISZ gests that estrogens act in­
drawal stimulates osteo­
clasts to resorb bone resulting in bone 
loss and that estrogen replacement halts 
bone resorption, the mechanisms medi­
ating these effects remain an enigma. It 
has been difficult to demonstrate inhibi­
tion of bone resorption in bone organ 
culture systems or in isolated osteoclast 
directly either on osteoclast 
precursors or on cells of the osteoblast 
lineage that are necessary for osteoclast 
activation. Estrogen may exert its indi­
rect effects by altering the production of 
local regulatory cytokines possibly in the 
bone marrow where osteoclast and os­
teoblast precursors reside. Factors se-
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M. Hall, D.C. Costa, 1. Shields, J. Heavens, M. Robenson and PJ. 
Ell. Institute of Nuclear Medicine, UCMSM, London, UK. 
BRAIN PERFUSION PATIERNS wrrn Tc-99m-HMPAOISPET 
IN PATIENTS wrrn GILLES de la TOURETTE SYNDROME. 
Gilles de la Tourette Syndrome (GTS) has an estimated prevalence 
of 0.5 per thousand giving figures of 110,000 patients in the USA 
and 27,500 in the UK. The biochemical aetiology is unknown but it . 
has been suggested that the basal ganglia are implicated in the 
pathophysiology of GTS. CT scanning shows no consistent 
sauctural abnormality. 
We studied 25 GTS patients with high resolution gamma camera 
HMPAO/SPET, paying particular attention to the perfusion of the 
basal ganglia. All patients had a wide range of mOlor and vocal 
"tics", and ages from 7 to 48 years. 6 were female. A bank of 10 
normal HMP AOISPET studies were used as control. 
HMPAOISPET was carried out with the IGE 400ACjST ARCAM 
.system using routine protocols for acquisition, reconstruction and 
analysis of the data. 10 MBq/kg (patient weight) of HMPAO was 
injected (Lv.) after a full explanation of the procedure and written 
consent signed. This study was approved by the local ethical 
committee. 
Qualitative analyisis of transverse and coronal slices revealed, for 
all patients, a significant decrease in the tracer concentration in the 
basal ganglia nd thalami. There were perfusion deficits identifiable in 
the cortex of the frontal and panicularly the temporal lobes. 
Semi-quantitative analysis with normalisation for the cerebellum 
confinncd these findings. 
Conclusion: for the first time perfusion deficits are shown with 
high resolution gamma camera HMPAOISPET in the basal gaglia of 
patients with GTS, which may help to explain the extrapyramidal 
motor and vocal abnormalities found in these patients. 
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HALL M, COSTA DC, SHIELDS J, HEAVENS J, ROBERTSON M, ELL P (1990) Brain perfusion patterns 
with 99 Tc HMPAO/SPET in patients with Gilles de la Tourette syndrome Nuclear Medicine Suppl 27, 
243-245 . . 
"BRAIN PERFUSION PATTERNS WITH 99TcID .HMPAOJSPET IN 

PATIENTS WITH GILLES de la TOURETTE SYNDROME· SHORT 

REPORT" 

M. Hall; D.C. Costa, J. Shields, J. Heavens, M. Robertson, PJ. Ell. 
UCMSM. London. UK. 
hItroduction _ In 1885 George Albert Brutus Gilles de la Tourette 
described a syndrome consisting of involuntary vocalisations, namely 
coprolalia, echolalia, echopraxia and a ·variety of complicated movements. 
These clinical characteristics seem to be independent of culture, as they 
occur with some uniformity, irrespective of the country of origin. The age 
of onset ranges from 2 to 15 years, with no sex predominance. 
The prevalence of Gilles de la Tourette syndrome (GTS) is 0.5 per 

thousand of population with an estimated total number of J 10,000 

patients in the U.S.A. and approximately 27,500 in the U.K. 

Genetic inheritance has been reported by Robertson, 1989. However, 

the etiology is unknown and there has been no consistent pathologic 

findings to explain symptoms and signs characteristic of this syndrome. 

Although basal ganglia and brain cortex pathology has been suggested, CT 

scan showed no consistent structural abnormalities, Robertson, 1989. 

This study was designed to investigate the perfusion patterns of the 
brain in patients with GTS, paying particular attention to the brain cortex 
and deep grey matter nuclei (basal ganglia and thalamus). 
Patients . 25 GTS patients with an age range from 7 10 48 years were 
studied. 19 were male and 6 female. All patients presented with a wide 
range of motor and vocal tics' characteristic of the disease. 60% of the 
patients had 'a family history of tics, and 40% family history of obsessive 
compulsive disorder (OCD). OCD was present in 60% of the GTS patients, 
whilst attention deficit disorder (ADD) was present in 50% of them. 
Echophenomena (echolalia and echopraxia) was found in 56% of the to!;] I 
number of patients. 48% had coprolalia and copropraxia, 
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A small percentage « 10%) of GTS patients were on treatment at time 
of SPET studies. All of these had obsessive compulsive disorder and 2 of 
them attention deficil disorder with hyperactivity. 
Materials and Methods 10 MBq per kg of patient weight (average 
adult dose = 740 MBq) was injected intravenously within 10 minutes of 
preparation. Patients were usually siuing in a comfortable position with 
the eyes open in a normal light room during the injection. For the 
majority of the cases (more than 90%) there were several involuntary 
movements before, during and immediately after the injection, that were 
reduced by the time patients were lying on the gamma camera couch. 
Single photon emission tomography (SPET) was started 15 minutes pj. or 
longer, according to the time taken by each GTS patient to feel 
comfortable and relatively still. ' 
The IGE 400 AC/STARCAM was used to carry out SPET following 
routine acquisition and processing protocols as previously described by 
our group, Costa et aI., 1988. Three patients with very severe and 
frequent involuntary head movements underwent short time acquisition 
(5 and/or 10 minutes total acquisition) SPET performed with the IGE 
NEUROCAM, a three detector gamma camera under evaluation at our 
Institute, Townsend, 1990. One young (12 year old 'male) patient was 
studied with the IGE 400 AC/STARCAM and the SME 810. 
Results - Qualitative analysis of transverse (parallel 10 the orbito meatal 
- OM line), coronal and sagittal sections of the brain demonstrated a 
wide range of perfusion deficits in the cortex of frontal, parietal and 
temporal lobes. The visual cortex always showed a normal perfusion 
pattern. There were no changes in the tracer distribution in the 
cerebellar hemispheres. The cortical perfusion deficits were nOI 
suggestive of cerebral vascular disease, as they were nol wedge shaped, 
Lateral ventricules were seldomly enlarged, 
Patients with more severe disease (intensity and frequency of 
involuntary movements) showed marked reduction in the perfusion to 
the frontal and posterior parietal lobes (fig. I), irrespective of the type of 
tics. 
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There were, however, consistent abnormalities found in the mesial 
cortex of the temporal lobes (perfusion deficits), as well as in the basal 
larly the heads of the caudate nuclei. These abnormalities 
were observed as either symmetric or more uently asymmetric 
deficits in perfusion. 
Fig. 1: Transverse slice at the level of 
OM line + 30 mm from the SPET siudy 
of a II year old GTS patient with 
family history of tics and OCD. He 
with echolalia and no 
ADD. He had been on treatment with 
no success and was studied under no 
medication. This transverse section 
demonstrates severe bilateral 
impairment of the perfusion to the 
cortex of frontal and lobes. [n addi tion, there is marked 
reduction of the perfusion In the heads of the caudate nuclei, particularly 
on the left 
Conclusion· This study demonstrates that h resolution gamma 
camera SPET studies ide deficits in the cortex of fron 
posterior parietal and temporal lobes in patients with Gilles de la 
Touretle syndrome. 
For the first time we have shown perfusion deficits (symmetrical or 
asymmetrical) in the basal gangl particularly the heads of the caudate 
nuclei, linked to thiS particular disease (GTS). 
These perfusion may explain the and vocal 
Jbnorrnalities found in patients with Gilles de la Touretle syndrome. 
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Introduction 
Patients with Gilles de la Tourette Syndrome (GTS) are afflicted by a movement disorder 
characterised by involuntary motor tics, vocalisations and, in some patients, coprolalia, 
copropraxia, echolalia and echopraxia 1. This wide variety of motor and vocal tics may change 
over time either in frequency, complexity, severity or anatomical localisation. The onset is 
usually before the adult life 2. Some kinds of obsessional disorders also seem to be an integral 
part of GTS. 
With an unknown exact prevalence, GTS has been found worlwide irrespective of culture, 
racial groups or social classes. It is accepted that 0.5 per thousand of population suffer from 
GTS, with an estimated total number of 110,000 patients in the U.S.A. and approximately 
27,500 in the U.K. 2. GTS is more frequently found in males than in females with a sex ratio 
of 4: 1. . 
The exact etiology of GTS is unknown. However, it is now generally accepted as a 
biological rather than a psychodynamic disorder. Several putative neurotransmitter 
abnormalitiOll have already been reported 3,4. Of them, dopamine has been most frequently 
associated with the disease due to the symptomatic improvement of GTS patients when treated 
with dopamine D2 receptor blocking agents (e.g. haloperidol and sulpiride). On the contrary, 
dopaminergic stimulants (e.g. pemoline, methylphenidate) worsen all the symptoms and 
particularly GTS patients' behaviour. 
The dopamine hypothesis to explain GTS etiology suggests either an abnormal 
concentration of dopamine released from the dopaminergic neurons or a super-sentivity of the 
dopamine receptors to this neurotransmitter 4. 
Objective of the study 
We decided to use the new dopamine D2 receptor ligand 123I-iodobenzamide (123I-IBZM) 
and single slice dynamic single photon emission tomography (Dynamic SPET) S to investigate 
possible changes in the availability of dopamine D2 receptors in the brain of patients with GTS, 
in comparison with a group of control subjects. 
Patient population 
This study had the approval of the Ethics Committees of all hospitals involved and 
ARSAC. 
Each individual gave infonned written consent before participating on the study. All GTS 
patients were recruited from the Gilles de la Tourene Syndrome clinic at the National Hospitals 
for Neurology and Neurosurgery, and clinically evaluated by a neuropsychiatrist (MMR) who 
has previously reported 6 on the patterns of referral and demographic distribution of GTS 
patients. 
Diagnosis of GTS was established according to the DSM mR criteria. 
The control subjects were recruited from hospital staff at the Institute of Psychiatry and 
clinically assessed by one of the authors (LP). 
15 GTS patients were studied and subdivided into 2 groups (Table 1). 
The control group consisted of 6 nonnal volunteers (4 males and 2 females) with a mean 
age of 30 years. All subjects (controls and GTS patients) were right handed. 
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TABLE I - Clinical characteristics of unmedicated (UNMED) and medicated 
(MED) GTS patients. 
Patients with 
GiII!::S dj,! la IQU[j,!!lj,! SYDd[Qmj,! 
UNMED MED 
OCD =Obsessive 
n 8 7 Compulsive 
Mean age 23 24 Disorder 
Age range 10 - 45 12 - 38 
M/F 5/3 6/1 ADDH =Attention 
CXD 6 3 Deficit 
ADDH 0 4 Disorder 
with Hyperactivity 
Medication 4 naivcs 3 clomipramine 
4 ofT (> 90 days) + sulpiride 
2 nupenlhixol 
1 haloperidol 
1 sulpiride 
Materials and Methods 
Dynamic SPET (Fig. I) was performed following the protocol previously described 5. 
Each individual was positioned supine on the couch of the SME 810 brain tomographic 
scanner. An intravenous antecubital line was placed in the basilar vein . A basal ganglia 
transverse plane, parallel to the canto-meatal line and 30 mm above was chosen to coincide 
with the detection ~Iane of the SME 810. . 
185 MBq of I 3I-IBZM was injected through the antecubital iv line and 5 minute slices 
were acquired for as long as possible (60 - 90 minutes) according to individual cooperation. 
Drug Naive GTS Medicated GTS 
Dynamic SPET with 123I_IBZM 
Figure 1. 1231-IBZM kinetics in drug naive GTS differs significantly from medicated GTS 
patients. 
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Image processing was performed using manufacrurers' software protocols in the Macintosh 
II computer. 
Regions of interest were drawn (Fig. 2) around the basal ganglia (8G) on each 
hemisphere, using a 70% isocontour, and around the frontal cortex (FC) at the 40% isocontour 
level. 8G over FC ratios of average counts per pixel were calculated and compared between the 
three groups (UNM GTS, MEO GTS and Controls). 
ROI analysis 
Figure 2. Regions of interest were drawn around the Basal Ganglia and frontal cortex. 
Independent two-tailed srudent t test and ANOV A were used to compare the means of each 
group. Both statistical methods showed comparative statistical significance. 
Results 
As expected, medicated GTS subjects taking dopamine 02 receptor blocking drugs showed 
a marked reduction (Fig. 3) of the 123I-IBZM binding to the BG (bilaterally). 
Drug Naive GTS Medicated GTS 
123I_IBZM 60 minutes post-injection 
(single slice 3S mm above the OM line) 
Figure 3. The Basal Ganglia are well defined at 60 minutes fost-injection in Drug Naive 
GTS patients. In medicated GTS patients, the distribution of 23I-IBZM is similar to the 
distribution of a brain perfusion tacer. 
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This was significantly different from controls from 20 to 60 minutes post-injection (Table 
2) . This may reflect lower availability of dopamine D2 receptors in the BG. 
TABLE 2 - Right and left BG / FC ratios of average counts per pixel. 
Time Control UNMED MEDI! I! 
5 1.22 1.16 1.15 
i 10 1.27 1.16 1.16 20 1.37 1.23 1.22 0.032 30 1.50 1.33 0.012 1.25 0.000 40 1.56 1.42 0.082 1.30 0.006 50 1.64 1.60 1.33 0.008 
60 1.77 1.70 1.31 0.013 . 
5 1.25 1.11 1.15 
10 1.15 1.13 1.19 
20 1.30 1.23 1.21 ~ 30 1.44 1.36 1.22 0.014 40 1.49 1.43 1.24 0.00 1 50 1.57 1.54 1.29 0.016 
60 1.60 1.61 1.27 0.033 
Unmedicated GTS patients showed 123I-IBZM lower than controls from 5 to 50 minutes 
post-injection on the BG of both hemispheres (Table 2). However, only at 30 minutes on the 
left BG and 25 minutes on the right BG, the differences were statistically significant. 
A small number of patients has been investigated. Nevertheless two hypothesis may be put 
forward to explain our findings: 
1) these results may be compatible with a diminished initial distribution of 123I-IBZM to the 
BG, possibly due to perfusion abnormalities, as already reported 7; 
2) these findings may suggest a slower binding of the 1231-IBZM to the dopamine D2 
receptors in the BG due to a hyperdopaminergic state. 
The fact that by 60 minutes post-injection the 123I-IBZM binding in the BG of unmedicated 
GTS patients is similar to nonnal controls does not help the distinction between these possible 
explanations. 
These preliminary results need further investigation. Neuroimaging with specific 
neuroligands and SPET is a promising tool to investigate the pathophysiology of Gilles de la 
Tourette Syndrome. 
References: 1) Robertson MM. Br. J. Psychiat. 154: 147-169; 1989. 2) Bruun R. D. Am. Acad. 
Child Adolesc Psychiatry 23: 126-133; 1988. J) Caine ED. McBride MC. Chivenon P, el al. Neurology 38: 
472-475 : 1988. 4) Singer HS. Hahn IH, Moran TIl. Ann. Neural. 28(3): 441; 1990. 5) Costa DC. Verhoeff 
NPLG. Cullum ID. et al. Eur. J. Nucl. Med. 16: 813-816; 1990.6) Robenson MM. Trimble MR. Lees AI. 
Br. J. Psychiat. 152: 383-390: 1988. 7) Hall M, Costa DC. Shields I. et al. Nuclear Medicine Suppl. 27: 
243-245: 1991. 
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Elevated Frontal Cerebral Blood Flow in Gilles de la 
Tourette Syndrome: A 99Tcm-HMPAO SPECT Study 
Mark S. George, Michael R. Trimble, Durval C. Costa, Mary M. Robertson, 
H.A. Ring, and Peter J. Ell 
Received November 13, 1991; revised version received June 4, 1992; accepted August 2, 1992. 
Abstract. ease reports, numerous brain imaging studies, and certain disease 
states suggest that the orbital frontal cortex and the striatum are dysfunctional in 
obsessive-compulsive disorder (OeD).· Interest has also grown recently 
concerning the genetic, neuroanatomic, and clinical links between OeD, chronic 
motor tics, and Gilles de la Tourette Syndrome (GTS). To test the hypothesis of 
possible orbito-frontal/basalganglia dysfunction in GTS, similar to OeD, we 
studied 20 unmedicated GTS subjects, 10 of whom also had comorbid OeD 
(GTS/OCD), and 8 control subjects. The subjects were examined with high­
resolutioil single photon emission computed tomography (SPEeT) and the 
labeled regional cerebral blood flow (reBF) ligand technetium-99m-d,l­
hexamethyi-propylene amine oxime (99Tcm-HMPAO). As a group, GTS subjects 
showed significantly elevated right frontal/visual cortex activity (mean = 0.879, 
SD = 0.107) compared with control subjects (mean = 0.798, SD = 0.049). A 
subanalysis comparing simple GTS versus GTS with comorbid OeD failed to 
reveal significant differences in regional flow. 
Key WoiGs. Single photon emission computed tomography, tic disorder, 
obsessive-compulsive disorder, orbital frontal cortex, basal ganglia. 
Links between Gilles de la Tourette Syndrome (GTS) and obsessive-compulsive 
disorder (OeD) are intriguing and theoretically very important. Georges Gilles de la 
Tourette first noted the clinical association between OeD and GTS in his original 
paper describing the syndrome that now bears his name (Gilles de la Tourette, 1885). 
Since then, numerous clinicians have noted that GTS patients often have associated 
OC symptoms (Wasman et al., 1978; Pitman eta!., 1987; Bornstein, 1991). From 
20% to 60% of GTS patients have comorbid OeD, and their OeD symptoms are 
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frequently more than their GTS tics (Robertson et at, 1988). Pards et al. 
(1986) showed that family members of patients with either OCD or have 
the other Pauls and Leckman (1986) demonstrated OCD, chronic 
motor disorder, and are genetically linked, a common 
dominant gene with differing This has led to speculation that may 
be a useful model for understanding aspects of OCD (Cummings and Franke!, 1985). 
Baxter and colleagues (Baxter et a1., 1989, 1990; Baxter, 1990) have developed 
a model of OCD and based on positron emission tomographic 
(PET) where OCD subjects orbital-frontal and ganglia 
act lVity with control subjects. Their model holds that, on the 
neuronanatomicallocation of pathology within basal one might express 
pure OCD, OCD with tics, or To examine this theory and to determine if a 
similar 
basal 
with GTS 
blood flow pattern (rCBF) in GTS, we studied the 
and cortex metabolism in with 
OCD, control subjects. study used 
computed tomography (SPECT). 
Methods 
Subjects. The subjects were recruited from the Gilles de la Tourette Syndrome Clinic at the 
National Hospitals for Neurology and Neurosurgery, Queen Squar . The clinic's referral 
pattern and the demographic of the patient population have been previously 
described (Robertson, 1989). Approximately 1-2 new GTS patients are evaluated per week 
from throughout the United Kingdom, with a referral base> 56 million. Subjects were 
examined by at least two of the authors to ensure that the of GTS and OCD were 
correct. The subjects and were specifically asked whether they had obsessions or compulsions. 
Additional OC screening included the Yale-Brown Obsessive-Compulsive Scale and the 
Leyton Obsessional Inventory (Goodman et 1989). Control subjects were volunteer 
medical personnel screened the authors to be free of present or past psychiatric illness. The 
GTS and control groups did not significantly differ with respect to mean age (GTS subjects: 
mean:::: 23.8 years, SD = control subjects: mean age = 34.7 SD 12.5), sex 
(GTS subjects: 3 women, 17 men; control 3 women, 5 or handedness (GTS 
subjects: 18/20 right-handed; control subjects, right-handed). 
Procedure. The rCBF SPECT scans were performed a high-resolution (7-9 mm full-
width at half-maximum) triple-detector SPECT Neurocam) at the Institute of 
Nuclear Medicine (UCMSM) (George et a!., Townsend et 1991). were 
an intravenous injection (average 10 MBq/kg) of technetium-99m-d,l-hexamethyl­
propylene amine oxime (99Tcffi-HMPAO) while they were sitting silently with their eyes open 
in a quiet, room. The 99Tcffi -HMPAO is a lipophilic compound that 
rapidly crosses the blood-brain within 5 minutes after injection, the radioJigand enters 
the brain, where it becomes hydrophylic and remains stable for hours (Ell et 1985). Thus, 
99Tcffi -HMPAO SPECT depicts blood flow, which under most conditions corresponds with 
brain metabolism (Sokoloff, 1977, 1978). . 
Approximately 10-30 minutes after the injection, subjects, who were supine, were scanned 
for approximately 15 minutes (128 projections in a 64 X 64 matrix acquisition) using high­
resolution (7-9 mm full-width at half-maximum) collimators. Tomographic slices were then 
reconstructed in the trans axial, coronal, and sagittal planes using a Hanning prefilter with 0.8 
cycles/ cm cutoff a Ramp filter, and attenuation correction. The uptake and 
levels of -HMPAO were computed for 4 X 4 nonoverlapping regio,ns 
of interest (ROIs) of size 1.6 X 1.6 cm2• ROls comprised the right and left frontal, medIa! 
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• 
temporal, lateral temporal, and occipital lobes, and the right and left basal ganglia and 
l "" rebellum (see Fig . 1). T he ROJ analysis was performed by one of the authors (M.S .G.), who 
was unaware of the subjects' identit ies. Nonoverlapping 4 X 4 pixel ROls were independently 
placed three times in each region on three different slices , with a neuroanatomic atlas being 
used for reference . The mean of these nine independent samples was the ROJ value for each 
region (total brain region covered = approximately 2.4 vertical cm) . This sampling method 
has a high intraclass correlation coefficient of 0.92 (1 = total correlation, > 0.70 = acceptable, 
and 0 = no correlation). 
t 1:0S~DCS. Multiple factors can influence an absolute ROJ level in a given patient for a given 
region (e.g., accurate dosing / kg, amount of tracer left in the syringe, tracer deposited 
subcutaneously and not intravenously). However, ratios of brain activity in each patient can 
be used to minimize these factors and compare regional values across subjects. The uptake of 
99T cm-HMPAO in different ROls was therefore calculated and expressed as a ratio to visual 
cortex values. We chose the visual cortex as the reference region over the cerebellum, which 
may be affected in GTS, especially in subjects who might be having, or suppressing, motor tics 
Fi . ~. A transverse 99Tcm~HMPAO SPEer scan of a GTS subject at the 
I ve~ off the basal ganglia 
Three 4 X 4 pixel regions of interest are shown over the right frontal region, where significant differences were found 
between GTS and control subjects. 99Tcm-HMPAO SPECT = single photon emission computed tomography with 
technetium-99m-d,l-hexamethyl-propylene amine oxime as ligand. GTS =Gilles de la Tourette syndrome. 
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during the injection. Regional values are also expressed as ratios to whole brain uptate. GTS 
subjects were largely quiet through the injection and scanning process, and were free of tics. 
No subjects had staring tics. Group means of regional brain-activity ratios were compared 
between GTS subjects and control subjects by a one-factor analysis of variance CANOVA) for 
the following regions: left and right basal ganglia/visual cortex and left and right basal 
ganglia/ whole brain; left, midline, and right frontal cortex/ visual cortex and left, midline, and 
right frontal cortex/whole brain). To test whether age was a factor in the results, a 
correlational analysis was done with age and left frontal Iwhole brain and also with left 
frontal/visual cortex (W = 0.109). 
Results 
GTS subjects had increased right frontal activity compared with control subjects 
when this region was normalized to the visual cortex (GTS subjects: mean =0.879, 
SD = 0.107; control sUbjects: mean = 0.798, SD = 0.049; p < 0.05, AI\!OVA) 
(Table 1). The difference was also significant when this region was expressed as a 
ratio to whole brain activity. A separate ANOVA that compared these same brain 
ratios between GTS subjects with and without OCD did not demonstrate significant 
differences. 
Table 1. Mean regional cerebral blood flow by regions and groups 
GTS 
Simple GTS+ 
GTS OCD Both COfltrols 
Ratio (n= 10) (n= 10) (n= 20) (n= 8) 
Left frontal/visual cortex 0.89 (0.09) 0.89 (0.105) 0.89 (0.095) 0.82 (0.065) 
Right frontal/visual cortex 0.87 (0.072) 0.88 (0.138) 0.88 (0.107)1 0.79 (0.049) 
Midline frontal/visual cortex 1.02 (0.075) 1.02 (0.15) 1.03 (0.115) 0.98 (0.067) 
Left basal ganglia/visual cortex 0.95 (0.038) 0.94 (0.095) 0.95 (0.071) 0.93 (0.086) 
Right basal ganglia/visual cortex 0.97 (0.08) 0.96 (0.086) 0.97 (0.082) 0.95 (0.089) 
Left frontal/whole brain 1.04 (0.06) 1.01 (0.07) 
Right frontal/whole brain 1.03 (O.OS)1 0.98 (0.06) 
Midline frontal/whole brain 1.20 (0.06) 1.19 (0.06) 
Left basal ganglia/whole brain 1.12 (0.05) 1.12 (0.07) 
Right basal ganglia/whole brain 1.14 (0.05) 1.14 (0.07)
-
Note. GTS = Gilles de la Tourette syndrome. OeD =. obsessive-compulsive disorder. Values are means; standard 
deviations follow in parentheses. 
1. Two-group (GTS vs. controls) analysis of variance, right frontal/whole brain visual cortex: F = 4.142; df == 26; 
p <0.0521. 
Discussion 
We have demonstrated elevated right frontal rCBF in unmedicated GTS subjects 
compared with control subjects. These results should be interpreted with some 
caution, however. A selection bias toward the most severe cases of GTS and oeD 
probably exists due to the referral pattern of the clinic. Also, the two groups differed 
in both age and sex ratios, which could have influenced the results, although the 
differences are not statistically significant. 
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We considered whether underlying brain atrophy or damage could possibly 
influence our results. However, atrophy would likely cause a decrease in rCBF, while 
we found increased rCBF in GTS subjects compared with our normal control 
subjects. We are now in the process of definitively excluding this possibility with 
magnetic resonance imaging of these same sUbjects. Most patients with GTS have no 
known underlying brain pathology. A series of 53 computed tomographic scans of 
GTS patients from this same clinic were uniformly normal (Lees et aI., 1984). 
Interpreted with caution, however, these results are interesting in light of current 
models of OCD and GTS. Case reports, neurosurgery results, and previous 
functional neuroimaging studies have all implicated frontal lobe and basal ganglia 
pathology in OCD. Numerous case reports have shown that orbital frontal and basal 
ganglia pathology are associated with OCD (for a review, see George et aI., 1992). 
Frontal tumors have been reported in association with.OCD (Brickner et aI., 1940; 
Cambier et ai., 1988; Seibyl et aI., 1989). Similarly, infarctions and infections of the . 
frontal lobes and basal ganglia have been reported in patients with OCD (Schilder, 
1938; Wohlfart et ai., 1961; Laplane et aI., 1981; McKeon et ai., 1984; Swedo et aI., 
1989; Tonkonogy and Barriera, 1989; Weilburg et ai. 1989). 
Further evidence of the role of the orbital frontal lobes and basal ganglia in OCD 
is provided by the results of neurosurgery for OCD. Surgically interrupting the 
frontally projecting fibers in the cingUlum (a procedure known as cingulotomy) can 
often alleviate OC symptoms (Talairach et aI., 1973; Tippin and Henn, 1982; lenike 
et aI., 1991). . 
Previous functional neuroimaging studies (PET and SPECT) of OCD have almost 
uniformly found hypermetabolism of the frontal lobes (Baxter et aI., 1989, 1990; 
Nordahl et aI., 1989; Swedo et aI., 1989a; Machlin et aI, 1991; George, 1992). Three 
PET studies of OCD have shown similar but not identical results. In a study' with 
F-2-deoxy-2-fluoro-d-glucose (F2FDG) PET, Baxter et ai. (1989) found that 10 
OCD subjects had increased absolute metabolic rates in the heads of the caudate 
nuclei and orbital gyri when compared with control sUbjects. These findings were 
later replicated in a medication-free, age- and sex-matched, controlled study with 10 
OCD subjects. In this replication study (Baxter et aI., 1990), OCD subjects had 
increased metabolic rates in their orbital gyri when expressed as a ratio to the 
ipsilateral cerebral hemisphere. A PET study by Nordahl et al. (1989) revealed 
increased metabolic rates in the orbital gyri of eight OCD subjects relative to the 
whole brain metabolic rate. Finally, Swedo et ai. (1989b) described 18 childhood­
onset OCD subjects whose scans were compared with those of age- and sex-matched 
control subjects. The OCD subjects had prefrontal abnormalities, with elevated 
glucose metabolism in the left orbital frontal, right sensory motor, and bilateral 
prefrontal and anterior cingulate regions. The right prefrontal and left anterior 
cingulate regions showed increased relative glucose metabolism. In addition, a 
significant positive correlation emerged between right orbital glucose metabolic rate 
and OCD severity. 
In contrast, Laplane et aI. (1989) reported on eight patients with bilateral basal 
ganglia lesions and behavior suggesting a "frontal-lobe" syndrome and OCD. PET 
scans with 18FDG as tracer in seven patients revealed hypometabolism of the pre­
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frontal cortex relative to other parts of the brain. These studies suggest that damage 
to the lentiform nuclei causes prefrontal cortex dysfunction, which leads to OCD. 
Using 99Tcm-HMPAO SPECT, Machlin et al. (1991) found medial frontal and 
cingulate hypermetabolism in 10 OCD subjects compared with control subjects. 
In contrast, there has been one case report of decreased right basal ganglia and 
right anterior temporal lobe activity in OCD on the basis of 123I-amphetamine 
SPECT scans. These abnormalities resolved with pharmacologic treatment (Hamlin 
et aI., 1989). 
Recently Swedo et aI. (1991) studied 10 female subjects with trichotillomania, a 
disorder of compulsive hair pulling, whose ISFDG PET scans were compared with 
those of 20 age- and sex-matched control sUbjects. Results in this study were very 
different from those reported by others investigating OCD. They discovered 
increased blood flow in parietal and cerebellar regions, but not in the frontal lobes or 
basal ganglia. From this one study, it appears that trichotillomania, often referred to 
as an OC-spectrum disorder (George et aI., 1990; George, 1991), may be associated 
with a different regional metabolic pattern than OCD. 
In summary, most PET and SPECT studies have found a surprisingly similar 
picture of elevated right frontal metabolism in OCD. The one study in an OCD­
related disorder (trichotillomania) found a different rCBF map. Previous SPEer 
work in GTS is limited, although some have reported qualitative asymmetries in 
basal ganglia metabolism (Hall et aI., 1990). Our results indicate that GTS subjects, 
similar to subjects with OCD, have elevated right frontal activity compared with 
control subjects. These findings may be due to the presence in the study group of 
comorbid OCD/GTS subjects, although the power for this analysis is limited. No 
basal ganglia differences were observed in GTS, with or without OCD, or in 
comparisons of either of these groups with control subjects." 
Our hypothesis before the study began was that the rCBF picture of GTS versus 
GTS/OCD subjects would vary, in a manner similar to that postulated by Baxter 
(1990), with elevated orbital frontal activity in those subjects with OeD and elevated 
basal ganglia activity in "pure" GTS. We discovered, however, that the entire group 
of GTS subjects had elevated frontal activity and that there were no statistically 
significant differences between subgroups of GTS subjects with and without OCD. A 
previous trend reported by our group (George et al., 1991) continues, with subjects 
with. OCD / GTS having consistently elevated frontal and decreased basal ganglia 
activity compared with subjects with simple GTS without OeD. These trends, 
however, failed to reach statistical significance. 
The elevated right frontal activity in these GTS subjects strengthens the previous 
biological associations between GTS and OCD. Our failure to find regional 
differences between subgroups of subjects with or without OCD does not contradict 
previous models. Rather, in view of the small number of subjects in this study, and 
the limited spatial resolution of current SPECT scanners, there is a high likelihood 
of a type II error (Le., a difference existed but could not be detected). 
Further studies are clearly needed to confirm, extend, and refine these findings. 
We are now using 99Tcm-HMPAO SPECT to study "pure" OCD subjects (without 
tics). Additional SPECT studies using specific neurotransmitter ligands (dopamine 
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and serotonin) or specific activation protocols (George et aI, 1991; Ring et aI., 1991) 
may help to unravel links between OeD and GTS. 
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Brain Perfusion Abnormalities in 

Gilles de la T ourette's Syndrome 

JOHN MORIARTY, DURVAL CAMPOS COSTA, BETTINA SCHMITZ, 

MICHAEL R. TRIMBLE, PETER J. ELL and MARY M. ROBERTSON 

Background. Functional brain imaging with technetium-99m d,l·hexamethyl propyleneamine 

oxime (HMPAO) Single Photon Emission Tomography (SPET) allows us to explore the cerebral 

pathophysiology of Gilles de la Tourette's Syndrome (GTS). 

Method. Fifty patients and 20 controls were examined. Patients were rated for tic severity 

and mood. Scans were analysed quantitatively using internal ratios to the occipital cortex. 

Results. Patients differed from controls on measures of relative blood flow to the left caudate, 

anterior cingulate cortex and the left dorsolateral prefrontal cortex. Severity of tics was related 

to hypoperfusion of the left caudate and cingulate and a left medial temporal region. 

Hypoperfusion in the left dorsolateral prefrontal region was related to mood. 

Conclusions. The areas found to be hypoperfused in this study are consistent with known 

functions of fronto-striatal circuits. A wide range of perfusion patterns is seen, however, and 

no characteristic patterns for behavioural subgroups has been documented with this technique. 

Patients with Gilles de la Tourette's syndrome (GTS) 
have a wide range of symptoms. The central feature 
of the condition is the presence from childhood of 
multiple motor and vocal tics (American Psychiatric 
Association, 1987). Other/characteristic signs, not 
essential for the diagnosis, are coprophenomena, 
echophenomena .and palilalia. 
The aim of this study was to document the regional 
cerebral blood flow correlates of GTS and its 
component symptoms. Firstly, we wished to 
determine if there were any fundamental differences 
in perfusion' patterns between our patients and a 
group of normal controls. Secondly, we wanted to 
examine whether specific patterns of regional blood 
flow were correlated with the presence of obsessive­
compulsive behaviours (OCB), echolalia, coprolalia, 
echop'raxia, copropraxia, treatment, tic severity, 
mood"and demographic characteristics. 
Method 
Consecutive patients referred to the GTS clinic at the 
National Hospitals for Neurology and Neurosurgery 
were asked to have a.SPET scan. Women of child­
bearing age who were not using adequate contraception 
were excluded. The project was approved by the 
ethical committee of the National Hospitals for 
Neu'rology and Neurosurgery and the Administration 
of Radioactive Substances Advisory Committee. All 
subjects gave informed consent. In all, 50 patients and 
20 normal controls were scanned over three years. 
Diagnosis of. GTS according to DSM-III-R 
criteria (American Psychiatric Association, 1987) was 
confirmed by one of the authors (MMR), who 
also questioned patients about the presence or 
absence of coincident OCB (enquiring specifically 
into the presence or absence of obsessive thoughts, 
forced touching, arithmomania, evening-up and 
compulsive rituals). Also documented was' the 
presence or absence of echolalia, echopraxia, 
coprolalia and copropraxia. Tic severity at the 
time of the scan was rated on a 3-point scale 
(I = minimal or mild, 2 = moderate, 3 =severe) (more 
elaborate rating scales are now in use in our 
clinic but were not when the early scans were being 
acquired). The Beck Depression Inventory (BOI), a 
self-rating scale for depression, was completed by 
42 patients (Beck et 01, 1961). 
The study group comprised 38 males and 12 
females with a mean age of 24 years (range 7-65); 
16 patients were rated as mild, 21 moderate and 13 
severe; 27 had significant OCB. Only one of the 
patients had an IQ less than 80; a further nine were 
in the range 80-100. Only three had any neurological 
abnormalities, these being minor 'soft' signs. Of 
other symptoms, 21 patients had echolalia, 22 
echopraxia, 18 coprolalia and 10 copropraxia. BDI 
scores ranged from 1 to 39 with a mean of 12. Thirty· 
four patients were drug-free, of whom 24 were drug 
naIve (never taken drugs). Patients on medication 
were receiving neuroleptics, mostly low-dose 
sulpiride; no other medications were being taken. 
The scans were compared with those obtained from 
normal volunteers. 
Of the volunteers, nine were male and 11 female, 
with an average age of 23 years. None suffered from 
249 
El
-
I
lts_
!
. .
·
-
.
· 
", .. n ,'." 
·
i
l  
aI
]
l tl , l
IS t'f'lT,rf'lnr",Y," 
I 
II
Un
ive
rsi
ty 
of 
Ca
pe
 T
ow
n
250 MORIARTY ET AL 
physical or psychiatric illness, and all were drug­
free. 
Two distinct scanning technologies were used over 
the three years, the design and performance 
characteristics of which have been described 
previously. The Starcam single-headed gamma 
camera was used for scanning 33 patients (Costa et 
aI, 1988) and the GE Neurocam triple-headed brain­
dedicated camera for 17 (Kouris et aI, 1992). All 
controls were scanned on the Neurocam. Subjects 
were injected with 550 MBq HMPAO at rest with 
their eyes open, and scanned for a maximum of 
30min. Ambient light conditions were artificial and 
the same for all scans. Some patients who could not 
tolerate this length of time without disruptive tics 
were scanned for a shorter period. All scans were 
reconstructed and analysed by the same investigator 
on the Star 4000 computer. Reconstructions used a 
filtered back-projection technique with Hanning pre­
filter and attenuation correction as described 
previously (Costa et aI, 1988). These were in three 
planes with a final slice thickness of 2 pixels. 
Transaxial images were reconstructed to include a 
line drawn from the base of the occipital to the base 
of the frontal cortex on a midline sagittal slice. 
Sagittal planes were those parallel to the midline and 
coronal planes were perpendicular to the axial and 
sagittal. 
Scans were analysed using a region of interest 
(ROI) method. Regular ROIs were placed manually 
in 15 regions. For Neurocam scans these were 4x4 
pixels (voxel size 1.6 x 1.6 x 0.8 cm) and for Starcam 
scans 6 x 6 pixels (voxel size 2 x 2 x 0.6 cm). We chose 
the visual cortex as our reference region, both 
because of the reliability of measurements in this 
region and because we felt that it is unlikely to be 
in\fOlved in the pathophysiology of GTS (unlike the 
. cerebellum). 
The brain regions analysed were as follows: 
(a) in..transverse images: right and left anterior 
striatum at tlie level of the thalamus, cingulum 
and visual cortex (as reference area) at the 
same level, three cerebellar regions (right, left 
and midline) at the level where the inferior 
poles of the temporal lobes are first seen. 
(b) in coronal images: the cingulum measured in 
the slice immediately posterior to that 
containing the cingulum in its caudal direction, 
orbital frontal cortex bilaterally, dorsolateral 
,prefrontal region bilaterally in the same slice 
at the same levcllateral to the cingulum, and 
anterior and posterior medial temporal regions 
bilaterally, the former immediately anterior to 
the slice containing the temporal lobes in their 
greatest width and the latter at the slice 
containing the brainstem, two slices posterior 
to this. The measure for the cingulum was 
taken as the average of the coronal and the 
horizontal readings. 
All ROls were expressed as within-subject ratios 
to the visual cortex (Table 1). No attempt was made 
to compare counts in ROIs directly. The variability 
of final counts between subjects precludes such 
comparisons because of inter-subject differences in 
uptake and retention of HMPAO. These differences 
depend on the exact dose administered, bodyweight 
and carotid blood flow as well as cardiac output. The 
investigator analysing the scans (JM) did not.know 
which scan belonged to which patient and so did not 
know the specific clinical details of the patients. For 
those patients scanned on the Starcam, it was not 
possible to be blind to whether subjects were patients 
or controls nor, obviously, to which camera was 
used. 
The normal distfibution of the ratios for each 
region individually, in both patients and controls, 
was established using the Kolmogarov-Smirnov tests 
for normality. The first analysis looked at the 
differences between the GTS patients and controls 
using a 2-tailed t-test. The Bonferroni correction for 
multiple comparisons was applied. We then 
performed a one-way analysis of variance for all 
regions across the three groups divided according to 
tic severity. To examine the effect of depression on 
SPET blood flow pattern, we subdivided the group' 
according to their score on the BDI. We determined 
two subgroups of our sample: first, those with EOI 
scores less than 10 (n 19); and second, those with 
scores greater than 20 (n = 8). Patients with scores 
between 10 and 20 were excluded from further 
analysis. A one-way analysis of variance for all 
regions across the three groups (EDI < 10, BOI >20 
and controls) was then performed. A similar analysis 
of variance was applied across the groups divided 
according to medication status. 
A modified least significant differences test of 
significance was applied. This corrects for multiple 
comparisons. 
Pearson's correlations (r) were calculated for each 
region and our measure o( tic severity, and for each 
region and the BDI score. Finally, we looked within 
the GTS patient group for any differences between 
those patients with and without OCB, echolalia, 
echopraxia, coprolalia or copropraxia. In addition, 
we looked for any differences between patients of 
different sex and between those whose scans were 
performed on the Neurocam and those whose scans 
were performed on the Starcam gamma camera system. 
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• 
All statistical tests were carried out using the 
SPSS/PC + computer programme (v. 4). 
Results 
All ratios were normally distributed. The mean 
values and s.d. of relative blood flow for all 14 areas 
in patients and controls are given in Table I. The 
values are lower for the patient group in both caudate 
nuclei, the anterior cingulate, both cerebellar 
hemispheres and the left dorsolateral prefrontal 
cortex; and higher in the right posterior medial 
temporal area. There are no differences for the 
midline cerebellum (vermis), right dorsolateral 
prefrontal cortex, bilateral orbitofrontal cortex, 
bilateral anterior medial temporal cortex and left 
posterior temporal cortex. The left caudate and 
anterior cingulate survive strict Bonferroni 
correction. The reduction in the left dorsolateral 
prefrontal area (P == 0.007 before correction) shows 
a trend (P = 0.098) after correction. The distribution 
of values is wide, both in normal controls and in 
patients. 
We found that the only region where there are any 
between-group differences for the patients of 
different degrees of severity was in the left anterior 
temporal region. The difference is' significant 
Table 1 

Mean values (s.d.l far eachaf 14 regians expressed as ratio 

to visual cortex 

GTS Controls P 
Right caudate 0.B41O.081 0.B9 (0.07) 
Left caudate 0.85 (0.07) 0.92 (0.071 
Cingulum 0.89 (0.061 0.94 (0.06) 
Right cerebellum 0.99 (O.OBI 1.04 (O.OB) 
Left cerebellum 0.98 (0.07) 1.02 (0.091 
Midline cerebellum 0.97 [0.07) 0.97 (O.OB) 
Right dorsolaieral 
prefrontal 0.79 W.05) 0.B1 (007) 
Left dorsolateral 
prefronial 0.77 (O.OBI 0.B3 (O.OB) 
Right orbital frontal 0.72 (0.07) 0.74 (0.05) 
Left orbital frontal 0.71 (0.09) 0.74 (0.06) 
Right anterior medial 
temporal 0.75 (0.06) 0.75 (0.05) 
Left anterior medial 
temporal 0.77 (0.07) 0.79 (0.06) 
fljght posterior medial 
temporal O.BO (0.08) 0.77 (0.051 
Left posterior medial 
0.80 (0.07) O.Bl (0.071 
s.d. =St~ndard deviation 

Results of unparred t-test co~pafison of group means: 

'0.01 <P<0.05 
• 'O.005<P<0.01 
., '0.001 <P<0.005 
••• ·P<O.OO1 
(P<0.05) between the patients rated as mild (0.80, 
s.d. 0.06) and those rated as moderate (0.75, s.d. 
0.06). 
Dividing the patients according to BDI score 
showed there to be significant between-group 
differences for blood flow in several regions: the right 
and left cerebellum, the left caudate, the cingulum 
and the left dorsolateral prefrontal cortex. For the 
cerebellar areas, the caudate and the cingulum, the 
differences were only significant at the 5OJo level 
between controls and patients with a low BDI score. 
The means of the low and high BDl score 'patients 
are, however, comparable for the caudate and 
cingulum, whereas for the cerebellar areas, the more 
depressed GTS patients have cerebral blood flow 
ratios comparable to those of the control group (see 
Table 2). The differences for the dorsolateral 
prefrontal area are, however, more marked in (and 
significant for) the high BDI score patients. 
The Pearson's correlations are shown in Table 3. 
The strongest correlation for tic score was with the 
left caudate and cingulum, followed by the left 
dorsolateral prefrontal and left anterior temporal. 
These were all inverse correlations. The BDI Score 
showed an inverse correlation with left dorsolateral 
prefrontal perfusion. 
The patients on medication at the time of the scar 
had higher blood flow than those not on medicatior 
(drug-free or drug-naive). These differences were no 
significant. 
Table 2 

Summary of means (s.d.) for regians showing between 

group differences for low and high Beck score patients an. 

for controls 

Low Beck High Beck Controls 
ROI score (n = 19) score (n=8) (n=20) 
--~.~~.. .~--~.~-.~----.~~~-~--~ 
Right cerebellum 0.97 (O.OB), 1.01 (0.05) 1.04 (O.OBI 
Left cerebellum 0.94 (0.06)' 1.0010.08) 1.02 (0.09: 
Left caudate 0.B3 (0.07)' 0.86 (0.04) 0.92 (0.07 
Cingulum 0.B8 (0.05)' 0.B9 (0.061 0.94 (0.06 
Left dorsolateral 
prefrontal 0.79 (0.09) 0.74 (0.07)' 0.83 (0.08 
• indicates difference from normal controJs significant (P< 0.05) aft 
correctlon for mUltiple comJ}arisons. 
Table 3 
Correlations between regions and measures of tic severi' 
and Beck score 
Variables 
Tic severity Left caudate -0.41 
Cingulum -0.3' 
Left dorsolateral prefrontal -0.3: 
Left anterior temporal -0.3 
aDI score Left dorsolateral prefrontal -0.3 
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There were some further tendencies of interest. 
Because of the number of varjables involved, these 
differences were not significant after correction for 
multipJe comparisons. Males had similar or lower 
blood flow than females in all regions except the 
dorsolateral prefrontal regions bilaterally. Patients 
with OCB had lower perfusion in all regions than 
those without OCB; 580/0 of the males and 41 % of 
the females had OCB and the mean BD! score was 
10 in males and 15 in females, but these differences 
are not significant (i and I-test). Patients with 
echolalia, echopraxia, coprolalia or copropraxia 
could not be distinguished and there were no 
differences attributable to the type of scanner used. 
Discussion 
The central feature of GTS is the occurrence of tics. 
It has been agreed that the diagnosis should be 
confined to those with both motor and vocal tics 
(though these need not necessarily have been 
concurrent). In addition, the disorder has been 
associated with a range of pathological behaviours 
such as OCB and self-injury (Robertson, 1989). 
Structural imaging studies of GTS have, until very 
recently, been disappointing. More recently, 
volumetric magnetic resonance imaging techniques 
(Peterson et ai, 1993; Singer et aI, 1993) have 
suggested a reduction in volume of the left lenticular 
region (putamen and globus palHdus) in patients with 
GTS compared to controls with some loss of the 
usual left predominant anatomical asymmetry. 
. One group has reported a series of PET scans of 
GTS subjects. They have describ~d abnormal 
associations between metabolic rates in sensorimotor 
-cortex and limbic areas (Stoetter et aI, 1992). A single 
repott of HMPAO brain scans in a series of nine 
adults with GTS found left striatal hypoperfusion 
(Riddleet ai, 1992). A preliminary report from 
Dimitsopulos et af ,(1993) of six patients showed 
reduction in perfusion of the non-dominant basal 
ganglia. Existing studies thus support the hypothesis 
(Leckman et ai, 1991) that the basal ganglia are 
involved in the pathogenesis of GTS. 
There are a number of methodological problems 
with our study. Our GTS population and controls are 
not matched for age or sex, and our GTS population 
was studied with two quite different scanning tech­
nologies. The first of these problems results to a large 
degree from the ethical problems associated with the 
administration of radiotracers to normal populations, 
which obliged us to use existing data collected for 
the newer scanner (Neurocam). If we were to limit 
our patient gr~up ~o the same age range (young 
adults), our samplesiie would be prohibitively small. 
The second problem also relates to sample size. 
We aimed in this study to examine the spread and 
pattern of perfusion abnormalities seen in patients 
with GTS. The approach we took is supported oy 
our finding that there were no differences between 
the results obtained for our Tourette patients with 
the two different scanners. We chose the box ROls 
described in order to get the best agreement for voxel 
size between the two methods of measurement. 
Finally, we cannot exclude the possibility' of a 
greater partial volume effect occurring in our patient 
group because of the scanner used and because of 
a greater degree of head movement expected in the 
GTS group. Again, however, we would expect such 
systematic error to result in differences within our 
patient group according to which scanner was used, 
and it would not explain the specificity of our 
findings for any particular structure. Such an error 
would be likely to have contributed to the large 
variance in our measurements. 
We believe'" that, in the absence of 
contemporaneous MRI images for co-registration, 
our ROI technique maximises the validity of the 
measurements at some cost to reliability. The latter 
can probably be improved by the use of anatomical 
templates. This would then involve the assumption 
that all our subjects' scans could be analysed as if 
their brains were of identical shape and size. Indeed, 
what is as striking as our findings of regional 
differences between our patient and control groups, 
,­is the considerable variations we found, not only 
among patients but also among normal subjects. It 
is likely that subtle differences of cerebral perfusion 
which might correlate with the range of behavioural 
abnormalities seen in this condition could be lost in 
the within-group variability. 
Notwithstanding these methodological reserv­
ations, we found the left caudate to be the area 
showing the most marked hypoperfusion in our 
patients. The striatum is involved in the initiation 
and execution of movement (Montgomery & 
Buchholz, 1991). Ventral striatal areas are also 
involved in wider behavioural functions. Moreover, 
the left caudate has consistently been more deeply 
implicated than the right in the development of 
depression (Starkstein et ai, 1988). The reduced 
caudate perfusion we find in GTS is consistent with 
the motor and affective functions identified in this 
structure. The resolution of these scans does not 
allow us to differentiate reliably between caudate and 
lenticular perfusion. 
We also found that the anterior cingulate and left 
dorsolateral prefrontal cortices showed hypoperfusion 
in the GTS patients. These areas, along with the 
orbitofrontal cortex, are the cortical areas where the 
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prefrontal-subcortical circuits originate (Cummings, 
1993).. 
The dorsolateral prefrontal cortex projects 
primarily to the dorsolateral head of the caudate 
nucleus, and the projections from here are to the 
dorsomedial globus paJlidus interna and rostral 
substantia nigra. Pallidal and nigral neurones then 
project to the ventral anterior and medial dorsal 
thalamic nuclei, which in turn connect back to the 
dorsolateral prefrontal cortex (Alexander et ai, 1986). 
Deficits in motor programming, as evidenced by 
impaired performance on alternating and reciprocal 
motor tasks, characterise lesions in this circuit 
(Cummings, ]993). These deficits have recently been 
documented by our group in GTS. 
Our finding that the left anterior temporal region 
is the only region showing between-group differences 
in our analysis of variance across groups of differing 
severity, and the (admittedly weak) correlation 
between this area. and our measure of tic severity, 
are intriguing as it has been elegantly argued that 
medial- temporal structures, and the amygdala in 
particular, may,play a.cruCiiil role in the pathogenesis 
of GTS (Jadresic, 1992).The natural history of this 
disorder is such that it· will tend to wax and wane 
and its 'severity' will reflect a complex interaction 
of the tics thems'elves, fhe' associated behavioural 
disturbances and the distress and dysthymia these 
may evoke in the patient. This makes the 
interpretation of this finding particu]arly difficult. 
Our finding that the dorsolateral prefrontal 
hypoperfusion is most marked for the patients with 
high BDI score, and the correlation between 
perfusion of this area and the BDI score, suggest that 
hypoperfusion of this area may be related to affect 
as much as to diagnosis. This is consistent with other 
. function<;ll imaging studies of depressive illness 
(Bench et ai, 1992). 
The anterior cingulate cortex has significant 
projectkms to the ventral striatum and forms part 
of a distinct circuit from bere to a rostrolateral sector 
of the internal pallidal segment, which projects in 
turn to a. paramedian portion of the mediodorsal 
nucleus of the thalamus. Posterior and medial 
. portions of the medial dorsal nucleus project to the 
cingulate (Alexander et ai, 1986). Stimulation of this 
area of the cortex is associated with the generation 
of involuntary vocalisaticins. (Jurgens, 1976) and 
cingulate epilepsy is associated with complex motor 
automatisms at onset of theseizure. Our finding of 
hypoperfusion of this area in a disorder characterised 
by involuntary vocalisations and motor activity is 
thus intriguing. 
Some degree of consensus has emerged in the 
Jiterature regarding the finding of hyperperfusion of 
frontal brain areas in obsessive-compulsive disorder 
(OCD). A previous report by our group (George et 
ai, 1992) of 20 patients with GTS, including 10 with 
coincident OCD, showed increased right 
orbitofrontal blood flow compared to a group of 
eight normal controls. (These patients were not part 
of the present study.) This earlier study did not 
include a correction for multiple comparisons, and 
the frontal hyperperfusion was relative to an 
unusually low measure of perfusion in the c.ontrols. 
It is perhaps not surprising that we did not find such 
hyperperfusion in our GTS patients with OCB. The 
obsessive characteristics of patients with GTS are 
different from those seen in OCD (George .et ai, 
1993). Frontal hyperpei'fusion may be more a feature 
of increased arousql and anxiety, which is more 
prominent and more frequent in OCD than in GTS 
with OCB. 
The cerebellum has been impliCated in quite a 
range of cognitive processes, as well as playing a key 
role in motor coordination. It has been shown to be 
involved in the imagining of movement and not just 
in movement itself (Decety et ai, 1990). We find 
relative hypoperfusion of this area in GTS. Within 
the patient group, greater perfusion in the cerebellar 
hemispheres in the more depressed GTS patients is 
consistent with the findings described by Bench et 
al (1992) in a PET study of primary depressive illness. 
The mean BDI score was higher in our female 
than in our male patients. Although this difference 
was not statistically significant, it may contribute to 
the finding that the blood flow in dorsolateral 
prefrontal regions in women is relatively lower than 
in men. 
Essentially, we have shown that there is 
hypoperfusion of certain brain areas in patients with 
GTS. These areas are consistent with previously 
proposed cortico-striatal-thalamo-cortiCal (CSTC) 
circuit abnormalities in GTS. The clinical variability 
of the disorder is likely to reflect differential 
involvement of circuits subserving motor, affective 
and volitional aspects of behaviour. The nice 
dissection of these discrete but interlinked circuits 
remains beyond the scope of present SPET techniques, 
but studies are under way using PET technologies. 
Further research should now also be directed at 
determining the clinical significance of the prestnt 
findings and, in particular, whether the finding of 
cerebral hypoperfusion has prognostic significance. 
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BRIEF COMMUNICATION 
HMPAO SPET does not distinguish obsessive--compulsive 

and tic syndromes in families multiply affected with 

Gilles de la Tourette's syndrome 

J. MORIARTY,' V. EAPEN, D. C. COSTA, S. GACINOVIC, M. TRIMBLE, P. J. ELL 

AND M. M. ROBERTSON 

From the Raymond-Way Neuropsychiatry Research Group, Institute of Neurology and the Institute of 

Nuclear Medicine, University College London Medical School, London 

ABSTRACT 
Background. Gilles de la Tourette's syndrome CGTS) is a familial neuropsychiatric disorder 
characterized by tics and obsessive-compulsive behaviours (OCB). Previous HMPAO SPET 
studies of subjects with GTS have shown hypoperfusion of striatal and frontal areas. Studies of 
patients with primary obsessive-compulsive disorder have shown, in contrast, hyperperfusion of 
similar areas. 
Methods. Twenty subjects from five families affected by GTS, including individuals with OCB 
but no tics, were examined using HMPAO SPET. 
Results. There were abnormalities of regional cerebral perfusion in individuals with GTS, OCB 
and tics. Hypoperfusion was ill striatal, frontal and temporal areas. There was no 
hyperperfusioll. 
Conclusions. Regional cerebral blood flow patterns in individuals with OCB in families affected 
by GTS are comparable to their relatives with GTS and differ from individuals with primary 
OCD in the absence of a family history of tic disorders. 
INTRODUCTION 
Functional neuroimaging offers the possibility 
of a deeper understanding of the physiology of 
behaviour. Images of regional cerebral blood 
flow or metabolism in patients with neuro­
psychiatric disorders help us to describe the 
neurology of conditions that can currently only 
be described in behavioural terms. 
GTS is a neuropsychiatric disorder defined by 
the presence of multiple motor and vocal tics 
(American Psychiatric Association, 1987). GTS 
is associated with more complex abnormal 
Address for correspondence: Dr J" Moriarty, Room 808, 
Institute of Neurology, Queen Square, London Wel N 3BG. 
behaviours involving imitation and profanation. 
Echolalia, echopraxia, coprolalia and copro­
praxia need not be present to make a diagnosis 
of GTS, but are characteristic of the disorder. 
OCB are also associated with the condition, as is 
attention deficit and hyperactivity (Robertson, 
1994). Genetic (Pauls & Leckman, 1986; Eapen 
et al. 1993) and epidemiological (Myers et al. 
1984; Robins et al. 1984) studies suggest that for 
OCB at least, the association is biological. There 
are similarities of phenomenology between tics, 
obsessions and compulsions that suggest a 
shared pathophysiology. 
Functional imaging studies of GTS and OCD 
have thrown some light on the brain substrates 
of these syndromes. Although no definitive 
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abnormalities have been found there is a 
tentative consensus as to the brain areas in­
volved. Particularly implicated are striatal and 
frontal areas. OCD has been associated with 
hyperperfusion of frontal areas (Nordahl et al. 
1989; Baxter, 1990; Benkelfat et al. 1990; 
Machlin et al. 1991; Swedo et al. 1992). The 
available literature on perfusion patterns or 
abnormalities in GTS is limited. Preliminary 
studies by Riddle el al. (1992), KurIan's group 
(Dimitsopulos et al. 1993) and our own series 
(Moriarty et at. 1995) suggest involvement of 
caudate, anterior cingulate, medial temporal 
and dorsolateral prefrontal areas. In all studies 
the abnormalities are in the form of hypo­
perfusion rather than increased blood flow. 
Thus, OCB and GTS have apparent genetic 
and biological associations but conflicting cer­
ebral blood flow findings. We explored the 
patterns of cerebral blood flow seen in families 
containing subjects with GTS and OCB. Specifi­
cally, we wished to test the hypothesis that 
patients with OCB could be distinguished from 
patients with GTS by SPET. We chose to use the 
term OCB rather than OCD in this context to 
refer to subjects who fulfilled the symptoms 
criteria of the DSM-III-R (American Psychiatric 
Association, 1987) diagnosis of OCD but where 
these symptoms did not necessarily interfere 
with the social and occupational functioning of 
the individuaL 
METHOD 
Five families with at least one child affected by 
GTS were identified. These were selected by one 
investigator (V. E.) to include specificalIy a 
spectrum of disorder comprising GTS, OCB and 
unaffected family members. Families consisted 
of two parents and two children. Dircct clinical 
examination was carried out on alI subjects, 
using the National Hospital Schedule for tics 
and related disorders. This instrument has been 
described previously (Eapen et al. 1993). In 
addition, each family member was askcd in­
dependently about the other members of his/her 
family. For those subjects reported by family 
members as having tics or OCB, we established 
this on direct clinical interview. Definite di­
agnosis of tics or OCB was made if symptoms 
were present both on history and on exam­
ination. Thc diagnosis of GTS was made 
according to DSM-III-R criteria (American 
Psychiatric Association, 1987). In all, there werc 
eight subjects with GTS, four with OCB, two 
with tics (that did not fulfil the criteria for GTS) 
and seven SUbjects were unaffected. One subject 
had OCB and tics, but not GTS. 
Scans were acquired following the routine 
protocol of the Institute of Nuclear Medicine 
(INM). All subjects were studied with the GE 
Neurocam triple-headed brain dedicated gamma 
camera (Kouris et al. 1992) after injection with 
550 MBq of 99mTc hexamethylpropylene amine 
oxime (HMPAO) at rest with eyes closed. Data 
processing and analysis were performed on a 
Star 4000 computer (Costa et al. 1988). Three 
orientation planes with a final slice thickness of 
2 pixels were studied. All scans were read by 
D. C. C. who was blind to the subjects' clinical 
status. The scans were reported qualitatively 
and quantitative radioactivity ratios (cortical/ 
cerebellum) were calculated. Normality was 
defined relative to a control database following 
the protocol at the INM (Costa et al. 1993). 
All patients were rated at the time of the scan 
for degree of anxiety using a visual analogue 
scale. 
After a complete description of the study, 
written informed consent was obtained from all 
adult subjects and from the parents of children, 
with the child's assent. None of the subjects had 
been scanned previously. The subjects with GTS 
were not part of the cohort we have previously 
reported (Moriarty et al. 1995). 
RESULTS 
Detailed results are presented in the Appendix 1, 
the subjects are grouped according to family (A 
to E). None of the seven family members who 
were entirely symptom free had abnormalities of 
their SPET scans. Of the 13 symptomatic 
subjects, only three had normal SPET scans and 
nine were abnormal (Fisher's Exact Test, two­
tailed, P = 0'0031). One scan, in an 8-year-old 
boy with GTS (A4) was obscured by movement 
artefact. Of the seven subjects with GTS who 
had good quality scans, hypoperfusion of the 
caudate nucleus (on either side or bilaterally) 
was seen in five, parietal or temporal in five, 
thalamus in two, frontal in one and brainstem in 
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one. Frontal, parietal, temporal and caudate 
involvement was seen in the three subjects with 
OCB. No hyperperfusion was reported in any of 
the scans. 
Affected subjects, including those with OCB, 
scored lower than the unaffected family mem bers 
on the visual analogue anxiety scale. (Patients 
1'6, S.D. = 1.4; normals 3'1, S.D. 2'2.) This is not 
a statistically significant difference. 
DISCUSSION 
Perfusion in GTS subjects 
The SPET findings of a variable pattern of 
hypoperfusion involving frontal, striatal and 
temporal areas in patients with GTS which has 
been reported by ourselves and others (Riddle et 
al. 1992; Dimitsopulos et al. 1993; Moriarty et 
al. 1995) is confirmed by this study. Unaffected 
family members had normal scans. Norn1al 
scans in clinically symptomatic subjects were 
seen in both patients with tics alone but without 
GTS itself and in the one subject with OCB and 
tics but not GTS. This suggests that whatever 
the perfusion abnormalities seen in patients with 
GTS they are not a reflection of the tics per se. 
They may be related to severity (this was not 
formally rated as part of this study) or reflect the 
complexity of the affective, cognitive and motor 
abnormalities which may be seen in patients 
with GTS. 
Perfusion in subjects with OCB 
The scan of the subject with tics and OCB was 
suboptimal and it cannot be unequivocally 
described as normal. None of our four subjects 
with OCB showed increased cerebral perfusion, 
although one had a normal scan. The others 
showed areas of decreased perfusion similar to 
those seen in the patients with GTS. Although it 
is unlikely that symptoms would be missed both 
on history and on clinical examination, it is still 
possible that in some of the younger subjects, 
symptoms may not yet have been expressed. It is 
possible that our subjects with OCB represented 
a less severe population than those subjects 
reported elsewhere in the literature. While this 
would possibly account for us not finding the 
frontal hyperperfusion described in patients with 
OCD, it cannot account for our finding of 
abnormal hypoperfusion. Further studies of 
patients with OCB matched for severity, with 
and without family histories of tic disorders 
would clarify this issue. 
In our efforts to control for anxiety, we 
observed that all affected subjects, including 
those with OCB, scored lower than unaffected 
on the visual analogue anxiety scale. Although 
this is not a statistically significant difference, we 
believe it reflects a clinical difference between 
patients with GTS (including OCB) and primary 
OCD which can be ignored in a literature bent 
on emphasizing similarity. Patients with GTS, 
unlike those with OCD, are not distressed by 
many of their ruminations. Neither are they 
plagued with the obsessional's fear of acting out 
their ritualistic ideas. Indeed, it is arguable that 
patients with GTS are at the opposite pole to 
those with OCD in that their scatological ideas 
are not resisted and associated with marked 
anxiety, but are vented, any resultant anxiety 
being associated with the embarrassment caused 
rather than the dislike of the thoughts them­
selves. Further evidence for the validity of this 
distinction comes from the study of OCD by 
Swedo et al. (1992), in which orbitofrontaJ 
hyperperfusion was shown to have a positive 
correlation with global anxiety when patients 
were treated with selective serotonin reuptake 
inhibitors (SSRIs). 
Subgroups of OCB 
McDougle et al. (1994) performed a double­
blind placebo controlled trial of haloperidol as 
add-on therapy for patients with OCD refractory 
to treatment with fluvoxamine. Treatment was 
of benefit in patients who had a co-morbid tic 
disorder. However, McDougles's study did not 
distinguish patients without a co-morbid di­
agnosis of a tic disorder but with a family 
history of a tic disorder from those without a 
family history (although it is stated in the 
discussion that none of the three responders to 
haloperidol without a co-morbid tic disorder 
had a known family history of tics). If the 
relevant distinction were between those with a 
genetic predisposition towards tic disorders 
(including a variant ofOCD), and those with no 
family history of tic disorders, this would be 
consistent with our finding of regional cerebral 
hypoperfusion in our selected patients with OCD 
in contrast to the usual finding ofhyper perfusion 
in patients with OCD described in the literature. 
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CONCLUSION 
We propose that our patients with OeB rep­
resent a specific subgroup of all patients with 
OeB, namely those patients with a personal or 
family history of tics. Present SPET meth­
odology cannot distinguish between different 
symptomatic subgroups (i.e. patients with OeB 
from patients with tics alone). Our findings 
suggest that OeB patients from families affected 
by tic disorders differ from patients with OeB 
without such family histories in being less 
anxious, and being characterized by reduced 
cerebral perfusion. 
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Al 43 M OCB 
A2 39 F Tics 
A3 6F Nil 
A4 8M GTS 
BI II M OCB 
B2 15 M GTS 
B3 47 F Nil 
B4 57 M GTS 
Cl 49 F Nil 
C2 15M GTS 
C3 13 F Nil 
C4 55M GTS 
DI 10M GTS 
D2 43 F OCB 
D3 43M Nil 
D4 20 F Nil 
El 45 F OCB and 
Tics 
E2 12 M GTS 
E3 46 M GTS 
E4 9M Nil 
IB PAR, lL, FR, 1R, 
TMP 
Normal 
Normal 
Obscured by artefact 
lIB PAR 
3 IB PAR lR CN 
2 Normal 
I IB PAR 1B FR IB THA 
lLTMPIBS 
Nonnal 
Normal 
Nonnal 
1B PAR 1B TMP 1 B CN 
1B CN 

IB CN 

Normal 

Normal 

Normal-
o 1BCNIRTMP 
o 1L PAR 1 R TMP 1 B CN 
1R THA 

Normal 

1, Hypoperfusion {compared to control database of lNM}; - due 
to a degree of claustrophobia in this subject, this scan excluded some 
of the inferior and anterior parts of the temporal lobes bilaterally, 
BS, Brainstem; CN, Caudate; FR, Frontal; PAR, Parietal; THA, 
Thalamus; TMP, Temporal; B, Bilateral; R, Right; L, Left. 
REFERENCES 
American Psychiatric Association (1987). Diagl10stic and Stalistical 
Manual of ;"fCTlfal Disnrt/ers (third e(ln- revised). American 
Psychiatric Association; Washington, DC 
Un
ive
rsi
ty 
of 
Ca
pe
 T
ow
n
193 
Elsevier 
Psychiatry Research: Neuroimaging, 55: 193-203 
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Abstract. A large body of evidence suggests that abnormal dopaminergic activity 
is present in Gilles de la Tourette Syndrome (GTS). To investigate whether dopa­
mine dysregulation involving the D2!D3 receptor occurs in GTS, we performed 
single slice dynamic single photon emission computed tomography (SPECT) with 
123iodo-6-methoxybenzamide (1231-IBZM) in 15 GTS patients (eight unmedicated) 
and six healthy volunteers. After intravenous administration of 5 mCi (185 MBq) 
of 1231-IBZM, dynamic SPECT (5 minutes per slice) studies were performed at the 
level of the basal ganglia for 55 minutes. The mean activity per pixel in the basal 
ganglia was compared with the mean activity per pixel in the visual cortex. Un­
medicated GTS patients showed no differences from control subjects. However, 
GTS patients taking D2 blocking medications had significantly decreased 1231_ 
IBZM binding compared with control subjects in both the right and left basal 
ganglia. Thus, D2! D3 receptor availability, as measured by 123I-IBZM SPECT, is 
not abnormal in GTS. 
Key Words. Single photon emission computed tomography, neuroleptics, 
123iodo-6-methoxybenzamide, tics. 
Gilles de la Tourette Syndrome (GTS) is a movement disorder characterized by 
chronic motor and vocal tics (Robertson, 1989). The anatomical location, frequency, 
complexity. and severity of the tics change over time, and the onset of the disorder 
characteristically occurs before the age of 14 years (American Psychiatric Associa­
tion, 1987; Bruun, 1988). Although the exact prevalence of GTS is' unknown, a 
currently accepted figure is 0.5 per thousand (approximately 110,000 patients in the 
United States and 27,500 in the United Kingdom) (Bruun, 1988), but even this may 
prove to be an underestimate. GTS is found worldwide and in all cultures, racial 
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groups, and social classes (Robertson, 1989). It occurs three or four times more 
commonly in males than in females. 
The etiology of GTS is now generally thought of as being biological, rather than 
psychodynamic, although stress exacerbates tics. Some authors have suggested an 
. autosomal dominant gene involving tics, GTS, and obsessive-compulsive disorder 
(OCD) (Pauls et aL, 1986; Robertson, 1989). The neurochemical basis for GTS is, as 
yet, not known, with several putative neurotransmitter abnormalities already 
reported (Caine et al., 1988; Singer et aI., 1990). However, the neurotransmitter 
dopamine has received the most attention, mainly because dopamine-blocking 
agents (e.g., haloperidol) reduce GTS symptoms, 'while dopaminergic stimulants 
(e.g., pemoline, methylphenidate) worsen tics and related behavior. There are many 
potential steps at which dopamine dysfunction might occur in GTS (e.g., over­
production, decreased catabolism, abnormal receptor binding, heightened post­
receptor signal) (Singer et al., 1991). Genetic studies, however, have failed to find 
linkage to the Dl or Dz receptor (Gelernter et aL, 1990). 
To investigate the possibility of abnormal D2 receptor binding or availability, we 
used brain-dedicated multidetector single photon emission computed tomography 
(SPECT) (George et aL, 1991) and the recently developed Dz/Drreceptor ligand, 
123iodo-6-methoxybenzamide (123I-IBZM) (Kung et al., 1989, 1990) to examine 
Dz/D3-receptor activity in GTS patients and control subjects. 
Methods 
Subjects. GTS subjects were recruited from the Gilles de la Tourette Syndrome Clinic at The 
National Hospitals for Neurology and Neurosurgery, Queen Square, London, U.K. The 
referral pattern and demographic makeup of the GTS clinic has been previously described 
(Robertson et aI., 1988; Robertson, 1989). Approximately one to two new GTS patients are 
evaluated per week from throughout the U.K., with a referral base of more than 56 million. 
Subjects were initially examined by a neuropsychiatrist (M.M.R.) to ascertain the diagnosis 
of GTS according to DSM-III-R criteria (Table 1) and then confirmed by another 
neurologist/ psychiatrist (M.S.G.) before study entry. Additional measures included the 
National Hospital Tourette Interview and a specially chosen battery of standardized psychi­
atric rating scales to measure specific aspects of psychopathology (Robertson et al., 1988; 
Robertson, 1989). The mean duration of illness was 10 years (SD 9.8), with a mean tic 
severity of 65 on the Yale Global Tic Severity Scale (Leckman et aI., 1989). Exclusionary 
criteria for both patients and volunteers included hepatic, renal or cardiac disease, pregnancy, 
seizure disorder, mental retardation, past history of cocaine or stimulant abuse, encephalitis, 
exposure to methylphenidate, or the presence of depression or severe psychiatric illnesses 
(other than OCD or GTS in the case of the patients). 
Healthy volunteers were recruited from hospital staff at the Institute of Psychiatry using the 
inclusion and exclusionary criteria defined above. This research was approved by the ethics 
committees of The National Hospitals for Nervous Diseases, The Middlesex Hospital, and 
ARSAC (the U.K. regional radiation safety committee). Informed written consent was 
obtained from each individuaL 
Procedures. Scanning was done using a brain-dedicated single-slice tomograph, the 
Strichman Medical Equipment (SME) 810 Brain Tomograph, at the Institute of Nuclear 
Medicine (UCMSM). Subjects were placed supine on the SME 810 couch. The orbitomeatal 
line (OM line) was visually aligned with the gantry to obtain OM parallel slices. Dynamic 
SPECT was performed at the level of the OM line + 30-40 mm. Subjects were instructed to 
, i l ""~U''''')\J''' 
   
I '-'AU' ..... ~ 
m
 
Un
ive
rsi
ty 
of 
Ca
pe
 T
ow
n
195 
Table 1. Subject data 
Subject Age Medication 
# (years) Sex (time since last taken) OeD ADHD Handedness 
1 27 F Haloperidol, 3 months + R 
2 45 F Sulpiride, 4 months + R 
3 29 M Never medicated + R 
4 10 M Never medicated R 
5 15 M Sulpiride, 3 months R 
6 31 F Neyer medicated + R 
7 12 M Never medicated + R 
8 15 M Pimozide, 3 months + R 
Medicated mean 
23 5/3 (M/F) 612 0/8 
9 47 M Clomipramine, 100 mg/day + R 
Sulpiride, 800 mg/day 
10 27 M Clomipramine, 100 mg/day + R 
Sulpiride, 80 mg/day 
11 14 F Haloperidol, 5 mg/day R 
12 38 M Flupenthixol, 40 mg/4 wks + R 
13 12 M Sulpiride, 200 mg/day + + R 
14 16 M Flupenthixol, 40 mg/2 wks R 
15 14 M Sulpiride, 400 mg/day + + R 
Clomipramine, 30 mg/day 
Medicated mean 
24 611 (M/F) 314 4/3 
Control mean 
30 4/2 (M/F) 0 0 AIIR 
Note. OCD :=::. obsessive-compulsive disorder. ADHD = attention deficit hyperactivity disorder. F female. M male. 
R = right. L left. 
keep their eyes open and not to talk. After resting quietly for 1-2 minutes, subjects were given 
an intravenous injection of 123J-IBZM through a 19-9auge needle in tqe right antecubital vein. 
The average dose of 5 mCi (185 MBq) was flushed through with 20 ml of saline. ('23I-IBZM 
was supplied by Cygne B.V., University of Eindhoven, The Netherlands.) Binding of i23J_ 
IBZM peaks 30-40 minutes after the injection and has a linear washout rate, resulting in a 
relatively stable target-to-background ratio of activity for up to 2 hours after the injection 
(Kung et a1., 1989,1990; Costa et aI., 1990; Brucke et a1., 1991). 
Scanning began immediately after the injection and continued for as long as the subjects 
could accept. Most subjects and volunteers tolerated at least 55 minutes of scanning, and thus 
the data analysis for this study is limited to 55 minutes. Acquisition time per slice was 5 
mihutes with a 1.5-minute interscan interval. The in-plane resolution of this system is 7-9 mm 
(full width at half maximum). The average slice thickness was 1.25 cm. Images were then 
reconstructed using SME software on an Apple MacIntosh computer. 
Image Analysis. Regions of interest (ROIs) were drawn with a mouse around the entire 
frontal lobe, entire visual cortex, and the right and left basal ganglia by a neurologist (M.S.G.) 
who was unaware of diagnosis at the time of the analysis. A template for the right and left 
basal ganglia was drawn around the 60-minute image with the 70% isocolor contour (Fig. I). 
Frontal lobe and visual cortex templates were drawn on the IO-minute image (blood 
flow I perfusion dependent distribution of 123I-IBZM) at the 40% isocolor contour. The same 
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Fig. 1..Transverse 1231-IBZM image at 60 minutes after injection with the 
color scale adjusted such that the 70% isocolor contour defines peak 
basal ganglia definition 
1231-1BZM 123iodo-6-methoxybenzamide. The 60-minute image was used for optimal placement of the basal ganglia 
region of interest used for all subjects. 
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templates were used for all scans, adjusted to fit optimally over the defined regions. This ROI 
sampling method has a 2.2% mean variation in the regions used. 
Statistical Analysis. 
Ratios. Because numerous factors can affect the total count rate in a given patient (e.g., 
amount of ligand absorbed, ligand remaining in the syringe), basal ganglia to visual cortex 
(BGIVC) and basal ganglia to frontal cortex (BGIFC) ratios were used to express relative 
123I-IBZM regional activity and produce a qualitative index of Dz receptor availability. The 
regions used included both hemispheres. 
Similar results emerged when basal ganglia to frontal cortex (BG 1FC) ratios were used. 
However, some of the GTS patients in this study also participated in a SPECT blood flow 
study that found increased right frontal blood flow in GTS subjects compared with control 
subjects (George et al., 1992). Thus, to avoid possible confounds due to changes in frontal 
blood flow, we present only BG/VC ratios. 
Relative binding curves. Mean BG/VC ratios for the left and right hemispheres were 
computed by group (control subjects, unmedicated and medicated GTS patients) for each time 
data point (from 0 to 55 minutes after injection). To produce a relative binding curve for 
'23I-IBZM, group right and left BG 1VC ratios were expressed over time (Fig. 2). Group means 
of each BG/VC value at each time point were compared by two-way repeated measures 
analysis of variance (ANOVA) (3 groups X time) for each hemisphere, with post hoc Student­
Newman-Keuls tests for significance. 
Slopes of binding curves. The ANOVA cannot deal with missing data points, and thus 
9/21 cases were rejected. These initial and late missing data points were due to patient 
movement, artifact, or the inability to tolerate 55 minutes of scanning (see Fig. 2). To test 
whether the results were erroneously influenced by the small number of subjects that entered 
the ANOVA, we used an additional method of data analysis. Each subject's relative binding 
curve for each hemisphere from 0 to 55 minutes was plotted on a Macintosh computer with 
commercial software (Cricket Graph) which then computed a simple linear (first-degree 
polynomial) equation (y = mx + b) to fit each subject's relative binding curve. Initially, we 
performed a hemisphere X group ANOVA to assess hemispheric differences. Then, for both 
the right and left hemispheres, the mean slopes for each group were compared by one-way 
ANOVA, with post hoc t tests (Student-Newman-Keuls procedure). 
Fig. 2. 1231-IBZM binding curves of the right and left basal ganglia/visual 
cortex over time by groups (medicated GTS patients, unmedicated GTS 
patients, and control subjects) 
1.1 
1.5 
1.3 
1.1 
5 
10 20 30 40 50 
1.1 
5 
Cont",1s (n=6) 
1.5 Unmedicaled GTS (n=8) 
LEFT RIGHT 
B...I Ganglial S...I Ganglial 
Yi.u.1 Corte. Yiaual Cortex .. 3 Modocaled GTS (0=7) 
1.1 
4 
0.9 -I-~-....--.~--.-........-.-.....-...--..---, 
60 o 10 20 30 40 50 60 
TIME (MINUTES POST INJECTION) TIME (MINUTES POST INJECTION) 
1231-IBZM = 123iodo-6-methoxybenzamide. GTS Gilles de la Tourette's Syndrome. For both the right and left basal 
ganglia, the medicated GTS group shows differences that became apparent at 20 minutes after injection. The 
unmedicated group did not differ significantly from control subjects. The numbers immediately above a graphed point 
indicate where the number of subjects included in the group mean is less than the total stated on the right due to motion 
or artifact. 
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Results 
Two-Way Repeated Measures ANOVA (3 Groups X Time), 
Within subjects (time effect). For both hemispheres, a significant time effect 
occurred, demonstrating significant binding of the ligand to receptors over time 
(n = 13; right: F= 27.72; df= 9, 90;p <0.001; left: F= 38.89; df= 9, 90;p < 0.001). 
Between subjects (group effect), A significant between-subject group effect 
was found in the right basal ganglia (F= 6.07; df= 2, 10;p = 0.019). This was due to 
a significant difference between normal control subjects and medicated GTS subjects 
(n = 13 total; 6 control subjects: mean BG/Ve slope = 1.31, SD =0.11; 4 medicated 
GTS patients: mean BG/Ve slope = 1.12, SD = 0.03; 3 unmedicated GTS sUbjects: 
mean BG/Ve slope = 1.19, SD = 0.09;p < 0.05). 
A significant between-subjects group effect was found. In the left basal ganglia 
(F = 8.08; df = 2, 10; p = 0.008). Post hoc tests revealed that this was due to 
significant differences between medicated GTS patients and control subjects, and 
between unmedicated GTS patients and control subjects (n = 13 total; 6 control 
subjects: mean BG/Ve slope = 1.37, SD = 0.10; 4 medicated GTS patients: mean 
BG/Ve slope = 1.18, SD =0.025; 3 unmedicated GTS patients: mean BG/VC slope 
= 1.24, SD = 0.15; p < 0.05). 
One-Way ANOVA of Uptake Slopes X Group. A group X hemisphere ANOVA 
revealed significant effects of group (F - 8.91; df= 2, 18;p =0.002) and hemisphere 
(F = 5.95; df = 1, 18; p = 0.025), although there was no significant group X 
hemisphere interaction. For both the right and the left basal ganglia, the medicated 
group had significantly lower slopes (reflecting lower Dz/ D3 binding over time) than 
control subjects or unmedicated GTS patients on the basis of post hoc Student­
Newman-Keuls tests. Other differences (i.e., between unmedicated GTS patients and 
control subjects) were not significant. 
A significant between-group difference existed for the right and left BGIVe mean 
slopes. On the right, this difference (F = 5.86; df= 2, 18; p = 0.01) was attributable 
to a significantly lower group mean slope (p < 0.05) in medicated GTS patients 
(n = 7; mean group slope = 0.001943, SD =0.0048) than in control subjects (n = 6, 
mean group slope = 0.0064, SD =0.0022), and between medicated GTS patients and 
unmedicated GTS patients (n = 8, mean slope = 0.008388, SD = 0.0034). On the 
left, this significant difference (F= 10.45; df= 2, 18;p =0.001) was attributable, as 
it was on the right, to significant differences (p < 0.05) between medicated GTS 
patients (n = 7, mean slope = 0.003129, SD = 0.003087) and control subjects (n = 6, 
mean slope - 0.0072, SD = 0.002158) and between medicated GTS patients and 
unmedicated GTS patients (n = 8, mean slope = 0.010450, SD = 0.003625). 
More consistent results were found with the slopes method, which used a larger 
number of subjects, than with the repeated measures ANOVA. 
Discussion 
Dopamine Theory. There are several reasons for believing that dopamine may be 
involved in the pathophysiology of GTS. The main argument for dopamine's 
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involvement in GTS comes from observations of treatment effects. The brain 
dopamine neurotransmitter system acts through at least two different receptors, DI 
and D2 (Singer et aI., 1991), although more are being identified and cloned. The 
affinities of neuroleptics for D2 sites are closely correlated with the amelioration of 
psychotic and movement disorders (Singer et aI., 1991). Thus, the,02 receptor could 
playa crucial role in GTS since the largest class of medications that successfully treat 
GTS are D2 receptor antagonists such as haloperidol (Shapiro and Shapiro, 1982), 
pimozide (Golden, 1984; Colvin and Tankanow, 1985), and sulpiride (Robertson et 
aI., 1990). Some GTS patients, however, do not benefit from neuroleptic medication 
(Robertson, 1989). It is therefore possible that responsiveness to dopamine (D2) 
antagonists may identify two distinct subgroups of GTS patients. 
Another argument for the involvement of dopamine in GTS comes from the fact 
that dopaminergic agonists such as L-dopa (Sacks, 1982) and central nervous system 
(CNS) stimulants such as methylphenidate (Golden, 1984) have an adverse effect on 
GTS symptoms, while dopamine depletors such as tetrabenazine (Jankovic et aI., 
1984) are associated with moderate improvement. The monoamine metabolite homo­
vanillic acid has been found to be decreased inthe cerebrospinal fluid of some GTS 
patients, although the methods involved have been criticized (Caine, 1985). 
Neuroimaging in GTS. Several groups are currently using imaging techniques to 
investigate abnormalities in GTS, and their results suggest that the abnormalities 
involve both CNS function and structure. Robertson et ai. (1988) reported 71 out of 
73 patients with GTS to have normal findings on computed tomography (CT). Other 
studies have noted CT scan abnormalities in 16 GTS patients; only 18 out of 172 
documented CT scans have been abnormal, and the abnormalities do not appear to 
be of direct etiological significance (Robertson, 1989). Recently, two separate studies 
have found reduced basal ganglia volumes in GTS patients compared with control 
subjects. Peterson et al. (1993) studied 14 adult GTS patients and found them to have 
decreased volume, as indicated by magnetic resonance imaging, in the left lenticular 
nuclei compared with findings in age-matched control subjects. In another MRI 
study, Singer et al. (1993) found that 37 GTS children had decreased volume in their 
left glo bus pallidus compared with their right, an asymmetry that was not present in 
18 control subjects. 
An initial study with positron emission tomography (PET) that used 18F-deoxy­
glucose found abnormalities in five GTS patients compared with control subjects 
(Chase et aI., 1984). GTS patients showed a relatively close positive association 
between metabolism in the basal ganglia (particularly the corpus striatum) and 
metabolism throughout the cerebral cortex. Vocal tic severity varied inversely with 
glucose metabolism in the middle and inferior parts of the frontal lobes bilaterally, 
extending posteriorly from the frontal poles to the postcentral gyrus. Coprolalia, in 
contrast, was inversely correlated with hypometabolism in the left parasylvian region 
(Chase et aI., 1984). In a more recent study that used a PET scanner with higher 
resolution and sensitivity, Chase et al. (1986) compared 12 untreated GTS patients 
with matched normal control subjects. At horizontal levels from 8.4-8.8 cm caudal to 
the vertex, nonnormalized glucose utilization rates were approximately 15% below 
control values in the region of the frontal cingulate and possibly insular cortex and in 
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the inferior corpus striatum (p < 0.01). Further studies by the same group (Braun et 
aI., 1991; Stoetter et aI., 1991) have revealed focal neuroanatomical abnormalities 
that primarily involve portions of the putamen and frontal and limbic cortices. In a 
recent SPECT study with technetium-99m-d,l-hexamethyl-propylene amine oxime 
. as tracer, George et al. (1992) found elevated frontal cerebral blood flow in 20 
unmedicated GTS patients compared with eight healthy volunteers. Finally, Singer 
et aI. (1992) failed to find differences in dopamine binding between GTS patients and 
control subjects in a PET study with lIC-N-methylspiperone as the ligand. 
Obsessive-compulsive disorder (OCD) is believed by some investigators to be 
genetically, phenomenologically, and probably neuroanatomically linked to GTS 
(Pauls et at, 1986; Baxter, 1990; George, 1992). Studies of brain structure in OCD 
are conflicting, with some reporting decreased caudate volume in OCD 
(Luxembourg et aI., 1988) and others not (Garber et aI., 1989; Kellner et aI., 1991). 
Functional neuroimaging studies of OCD using 18F-deoxyglucose PET have 
consistently revealed increased glucose metabolism in the caudate nuclei and orbital 
frontal lobes (Noidahl et aI., 1989; Swedo et aI., 1989; Baxter, 1990). 
Interpretation of Results. As would be predicted, GTS patients taking dopamine­
blocking medications displayed decreased 123I-IBZM activity in both basal ganglia, 
consistent with blocked D2! D3 receptors. Activity was significantly lower than that 
in healthy control subjects and unmedicated GTS patients. Two separate methods of 
data analysis corroborate this finding. 
In addition, this study failed to demonstrate significant differences between 
unmedicated GTS patients and control subjects in basal ganglia D2! D3 uptake. The 
repeated measures ANOV A did find a marginally significant difference on the left, 
but this analysis used only three subjects and the effect was not significant when the 
the mean slope method was used. 
Some caution should be used in interpreting these results. The numbers were small 
(eight unmedicated GTS patients, seven medicated GTS patients, and six control 
subjects). Thus, a Type II error cannot be excluded. We considered and excluded the 
possibility of "contamination" or mislabeling of a patient taking occult D2 blocking 
agents as being unmedicated. The unmedicated group consisted of four drug-naive 
subjects and four subjects who had not taken medications for more than 3 months. 
Subanalyses of these two subgroups revealed similar results. 
Differences in regional brain volume could conceivably have influenced our 
results. The most recent CT and MRI evidence indicates that GTS subjects have 
abnormally small left basal ganglia or globus pallidus. This decrease in left-sided 
caudate volume might explain the transient lag in GTS caudate D2 receptor binding 
(Fig. 2). Thus, decreased caudate volume, with decreased initial first pass of IBZM, 
might influence or partially explain our present results. We are investigating subjects 
in this study with MRI to quantitate volume of the basal ganglia, frontal cortex, and 
visual cortex. 
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Finally,there are methodological questions about the specific ability of 123I-IBZM 
to identify D2/ D3 receptors and the precise time at which the SPECT picture 
changes from one of general blood flow to more specific D2 binding. Studies show 
that 123I-IBZM binding to postsynaptic D2 receptors begins reliably at 20 minutes 
after injection, with peak binding at 35-40 minutes after injection (Kung et ai., 1989, 
1990; Costa et aI., 1990; Brucke et aI., 1991; Malison et aI., 1991). These results could 
.also be influenced by different levels of endogenous dopamine between control 
subjects and GTS subjects. For example, it is conceivable that GTS subjects might 
have higher levels of D2/ D3 receptors, but that the higher number is offset by higher 
resting levels of endogenous dopamine, thereby occupying and blocking some of the 
receptors. 
The present findings do not appear to support the theory of heightened or 
excessive D2 receptor binding of dopamine in GTS. The preliminary findings need to 
be replicated in other centers and with other D2 ligands, however, before firm 
conclusions can be drawn. It is to be hoped that functional neuroimaging studies 
with specific neuroligands will ultimately prove to be a powerful tool in unraveling 
the pathophysiology of Tourette's Syndrome. 
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Objective: To investigate dopamine transporter binding in Gilles de la 

Tourette syndrome (GTS) with SPECT and [123J]FP_CIT. 

Method: Ten neuroleptic naive/free patients with GTS, and 10 age­

and gender-matched normal volunteers were studied. Subjects were 

clinically evaluated. GTS severity and affective symptoms were 

measured~;~nd the presence of GTS-related behaviours were 

recorded. 

Results: The GTS group showed significantly higher binding in both 

caudate and putamen nuclei than the controls. No associations were 

found between striatal binding ratios and measures of affect or 

GTS-related behaviours. 

Conclusion: Patients with GTS show higher striatal binding of FP-CIT 

to the striatum in comparison with age- and gender-matched control 

subjects~ indicating that dopamine transporter abnormalities are 

involved in the pathophysiology of GTS. These abnormalities appear 

to be distributed across both caudate and putamen. 
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Introduction 
Gilles de la Tourette syndrome (GTS), also known 
as Tourette's disorder, is a neuropsychiatric con­
dition characterized by the presence of multiple 
motor and one or more vocal (phonic) tics, with an 
onset before the age of 18 years (1). Its prevalence 
has been suggested to be of the order of five per 
10 000 (2). In addition, some patients may present 
with coprophenomena, echophenomena, palilalia 
and a variety of other neurobehavioural disorders 
such as obsessive-{;ompulsive phenomena, depres­
sion, self-injurious behaviour and attention deficit 
hyperactivity disorder (2). 
The biological basis of GTS is not known yet 
and functional brain imaging studies using PET 
and SPECT have reported various findings in GTS 
patients. Considering markers of regional cerebral 
activity, findings of both increase and decrease in 
activity have been noted. Braun et aL (3) reported 
decreases in glucose metabolism in midbrain and 
ventral striatum and Eidelberg et al. (4) described 
metabolic decreases in caudate and thalamus. 
Moriarty et aL (5) similarly noted hypoperfusion 
of the left caudate, the anterior cingulate cortex 
and the left dorsolateral prefrontal cortex, as well 
as found that tic severity correlated with hypoper­
fusion in the left caudate, the cingulate and left 
medial temporal regions. However, George et al. 
(6) observed elevated frontal cerebral flow in their 
group of patients with GTS. 
Although the neurochemical basis of GTS is 
unclear, there is evidence of involvement of the 
dopaminergic system, based on the observations of 
the beneficial effects of dopamine blocking agents 
on the motor symptoms of GTS and of the 
exacerbation of these symptoms with dopamine 
enhancing drugs such as methylphenidate (2, 7) 
and cocaine (8). In addition, h0l110vanillic acid, the 
metabolite of dopamine, has been reported to be 
decreased in the cerebrospinal fluid of patients with 
GTS (2). 
Several aspects of dopaminergic system activity 
have also been investigated in patients with GTS. 
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neuroimaging studies of presynaptic (using 
and ftuoro-dopa) and postsynaptic (D2) 
amine receptors (using PET and [C11]raclo­
and SPECT and [123I]IBZM) have failed to 
any abnormalities in dopaminergic 
systems (9-12). However, Wolf et aL (13) 
greater IBZM binding to striatal D2 
in the clinically more affected sibling of 
pairs in their SPECT study. 
e
contrast with these findings, two PET studies 
dopamine re-uptake sites and DOPA decarb­
activity using [C11]WIN 35 428 and [18F]_ 
respectively and more recent ones using 
and e23I]J3-CIT, have demonstrated 
binding to presynaptic striatal dopamine 
uu<""",, sites in GTS patients when compared 
control subjects (14-16) and higher striatal 
ratios (17). These results are also in 
with a postmortem study of striatal 
amine re-uptake sites in patients with GTS 
eH] mazindol, in which an increased binding 
observed in patients with respect to control 
(18). It was speculated that these findings 
be explained by an enhanced dopaminergic 
. within the striatum. In contrast, two 
23I]J3-CIT/SPECT studies found no differ­
between GTS patients and normal control 
binding ratios to striatal dopamine 
molecules (19, 20). A recent study 
and DTBZ, to measure binding to 
vesicular monoamine transporter type-2 
), found no evidence of increased binding 
GTS patients (21). 
present study was to further 
the findings of previous studies of 
transporter binding in patients with 
by using high resolution SPECT and 
123I]FP_CIT in a sample of GTS patients and 
and gender-matched normal volunteers. 
1\JI,,'tD.i,,1 and methods 
and assessments 
project received ethical approval by the 
ational Hospital for Neurology and Neurosur­
and the Institute of Neurology (UCL) and 
by the Administration of Radioactive Sub­
stances Advisory Committee (ARSAC). Written 
consent was obtained from all the subjects. Ten 
consecutive patients with GTS meeting DSM-IV 
criteria (I) were studied. Eight patients were 
recruited from the GTS clinic at the National 
Dopamine transporter binding 
Hospital for Neurology and Neurosurgery, 
London. The referral pattern and demographical 
, makeup of this clinic has been previously described 
(22, 23). The patients were initially examined by a 
neuropsychiatrist (MMR) to ascertain the diagno­
sis of GTS and re-assessed by another neuropsy­
chiatrist (JS-M) before study entry to establish 
symptoms near the time of scanning. Two GTS 
patients were recruited via the UK Tourette's 
Association and were assessed by a neuropsychia­
trist (JS-M) prior to being studied. They had both 
been previously diagnosed as suffering from GTS 
by consultant neurologists elsewhere. 
Exclusion criteria were: drug and/or alcohol 
dependence, abuse of cocaine, ecstasy or amphet­
amines and derivatives, current treatment with 
methylphenidate, current or recent treatment with 
dopamine stores depleting agents (such as tetra­
benazine), current psychotic or other severe psy­
chiatric illness (other than OCD), presence of 
general medical conditions including neurological 
disorders other than GTS, history of head injury, 
pregnancy, learning disability, treatment with neu­
roleptic drugs within 2 months preceding the scan 
and age outside the range of 18-70 years. 
Information was obtained on duration of the 
disease and current and past medications. Severity 
of GTS was measured with the Yale Global Tic' 
Severity Rating Scale (24), which gives total scores 
on motor symptoms, vocal tics, general impair­
ment and a global score. Presence of current 
Attention Deficit Hyperactivity Disorder 
(ADHD) was checked by applying DSM-IV (I) 
criteria. Affective and anxiety symptoms were 
measured with the Hospital Anxiety and Depres­
sion Scale (HAD) (25). Obsessive-compulsive phe­
nomena were assessed with the Ley ton Obsessional 
Inventory (LOI) (26). The presence or absence of 
self-injurious behaviour (SIB), echophenomena 
and coprophenomena during the coprse of the 
disorder were recorded. .,' 
All but one of the patients were 'neuroleptic­
naIve' and this subject had not taken any anti­
psychotic drug for more than 1 year. None of 
the patients had taken any selective serotonin 
re-uptake inhibitor for 2 months prior to the study 
and none of them had ever taken clonidine. 
The GTS patients were compared with 10 age­
and gender-matched healthy volunteers. Patients 
were matched by age with control subjects within a 
range of 10 years, because striatal binding to 
dopamine transporter molecules declines between 
6.6 and 10% per decade in normal subjects (27, 28). 
The same exclusion criteria applied to control 
subjects as to the GTS group. No control subject 
achieved case ness in any of the assessments 
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described above. The subjects recruited were from 
among the hospital staff, staff from a hostel for the 
homeless, and spouses of patients with Parkinson's 
disease and dementia with Lewy bodies, and 
underwent a clinical interview with a neuropsychi­
atrist (JS-M). 
Radiopharmaceutical and scanning protocol 
The radiopharmaceutical e23I]FP-CIT or 2J3-car­
bometh oxy-3 13-(4-iod opheny1)-N-(3- fl uoropropy1) 
nortropane has been developed by Neumeyer et al. 
(29) for the imaging of the dopamine transporter 
(DAT) in the living human brain. It is a tropane 
analogue and hence a cocaine congener. Pseudo­
equilibrium of this tracer in the basal ganglia 
occurs between approximately 3-6 h postinjection 
(30).
e23I]FP-CIT was supplied by Nycomed Amer­
sham pic. (Little Chalfont, Bucks, UK). All sub~ 
jects received potassium iodide 120 mg/day orally 
in a single,dose for 2 days prior to the scan, on the 
day of th~ scan and "for 2 days after the scan, to 
block thyroid uptake of 1231. On arrival for the 
scanning session, subjects were asked to sit quietly 
on a chair and a 19-9auge cannula was inserted in 
the right antecubital vein. Between 10 and 15 min 
later the radiotracer was injected over a period of 
20 s, followed by a 20 ml flush of normal isotonic 
saline solu'tion. Each subject received approxI­
mately 185 MBq of e23I]FP-CIT. 
Data acquisition 
Data acquisition started between 3.5 and 5 h 
postinjection during pseudo-equilibrium (basal 
ganglia over background radioactivity ratios are 
almost constant between 3 and 6 h postinjection). 
Acquisition time was between 30 and 35 min 
(5 min per slice). The scans were performed in a 
brain-dedicated single-slice tomographic scanner 
(SME 810 Brain Tomograph: Strichman Medical 
Equipment, Medfield, MA, USA) at the Institute 
of Nuclear Medicine (University College London 
Medical School), The SME is made of 12 detectors 
equipped with high resolution (800 holes) collima­
tors, arranged on a circle around the patient's 
head. The number of counts acquired per slice at 
the basal ganglia level was approximately 500 000. 
The reconstructed spatial resolution measured 
using the high resolution collimators at our insti­
tution was 8.1 mm at the centre and 8.7 mm full­
width half maximum (31). Subjects were placed 
supine on the scanner's couch. The orbitomeatal 
line was visually aligned with the gantry to 
obtain orbitomeatal parallel slices. At least three 
contiguous slices were acquired from 25 to 55 mm 
above the orbitomeatal line. The subjects' heads 
were strapped to the head rest with tape around the 
forehead and the chin. Subjects were instructed to 
lie quiet and not to talk. No significant head 
movement was observed during scanning. Data 
acquisition followed manufacturer's recommenda­
tions. 
Data processing 
Data processing was carried out by DCC following 
manufacturer's recommendations. Iterative recon­
struction was employed and Hanning-type filters 
were used to obtain good contrast resolution with 
attenuation correction. Hanning filters are set by 
the manufacturers and never changed. 
Data analysis 
Circular regions of interest (ROI), all of the same 
size (Ill pixels), were used to calculate striatum/ 
occipital radioactivity ratios for the caudate nuc­
leus and putamen (anterior or rostral and posterior 
or caudal) on each hemisphere. Placement of the 
ROI was always made by the same observer (DCC), 
according to the anatomical visualization and 
tracer distribution, and following Tailarach coordi­
nates. For the striatum, one ROI for the caudate 
nucleus, one for the anterior putamen and another 
for the posterior putamen were placed with the 
pixel with maximum counts on the centre of each 
ROI. In the occipital cortex, five ROJ on each 
hemisphere were displayed along the calcarine 
cortex and the accessory visual cortex. Average 
counts per pixel were obtained from each striatal 
region on three contiguous slices with the highest 
radioactivity signal. Ratios were calculated with the 
average counts per pixel on the three striatal slices 
and ten ROI per slice placed in the visual cortex. 
The latter were used as the denominator. Simple 
radioactivity ratios were then calculated between 
each of the striatal ROI and the oCclpital cortex. 
Results 
Clinical results 
There were six males and four females in each study 
group, Data for the emotional state of one control 
subject were accidentally lost. The mean age in the 
GTS group was 43.5 years (range = 18-64, 
SD = 13.15) and in the control group 45.7 years 
(range = 28-67, SD = 14.76). The mean ages in 
the two groups were not significantly different 
(I-way ANOVA, FO,ls) = 0.124, P = 0.7). 
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Table 1 shows the clinical characteristics of the 
group. In this group there were two subjects 
th echolalia, one with echopraxia and two with 
. Two subjects had coprolalia, two had 
ropraxia and one had both phenomena. There 
six subjects with SIB and five subjects had 
od ADHD, but not the current disorder 
(1). 
The two study groups were significantly different 
measures of depression and anxiety, and obses­
",,,,··,,r.,",,y'''lsive symptoms; with GTS patients 
than controls in all measures 
GTS group as a whole showed a higher level of 
ding in caudate and putamen nuclei compared 
th the control group, and this difference was 
tistically significant (I-way ANOVA) (Table 3). 
account for the fact that variances in striatal 
nding ratios in the GTS group may not be 
distributed, binding ratios for the two 
were also compared using non-parametric 
(Kruskal-Wallis Test). This showed that 
in binding ratios remained significant 
ratios P < 0.05). 
Considering the GTS group, there were no 
. correlations (bivariate) between total 
severity and binding to the basal ganglia sites 
were studied. Similarly, within the GTS 
there were no significant correlations 
...",t,,,,p~·rt basal ganglia binding and depression or 
1. Clinical characteristics of the GTS group 
Mean Range SO 
43.50 18-64 1:3.15 
35.00 13-57 14.66 
12.50 9-21 3.75 
8.10 2-18 4.36 
4760 27-68 13.27 
Yale Global Tic Severity Scale. 
Mean scores on psycnopathological scales for both groups 
GTS' Controlst 
Mean Range SO Mean Range SO 
880 
10.90 
34.20 
0-18 
5-21 
15-53 
6.84 
6.03 
1423 
2.00 
2.75 
11.56 
0-5 
1~6 
5-26 
160 
1.67 
6.33 
Hospital Anxiety and Depression Scale. LOI = Leyton Obsessional 
Inventory. 
• GTS In 101 
t Controls in 91 
Dopamine transporter binding 
Table 3. Mean binding ratios in the two study groups 
GTS Control 
Mean SD Mean SO 
LAp·t 6.58 1.26 5.51 0.72 
LCWt 7.40 1.37 6.07 0.72 
LPP*t 5.43 0.89 4.70 0.55 
RAP't 6.80 1.34 5.65 0.65 
RCN*t 7.22 1.15 6.22 0.78 
RPP"t 5.94 1.16 4.71 0.56 
RCN right caudate, LeN left caudate, RAP"" right anterior putamen. 
RPP= right posterior putamen, LAP left anterior putamen. LPP left posterior 
putamen. 
GTS = Gilles de la Tourette syndrome, SD = standard deviation. 
• p < 0.05 p·way ANOVA) 

•• P< 0.01 (l·way ANOVA). 

t all P< 0.05 (Kruskal-Wallis). 

anxiety scores, obsessive-compulsive symptoms, or 
childhood ADHD; nor were there any significant 
differences in binding between those GTS patients 
with echophenomena, coprophenomena or SIB 
and those without such symptoms (I-way 
ANOVA). No associations were found between 
striatal binding ratios and age within either of the 
study groups (bivariate correlations). There were 
significant bivariate correlations between disease 
duration and binding to right caudate (r = -0,65, 
P = 0.04), left caudate (r -0.66, P 0.039) and 
right posterior putamen (r -0.66, P = 0.036), 
indicating that the shorter the duration, the higher 
the binding. Closer inspection of regional binding 
data from the individual subjects re"ealed that 
those subjects with higher DAT binding tended to 
be younger and to have a shorter duration of their 
disease. Further analysis was not conducted 
because of the small sample sizes. 
Discussion 
. In this. study, it was found' that patieI{is with GTS 
show significantly higher binding of FP-CIT to 
striatal DAT molecules than age- and gender­
matched healthy volunteers. The high resolution 
methods used in this study allowed the differenti­
ation between the various components of the 
striatum: caudate nucleus and anterior and poster­
ior aspects of the putamen. This is an advantage 
over the previous in vivo studies that have, at most, 
separated caudate from putamen (11, 14-20). This 
study, as far as known, is the first one to define 
three ROI in the striatum corresponding with the 
caudate nucleus and the two divisions of the 
putamen nucleus, and also the first study using 
FP-CIT in GTS. It is therefore noteworthy that 
increased binding ratios were observed in each of 
these different regions of the basal ganglia. 
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Measures of psychopathology frequently associ­
ated with GTS, such as obsessive~compulsive 
beha viours, depressive symptomatology, or anxi­
ety, did not show any associations with striatal 
binding to DAT. The same was true for echo and 
coprophenomena and SIB. This may suggest that 
these behavioural abnormalities, whilst related to 
some aspect of the pathophysiology of GTS, do 
not arise out of disturbances in striatal DAT 
binding. 
Higher striatal binding to DAT in GTS patients 
has already been observed in previous in vil'o (16, 
17) and postmortem studies (18). The significance 
of this finding is still a matter of speculation, 
especially in relation to whether it is a primary or a 
secondary phenomenon. An increase in binding to 
DATs could be explained by a hyperinnervation of 
the dopaminergic system (I8) leading to increased 
number of re-uptake sites, or by an increase in the 
concentration of re-uptake sites on normal num­
bers of dopaminergic terminals (18). 
Hyperinnervation sh0uld also cause an increase 
in the release of dopamine, but as Singer et a!. (18) 
have suggested, this would be incompatible with 
the reported finding of low levels of homovanillic 
acid (HVA) in CSF of GTS patients. They specu­
lated that low HVA is because of an enhanced 
clearance of dopamine from the synapse by 
increased nUp1bers of DATs (18). Singer et al.'s 
study (18) has als'o shown normal levels of 
tissue dopamine, 3,4-dihydroxyphenylacetic acid 
(DOPAC) and HVA. An increased dopaminergic 
innervation could explain why D2 receptor block­
ers or dopamine storage blockers improve tics (18). 
Low levels of endogenous synaptic dopamine 
should cause an increased binding to postsynaptic 
D2 receptors. However, till date, only one study 
has found increased IBZM binding to D2 receptors 
(in monozygotic twins discordant for GTS) (13), 
while others have not observed any abnormalities 
(lO~12, 18, 32). 
Both postmortem and structural neuroimaging 
studies in GTS have reported morphometric 
abnormalities in components of the striatum. In 
the former, it has been observed that in these 
structures there are greater number of neurones 
but of a smaller size (33) and a greater number of 
dopamine transporters (J 8). In the latter, smaller 
striatal volumes have been observed (34~36). 
Reduced striatal volumes may have contributed 
to the reduced striatal blood perfusion and glucose 
metabolism in GTS reported by some authors 
(3, 5, 37). 
In this study, a shorter duration of the sympto­
matology tended to be associated with higher 
bilateral caudate and right posterior putamen 
binding to DATs, but as there was no correlation 
between age and binding, this finding is not 
explained simply as an age effect. However, it 
may relate to the observations that peak tic severity 
occurs during adolescence and then gradually 
decreases over time (38). 
Possible confounding factors in this study will 
now be addressed. First, it may be argued that 
there is a potential sample bias because these 
patients were recruited from a tertiary referral 
centre for GTS, and could present with more 
severe forms of the disease and higher levels of 
comorbidity than the average GTS patient. How­
ever, the clinic assesses large numbers of patient in 
whom GTS is suspected in the United Kingdom; 
hence, they present with a range of symptom 
severity and associated behaviours. 
A second criticism may relate to the effects of 
antidopaminergic drugs on FP-CIT binding. The 
study patients were all neuroleptic-naive, except for 
one who had not taken any antipsychotic drug for 
more than a year before the scan. It is possible that 
patients may have unknowingly taken these drugs 
(Le. prescribed by family doctors, etc.); however, 
we are very confident that this is not the case. It has 
also been reported that the effects of chronic 
treatment with neuroleptics does not significantly 
change the pattern of tracer binding to DAT in 
humans (39, 40) or rats (41, 42). None of the 
patients had a drug screen test, but the use of 
amphetamine or derivatives (both prescribed and 
non-prescribed) and of cocaine was ruled out by 
careful clinical assessment and history taking. 
None of the patients had taken any dopamine 
depleting drug ever. 
A third criticism may relate to the effects of tic 
suppression and tic activity during scanning. No 
instructions were given to patients to suppress any 
abnormal movements during tracer injection and 
uptake. Image acquisition took place after the 
relatively irreversible accumulation of FP-CIT in 
the basal ganglia. Tic activity during scanning was 
minimal in all patients. Hence tic suppression 
during scanning was not expected to affect the 
results. 
A fourth criticism could be related to the effects 
of ADHD on binding ratios. Five of the GTS 
patients had a history of childhood ADHD but 
none had current ADHD according to the DSM­
IV (J) criteria. Furthermore, it has been reported 
that adult ADHD is not associated with abnor­
malities in DAT (43). 
Finally, factors related to sample size needs to be 
taken into consideration. Although with ten sub­
jects in each group, we have observed significant 
differences in striatal binding, as the sample size 
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ay not be large enough to show associations 
tween binding and measures of psychopathol­
ln conclusion, in this study we have demonstra­
that patients with GTS show increased striatal 
. g to DATs across both caudate and putamen 
comparison with control subjects matched for 
and gender. However, it appears that other 
vioural and psychiatric symptoms that can 
in GTS patients are not directly related to 
able abnormalities in striatal DAT activity. 
The radiotracer was supplied free of charge 
Nycomed Amersham pIc., UK. 
nntAtI."f"ements 
American Psychiatric Association. DSM-IV. Washington: 

American Psychiatric Press,. 1994. 

ROBERTSON MM. Annotation: Gilles de la Tourette syn­

drome - an update. J Child Psychol Psychiatry 1994;35: 

597-611. 

BRAUN AR, STOETIER B, RANDOLPH C et al. The functional 

neuroanatomy of Tourette's syndrome: an FDG-PET 

study, I. Regional changes in cerebral glucose metabolism 

differentiating patients and controls. Neuropsychophar­

macology 1993;9:277-291. 

EIDELBERG D, MOELLER JR, ANTONJI\1 A et a1. The metabolic 

anatomy of Tourette's syndrome. Neurology 1997;48:927­
934. 

MORIARTY J, COSTA DC, SCHMJTZ B, TRIMBLE MR, ELL PJ, 

ROBERTSON MM. Brain perfusion abnormalities in Gilles de 

la Tourette's syndrome. British J Psychiatry 1995;167:249­
254. 

GEORGE MS, TRIMBLE MR, COSTA DC, ROBERTSON MM, RL'IG 

HA, ELL PJ. Elevated frontal cerebral blood flow in Gilles 

de la Tourette syndrome: a 99Tcm-HMPAO SPECT study. 

Psychiatry Res: Neuroimaging 1992;45: 143-151. 

7. 	 SHAPIRO AK, SHAPIRO ES, FULOP G et al. Controlled study of 
haloperidol, pimozide and placebo for the treatment of 
Gilles de la Tourette's syndrome. Arch Gen Psychiatry 
1989;46:722-730. 
8. 	 CARDOSO FE, JANKOVIC ]:, Cocaine-related movement disor­
ders. Mov Dis 1993;8:!75-l78. 
9. 	 BROOKS DJ, TVRJANSKl N, SAWLE GV, PLAYFORD ED, LESS AJ. 
PET studies of the integrity or the pre and postsynaptic 
dopaminergic system in Tourette syndrome. Adv Neurol­
ogy 1992;58:227-231. 
GEORGE MS, ROBERTSON MM, COSTA DC et aJ. Dopamine 
receptor availability in Tourette's syndrome. Psychiatry 
Res: Neuroimaging 1994;55: 193-203. 
II. 	TURJANSKl N, SAWLE GV, PLAYFORD ED et al. PET studies of 
the presynaptic and postsynaptic dopaminergic system in 
Tourette's syndrome, j Neurol Neurosurg Psychiatry 
1994;57:688-692. 
Dopamine transporter binding' 
12. 	 MULLER-VAHL KR, BERDING G, KOLBE H et al. Dopamine D2 
receptor imaging in Gilles de la Tourette syndrome. Acta 
Neurol Scand 2000;101:165-171. 
13. 	 WOLF SS, JONES DW, KNABLE MB et a1. Tourette syndrome: 
prediction of phenotypic variation in monozygotic twins 
by caudate nucleus D2 receptor binding. Science 1996; 
273:1225-1227. 
14. 	 WONG D, SINGER H, MARENCO Set al. Dopamine transporter 
reuptake sites measured by [II C]WIN 35,428 PET imaging 
are elevated in Tourette syndrome (abstract). J Nucl Med 
, I 994;35: 130P. 
15. 	 MALISON RT, MCDOUGLE CJ, VAN DYCK CH et al. [123IJI3-CIT 
SPECT imaging of striatal dopamine transporter binding 
in Tourette's disorder. Am ] Psychiatry 1995;152: 1359­
1361. 
16. 	 MULLER-VAHL KR, BERDING G, BRUCKE T et al. Dopamine 
transporter binding in Gilles de la Tourette syndrome. 
J Neurol 2000;247:514--520. 
17. 	 ERNST M, ZAMETKlN AJ, IONS PH, MATOCfllK lA, PASCUALVACA 
D, COHEN RM. High presynaptic dopaminergic activity in 
children with Touretle's disorder. J Am Acad Child Ado­
lesc Psychiatry 1999;38:86-94. 
18. 	 SINGER HS, HAHN ill, MORAN TH. Abnormal dopamine 
uptake sites in postmortem striatum from patients with 
Tourette's syndrome. Ann Neurol 1991;30:558-562. 
19. 	 HEINZ A, KNABLE MB, WOLF SS et al. Tourette's syndrome: 
[I-123JI3-CIT SPECT correlates of vocal tic severity. 
Neurology 1998;51:1 069-- 1074. 
20. 	 STAMENKOVIC M, SCHIl\'DLER SD, ASENBAUM S et al. No change 
in striatal dopamine re-uptake site density in psychotropic 
drug na and in currently treated Tourette's disorder 
patients: a [(l23)I]-beta-CIT SPECT study, Eur Neuro­
psychopharmacoI2001;11:69-74. 
21. 	 MEYER P, BOHNEN NI, MINOSHIMA S et al. Striatal presynaptic 
monoaminergic vesicles are not increased in Tourette's 
syndrome. Neurology 1999;53:371-374. 
22, 	 ROBERTSON MM, TRIMBLE MR, LEES AJ. The psychopathol­
ogy of the Gilles de la Tourette syndrome. Br J Psychiatry 
1988;152:383-390. 
23. 	 ROBERTSON M. The Gilles de la Tourette ~yndrome: the 
current status. Br J Psychiatry 1989;154:147-169. 
24. 	 LECKMAN I, RlDDLE M, HARDlN M et al. The Yale Global 
Tic Severity Scale: initial testing of a clinician-rated scale 
of tic severity. J Am Acad Child Psychiatry 1989;28: 
566-573. 
25. 	 ZIGMOND AS, SNAITH RP. The Hospital Anxiety and 
Depression Scale. Acta Psychiatr Scand J.283;67:361-370" 
26. 	 COOPER lE. The Ley ton obsessional invent6fy. Psychol Med 
1970;1 :48--64. 
27. 	 VAN DyCK CH. SEIBYL JP, MALISON RT et al. Age-related 
decline in stria'tal dopamine transporter binding -with iod­
ine-123-I3-CIT SPECT. J Nucl Med 1995;36:1175-1181. 
28. 	 VAN DYCK CH, SEIBYL lP, MALISON RT et aL Age-related 
decline in dopamine transporters: anaJysis of striatal sub­
regions, nonlinear effects, and hemispheric asymmetries. 
Am J Geriatr Psychiatry 2002;10:36-43. 
29. 	 NEUMEYER JL, WANG S, GAO Y et a!. N-w-FluoroalkyJ 
analogues of (I R)-213-(4-iodophenyl)tropane (I3-CIT): 
radio tracers for positron emission tomography and 
single photon emission computed tomography imaging 
of dopamine transporters. 1 Med Chern 1994;37: 
1558-1561. 
30. 	 KUIKKA JT, BERGSTROM KA, AHONEN A el a!. Comparison 
of iodine-123 labelled 213-carbomethoxy-313-( 4-iodophe­
nyl)tropane and 2J3-carbomethoxy-3 /3-(4-i odophenyl)­
N-(3-fluoropropyl)nortropane ror imaging of the 
145 
~~ w j ~ ; -~y. 
. 1 -
~d 
in din 'r
1 
ge 
eha
ceur 
leasur
ollflict of interest 
Jone. 
y 
ck owledg
Ie are grateful to Nycorned Amersham pk. for supplying free 
f charge the [123IJFP-CIT used in this study. 
eferences 
l. d t
2. J  -
1
). T II e
t:.
.
-
1. l ll J
-
5. I l
-
S. ll
e
l
5 J. -
; :1 1  
~ t: J
f
l -
J. 
:
 
.
 
O l. ·· l V m
: -·
f 5 l
Ol
: 
Fl
l
] e
. 1 :
 -
O H !
:514
I H
o t
J
J IH  .'1
ret -
H ."r,tir.",.,.,p·
 ]J
] 
;; !
J . m -
b l 200 I  1  :
l o n .'<"n~"I;~
111 
.
S
J
o H
J I I
i
)283; 0 .. 
I r
Y , l li J
':." -
-iI :1 5-··  18l
J U !.
l -
] : ·
 l i i
 S-( 4-iodophenyl)tropal1 S I  
j m J 
I(j(
Ikarbomethoxy-3 -
t -3fJ-(4-iodo -
f
Un
ive
rsi
ty 
of 
Ca
pe
 T
ow
n
Serra-Mestres et al. 
dopamine transporter in the living human brain. Eur 1 
Nucl Med 1995;22:356-360, 
31. 	 GEORGE MS, RING HA, COSTA DC, ELL PJ, KOURIS K, JARRITT 
PH, SPET instrumentation: characteristics and new devel­
opments. In: GEORGE MS, RING HA, COSTA DC, ELL Pl, 
KOURIS K, JARRITT PH, eds. Neuroactivatiol1 and Neuro­
imaging with London: Springer-Verlag, 1991: 
29--49. 
32. 	 WONG OF, SINGER HS, BRANDT J et al. D2-1ike dopamine 
receptor density in Tourette's syndrome measured by PET. 
1 Nue! Med 1997;38:1243-1247. 
33. 	 RICHARDSON EP. Neuropathological studies of Tourelte 
syndrome. In: FRlEDHOFF AJ, CHASE TN, eds. Gilles de la 
Tourette Syndrome. New York: Raven Press, 1982:83-87, 
34, 	 HYDE 1M, AARONSON BA, RANDOLPH C, WIENBERGER DR. 
Cerebral morphometric abnormalities in Tourette's syn­
drome: a quantitative MRI study of monozygotic twins. 
Neurology 1995;45:1176-])82. 
35. 	 PETERSON B, RlDDLE MA, COHEN DJ et al. Reduced basal 
volumes in Tourette's syndrome using three 
dimensional reconstruction techniques from magnetic res­
onance Neurology 1993;43:941-949. 
36. 	 SINGER HS, REISS AL, BROWN JE et al. Volumetric MRI 
in basal ganglia of children with Tourette's syn­
drome. Neurology 1993;43:950-956. 
37. 	 RIDDLE MA, RASMUSSON AM, WOODS SW, HOFFER PH. 
imaging of cerebral blood flow in Tourette syndrome, Adv 
Neural 1992;58:207-211. 
38. 	 LECKMAN JF, ZHANG H, VITALE A et al. Course of tic 
in Tourette syndrome: the first two decades, Pediatrics 
1998;102: 14-19, 
39, 	 PEARCE RKB, SEEMAN P, lELLlNGER K, TOURTELLOTTE WW, 
Dopamine uptake sites and dopamine receptors in Par­
kinson's disease and schizophrenia. Eur Neurol 1990;30 
(Suppl. I): 9-14, 
40. 	 CWDEK C, REYNOLDS GP. [3H1GBR 12935 binding to dop­
amine uptake sites in schizophrenia. Br J Phannacol 
1988;5:765P. 
41. 	 READER TA, ASE AR, HUANG N, HEBERT C, VAN GELDER NM. 
Neuroleptics and dopamine transporters. Neurochem Res 
1998;23:73-80. 
42. 	 ASE AR, AMDISS F, HEBERT C, HUANG N, VAN GELDER NM, 
READER TA. Effects of antipsychotic drugs on dopamine 
and serotonin contents and metabolites, dopamine and 
serotonin transporters, and serotonin I A receptors. 
J Neural Transm 1999;106;75-105. 
43. 	 VAN DYCK CH, QUINLAN DM, CRETELLA LM et al. Unal­
tered dopamine transporter availability in adult attention 
deficit hyperactivity disorder. Am J Psychiatry 2002;159; 
309-312. 
146 
; :356··· .
I, l II
. -
1I -
. ]
·· -4
~.N L
J 
t
I HOff c
ll .
. IhD T  1 O
-
 
: 176-11
L
-
images, 
L
-
l .
o ·· ! I
L
.
: .
. J I TI .
-
J 1 .
O eH]
 L  A
-port
lss
rlnn~l-n;,·,~
J
] :
-
]
Un
ive
rsi
ty 
of 
Ca
pe
 T
ow
n
A Functional Neuroanatomy of Tics 
in Tourette Syndrome 
Emily Stern, MD; David A. Silbersweig, MD; Kit-Yun Chee, MD; Andrew Holmes, PhD; Mary M. Robertson, MD; 
Michael Trimble, MD; Christopher D. Frith, PhD; Richard S.]. Frachowiah, MD; Raymond]. Dolan, MD 
Background: Tics are involuntary, brief, stereotyped mo­
tor and vocal behaviors often associated with irresist­
ible urges. They are a defining symptom of the classic 
neuropsychiatric disorder, T ourette syndrome (TS), and 
constitute an example ofdisordered human volition. The 
neural correlates of tics are not well understood and have 
not been imaged selectively. 
Methods: Event-related [150 ]H20 positron emission to­
mography techniques combined with time-synchro­
nized audio and Videotaping were used to determine the 
duration of, frequency of, and radiotracer input during 
tics in each of 72 scans from 6 patients with TS. This per­
mitted a voxel-by-voxel correlational analysis within Sta­
tistical Parametric Mapping of patterns of neural activ­
ity associated with the tics. 
Results: Brain regions in which activity was signifi­
cantly correlated with tic occurrence in the group in­
cluded medial and lateral premo tor cortices, anterior cin­
gulate cortex, dorsolateral-rostral prefrontal cortex, 
inferior parietal cortex, putamen, and caudate, as well 
as primary motor cortex, the Broca's area, superior tem­
poral gyrus, insula, and claustrum. In an individual pa­
tient with prominent coprolalia, such vocal tics were as­
sociated with activity in prerolandic and postrolandic 
language regions, insula, caudate, thalamus, and cerebel­
lum, while activity in sensorimotor cortex was noted with 
motor tics. 
Conclusions: Aberrant activity in the interrelated sen­
sorimotor, language, executive, and paralimbic circuits 
identified in this study may account for the initiation and 
execution of diverse motor and vocal behaviors that char­
acterize tics in TS, as well as for the urges that often ac­
company them. 
Arch GenPsychiatry. 2000;57:741-748 
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T OURETTE SYNDROME (TS) is a classic neuropsychiatric disorder characterized by multiple motor and vocal tics. Tourette syndrome is 
seen worldwide, with typical onset in 
childhood, and a prevalence of approxi­
mately 5 per 10000.1 Comorbid obsessive­
compulsive, attention-deficit, and learn­
ing disorder features have been described 
as well. 2 There is a significant genetic com­
ponent in TS, with a suggestion of auto­
somal dominant transmission, although 
there have been no significant linkage find­
ings to date. I ,3,4 Autoimmune mecha­
nisms have also been implicated in some 
cases.5,6 
See also page 753 
Tics, the defining symptom ofTS, are 
sudden, brief, stereotyped actions. They 
may be simple vocalizations (such as 
grunting or sniffing), or movements of in­
dividual muscle groups. Alternatively, they 
may be complex in nature, comprising 
whole words (including curses [coprola­
lia]) or clusters of movements. 2 Mild tics 
can be unintentional, involuntary actions 
that can occur without a patient's aware­
ness. However, the more severe or com­
plex tics are often intentional, "unvolun­
tary" actions, in that they are briefly 
suppressible, performed to relieve a local 
tension, sometimes preceded or provoked 
by an uncomfortable sensation, or per­
formed compulsively in association with ir­
resistible urges 1 ,7 In these cases, the sub­
jective sense of free will is disrupted: tics 
are performed against the patient's will, or 
the will to act is not under the patient's con­
troL Therefore, TS provides a model ofone 
type of disordered human volition. 
The neural correlates of these strik­
ing symptoms of volitional disruption are 
not well defined. Basal ganglia dysfunc­
tion has been suggested by the occur­
rence of tics in patholOgical conditions that 
affect these deep structures, such as car­
bon monoxide poisoning and encephali­
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SUBJECTS AND METHODS 
SUBJECTS AND CLINICAL CHARACTERIZATION 
Six right-handed male patients with a DSM-lVOs diagnosis 
of TS (mean age, 36.7 years, range, 25-47 years; duration 
of illness: mean±SD, 30.3±10.9 years) and frequent tics 
were studied aher informed consent was obtained. Two pa­
tients were unmedicated and 4 suffered from tics despite 
neuroleptic medication (chlorpromazine dose equiva­
lents, 2175, 50, 300, and 75 mg). All patients were as­
sessed with the Yale Global Tic Severity Scale (mean ±SD 
score, 39.3±12.20f55), the questionnairefonn ofthe Ley­
ton Obsessional Inventory (mean ±SD score, 23.0± 15.9 of 
68), and the Beck DepreSSion Inventory (mean±SD score, 
7.2±6.0 of 39). Patients with notable head or neck tics, 
which could produce substantial head movement, were ex­
cluded. DUring the study sessions, all patients had simple 
and complex motor tics in varying muscle group distribu­
tions. Five patients had simple vocal tics, 4 of them had 
complex vocal tics, including coprolalia in 3. 
SCAN CONDITIONS 
Each of the patients was scanned 12 times, once every 10 
minutes. Before each of the scans in the study session, each 
patient was instructed to relax, to close his eyes, and to al­
low the tics to emerge if they happened to occur, without 
any effort to induce or suppress them. The motor tics were 
monitored with 2 video cameras: I focusingjust on the face 
and 1 covering the entire body. The vocal tics were moni­
tored with a throat microphone and tape recorder, as well 
as with the video/audio camera. The video and audio tapes 
were time-synchronized with the computer that logged the 
whole-brain time-activity curve, which reflects radio­
tracer delivery to the brain during each scan. Head motion 
was kept to less than the full-width half maximum of the 
smoothed spatial resolution of the images with a custom­
designed head holder that provided comfortable restraint. 
IMAGE ACQUISITION, PROCESSING, AND 
STATISTICAL ANALYSIS 
Regional cerebral blood flow was measured (as an index of 
neuronal activity) with a Siemens 953B PET scanner 
(Siemens Medical Systems, Hoffman Estates, Ill) in high­
sensitivity 3-dimensional mode using a low-dose (I5-mCO 
[50]HPslow-bolus technique, with 90-second acquisition 
(including a critical period of approximately 30 seconds, dur­
ing which the pattern of radio tracer distribution in the 
brain is determined).3s The procedure was covered under 
an approval by the local hospital ethical committee and the 
Administration of Radioactive Substances Advisory Com­
mittee, United Kingdom. The data were corrected for back­
ground activity and attenuation, reconstructed (Hanning fil­
ter 0.5; 8.4-mm resolution full width half maximum). and 
the images were realigned to one another, smoothed with a 
15 X 15 X 15-mm gaUSSian filter, transformed to the stereo­
tactic space of Talairach and Toumoux,39 and normalized 
using an analysis of covariance to remove the effect of dif­
ferences in global blood flow across scans or sessions.·oFor 
each of the 12 scans in the study session, the type and dis­
tribution of each tic, and the timing and duration of each 
tic in relation to radiotracer delivery was noted on video and 
audio tapes. This information was obtained by a neuropsy­
chiatrist (K.-y.c,) extremely experienced with tics and TS 
patients, who repeatedly watched and listened to the tapes 
(which had time markers) to determine the tic information 
for each second of the critical radiotracer delivery periods. 
This information was then used to derive a weighted score 
for each scan,36 reflecting the contribution of radiotracer depo­
sition during tics to the image (Table 1). There Was a spread 
of scan scores over the study session, reflecting differences 
across scans in the exact timing, duration, and frequency of 
tics, as well as the dynamic nature of the radio tracer input 
function during each scan. An event-related count rate cor­
relational analysisltl was then performed within the frame­
work of voxe!-by-voxeI Statistical Parametric Mapping!O 
Without the need for separate "nontic control scans," this 
symptom-specific analysis identifies voxels with intensities 
covarying with the scores, corresponding to areas of the brain 
in which activity is specifically associated with the tics. The 
group analysis was performed for all 72 scans by determin­
ing the significance of the average covariate (tic scan score) 
effect, or average correlation, at each voxel, in a linear model 
(multiple regression with block effect), including subject­
specific parameters for the scan scores, an effect for global 
cerebral blood flow, and additive subject effects; the latter 
adjust for between-subject differences in mean regional ce­
rebral blood flow not accounted for by global changes. The 
effect of neuroleptic medication was minimized within sub­
jects by fOCUSing exclUSively on the variance induced by tics 
(present despite medication in the medicated subjects) within 
a study session in which the dose was constant; itwas mini­
mized across subjects by the removal of subject-specific ef­
fects (which included medication dose), and by consider­
ing chlorpromazine eqUivalent doses as covariates of no 
interest. A similar, single-subject analysis was performed with 
data from an individual patient, for whom separate coprolalia! 
vocal tic and motor tic scores were calculated for each of 12 
scans in the study session. 
tis lethargica.8.9 The dopaminergic system has been im­
plicated in TS because dopaminergic medication can induce 
tics, while blockade of dopaminergic neurotransmission 
can be effective in their suppression.2 Most in vivo radio­
ligand imaging and postmortem histochemical studies of 
IS have therefore focused on presynaptic and postsynap­
tic dopaminergic function in the basal ganglia,1O-\5 al­
though a number of other brain regions and neurochemi­
cal (includingpeptide and second messenger) systems have 
been examined. 16- 18 Recent structural magnetic reso­
nance imaging studies have demonstrated abnormalities 
of volume and lack of normal asymmetry in the basal 
ganglia.19-22 A possible role for the anterior cingulate and 
midbrain in the generation of tics has also been sug­
gested. 23•24 Single-photon emission computed tomogra­
phy and fludeoxyglucose F 18 positron emission tomog­
raphy (PET) studies in the "resting" baseline state25-33 have 
produced variable results, with decreased or increased 
activity described in regions such as the striatum and thala­
mus, and premotor, sensorimotor, and paralimbic corti­
ces. Disordered interactions between subcortical, paralim­
bic, and sensorimotor brain regions have also been 
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postulated.30 A recent functional magnetic resonance im­
agingstudyl4 focusing on the suppression ofties found that 
increased severity of tics outside the scanner was associ­
ated with less of a suppression-related decrease in ventral 
globus pallidus, putamen, and midthalamus activity (and 
less of a corresponding increase in midfrontal, lateral tem­
poral, inferior OCcipital, and head of caudate activity). 
To date, the functional neuroimaging experiments of 
TS have provided extremely valuable information, but have 
not measured (or, in some cases, controlled for) tic oc­
currence during scanning, and therefore have not gener­
ated an image of the brain state specifically associated with 
ties. We have developed and validated methods of PET im­
age acquisition and analysis35,36 that can isolate patterns 
of brain activity associated with transient, randomly oc­
cUrringneuropsychiatric states. These methods have been 
used to study the functional neuroanatomy of hallucina­
tions (involuntary perception) in schizophrenia. 37ln this 
study, they were used to examine the pathophYSiology of 
tics (unvoluntary/involuntary action) in TS. 
------_dM""_I-----­
The group results were assessed at a threshold ofP<'005, 
with spatial extent of activations corrected for multiple 
comparisons at a threshold ofP<.05. Increased brain ac­
tivity highly correlated with tic behavior was detected in 
a set of neocortical, paralimbic, and subcortical regions, 
including supplementary motor, premotor, anterior 
cingulate, dorsolateral-rostral prefrontal, and primary mo­
tor cortices, the Broca's area, insula, claustrum, puta­
men, and caudate. Activations in superior temporal gy­
rus, inferior parietal cortex, and a point near the anterior 
thalamus, extending toward the head ofcaudate were also 
detected. These foci of activation are displayed and char­
acterized in Figure 1 and Table 2. 
For a single subject in whom greater than 90% of 
vocal ties were coprolalia, separate scan scores were gen­
erated for coprolalia/vocal tics and for motor tics. At a 
threshold of P<'005, with spatial extent corrected for mul­
tiple comparisons at P<.05, coprolalia was associated with 
activity in a set of regions, including the frontal opercu­
lumand the Broca's area (Brodmann areas [BAsj44, 45) 
(z=4.34;x,y, z==-30, 20,16) (extending ventrally in the 
opercular region adjacent to BA 47; Z= 2.88; x, y, Z= 22, 
28,0); superior temporal gyrus (BA 42; z=4.22; x, y, 
z=-60, -26, 8) (BA 22; z=4.05; x, y, z=-50, -40, 12); 
head of caudate(z=3.46;x,y, z=-4, 10,12); bodyofcau­
date (z= 2.72; x, y, Z= 12,6, 20); a region near the tail of 
the caudate and hippocampus (z=3.67;x,y, z=34, -40, 
4); supramarginal gyrus (BA 40; z=3.43;x,y, z=-54,-50, 
32); posterior insula (z=3.37; x,y, z=30, -26, 4 ); middle 
temporal gyrus (BA 21; z=3.31;x,y, z=-54, -60, 0); pu­
tamen (z=3.29; x, y, z=-16, 16,4); cerebellar vermis 
(:;;:=3.23; x, y, z=4, -54, 0); cerebellum (z=2.77; x, y, 
z= 12, -48, -12); posterior thalamus (z=2.98;x,y, z=22, 
-26,8); medial thalamus (z= 2.78;x,y, z=-6, -12, 16); 
and posterior cingulate gyrus (z= 2.82; x, y, z=6, -44, 
8). At the same threshold, motor tics were associated with 
activation in a region deep to inferior parietal and sen­
sorimotor cortex (z=5.04; x, y, z=-40, -22, 28); senso­
rimotorcortex (BAs 2, 4; z=3.96; x,y, z=-48, -22, 36); 
Table 1. Tic Scan Scores* 
Subject No. 
Scan No. 2 3 4 5 6 
1 0.269 0.096 0.761 0.532 0.509 0.959 
2 0.798 0.167 0.942 0.822 0.309 0.944 
3 0.607 0.494 0.953 0.955 0.156 0.765 
4 0.590 0.435 0.946 0.997 0.389 0.686 
5 0.745 0.192 0.284 o.72i ' 0.291 ' 0.379 
6 0.657 0.087 0.514 1.000 0.302 0.307 
7 0.331 0.099 0.477 0.850 0.322 0.581 
8 0.389 0.135 0.791 0.986 0.202 0.338 
9 0.796 0.624 0.588 0.954 0.776 0.767 
10 0.818 0.998 0.883 0.952 0.589 ' 0.998 
11 0.588 '0.576 0.887 0.826 0.859 0.998 
12 0.953 0.621 0.866 0.771' 0.849 0.999 
$ SCiJn scores represent the radio tracer deposition during motor and VOCiJI 
tics, hence the contribution of these events to the resultant image. These 
weighted scores constitute the covariate of interest in the group correlational 
analYSis performed. See the "Image Acquisition, Processing. and Statistical 
Analysis" subsection of the "Subjects and Method" section, as well as 
Silbersweig et al.36 
superior temporal gyrus (BAs 42, 22; z=3.60;x,y, z=-56, 
-26,16); and somatosensory cortex (BA 2; z=2. 70;x,y, 
z=-60, -22,24) (Figure 2). While the sensorimotor ac­
tivations were on the left at this threshold, right-sided 
activations, as well as putamen activation, were seen at 
a lower threshold (P<.Ol, uncorrected) in this subject. 
It should be noted that, although the distribution dif­
fered, vocal tics occurred Simultaneously with a subset 
of the motor tics in this subject, so one would not ex­
pect that these activations represent maps purely of vo­
calor motor tics. It should also be kept in mind that cer­
tain regions of activation may become apparent with the 
increased power of the group analYSiS, while other re­
gions may be more specific to an individual analysis. 
These results define a distributed neural system in which 
abnormal activity is associated with the spontaneous ini­
tiation of, or failure to suppress, motor and vocal behav­
ioral repertoires in this group ofTS patients. Prominent 
activity was noted in primary motor and Broca's areas, 
corresponding to the modality-specific outflow path­
ways of behavioral expression in motor and vocal tics. 
Striatal activity was also noted, supporting the involve­
ment of basal ganglia circuits that are emphasized in tra­
ditional pathophysiological models of TS. The exten­
sive activity in executive and premotor regions may be 
particularly notable, and may help to extend our under­
standing of disordered action and volition in TS, be­
cause these regions have traditionally been associated with 
the selection, preparation, and initiation of behavior. 
Activity detected in the striatum can be seen in the 
context of cortico-striato-pallido-thalamo-cortical cir­
cuits that modulate activity in parallel brain systems un­
derlying discrete psychomotor functions with specific 
functional and somatotopic organization.~1 Within these 
circuits, the direct and indirect basal ganglia pathways 
provide a balance of excitation and inhibition42 that may 
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be disrupted in TS. A failure of inhibition in motor cor­
tex of TS patients, due to subcortical afferent disinhibi­
tion anc\Jor to failure of intracortical inhibition, has been 
suggested by a transcranial magnetic stimulation study') 
The findings of the current study implicate 3 of the cortico­
striato-pallido-thalamo-cortical circuits in particular: the 
motor, dorsolateral prefron tal, and anterior cingulate cir­
cuits. These circuits are involved in the selection, pro­
gramming, initiation, and control of movement." Do­
paminergic projections from the midbrain tegmentum, 
a region where activation was noted at a threshold of 
P<.005 (uncorrected), are involved in the modulation 
of these circuits. 41 This modulation may provide a mecha­
nism of symptom formation (excess dopamine) and treat­
ment effect (dopamine blockade) in TS.2 
For particular tics, the specific cortical and subcor­
tical regions that are activated may determine the phe­
nomenology of the behavior. In the individual analysis, 
coprolalia (which comprised more than 90% of the vo­
cal tics) was associated with activation in the region of 
the Broca's area and the frontal operculum, known to be 
involved in the generation of speech. Activation was also 
noted in the head of the caudate, which has recently been 
Right 
t6mm 
identified by lesion methods as a critical component of 
the network underlying language·' The other language 
regions noted (including posterior superior temporal gy­
rus, middle temporal gyrus, and supramarginal gyrus) 
may have been involved in the generation or the subse­
quent hearing of the self-generated linguistic materiaL 
Activation in the posterior congulate gyrus has recently 
been described in association with emotional linguistic 
materiaL46 The thalamic and cerebellar activations are con­
sistent with the roles of these structures in modulating 
outOow of the cortical-subcortical circuits implicated. In 
contrast to the vocal tics, motor tics were associated with 
notable sensorimotor cortex activation. It is likely that 
activations of somatotopically speCific subregions in sen­
sorimotor cortices would be associated with move­
ments in specific corresponding muscle groups. 
Activity in anterior cingulate, premotor, and supple­
mentary motor areas, and dorsolateral prefrontal cor­
tex, detected in the current study, has been described in 
tasks involving conscious, volitional behavior, and is 
thought to be involved in the selection, preparation, and 
initiation of actionD.47.s2 Activity in the supplementary 
motor area has also been noted in the performance of over-
Figure 1. Stereotactic axial sections of brain areas with significanlly increased activity during tics (motor and vocal) in 6 patients with Tourelte syndrome. 
Functional positron emission tomography results (thresholded at P<.005. with spatial extent corrected for multiple comparisons at a threshold ofP<.05) are 
displayed in color, superimposed on a single slruclural TI-weighted magnetic resonance imaging scan that has been transformed into the stereotactic coordinate 
space of Talairach and Tournoux" (for anatomical reference). Section numbers refer /0 the distance (in millimeters) from the anterior commissure-posterior 
commissure line, with positive numbers being superior to the line. The areas of maximal activation are described in the text and listed in Table 1. 
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learned (automatic) motor sequences.53 Activation of me­
dial premotor association cortices has been associated with 
self-generated movements and activation of lateral pre­
motor association cortices has been associated with ex­
ternally cued voluntary movements. 51 The striking acti­
vation of both medial and lateral premotor systems in this 
study suggests that both systems can be implicated in "un­
voluntary" internally generated action. The involve­
ment of the lateral premotor system may reflect the re­
sponse to internal sensations, which are now known to 
be a common component of tics in TS. 55.56 One study has 
reported a lack of normal premovement potentials asso­
ciated with simple tics,57 while another study found that 
premo tor potentials were present during tics in some pa­
tients.58 In either event, tics may differ from externally 
cued, planned movement in the timing, sequence, co­
herence, or distribution of premotor activity, and com­
plex tics might be expected to involve more premotor ac­
tivity than simple tics. A study of electroencephalogram 
microstates suggested differences between TS patients and 
normal subjects during simple and complex move­
ments.59While the purpose of this study was to charac­
terize the functional neuroanatomy of tics, future com­
parisons of tics vs volitional movements in TS patients, 
and of volitional movements in TS patients vs normal sub­
jects, may help to clarify these issues. 
The lesion and stimulation literature is also rel­
evant to the interpretation of the findings in this study. 
Lesions or failure of activation of the medial frontal pre­
motor system, prominently activated in this study, have 
been associated with the inability to initiate voluntary ac­
tion 60.61 Conversely, stimulation of, or seizure activity 
in, these regions can produce complex vocal and motor 
automatisms (sometimes associated with urges and emo­
tions) resembling tics. This is particularly the case with 
the anterior cingulate, which is part of the rostral limbic 
system, and integrates affective cues with executive func­
tions for the selection of context-dependent behav­
ior D . 62 The prominently activated insula is also in­
volved in the integration of internal motivational states, 
with behavior appropriate for the extrapersonal world (en­
tailing behavioral triggering or inhibition functions), in 
the imparting of affective tone to experience and behav­
ior, and in somatosensory, linguistic, and self-generated 
motor functions .53 Like the cingulate, it performs these 
roles by serving as a convergence point with Widespread 
multimodal, limbic, and basal ganglia connections63 Dys­
function (including abnormal gating) in these phyloge­
netically older paralimbic regions may contribute to the 
primitive, uninhibited behavior of TS. The maxima of 
some of the activations in the insular region were cen­
tered on the claustrum. While such a small localization 
must be considered with caution, it is worth noting that 
the claustrum has connectivity with sensorimotor, pre­
motor, and anterior cingulate regions, and is involved in 
the performance of movements 64.66 
The predominantly dorsal location of anterior cin­
gulate activation, rostral location of supplementary mo­
tor activation,67 and dorsolateral location of prefrontal 
activation associated with tics in this study represents in­
termittent increased activity of executive components of 
the motor system (although supplementary motor cor-
Table 2. localS.lalislical Maxima In the Pallernlil Brain 

AclivHy Durln9 Tics in 6 Palienls With Tourelle Syndrome 

Region (Brodmann Area) X,}', z* zScore 
left 
Precentral gyrus (4) 
-46, ;:12, 28 .5.82 
Precentral gyrus (latera(6) . 
-46, ~4, 20 5.33 
Middle frontal gyrus (lateral 6) . 
-44, 4, 12 4.93 
Middle froniaigyrus (10) 
-32\ 40, 20 4:32 
Superior frbntal gyrus (9) ' 
-26, 36,28 3.76 
Middle frontal gyrus (9/46) . 
-32,32.24 372 
Claustrum/insula 
-30.10,0 9:56 
Inferior frontal gyrus (45) . 
-38.26,16 3.23 
Putamen ~22. 2.0 3.17 
Inferior parietal lobule (40) 
-34, -32.40 3:02 
Anterjorcingulate gyrus (32) " 
-22. 20;28 2.74 
RighI 
Precenlralgyrus (4/6) 46; -:8. 28 4.91 
Caudate (tail), posteriorinsulat 36;~38.4 4.72 
Superior temporal gyrus (22) >46~::22 i . 4 4.72 
.48, -3S.8 3.70 
Insula 38.-26.0 . 4.56 . 
38,4,8 3.13 
Medial frontal'gyruiHW 0;.14.44 4.43 
Ariieriorcingulate (24)t 2,4,20 191 .. 
. Anterior cingulale (32) 8,16.40 3.86 
. Infer.ior parietallobuf~(40) 42.-28,28 3.76 ". 
Caudate (head) 4,12,16 3.58 
'Postcentralgyrus (3)
.. 
2~, ~'24. 44 3.47 
Anterior thalamus/caudate (head) ' 10,0.8 3.26 
Claustrumlinsula 34.'-2,4 3.24 
• Coordinates in millimeters relative to the anterior commissure: x is the 
lateral distance from the midline (positive =righ/);y. the anteroposterior 
distance from the anterior commissure (positive = anterior); and z, the height 
relative to the intercommissuralline. 
t/ndicates the maximum coordinate in a brain region adjacent to agray 
mailer structure that is part of the same contiguous activation. 
tex overall is considered premotor. and the cingulate also 
contains direct corticospinal projectionsD ). Executive dys­
function has been noted in neuropsychological tests of 
patients with TS. 68. 69Tonic overactivity of frontal execu­
tive systems, coupled with hypoactivity in primary sen­
sorimotor cortices, has been implicated in idiopathic dys­
tonia, characterized by involuntary motor posturing and 
slowingJO Increased activity in orbitofrontal cortex and 
anterior cingulate cortex, and their subcortical connec­
tions (including the head of the caudate), has been im­
plicated in obsessive-compulsive symptomatology.71 char­
acterized by involuntary thoughts and complex actions. 
and seen with increased frequency in patients with TS.2 
Given the differential prefrontal projections to various 
regions of the striatum (premotor to putamen and pre­
frontal to head of caudate), it might be expected thaqJU­
tamen dysfunction would be associated with a greater de­
gree of motor symptomatology, whereas caudate 
dysfunction would be associated with a greater degree 
of cognitive symptomatologyH 
The results of this "state" study of tics in TS may 
also be seen in the context of prior "trait" studies25.31 of 
TS. When the variable results of the previous trait stud­
ies are taken together, they suggest a tonic dysregula­
tion of a number of the regions in which increased ac­
tivity was detected in this symptom-state examination. 
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Figure 2. Correlations in a single patient with Tourelte syndrome between regional cerebral blood /low (rCBF) and scan scores lor coprolalia in the left Irontal 
operculum! inferior frontal gyrus (A). and for motor tics in the left sensorimotor cOItex (8). These activated regions (thresh aided at P<.OOI. with spatial extent 
corrected for multiple comparisons at P< .05) are superimposed in cotor on axial slices from a stereotactically transformed structural magnetic resonance 
imaging template. L indicates left. 
The decreased activity noted in some of the previous stud­
ies may reflect inhibition of tics during those study ses­
sionsJ1 (such inhibition is unlikely in the current study, 
as patients were reminded not to supress tics bdore each 
scan and had frequent tics during each scan, with which 
brain activity was directly correlated). It is also possible 
that tonic decreased activity alternates with intermittent 
Increased activity during tics in the regions implicated in 
T5. Although tics are not frank seizures, such a temporal 
pattern would be similar to that described in PET studies 
of epUeptic [oci,73 and consistent with an imbalance of ex­
citation and inhibition. 
The results of this study may help to expand the in­
terpretation of the results of a previous functional mag­
netic resonance imaging study that examined tic suppres­
sion in T53 4 That study compared a condition in which 
tics were suppressed wi.th a condition in which tics were 
expressed. The authors interpreted their findings wi.th an 
emphasis on the issue of suppression, and make the rea­
sonable suggestion that failure to inhibit tics in T5 may 
result from an impaired ability to alter subcortical neuro­
nal activity. WhiLe they noted that the higher rate of spon­
taneous tics in their control condition was a possible con­
founding factor, they felt that this was unlikely because 
they expected that the higher rate of tics would produce a 
greater change in magnetic resonance imaging signal in­
tensity during successful tic suppression, and correlate posi­
tively (not negatively, as observed) with severity of tic symp­
toms (measured outside of the scanner). However, this 
would not be the case in regions active during both tics 
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and (possibly to a different degree in) their suppression. 
In the current study, tics were not suppressed, and were 
counted and characterized during the scans and differ­
ences in numbers of tics, and possibly urge, are not an is­
sue. The results of these 2 studies can therefore be taken 
together, possibly suggesting that anterior cingulate and 
midfrontal activity is common to both tics and their sup­
pression, and that putamen and sensorimotor cortex (mo­
tor outflow) activity is higher during tics and lower dur­
ing suppression. While the pallern of increased activity 
noted in the current study could be primary, it is also quite 
possible that it could result from failure of inhibition. 
Although these statistically significant results rep­
resent a sampling of hundreds of tics in 72 images from 
multiple subjects, the population studied is still rela­
tively small, the analysis applies for just this group of sub­
jects, and further studies will be necessary to replicate, 
extend, and assess the generalizability of these findings. 
Possible medication effect in 4 of the subjects also has 
to be considered as a potential limitation, although a num­
ber of points make this issue less likely to affect the re­
sults: the target symptom (tics), and therefore the neu­
ral firing underlying it, was active despite medication in 
the 4 medicated patients (2 were unmedicated); the analy­
sis determines the variance induced by tics in a constant 
pharmacodynamic/pharmacokinetic selling over the 
course of the study session; and subject-specific effects, 
including medication and dosage (chlorpromazine equiva­
lents) , were partialed out in the analysis. Despite the 2 
videotapes and throat microphone, it is possible that ex­
tremely subtle tics may have been missed, although pa­
tients with known severe, stereotypical tics were stud­
ied. Regarding timing, it should be kept in mind that the 
temporal discrimination achieved with this technique is 
not due to direct temporal resolution, the timing mea­
sures were to the nearest second, possible subcompo­
nents of tics cannot be resolved, and it is not possible to 
say where the activation in the identified systems be­
gins, or whether it occurs in parallel. Future analyses and 
studies can examine these issues, as well as similarities 
and differences between subtypes of tics, within and be­
tween indi vidual unmedica ted patien ts. 
In conclusion, activity was noted speCifically dur­
ing tics in motor/vocalization, para limbic, premotor, and 
executive frontal-subcortical brain systems. Alllono­
mous activity in these regions may account for the strik­
ing motor and vocal acts of TS patients, and may con­
tribute to the "unvoluntary" experience of an irresistible 
urge that often accompanies these acts. Indeed, tics may 
represent a paradoxical state in which brain regions im­
portant for motivational aspects of behavior, and nor­
mally associated with a subjective sense of volition as they 
initiate action, are not operating under the volitional con­
trol of the patient. This suggested systems-level patho­
physiology of TS is consistent with observations of be­
havioral changes associated with lesions and stimulation 
in medial frontal regions , and these findings may con­
tribute to a framework for future studies. 
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A volumetric MRI study of Gilles de la 

Tourette's syndrome 

J. Moriarty, MB; A.R. Vanna, MD; J. Stevens, MD; M. Fish, BSc; M.R. Trimble, MD; and M.M. Robertson, MD 
Article abstract-The neuroanatomic or neuropathoiogic basis o[ Gilles de la Tourette's syndrome (GTS) remains 
unknown. Recent studies have suggested abnormalities of cerebral asymmetry and basal ganglia volumes. We studied 17 
patients with GTS and eight normal controls using volumetric MRI techniques [or measuring the caudate nucleus, 
amygdala, and corpus callosum. One subject with GTS was subsequently excluded because he was left handed. No 
absolute differences in caudate nucleus volumes between patient and control groups were evident. There was an increase 
in corpus callosum (CC) cross-sectional area and a loss of the normal asymmetry of the caudate nucleus in the patient 
group. A loss of the normal correlation between cross-sectional area of the CC and whole brain index (WBI) in the patient 
group also was found. The amygdala measurements had a poor interrater reliability. 
NEUROLOGY 1997;49:410-415 
Gilles de la Tourette's Syndrome (GTS) is a disorder 
defined by the presence of multiple motor and one or 
more vocal tics with childhood onset and a fluctuat­
ing course.1,2 It is further characterized by the pres­
ence of symptoms s'Uch as coprolalia and echolalia. 
Genetic3,4 and epidemiologic5 .6 studies have shown 
GTS to be associated with obsessive compulsive dis­
order. The precise etiology of GTS remains unknown, 
but it is thought to be an autosomal dominant ge­
netic disorder .4 
The neuropathologic basis of GTS also is un­
known. Postmortem pathologic studies of patients 
with GTS suggested reduced dynorphin in the lateral 
globus pallidus7 and neuronal hypoplasia in the cau­
date nucleus (CN) and putamen.s Cases of "second­
ary GTS," in which the symptoms of the syndrome 
are seen to develop following identified brain lesions 
in persons without any family history of GTS,9.10 
have also shown involvement of the basal ganglia 
and medial temporal structures. It is therefore rea­
sonable to assume that dysfunction of the basal gan­
glia and medial temporal lobe may be the basis of the 
clinical syndrome of GTS.lI Neuroimaging tech­
niques offer us the prospect of examining such hy­
potheses . 
Single photon emission computed tomography 
(SPECT) studies have found regional cerebral blood 
flow (rCBF) abnormalities in the striatum and me­
dial temporal areas12. j4 PET studies have revealed 
metabolic dysfunction in the striatum and frontal,
19cingulate, and insular corticesY·16 MRI studies J7· 
have found subtle anatomic abnormalities in the len­
ticular and caudate nuclei using volumetric MRI 
methods. These studies support neuroanatomic data 
implicating the basal ganglia in the clinical syn­
drome of GTS. However, they also raise important 
questions, which we propose to address. The hypo­
function of medial temporal and anterior striatal ar­
eas, observed in previous studies using functional 
imaging techniques, might relate to underlying 
structural abnormality. The present study is a mor­
phometric study of the CN and amygdala using MRI 
volumetric techniques. We also examine whether the 
changes to normal cerebral asymmetry reported by 
other investigators are seen in the CN and amyg­
dala. 
In addition, Witelson20 has argued that the consis­
tency in loss of asymmetry in basal ganglia struc­
tures is compelling, and she suggests that measure­
ment of size of the CC may be illuminating in the 
study of GTS, given that this structure appears to be 
a sensitive indicator of cortical anatomy.21 Other 
studies have to date produced conflicting results in 
the measurement of CC size with both increases22 
and decreases23 having been described. Therefore, we 
measured the cross-sectional area of the CC to deter­
mine whether there is any difference in the size of 
the CC in patients with GTS compared with normal 
controls. 
Methods. Twenty-five scans were performed on 17 pa­
tients (11 male , six female) and eight normal controls (four 
male, four female). The mean age of the patients was 35 
years, (SD,13; range, 17- 62); that of the controls 33 years , 
(SD, 10; range, 20-45). All patients were recruited from 
consecutive referrals to the GTS clinic at the National 
Hospital for Neurology and Neurosurgery, Queen Square, 
London. All subjects were drug free for at least 3 months 
prior to the scan. One patient and none of the controls was 
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left handed, as determined by exclusive preference for the 
right hand on all 12 items of the Annett handednessques­
tionnaire 21 This patient (a 35-year-old man) was not in­
cluded in subsequent analyses. 
MRl. All scans were acquired using a GE l.5 tesla 
scanner with an identical protocol: (1) Sagittal 90° fast 
multiplanar spoiled gradient acquisition in steady state 
(SPGR), TRiTE 131 /3.4 , 12 images, 256 X 192 matrix and 
two excitations, 5 mm thickness; (2) kcial fast dual echo 
multiplanar acquisition TRiTEliTE2 2000/30175 , 256 x 
192 matrix, two excitations, thickness 5 mm, 40 images; 
(3) Coronal volumetric SPGR, TRiTE 35/5, flip angle 35°, 
256 x 158 matrix, one excitation, 124 images, 1.5 mm 
thickness. The last sequence was used for volumetric anal­
ysis because of the small slice thickness and large number 
of available slices through the structures of interest, allow­
ing the most appropriate sampling rates to be selected 
according to described stereologic principles. This protocol 
is identical to that described elsewhere for the volumetric 
analysis of the hippocampus in patients with localization­
related epilepsy undergoing presurgical evaluation. 25 
There is no interslice gap for these images. 
Analysis. The settings for the gray-scale window and 
level were chosen visually to maximize the contrast be­
tween gray and white matter. For the amygdala, at x l 
magnification, the most anterior slice to be measured was 
identified as that in which the anterior commissure was 
visible ipsilaterally. The images were magnified by a factor 
of 3. Measurements proceeded from the posterior aspect of 
the amygdaloid complex. Reference was made to a stan­
dard neuroanatomic atlas throughout. 26 The criteria used 
to define the amygdaloid complex were adapted from those 
described by Watson et aJ.27 Pos teriorly, the inferior horn 
of the lateral ventricle was used to identify the separation 
of the amygdala from the hippocampus. The superior limit 
of the region of interest was consistently defined by a 
straight line joining the most lateral aspect of the entorhi­
nal sulcus and the most inferior aspect of the circular 
sulcus of the insula. The gray matter-CSF boundary was 
used to identify the medial boundary of the region of inter­
est. Inferolaterally, the wall of the uncal cleft of the infe­
rior horn of the lateral ventricle was used as a boundary. 
The white-gray interface provided the more anterior lat­
erallimit. The lateral and medial ends of the hippocampal­
amygdaloid articulation were taken as the most medial 
aspect of the inferior horn of the lateral ventricle and the 
gyrus ambiens respectively. If, as was the case in some 
slices, the hippocampal-amygdala articulation could not be 
clearly seen, a straight line was used to join these two 
points. Otherwise, the articulation was traced manually 
along the line of the alveus . In cases in which the gyrus 
ambien s was not visible, a horizontal line was drawn from 
the most medial aspect of the inferior horn to the crural 
cistern, to define the inferior limit of our region of interest 
(figure 1) 
The CN was measured bilaterally from its appearance 
anteriorly for a maximum of 20 slices (30 mm) (figure 2) . 
As can be seen from the figure, the separation of the CN 
from the nucleus accumbens (NA) is not possible visually, 
and so when we speak of CN, we include part of the N A in 
that structure. 
For the CC, the midline sagittal section was used, iden­
tified as the section that included the pituitary stalk, and 
Figure 1. Coronal section with circumscribed region of 
interest for left amygdala (300% magnification). 
cross-sectional area measured by tracing manually along 
the border of the CC (figure 3). 
1n addition, a measure to correct for whole brain volume 
was calculated using Peterson's method. l7 This index of 
brain volume, which is a morphometric approximation, is a 
product of three distances in three dimensions. The verti­
cal distance is that of a line joining the inferior border of 
the mammillary body to the vertex perpendicular to a line 
joining the most anterior point of the genu of the CC to the 
most inferior point of the splenium. The anteroposterior 
and transverse diameters are perpendicular in a transax­
ial section at the level of the inferi!?r border of the CC. 
Reliability measures were based on two independent 
observer measurements (different observers at different 
Figure 2. Coronal section with circumscribed region of 
interest for left caudate nucleus (300% magmfication). 
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Figure 3. Midline sagittal section with circumscribed re­
gion of interest for corpus callosum (200% magnification). 
times) on all 17 patien:-.is calculated' as an intraclass corre­
lation coefficient (ICC).2s Three raters in all were used 
(J.M. and M.F. for the amygdala and J.M. and A.V. for the 
CN). Raters were blind to subject characteristics. 
For the CN and the amygdala, an asymmetry index (AI) 
was calculated according to the formula 
(Right - Left) 
Al = ' (Right + Left) 
Differences between groups in volume or AI were tested 
using one-way ANOVA with correction for multiple com­
parisons. Correlations between WBI and CC cross­
sectional area were calculated (Pearson's product­
moment). 
Results. The ICC for the amygdala measurements was 
0.47 on the right and 0.38 on the left. For the CN, 0.84 on 
the right and 0.91 on the left. The coefficient for both the 
WBI and the CC area was 0.96. 
Mean volumes for the amygdalae are not reported here 
because of poor interrater reliability. Mean volumes for the 
CNs and the values for the WBI and callosal cross­
sectional area are shown in table 1. There were no volume 
differences between GTS and controls for the amygdala or 
Table J Mean (standard deviation) fo r volumetric measurements 
o{ caudate nucleus and far ca.llosal cross-sectional area and 
whole-brain index 
GTS (n = 16) CN (n = 8) 
Righ t caudate 2,916 (385) mm3 3,134 (525 ) mm3 
Left caudate 2,947 (4 20) mm3 2,958 (473) mm3 
Corpus callosum 641 (57) mm2 564 (67) mm 2 p=.OI6 
WB] 1.67 (17) 1.60 (.15) 
GTS = Gill es de la Tourette syndrome; WBI = whole brain in­
dex . 
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Table 2 Pearson product-moment correlation coefficients {or age 
and callosal cross-sectiollal area 
Clinician group N p 
Male 14 01 
Female 10 
.19 
Total 24 08 
GTS male 10 19 
GTS female 6 .70 
GTS total 16 .34 
NC male 4 -67 
NC female 4 -.73 
NC total 8 -.65 
(AJI not significant) 
GTS = Gilles de la Tourette's syndrome; NC = normal control. 
the CN, nor any difference in WBI between the two groups . 
Area of the CC was significantly greater in patients than 
in controls. Correcting the volume of the subcortical nuclei 
or CC for WBI did not affect the results. 
Values for the asymmetry index for the amygdala are 
not reported, given the poor interrater reliability of the 
measurements. For the CN the mean asymmetry index is 
0.00 (SD 001) for the GTS patients and 0.03 (SD, 0.01) for 
the normal controls , p = 0.05. Thus, there is a significant 
loss of normal right-side predominance of the CN in the 
patient group. If we divide our groups according to sex, we 
find the same patterns. The mean Al for male controls is 
0.024, and for female , 0.033. The mean Al for the 10 male 
GTS patients is 0.005, and for the six females, 0.018. 
A correlation exists between callosal cross-sectional 
area and WBI seen in normal controls (p = 0.86, p < 0.01). 
This is absent in the patient group (p = - 0.35, NS)_ 
No correlation was seen between age and CC cross­
sectional area in men or women considered separately, or 
in the group as a whole (table 2). A decline in the cross­
sectional area of CC with age is suggested in the normal 
controls but not in the patient group. This correlation is 
not significant. 
Discussion. Most evidence from existing literature 
points to the involvement of basal ganglia and limbic 
structures (orbitofrontal, cingulate, insular, and me­
dial temporal cortices) in GTS. Studies to date have 
not, however, clarified whether these findings are 
merely functional or linked to structural abnormali­
ties of the same areas. 
In our previous studies of patients with GTS using 
SPECT, we found reduced rCBF in the anterior stri­
atum and left medial temporal areas.]2 Similar find­
ings have been reported by other groups. Riddle et 
a1. 13 found left striatal hypo perfusion in nine pa­
tients whereas KurIan's groUp]4 found similar rCBF 
abnormalities in the right striatum in six . Chase et 
al 15 described a PET study of 12 untreated patients 
(10 men and 2 women). No apparent abnormalities 
were found on visual inspection of the scans but 
quantitative analysis showed reductions in frontal , 
cingulate, and possibly, insular cortices and m the 
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Table 3 Findings from structural imaging in Gilles de La 
Tourelte syndrome'" 
Study N Findings 
CspaJ"ulo et aJ. (1981)38 16 Ventricular enlargement 
Lees e t aJ. (1984)"' 53 Normal 
Harcherik et aJ. (1985)" 19 No characteris tic differences 
Regeur et aJ. (1986)" 53 5 Varied abnormalities 
Chase et aJ. (1986)15 9 2 Minor abnormalities 
Robertson et al. (1988)'2 73 2 Cavum septum 
pellucidwn 
Demeter (1992)·13 10 2 Focal abnormalities of 
basal ganglia 
Case studies 
Yeragani et al. (1983)" ? Calcification of the 
caudate nucleus 
Shaenboen et aJ. (1984)"' 1 Enlargement of occipital 
horns lateral ventricles 
Lakke and Wilmink (1985)'· 1 Pineal tumor 
Kjaer et al. (1986)'11 1 Porencephalic cyst 
Sandyk (l9881'1B 1 Asymmetric cerebral 
peduncles 
Robertson et al. (1990)" Right globus pallidus 
twin as well as a loss of the normal ventricular 
asymmetry. 
We found a loss of the normal CN asymmetry in 
patients with GTS. This is consistent with the report 
by Hyde et a1. 19 In the study by Peterson et al F of 
fourteen right-handed adults, there was a loss of the 
normal left-sided predominance of the lenticular nu­
cleus. However, unlike us, they did not find a loss of 
the normal right-sided predominance of the CN in 
their GTS group. Singer IS reported findings similar 
to those of Peterson et a1. In their study, a male-only 
subgroup showed a trend towards absolute reduction 
in left lenticular volume. Although in our study we 
found no such absolute reduction in CN volume, the 
loss of asymmetry would seem to relate primarily to 
reduction in volume of the right CN. Our previous 
SPECT study l2 found decreased rCBF to be more 
marked in the left CN. SPECT measures are semi­
quantitative and only an indirect indicator of neural 
metabolism. Furthermore, the CN region of interest 
using SPECT does not exactly reflect the anatomic 
CN. Differences of resolution between the two tech­
niques (the resolution of SPECT is considerably 
lower) are also present. Thus, if the CN was smaller, 
the fixed region of interest method using SPECT 
would include adjacent structures. However, even if 
this were the case, we would expect the effect would 
be to show an apparent reduction in blood flow to 
what was the smaller structure. The findings with 
functional imaging, especially in the light of recent 
MRI literature (including the present study) there­
fore need further elucidation. Coregistration of MRI 
and SPECT images or statistical parametric maps 
derived using PET would be most helpful in this 
endeavour. 
Although the CN is primarily involved in the me­
diation of motor behavior, there is extensive evidence 
of its role in other complex behaviors.29 Unilateral 
CN hemorrhage has been associated with amnesia, 
abulia, language disturbances, hallucinations, and 
varying degrees of apathy and disinhibition. These 
disturbances are reminiscent of frontal lobe disor­
ders and indeed the cortical aff-erents to the striatum 
maintain the topographic rep'iesentation of the corti­
cal areas of origin. It would be inappropriate to try to 
account for the neurobehavioral manifestations of 
GTS solely with reference to the caudate itself. As 
already discussed, abnormalities of cerebral asym­
metry and lateralization have been found by others 
in other structures and are likely to continue to be 
found in brain areas not at present amenable to 
volumetric MRI measurement. 
We were aware from the outset that measurement 
of the amygdala on MRI images is difficult. The cri­
teria described in the methods section were adapted 
from previous publications in an effort to maximize 
reliability and validity. The low ICC for these mea­
sures suggests that, using this methodology at least, 
measurement of the amygdala is not reliable. This 
does not exclude the possibility that less easily iden· 
tifiable differences in amygdala volume might exist, 
August 1997 NEUROLOGY 49 413 
*This list does not include the studies by Peterson et aL," 
Singer et aL,1B and Hyde et al.,'9 which are referred to in more 
detail in the text. 
inferior corpus striatum. There was an inverse corre­
lation between the severity of both vocal and motor 
tics and glucose utilization rates in these areas. 
More recently, this group has described abnormali­
ties in terms of abnormal associations between met­
abolic rates in sensorimotor cortex and limbic ar­
eas16 Thus, consensus is emerging from the 
functional neuroimaging literature that patients 
with GTS show reduced CBF and metabolism in lim­
bic structures. 
Before 1993, no detailed structural imaging stud­
ies in GTS were done (table 3). CT studies found no 
characteristic abnormalities in the disorder or only 
minor abnormalities of doubtful significance, such as 
cavum septum pellucidum, porencephalic cyst, or 
asymmetry of cerebral peduncles. More recent stud­
ies, using sophisticated MRI morphometric method­
ology, have found more specific structural abnormal­
ities. Two complementary papers in 1993 described 
reduced lenticular volume and a loss of the usual 
left-sided predominance of the lentiform nucleus in 
both adults 17 and children J8 with the syndrome. In 
the adult study, right-sided predominance of the CN 
was seen in both GTS and normal controls. In the 
study involving children, no significant CN asymme­
try was found in either controls or patients. The 
possible role of the CN is again raised by Hyde et 
a1. 19 This group studied monozygotic twin pairs dis­
cordant for severity of GTS and found reduced right 
CN volume in the relatively more severely affected 
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but remain 	 to detect with this 
of our measures of cau­
callosal area, WBI is to 
by Peterson et a1. found an of 
the caudate and 0.99 for the WBI. 
calculated the on a random sample 
including 5 con troIs. We ....O".\.. ..... "H.<;7 ..... 
ours on the entire of 17 patients, which 
tend to maximize our detection of inter-rater 
error. 
The 
the CC 
tion. between 
CC area and brain size in our group. 
ences in CC size in relation to sex and handedness 
remain unclear. Witelson30 describes a postmortem 
the CC in 50 Subjects with non-
consistent right hand (NCRH) 
the same 12-item handedness 
so that were asked to 
ence being seen the isth­
mus. Significant sex in 
anatomy. as a factor, inter-
with sex. The difference due to hand­
edness was seen in males but not in females. This is 
consistent in with the hypothesis of 
less clear than 
area correlated with brain (p = 
Not all have found these 
however.31 Increased size in the CC has 
fow1d in epilepsy32 ~nd' in schizophrenia.33.35 uuuu.t1a­
12 published from either n'-H'1'""",""""O", 
or MRI data (4), 3 further 
son30 determined that the of 
to sex 
handedness was found as 
It is also whether there may neu­
loss in the with aging. Witelson21 
found a decrease in size with age in men, 
but not in women. finding of an inverse correla­
tion between age and area in controls 
which was absent in the GTS 
that other factors to asym­
than age in determin­
dent of age, intracranial area, or comor­
bid attention-deficit-hyperactivity disorder. That 
considered children and whereas 
the study by et aJ.23 was adults. Our 
suggests that the age does not ac­
count for the findings of Peterson et a1. 
results also a decline in callosal cross-
sectional area with m absent in 
the GTS This is again consistent with the 
fmdings of et a1., found 
no correlation with age in this 
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raises the of cc 
development in with GTS differs from nor­
mal controls; we agTee with et a1. that 
assessment of size longitudinally is necessary to 
unravel the interaction between age callosal 
morphology in 
It is 
androgenic steroids acting on brain pre­
natally.36 Kurlan37 has hypothesized that the defec­
tive gene in may influence the development and 
neural networks the basal 
ganglia) under sex hormone The loss of cere­
bral seen in our and other of GTS 
implicate some effect on the developing 
CNS and is thus consistent with this hypothesis. 
However, abnonnalities of in the 
CN and increased callosal area in 
GTS when with controls may 
abnormality. 
may subse­
brain 
MRL Al-
it would 
be if such generalized abnormalities man­
ifested only as GTS. To establish their specificity for 
GTS, further studies with GTS 
with other neurodevelopmental abnor-
We would like to acknowledge the 
MRI unit at St. Mary's Hospital and 
of the staff of the 
tee red to be scanned. 
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The Gilles de la Tourette's syndrome (GTS) is a move­
ment disorder characterised by both multiple motor and 
one or more vocal tics which usually occur many times 
a day, in bouts. The anatomiGll location, frequency, 
complexity and severity of the tics change over time, 
and characteristically the onset of the disorder is before 
the age of 21 years (Robertson 1989). 
The exact prevalence of GTS is unknown, but a cur­
rently accepted figure is 0.5 per thousand (approximately 
110000 patients in the,USA and 27500 in the UK (Bruun 
1984), but even this may prove to be an underestimate. 
Recent studies (Kurian et al. 1987; Caine et al. 1988; 
Robertson and Gourdie 1990) suggest that many cases 
of GTS are mil.d, do not come to medical attention and 
do not require pharmacological treatment. 
GTS is found in all cultures and racial groups, but 
it is rare among the American black population. Most 
large cohorts of patients with GTS have come from the 
USA, but substantial numbers of patients have also been 
reported from the Soviet Union, UK, Japan, FRG, the 
Netherlands, Denmark and China. These studies plus 
case reports from all parts of the world highlight the 
worldwide distribution of the disorder. GTS occurs three 
or four times more commonly in men than in women, 
and it is found in all social classes (Robertson 1989). 
The clinical characteristics of patients with GTS ap­
pear to be independent of culture, as they occur with 
some degree of uniformity irrespective of the country 
of origin. The age of onset of symptoms ranges from 
2 to 15 years with a mean of 7 years being commonly 
reported. The most frequent initial symptoms are tics 
involving the eyes (such as eye blinking), head nodding 
and facial grimacing, which are also the most common 
tics. GTS is often referred to as a tic disorder, but pa­
tients with GTS usually exhibit a wide variety of compli­
cated movements including touching, hitting, jumping, 
smelling of the hands or objects, spitting, kicking, stamp­
ing, squatting and a range of complexities of gait (Ro­
bertson 1989). 
The onset or vocalisations is usually later than that 
of the motor tics, with a mean age· or 11 years, and 
grunting, coughing, throatclearing, barking, snorting, 
explosive utterances, screaming, humming, hissing, 
clicking, colloquial emotional exclamations and inarticu­
late sounds are the usual utterances. Coprolalia (the in­
voluntary inappropriate uttering of obscenities) is re­
ported in approximately one-third of patients and usual­
ly has .a mean age of onset of 14 years. Copropraxia 
(the involuntary and inappropriate making or obscene 
gestures) is reported in 3%-21 % or GTS patients. Echo­
lalia (the imitation of sounds or words) and echopraxia 
(imitation of actions) occur in 11 %-44% of patients. 
Tics and vocalisations are characteristically aggravated 
by anxiety, stress, boredom, fatigue and excitement, 
while sleep, alcohol, orgasm, fever, relaxation or concen­
tration leads to a temporary disappearance or symptoms 
(Robertson 1989). 
Many types of behaviour have been reported to oc­
cur frequently in patients with GTS. Some types of 
behaviour, such as obsessive - compulsive disorder, are 
intimately linked to GTS (see below) and are thus prob­
ably an integral part of the syndrome, whereas others, 
such as hyperactivity, attention deficit disorder and 
learning difficulties, occur in a substantial number of 
patients (30%-60%) and are probably often the symp­
toms ror which the patient is rererred to the physician 
(Robertson 1989). Anti-social behaviour, inappropriate 
sexual activity, exhibitionism, aggressive behaviour, dis­
cipline problems (Robertson 1989) and selr-injury (Ro­
bertson et al. 1989) are found in a substantial percentage 
or clinic GTS populations. From my experience in clini­
cal (Robertson et al. 1988) and ramily/pedigree (Robert­
son and Gourdie 1990) settings and rrom the data of 
epidemiological surveys (Caine et al. 1988), it would 
seem that relatively few GTS subjects in the community 
exhibit antisocial behaviour and that the reporting of 
such behaviour may well reflect an artefact of referral, 
and thus represent ascertainment bias (Robertson 1989). 
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Electroencephalogram (EEG) abnormalities have 
been found in 12%-37% of patient cohorts: abnormali­
ties are non-specific, and there is no evidence of any 
paroxysmal activity time-locked to the tics (Robertson 
1989). Complementing the wide spectrum of clinical 
manifestations of GTS is an equally wide variety of EEG 
patterns (Robertson 1989). Visual and sensory evoked 
potentials have been studied in patients with GTS, but 
no consistent abnormalities have been demonstrated 
(Robertson 1989). 
Robertson et al. (1988) documented that 71 of 73 
patients with GTS have normal CT scans (both abnor­
malities were septum pel\ucidum cavities). Other studies 
have noted CT scan abnormalities in 16 GTS patients; 
thus, only 18 of 172 documented CT scans have been 
abnormal, and the abnormalities do not appear to be 
of direct aetiological significance (Robertson 1989). The 
99 normal scans suggest that the pathology in GTS is 
not structural. 
Only one group has used brain imaging studies to 
investiga te function in GTS (Chase et al. 1984, 1986). 
In the first study a PET (ECAT 11 scanner) scan (using 
Ouorodeoxyglucose F18) showed abnormalities in 5 
GTS patients compared with controls (Chase et al. 
1984). In the GTS patients there was a relatively close 
positive association between metabolism in the basal 
ganglia (particularly the corpus striatum) and metabo­
lism throughout the cerebral cortex. In addition, the 
cortical distribution of regions in which glucose metabo­
lism seemed to have a close inverse association with the 
severity of vocal tics clustered in the middle and inferior 
parts of the frontal lobes bilaterally, extending posterior­
ly from the frontal poles to the post-central gyrus. Co­
prolalia, in contrast, was inversely correlated with hypo­
metabolism in the left parasylvian region (Chase et a!. 
1984). Continuing their work in this area, Chase et a!. 
(1986) assessed 12 untreated GTS patients with matched 
normal controls using the improved NINCDS neuro 
PET scanner with higher resolution and sensitivity than 
the ECAT 11 scanner: at horizontal levels from 8.4 to 
8.8 em caudal to the vertex, non-normalised glucose util­
isation rates were approximately 15% below control 
values in the region of the frontal cingulate and possibly 
the insular cortex and the inferior corpus stria tum (P < 
0.01). 
Chase et a!. (1986) also evaluated two men (21 and 
40 years old) and one woman (28 years old) with GTS 
using magnetic resonance imaging (MU) with a 0.5­
Tesla Picker International scanner or a 1.5-Tesla General 
Electric Sigma scanner, and no definite abnormalities 
were detected. 
Post-mortem studies have not revealed any consis­
tent abnormalities (Dewulf and Van Bogaert 1941; Bal­
thasar 1957; Haber eta!' 1986). Robertson eta!' (1987) 
reported that 10 of 80 GTS patients had an abnormally 
low serum copper level. Two of the 10 were investigated 
in detail with copper radioisotope studies, and both ex­
hibited abnormalities of copper handling. 
The aetiology of GTS is unknown, but it has been 
suggested that it is inherited as an autosomal dominant 
with incomplete penetrance (Robertson 1989; Robertson 
and GOUl'die 1990). The biochemical aetiology is also 
unknown, but it is thought that dopamine is particularly 
implicated, as dopamine antagonists are useful in the 
treatment of symptoms in the majority of patients with 
GTS. In addition, the pathophysiology of GTS may be 
localised to the basal ganglia (Robertson 1989). 
There is a growing amount of literature on the rela­
tionship between obsessional disorder and GTS, and it 
is becoming increasingly evident that there is a clear 
and strong association between the two disorders (Ro­
bertson 1989). To date, 11 studies have documented GTS 
patients to have obsessional symptoms, traits or illness, 
varying from 11 % to 80% of the patient popUlation 
(Robertson 1989). Moreover, in controlled studies 
(Frankel et al. 1986; Green and Pitman 1986; Comings 
and Comings 1987; Van de Wetering et al. 1988) GTS 
patients were found to have higher obsessive-compulsive 
inventory scores and/or behaviours - more than normal 
control populations and equal to patients with obsessive­
compUlsive disorder (OCD). Robertson et al. (1988) 
found that 37% of clinic GTS patients have obsessive­
compUlsive behaviours and, using standardised rating 
scales, found much higher scores in GTS patients com­
pared with normative data. In addition, coprolalia and 
echophenomena were significantly associated with ob­
sessive-compulsive phenomena (Robertson et al. 1988). 
The argument for a strong association between GTS 
and obsessive disorder also comes from both pedigree 
(Pauls et al. 1986; Robertson and Gourdie 1990) and 
epidemiological (Caine et al. 1988) studies which suggest 
that not only do patients with mild GTS have significant 
obsessive-compulsive behaviours but also that OCD 
may well be a phenotype of the anticipated GTS gene. 
Serotonin is the neurotransmitter most implicated in 
the pathogenesis ofOCD (Rapoport 1988). Non-specific 
neuroradiological abnormalities have been documented 
in OCD (Behar et al. 1984; Garber et al. 1989). More 
specifically, it has been suggested (Laplane et al. 1981, 
1982; Swedo et al. 1989) that OCD, at least in some 
patients, may be due to basal ganglia dysfunction, while 
other findings support evidence of involvement of the 
caudate nucleus (Lux en berg et al. 1988). One study doc­
umented that in OCD metabolic rates were significantly 
increased bilaterally in the caudate nucleus and hyper­
metabolism in the orbito-frontal cortex (Baxter et al. 
1987). 
~lllgle photon emISSIOn tomography t:)/:"c 1) stUdies 
using dopamine receptor ligands would be useful to ex­
plore the functional aetiology of GTS. They would, for 
example, enable the hypothesis that dopamine is in­
volved in the GTS to be tested. This clearly has wide­
spread implica tions. 
SPET may clarify whether GTS can be divided into 
two groups: GTS patients with or without dopamine 
receptor abnormalities, and in particular whether pa­
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tients in the OCD group have dopamine abnormalities . 
It is likely that serotonin ligands for SPET studies will 
be available in the near future: this would clearly also 
have potential to elucidate the role of serotonin in GTS 
with or without OCD. 
Treatment may well be different for the different 
groups. Dopamine antagonists (haloperidol, pimozide, 
sulpiride) may be the first choice for those with excessive 
dopamine uptake, whereas serotonin re-uptake inhibi­
tnr~ (chlnmi!lr::1mine nuvoX;:Imine . nlloxetine) m;:lv he 
more useful for those subjects without dopamine recep­
tor abnormalities and/or those with more obsessive-com­
pUlsive features. 
It is suggested that studies employing SPET may 
therefore be useful in exploring the functional aetiology 
and treatment of GTS. 
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1. Structural neuroimaging 
in Gilles de la Tourette's syndrome 
M. ROBERTSON 
Gilles d~ la Tour~tt e's syndrome (GTS) is a genet­
ically determined movement disorder chJ.racterised 
by multipl~ motor and one or more vocal tic s 
(World Health Organisation, 1992; American Psychi­
atric Associa tion , 199·1; Robertson, 1994). Associated 
beha\'iour :lI1d psychopathology include coprolalia 
(inappropriak uttering of obscenities) in approxi­
mately 30% of clinic pati~nts, echophenomena 
(copying behaviour) in roughly 40% (Robertson, 
1989; 1994) and attention deficit hyperactivity dis­
order (ADHD) in 20~'O-90% of clinic p,llients (Ro­
bertson and E,lpen, (1992) . The most specific psycho­
pathology, which is probably also gene tically related, 
is obsessive cOlllpulsi\'e disorder (OCD) (Robertson, 
1995)· Although GTS is genetically-dete rm ined , and 
th e l\lost likely inheritance pattern is autosomal 
dominnnt transmission (Eapen et aI., 1993), envi­
ronmental innuences are also important. Thus, pre· 
natal e\'e nt s including maternal illness, eg., severe 
nausea ilnd/or vomiting during th e first trimester 
and maternal life stress dur ng pregnancy, as \\'ell as 
the sex of the child, lllay lead to changes in the sensi­
ti\'ity of some dopaminerg ic receptors, and this 
could pani,llly determine the even tual severity of ex· 
pression of the syndrome (Leckman et aI., 1990). 
The precise brain pathology is, as yet, unknown, 
in part due the lack of adequate post-mortem (PM) 
studies. However, in general, PM studies have impli­
cated the basal ganglia. The first PM undertaken on 
a patient \vith " Jlidiopathic" GTS was normal (De­
" 'ulf and \':1n Bogaert (1941). Subsequent studies, 
howe\'er, have implicated th e striatum (Balthasar, 
1957; Singer et ai., 1991) and the globus pallidus 
(Haber et ai., 1986; Haber and Wolfer, 1992), 
Struc tural neuroimaging allows us to examine 
anatomy in vivo and provides evidence complemen­
tary to these PM studies. Functional neuroimaging, 
examining regional blood tlow, metabolism and re­
ceptor function, provides anothe r aVenue of explor­
ing the neuropathological lesions ot' GTS. In thi s 
chJ.pt er, I co nfine myself to a description of st ruc­
tural neuroimaging studies, including computed to­
mography (CT) and magnetic reson<lnce imaging 
(MRI), 
In order to gain as comprehensive review of the 
literature as ~lossible, MEDLlNE and PSYCHLIT 
searches were periormed using the titles "Tou­
rett es", X RAY, CT scan and MRI scan , t\o articles 
in vo lving GTS and X ray ex~m in a tio ns were found, 
The literature on CT and l'-1R,1 scans in pat ients with 
GTS will be revie\\·ed. When considered relennt" in 
some cases, more details \\ ill be gi\'en about in­
dividuel cases or the s tud \', to illustrate the are,\s 
possibly in volved in the pa~~ogenes i s of GTS. 
Individual (T case reports 
The first report of CT scan in GTS was by Yeragani 
et al (1983), who documented a 12 -year-old girl with 
GTS, whose CT showed mild increase in the density 
of the caudate nuclei, thought to be du e to calcifica­
tion . There was no relevan t family history. The pa­
tient had eleva ted levels of beta-phenylethylamine 
and the catecholamine fT,C'tabo lites normetane­
phrine, MHPG and 3-metho\11yramine, and a de­
crease in urinary 5-HT. 
Soon afterwards, Shaenboen et a1. (1984) reported 
the CT appea rances in a 16 ;'ear old girl with GTS 
who had a brief acyanotic si'ell at 30 h of age, and 
delayed speech, but an other,\'jse unremarkable his­
tory. CT showed markedly enlarged occipital horns 
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of both lateral ventricles. Lakke and Wilmink (1985) 
reported a 27 year old man with GTS whose CT 
showed a pineal tumour and calcification in the re­
gion of the third ventricle and periaqueductal grey 
matter. Kjaer et al. (1986) described the CT of a 28 
year old woman with GTS, which showed a large po­
rencephalic cyst in the right hemisphere, virtually re­
placing the temporal lobe and involv:ing the basal 
ganglia, and contrast enhancement in the region of 
the left basal ganglia. The patient had been born 4 
weeks premature, had a left sided clonic seizure at 
weeks old and a hyperactive stretch reflex on the left. 
Vieregge (19S7) documented monozygotic (MZ) 
twins concordant for GTS. Both had unremarkable 
gestations and births. In preschool age both were hy­
peractive and "destructive"; developmental mile­
stones were :-Jorma!. From the age of 6 years both 
showed compulsive behaviour. Motor tics began at 
the age of12 (8) and 13 (A) years, followed soon after 
by vocal tics. The more severely affected twin (8) 
sho\\'ed marked asymmetrical left involvement and 
soft neurological signs. There was a positive family 
history of GTS. l\'europhysiological investigations 
(eg., visual evoked responses) \\'ere normal, as was 
the EEG, apart from muscle artefacts. CT revealed 
some ventricular asymmetry in both, without ob­
servable di fferences. 
An interesting, acquired Tourette-like syndrome 
was reported by Northam and Singer (1991) in a 6 
year old girl following presumed herpes encephalitis. 
She had no prior neuropsychiatric history and no 
family history of tics or OCD. After a 3 day pro­
drome of headaches, malaise, nausea and vomiting, 
she developed a fever (39.5.c) and presented, with fo­
cal motor seizures invol ing the left side of the face 
and left arm. CT without contrast medium was nor­
mal. She was treated with diazepam and phenytoin . 
Repeat CT on hospital day 3 showed an acute hae­
morrhagic lesion in the right mesial temporal region, 
and MRI on day 5 a small high-signal lesion in this 
region, involving both grey and white matter, and 
progressive oedema in the right temporal lobe, basal 
ganglia and thalamus. 
After a presumptive diagnosis of herpes encepha­
litis, the patient was treated \'lith acyclovir and main­
tained on phenytoin. At discharge 2 weeks later she 
had obvious neurological signs (eg., mild left facial 
and arm paresis), marked anxiety, personality 
change, emotional lability and hyperactivity. Two 
weeks later she developed both motor and vocal tics. 
CT two months after the onset showed encepha­
loclastic change in the right temporal lobe. Four 
months later she had no neurological abnormalities 
apart from the tics, which responded to small doses 
of pimozide. 
Of course, individual case studies, while useful, are 
limited by difficulty in knowing the relevance the 
pathological findings in specific indiv:iduals with 
GTS, when most do not have any abnormalities . 
Thus, studies of series of patients with GTS aUow us 
to ddermine whether any more systematic abnor­
malities are to be found. 
CT studies In patients with GTS 
Caparulo et al. (1981) reported CT abnormalities in 
(6) 38% of 16 patients \\'ith GTS, including mildly en­
larged lateral ventricles (in 2 cases), substantially en­
larged, symmetrical or asymmetrical ventricles (in 3) 
and an enlarged right Sylvian fissure. No systematic 
relationship was found between EEG and CT scan 
abnormalities. No mention was made of family 
history. 
In a controlled study (Harcherik et al. 1985) CT 
was performed on 19 patients \\ith GTS and com­
pared with studies of FJtients \\'ith infantile autism, 
ADHD, and a language disorder, and a control group 
of medical patients (\\'ith headaches, post concussion 
or inner ear problems) . No significant difference 
was found between groups or controls \\'ith respect 
to total ventricular volume, right/left ventricular vol­
ume ratio, ventricular ?symmetry, ventricle/brain ra­
tios or brain density. 
Chase et a!. (1986) rerorted se\'en normal CT stud­
ies in a cohort of nine patients \\'ith GTS, The only 
abnormalities were mild ventri(Ular dilatation in a 
21 year old man, and mild, diffuse cortical atrophy in 
a 40 year old man. 
Regeur et al. (1986) reported 47 normal CT exam­
inations in a cohort of 53 patients with GTS , Ab­
normalities included 2. small occipital arachnoid cyst, 
a suprasellar epidermoid, a large defect in the right 
temporo parietal region, slight cortical atrophy, and 
asymmetry of the ventricles in two cases. 
The largest CT study is that of Robertson et al. 
(1988) who found 71 Of73 patients to have normal CT 
examinations. The onh' abnormalities were a can.lm 
of the septum pellucid'um and two patients, both of 
whom had a history of head banging. The report of 
normal CT studies by Lees et a!. (1984) included the 
same patients. 
Thus, although some groups have found subtle 
abnormalities of ventricular size or symmetry, and 
there are occasional reports of cerebral anatomical 
abnormalities or structural pathology, the overall 
conclusion must be that there are no structural ab­
normalities are systematically revealed by CT in pa­
tients with GTS. The literature reviewed, reveals that 
154!t77 (87'Yo) of the CT studies were normal. The 
mutation abnormalities described, may not distin­
guish GTS from other neuropsychiatric disorders 
presenting in childhood, It is of course possible that 
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more subtle structural abnormalities are not detec­
table with CT. 
MRI case reports In patients 
with GTS 
To date, there have been five reports of normal MRI. 
Chase et al. (1986) reported two men aged 21 and 40 
years, and a woman of 28 years who had normal 
MRI. Robertson and Trimble (1991) reported a 21 
year old woman with typical symptoms with no as­
sociated behaviours, whose MRI was also normal, as 
were the neurological examination and EEG. Rele­
vant family history was that a paternal aunt had fa­
cial tics. Hartman and Yuvarajan (1994) described an 
82 year old woman who presented with motor and 
vocal tics, and coprolalia, which had developed in 
the months following an acute confusional state as­
sociated \\'ith posterior neck pain 10 years earlier, 
presumed to be encephalitis lethargica; the patient 
would therefore not fulfil criteria for "Ilidiopathic" 
GTS both because of her age and the organic insult. 
Ne-"ertbeless, despite her age and "Ilorganic" insult. 
MRI was normal. 
T\\'o case reports have documented MRI abnor­
malities. Sand)'\.: (1908) reported a 7 year old boy 
who also had coprolalia, abnormal sexual behaviour 
and ADHD . At the age of 5 years he was prescribed 
methylphenidate (ritalin) for his ADHD. Neurolog­
ical examination was normal. lvlRI being showed 
asymmetry of the cerebral peduncles, the left being 
larger than the right. 
Robertson et al. (1990) documented a 19 year old 
man with severe GTS, obsessive compulsi\'e (OCB) 
and self-injurious behaviours (SIB) and coprolalia, 
whose symptoms were so severe that he required 
psychosurgery, in the fonn limbic leukotomy. He 
was born at term by caesarian section following an 
antepartum haemorrhage due to placenta praevia; he 
\\'as nursed in an incubator for the first four days of 
his life. His presurgical I\IRI revealed a single high 
signal focus in the right globus pallidus; CT and EEG 
were both normal. 
MRI studies in GTS 
There have been several MRI studies in GTS pa­
tients, although some have not been on patients with 
"pure" GTS and have included patients with, for ex­
ample, GTS plus ADHD and Asperger's syndrome 
(AS). l\'evertheless all studies will be reviewed and 
conclusions drawn where possible. 
A preliminary MRI study of 10 children with GTS 
who also had ADHD found significantly larger ven­
tricles (6.0% vs 3.2% of total brain volume; P==0.007), 
larger caudate nuclei (2.7% vs 2.S% of total brain vol­
ume; p==o.oS) and trends toward a smaUer globus 
pallidus compared with normal controls (Denkla et 
aI., 1991). 
Demeter (1992) compared 10 adult patients with 10 
medical controls using MRI: no quantitative differ­
ences were found. However, two of the patients with 
GTS had focal abnormalities involving the basal gan­
glia, one of whom had a family history of tics. 
Berthier et a1. (1993) investigated nine males with 
GTS, and compared them to seven with concurrent 
GTS and AS using MRI. Eight of the patients with 
GTS had normal MRI; the only one patient with ab­
normal MRI had moderate enlargement of lateral 
ventricles. In contrast, five of the seven (71%) with 
both GTS and AS had abnormal imaging. Peterson et 
al. (1993) used MRI to examine 14 caucasien patients 
with GTS aged 18-49 years (II men, 3 women) who 
had minimal lifetime neuroleptic exposure (10 had 
never received neuroleptics), and compared them 
with age- and sex- matched controls, who had no 
personal or family history of tic or obsessive com­
pulsive symptoms. All patients were medication free 
for a month prior to imaging. Results showed a sig­
nificant reduction in the volume of the left (but not 
the right) lentiform nucleus. Post hoc analyses re­
vealed smaller mean volumes of the caudate and len­
tiform nuclei and globus pallidus then in controls on 
both the right and the left. Further analyses of basal 
ganglia asymmetry indices suggested that in GTS the 
basal ganglia do not have the volumetric asymmetry 
(left greater than right) observed in normal controls. 
In contrast, the patients had lateral \'entricular 
asymmetry not seen in the normal subjects, which 
appeared to be due to a 33% increase in mean vol­
ume of the right lateral ventricle over control values, 
compared with a 12% increase the left lateral vent~i­
cleo Interestingly, vocal but not motor tiC seventy 
correlated positi\'ely with all basal ganglia volumes 
(globus pallidus excepted), on both right and left 
sides. 
Singer et al. (1993) performed an MRI study on 37 
outpatient children with GTS (29 boys, 8 girls; age 
range 7-16, mean 11.5 years) and compared them 
with 18 controls (14 boys, 4 girls; age range 6-15. 
mean 9.8 years). Of the patient 78% had a family his­
tory of either tics or OCD; of the controls none had a 
family history of tics or GTS. At t!le time of MRI 25 
patients (68%) were receiving medication, m.ost 
commonly desipramine (in 14); 6 were recelvmg 
neuroleptics. There were no statistically significant 
differences in the size of the right or left caudate nu­
cleus, putamen, globus pallidus or lateral ventricles 
between the groups. In contrast, there were signif­
icant differences in symmetry in the putamen and 
lentiform nucleus. Virtually all the controls had a 
left-sided predominance of the putamen, whereas in 
13/37 patients (35%), a right predominance exceeded 
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that of any control. Statistical comparisons of 18 pa­
tients with and 19 without ADHD and the controls 
showed significant differences in volume of the left 
globus pallidus and lenticuform nucleus asymmetry. 
In the GTS+ADHD group, the left globus pallidus 
was significantly smaller than the right, and the len­
ticuform asymmetry was due to a greater right-sided 
predominance in the GTS+ADHD group. 
Peterson et al. (1994) measured the midline cross­
sectional area and other morphological features of 
the corpus callosum (ee) on MRI of 14 medication 
free patients with GTS (11 men; 3 women) and 14 
normal controls (matched for age, sex, socio econo­
mic status and handedness; all were right handed); 
the ages ranged between 18 and 49 years. Exclusion 
criteria in the patient group included history of head 
trauma causing loss of consciousness, past or cur­
rent depressive or psychotic illness, neurologic ill­
ness, pregnancy and a history of alcohol or drug 
abuse. No control subject gave any reported no per­
sonal or family history of tics or obsessive-com­
pulsive symptoms. The cross-sectional area of the 
ee correlated positively with brain size and basal 
ganglia volumes. Overall, ee area was 17.7% less in 
the patients than in the controls (p < 0.006); there 
was also a 10% reduction in the circumference of the 
ec. The reduction in area was similar in degree 
throughout the ec. Analyses of covariance with total 
midsagittal area of the head revealed the reductions 
in the overall ee area of the eT and all its sub­
sections to be statistically significant. The width of 
the ee tended to be insignificantly less throughout 
(5%·11%); its overall length from rostrum to sp!e· 
nium was signiiicantly reduced (by 5.3%). The bend­
ing angle and mean curvature of the ee were both 
increased in GTS, suggesting that the ee was less 
rounded than that of normal controls. \Vorst-ever 
motor tic symptoms showed the strongest significant 
correlation with the length of the ee in the patients. 
These findings suggested that structural interhemis· 
pheric connectivity may be aberrant in the central 
nervous system in GTS, and the authors suggested 
that they provide indirect supportive evidence for 
the presence of altered cerebrallateralisation in GTS. 
A careful monozygotic (MZ) twin study was un­
dertaken by Hyde et al. (1995) who performed mor­
phometric analyses of MRIs of 10 MZ twin pairs con­
cordant for tic disorders, but discordant for tic 
severity. Twins were considered to be MZ only if 
their blood samples matched on all 19 blood antigens 
tested. The mean age of the group was 16.3 years 
(range 9-31). No focal neurologie abnormalities were 
found other than tics, and no patient had abused 
drugs . The right caudate nucleus volume was slightly 
(6%) but significantly reduced in the relatively more 
severely affected twins compared with the less af­
fected (t=3.34; p < 0.009). Most of the difference was 
attributable to reduced volume of the anterior right 
caudate nucleus (t=2.26; p < 0.02), which was 
smaller in the more severely afiected twin in nine out 
of ten sets. There was also a trend for the left ante­
rior caudate nucleus to be smaller in the more se­
verely affected twin sets. In addition, the mean vol­
ume of the left lateral ventricle was 16% less in the 
more severely affected than in the less severely af­
fected hvins (t=2.86; p < 0.01). In eight of ten sets, 
the more severely affected twin had a smaller left lat­
eral ventricle. The normal left greater than right 
asymmetry of the lateral ventricles was not present 
in the more severely affected twins (t=-3.39; 
p < 0.008). In addition, the difference within a pair 
in the degree of loss of the normal ventricular 
asymmetry correlated with the difference within a 
pair in the severity of the tic disorder. In contrast to 
the maintenance of the normal ventricular asymm­
etry in the less severely affected t\l'ins, both less and 
more severely affected twins had a predominance of 
the caudate nuclei and striatum as a \I·hole. The au­
thors suggested that because Jl.IZ twins are genet ­
ically identical, the structural abnormalities must reo 
fleet adverse environmental events. 
The nost recent study is from our group (Moriarty 
et al. submitted for publication). In brief, MRI \,'as 
used to assess 17 patients with GTS and eight normal 
controls. There were no differences in volume be­
tween patients and controls in the amygdala or cau ­
date nuclei and no difterence in \vhole brain index. 
There was, however, loss of the normal caudate 
asymmetry in the patients. The area of the corpus 
callosum was significantly greater in patients than in 
controls and there \,'as a loss of the normal correla ­
tion between it and whole brain index. 
In summary, and not unexpectedly, the '\lRI stud­
ies reveal substantially more abnormalities than the 
eT investigations. Th'ese include primarily those in 
the basal ganglia and lateral ventricles: abnormalities 
of caudate nucleus size (mostly decrease) and loss of 
normal caudate nucleus asymmetry: in the asymm­
etry of other basal ganglia (eg., putamen and lenti­
form nucleus); and in the size of the lateral ventri­
cles, with loss of normal ventricular asymnetry. 
Finally, two studies ha\'e found abnormalities of the 
corpus callosum, Jikel~' to reOect abnormalities in the 
development of cerebral lateralisation (Witelson 
1993). However, one group found an increased cross­
sectional area of the corpus callosum in GTS 
patients, while the other found it lobe reduced, 
reinforcing the fact that structural neuroimaging 
studies have methodological limitations, and further 
systematic investigation will be needed to clarify 
these findings. 
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Conclusions 
While PM and earlier CT studies did not show con­
vincing or consistent abnormalities in patients with 
GTS, recent studies with the more sophisticated 
techniques of MRI show a reasonable consistency in 
abnormalities of cerebral lateralisation, affecting 
particularly the basal ganglia. Whether or not these 
structural abnormalities are genetically determined, 
or, as suggested by Hyde et al. (1995), are the result 
of environmental factors is as yet unknown. More 
controlled studies and more \>vin studies are called 
for. The next phase of neuroimaging investigations 
References 
American Psychiatric Association (1994) Diagnoslic and 
Statistical 1'-lanual or 1'-lentol Disorders (4th Edition) 
(DS;\! IV), Washington DC 
Balthasar K (1957) Uber das anotomische Substrat der gen­
eralisierten Tic-Krankheit (maladie des tics, Gilles de la 
Tourette): Ent\\'ickiungshemnlllng des Corpus striatum. 
Arch PS\'chiat Nervenk 195: 511-5.19 
Berlhier :--iL. Ba)'es A, Tolosa ES (199.1) ~Iognetic reso­
nance imaging in patients \\'ith concurrent Tourette's 
Disorder and Asperger's syndrome. I Am Acad Child 
Psychiat )2 3: 633-6.'9 
Caprulo BK, Cohen DI. Rothll1Jn SL (1981) COlllpuled to­
mographic brain scanning in children \\'ith de\·elop· 
mental neuropsychiotric disorders. I Am ,'\c<ld Child 
Psychiat 20: .133-35; 
Chase G\, Geoffrey V, Gilkspie :'1, Burro"'s GH (1936) 
Structmal and illnctional studies of Gilks de la Tou­
rette's s\·ndrome. Rev l\eurol q~: 351-355 
Demeter S' (1992) Stflillural illlJging in Tourctte's ,»'n­
drol11e..'\dvan Neurol 58: 201':06 
Denckla i\113, Harris EL, .'\)'I\\'ard EH, Singer HS, Rei ss AL, 
R"ader :'1], I3ryan R\', Chase G.'\ (1991) Executive func· 
tion and \'olume 01 the basal ganglia in children \\'ith 
Tourette's s),ndrome and attention deficit hyperaclivity 
disorder. Ann :--:eurol )0: 4;6 
De\\'ulf A, \'on Bogaert L (19-\1) Eilides anatomo·cliniques 
de syndromes hYFercinetiques complexes - Partie .'. 
Une observation anatomo-clinique de maladie des tics 
(Gilles de la Tourette) . Monat Psychiat Neurol 104: 5361 
bpen V, Pauls DL, Robertson Mi\l (1993) hidence ror au­
tosomal dominant transmission in Gilles de ]a Tou­
rette's syndrome - United Kingdom cohort study. Brit­
ish I PS\'chiat, 162: 593-596 
Haber SN,'Ko\\'all NW, \'onsattel IP, Bird ED, Richardson 
EP (1936) Gilles de la Tourette's syndrome: a postmor­
tem neuropathological and immunohistochemical 
study. I 1\eurol Sci 75: 225-241 
Haber S1", Wolrer D (I 992) Basal gangli3 peptidergic 
staining in Tourette's syndrome. Advan l\'eurol 53 145­
15 0 
Harcherik DF, Cohen DI. Ort S (19S5) Computed tomo­
graphic brain scanning in four neuropsychiatric dis­
orders or childhood. AmI Ps\'chiat 142: 73t-743 
Hartman lA, Yuvarajan R (199~) Tourette's syndrome in 
the elderly. Int I Geriat Psycniat 9 2: 157 ' 159 
in GTS be functional MRI studies, which might 
bridge the gap between the traditional functional 
studies such as single-photon emission tomography 
and positron emission tomography (PET) and tradi­
tional MRI, and allow further insights into the path­
ophysiology of GTS. 
Acknowledgements 
I wish to thank Dr John Moriarty for his helpful 
comments. 
Hyde H!, Stace)' ~IE, Coppola R, Handel SF, RickJer KC, 
Weinberger DR (1995) Cerebral morphometric abnor­
malities in Tourette's syndrome. Neurology 45: !l761182 
Kjaer 1'-1, Boris P, Gadegaard Hansen L (1936) Abnormal 
CT scan in a patient with Gilles de IJ Tourelte's s)'n­
drome. l\'euroradiology 23 362-36) 
Lakke JP, Wilrrunk JT (t935) A case or Gilles de IJ Tou­
r<?lte's s),ndroll1e with midbrain il1\·ol ':em enl. J \'eurol 
Neurosurg Psychiat 43: 1:!93-ll96 
Leckman IF, Dolal15k), ES, Hardin 1'.!T, C!ubb 1'-1, Walkup 
IT, Stevenson j, Pauls D (1990) Perin,~I~1 iaclors in the 
expression or Tourette's s)'ndrome: ;)n explorotor)' 
stud)'. I Am Acad Child Ps),chiat 29 :!: 220-226 
Lees A). Robertson !I!!'-!, Trimble 1'-fR. !'v!urra\' ~l\'~! 
(191'·\). A clinical slud»' or Gilles de l~ Touretl'e's s)'n· 
drome in Ihe United Kingdorn I Neuroi \'eurosurg PS)'­
chiat .p: 1-3. 
i\!ori;Ht)' j, Varma .'\R, Stephens I, Fish ":, Trimble 1\1 R, 
Robertson M:-'·! (1996) Subcorti(;J1 abnC":ll a lity in Gilles 
de la Tourette's smdrome: an "'·IRl stuj·... Submitted for 
publication ' . 
\'onham RS, Singer HS (1991) Posle ncefi1~litic acquired 
Tourelte·like s)'ndrome in a child. l\e'~rology 41: 592­
593 
Pel"rson B, Riddle ",lA, Cohen Dj, Katz LD, Smith Ic' Har­
din ,\IT, Lecklmn IF (1993) Reduced b~;al ganglia vol­
umes in Tourelle's syndrome using th~<,e·dimensional 
reconstruclion lechniques rrom mag;letic resonance 
images. l\'eurology 4Y 941-949 
Peterson BS, Leckman IF, Duncan IS, \\'e:zles R, Riddle 
MA, Ha rdin IvIT, Cohen DI (1994) Corpus callosum 
morphology rrom m3gnetic resonance images in Tou­
rette's syndrome, PS)'chiat Res Neuloirr,2g 55: 35'99 
Regeur L, Pakkenberg B, Fog R (1986) Clinical features and 
long-term treatment with pimozide in 65 patients with 
Gilles de b Tourette's syndrome. J l\'c.:rol Neurosurg 
Psychiat 49: ;91-795 
RobertSon j>,,11\·1 (1989) The Gilles de la Tourette's s)'n­
drome: the current status. British I Ps),cl-.iat 154: 14;'169 
Robertson !vi;'>..! (1994) Annotation: Gilles C<, la Tourelte 's 
s)'ndrome - an update. J Child Psychol Ps),chiat 35 4: 
597·611 
Robertson J\\.\I (1995) The Relationship be~.·:e en Gilles de 
la Tourette's syndrome and obsessi\'e compulsi\'e dis­
order. J Serotonin Res, Suppl I: 49-62 
Un
ive
rsi
ty 
of 
Ca
pe
 T
ow
n
132 Neuroim:lging in child neuropsychi:llric disorders 
Robertson MM and Eapen V (199:?) The pharmacologic 

controversy of CNS stimulants in GiUes de la Tourette's 

syndrome. Clin Neuropharmacol 15 5: 408-425 

Robertson MM, Doran M, Trimble MR, Lees Al (1990) The 

treatment of Gilles de la Tourette's syndrome by limbic 

leucotomy. I Neurol Neurosurg Psychiat 53: 691-694 

Robertson M~I, Trirnble MR, Lees Al (1988). The psycho­

pathology of the Gilles de la Tourette's s),ndrome: a 

phenomenological anal),sis. British I Psychiat 152: 383­
390 

Robertson jvl!ll, Trimble MR (1991) Gilles de la Tourette's 

syndrome in the Middle East. British I Psychiat 158: 416­
419 

Sandyk R (19S8) A case of Tourette's syndrome with mid­

brain im·oh·ement. Int I Neurosci 43: 171 -175 

Shaenboen MJ, Nigro MA, j>.Iartocci RJ (1984) Colpoce­

phali and GUles de la Tourette's syndrome. Arch Neurol 

41: 1023 

Singer 	HS, Hahn I-H, Moran TH (1991) Abnormal dopa­
mine uptake sites in postmortem striatum frolll pa­
tients with Tourette's syndrome. Ann Neurol 30: 558­
562 

Singer HS, Reiss AL, Brown IE, Aylward EH, Shih B, Chee 

E, Harris EL, Reader MI, Chase GA, Bryan RN, Denckla 

MB (1993) Volumetric MRI changes in basal ganglia of 

children with Tourette's syndrome. Neurology 43: 950­
956 

Vieregge P (1987) Gilles de la Tourette's syndrome in 

monozygotic twins. J Neurol Neurosurg Psychiat 50: 

1554-1556 

Witelson SF (I 993) Clinical neurology as data for basic 

neurosciences Tourette's syndrome and the human mo­

tor system. Neurology, 43 : 859-861 

World Health Organisation (1992) International classifica­
tion of diseases and health related problems (tenth revi­
sion). Geneva 
. Yeragani VK, Blackman :-1. Baker GB (1983) Biological a<ld 

psychological aspects of a case of Gilles de lil Tourelk's 

syndrome. J Clin P:;ychiat 44: 27-29 

Un
ive
rsi
ty 
of 
Ca
pe
 T
ow
n
968 BIOl PSYCHIATRY 
1987:22.96&-978 
Abnonnalities of Copper in 
Gilles de la Tourette Syndrome 
Mary Robertson, Kenneth Evans, Anthony Robinson, 
Michael Trimble, and Peter Lascelles 
The Gilles de la Tourette syndrome is a disorder whose etiology and pathogenesis are 
liale understood. The number of biochemical abnormalities described in this disorder is 
minimal. Ten of a total of 80 patients were found to have an abnormally low serum 
copper. A report is presented on two patients who consented to further detailed im'CS' 
tigation and in whom copper radioisotope studies were carried out. Both exhibited ab­
normalities of copper handling. in that we observed an abnormally fast disappearance 
of copper from the plasma and an ablWrmally slow uptake by the liver. The rates of 
intestinal absorption and urinary excretion were normal. We did not identify an abnormal 
site of sequestration of the metal in the body. 
Introduction 
Prompted by reports of copper abnormalities in patients with movement disorders such 
as Wilson's disease (Cumings 1948), Menkes's disease (Menkes et al. 1962), Huntington'$ 
chorea (Perry 1961), and at least four other rare conditions (Willvonseder et al. 1973: 
Godwin-Austen et al. 1978; Haas et aI. 1978; Parker 1985), we decided to request assays 
of serum copper and ceruloplasmin in patients with the Gilles de la Tourette syndrome 
(TS) and found that a significant proportion seemed to have abnormal resulis . Thus, the 
finding of 10 of 80 patients with abnormally low levels in this specialist population, with 
symptoms, made it unlikely that this could be attributed to a normal distribution curve. 
Eighty subjects who were seen and examined by one of us (M.R.) over 4 years 
(1980-1984) and who fulfilled the diagnostic criteria for the Gilles de la Tourene syndrome 
(TS) laid down in the Diagnostic and Statistical Manual of Mental Disorders (1980) were 
investigated. All were British, and all were white. The clinical features and neurological 
examinations of the first 53 subjects have been described elsewhere (Lees et al. 1984). 
Wilson's disease was excluded in all 80 subjects on the basis of detailed clinical ex­
amination. As abnormalities of copper have never been described before in TS, it was 
decided to further investigate two patients in detail. using radioisotope studies. The results 
were compared with similar information collected by one of us (A.R.) over many years 
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in 6 normal controls, 14 subjects heterozygous for Wilson's disease, 7 untreated subjects 
homozygous for Wilson's disease, and 7 treated subjects homozygous for Wilson's dis­
ease. 
Case Reports 
Subject 1 
Subject I was born at term to unrelated parents after a normal pregnancy and delivery 
in 1936; he was the sixth of nine children. There is no family history of neurological 
illness nor movement disorder. One brother was mentally retarded, another treated for a 
"persecution complex," and a third had a brain tumor; one sister had consulted a psy­
chiatrist. As a child, the subjecl bit his nails, was prone lo temper tantrums if frustraled, 
and exhibited breath-holding allacks. His childhood was disrupted by World War II and 
his mother's death when he was 3 years old. Funhermore, there was maltreatment by 
several older relatives. At school, he was academically good, passed secondary school 
examinations, but received no formal education after the age of 16 years . After school, 
he enjoyed a good work record until 1980, when he was made redundant. He was married 
at the age of 22 years, fathered 3 normal children, and was subsequently divorced. 
At the age of 7 years, the subject developed a facial twitch that was soon followed 
by a wide repertoire of motor and vocal tics. The symptoms wax and wane in severiry 
and affect various parts of the body at different times. He is able to suppress them 
voluntarily for a short while, but at the expense of experiencing anxiety . The symptoms 
disappear in sleep, are reduced with alcohol, and worsen with anxiety. He also experiences 
echolalia, echopraxia, arilhmomania, and the unering of obscenities (coprolalia). As a 
child, he was lhoughl to have St. Vitus dance. 
He presented lo the National Hospilals at the age of 44 years and was diagnosed as 
having TS . There was no olher relevant previous medical or psychiatric history. On 
examination, he answered queslions appropriately, but appeared tense and arxious. His 
lalk was interrupled by expletives and inappropriale fluctuations in pitch . There was some 
depression of mood, wilh diurnal variation, bUl there were no other biological features. 
Cognitive lesting was normal, and lhere was no evidence of psychosis. 
Physical examination revealed multiple molor lics and vocalizations, and mild left­
sided dysdiadochokinesis . There were no Kayser-Fleischer rings . He was complelely 
righl-handed (Annen 1970). Normal laboralory invesligalions included hemoglobin , full 
blood counl, ESR , plalelels, serology (WR , VDRL. TPHA), choleslerol, prolactin, urea 
and eleclrolytes, liver funclion lesls and protein eleclIophoresis, serum vitamin B I ] , red 
cell folale, uric acid, T4 and free T4, creatinine, iron, total iron binding capacily, calcium , 
inorganic phosphorus , alkaline phosphalase. glucose, and 24-hr urinary copper excretion . 
An aUloimmune screen was negalive for lhyroid and gasuic parietal cell anlibodies, smoolh 
muscle and milochondrial anlibodies, bUl was positive at I in 20 for anlinuclear bodies. 
Two eleclroencephalograms were similar in lhal lhey were flat and featureless wilh low 
voltage; lhere was frequenl generalized and focal muscle aClivilY corresponding lo in­
voluntary movemenls. A compulerized axial IOmography (CAT) scan was normal, as 
was the eleclrocardiagram. The subjecl was assessed on the Wechsler Adult Inlelligence 
Scale and had verbal IQ of 103, a performance IQ of 103, and a full-scale IQ of 103 
(Departmenl of Neuropsychology, Nalional Hospilal, Queen Square). 
The subjecl has been ad milled lo the hospilal on several occasions and has been 
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followed-up monthly as an outpatient. Depending on what symptoms were disturbing 
him most--tics. anxiety. depression. or insomnia-he was treated with various medication 
regimens. which have included tranylcypromine, clomipramine. lorazepam. diazepam. 
chlormethiazole. glutethimide. haloperidol, pimozide, chlorpromazine, fluspirilene. sul­
piride, c1onidine, phenobarbitone, and carbamazepine. There have been temporary reliefs 
of mood, anxiety. and movements, but no consistent and fundamental change in his 
presentation or mental state. 
Subject 7 
Subject 7 was born in 1962 by caesarian section, for cephalopelvic disproportion, to 
unrelated parents after a nonnal full-term pregnancy. He is the second of two children. 
His mother has grand mal epilepsy and his elder sister has absence seizures. There is no 
family history of psychiatric illness or movement disorder. 
His early development was unremarkable, and he achieved nonnal milestones. He wet I 
his bed as a child and has always bitten his nails. He was at school until he was 17 years 
old and was academically average. He enjoyed a good work record as a printer. His 
psychosexual development was normal, and he married at the age of 22 years. 
At the age of 11 years, · the subject began to shake his head from side to~~ide. Soon 
other involuntary movements followed, and at the age of 16 he developed v~alilations 
in the form of throaty grunts. The symptoms, which wax and wane in seveqiy, can be 
suppressed voluntarily and disappear in sleep. They are worsened when he js~excited or I 
annoyed, and reduced when he plays football, relaxes, or is in company. Hewa~;:diagnosed . 
as having Sydenham's chorea at the age of 14 and was treated with phenobarbitone for 
3 years, to no avail. ..> 
He presented at the National Hospitals at the age of 18 years and TS was diagnosed. 
There was no other relevant previous medical or psychiatric history. On examination, J 
his talk was normal, his mood euthymic, and there were no psychotic phenomena. He 
exhibited mUltiple tics of head, shoulders, and trunk and made occasional grunts. Physical 
examination was unremarkable. No Kayser-Aeischer rings were detected. He was pre­
dominantly right-handed (Ann ell 1970). Nonnallaboratory investigations included hemo­
globin, full blood count, ESR, calcium. inorganic phosphorus, alkaline phosphatase, liver 
function tests, protein electrophoresis and immunoglobulins, urea, glucose, electrolytes. 
24-hr urinary copper ex.cretion, and cytogenetic studies. Electromyogram (EMG) studies 
and CAT scan were normal. Two electroencephalograms were moderately and diffusely 
abnormal, with excess slow activity and a rather paroxysmal character, but no frank 
epileptiC activity was seen, and there were (10 focal features. 
He was assessed on the WAIS and had a verbal IQ of 100, a performance IQ of III, 
and a full-scale IQ of 105; there was no sign of a specific language problem (Department 
of Neuropsychology, National Hospital, Queen Square). 
A double-blind trial of single-dose clonidine, placebo, and haloperidol was carried 
out, and in view of his good response to haloperidol, he was discharged on this drug, 
taking 2 mg daily. He is followed-up regularly in the outpatient department, and 4 years 
later (aged 22 years), maintains improvement concerning his tics, with a normal mental 
state and good adjustment to life. His only medication has been haloperidol 2 mg daily. 
In view of the abnormalities of copper metabolism, his parents and sister were inves­
• 	 tigated. None of them had abnormal movements nor a Kayser-Fleischer ring. Blood was 
taken for estimation of serum copper and ceruloplasmin; the levels of both in his father 
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were normal, whereas the copper in his mother and sister were identical and just above 
the upper limit of normal (21. 6 j.lm01JIiter). Ceruloplasmin levels were normal. 
Methods 
64Cu with a specific activity of 5-30 mCilmg copper, in the form of cupric chloride, was 
obtained from Amersham International pic (code CMS2) and was used for both intravenous 
and oral administration . The 64Cu was passed through a Millipore filter (Millipore Corp., 
Bedford, MA), diluted with saline, and sterilized in an autoclave. The standard and 
intravenous doses were calculated by weight, and the dose syringes flushed with the 
patient's blood and checked for residual radioactivity. No significant radiocopper appeared 
to be sequestered by the plastic syringes, which was confirmed in a separate experiment 
using nonradioactive cupric chloride of the same concentration as the doses. Two hundred 
microCuries of 64Cu were given intravenously. and heparinized blood samples were 
collected after 5, 10, 15, 20, 30,40, 50, and 60 min and then at 1.25, 1.5, 2, 3, 5, 7, 
and 10 hr. A further 4 samples were taken up to 48 hr after the injection. All stools and 
urine were collected . Three days later, 150 j.lCi of 64Cu was given orally. Twelve blood 
samples were taken during the next 48 hr. Stools and urine were collected for 3 days. 
Samples of plasma, stool, and urine were counted together with a standard, made up 
from the dose solution, and the percentage of the dose in these samples was calculated. 
The percentage in the plasma after both i.v . injection and oral administration was plotted 
against time, and the absorption rate of 64Cu from the gut was calculated using a decon­
volution technique (Godwin-Austen et al. 1978), The percentages absorbed during 6-min 
intervals were plotted and the total percentage during 10 hr was calculated . 
To measure the 64Cu incorporated into ceruloplasmin, samples were incubated with 
diethyldithiocarbamate to release 64Cu bound to albumin. Free copper was then absorbed 
onto activated charcoal, leaving the ceruloplasmin-bound 64Cu in solution (Tauxe et al. 
1966). The percentage in the supernatant was again plotted against time on semi log paper 
to give the ceruloplasmin ncorporation curve . 
The ratio of the activity over the liver and thigh was obtained using a scintillation 
probe and rate meter. The ratio was normalized to unity by the technique of Osborn and 
Walshe (1964) . The normalized ratio was obtained during the first 2 hr and again at 24 
hr. Ceruloplasmin was measured by the method of Houchin (1958). Copper in plasma 
and urine was measured by the method of Meret and Henkin (1971) . 
Results 
Table I shows the data for all 10 subjects from the total sample of 80 subjects with TS 
in whom serum copper was abnormal. The differences in ceruloplasmin incorporation 
between representative normal, heterozygous Wilson's disease, and homozygous Wilson's 
disease subjects are shown in Figure I. The plasma disappearance curves are also included . 
Of 6 normals and 14 helerozygotes for Wilson' s disease examined , we have found that 
there is an overlap between the lower normal and upper heterozygote ranges . In these 
subjects, there is always a quantifiable percentage uptake of copper. However, of 14 
subjects with Wilson's disease, 7 untreated and 7 treated, there is invariably zero incor­
poration of radiocopper into ceruloplasmin . 
The shaded area of Figure 2 represents the range of the ceruloplasmin incorporation 
curves for the 14 obligate heterozygous Wilson 's di sease subjects . The dotted curves are 
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Table I . Summary of Data on the 10 Reported Subjects with TS Exhibiting Abnormalities of Serum Copper 
Age Age at Wechsler" Family hislOry Neurological Serum copper Serum ceruloplasmin 
Subject (years) Sex onset full scale of tics examination EEG Scan (IJ,moUliterlb (IJ,moliliter)b 
I' 44 M 7 103 No ABNJ ABN N 11.0 0.9 
2 27 M 7 110 Yes N N N 11.9 1.3 
3 18 M I I 102 Yes ABN ABN N 12 .2 1.3 
4 23 M 5 87 No ABN N N 12 .2 1.6 
5 16 M 7 75 No ABN ABN N 11.0 1.6 
6 17 M I 107 Yes N N N 10.0 1.1 
7' 22 M 10 105 No N ABN N 9.3 1.5 
8 40 M 3 114 Yes N N N 12 .3 1.2 
9 22 M 4 87 Yes N ABN 12 .4 1.6 
10 14 F 7 No N 11.4 1.4 
Normal 12.5-19.0 1.3-2.9 
'WA1S or Wise. as Hppropriale . 

'eonv<~ion faclor by muliipJicaliQn: SI- traditional unils--..:rum copper: 6.4 10 ~gil OO mi • ..:rum ceruloplasmin: I~ .O 10 ~g/IOO ml. 

' Subjects descrillcd Hnd invesligHled in funher delail. . ' 

"N. nonnal: ABN. abnormal. 
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a) Normal 
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Figure I. Curves of 10lal plasma radioaclivity and incorporalion into ceruloplasmin of intravenously 
adminislered radioaclive copper in lhree representalive subjecI groups: (A) normals (6). (8) hel­
erozygous Wilson's disease (14), and (C) homozygous Wilson's disease (7 treated, 7 untreated). 
The upper curve for each subjecI is thaI of lolal plasma activity. and the lower curve is the 
incorporation of copper inlo ceruloplasmin . 
the corresponding data for the two subjects with TS (heavy line, subject 7, and the light 
line, subject I). It can readily be seen that the incorporation of copper into c.~ruloplasmin 
of subject I is les  than the lowest found in subjects heterozygous for Wilson's disease 
and markedly less than any normal individual. That of subject 7 is also much lower than 
the lowest normal, but not outside the helerozygote range. The normal range overlaps 
the upper range for heterozygotes to only a minor degree and is not shown in Figure 2. 
The continuous lines represent total plasma radioactivity for the two subjects . 
The absorption rate curve of subject I, derived via deconvolution from the curves of 
percentage &.<Cu in the plasma after both intravenous and oral administration, is shown 
in Figure 3_ A similar curve for subject 7 is not available. 
The uptake of copper by the liver (Figure 4), as measured by ule liver/thigh ratio, was 
only available for subject 7. Figure 5 shows the rate of disappearance of radioactive 
copper from the circulation in the two subjects over the first 48 min following injection 
compared with 6 normals. 
Discussion 
Abnormalities of copper metabolism have been described in a number of diseases affecting 
the central nervous system, such as Wilson's disease (Cumings 1948), Menkes's disease 
(Menkes et al. 1962), Huntington's chorea (Perry 1961), and at least three other rare 
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Figure 2. The curves for incorJX)ration of radioactive copper into ceruloplasmin in the two subjects 
with Gilles de la Tourene syndrome are shown by the heavy and light broken lines, res~ctively, 
as compared to the range of 14 subjects heterozygous for Wilson's disease (shaded 3[l:a). The 
heavy and light continuous lines indicate tot l plasma activity for the same two subjects-;;, 
conditions (Willvonseder et al. 1973; Godwin-Austen et a1. 1978; Haas et a!. 1981). On 
history, examination, and special investigation of our subjects, there was no evidence to 
suggest that the low copper and/or ceruloplasmin levels found were attributable to any 
of these conditions . 
. Recently, Parker (1985) described the syndrome of hereditary whispering dysphonia. 
The affected individuals belong to an Australian family in which at least 20 members 
have inherited torsion dystonia. which presents as an unusual speech disorder in that 
when they try to speak, they exhibit only a faint whisper. What is of special interest is 
that two siblings with an affected mother have similar clinical manifestations and detailed 
oiochemical investigations, including a liver biopsy in one child and the presence of a 
Kayser-Fleischer ring in the other, suggested Wilson's disease, yet none of their immediate 
or distan! relatives had any of the biochemical changes found in Wilson's disease, and 
there was no suggestion of consanguinity in that branch of the family. 
Two of our subjects were found to incorporate cop(Xr into ceruloplasmin, but at a 
considerably reduced rate . We have insufficient data to determine whether or not this 
finding correlates with the serum ceruloplasmin concentration, but in patients homozygous 
for Wilson' s disease it does not, there being aJmost zero incorporation even when the 
ceruloplasmin concentration is nonnal. In Menkes's disease and related conditions, this 
also seems to be the case (Godwin-Austen et a1. J978: Haas et al. 1981). Therefore, 
interpretation of this observation in our two subjects is difficult. 
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Figure 3. This shows nonnal gastrointestinal absorption of radioactive copper during 6-min intervals 
in subject I with Gilles de la Tourene syndrome. 
Figure 4 . Liver/thigh uptake of radioactive copper in two nonnal individuals and in subject 7 . The 
normal ranges shown are those of Osborn and Walsh (1964) . 
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Figure 5. Curves of the disappearance of radiocopper from the circulation in the two subjects and 
a range from 6 normal individuals. 
A further abnonnality noted was that the disappearance of radiocopper from the cir· 
culation was much greater in our two subjects than in the nomial subjects (F~ure 5). At 
30 min, subject I had 3.7% of the dose of injected copper in the plasma compartment, 
and subject 7 had 4.2% of the dose in the plasma compartment. Our normal range at this 
time is 7.7%-14.4%. Whether or not this indicates a higher affinity for <:;9,pper by a 
protein, such as metallothionein, is clearly not known. In Wilson's disease,this protein 
is found to be abnonnal (Evans et al. 1973); therefore, it cannot be discounted that in 
other disorders displaying abnonnalities of copper metabolism there are also abnonnalities 
of other metal-binding proteins. The hepatic uptake of copper as measured by the liver! 
thigh ratio was also abnormal (Figure 4). At 15 min, the ratio was 1.4, whiC;tJ very closely 
approaches the value of 1.5 obtained by Osborn and Walshe (1967) for their group of 
asymptomatic subjects homozygous for Wilson's disease. At this stage of the disease, 
the liver is in a phase of copper accumulation, with many binding sites saturated, but as 
information from liver biopsies in our subjects was not available, it has not been possible 
to measure the concentration of liver copper in these subjects with TS. 
The intestinal absorption rate of copper, as calculated from the oral and intravenous 
radiocopper data in subject I, is normal; therefore, neither delayed absorption in the 
upper gastrointestinal tract, as in Menkes ' s disease, nor binding in the distal part of the 
gastrointestinal tract, as in the patient reported by Godwin·Austen et aI. (1978), can be 
implicated in the pathogenesis of the decreased serum copper levels . 
Total serum copper is accounted for by a protein-bound fraction tightly bound to 
ceruloplasmin and a small fraction loosely bound to amino acids (Neumann et al. 1967). 
Both fractions are involved in the transport of copper in blood to the liver where, in rats, 
the copper is incorporated into a protein of low molecular weight of about W,OOO (Marceau 
and Aspin 1973). Other animal studies suggest that this might be metallothionein (Brenner 
et al . 1976; Hartman and Weser 1977). In Wilson's disease, this protein has been found 
to have a copper binding constant 4 times that of normal (Evans et a1 . 1973) and may 
be responsible for a large pool of copper that makes copper unavailable to the normal 
Un
ive
rsi
ty 
of 
Ca
pe
 T
ow
n
ICopper in Gilles de la Tourette Syndrome BIOl PSYCHIATRY 977 
1987:22:968--978 
pathways of copper metabolism. This, in part, may be responsible for the low concen­
trations of serum ceruloplasmin found in this condition . 
As our patients do not have Wilson's disease, it is unlikely that an identical metabolic 
disorder exists, but our findings do suggest that there is a disturbance of copper metabolism 
in a subgroup of patients with TS . The biochemical changes were not associated with 
any particular motor, psychopathological, or demographic variables. It is important to 
note that there was no association with current or previous medication, including butyT­
ophenones, benzodiazepines, tricyclic antidepressants, and anticonvulsants. The fact thaI 
only an apparent subgroup of patients with TS exhibits an abnormality of copper metab­
olism highlights again the heterogeneity of the syndrome previously reported by ourselves 
(Lees et al. 1984) and other investigators (Shapiro et aI. 1978; Comings and Comings 
1985). 
It is felt that these abnormalities do not carry implications for any new form of 
management. Indeed, copper treatment was not attempted at this stage because of the 
dangers associated with possible abnormal distribution in various body tissues that may 
not all be copper deficient. In addition, administration of copper to children with Menkes's 
disease has not been shown to be effective. 
We do not necessarily postulate that the two abnormalities, i.e . , TS and abnormal 
copper metabolism, are causally related . However, we suggest that a genetic mechanism 
may be responsible, as many of the movement disorders associated with abnormally low 
copper (Cumings 1948; Perry 1961; Menkes et aJ. 1962; WiJlvonsederet al. 1973; Haas 
et aJ. 1981; Parker 1985) and TS (Comings et al. 1984; Devor 1984) have been shown 
to be compatible with mendelian transmission. 
We are grateful to the physicians who helped our project. particularly Dr. A. 1. Lees. We also thank those 
who referred cases. and the Tourene Syndrome (UK) Association . M.R. received generous grants from the 
Goldsmith's Company. and from lannsen Phannaceuticals. We also thank Berenice lones. Marina lones. and 
Linda Dudderidge for preparation of the manuscript. 
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L, MIDDLETON OJ, ROBERTSON MM (1995) Visual fields in Gilles de la 
Tourette Syndrome. ~~~!:!!..!..!:!:!.!...!:!.!...L~~!!!..Y., 167. 825-826 
CORRESPONDENCE 
Visual fields in Gilles de la Tourette Syndrome 
SIR: Gilles de la Tourette (GTS) is a complex 
disorder characterised by multiple motor and one 
or more vocal tics (DSM-III-R; APA, I It has 
been shown that GTS is a genetic disorder and the 
inheritance pattern is consistent with autosomal 
dominant transmission with incomplete but high 
penetrance 1993). In such a disorder there 
is always a quest for markers. Enoch (!( al 
(1988) described anomalous kinetic visual fields in 
100% of children with GTS. It was suggested that 
visual field defects may serve as a genetic marker for 
GTS. Repka & Singer (1992) performed automated 
static perimetry on 18 children with GTS. They 
demonstrated field defects in 25% of cases, however, 
they observed that these rates to 
those observed in patients undergoing first time 
visual field testing. 
We undertook a prospective controlled study to 
which 12 GTS (24 and 12 (24 
~~~ ~"t~I'A'" controls were recruited. No 
was detected in any of the none had 
previously undergone visual field testing. Visual field 
tests were performed a Humphrey Field 
running a central full threshold test. 
Data collected included mean deviation (MD) 
scores, an indication of the overall field abnormality 
and corrected pattern standard deviation (CPSD) 
scores, localised field defects. out of 
24 visual field tests in each group were reliable ac­
cording to the indices built into the field 
analyser software and were included in statistical 
analysis. There were no dif­
ferences in either MD (P=0.08) or (P::::0.21) 
between GTS and control (see Table I for 
results for Humphrey fields). difference in MD 
approached significance, and a might 
be to a significant result. However, the 
MD score for a particular would not serve as 
a biological marker for since there is a 
overlap of MD scores in the GTS and control 
groups, Our study indicates a trend for a higher 
negative MD score in GTS patients, but we conclude 
that visual fields do not serve as a useful biological 
marker. 
AMER,eA:-i PSVCIIIATRIC AS.~'ATION t 1987) IJwpnOJ'JIl and SUllis' 
lieu/ Manlla/ of Mmlfll Disorders (3rd edn. (DSM-Hl-
R). Washington. DC: 1\1'1\. 
Table 1 

Results of Humphrey 24·2 fields 

GTS patients Controls 
MD CPSD MD CPSD 
Sex/Age R eye l eye R eye l eye Sex/Age R eye l eye R eye l eye 
M 22 y 2.70 2.02 0,00 0.00 M 23y 1.68 1.64 0.00 0.92 
F 46 y 3,22 - 2.33' 2.50 0,00' F 44 y 0,08 0.16 1.12 0,00 
F 51 y 2,27 2.36 0.00 4,06 F 50 y - 2,84 - 463 0.00 5A8 
M 23y 9.72 13.9" 7,27 9.60" M 24y -1.46 1.38 0.00 0,00 
M 50y -0.70 1,66 1.38 0,00 M 46y 0.24' 0.63 0.52' 0,00 
F 52 y - 2.78' 1,67 1.07' 0.00 F 51 y 0.77 - 1.25 0.00 0,00 
M 20y -3AO - 1.92 0.00 143 M 23y 1.29 -1.17 0.39 0.00 
F 29 y 1.69 - 2.55 0.00 1.79 F 22y 0.78 1.17 0.60 1.23 
M 21 y 2.10 - 0.96 1.26 1.79 M 21 y - 2,33 0.53 0.00 1.45 
M 29y 2,58 208 0.97 0.00 M 32y 126 0.40' 1.11 1.34 • 
M 50y 2.10 - 0.96 1.26 1.79 M 48y - 1,78 - 2.53 1.32 0.00 
F 31 y - 3,25 3.21 0.20 0.00 F 32 y - 8.39 7,86' 3.75 4,56' 
'low reliability score (excluded from statistical analYSIS). 
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EAPES. V .. P.'L·L.S. D. L. & RORERT50s. M. M. (1993) Evidence for L. WHITEFIELD 
autosomal domin~nt transmission in Gilles de la Tourellc' E. M. MIDDLETON 
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89) Anom~lous hnetic visual fields in Gilles de la Touretle London WCl E 6A U 
Syndrome palients and family memb.:rs. Perimetry Update. 
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INCREASED PLASMA KYN IN TOURETTE SYNDROME 
MAY BE DUE TO INDUCTION OF IDO 
Kariyawasam, S.H., F.M., Robertson, 
S.L. Pharm. Sci, Aston University, 
HU<U'!'r'''''' 815 2QZ and National 
Queen London 
Kynurenine (KYN) in an animal 
Tourette Syndrome (TS) (McCreary & Handley, 1995, J 
Psychopharmacol 9: 68) and has been reported to be elevated in TS 
(Dursun et al, 1994, Mol Chern Neuropatho! 21: 55). The KYN 
pathway is the principal route for metabolism of tryptophan (TRY); 
KYN levels give a gross index of this pathway's activity. In 
liver, the first enzyme is the Tryptophan 
dioxygenase (IDO), while in extrahepatic tissues, including brain, 
this is replaced by the indoleamine dioxygenase 
(IDO). Cytokines also induce neopterin formation. Plasma samples 
were obtained 72 TS patients and 46 
following an overnight fast. TRY and KYN were measured by 
by RIA and neopterin was Prof D 
Fuchs (I nsbruck). There was no significant change in TRY but 
KYN were 1.43 ± C: 1.29 ± 
0.06; IJ..mol/L p<0.05). Cortisol was unchanged, while 
was significantly elevated (TS: 8.65 ±0.68; C: 6.89 ± 0.31; nmollL 
p<0.05). Levels were not related to current 
medication. was not significantly with KYN in 
TS subjects or controls, while neopterin was significantly correlated 
with KYN in controls (r = p<O.OOl) and even more 
in TS subjects (r 0.613, p<O.OOOl). These results suggest that the 
increase in KYN in TS is more likely to be due to induction 
of IDO than TDO, suggesting a possible autoimmune basis for the 
condition. 
'f TS 
 
  n '1'0 I 0
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Square, 
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EEG 91646 
Electroencephalography and clinical Neurophysiology, 82 (1992) 12P~ 14P 
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Society .-.rl'."...·11 
The Society 
Birmingham, 12 June 1991 

Hon. Meetings Secretary: Barrett 

The National Square, London WClN 3BG (UK) 
(Received for publication: 16 August 1991) 
6. 	 Event-related potentials (ERPs) recorded from auditory 
sual oddball and auditory selective attention tasks in Tourette's 
syndrome. - M. Gobel, G. Barrett, Z. Pirtosek and M.M. Robert­
son (The National Hospital and Middlesex Hospital, London) 
Van Woerkom et (Electroenceph. clin. Neurophysiol., 1988, 
demonstrated abnormalities of Nl potential 
recorded from adult patients with Gilles de la Tourette's syndrome 
a auditory oddball It 
that subjects with syndrome have an attention deficit and 
as the auditory Nl potential is related to attention we to 
extend the oddball result to an test which assesses attention 
directly. 
Thirteen patients years and 10 subjects with 
.. the same age range performed auditory and visual 3-stimulus oddball 
and an auditory selective attention task which of a 
high (1.5 kHz) or low (1.2 kHz) pitch tone delivered to the or 
ear in random order at a rate of 1 All pitch/ear combina­
tions were equiprobable and one was designated as on sepa­
rate runs with responses for all 4 possible targets being recorded.. 
Division of attention was evaluated by' wave 
forms for responses to the same physical stimulus presented to 
attended and unatte ears. 
Results from oddball tasks the Tourette's 
cases attentlonal difficulties responses in the 
. selective atte task indicated a clear difference from controls 
. suggesting impaired ability to attend to one ear at a 
l oi . !  ! t
© i , j j 05
p oceedings 
EEG 
Dr. G. 
Hospital. Queen ; l  
l 90 
and vi-
-
di L
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task. has been suggested 
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control 
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right 
l/sec. i -
\ target -
. 
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Grip Force Behavior in 

Gilles de la Tourette 

Dennis A. Nowak, MD,I.2* John Rothwell, PhD,l 
MD,2 Mary M. MD,3,4 
and Michael Orth, MD 1,4 
ISabel! Department of Molor Neuroscience and Movements 

Disorders, Instilllte of Neurology, University of Lonoon, 

London, United Kingdom; 2Department of Neurology and 

Clinical Neurophysiology, Academic Hospital DO.f?efWaIlS,m 

of the Technical University of Munich, Munich, 
"Department of Psychiatry and Behavioural Sciences, 
University and the National Hospital for Neurology 
and Neurosurgery, London, United Kingdom; 4 Department of 
Neuropsychiatry. The National Hospital for Neurology and 
Neurosurgery, Queen Square, London, United Kingdom 
Abstract: We analyzed and reactive grip force behav­
ior in 15 with de la Tourette syndrome (GTS) and 
IS sex- age-matched healthy control subjects. Nine patients 
were without medication; six were on medication. In a 
first and held instrumented 
of weight. In a second experiment, panicipants per­
fonned vertical point-to-point and continuous arm movements at 
different with a hand-held object. In a third 
men!, preparatory and reactive grip force to sudden 
perturbations were when a 
hand-held cup either by the subject or unexpex:tedly 
imenter. Compared to the healthy 
increased grip forces relative to the load force in all tasks. Despite 
this they the force to changes in load force 
(due to a in the mass lifted or accelerating the mass 
continuous movements) in the same way as healthy sub-
temporal coupling between and load force 
was also similar in patients imd controls, and 
played nonnal anticipation of impact forces when they 
weight into hand-held cup. We found no 
medication on the of GTS 
task perfonned. These results are consistent with senso­
ry-motor in Gilles de la Tourene syndrome. © 2004 
Movement Disorder 
Key words: force; manipulation; force 
control; Gilles Tourelle syndrome 
Gilles de la Tourette syndrome (GTS) is a developmental 
nel1ro,DS'i/ctIl3tnc disorder characterized multiple motor tics 
and one or more phonic tics that have to present for more 
Published online 
J)"na.1men! of Neurol­
~eIHelnD<~r 2004 in Wiley InterScience (www. 
10.1002lmds_20309 
Movement Disorders. Vol. 20. No.2. 2005 
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218 D.A. NOWAK ET AL. 
tics often relieve internal sensory urges 
tic sensations) while more 
complex tics such as to the perception 
of external stimuJi. 2•3 These clinical observations suggest that 
GTS is a sensory-motor disorder, for which the to 
external stimuli be increased and unwanted 
motor, or stimuli cannot be sufficiently 
This combination may lead to tics and possibly other 
of GTS as habitual motor to sensory cues.v 
The pathophysiology of been associated with the basal 
thalamocortical circuits, and related sensorimotor cortical 
areas.4.5 In basal ganglia disorders, such as Parkinson's disease 
and Huntington's disease, there is often a disruption of 
ordered movements.6.7 In GTS, fast aiming movements 
were not to nonnal controls.8 However, GTS patients 
were more reliant on external (visual) cues to execute a motor 
program during sequential movements,9 that they have 
difficulties in internally their movements and to switch 
between subsequent motor This would be con­
sistent with the idea that ganglia function may be compro­
mised in GTS, because a similar can be seen in 
patients with Parkinson's disease6 ,7.10 
Two more recent studies examined the control of grip force 
during manipulation in GTS. Flanagan and colleagues 
examined a single untreated and normal 
force control during both movement and 
involuntary ticsIl In contrast, Serrien and coworkers, 
examined 9 GTS found they manipulated objects with 
excessive grip force l2 similar 10 patients wilh other basal gan­
disorders, Parkinson's disease, !3-1 5 Huntington' s 
and dystonia. 19.20 
The aim of the present therefore, was to resolve the 
Isclrepan(;y between the work Flanagan and associates ll and 
and This difference may have been 
due to the fact that 5 of patients of Serrien and coworkers 
were taking medication at the time of the study, whereas the 
of and was untreated. We, there-
force control in a greater number of 
and the results with those in 
and GTS treated with dopamine an­
tagonists. 
SUBJECTS AND METHODS 
Subjects 
A tOlal of 15 patients with a DSM IV diagnosis of GTS (7 
women; mean age, 37, I years; range, 19-62 years) and 15 
subjects (7 women; mean age, 37.5 years; range, 
years) in the Nine patients 
""""v'",'''''' for GTS I). Tic severity was 
assessed the Yale Global Tic Severity Scale (YGTSS)21 
All subjects were right-handed, na"ive to the purpose of 
the study, and gave informed written consent. All "o<,ttr,mlfll< 
nt>;T'fm'mi-rlthe experiments with their dominant 
was conducted in accordance with the of 
aUlJ'VVCU by the National Hospital for Neu­
m<l!rol'rv and the Institute of Neurology joi!lt 
Instrumented Object 
Subjects a cylindrical and cordless instrumented 
between the of the dominant right hand. De-
about the described elsewhere22- 24 In 
brief, the object grip force (GF) and linear acceler­
ation in three dimensions. Data were stored within the object 
and transferred 10 a personal computer for after each 
setting with a subject. For arm movement 
the object was used alone (mass, 0.35 kg). For 
experiments, the object was mounted onto an empty 
C;UlmHlIt:1 or a container loaded with a 100-g weight (mass, 0.40 
and 0.50 kg, For the catch-up the 
object was onto a cup in which a was 
dropped (mass, 0,45 kg). surfaces were at a 
medium (#240) in all performed. 
Procedures 
washed their hands with 
experiments gave 
verbal instructiolls, then demonstrated the prclceljure, and fi­
nally observed the as they did the tasks. 
TABLE 1- Clinical details of palients with Gilles de la Tourelte syndrome 
Patient Gender Age (yr) Duration of symptoms (yr) YGTSS Treatment 
V.R. M 24 14 46/100 None 
K.B. F 19 12 791100 None 
R.C. M 45 35 261100 None 
D.H. M 49 44 521100 None 
B.C. M 30 22 311100 None 
D.B. F 27 21 59/100 None 
K.B. F 19 13 72/100 None 
D.O. M 32 27 25/100 None 
M.L, M 55 49 401100 
A.B. M 41 35 171100 
1.0. F 53 42 481100 
K.O. F 19 8 191100 
OK M 41 34 391100 
P.R. M 41 41 28/100 
M.R. F 62 59 63/100 
YGTSS, Yale Global Tic Severity Scale. 
MovemeHl Disorders. Vol. 2005 
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the Object 
The sat in a chair in front of a table with their 
to the tnmk, and with their unsupported 
forearm anteriorly. The object was between 
the of the thumb and index finger on either lifted to I 
cm the table indicated by a marker, held in this 
for 5 seconds, and then replaced and released. could 
see the object and their hand and ann during all phases 
of the task. After 10 either the OAO- or 0.50-kg 
weight, were asked to slowly release the until it 
dropped to the This procedure was 
obtain an estimate the minimal force 
essary to prevent the from The was 
defined as the first detectable the 
vertical z-axis and the 

at this time point 

Voluntary Arm Movements 
grasped the object between the of the thumb 
They were instructed to move the fast 
between two 30 em apart (indicated by a ruler) on a 
vertical line its z-axis and to the object's 
point-to-point movements short 
second duration were introduced in 
between up and down movements. During continuous 
movements, there were no breaks and subjects were 
paced by an auditory stimulus to move the 
downward at three different cycle trp.{111f'nr, 
and 1.5 Hz. For both pOint-to-point cyclic movements, five 
trials consisting of 8 to 10 movements with inter-trial breaks of 
to 30 seconds duration were performed. At the end of the 
the minimum force required to prevent the object 
from slipping (slip was measured twice for each indi­
vidual as described above. 
Catch-Up Trials 
sat in a stable chair in front of a table with the 
dominant arm slightly abducted and the forearm held unsup­
ported and rotated in front and in parallel to the trunk with the 
elbow flexed at 90 held the 
object mounted onto a cup between tips of 
thumb. were instructed to hold the 
and to prevent it from slipping. In the 
condition, subjects were asked to 
entire experiment. The 
unexpectedly into the cup a height em 
a mark. In a second experiment, subjects themselves 
the 100-g weight into the cup with their eyes open. Ten such 
trials with intertrial intervals of 5 seconds were for 
the and self-release conditions, Af­
forces were as 
Data Analysis 
Positive kinematic acceleration (ACC) of the 
the z-axis) was directed upward during and arm 
movements, but directed downward during catch-up 
ments. When the object was held 
was measured. The net load force (LF) was 
mass and the vectorial summation of gravity (9.81 
and inertial accelerations along the object's X-, y-, and 
z-axes. This method included additional inertial loads, which 
arose from incidental acceleration components in the x- and 
y-directions. 
Lifting the Object 
For the last 5 of 10 lifts, (I) maximum kinematic acceleration 
of the lifting movement (Max. ACC), (2) maximum rate of grip 
force increase (Max. GF Rate; maximum of the first time 
derivate of force), (3) maximum force, and (4) static 
force GF) from a interval of 
holding the object were determined. The ratio be­
tween maximum and load forces was also calculated. Time 
lags between acceleration and maximum grip force 
were assessed to quantify the temporal coordination between 
and load force profiles. 
statistical analysis, we first asked whether patients used 
forces compared with controls and whether this 
depended on the load forces. To this end, we used analyses of 
variance (ANOYA) with the factors (OAO kg and 0.50 
kg) and "disorder" (GTS patient and control). Next, we 
examined whether medication had an in the GTS 
This aspect was tested using ANOY A with the 
(0.40 kg and 0.50 and "medication" (on 
medication and off medication). 
Point-to-Point Arm Movements 
within the course of voluntary movements 
(I) movement start as determined when the 
deviated more than 2 standard deviations 
level, and (2) maximum kinematic accelera­
tion (Max. ACC; maximum upward acceleration and maximum 
downward deceleration). At these time points, force and 
acceleration signals, as well as calculated were 
detemiined. The maximum load force coincided with maxi­
mum kinematic acceleration. The grip force at the movement 
onset a measure of force established during 
stationary of the object in single movements. 
The ratio between and load force (Force Ratio) at move­
ment Oil set and at of maximum kinematic acceleration 
with maximum load force) was used to relate Ihe 
magnitudes of the two forces This force ratio is con­
sidered to be a highly sensitive measure of the efficiency of grip 
force produced in relation to the load force. To describe the 
stability of the temporospatial coordination between the grip 
and load force profiles, a correlation between and 
load forces was for the entire course of move­
ment. The average? correlation coefficients were calculated 
for each to assess the and stability of the grip 
force with the movement-induced load fluctuation. 
The and intercepts were calculated for each 
to the gain of modulation of the force 
with the load force profile. 
Statistically, for each movement direction or down), we 
tested whether the grip forces of patients from controls 
using ANOY A with the factors "disorder" (GTS patients or 
healthy control) and "direction" or down). A second 
ANOY A examined the effect of medication on force in the 
Movemen! Disorders, Vol. 20. No.2. 2005 
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patient group with the main factors "medication" (on or off 
medication) and "direction" (up or down), 
Continuous (Cyclic) Arm Movements 
Data analysis focused on the coupling between the grip and 
load forces with to the level of produced forces and the 
temporal between the force To evaluate 
the scaling of the grip force level in to the movemen!­
induced loads, the ratio between grip and load force 
(Force Ratio) at the lime of maximum acceleration 
turning point of the movement cycle) was determined, To 
describe the stability of the coordination be­
tween the and load force profiles a correlation analysis 
between and load forces was for movement 
cycles at different cycle rre!:juemCles. 
Statistically, we first asked grip forces differed 
between patients and controls, To test this 
ANOY A with the main factors of "rilor.rtiM'" 
healthy control) and (1.5 Hz, 1.2 Hz, and I Hz 
cycle frequency). In a second AN OY A with the main factors 
"medication" and "frequency", we examined the influence of 
medication in the patient group. 
Catch-Up Trials 
The maximum of load perturbation was only indirectly as­
sessed by determining the maximum of downward acceleration 
of the cup due to impact. When controlling this measure with 
an additional load sensor between the grip object and 
the cup, the maximum indeed occurred 
with the maximum peak in downward acceleration. However, 
the load magnitudes, either measured with the load sensor or 
calculated from the maximum downward deceleration at im­
pact, did not reliably reveal similar magnitUdes, 
we focused our analysis on the temporal measures, We 
two lime points within the grip and acceleration traces of the 
last five trials in the experimenter- and self-release conditions: 
(I) maximum acceleration (coinciding with maximum load 
force) and (2) maximum grip force, The time between maxi­
mum grip force and maximum acceleration on the 
predictability of the task and was assessed to 
of the precision of the temporal coupling between 
forces, 
We used ANOY A to the influence of "disorder" 
(GTS patients and healthy control) and "condition" 
menter- and self-release conditions) on the time lags between 
maximum grip and load force. Next, we tested whether medi­
cation had an effect on this parameter using ANOYA with the 
main factors "medication" (on/off medication) and "condition" 
A significant difference in the ANOYA was followed by post 
hoc using Student's t tests, A P value of 0,05 
was statistically Significant. 
RESULTS 
Slip Forces 
The average slip forces of GTS palients, Jllt:~IJ'OCIl 

medication, and healthy controls were similar (P ~ 

Lifting the Object 
In all patients and controls, the maximum force rate and 
force occurred before liftoff, Similar to controls, 
produced a greater peak fale of force increase and 
force when lifting the In addition, 
in groups the static force (averaged from 3 seconds of 
stationary holding) was greater when holding the heavier ob-
Thus, the ability to scale the force output 
differentially to different object weights was preserved as 
previously described in detail by Johansson and Westling25 in 
healthy subjects. Medication did not have a influ­
ence on of the data in the experiments. Therefore, 
for all the data from all patients were combined. 
There was no difference between patients and controls in the 
component of the task. The accelerations 
of lifting movement were the same groups (0,5 
0.1 mlsec2), of weight (P ~ 0.8 for all !':O!l"'O,'­
sons). The main between the groups was seen in the 
component of the task I), The maximum rate of grip 
increase (FlAB 7.5; P 0.01), the maximum force 
= 37.2; P < 0.001), and the static force 27; 
0,001) were in GTS 
controls, We calculated 
value was also greater in the than the conlrols (F 1.48 
40,7; P < 0,001, 1), but it was similar when both 
weights, This finding that the GF was a constant 
of the LF in groups of subjects. 
between the acceleration of the lifting 
movement and the grip was similarly precise in 
GTS patients and healthy conlrols with maximum grip force 
and maximum acceleration coinciding closely in time. The 
average time lags between maximum grip force and maximum 
acceleration were similar for GTS patients (with medication: 
10 ::: S msec and 7 ::: 10 msec for lifts with the 0.4- and O.S-kg 
weight, respectively; without medication: 16 10 msec and 
- 3 ::: 5 msec for lifts with the 0.4- and O,S-kg weight, respec­
tively) and healthy controls (15 ::+: 10 msec for lifts with the 
O.4-kg weight and 16 12 msec for lifts with the 
weight), 
Arm Movements 
In all our patients and healthy controls, we observed a similar 
basic relationship between grip force and arm movements as 
has been reported previously in detail by Flanagan and Wing in 
healthy subjects.26 Medication did not have an influence on the 
data in the group. Therefore, for all further analyses, the 
data of aU patients were combined, 
Point-to-Point Arm Movements 
Patients had force ratios at the onset of movement 
= 10,9; P = 2) and at maximum acceleration 
13.2; P 2), irrespective of movement 
A correlation was performed between grip 
and load force profiles to examine their temporospatial cou­
pling. Despite higher the correlation coefficient was 
similar in GTS patients controls. indicating a very 
and stable coupling between and 
in all (r 0,78; SO patients versus 
0.78; SO in controls). The gain of grip force mod-
Movemelll Disorders. Vol. 20. No.2, 2005 
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FIG.!. Grip force rate, grip forces, and force ratios . With either weight, maximum grip force rate (Max, GF Rate, A), maximum grip force (Max. 
GF, B) , static grip force (Static GF, C) and grip force: load force ratios (Force Ratio, D) are higher in Gilles de la Tourette syndrome patients compared 
with controls. Note the different scale in Band C. Data are expressed as means (±SD), The results of post hoc comparisons between patients and 
healthy controls are indicated ('P < 0.03; up < 0,01; "'*P < 0,001), 
ulation with movement associated load fluctuations in both 
directions was greater in GTS patients than healthy controls 
(F) ,56 = 12; P = 0.001 for slopes and FI.56 = 10; P < 0,01 for 
intercepts of the least square regression lines), This finding is 
consistent with the increase in the GFILF ratios in the lifting 
experiment. There was no correlation between the amount of 
grip force overflow and the severity of GTS as measured with 
the YGTSS.2) 
Cyclic Movements 
Grip and load force profiles were tightly coupled for move­
Movement onset 
ments at each frequency with their respective force peaks 
A 
r--I 
I 
.......... 
0 10 
+-' 
ro 
0::: 5 
ill 
0 
~ 
0 0 
LL up down 
coinciding closely in time. These characteristics have been 
described in detail by Flanagan and Wing in healthy subjects27 
and were observed in all our GTS patients and healthy controls, 
There was no difference between treated and untreated GTS 
patients in any of the different parts of the experiment. There­
fore, the data of all GTS patients were combined for further 
analyses, 
As in the other experiments, the grip force component of the 
task was impaired in patients, Higher force ratios were noted in 
GTS patients (F),66 = 124; P < 0,001, Table 2). The force 
ratios were higher with higher cycle frequencies in both pa­
tients and controls (F2 .66 = 66; P < 0.001, Table 2). Interest-
B 
Maximum ACe 
5 
2.5 
o 
up down 
FIG. 2. The ratio between grip and load force at the time of movement onset (A) and at maximum acceleration for upward and downward movements 
(B) is greater in GTS patients than controls, Note the different scale in A and B, Data are expressed as means (±SD). The results of post hoc 
comparisons between patients and healthy controls are indicated (*P < 0,03). White bars, controls ; black bars, patients , 
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TABLE 2. Force rarios (grip forcelload force) wiriJ cyclical 
arm movemenls in patients and conlrots 
at differenl 
Cycle frequency 
I Hz 1,2 Hz 1,5 Hz 
-------------------------~-----------
GTS pmiems 1.4 (0,2) 2,5 3.8 (0.9) 

Healthy controls 0,8 (0,1) 1.1 1,7 (OA) 

Values are eX[He,.,w 

GTS, Gilles 

ingly, we found an interaction between the factors "disorder" 
and = 14; P < 0,001), indicating that the 
effect of in GTS palients. 
This finding force 
offset, had a greater increase in grip at 
higher cycle frequencies, There was no correlation between the 
amount of grip force overflow and the severity of GTS as 
measured with the YGTSS2l 
Catch-Up Trials 
The time lags between maximum grip force and maximum 
acceleration were calculated for GTS patients and healthy con­
trols during both conditions, The average lime 
were 106 :':: 5 msec and -6 ± 5 msec for patients on 
,<ou."atlVIl, 108 ± IS msec and - 8 :':: 12 msec for patients off 
medication, and 105 :':: 10 msec and - 8 19 msec for healthy 
controls in the and self-release condition, 
tively, The time for the 
condition than for self-release condition 1223; P < 
0,001) but not different between controls or be­
tween GTS on and off Thus, as described 
in healthy patients were capable of predicting the 
load due to impact and to force in 
anticipation in the self-release condition. 
release condition, the perturbation was not predictable and a 
reactive control mechanism was by impact with the 
consequence that grip force lagged load due to nerve 
conduction delays2~ 
DISCUSSION 
study was to resolve the differences 
between the of two studies that examined 
sensory-motor integration in force 
ments.ll,12 Consistent with the and col­
leagues,12 our results confirm that 
force than healthy controls in all tasks 
we were able to show in a reasonably large 
that the increased force is 
between GTS receptor U'~'''''-W5 
and untreated indicates that 
force in GTS medication, We 
correlation between the degree of grip force offset 
clinical severity of GTS as assessed with the YGTSS. How­
ever, because the YGTSS is a global score for rating tic 
severity, it may not correlale with abnormalities in a 
subset of muscles involved in grip force experimellls, 
Some tasks involved subjects 
move of different weight or them at different 
rates, The common feature of the results was thaI GTS palielllS 
were able to adjust force to the load force on the 
object being was 
constant. The same was true in the control group with 
the only difference that the ratio was smaller than in the 
That is, for any load on an object, patients 
exerted a proportionally larger grip than controls. The 
results also extended the study of Serrien and coworkers l2 by 
that the timing of and reactive grip force 
to sudden or load force 
were also similar to healthy controls, Our results 
suggest that the motor force adaptation) to an 
external sensory cue a higher in GTS 
than nonnal and that this difference is for 
the inefficiently high 
force changes, however, 
GTS increase the ratio force more than 
when objects at higher cycle 
cies, 
Our data suggest that, m GTS, the sensory infonnation 
conveyed to the brain about the load acting in an is 
translated into an abnonnally large motor response, i.e., inef­
ficiently force. However, the detection of in 
the execution of the motor programs regu­
force output were nonnal. On clinical 
examination and neurophysiological there is no evi­
dence for sensory abnonnalities in Thus, it is more 
likely that the link between sensory in the brain and 
motor output is abnormal. This <OAlmll""'IVIl 
with the of abnormal of sensory infor­
mation or an control of unwanted behavior 
motor responses in The increased 
force in is strikingly similar to that reported in other basal 
diseases including hypokinetic disorders, such as Par­
disease, l3.14 and hyperkinetic disorders, such as Hun­
tington's disease l6 - l8 and Abnormal central pro­
of has been shown in Parkinson's disease 
and focal hand dystonia, The gating process of 
sensory input and the with motor programs involves 
di fferent cortical and structures as well as their 
respective input and outflow It is conceivable, 
therefore, that the pathological processes underlying each of the 
basal ganglia disorders might affect different parts of these 
circuits, leading to abnormalities common to all. 
In conclusion, we confirmed that GTS patients use excessive 
grip force, whereas the precision of the temporal coupling 
between and load force in both predictive and 
reactive grip behavior was similar to controls. This find­
ing further evidence to that GTS is a sensory-
motor disorder that may result involvement of basal 
circuits, Future research using differ­
ent tasks linked in with other, neurophysiological or im­
some light on which patho­
deficits of finger force control 
disorders, 
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Excitability of motor cortex inhibitory circuits in 
Tourette syndrome before and after single dose 
nicotine 
M. Orth,1,2 B. Amann,2 M. M. Robertson2 and J. C. Rothwell1 
I Sobell Department of Motor Neuroscience and Movement 
Disorders and 2Department of Neuropsychiatry, The 
National Hospital for Neurology and Neurosurgery, 
Royal Free and University College Medical Sclwol, 
Queen Square, London WCI N 3BG, UK 
Summary 
The pathophysiology underlying the involuntary tics of 
Gilles de la Tourette syndrome (GTS) remains unknown. 
Here we used transcranial magnetic stimulation (TMS) 
to examine the exciutbility of two'different inhibitory sys­
tems in the human motor cortex: short interval intracor­
tical inhibition (SICD and short interval afferent inhibition 
(SAl) in 10 healthy non-smoking controls and eight 
untreated non-smoking patients with GTS. Compared with 
the healthy control group, both SI CI (measured at a range of 
conditioning intensities) and SAl were reduced in patients. 
This is consistent wi:th the suggestion that reduced excitab­
iHty of cortical inhibition is one factor that contributes to 
Correspondence to: Dr M. Orth, The National Hospital of 
Neurology and Neurosurgery, Sobell Department of Motor 
Neuroscience and Movement Disorders, Institute of Neuro­
logy, Box 77, Queen Square, London WC1N 3BG, UK 
E-mail: m.orth@ion.ucl.ac.uk 
the difficulty that patients have in suppressing involuntary 
tics. In addition, the reduced SAl indicates that impaired 
intracortical inhibition may notbe limited to the motor 
cortex but also involves circuits linking sensory input 
and motor output. A single dose of nicotine reduced tic 
severity as assessed by blind video scoring in the majority 
of patients. In addition, it abolished the difference between 
patients and controls in SICI and SAL There was no effect of 
nicotine, and no difference between controls and patients in 
measures of motor or SICI threshold. This indicates that 
cholinergic input can modulate the efficiency of SICI and 
SAl differently in GTS and healthy controls. 
Keywords: transcranial magnetic stimulation; tic treatment; Gilles de la Tourette syndrome; intracortical inhibition; 
sensory afferent inhibition 
Abbreviations: AMT = active motor threshold; CSI = conditioning stimulus intensity; CSP = cortical silent period; FDI =first 
dorsal interosseus muscle; GCI = global clinical impression; GTS = Gilles de la Tourette syndrome; ICF = intracortical 
facilitation; lSI =interstimulus interval; MEP = motor evoked potential; MRVS =modified Rush Video Scale; SAl = short 
interval afferent inhibition; SICI =short interval intracortical inhibition; TMS =transcranial magnetic stimulation 
Received August 23, 2004. Revised December 8, 2004. Accepted January 29, 2005. Advance Access publication 
March 17, 2005 . 
Introduction 
The pathophysiology of Gilles de la Tourette syndrome (GTS), 
a developmental disorder characterized by several motor and 
one or more phonic tics present for> 1 year, is little understood. 
Simple tics often relieve internal sensory urges felt in the area 
of the tic (premonitory sensations) (Bliss, 1980), while more 
complex tics such as echophenomena respond to the percep­
tion of external stimuli. These clinical observations suggest 
that GTS is a sensorimotor disorder where the sensitivity to 
external stimuli might be increased, and unwanted sensory, 
motor or emotional stimuli cannot be sufficiently suppressed 
(Ziemann et al., 1997; Greenberg et al., 2000). This may lead to 
tics and perhaps other features of GTS such as habitual motor 
responses to sensory cues (Leckman, 2002). 
There are few electrophysiological studies of GTS. Some 
have used pre-movement EEG analysis to reveal differences 
in cortical activity preceding involuntary tics and volitional 
movement (Obeso et aI., 1982; Karp et al., 1996). More 
recently Ziemann et al. (1997) emphasized possible deficien­
cies in some forms of cortical inhibition. In the motor cortex, 
they found that patients had reduced short interval intracor­
tical inhibition (SICI) and a short cortical silent period (CSP). 
The former is thought to reflect excitability in GABAa-ergic 
© The Author (2005) . Published by Oxford University Press on behalf of the Guaramors of Brain. All rights reserved. For Pennissions, please email: joumals.penniss;ons@oupjouma{s.org 
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inhibitory whereas the latter may use a GABAb­
pathway. The authors suggested that reduced activity in 
inhibitory could be one factor that leads to reduced 
~A"'M~"~U movements. 
was to confirm this 
observation in more detail. Ziemann et al. (1997) measured 
SICI using a paired-pulse transcranial magnetic stimulation 
(TMS) with only one conditioning stimulus intens­
ity we and others recently pointed out that 
this could produce results since the amount of 
SIC! is dependent on the CSI et al., 2002; Butefisch 
et al., 2003; Orth et If the relationship between 
intensity and amount of SICI differs in patients and controls, 
a measure can give an erroneous estimate of the max­
imum of SICI. in this study, we meas­
ured SIC I at a range of intensities to test the 
hypothesis of Ziemann et ai. (1997) more 
The second aim of the project was to extend the measures to 
another form of cortical inhibition. If some tics are an unsup­
response to sensory urges, then we to see 
abnormalities in pathways that specifically link 
sensory input and motor output. One such that can 
be tested in humans is short interval afferent inhibition (SAl: 
Tokimura et ai., 2000) in which a transient sensory input leads 
toarapid inhibition of motor cortex. We added 
this test to our of GTS patients. 
The third aim of the project was to test whether any of these 
physiological measures would be of use in a clinical 
Clinical evaluation of GTS is notoriously difficult because of 
the of and this includes the assessment of any 
with treatment. Thus, it would be very 
useful to have a objective measure that could 
be used to evaluate the effectiveness of new therapeutics. We 
therefore tested whether differences between patients and 
healthy controls in measures of cortical inhibition could be 
normalized by effective clinical treatments. The treatment 
we chose was nicotine. Several studies have that 
nicotinic drugs, such as nicotine the alkal­
oid in tobacco, or mecylamine may influence tics particularly 
in conjunction with haloperidol (McConvilleetai., 1991, 1992; 
Silver et al., 200 la,b). In addition, nicotine is easy to apply and 
is absorbed rapidly when as a chewing gum. This allowed 
for measurements on the same day after a nic­
otine dose. Nicotine also has the of being safer to test 
on healthy control than some of the 
that are also used to treat Tourette I/WU~,'HJ 
such as haloperidoL We evaluated the clinical response 
using video and whether the TMS meas­
ures of motor cOltex excitability following nicotine. 
Material and methods 
Patients and control subjects 
(six men, mean age 31.3 years, range 19-48) with a 
of GTS and 10 control subjects (seven men, mean 
age 32.6 years, range 24-38) were recruited. In GTS the 
Intra-cortical inhibition in Tourette 1293 
Table 1 Demographic and clinical features 
Gilles de la Tourette syndrome patients 
Patient Gender, age DCI (%) YGTSS (%) Co-morbidity 
(years) 
I M,31 41 21 None 
2 F,27 76 66 None 
3 F,33 66 67 None 
4 M,48 47 45 None 
5 M,19 59 52 ADHD 
6 M,30 58 45 ADHD 
7 F,20 52 40 None 
8 M,43 56 33 ADHD,OCD 
9 M,31 62 40 None 
of tics was rated on the of the the 
Yale Global Tic Scale (Leckman et ai., 1989); the lifetime 
history of symptoms indicative of GTS was the dia­
confidence index (DCI; Robertson et ai., 1999) (Table 1). All 
patients and all control subjects were non-smokers, and no patient 
was on medication at the time of the study. 
Patients gave infonned written consent according to the Declara­
tion of Helsinki, and the Joint Ethics Committee of the Institute of 
Neurology and the National Hospital for Neurology and Neuro­
surgery the study vn_nUl.UI. 
Nicotine assay 
Before and", 1.5 h after to chew a nicotine gum (2 mg, 
Nicotinell, Novartis, West Sussex, UK), 5 ml of venous blood were 
drawn. were centrifuged at 5POO cp.m. on a benchtop 
and serum into a clean screw top container. 
Samples were stored at -80°C until they were analysed for nicotine 
concentration gas chromatography as described (Feyerabend 
and Russell, 1990). We had to include a placebo condition 
in which patients were a non-pharmacologically active gum, 
but the highly distinctive taste of the nicotine gum meant that 
were able to between the placebo and 
'real' gums, so that this approach was ab'andoned. 
Electromyography recordings 
Surface EMGs were recorded from the right first dorsal interossoeus 
(FDI) muscle silver/silver chloride disc surface electrodes 
(I cm diameter) in a belly tendon montage. The EMG 
amplified and analogue filtered (30 Hz to 3 kHz) with a ~'F"U'H~' 
D150 amplifier Ltd, Welwyn Garden UK). Data 
(sampling rate 4 kHz) were for off-line analysis using 
software Electronic Devices, UK), 
Peak to peak amplitude of motor evoked (MEPs), the 
area under the curve of the MEP and the silent duration 
were measured with in-house software. 
Transcranial magnetic stimulation 
Patients and controls were seated in a comfortable chair. They were 
asked to relax as much as possible, Patients had tics throughout the 
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experiments but were asked not to suppress their tics. Magnetic 

stimuli were with hand-held coil (outer 

diameter 9 cm) connected to a High Power 

200 stimulator Co., Whitland, UK). This stimu­
lator generates a with monophasic waveform and 

in the brain induces a current with flow when 

the coil handle is at an of 45° pointing backwards. 

The optimal spot for right FDI stimulation was marked with a felt-

pen. 
Motor thresholds 
motor threshold was defined as the minimum intens­
needed to evoke an MEP of >50 IlV in five out of 10 consecutive 
trials in the relaxed FDI. Active motor threshold (AMT) was defined 
as the minimum intensity needed to evoke an MEP of >200 IlV in 
five out of 10 trials in the active FDI of maximal 
contraction as assessed visually on an Thresholds 
were from above threshold in steps of I% stimulator 
output. Once no MEPs could be elicited, the was increased 
in steps of 1% stimulator output until a minimal MEP was observed. 
This intensity was taken motor threshold. 
Paired pulse paradigm 
In each individual, a test stimulus was chosen that elicited 
an MEP of 0.5- L5 m V UJUIJU"'UV. pulse 
in four different 
experimental blocks. With each pulse and in a 
randomized order, the 2 and 3 ms interstimulus intervals (ISIs) and 
the 12 and 15 InS ISIs were examined. The former examine SIcr 
and the latter ICE With an interval of 4 s between trials, 10 conditi­
oned MEPs were collected for each lSI, and in each experimental 
block a total of 20 unconditioned MEPs were recorded. The order of 
data collection for each pulse was randomized 
between subjects. Trials recorded while the patients contracted the 
hand muscles or those coinciding with a tic were excluded on-line. 
No trials were excluded in the off-line analysis, The average of the 
''HllIJW'U''',,~ of each conditioned MEP was as a percentage 
of the average unconditioned MEP amplitude in the same session. 
,"nIP('fO were asked to refrain from caffeine on the day of the 
No of mood or other factors 
Cortical silent periods 
CSPs were recorded from the tonically active FDI with the 
subjects an object between the thumb and index at 
~20% of maximum force output. Ten trials at a fixed test stimulus 
of 150% AMT were collected in each with an 
interval of 4 s between trials. In each individual trial, the duration 
of the CSP was measured from the of the MEP evoked by 
the test stimulus to the of (any level of) sustained EMG 
activity. In addition, the area under the MEP was determined and a 
ratio of CSP durationfMEP area calculated (Orth and Rothwell, 
2004). The of the recordings was set to 1 mVN in order 
to measure the end of the CSP, and in a second channel was set 
to 10 mVN in order to measure the size of the MEP. Gain 
were the same for all eX!)enlm{:nts 
n/~'r""l1 afferent inhibition by somatosensory 
from the nerve 
SAl of the motor cortex was examined as described 
et at., 2000). In brief, a test MEP of ~J mV 
peak amplitude was elicited in the FDI TMS. A paired 
paradigm examined the influence on MEP size of a 
electrical stimulus to the median nerve through elec­
trodes. The electrical stimulus to the median nerve was delivered at 
an intensity just above the threshold to elicit a visible contraction in 
the thenar muscles and the TMS pulse to the FDI hot spot 
by 14, 18,20,22,24,26 or 29 ms. Twenty trials of the MEP elicited 
by TMS alone and 10 trials of conditioned MEPs for each lSI were 
collected, The amplitude of the MEP in the FDI was measured with 
in-house software. The average of the conditioned MEP 
was as a percentage of the average amplitude of the test 
MEP alone, Trials recorded while the patients contracted the hand 
muscles or those with a tic were excluded on-line, No 
trials were excluded in the off-line 
Video-recordings 
Videos were recorded before and after patients chewed the nicotine 
gum. Patients were seated in a quiet room for several 
minutes Video and audio were then made first of the full 
frontal body view and then of the head and shoulders For each 
view, were filmed for 2 min in the chair with the 
examiner in the room, for 2 min reading aloud and for 2 min sitting 
in the chair with no examiner present, so that the total time of the 
vldleotaolUe: was 12 min. One of the authors (M.MR) who did not 
and was blinded to the treatment conditions rated 
on each of the two videos for each 
was clinical (GCI); a differ­
ence was rated as one video being 'better' and the other 'worse', or 
as 'no difference'. Next, for each video, the total number of motor or 
tics was counted the 2 min of full and head and 
shoulder view with and without the examiner in the room. The total 
number of motor and phonic tics was related to time and expressed 
as tics/min, The data were the Modified Rush Video 
Scale (MRVS) (Goetz el aI., 1999). The MRVS consists of five tic 
domains: the number of body areas involved with tics; motor tic 
"',,,,'nllv' phonic tic frequency of motor tics; and frequency 
tics. Within each of the domains, the is rated on a 
scale from 0 to 4. The sum of the five domain scores provides a total 
tic score (0--20). 
Data analysis 
For baseline data SICI or ICF, we examined whether 
there was a main effect of 'intensity' (60, 70, 80 or 90% AMT) 
on the amount of SIC! or ICE This was tested analysis of 
variance (ANOV A) statistically. For SIC!, ICF or SAl inhibition, we 
tested whether there was a main effect of 'lSI' on the size of the 
conditioned MEP ANOVA. To test whether controls differed 
from GTS patients, we also used an ANOV A model the 
main effect of 'condition' on the size of the conditioned MEP. In the 
same way, we statistically evaluated the CSP data. We this 
with the data recorded after nicotine. 
In both controls and GTS patients, the data before and after 
nicotine were observations. Therefore, in order to examine 
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whether nicotine had an effect on the size of the conditioned MEP, or 
on the CSP data, we used repeated measures ANOV A, with 'time' 
and 'intensity' as within-subject factors and 'group' as between­
subjects factor. 
In order to assess the correlation of SICI, or SAl, with clinical 
data, i.e. tic or nicotine serum concentrations, we used 
linear 
A statistical difference III the ANOVAs was followed a 
post hoc I test test was used to test 
for sphericity in the measures ANOVAs, and the 
Greenbouse-Geisser correction applied to the degrees of freedom 
if necessary. Statistical levels were set to P 0,05. All 
statistical analysis was performed using SPSS 11 for Windows 
software fJ'''"r..''E,C.. 
Results 
Motor thresholds 
Control subjects and GTS had similar mean AMTs 
and RlvITs (Table 2). Nicotine had no effect on thresholds 
(Table 
lntracortical inhibition and facilitation 
The theoretical threshold for SICI and ICF was I;;.Al!"flVla,I;;.U 
described Material and me!tho(js Orth et 
Table 2 Mowr thresholds 
RMT AMT 

Nicotine + + 

Controls 38.7 (6.2) 38.7 (5.7) 29.3 (6.8) 29.3 (6.8) 

GTS 41.8 (8.1) 41.7 (8.2) 30.9 (6.9) 30.6 (6.8) 

difference between the motor thresholds 
de la Tourette syndrome (GTS) and 
controls. Data are means (SD) from nine GTS and 10 
controls. Rl\1T =resting motor threshold; AMT =active motor 
threshold. 
A 
.... 
::l: 
~ (5 
..c::: 
~ 
..c::: 
U­
"In 
+ 
GTS 
0.25 
0.00 .........1..----'-_ 
nicotine + 
controls 
was not possible in one control subject for SICI and in two 
control for ICF because the data were too variable.· 
The threshold of both SICI and rCF as a "",,·~"'ntQ 
of each individual's AMT was similar in controls and GTS 
,",'''''CIllO.. and was unaffected by nicotine (Fig. IA and B). 
We went on to examine how SICI or rCF varied at different 
CSIs (60,70,80,90% AMT). An increase in the CSI increased 
the effectiveness of both SICI and rCF 2A-D). We 
analysed the data from SICI or rCF separately in two three­
r"r",,,,t,,"; measures ANOV As, with 'time' and 
factors and as 
For there was, as expected, a main effect of 
[F(3,5l) ::: 15.9, P < 0.001] but also a significant 
interaction between 'time' and [F(l,17)::;: 5.871, p::: 
0.027]. This was due to the greater amount 
of SICI in controls than in GTS patients before nicotine 
[two-way ANOV A, main effect of on the data of 
2A; F( 6.9, p::: 0.011]. After nicotine, both groups 
behaved (two-way ANOV A, main effect of 
. not We then examined the 
effect of nicotine in controls and GTS patients This 
revealed that nicotine did not have a significant effect when 
either group was tested alone repeated measures 
ANOVA). 
We perfonned a similar for rcF. There was a 
significant increase of the amount of reF with ~'~A~_'uU"" 
CSIs measures 
F(3,5l) ::: P = There was no ""l<IlW'''a..tll 
of nicotine (no main effect of 'time', P > 0.05, no interaction 
of 'group' and 'time'). 
Short interval afferent inhibition ' 
In controls and GTS patients, a electrical 
stimulus to the median nerve at the wrist before the TMS 
pulse to the FDr hot-spot reduced the mean amplitude of 
the test stimulus predominantly at ISIs of 20, 22 and 24 ms 
3B shows the time course of SAl after nic­
otine. It appears that the initial di11ereni;e between GTS 
B 
nicotine + 
controls 
+ 
GTS 
1 Thresholds for SICI and ICF. There was no difference between the ratios of the theoretical thresholds for SICl or ICF, 
AMT between patients with GTS and control In both groups, these ratios remained similar in the presence of 
(black bars) compared with baseline values bars), Values are means SD, n = 9 for controls and GTS for SIC!; n 
for controls and n = 9 for GTS for 
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Fig. 2 SICI and ICF with different CSIs. (A) Control subjects and GTS patients had increasing amounts of SICI with increasing CSI (main 
effect of intensity, repeated measures ANOVA, P < 0.001) but patients had less SICI (main effect of group, ANOV A, *P = 0.011). 
(B) Nicotine markedly reduced the difference between GTS patients and controls. (C) With increasing CSI, the amount of ICF increased 
(main effect of intensity, repeated measures ANOVA, P = 0.015); however, there was no statistical difference between GTS patients 
and controls. (D) With nicotine, controls had more ICF than without but this difference was not significant. Values are means:!: SEM, n =9 
for GTS patients, n = 10 for controls. 
patients and controls in the amount of inhibition was abolished 
after nicotine. Since the early period of inhibition is more likely 
to have a partly cortical origin than later timings (Tokimura 
et al., 2000), we assessed the maximum amount of afferent 
inhibition in each individual. At baseline, GTS patients had 
significantly less inhibition than controls (ANOY A, F(1 ,17) = 
9.7, P = 0.006, Fig. 3C). Nicotine had a different effect on 
GTS patients and controls; a two-way repeated-measures 
ANOYA with 'time' as within-subject factor and 'group' as 
between subject factor revealed a significant interaction 
between 'group' and 'time' [F(1,17) = 8.0, P = 0.012, 
Fig. 3C]. Following nicotine, the difference between controls 
and GTS patients disappeared (no main effect of group, 
P > 0.1). We then analysed the effect of nicotine separately 
in controls and GTS patients. This revealed that there was no 
significant effect of nicotine on maximal SAl in controls or 
GTS patients (Fig. 3C). 
Cortical silent periods 
We analysed the duration of the CSP and the MEP area, 
and calculated the ratio (duration)/(MEP area) as described 
previously (Orth and Rothwell , 2004). We analysed data 
using a two-way repeated measures ANOY A, with ' time' 
as within-subject factor and 'group' as between-subject 
factor. This revealed that nicotine increased the MEP 
area [F(1,17) = 5.081, P = 0.038, Fig. 4A] with a similar 
effect in both groups (no significant interaction between 
'group' and 'time). There was a tendency for MEP area 
to be smaller in GTS patients, but this was not significant 
(no main effect of 'group', Fig. 4A). There was no signi­
ficant difference between the groups and no significant 
effect of nicotine on either CSP duration or the ratio (dura­
tion)/(MEP area) (Fig. 4B and C), although CSP duration 
was slightly shorter in patients as reported by Ziemann 
et al. (1997). 
Behavioural effect of nicotine 
No participant had side effects from the nicotine chewing 
gum or the TMS. No blood sample taken before the 
nicotine chewing gum contained nicotine. After the chewing 
gum, controls had mean nicotine plasma concentrations of 
4.4 ng/ml (SD 1.26). This was similar to GTS patients (mean 
4.2, SD 1.62). The analysis of the videos revealed that on 
GCI, tics were better following nicotine in six patients, while 
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Fig. 3 Short interval afferent inhibition curves. (A) In the absence 
of nicotine, both controls and GTS patients showed significant 
inhibition at ISIs of 20, 22 and 24 ms (repeated measures 
ANOVA, P =0.001). (B) In the presence of nicotine, the amount 
of inhibition was similar in controls and GTS patients. (C) The 
analysis of the cortical inhibitory effects at maximum inhibition 
reveals that patients had less inhibition than controls (* P =0.006). 
Nicotine had a different effect in controls and GTS patients 
(repeated measures ANOV A, interaction between 'group' and 
'time', P = 0.012). In the presence of nicotine, controls had less 
inhibition while GTS patients had more inhibition, but these 
effects were not significant. Values are means :t SEM, n =9 
for GTS patients, n = 10 for controls. 
in two patients there was no change and one patient was 
worse. MRVS total scores revealed a ntild but significant 
improvement of the objective tic video analysis [mean 
11.2 (SD 1.7) before versus 10 (IA) after nicotine, paired 
samples t test, t =3.l, P = 0.016). 
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Fig. 4 Cortical silent period. ?A) Nicotinei~creased the MEP size 
(repeated measures ANOV A, P = 0.038) but the effect was similar 
in controls and GTS patients. (B and C) Silent period duration (B) 
and the ratio (MEP sizelCSP duration) (C) were similar between 
contr'ols and GTS patients, and there was no significant effect 
of nicotine. Values are means :t SD, n = 9 for GTS patients, 
n = 10 for controls. 
Co"elation of clinical parameters with TMS 
parameters and nicotine readings 
We expressed the nicotine-induced change of electro­
physiological parameters, i.e . SICI and SAl, or tic severity 
as judged by video scores, as a percentage of baseline (pre­
nicotine) measures (see Table 3). The percentage change of 
SICI or SAl did not correlate with the percentage change of 
tic severity (linear regression analysis). We then correlated 
the percentage change of either SICI, SAl or tic severity with 
serum nicotine concentrarion. This revealed that there was no 
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Table 3 of nicotine on parameters and tic in individual GTS 

Patient SICI SICI nicotine SAl SAl nicotine Tics GCI MRVS Nicotine 
I 61.4 67.6 79 41.8 Better 9.1 5.2 
2 58.9 55.3 47 49.9 Better 9.1 7.2 
3 28.4 66.4 51.4 26.3 Better 20 2.4 
4 32.5 22.1 61.1 50.1 Same 8.3 2.3 
5 110.4 67.6 70.4 48.2 Better 16.7 5.4 
6 116.6 53.4 56.5 21.2 Same 0 2.9 
7 21.8 14.4 37.1 52.9 Better 0 4.5 
8 49.4 43.9 34.6 30.9 Better 30 4.4 
9 70 45.9 25.5 35.2 Worse 0 3.3 
Pooled controls 32.5 (15) 35 (18.6) 26 (18.1) 38.6 (21.8) 
SIC! and SAl are as a percentage of unconditioned MEP. Values represent the maximum SICI obtained with different 
stimulus intensities, or the maximum SAl with different interstimulus intervals as described in Material and methods. The 
data of controls were pooled for values are the means (SD). SICI :::: short interval intracortical inhibition; SAl short latency 
afferent inhibition; Gel == MRVS: modified Rush Video Score. 
correlation of any of these parameters. Next, we looked at 
those patients that improved GCl on tic Improve­
ment of any of the electrophysiological parameters did not 
correlate with clinical ,. (Table 
We went on to evaluate the responses of individual 
To this end, we took the maximum SIC! or SAl of controls and 
calculated the mean and the SD. We then rated the patients' 
maximum measures ofSIC I or SAl as either 'normal' or 'abnor­
mal' than the 1 see Table 3). 
six had 'abnormal' SICI and six patients had 'abnor­
mal' SAl; only one had both 'normal' SICI and SAl 
(see Table 3). We then this with the dataafternicotine. 
First, we looked athow many were now in the 'normal' 
i-'n~-Hj"''''Wli',", range; fom were now 'normal' for SICI 
and five for SAL Only had both 'abnormal' SICI 
and SAl, but only two patIents 
(Table 3). We then calculated the mean and SD of controls after 
nicotine and rated the data. This showed that five 
were now in the 'normal' range for and all 
patients were now in the 'normal for SAl. 
Discussion 
The present shows that 
in GTS patients at all intensities of stimulus. In 
addition, we show that a measme of inhibitory interactions 
between afferent and motor is also reduced. 
A single dose of at serum nicotine levels similar to 
those seen after a adjusts electro­
physiological measures of the excitability of circuits within 
the motor cortex to normal levels in GTS and reduces tics. 
Baseline (pre-nicotine) electrophysiology 
in GTS patients 
As previously (Ziemann et 1997), we found that 
in the basal state (pre-nicotine), motor thresholds of untreated 
and GTS were similar to those of 
controls and that SICI was smaller than normal. In addition, 
the duration of the CSP tended to be shorter in than 
in controls, but this was not significant in our group of indi­
viduals. The shorter CSP duration was by a 
smaller MEP size in so that the ratio of CSP dura­
tionlMEP size was similar in and controls (Orth and 
Rothwell, 2004). 
Our results extend data in two ways. First we 
u!'"",,,,,",u between the threshold needed to pro­
duce SICI and the amount of SICI at suprathreshold intens­
ities of conditioning shock (Orth et al., 2003). This showed 
that patients had normal thresholds for SICI, but that recruit­
ment of inhibition at intensities was reduced. 
It is that TMS pulses recruit SICI by axons 
and that this leads to synaptic release of inhib­
neurotransmitters. Thus, normal thresholds in the pres­
ence of decreased recruitment would be compatible with the 
idea that in axonal is normal whereas the 
inhibition in the SIC! circuit is 
the motor system might use SICI to 
patterns of motor output. If the sensitivity of this sys­
tem were then a input would lead to less 
effective output, and hence less effective shaping of the 
motor command. 
The second new result was that our electrophysiological 
measure of interactions between sensory input and 
motor output, SAl, was reduced in the baseline state in 
this is consistent with a reduced 
inhibition. Given the influence of sensory 
in our electrophysiolo­
gical data suggesting impaired sensory motor inhibition may 
be a direct physiological reflection of increased access of 
sensory input to motor output in GTS. In essence, we uUU5"Uv 
that sensory input can influence motor output through a vari­
ety of some inhibitory and some If the 
motor system needs to reduce the of sensory input 
movement, then it may be necessary to shift the 
balance of towards inhibition. If some of the 
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inhibitory pathways (such as SAl tested here) are less 
responsive than a will lead to less effect­
ive suppression of sensory influences than expected, and may 
contribute to release of involuntary movements. 
it is important to note that a deficit in these two 
inhibitory pathways at rest does not the 
that input from other areas of the brain can 
their at least temporarily. It is very clear, 
example, that can sometimes pertorm at 
levels of despite this lack of inhibition. 
Patients can also suppress their tics with effort of will and, 
in these studies show activation of cir­
cuits linking striatum, frontal lobe and those cortical areas 
involved in movement execution (Peterson et 1998; Stern 
et at., 2000). EEG-coherence analysis indicates that move­
ment inhibition increases cortico-cortical more in 
GTS compared with normal controls, suggesting that 
the increased activity may compensate for abnormal input 
into the motor cortex (Serrien et at., 2005). The to 
which are able to suppress their tics may thus reflect 
the balance between deficits and adaptive, com­
pensatory in other parts of cortico-subcortical net­
works involving the basal ganglia, motor and 
cortex, thalamus and pre-frontal cortex. Much as tics take 
a and course in intensity, and can occur in 
bouts, the interactions between different parts of these 
cortico-subcortical networks, and ultimately their influence 
on shaping motor output, are not static but 
ously. many that in 
tasks can abolish their 
altogether and thus enable them to normally in highly 
complex and demanding motor activities; it seems therefore 
that in brain areas relevant to attention such as the 
cortex may have a particularly compen­
satory influence on motor output via neuronal 
networks. 
Effects of single nicotine dose 
The present data confirm that a nicotine dose in GTS 
can reduce tic severity in the of the tested. 
However, while significant, the improvement was small and 
it is not certain that this will be clinically meaningfuL In 
addition, the distinctive taste of the nicotine 
gum meant that we were not able to include a blinded control 
condition so that a effect could have contributed to 
the clinical effect that we observed. while our data 
are in agreement with studies showing that modu­
lation of the acetylcholine system may be promising as a 
treatment for GTS (Silver el al., 2001a,b), we do not think 
that our data provided conclusive evidence to recommend 
nicotine gum. This study, the short-term 
effect of a low dose of 
evaluate nicotine as a treatment for 
subject of further research. Thus, It IS to 
note that overall the electrophysiological data were consistent 
Intra-cortical inhibition in Tourette 1299 
with the clinical we also found that there was no 
correlation in individual patients between improvements in 
clinical and scores. This suggests either 
that there is too much variation in the systems to 
with the numbers of that we 
or that other such as a placebo 
may have influenced the clinical response. Further studies 
are needed to address these questions perhaps using other 
agents with an established effect on tics such as dopamine 
While it is conceivable that the clinical effect of nicotine 
may be due to a we think it is unlikely that 
such a placebo effect could account for the effect on SICI or 
SAl that we measured because clinical and '.d~,"'WVl.)ll 
effects did not correlate. However, placebo may 
increase release of striatal dopamine la Fuente­
Fernandez et al., 2001), that placebo may in 
some circumstances even be able to modify physiological 
measures. Future studies will be to address this 
The electrophysiological data suggest that these two 
inhibitory pathways in the motor cortex can be modulated 
by and (ii) that this effect differs between 
GTS and normal controls. There is evidence 
from in vitro studies in tissue of animals and humans for 
'~''''~''F.''- modulation of inhibitory in the brain. 
Nicotinic and muscarinic acetylcholine receptors (AchRs) are 
widely distributed the human CNS et at., 
2003; Podruchny et 2003) and the effects mediated at these 
not only have direct effects themselves but 
also modulate synaptic transmission. at and 
..____ "'__ synapses (McCormick and Prince, 1985; Lena 
1993; Jones and 1997; Lena and 1997; 
1998; 1998; et al., 2003). 
Indeed, recent in vivo experiments in hwnans have shown 
that the muscarinic antagonist scopolamine reduced SAl, 
consistent with modulation of inhibitory transmis­
sion Lazzaro et 2000). Di Lazzaro et al. 
(2000) did not find of on they 
did not test for nicotinic effects on either SICI or SAl. 
If the effects on SICI and SAl in the present experiments 
are due to a cholinergic action of nicotine on the v",.H<'VUH 
of two classes of inhibitory interactions in the motor cortex, 
then the fact that differences between patients and controls 
can be administration of nicotine suggests that 
there is no structural in these connections in 
n<>"pn'c This would be consistent with the normal threshold 
for recruitment of inhibition. This that the deficien­
cies in GTS are likely to be caused by a subtle loss of neur­
omodulatory function in cortical circuits. 
Our finding that cholinergic stimulation can remove the 
lV"J;:!CAv<U differences between GTS and controls 
indicate that GTS is ..,1!.""'AUY 
a 
since both transmitters can serve 
as neuromodulators, it is conceivable that one can substitute 
-
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Un
ive
rsi
ty 
of 
Ca
pe
 T
ow
n
1300 M. 0 rth et al. 
to some extent for the other or that the functional cholinergic 
deficit in GTS patients is a consequence of abnormal neur­
omodulation by dopamine. Clearly, further studies are needed 
to address this issue more fully .. 
In conclusion, we show that in GTS patients, inhibitory con­
trol over motor output was reduced. This was not restricted 
to SICI, a measure of motor-motor inhibition, but included 
SAl, thus supporting clinical observations indicating a role 
for sensory symptoms in provoking tics. Nicotinic modulation 
of inhibitory cortical pathways differed between controls and 
GTS patients and provides further insight into possible mech­
anisms that underlie these physiological changes. 
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Attentional Gilles de la T ourette Syndrome 
Shelley 
Mary M. 
Rynn, B.Se. 
MD., D.P.M., M.R.C Psych. 
Departmelll , University and k/iddlesex School 
Summary: Both clinicians and patients with Gilles de!a Tourette syndrome 
describe difficulties in everyday related to altentionai Yet httle 
of these has been carried out using behavioural measures. The 
compares adults with GTS and control on a range of 
and measures of measures of mood. 
and obsessionality were also employed. the GTS group was 
more and on the mea-
sures tended not to correlate with these. Deficits in attention were 
found in the GTS group on several of the more including serial 
addition, block sequence span the test. and a letter can-
cellation [ask. Possible for ruture work are 
Words: Tics-Attentional mentaltasks-Be-
havioural measures. NNBN 5:170-177,1992 
detaiL Golden (6) pointed out 
menl disorder prevalence of atten-
lics occur most in tew studies have ap-
and also demonstrate a control groups to investigate this. 
variety movements Problems in school are frequently 
While the aetiology of the 
there is now 
it has an organic basis. Some research has a 
proportion of central nervous system abnormali-
ties in patients (1), but others have not supported this 
(2). Neurotransmitter in the 
system, have been implicated ( 
have usually the distribution 
ofGTS 
or sustaining attention 
contributing to 
correspondence and reprint requests to Dr. S. Chan non 
at the Wolrson Building, Middlesex Hospital, Mortimer Street, 
London WIN BAA, England. 
J 
behind their peers despite 
ability. Robertson (7) drew atten-
that features ofGTS such as 
disabilities, and defi-
may often be the that 
to medical attention. Erenberg 
et aL learning of a sam-
ple of200 children with and 
assessed attentional deficits in GTS by 
and concluded on the basis of patients' or par-
ents' impressions that 62% of the GTS had 
attention deficit disorder compared 6.3% of con-
trols; higher rates of special 
were also among the GTS 
possibly rate of ADD has been rpr,('\l',tpf1 
others (10, II). and Comings (12) noted that 
some school may arise because the tics and 
vocal noises are so in some 
cases, the tics were so severe that it was difficult for the 
to their eyes on what were 
also described reported 
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with out extraneous and 
tion on timed tasks. et al. (13) studied 10 chil-
dren with GTS using a neuropsychological 
that all but one of the children were 
able to carry ou t the more 
test, which requires and sustained 
but, a control group was not em-
ployed, it is unclear whether performance was in the 
also on an auditory dis-
where the majority of children per-
formed below average; they stated that poor 
mance have been due to either poor auditory 
discrimination or in attention. 
The authors concluded overall that children with 
showed fairly problems in 
attention on stimuli and in 
sponses over time. 
More information is needed about pro-
cesses in in order to further our understanding of 
the nature of the and the such 
life. In the absence 
model of neuropsychological 
tentional processes in 
havioural measures of attention. 
was 
to explore at-
detail, using be-
Diagnoslic alld Manual of klemal Dis-
3rd Edition Revised (OSM-III-R) criteria (14) 
were used to select 19 
(12 men, 7 
English as their first 
both 
clinic, and the United 
and indeed many 
clinical experience indicated that the severity of 
symptoms in the cohort studied was not markedly 
different from the two referral sources. The sub-
were of mean age 32.74 (SO 13.15) and mean 
full-scale 107.42 (SO 21 10). of them were 
taking antagonists to control their motor 
and vocal tics (haloperidol, sulpiride, or pi 
four were serotonin inhibitors for de-
or obsessional (fluvoxamine, clo-
mipramine, or fluoxytene). General exclusion criteria 
history of alcohol or drug abuse, 
or other disorder. One sub-
was since his motor tics were so severe 
that they disrupted his ability to make written re-
IN TOURETTE 171 
sponses on the tests. Similar exclusion were 
used to select the 22 control subjects (7 men, 15 
women), of mean age 29.73 (SO 10.7 I) and mean 
IQ108.00 14.1 The l tests showed 
that the groups did not differ significantly in age or 
I Q, nor did sex differ a chi-
test. 
Clinical Measures 
The Wechsler Adult Intelligence Scale-Revised 
(WAIS-R), or a shortened (15) was used to pro-
vide an of full-scale IQ; ina few cases where 
had recently been tested on the W AIS, a sub-
traction of7 IQ points was made from full-scale IQ for 
with the WAIS-R. The standar-
measures were also administered to 
and v ..... '" .... .,,,'v',,'",, 
Inventory (16), the State-Trait 
(17), and the Obsessional 
Experimental i\leasures 
and Unpaced Serial . ..Jddition Tesl 
The PASA T tests ability to 
while nF'lrrnrrn mental arithmetic on items held in 
31 at 
required subjects to add pairs of digits so that each 
new digit is added to the immediately 
(19). series were used in the 
task, with slightly slower speeds of 
Jowing Gotham et al. (20). 
correct were recorded. 
Block 
The block sequence span is a working memory task 
that measures span of immediate recall for a 
sequence Milner I )]. It consists 
of nine black 1.5-in. cubes attached in a fixed random 
pattern to a black base. The examiner tapped the 
blocks in a sequence at the rate of I per 
was then asked to copy the 
pattern. The were increased in every sec-
ond trial, until the subject failed two trials the same 
I·v/. 5. No 1. 1992 
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A second series was then where the 
subject was required to tap the blocks in the reverse 
order to that of the examiner. The number of correct 
forward and backward sequences was recorded. 
Slroop Test 
The Stroop task presents colour words written in 
colour inks (22), and measures the effi-
can to 
one two attributes in the same stimu-
lus. Subjects were presented with groups of letters 0.5 
stencilled in coloured ink blue, green, 
in columns onto an A4 size no colour 
appeared twice consecutively in each column. A con-
trol colour Stroop card the letter 0 written 
in a of four in words. A 
colour Stroop contained the words "red", "blue", 
, or "black". written in ink of a conflicting 
colour. In each the was asked to go 
down the columns the colours of the inks, as 
quickly as but without errors. Both 
overall time and errors were recorded. 
Leller Cancellal.ion TeSl 
tasks of the letter test type, 
are required to sustain attention in cancelling 
out stimuli from among an array distractors 
(23), The task consisted of six rows of 
presented letters, with no single letter appearing more 
than once consecutively, Target letters were ran-
tF'r~nf'r<f'l1 with distractor and identi-
subjects were asked to work the rows, crossing 
out a target letter ("H") as quickly as 
without any. In the second 
were two targets to cross out ("e"s and 
time taken and errors were recorded. 
Trai!~Making Test 
The test, described by Reitan (24), re-
quires to attention while se-
ries of targets and alternating between them. The first 
part of the test consists of 25 numbered circles, and 
the is to draw a line connecting them 
in order. In the second part, the circles con-
tain both letters and and the is asked 
to draw a line 
ters, proceeding in ascending order. Appro-
examples are and the is asked to 
quickly as possible, errors. Any errors 
N'·lIrops},cbialf)'. NcumpsrcllOlvgy, and Behavioral Nmrology 
made are out to the 
and the total time to complete each 
recorded. 
for correction, 
of the test is 
Procedure 
consent had been obtained, 
pants carried out the experimental and clinical tasks. 
Order of of tasks was counterbalanced 
within each group to control for any 
or The 
istered after the 
A measures 
used to compare two groups, those with 
mal controls. The groups were 
of 
The mean scores and standard deviations for the 
and control groups for each measure are shown 
in T ble I. A level of 5% was 
with alpha adjustment (al-
pha divided by number of tests) when post hoc tests 
were 
Paced and Unpaced .-i.llciitory Serial Addition Test 
to reduce skewness, measures 
variance was performed to compare the groups on the 
three 4-second and 2-second serial ad-
factor and 
factor (task). The group X task 
there was a 
effect group = 5.05, 1, P < 0.03), Post-
hoct'tests showed a near-significant group UH'"'''' 
in each (l = 2.04, df39, P < 0.05), 4-sec-
and (t df = p < 0.09) and 2-second serial 
addition (l = 1 P < 0.08), An of 
the mean scores showed that the GTS group tended to 
make more errors than the controls in each condition. 
Within each group, the mean scores little dif-
ference in error rates between the unpaced and 4-sec-
ond tasks, but a faster speed of presentation (2 sec-
increased the error rates markedly for both 
groups, To any of sex, age, or 
Pearson coefficients were calculated 
within each group for each of the variables with the 
----"--- -
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TABLE 1. Means/or lhe GTS alld cul1lru! groups OIJ lhe 
experimental and se!freport measures 
Mean 
Experimental measures 
PASA Terrors 
Unpaced 6.16 
4 seconds 6.63 
2 seconds 14.42 
Block span 
Forward 5.26 
Backward 5.21 
Stroop control (seconds) 54.79 
Errors 0.16 
colour (seconds) 101.26 
Errors 1.84 
Letter cancellation (seconds) 62.95 
Errors 0.37 
Leller cancellation double (seconds) 119.89 
Errors 1.05 
A (seconds) 31.95 
Trail-making B (seconds) 93.00 
Self-report measures 
BDI 10.74 
STAl 
State 45.14" 
Trail 44.47 
LEYTON 
Stale 16.84 
Trail 9.26 
GTS. Gilles de la Tourwe 
Beck Depression Im'entory: 
N", 20. 
b N = 14. 
, tV = 12. 
dlV 16. 
'N = 21. 
addition tasks. Within the GTS group, there 
were correlations between IQ and 
number of errors on unpaced (r -0.59, p < 0.01) 
and 2-second addition (r -0.63, p < 0.0 I); 
there were no correlations within the nor-
mal control group. 
Block 
pr"'",,,'1"1 measures variance was per-
, ..... ,..-r,..".r! to compare the groups on the two 
ward and backward span, with one between-subjects 
and one factor (task). 
The group X task interaction 
(F 3. ! p < and there was a 
group 4.59, dl = 1 p < 0.04). 
showed a significant group 
GTS Comrols 
SO Mean SO 
(7.8 I 2.:59 (J.n) 
3.05 (2.32) 
10.50 O.71) 
(099) 6.14 (1.04 ) 
(1.I3) 5.45 (0.86) 
( 12.62) 52.27 (6.76) 
(O.SO) 0.23 (0.61 ) 
(40.47) 85.95 (14.98) 
(5.03) 0.27 (0.70) 
(23.24) 5S.77 (lUI) 
( LID) 0.05 (0.21) 
ODD} 102.68 (! S.55) 
( 1.78) 0.82 ( 1.30) 
(11.36) 28.64 (9.76) 
(52.69) 60.82 (23.44) 
(1001) 3.15' (4.17) 
(lUI) 29.58' (6.32) 
(lO.OS) 33.25d (9.26) 
(I 1.26) 9.43' (9.21 ) 
(4.75) 5.30' (2.98) 
in forward span (t == dl p < 0.0 I), but the 
difference in backward span did not reach 
cance. Mean scores showed that the control group 
tended to recall sequences slightly better than 
backward' whereas the GTS 
tended to r"IP'rtArrn 
backwards. There were no significant 
within each group between T"IP,rtArm 
and age or sex, although correlated 
backward span for the group (r == 
Stroop Test 
correlations 
on the tasks 
measures of variance was per-
formed to compare the groups on the two con-
trol Stroop and conflicting colour with one 
factor (group) and one within-sub-
Vol. 5, No.3. 1992 
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factor (task). The group X task interaction did 
not reach nor was there a 
feet group. Errors were rare, and chi-squared tests 
revealed no differences between the groups 
in the number of errors made in each task. 
Leller Cancellation Test 
i'.'-IJ'-,"l'-U measures of variance was per-
to compare the groups on the two sin-
cancellation and cancellation, 
with one (group) and one 
within-subjects There was a 
group X task interaction (F = dj = 1 P 
< Post-hoc l tests showed that the groups did 
not on the the 
difference neared 
task (l 2.06, dj = P < 0.05), 
group tending to perform slower than the controls. 
were mfrequent, and chi-squared tests showed 
that the 
rates on each task. There were no 
with sex, age, or within the 
correlated with of on 
both (r 0.54, p < I) and double-letter 
cancellation (r p < 0.0 I) within the normal 
control· group. 
Trail-making Tesl 
measures was per-
formed to compare the groups on the twO A 
numbers alone) and B 
ing numbers and with one 
factor (group) and one 
There was a group X task 
I p < Post-hoc l tests revealed 
that the groups did not differ but 
there was a significant on 8 (t = dJ 
p < 0.02), showing the GTS group to nprll"lrrn 
slower than the controls on this task. Within the 
group, age correlated with speed per-
tl"lnm::l'Clrpon A (r == 0.55,p < 0.01), but there were no 
the normal control group. 
Effects of Medication 
a proportion the group were 
nor 
for 
antagonists or serotonin reuptake inhibi-
tors, the 
on the 
between and results 
tasks were examined. In order to 
N"lImpsy,hialr.!'. N(,IIWIISrclwlvgy, and Bl!llIll'ioral Nwr%!:)' 
.' . 
equate levels of drug, the minimum dose 
recommended the British National (25) 
each was taken to represent one 
to each individual patient 
were in units as the mini-
m um therapeutic dose. Anal yses were also rlP,-tn,-n->,>ri 
presence or absence as the 
mlDe 
reached 
None of the correlations between 
tasks and usage of dopa-
inhibitors 
Psychopathology 
port measures of 
for the two groups are 
groups significantly in level of riplnrp,~~prl 
mood (l = dj 37. p < 0.01). 
of variance with one between-sub-
(group) and one 
the group >~ state/trait 
not significant, but there was a significant group 
for == I 1,24, P < 0.01). Post-hoc [ 
tests revealed a in both 
state (I 4.17, 24 . .0< (t 
3.41, 33, p < 0.01) measures 
of variance obsessionality with one between-
subjects factor (group) and one 
also showed a group 
X state/trait interaction, and a significant group effect 
(F = 1,37, P < The t tests revealed a 
< 0.01). 
mean score 
control group. 
and a significant 
(£=3.14, p 
measures, the 
than for the 
In order to examine any between the 
measures and on the 
mental measures that differentiated the two groups, 
Pearson product moment correlations were calcu-
lated within each group. Performance on the letter 
cancellation and tasks did not correlate 
significantly with trait state, 
Or trait obsessionality within each group. Within the 
normal control group, there was a significant associa-
to an 
cant 
between state anxiety and on trail-
A (r O.88,p<0.0!), 
had this measure due 
error. There were no other 
either group. 
--~. ----
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DISCUSSION 
The main findings were that the were 
impaired to normal controls on 
several of the 
block sequence span 
quences and 
when alternation between two sets targets was re-
in the latter two tasks. Since the groups did not 
in IQ, which was in the normal 
range, these findings represented selective 
rather than global m for the 
group. 
addition taps memory by requiring 
to hold two numbers in mind while 
and the GTS sub-
relative to controls on each of the 
three tasks. Errors be produced by III 
attention, by loss' from 
memory of either the numbers themselves or 
or by 
not since failures to 
several different types of error, and a more detailed 
qualitative would be needed to pin these down 
The ficant be-
tween IQ and error rates within the GTS group on two 
of the three tasks suggests ability to be a con-
but this influence per-
formance in the control group. 
Block sequence span is primarily a nonverbal work-
mg memory task. The task involves 
a sequence long enough to reproduce it 
correctly; the backward task also of 
the sequence, and mental reversal of its order before 
reproduction. The GTS failed to show the 
normal advantage on the forward but performed 
to the control on reversed se-
quences. Again, to influence 
on reversed sequences for the GTS 
group, but not for the control group. 
In both the trail-making and letter cancellation 
group showed 
to controls on the more r-ru-nnd"V 
for each test. The second the 
involves tracking two 
and 
tween 
get, and a motor response to 
The second letter cancellation task also invol ves hold-
two targ~t letters in memory while mak-
a visual search to identify tar-
gets among distractor and 
sponse to cross out targets. The GTS were 
slower than controls under these condi-
tions. did not make 
more errors than the control group in either 
letter 
mance to .be a successful 
nance of an accurate response. In both 
and letter the did not differ 
involved only a 
target letter, rpc"",.,,' 
which 
ond tasks in both 
involved similar search and motor responses, 
that their on the second task 
in each test are unlikely to be attributable to visual 
search or slow motor alone. 
ment is more likely to be attributable to difficulties in 
attention, holding in working 
memory, or shifting set between two 
sets of targets. Unimpaired on the 
test that 
slow speed of performance (verbal rather than motor 
in this is not an of 
group. 
on certain tasks did show some relationship 
with age. and IQ influenced 
within the group on others. 
correlations between most the atten-
tional measures and sex, age, or IQ within each group 
suggests that these did not an Important role in 
There was also no evi-
dence in our study that medication an 
tant role in producing on cognitive function. 
is consistent with the reached by Gol-
den on the basis of a review the 
neuropsychological function in 
found to be related to the 
tion rather than to per se. 
the possibility remains that attentional deficits of this 
nature could be attributable to and more 
studies will be necessary to 
further. 
The standard deviations of the group on the 
experimental measures were generally larger than 
those control group, indicating greater variabil-
In between the ex-
perimental measures were performed for the 
group be by the author's on 
and these were often that indi-
viduals tended to perform consistently across tests. 
This could be related to of heterogeneity 
in the clinical 
Vol. 5. No" ]. 1992 
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view the small the results should be 
viewed with caution. 
The subjects did report significantly 
and symptoms 
to the controls. There is evidence from other 
areas that certain aspects of cognitive 
affected by emotional disorders 
One this is that 
the amount of cognitive capacity available to process 
information is reduced because some 
taken up 
brook (29) have during 
ruminations reduce available process-
(30) forward an account of 
count for such a reduced 
might reasonably be 
levels of emotional 
between the 
sures questionnaires 
group in almost every case does not lend 
to argument. An alternative 
limita-
mea-
each 
be found in relation to symptoms, such as 
motor tics and These are to be 
and a range neurophysiological 
evidence has been cited to support view (31), al-
there is a minority who suggest the move-
ments are intentional A reduction in available 
cognitive resources be by the occur-
rence of the symptoms 
and 
to suppress symptoms consciously; or by distracting 
such as social embarrassment centred round 
the occurrence of it would 
be necessary to account for the pattern 
deficits shown. 
The do support clinical and 
attentional 
was found both in and in 
and shifting set between salient stimuli. Further 
work is needed in to explore the nature the 
and to mecha-
nisms involved, and the relevant 
ogy. As the frontal cortex has been implicated as hav-
ing a role in attention (33), and it has been suggested 
that may be involved in 
the pathophysiology 
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Executive Memory, and 
Shelley and 
University College London 
In 
Mary M. 
University College London and National Hospital for 
Neurology and Neurosurgery 
cunrlrf>,TY\p (TS) alone, TS attention-deficitlhyperactivity 
(+ADHD), or TS disorder were compared 
control group on a set of measures of executive functioning, and 
group was impaired on one executive measure involving UllllV1I,1UlI 
moon.,,.,,,,,,," but did not differ significantly from the control group on other 
measures. TS+ADHD group showed impairment on several executive measures. There 
was no evidence of impairment in of memory and for of the TS 
The are discussed the frontostriatal hypothesis of and the 
COfltrlloution of comorbid 
Tourette's syndrome (TS) is a neurodevelopmental dis-
order in which the core consists of motor 
and vocal tics. A range of cognitive behavioral features 
is often described in conjunction with the tics. TS has been 
linked to a of problems of inhib-
deficits and 
inappropriateness 
iors" (Cohen & Le\;KJIlan, 
(Kurian et aL, 
Channon, Flynn, & KObertson, 
associated with 
tioning. However, early 
account of comorbid sYlnpl~orrlat()lo:~y and con-
troversy exists as to whether any executive 
functioning are directly attributable to TS itself or to co-
morbid in particular aw ........ 1VJ"-
disorder (ADlID) or ""P'~~~"""-conlpullSI 
Pennington and Ozonoff (1996) postulated that cognitive 
functioning in TS be associated with selec-
tive inhibitory dysfunction because it characterized by 
difficulties in unwanted motor movements and 
, .... """"",,.,, the brain basis of TS have com-
"'V,HU'I ...... '" that frontostriatal 
e.g., 
1986; Moriarty et al., 1997; 
has implicated rll'I1~'m~in,"'rai(' 
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in the etiology of TS, with potential disruption of fronto-
subcortical circuits involving nonoverlapping parts of the 
striatum, globus pallidus, substantia thalamus, and 
frontal cortex (Alexander, DeLong, & Strick, 1986), al-
though other researchers have suggested alternative models 
e.g., Weeks, Turjanski, & Brooks, Support for 
the theory of basal dysfunction comes in 
from the relative efficacy of doparnirle 
ing TS symptoms 2000); eye movement stud-
ies, imaging, and biochemical data have provided addi-
tional, although sometimes evidence. Both 
functional and structural imaging have suggested abnormal-
ities in the basal most commonly the caudate (e.g., 
et 1995; Malison et 1995; Moriarty et aI., 
direct involvement of frontal the 
anterior cingulate cortex has also been described in an 
positron emission tomography study (Chase et aI., 
although these studies have often failed to assess comorbid 
syrnptomlatc,lol~Y Recent functional imaging studies of nor-
mal participants have that the anterior 'vw'C;UJ,a,\" 
a central role in by ael:ectmg 
potential competition in inhibition 
of a et al., 1998). 
The has most 
inhibitory functioning in TS. 
....... 'u"5' ...... and Ozonoff from a review of 
peJrfolrmianc:e on inhibitory tasks that there was inconsistent 
evidence of in perhaps because of comor-
bidity issues. is little to suggest impairment in TS 
partICIpants on aspects of executive function to 
involve dorsolateral frontal areas including planning, rule 
finding, and set shifting (Bornstein, 1991b; Ozonoff & 
Jensen, 1999) tasks such as the Wisconsin Card Sort-
Test {WCST; However, lateral frontal 
areas are thought to contribute to strategic aspects of mem-
ory encoding and retrieval, and on tasks includ-
ing recall of words listening memory span 
thought to involve strategic, explicit aspects of memory has 
been described in TS alone (Stebbins et Little 
work has been done examining implicit aspects of memory 
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and learning in although impaired skill learning 
has been reported in one study using a rotary pursuit task 
(Stebbins et ai., 
Although previous studies have addressed these 
very little work has been done that compared groups of 
people who have TS with and without comorbid symptom-
atology a comprehensive range of tests involving both 
inhibitory other aspects of executive tnTlf't,,('\n 
and implicit memory, and To the 
of TS from- those of comorbid symptomatology, we com-
pared a subgroup who had TS alone with 
who had TS plus ADHD (TS TS plus 
and a matched healthy control group. It was 
predicted that all TS might show impairment on 
executive tasks control and that comor-
bid to more severe and 
male, 10 female) who met the 
Disorders (4th text 
!>,,-waul<.- Association, cri-
teria for TS took part in the To establish the and 
rule out any comorbid disorders other than ADHD or we 
assessed the "National Interview 
Schedule & 
Eapen, 1996). 
comorbid other than ADHD or OCD (e.g., 
psychosis) were excluded from the as were n~rti,..in~nto 
of disorder (e.g., head 
were and age between J B years. 
Fourteen of the with TS alone, 9 
with TS+ADHD, (4B.3%) of the 
TS medication at the time of 
I' ... mmri,~ino 7 (50.0%) of TS-alone group, 3 (33.3%) of 
group, and 4 (66.7%) of the TS+OCD Eight 
participants were taking antipsychotic were taking 
antlps1iCn,i)UC preparations alone, 2 were 
in combination with selective serotonin 
tors (SSRls), and 1 was an antipsychotic preparation in 
combination with a stimulant. participants were taking SSRIs 
Table 1 
an drug alone, 1 was laking 
alone, and 1 was taking a stimulant alone. 
matched healthy control participants (13 male, 8 
also took part in the The control group and TS 
subgroups were using an of 
(ANOVA), and this showed that they did not slglllnc:antly 
age, 46) .163,oronRaven's 
matrices (prorated; 1960), F(3, 46) 0.97,p 
scores and standard deviations are shown in Table 
informed consent was given by parents or guardians for all par-
ticipants. Breaks were given between tasks as necessary to avoid 
fatigue. 
In addition to the clinical described above, several symp-
tomatology measures were also used. First, tic 
sessed using the Yale Global Tic Scale et aI., 
1989); no significant differences were found between the three TS 
groups, F(2, 25) = 0.20, p .818. Second, the groups differed as 
eXJJec:ted when on ADHD and OeD symptomatology 
measures, Brown Attention-Deficit Disorder Scales 
(Brown, 1996) the short Ley ton Obsessional ln\1pnt,,...,.u 
Whitaker, Davies, Flament, & Rapoport, 1988). For 
Attention-Deficit Disorder Scale, ANOVA showed a slgml1lcalll 
group effect, F(3, 43) 7.61, p .0001, and the TS+ADHD 
scored higher than all the other Scheffe tests con-
that this difference reached for comparison 
with the control group = .0001). For the Ley ton Obssessional 
Inventory, ANOV A a significant group effect, 
= 13.92, p = .0001, and the TS+OCD scored 
than all the other Scheffe tests this 
ence reached with the control 
(p = .0001), the .0001), and the 
.001). Third, form of the Child Behavior 
\'-lI'~I.."J!"l (Achenbach, was also administered, and this 
showed a effect of group, F(3, 43) = 13.24, p = .0001. 
Scheffe tests showed that the TS+ADHD group scored 
cantly than the control (p .0001) and the 
group .004); the group, in turn, scored signifi-
cantly than the control group (p = .041). 
Executive Measures 
Tests were selected to assess aspects of executive function. The 
executive functions tested were as follows. 
Inhibition and First, the Hayling Test 
& ShalJice, involved completing sentences as 
Mean Scores and Standard the Demographic and Clinical Symptomatology Measures 
Group 
TS alone TS+ADHD TS+OCD Control 
(n == 14) (n = 9) (n 6) (n = 
Variable M SD M SD M SD M SD p 
Age (years) 13.71 2.05 12.33 2.24 15.17 2.48 13.67 2.52 > .05 
Raven's matrices 40.50 9.49 38.00 9.29 35.50 7.61 41.33 6.92 > .05 
Yale tic severity scale· 32.64 20.98 27.88 21.64 27.83 13.29 > .05 
Brown attention deficit scale 39.43 22.06 60.00 16.37 46.33 20.01 25.76 14.03 .0001 
Ley ton Obsessional Inventory 4.50 6.43 5.22 6.00 17.17 5.27 2.10 3.05 .0001 
CBCU·b•c 39.85 17.47 76.25 28.94 52.00 24.65 22.90 17.89 .0001 
+ ADHD = plus attention-deficitlhyperactivity disorder; +OCD obsessive-compulsive 
13 in the TS alone group. e n 20 in the control group. 
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quickly as with words that make sense (part 
nonlsenlsic;al words (part B). Patients with frontal-lobe 
been found to have both in 
(Part A) and in inhibiting 
generate nonsensical completion words (Prot Part B, the 
nwnber of errors involving related completion words 
(Caltegory A errors) was scored, and also the number of errors 
related but less direct completions (Category B errors) 
was Second, the test involved the color of 
ink in which words out colors are written (e.g., red is 
written in green Third, the Letter Fluency Test (Thurstone & 
Thurstone, 1962) required the of as many words 
with s as possible in 5 
The Six Elements Test Wilson, Alder-
man, Burgess, & Evans, involved carrying out a set 
of six tasks within a la-min with certain rule constraints 
about the order in which the should be The task 
instructions informed that the could not all be 
cOlmpletf~d within the and that would score better 
attempting items from each of the tasks rather than 
a small number. No cues were to assist the PaItlc.lpants 
the order of tasks attempted or in monit()rinlg 
time other than providing them with a clock. with 
frontal-lobe lesions have been shown to have difficulties in elect-
to alter their behavior appropriately in the absence of environ-
mental cues to maximize gains by fewer tasks or 
breaking the rules more frequently than comparison groups. 
score obtained for the test takes into account both the allocation of 
time to the different tasks and the order of peJ10l:m,mce. 
Rule following and set shifting. First, Shift test (Wil-
son et a!., 1996) involved as quickly as to a 
cards to one rule to red, "no" to 
then rule to cards with the 
SaIne color as the one, "no" to of a different color) 
with a second series of cards. This test, therefore, contained a 
component but was simpler than tests such as the 
WCST because the Rule Shift test did not involve deductive 
reasoning to work out which rule was in Normative data 
are provided in the manual for control adults and for those 
with neurological lesions. The score obtained for the test takes 
account of the number of errors made and the time taken. Second, 
the Trail Test (Reitan, 1958) required 
number (part and alternation between number and 
(Part B). 
Memory and Measures 
it after a time 
LNGWU10 Test (RA VLT; 
list over trials, an int,>rf"rin," 
Visual Reproduction test of the 
(WMS-R; Wechsler, 1987) 
drawings, drawing them "'U'U"'~"""""J 
a filled time delay. 
First, (based on W~rrirl"um 
after a study phase in 
aspects of 
IJU~;lHC"lL~ for 40 low-frequency words, in a 
half in a female voice. Priming effects were 
I .. JlC;~"'HH'1'. 40 word stems "clo") and 
the first word that came to mind. Each 
of the three-letter word stems could be to fonn at 
least 10 common nouns. Twenty of the word stems could 
be used to words in the initial phase, and 20 
were new distractor items from target words matched in 
t.Plln,>nr·v and number of alternative word endings to the study 
was measured the number of 
(out of 20) versus the of times the 
(out of 20) was a target word of the same 
words .. Second, skill (based on 
was exmuined 
with mirror-reversed words and the to 
words aloud as quickly as were low-frequency 
nouns, between five and letters. After a practice trial, 20 
triads of words were After a 30-min filled 10 of 
the study triads were presented, mixed with 10 new triads. 
was measured the decrease in the time taken to cOlnpllete 
second triad with the first. Third, in the Serial ",.""""vu 
Time (SRT) on Nissen & Bullemer, 
was assessed presenting a series of letters on a computer screen 
in four different locations and asking to select 
the The screen 
display of a central box and in a 
cross, and the response apparatus consisted of four response keys 
and a central home to the locations on 
the screen. Each response key was U up, D for down, 
L for left, and R for Each trial started when the n"'1i("iin~I't 
the central home key, which was by a 
on the screen lighting up. For each trial, a appropriate to the 
location appeared in one of these four boxes U in the upper 
box), and participants had to press the corresponding key on the 
response apparatus. Letters were presented 100 ms after the central 
home was and terminated with the response. Each 
condition consisted blocks of 120-leuer with 
a 30-s break between each block of trials. to partici-
sequence. Two 
to eliminate 
nonspecific the next four contained a 12-item 
sequence, UWUDRLURDLR, followed by a different test se-
RULRDURLDRUD, and finally another block of the 
sequence. Overall, reaction time (RT) decrease with seq:ueIlce 
was assessed median R T scores 
Block 3; to the specific seCluellce 
sessed by comparing RT slowing on Block 7 
Results 
The groups were using with Scheffe 
tests for hoc comparisons as Level of 
"A""UW ............ '" was adjusted for each set of measures by di-
.05 by the number of measures. trans-
fonnations were used for several variables times, 
Trail Making Stroop 
Mean scores and standard deviations for the tests of 
executive functions are shown in Table 2. Mean scores and 
standard deviations for the tests of memory and are 
shown in Table 3. 
Executive Measures 
Inhibition and strategy Because four mea-
sures of inhibition and strategy generation were a 
level of .05/4 (.0125) was adopted. On the 
test, ANOVA showed that the groups differed 
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Table 2 
Mean Scores and Standard Deviations for the Tests Function 
TS alone TS+ADHD TS+OCD Control 
(n = 14) en 9) (n 6) (n = 21) 
Variable M SD M SD M SD M SD P 
Inhibition and strategy 
1.43 1.16 2,1l 1.54 0.50 0,84 0.38 0.67 ,0001 
2.50 1.99 3.78 2,44 2.S3 2.14 1.24 1.22 .007 
77.50 25.95 62.44 21.09 64,50 20.38 81.67 25.94 > .050 
Letter 27,79 ILlS 24,11 6.57 24.50 7.20 33.33 9,26 .044 
Multitasking 
Six Elements Test 2.57 1.40 1.67 1.12 2,50 1.22 3.33 1.02 ,008 
Rule following! 
set shifting 
Rule Shift test 3.21 0.98 3.00 1.22 3.67 0.52 3.57 0,51 > ,050 
Trail Test 
Part A 35.69 22.14 31.24 10.84 43.61 15.36 28.29 9.82 > .050 
Part B 79.85 33.83 91.15 43.44 92.71 26.17 67.99 26.98 > .050 
Note. TS Tourette's +ADHD plus attention-deficillhyperactivity disorder; 
+OCD plus disorder. 
significantly in both the number of ",aU_",'UA .012) errors and from the TS+OCD .043) 
46) 7.30, = .0001, and the of 
errors, F(3, p .007. Scheffe of 
individual groups revealed that the TS-alone group made 
significantly more Type A errors than the control group 
= .045), and the TS-alone group neither differed from 
the control group for B errors nor differed from the 
other TS groups. The group made more Type A 
and B errors than the other groups, differing significantly 
from the control group for both A (p = .002) and B (p = 
Table 3 
errOrs. On the task, the was not 
'''1>'uu .... auL, F(3, p = .179. The of group 
was also not significant on Letter Fluency, using a strict 
F(3, 46) P = .044. 
Scores for the SET showed a 
46) = 3.80, p .008. 
the TS+ADHD group scored 
below the control group (p = .010); no other group differ-
ences were significant. 
Mean Scores and Standard Deviations for the Tests of Memory and Learning 
Group 
TS+ADHD TS+OCD Control 
(n 9) (n = 6) (n = 21) 
Variable SD M SD M SD M SD p 
Explicit 
AMIPB story 
recall 34,07 9.19 38.22 7.71 26.33 10.89 34.33 8.46 > .050 
Visual Rep. 34.29 6.18 27.44 7.07 29.50 10.09 34.33 4.87 .030 
Total Trials 1-5 49.93 lLl5 46,56 5.15 48.17 9.93 55,24 6.24 .039 
Trial 6 11.43 3.59 9.00 2.40 10.00 2.68 12.19 2.62 .044 
Implicit 
Stem completion 2.00 2.63 1.11 2.03 2.33 1.99 1.57 2.34 > .050 
Mirror reading 0~73 0.11 0.73 0.11 0.66 0.08 0.64 0.11 > .050 
SRTa 
RT Block 61Block 3 0.90 0.07 0.91 0.10 0.90 0.06 0.89 O~ll > .050 
RT Block 71Block 8 1.06 0.08 1.08 0.10 1.04 0.03 LIO 0.15 > .050 
syndrome; +ADHD = disorder; 
disorder; Adult Information Pro-
Reproduction test of the Wechsler Scale-Revised; 
Test; SRT Serial Reaction Time RT = reaction 
time. 
R n = 8 in the TS+ADHD group, 
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Rule and set A level of 
.05/3 (.0167) was used. The effect of group was not 
icant for the Rule Shift test, 46) 1.47, p = 
There was also no significant group effect for the Trail 
Making Test Part F(3, 46) = 2.27, p = .094, or Part B, 
46) = p .161. 
rank correlations with the 
measures for each group were examined separately for 
three executive measures that discriminated 
between the groups. There were no significant correlations 
for the control group a level of .05. For 
the TS-alone the A 
. 024. 
Category A errors 
scores, rs 
were in the eXtlec1ted 
correlation. 
For the TS-alone group, the number of ndVlll .. '
A errors was the measure that rlift"r,I"nti_ 
ated them from the control 
A errors also correlated 
scores for the TS-alone group, an analysis of covariance 
(ANCOV A) was performed to compare these two 
the Brown attention-deficit score as a covariate. 
effect of group remained (p .013). 
Memory and ."-UTILI.FLY Measures 
1l1ll1l1CanCe level of .05/4 was used. 
for AMlPB story recall showed no 
nificant effect of group, F(3, 2.20, p = .101. For 
Visual Reproduction test, the effect of group did not reach 
a strict F(3, 46) p = 
the effect of group did not reach 
a strict criterion for number of words 
recalled over the 46) = p .039, 
or number of words after an list, 
46) = p .044. 
Implicit. A significance level of .05/4 (.0125) was used. 
For the priming there was no Significant group differ-
ence for the number of primed-target distractor words, 
46) = 0.44, p .729. For the mirror task, ANOVA 
did not show a significant group effect for speeding up on 
Trial 2 divided by Trial 1, F(3, 46) 2.24, .096. For 
the SRT task, there was no significant group in 
speed of sequence when Block 6 divided by 
Block 3 was 45) = 0.14, p .934. There 
was also no group difference in RT on 
the transfer test when Block 7 divided by Block 8 was 
F(3, p = .602. 
Mc~au;allron and 
The effects of medication on were examined 
in relation to the three executive measures that had signif-
icantly differentiated the There were no significant 
differences between the and the unmedicated 
participants for the SET scores for the TS+OCD 
group in which the unmedicated scored 
t(4) = 6.00, p .004. 
rU1HV,."" the groups did not differ significantly in age •. 
the participants were the oldest in mean and 
the TS+ ADHD participants were the youngest 
older age in the TS+OCD does not seem to be a 
probable for on some 
YV1U,,,"',",1 age group is a potentially rele-
vant because also showed the evidence 
of impainnent. To any effects of age, we N.rnno,r,,!i 
the three executive measures that had significantly 
entiated the ANCOV A with age as a covariate. 
This of group remained significant 
for each of the measures . 
The present study explored cognitive functioning in TS 
using a wide range of tests and using careful to 
identify those with TS alone and those with 
ADHD or OeD the executive mea-
sures, there was a on two of the 
B errors) and 
the effect ap-
proached using a strict on the Letter 
Fluency measure. There was no evidence of """'''Ill ....... ''' 
associated with TS in of memOl'Y 
Q."'''V~'!;H the 
for of the 
duction, RA VLT and recall after an 
terfering list). Post hoc comparison of the groups for the 
three executive measures that differentiated them 
candy showed that the TS+ADHD differed 
candy from the control 
sures, the TS-alone group rlif1Fprp·£1 
control on one measure 
the group did not differ "I5!1llJl,",WlIU J 
on any of the measures. 
groups did not differ significantly in age, 
the was the youngest The effects of age 
were therefore but this did not alter the fInclmg;s. 
'''','Pn'", of tic symptomatology did not appear to 
differences between the TS groups because they were sim-
ilar on the Yale tic measure. Although some of the 
TS in each group were on medication, there was 
to suggest that this was an important factor in deter-
the of Small size may have 
been an issue in relation to failure to differences 
on other tasks between the TS-alone and the control groups 
because several of the measures failed to reach significance 
a strict criterion to for IllYI"",'" c.:>mpa11SC)fls. 
This may be another factor contributing to the inconsistent 
evidence with to in TS alone 
in the literature, if any associated deficits 
are mild. differences between the 
groups emerged clearly on several of the executive mea-
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sures despite the 
TS+ADHD and 
that comorbid 
the 
the 
findings 
is the contributor to any deficits assoclatc:a 
previous studies have sug-
gested that any cognitive deficits may be confined to re-
stricted of executive functioning involving inhibi-
tory processes. The study provided some support for 
this. There was no evidence of impairment on the Trail 
Making Test or the Rule Shift test, to the 
conclusion that these aspects of T'lPTTnT'rrI<>11I'P 
TS alone. The Rule Shift test in the 
a less demanding task than the WCST may 
have been less sensitive to possible differences. However, 
this seems an improbable the lack of 
differences found on the other groups. The 
WCST has been found to be intact in both adults and 
children with mixed TS and in with TS alone and 
TS+OCD (Bornstein, Crawford, 
& Ozonoff & Jensen, 1999; Schuerholz et 
aL, 1996). Bornstein (1991a) found that children who had 
TS with versus low OC symptoms performed worse on 
the no control was included. there 
is little evidence of in U"',VIJllpl'''''«'''' 
other executive tasks involving planning set 
For intact performance using the Tower 
of Hanoi has been reported in children with mixed TS 
(Ozonoff & 1999). on Part B of the 
Trail Test has been in some adults with 
mixed TS (e.g., Channon et 1992) but not in others 
Bornstein, 1991b). OC symptomatology did not appear to 
contribute to performance deficits in the Channon et al. 
(1992) study, but ADHD symptomatology was not assessed. 
Comorbid symptomatology may potentially have adverse 
effects, as indicated the found in the 
TS+ADHD 
Although little work has 
issues related to memory and in there is some 
evidence of difficulties in strategic aspects of memory func-
that involve learning of the relevant infor-
mation. The most comprehensive study to date was carried 
out Stebbins et aI. (1995), who impairment in a 
group of adults with TS alone on tasks including recall of 
words and memory span. Channon et 
used a story recall and also found irrln<lirml'nt 
of adults with TS alone. The 
evidence of in either explicit or 
memory and although the effect of 
group did approach for several of the explicit 
measures, and small sizes may therefore have led to 
an underestimate of on these. Mean scores 
show that the scores the TS-alone were closest to 
those of the control group and that with comorbid 
ADHD or OCD tended to lower. Further 
work is needed to examine memory performance in 
those with TS alone. There is little work the 
issue of implicit and although 
has been reported in to motor skill learning on the 
pursuit rotor task et 1995). Several different 
implicit tasks thought to have different brain bases 
were used in the present study, and there was no evidence of 
difficulties either in the TS-alone group or in those with 
comorbid diagnoses on any of the measures. 
By contrast, the TS-alone group in the study did 
show clear evidence of on an task, the 
",,"HV"!'." pertorma:nce on this measure for the 
group with ADHD symp-
tomatology, ANCOVA using ADHD scores as the covariate 
showed that this finding was robust because the TS-alone 
group still scored below the level of the control 
Impairment on the Hayling test has also been found 
adults with TS alone et 2003). stud-
ies examining inhibitory performance on the test 
have shown activation in normal participants in the 
anterior cingulate and left fr.ontal 
Fletcher, & 1997), inferior frontal 
gyrus et Collette et al., 
and the left middle frontal gyrus (Collette et al., 2001). This 
appears consistent with the view that TS 
is associated basal 
disruption of 
though 
TS is I'llTTPT.t 1\1 
pie circuits been described involv-
ing nonoverlapping parts of the striatum, globus lJ<tlJll<lU''', 
substantia thalamus, and frontal cortex Alex-
ander et Greater specificity is needed to isolate 
the mechanisms the particular motor and cog-
nitive characteristics associated with TS and to contrast 
these with mechanisms underpinning dopaminergic disor-
ders involving franta-subcortical circuits with differing cog-
nitive such as Parkinson's disease. 
studies inhibitory function in groups 
with mixed TS have reported intact on the 
test, both for adults (Channon et aI., and for 
children (Ozonoff & Jensen, 1999); a near significant dif-
ference was reported in adults by Como, 
Palumbo. West, and Osborn (1995), suggestmg 
formance in the small subset with 
i-tr'lricM,<Hl1 Phillips, Bradshaw, and Chiu (1995) used a task 
with five conditions of complexity, 
choice RT and congruent and incongruent stimuli 
rable with stimuli. et al. reported 
ment in an adult group with TS in conditions involv-
C;)IJ'UH"C conflict. On a different measure 
impairment has been rl'T'lnrt,>ti 
mixed TS Strayer, & Fil-
loux, 1998; Swerdlow, Magulac, Filion, & Zinner, 1996). 
Ozonoff et al. found that impairment was confined to 
a subgroup with comorbid ADHD or OCD, whereas Swerd-
low et al. (1996) did not find differences between small 
comorbid or in adults with mixed TS. Baron-
Cohen, & Robertson (1994) reported im-
pairments in children with mixed TS on two tasks involving 
hand alternation and inhibition. On inhi-
bition no were reported correct re-
in children with TS alone or mixed TS (Ozonoff, 
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McMahon, & Filloux, 1994; Benedict, 
Tekok-Kilic, & Lichter, 1997). Lower hit rates were re-
ported by Sherman, Shepard, Joschko, and Freeman (1998), 
particularly in children with comorbid ADHD but not OeD 
symptomatology. There are thus some indications of im-
of executive in 
which in some instances appears 
in with comorbid symptomatology than 
in those with TS alone, as in the study. Because 
impairment in TS alone appears to be mild, 
whether or not it is detected in a study may depend on 
factors such as the of the particular tasks used. 
In summary, the reexamined the issue of 
impairment in TS and associated comorbid disorders 
a wider range of measures than many studies have 
to look at several of executive and both 
eXl[)llc:n and implicit memory. This provided further 
support for the hypothesis that impairment in TS alone is 
confined to inhibitory aspects of executive function, and this 
was detected on only one of the measures. Some-
what more marked deficits in of exec-
utive function were associated with comorbid ADEill symp-
tomatology. This study the of exam-
comorbid carefully in TS both to aid 
the understanding of brain function in different disorders 
and to identify potential difficulties in functioning in every-
day educational and work environments. 
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Real-life-typ Problem Solving 
Tourette Syndrome 
• In 
"".''lPI.1P'lJ Channon, PhD, 
tMary M. Robertson, MD 
Crawj01'd, *Kian BA, and 
Abstract 
Objective, 
The main objective of the study was to examine 
social problem solving in real-life-type situations 
in Tourette syndrome (TS). 
Background, 
Studies of cognitive functioning in TS have usually 
focused on nonsocial, abstract tasks, with mixed 
findings as to whether there is evidence of impair-
ment in executive functions in those without co-
morbid disorders. The current study focuses pri-
marily on social functiOning, using a problem-
solving task known to be sensitive to frontailobe 
lesions. 
Methods, 
TS participants without comorbid diagnoses were 
compared with matched healthy control partici-
pants on a problem-solving task, using a range of 
interpersonal problem scenarios presented on 
video. A set of more abstract executive tests was 
also included. 
Results, 
Participants with TS were found to perform below 
a matched control group on the problem-solving 
task both in generating a range of potential prob-
lem solutions, and in selecting appropriate final 
solutions. They also performed more poorly on as-
pects of executive function. 
Conclusions: 
This study provides evidence of difficulties in both 
social and nonsocial aspects of functioning in TS. 
The implications of the findings for our under-
standing ofTS and problem solving are discussed. 
Key Words, Executive functions, Frontal lobes, 
Reasoning, Social problem-solving, Tourette syn-
drome. 
(Cog Bebav Neurol2003;16:3-15) 
The study of social cognition and behavior in relation to brain dysfunction is of con-
siderable ImDolrtallce est)ec:ialily in relation to 
P''''rv,rl<lV life. While dis-problem 
ruption to a variety of brain areas may poten-
tially impair aspects of problem 
interest has centered in on 
the effects of frontal lobe dysfunction. Tou-
rette syndrome is a neurodevelopmen-
tal disorder in which the core symptoms con-
sist of motor and vocal tics. TS has been 
linked to a range of problems sug-
of executive induding cop-
rolalia and social inappropriate-
ness (1), "disinhibited behaviors" and 
into trouble with the law (1). It is 
cognlu,re and motor are compro-
mised (3-5), although others have suggested 
Support for the 
UYSIUIIlCUQ,n comes in 
part from the relative of dopamine 
antagonists in treating TS symptoms (5); eye 
movement studies, and biochemical 
data have provided although 
sometimes confl.ictin,g, evidence. The current 
study was to examine the perfor-
mance of participants with TS on an pv,F'nribv 
social task known to be sen-
sitive to frontal lobe lesions 0), This 
task was found to perfonn better 
than a battery of standardized executive tests 
in between those with ante-
rior and po'su:n()r 
Most studies of TS to date 
have focused on nonsocial, abstract tasks. 
cognitive studies (8) suggested TS to be 
associated with impairn::Jel::Jt in aspects of ex-
ecutive runlCtlOn, although these studies did 
not screen for comorbid symptoms 
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m(:lmlmg attention deficit dis-
order (ADHD) or disor-
der (OCD) which may also contribute to any 
impairment. Studies TS partici-
pants with and withollt comorbid ADHD/OCD 
symptoms have tended to suggest more ex-
tensive im]pairment in those with comorbid 
disorder, ADHD (9-12), 'UUAV"&\A 
these fmdings are not 
Pelmingt:on and Ozonoff 
problems without dearcut right or wrong an-
swers, where contextual factors need to be 
taken into account to make appropriate de-
cisions. Everyday problem also relies 
more than laboratory tasks on the ef-
fective use of previously acquired social and 
nonsocial, knowledge. Channon 
and Crawford video-
problem scenarios to examine frontal 
lobe contributions to The 
TS be associated with inhibi- task examined ability to recount the problem 
dy:uunclt:!oJIl, since it is characterized by 
difficulties in suppressing unwanted motor 
movements and vocaliZations. the 
evidence for deficits in lIncompli-
cated TS is inconsistent, tasks such as 
the test 05-17). The current 
used the Hayling test (18) as a measure of 
inhibition and strategy generation. There is 
little to suggest in TS 
on tasks involving rUle-fmding, and 
using tasks such as the WCST 
Impairment in aspects of 
memory has been reported in TS alone (21). 
The the Six Elements llIlJ'''''''l>1'I.llj'15 
measure, and a story recall task were in-
cluded in the current to examine these 
issues. 
The current study examined 
mance on a problem-solving task de:signed 
be more linked to real-life 
Multiple processes both 
abilities and life contribute to 
real-life performance, and traditional tests of 
executive function using abstract materials 
might therefore be expected to share pro-
cessing demands with everyday 
solving. However, evidence from 
with frontal lobe lesions has emphasized that 
traditional executive tests are not always able 
to detect difficulties in life (22). 
Tasks that capture characteristics of real-life 
performance appear to be more successful 
than traditional executive tests in de:tectin:g 
performance difficulties in people with fron-
tal lobe lesions (7,23). Such characteristics 
include a lack of ordered, stnlctured cues for 
problem and the use of oOlen-emlea 
scenarios to generate a range of 
potential solutions, the qUality of the poten-
tial solutions, and the quality of the fmal so-
lutions selected to solve the problems. They 
found that people with anterior lesions, par-
left-sided ones, showed impairment 
in multiple aspects of performance, inclUd.ing 
those concerned with both geluelra1.'lll1g 
rial solutions and 
Those with 
circumscribed difficulties relative to those 
with anterior lesiOnS when with a 
matched control group. A later study 
(24) used a shortened version of the task to 
study young with Asperger syn-
compared with a matched healthy 
control group. The group with syn-
drome was found to show in as-
peets of including both gen-
,,<::,'''''-.JU15 high-quaIity solutions. 
Their solutions differed most from those of 
the typically group in social ap-
This task was used in the current study 
to examine problem-solving p ... ,,,v..,u,,,,,n.,- in 
TS, with a matched 
trol group. The prc)blc:ms 
tions that most 
ther or inclin:ct][y 
encounter d-
and are presented 
Inv'esl:igation of wheth· 
affected in 
uU.P'A'~'"'VIJ''' for our understand-
ing and management to achieve optimal func-
in everyday life. The study also exam-
pel:fOlrrmmc:e on a set of tasks concerned 
with different aspects of executive fWllctl,On, 
to see whether any impairments were found 
f'.in''''I'>tt Williams & Unauthorized .. .:.r."I'>,·1j of is 
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in a TS group who did not have comorbid 10.19). All gave written in-
and were given disorders. formed consent for the 
METHODS 
Participants and Procedures 
(18 men, 3 
women) who met criteria (25) for 
TS and had no other disorder took part in the 
To establish the and rule out 
any comorbid disorders such as ADHD and 
OCD, were assessed against 
DSM-IVlR criteria a clinician with exten-
sive in the of TS and 
related (MMR). An version 
of the National Hospital Interview Schedule 
was 
used to evaluate 
bid symptoms, 
instrument was C1e:mUleCl SP,eClnc;m~ 
and is widely used in the UK. The 
study showed that it had good con-
current validity when with an-
other widely used instrument, the Yale 
Schedule (27). It in-
formation on the presence and of 
characteristic symptoms of TS, and about 
possible comorbid behaviors including ob-
and ADHD symptoms, 
n~'~rh,,)"'i~ Partiicit:)ants were also in-
terviewed their educational and 
medical history. Those who met DSM_IVTR 
or any other comor-
nc,V' .. r,;<>j·rir disorder were excluded from 
the study, as were those with any history of 
learning or physical illness or in-
jury that have affected brain function. 
Inclusion criteria were in English, age 
between 18 and 65 years of age, and a Verbal 
IQ score of 80 or above on the NART (28). 
'''''''ntu_t'lnP healthy control 
pants (17 men, 4 women) also took part in 
the The TS and control groups did not 
differ (p :::: 0.280) in age (TS 
mean 32.90, SD control mean 
SD 11.86), years of education (p == 
mean 13.00, SD 2.30; control mean 1357, SD 
2.11); or NART IQ (p == 0536) (TS mean 
106.19, SD 1150; control mean 108.29, SD 
breaks between tasks as necessary, to avoid 
Task 
The task described by Channon and 
Crawford (7) consisted of sixteen brief sce-
narios involving eVI~rv'LIllV awkward situations 
(see 1 for an Each was 
intended to assess the individual's ability to 
generate solutions. They also exam-
ined ability to select solutions that show ap-
orc~ci;ltic)n of the aspects of the pre-
dicaments, and to solve them in a 
n~<~~~'~":q'~ and effective manner. The situa-
tions include a range of social rel.ation:ships, 
such as family, work '-VU<O'lKU' ... ." and strang-
ers, and the scenarios take in a range of 
work and sodal A fuller 
of the me:tn()C1C)iOj:!V 
de1,ell)oe~d a shortened version which 
used to stUdy young people with AS1Der·ller 
svlldr'ollie and a matched control group, se-
for inclusion the items that 
best discriminated between frontal and con-
trol in the study. The 
shortened version was used in the current 
study, and has also been used in a study 
older and younger adults 
(29). Channon and Crawford (1) compared 
idf~otllPf~d and story versions of the sce-
narios, and found that did not 
differ to which mode of presenta-
onesent~ltic'n was 
therefore used for all in the cur-
rent were asked to watch 
each situation, and then to answer a series of 
questions. 
Number of Prompts for 
Problem Situations 
After each problem situation was pre-
sented, were given an opportu-
nity to see it again. Memory for the characters 
COGNITIVE AND 
BEHAVIORAL 
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and overt actions was assessed by asking which considered to be optimal for the 
© 
them to describe the scenario. Unless 
recalled all the main were 
prompted and shown the video if 
necessary. If the answer remained unsatisfac-
tory after this, a verbal summary of any miss-
details was provided, up to three 
prompts in all to ensure awareness of the 
factual details of the awkward situation. 
Awkwardness Ratings 
For each problem :>lLlI<t!UUll. 
pants were asked to rate the 
wardness of the Situation, both for the main 
character, and for themselves if they were in 
that situation (0-100%). 
Solution 
For each situation, 
pants were asked to generate as many poten-
tial solutions as possible within a 2-minute 
any prompts for 
solutions, to ensure that no cues 
were provided as to the adequacy of their 
responses. To assess how eIIll:H:IlLIY 
gt:nt::rdl.t:U solutions, the number of ideas gen-
erated for each situation was added 
(number of solutions). Each of these ideas 
was scored for quality as described below, 
and scores were divided by number of solu-
tions to adjust for how many were l<:CllC,ltWCU, 
);CJIIC],<l.U,Ull problem aOllJrt:Cl,ILllJIl 
of Optimal and 
Personal Solutions 
After possible solutions, par-
rU"""'nr<' were asked to select the best solu-
tion from the of the main char-
acter (optimal solution). were then 
asked to state what themselves would 
do if they were in that situation 
solution), to examine to what extent 
chose a different course of action from that 
Williams & Wilkins. 
main character, 
Scoring of Quality for Solution 
Generation and Optimal and 
Personal Solutions 
Responses were scored 
three criteria (see below) as to whether 
were to show appreciation 
of the problem, to be appropriate, 
and to effective means of 
orclblt:m. An example of a prob-
lem is shown in Appendix 1. 
1. Problem appreciation: This measure as-
sessed whether the solution demonstrated 
recognition of the pertinent 
aspects of the 
OCl)blem situation that needed to be taken 
into account for a satisfactory outcome to 
be possible (scored 1 or 0). 
2. Social This measure 
solutions to 
with the 
situation was socially 
1 or 0). 
3. Practical effectiveness: This was used to 
solutions to whether 
the manner of dealing with the situation 
was to an effective lJ1<lLU,L<" 
means of resolving it 1 or 0). 
Ratings 
All responses for the were rated 
by one rater who was blind to the identiry 
and group of the participants, 
and by a second rater who was not blind. The 
two raters for 90.2% of All 
differences were resolved by reference to an 
additional blind rater. This was similar to the 
inter-rater agreement in 
their 
1000;6). 
studies using this task, which 
between 87% and 94%. 
their Optimal and Personal 
LlL;,vaUL" were asked to rate 
of satisfaction with each (0-
this is 
Un
ive
rsi
ty 
of 
Ca
pe
 T
ow
n
Problem-Solving in Tourette Syndrome COGNITIVE AND ~ 
BEHAVIORAL ... 
Jud2.mc~nj of Alternative Solutions 
After had each 
situations, they were assessed on 
their of alternative solutions. Five 
alternative solutions were for each 
problem situation, and were 
asked to order them from the best to the 
worst solutions. Their rank were 
scored them with the 
rank derived from Solution Quality 
scores For each the 
rank position of each answer scored between 
o and 4, to its distance from the 
optimal rank pClsit:iOlrl; this gave a maximum 
where all 5 answers were in the 
correct relative to the other 4. The 
maximum Judgment of Alternatives score 
was thus 160, 
Executive Tests 
A of executive tests was se-
lected to assess aspects of executive function 
1, Inhibition and Strategy Generation: 
The Hayling test (18) involved cOlmp>leting 
sentences as as 
words that make sense (part and with 
nonsensical words B). Patients with 
frontal lobe leSions have been found to 
have difficulty inhibiting straightforward 
completion words to generate nonsensi· 
cal words in part B of the 
task. 
2. IUIU.U,La!!'lUlrlg: The Six Elements test (23) 
was used to assess to and 
appnJp:na1te responses, In this test, 
are asked to attempt each of a 
set of six tasks within a lO·minute period, 
with certain rule constraints the 
order in which the tasks are performed, 
Patients with frontal lobe lesions have 
been found to have difficulties in Clt:<.,;l:mkl 
to alter their behavior appropriately in the 
absence of environmental cues to maxi-
3, The Wiscon· 
sin Card Test (30) involved match-
response cards to four key cards on 
Williams & Wilkins, 
the basis color, or ~"'~'~A' 
feedback to infer the rule currently in op-
eration, The test has been found to be par-
ticularly sensitive to dorsolateral or,erron· 
tal lesions, altlhOlu!:h 
4, The 
Although are _""A __ Uj 
involved in memory, the frontal lobes are 
known to a key role in en-
and for recall 
memory (33), 
5, Dysexecutive Behavior AU'U,J'"~''' 
D)"se;iCe<:utive questionnaire 
volved self-ratings and oOler-raltml?:S 
relative/friend 
",,,,,,,,,,rrl<l" life rl"c""'r",,',,.:uo n .. ,,,h!,,n"c in-
tion, behavior and I.:u:~muu.n, 
RESULTS 
A 5% level was 
throughout to compare the two groups. Data 
that did not meet of normality 
prior to 
as necessary, There were occasional 'U"'''''J'~ 
data on some tests for individuals as a 
result of administrative errors; numbers for 
each group are shown in the Tables if these 
fall below 21. 
Predicaments Task 
Mean scores, standard deviations, and 
results of tests for scores on the 
Predicaments task are shown in Table 1. 
t tests, or U tests 
were carried out as appropriate for each of 
the measures. 
Number of Prompts for the 
Problem Situations 
The number of prompts needed to re-
count the factual details of the situations was 
reproduction of this 
NEUROLOGY 
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TABLE 1. Mean scores and standard deviations for the test 
Number of Prompts/3 per item 
Awkwardness Ratings/100%* 
Main character 
Self 
Solution Generation 
Total number of solutions 
Generation problem appreciation/1 
Generation social 
Generation practical eff(:cti'ven:ess./l 
OptimaVPersonal problem appriciation 
Optimal/8 
Personal/8 
OptimaVPersonal social appropriamess 
Optimal!8 
PersonalIS 
PersonalIS 
Satisfcation ratingsll 00%' 
Optimal 
Personal 
effectiveness 
TS group 
(n = 21) 
Mean (SD) 
0,57 (0.48) 
69.13 (12.77) 
59.91 (15.18) 
27.05 (S.72) 
0.79 (0.07) 
0.54 (0.11) 
0.52 (0.11) 
7.05 (0.92) 
6.S6 (0.96) 
5.62 (1.12) 
5.33 (1.43) 
5.95 
5.62 
82.40 (9.76) 
84.93 (10.92) 
Control group 
(n = 21) 
Mean (SD) 
0.47 (0.34) NS 
Group x task NS, group p < 0.05 
62.1603.87) 
47.57 (17.07) 
33.71 (10.92) 
0.S3 (0.05) 
0.57 (0.10) 
0.54 (0.09) 
p < 0.05 
P < 0.05 
NS 
NS 
x task NS, group p < 0.01 
(0.64) 
7.67 (0.66) 
x task NS, group p < 0.05 
(0.93) 
6.14 (1.24) 
x task NS, group p < 0.05 
(1.69) 
6.71 (1.35) 
Group x task NS, group NS 
77.20 (14.59) 
SO.16 (12.69) 
Judgement of alternativest 125.67 (8.27) 127.62 (8.73) NS 
'N = 21 TS, 20 Control; tN = 19 TS, 21 Control. 
NS, not significant. 
low for both groups, and did not differ 
niti<:antly (z == P == 0.704). 
Awkwardness ..... " .... J'K'" 
ANOVA was used to compare the 
groups in their of the awkwardness of 
the situations from the of the 
main character and for themselves. The 
group by interaction was not sig-
nificant (F :::: 1,39, p :: O. 
There was a ",,,)'",fir,, effect of group (F = 
:= 0.029), and the TS group df::: 
rated the situations to be significantly more 
awkward than did the control group. 
Solution Generation 
N",,....!, .... of Solutions was assessed 
cOlLlmmg the total number of solutions gen-
erated across all problem situations. t tests 
revealed that the TS group 
cantly fewer solutions than the control group 
(t 2.19, :::: 40, p 0.035). The of 
the solutions was also examined 
by each solution for Problem Appre-
ciation, Social and Practical 
Effectiveness as described above, and divid-
by Number of Solutions, to derive an av-
for Generation Problem 
2.52, df:: p :::: 0.016), but not for Genera-
tion Social Appropriateness (t:::: 1.12, 40, 
P :::: or Generation Practical Effective-
ness (t 0.83, df == 40, P :::: 0.411). Pearson 
correlations were carried out to examine the 
relationships between the average solution 
quality measures and solution gelileratj,on. 
These showed correlations with 
Number of Solutions for Generation Practical 
Copyrlght Uppincott Williams & Wilkins. Unauthorized of article is prohibited. 
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Effectiveness (r == -0.46,p:::: for the TS 
group, and with Generation Social Appropri-
ateness (r 
== and Generation 
effect of group (F 
0.169). 
1.97, df = 1,39. P = 
Practical Effectiveness (r ::::: p 0,002) Judgment of Alternative Solutions 
for the control group, that smaller 
numbers of solutions generated tended to be 
in quality. 
Selection of Optimal and 
Personal Solutions 
For each 
tion from the perspective of the main char-
acter, and then to give their own pellSonal 
solution. These were rated on Problem Ap-
Social pproI)ri~lterless, and Prac-
tical Effectiveness. For Optimal and Person-
al Problem Appreciation scores, ANOVA 
group 
1 p There 
signitllcarlt effect of group (F :::: 10.31, 
p == 0.003), the TS group 
pe:rtorm more poorly than the control 
group. A similar pattern was seen for Optimal 
and Personal Social scores. 
ANOVA showed no significant group by per-
effect (F :::: O. 1,40, P :::: 
0.751). There was a 
group (F == df= 1 
the TS group to 
than the control group. 
ANOVA showed no signifi:caIlt group by per-
cn .. "ti"""'effect (F::: :::: 0.261) 
for Optimal and Personal Practical Effective-
ness scores. There was a effect of 
group (F == 4.65, df 0.037), with 
the TS group again 
group. 
Satisfaction RatU1tgs 
below the control 
Although the TS group scored below 
the control group on each of the measures of 
Optimal and Personal solution quality, the 
groups did not differ in the levels of satisfac-
tion expressed with their Optimal and Per-
sonal Solutions. ANOVA showed no signifi-
cant group by effect (F == 0.13, df 
== 0.719); nor was there a significant 
Copyright © Lippincott Williams & Wilkins. 
To examine whether 
showed any difficulties in IU<llgllllg 
equacy of solutions even when 
required to generate them, participants' rank-
ings of five alternative solutions for each 
problem situation were examined. COlmpari-
son of the groups showed no significant dif-
1U(!ge:m(~nt of Alternatives scores 
(t == p:::: 0.550). 
vo.· .. f'i"'" Tests 
Mean scores, standard deviations and 
slglllltlcarlce tests for the groups are shown in 
Table 2 t tests or Mann-Whitney U tests were 
carried out as appropriate for each of the 
nelllfC)psyClll010glcal tests, or ANOVA for tests 
two parts (Hayling and Re-
call). 
Inhibition and strategy I!e'neraltion 
On the test, part B error scores 
were for the TS group (z p ;;;;; 
0.050). When time taken for part A and part 
B was ANOVA showed that the 
effect of group was not significant (F 
== p == 0.100), but the group 
aPt:'roacnf:<1">A.&U""'-R.U"'- (F == 
Mean scores showed that 
the TS group was similar to the control group 
on sentence 
(part A), and tended to be slower on nonsen-
sical sentence completion, 
sponse inhibition and strategy ",,,,,,, .. ,'<>ti'''n 
TIle control group was at 
on the test, and thus signuicalflc'e was 
not The TS group aplJroactlea 
level on the test. 
Rule-flnding/Set-shifting 
The groups did not differ in the number 
of correct categories achieved on the WCST 
"n,",,-,:,on reproduction 
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TABLE 2. Mean scores and standard deviations for the executive tests 
TS (n = 21) Control (n e 21) 
Mean (SD) Mean (SD) 
Inhibition and Strategy Generation 
Hayling Test-Time 
Time A 
TimeB 
B Error score 
19.90 (4.43) 
37.71 (16.85) 
6.86 (6.09) 
x task NS, group NS 
1957 (5.00) 
33.24 (40.63) 
3.62 (3.11) P < 0.05 
Multitasking 
Six Elements test 
N of tasks attempted 5.71 (0.72) 6.00 (0.00) 
Rule-findinglSet-shifting 
Wisconsin Card Sorting test 
N of eategories 
Perseverative errors 
5.43 
6.57 
5.57 
5.29 (6.54) 
NS 
NS 
Delayed 
37.57 (9.91) 
3257 (12.22) 
Group x task NS, group p < 0.05 
42.71 (6.81) 
40.52 0.19) 
Other-rating' 
23.81 (9.10) 
29.27 (14.85) 
20.62 (8.34) 
19.20 (9.65) 
NS 
P < 0.05 
'N = 15 TS, 15 Control. 
NS, not signficant. 
(z == 0.07, P == 0.941), nor in the number of 
npr~pvPMtivp errors (z ::::: 0.81, p = 0.416). 
Strate2ic Encoding/Retrieval 
There was a effect of group 
(F 6.11, df:::: 1,40, p 0.018) on 
Recall; the effect of group X time of testing 
was not significant (F :::: 1.63, p == 
0.209), that the TS group recalled 
less material than the control group both im-
mediately after and after a time 
DEX 
For the DEX Qu.estiionnailre, all 
pants filled out Sel!-faltlOgs, and scores did not 
differ between the groups (t 
1.18, 
Correlations Between Executive 
Measures and Predicaments Task 
V',"Ull.'''-'l rank correlations were exam-
ined for each group between the 
executive measures that differentiated the 
groups error score, Story Recall and 
DEX-other) and the mea-
sures that differentiated the groups (Solution 
Generation and Final Solution scores). 
No correlations were found be-
tween the measures for either group. 
Effects of Medication 
Thirteen of the TS group were 
medication at the time of Eleven of 
them were taking antipsychotic prepara-
two of these in combination with a 
.... i,-",-·Iil' one with an SSRl, one with an SSRl 
LJc.UL.tJ .. .u;.u:.C:yllllc, and one with an anti-
Cn()lmler~~lc. One TS was taking an 
SSRl alone, and one an drug 
judged to show more d~;execllti,re 
than the control group (t == 2.20, 
0.036). 
28, P == mance were examined in relation to the mea-
sures that had differentiated the 
.n ..... n ..... r'n Williams & Wilkins. reproduction of this article is prohibited. 
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TS group from the control group (c()mllJining 
across Personal and Optimal Solutions, since 
there were no significant effects of perspec-
tive), although the fmdings must be treated 
with caution since power was low. Compari-
son of the medicated TS subgroup (N == 13) 
with the control group showed them to be 
significantly poorer on Number of Solutions 
(p Optimal/Personal Problem Ap-
pf(:Cl~ltlon (p 0.002), and Optimal/Personal 
Social Appropriateness 0.045), HAVIU .• '" 
0.014) and Story Recall :::: 
",--U'1l1IJdl1"U'1l of the unmedicated TS 
8) with the control group 
showed them to be ,"15.H.u ..... 'u ... } 
0.022), Problem Apprecia-
tion (p :::: 0.049) and Optimal/Personal Social 
0.036), and DEX-other 
Direct comparison of the 
medicated and un medicated TS 
did not reveal any significant effects on any of 
the measures (p > 0.05). 
DISCUSSION 
The main findings were that on the Pre-
dicaments task, the TS group was signifi-
poorer on several aspects of perfor-
mance, generating fewer potential problem 
solutions and poorer fmal solutions. 
They also the scenarios to b  more 
awkward than the control group, and did not 
differ in their satisfaction with their own per-
formance. With respect to the executive 
tests, the TS group differed Significantly from 
the control group in the number of 
errors and on Story Recall. The TS 
pants were also rated by others as displaying 
dYI.e}(ec'UtiLVe behaviors on the DEX 
There was no evidence to sug-
gest that the were attributable to the 
effects of medication. 
When solution quality was examined 
for the fmal optimal and solutions 
selected, the participants with TS scored sig-
nificantly below the control group in each 
aspect of solution rated, both for op-
timal and solutions. These included 
Lippincott & Wilkins. 
)f),~e"fh)Uj,VZ"H! in Tourette V'IJi'lr.W(1,n7 
ability to aPi)re,ciaite the pertinent mT,prt1,pr_ 
fn'~('ll('~1 aspects of the and 
to devise solutions judged likely to be socially 
aplDro,pnate and effective. On the problem 
apOf(~Ci~lti(>n measure, the control group but 
not the TS group ceiling levels. 
This is potentially a critical aspect of 
since it assesses 
ability to take into consideration the social 
and situa-
tion in selecting an solution. 
Weaker in the TS group on this 
measure may reflect a failure to make ad-
knowledge, abU-
and look 
ahead to the potential consequences of dif-
ferent courses of action. Solution quality also 
differentiated the groups for the problem ap-
preciation measure when fluency solutions 
were examined. Participants with anterior le-
sions studied by Channon and Crawford (7) 
were also characterized solution 
both for solutions they generated 
themselves and when asked to judge solu-
tions that did not generate. By contrast, 
those with J\.:>IJC:l:~Cl syndrome had dif-
ficulties prled()mirumtly in relation to a single 
aspect of solution 
solutions that were appropriate. For 
the current study, there was no evidence of 
difficulties in solution when 
",-,tl-''''.'''':> with TS were asked to judge 
solutions rather than generate them. 
However, this is probably a less sensitive 
measure than the selection of optimal and 
personal solutions, since the alternatives pre-
sented for each reflected l<:.ldLlVC.l 
differences in quality, in that some of 
the five solutions for each could eas-
ily be to be very poor. The presenta-
tion of alternatives which all provided at least 
partially solutions would have of-
fered a more subtle test of COml)al"3.tilVe 
ment of abstract solutions not opnprnfPr! 
the themselves. The current fmd-
may therefore underestimate tlle extent 
of difficulties in such judgments in 
the TS group. 
COGNITIVE AND 
BEHAVIORAL 
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The TS group did show clear evidence 
of on the more mea-
sures of problem-solving " .... tf' ... ",., 
flected in the of their "<:;ll-/5'Ol1'''d'CCU 
[mal solutions. this, it is of interest 
that did not rate satisfaction with their 
[mal solutions any lower than did the control 
group. Failure to or to report differ-
ences in satisfaction may reflect a subtle de-
gree of in awareness or acknowl-
ed!~m4::nt of their which may in 
tum be associated with similar failure to ap-
oneciate difficulties in life. To our 
knowledge, 
has not previously been studied in people 
with although there are some indications 
of difficulties associated with behaVior in ev-
eryday social situations. For ll'''U>.1.:''''', some 
individuals with TS show 
ate behavior, in addition to the 10I1'('-<·(>(',roo. 
nized symptoms of and copro-
associated with the disorder (1). There 
is also work that children with TS 
are at risk for having poor peer rela-
tions than a clinical control group 
The DEX was included to 
an indication of everyday life behavior, and 
nr,C\v"t1,,·t1 some support for the view 
be poorer in the TS group. 
groups did not differ signifi-
behaviors than the 
The participants with TS showed im-
pairment on the Predicaments test not only 
in the ofthe solutions 
but also in the number of possible solutions 
that they This is a potential source 
of difficulty in relation to [mal solution 
ity, since failure to generate solu-
tions could clearly contribute to poor selec-
tion of optimal and solutions. How-
ever, ability to generate a range of po:ssil:>ie 
solutions did not correlate with 
the final solution quality measures for either 
group. Presumably individuals used different 
"L14L~;O";;''' in potential solutions, 
with some individuals producing a small 
number of solutions that were nev· 
ertheless in quality. There was a rela· 
tionship between solution and the 
average quality of the solutions for 
the control "'-"I-'"n,-" on two of the three 
quality measures, and for the TS participants 
on one of the 
that those who 5~u~,a,~y more solutions 
tended to score lower in the average 
of those perhaps because they had 
pOSSllme range of solu-
tions to the in higher 
numbers of ideas. 
Real-life solving in """">..vli,,,,, 
situations involves selection of 
information as a focus of attention, identify-
ahead to po-
tential future consequences of different 
reasoned compara· 
and evaluating 
A set of abstract executive tests 
was also included in the current study, since 
nonsocial executive processes may share 
with real-life social problem 
scores on these executive 
tasks were not correlated with scores on the 
Predicaments measures that differentiated 
the groups. This may indicate that differ· 
ences in between the 
types of executive processes, but to other 
factors such as emotional processes or 
~~"kl~~ situations as slgnl.IICanllY 
more awkward than did the control 
pants, which may have indicated a stronger 
emotional response to the in the TS 
group. It is that emotional arollsal 
interfered with their ability to generate ad· 
equate or that impairment in other 
aspects of emotional contributed 
to their difficulties in solving. Re-
cent brain-imaging methodology has linked 
lateral frontal lobe areas to executive pro-
cesses such as memory and inhibi-
tion (37), whereas orbitomedial frontal lobe 
areas are LU""'~"H to be associated with emo-
tional processes based on reward 
© Uppincott & Unauthorized reproduction article is prohibited. 
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and punishment. Bechara et al. (37-39) pos-
tulate that somatic/emotional markers may 
playa crucial role in supporting de-
CISIOI1-rr:laK1l12 processes, and that these are 
co:ml:'rorru:se<1 in with lesions to ven-
tromedial frontal cortex. These markers are 
said to cues, overtly or sig-
of reward or pun-
experience, and 
perfolmlarlce before con-
scious is available to rea-
Rolls (40) also argues that areas of 
frontal cortex, orbital 
are involved in behavior accord-
ing to of reward and punishment, 
based on tasks such as reversal learning. 
cific difficulties in 111'''\..111;; "nnrl"\n,rj"lrp 
(' ... \11 ('I"",1In C1 a 
man with a right frontal lesion including the 
orbitofrontal cortex. Somatic/emotional com-
ponents in addition to components 
represent another source of potential 
ment for TS in the current study, 
although no direct evidence was available to 
evaluate this. 
The TS group at similar lev-
els to the control group on some of the ex-
ecutive measures, but did differ on measures 
of inhibition/strategy and strate-
gic memory. The Hayling test is to be 
a sensitive measure of response inhibition 
and strategy generation, known to be im-
after frontal lobe lesions (18). This is 
of interest in view of debate as to whether 
UU""V'''lfJ'''''''''''"U TS is associated with im-
nmC[l()nlIlg (14), The TS 
that involves both executive processes of 
"tr,tpCltr '-u .... v.~ .. "1S and retrieval, and 
term memory storage. Further work is 
needed to the particular difficulties 
memory Overall, 
these findings provide some support for the 
notion that uncomplicated TS is associated 
with deficits in aspects of execu-
tive function. However, none of the 
fW:lpanrs in the current study met criteria 
Lippincott & 
for comorbid it is possible that sub-
clinical comorbid symptoms contributed to 
addition to TS symptoms. 
f"XnIC)f'Ed further in a future 
selli-r<ep,ortloltls(:rver ratings to ex-
amine any correlations between task perfor-
mance and TS/OCD/ADHD symptoms. 
To what extent can it be inferred that 
performance on the Predicaments test pre-
dicts real-life problem-solving behavior? Ex-
nr,C\vi,l1p structured 
cues for that are in real 
leading to underestinlation of everyday 
difficulties. The use of open-elll<1e:<1 nrnt,lp,,... 
situations and limited use of questions and 
prompts in the current task was to 
minimize this. Conversely, 
lems also be overestimated by mea-
sures of this type as a result of uu.u<..UlI'Y 
""'''5'''''''5 the situations in reality, or limited 
0 ... ·"",..,,""1 investment in the outcome. Never-
tlle validity of the task was 
thought to be because successful solu-
CI.IUl1CU participants to take into ac-
contextual factors in antici-
ootel1tl:u outcomes, and there were 
or wrong answers. More-
over, the pr()oleII1S were based on real-life 
situations. The from the DEX ques-
tionnaire provide some evidence for the va-
of the test, since indicated 
that the TS group showed more 
d~;execlltiv'e features in life than 
the control group. 
In surrunary, the current rmon:lgs 
that problem-solving 
mance was impaired for with TS, 
who were poorer both in generating a range 
of potential solutions, and socially 
aOOf()ollial:e and effective fInal so-
lutions. below the level 
of the control group on more abstract execu-
tive but a lack of correlations between 
the executive and social 
measures raises the possibility that 
have dissociable and neural bases 
r"l.,tino to separate frontosubcortical path-
ways. The of clinical tools 
based on measures such as the current 
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March 2003 
leln·~iOIVnu'l task may aid in the clinical assess· 
ment of individuals with TS, to iden· 
tify any difficulties in situations in 
real life. 
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equate appreciation of the pertinent is-
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whether solutions were appropd-
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ments. 2. Social Appropriateness 
APPENDIX 1 
An Example of a 
Predicament: 
Anne is in her office when Tony comes 
in. She asks how he is, and he says he is 
but tired. She agrees that he looks 
and asks what is the matter. He has new 
who moved into the flat above his 
of weeks ago. 
them in their 
is directly above 
since moved in, the jump around 
to get to and bark. He fmds it ImpOSSible 
sleep. He says he has had a word with the 
and were very rea-
they said they had nowhere else to 
put the as it is a block of flats. 
nlli.aUt:lplt:i!i of Good Solutions 
with the neighbors and 
"""l1J."U~ of Solution ""'J_~" 
1. Problem Appreciation 
The scoring were classified as 
follows: 
Attelnp,[ to negotiate a solution with 
the nellgnlool·s. 
(B) Make further complaints 
landlord/council/police). 
(C) Alter your own life 
move house). 
go to 
(D) Extreme ideas (e.g. kill the dogs). 
(E) 
in 
The were classified as 
A answers scored 1 
point, category and E answers 
scored ° points, and category B answers 
were according to the degree of so-
cial appropriateness indicated ag-
PT"",,,,ivp or answers scored 0). 
3. Practical Effectiveness 
The 
A, B, and C answers 
were split into those 1 or 0 ac-
to the degree of practical effec-
tiveness indicated. 
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Social Cognition in Tourette's Syndrome: Intact Theory of 
Mind and Impaired Inhibitory Functioning 
Shelley Channon,1,3 Elizabeth Sinclairl, Denise Waller,! .L..IV."'."' .. Healey,1 and Mary M. 
Robertson2 
Although associations between social involving theory of mind and non-social 
executive skills have been dissociations in have also been 
found. The present study was designed to examine social and non-social cognition in 
uncomplicated Tourette Syndrome ([S). Adult TS without comorbid Ul<l.lSlllJ~'" 
were compared to matched healthy control on social cognition measures 
involving theory of mind and empathy, and on non-social executive tasks. Participants with 
TS were found to make more errors than a matched control group on an task, 
but did not differ on other executive measures or on the social measures. The 
H11I)"'-''''")I1> of the for our of TS and of the between 
"'V~'UH.IVU and executive skills are discussed. 
KEY WORDS: Theory of mind; mentalising; inhibition; social cognition; Tourette's syndrome. 
Controversy 
the relationship between of mind and execu-
tive where associations in pel'IOJrm;;lnc:e 
have often been reported. This may reflect the 
pOlcennal contribution of both executive and theory 
of mind skills to social 
dual route to 
executive theory of mind, 
that theory of mind may underpin executive func-
that embedded conditional 
both executive and 
rar'Art»,., in a range of 
I Department of Psychology, University College London, UK. 
2 Department of Psychiatry and Behavioural Sciences, University 
College London School of Medicine, UK. 
3 Correspondence should be addressed to : Dr. S. Channon, Depart, 
ment of Psychology, UeL, Gower Street, London WCIE 6BT, 
UK; Tel.: +44·20·7679·1099; e-mail: s.channon@ucl.ac.uk 
669 
young typically 
& 2002; 
children with autism (e.g., 
& Frye, 2002), and adults with 
Channon & 2000). 
Neuroanatomical could also account 
for the co-occurrence of deficits in both theory of 
implying 
Dissociations 
between in these two domains 
H1\, .... '.... 11 .• '" a 
Lumsden, & 
Blair, 2001) and one with frontal variant frontotem-
poral dementia linked to orbitofrontal cortex 
(Lough, & The converse 
dissociation of intact theory of mind and impair-
ment in aspects of executive has been 
reported in a with orbitofrontal 
& Powell, 2000) and in 
children at risk of attension deficit hyperactivity dis-
order (ADHD) (Perner, & 2002). 
OI62·1257104/1200.Q669/0 2004 Springer Science + Business Media, Inc. 
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The concept of has been used 
with respect to emotional processes involved in 
identifying with others' it poten-
tially encompasses both emotional and cognitive 
e.g., 1998 for a review). 
in ability have been 
reported in people with frontal lesions and in those 
with traumatic brain Bloomer, 
Archambault, & Both lesion studies 
(e.g. Channon & 2000; Rowe, Bullock, 
Polkey, & Baron-Cohen, & 
Knight, 1998; & Alexander, 2001) 
and functional studies Baron-Cohen 
2000; Fletcher 
Grafman, 
frontal lobe 
In 
these studies, 
In 
as the 
amygdala may also be involved. 
Taken the that social 
cognition is of non-social 
executive at least in the mature brain. In 
the present study, this contention was explored fur-
ther by social and executive 
functioning in adults with Tourette's syndrome 
(TS). TS is a disorder involving 
motor and vocal tics. Fronto-striatal pathways are 
believed to be (e.g. Leckman et al., 
1997; Moriarty et aI., 1997), and there has been 
considerable recent interest in the question of 
whether there are associated impairments in cogni-
tion as well as in motor Early studies 
<>UJ"r;'",.;,.,",u TS to be associated with impairment in 
of executive these studies 
did 
or 
which may contribute to any 
e.g., & Ozonoff, 
Current evidence based on studies that have 
points to a selective execu-
skills. Impairment on inhib-
.. p ... nrtpri in those with TS-alone 
Vakili, & Robertson, 
& Robertson, 2003b; Sher-
& Freeman, 1998), 
not There is little evidence of 
in TS-alone in skills including planning, 
or (e.g., Pennington & Ozo-
noff, 1996); these skills have been linked to regions 
dorsolateral cortex (PFC) 
Cabeza & Nvr.py·u 
Channon, Sirlchlir. and Robertson 
little attention has been paid to the 
of social in TS. From an every-
day there are some indications of social 
difficulties associated with TS coprolalia 
and social (KurIan 
et 1996), "disinhibited & 
Leckman, and 
law (KurIan et these are not 
always and may be more marked when 
there is comorbid It is currently 
unclear whether these arise from the same inhibitory 
deficit that appears to affect on non-
social executive or whether there are deficits 
of social that may reflect addi-
difficulties. One study to date 
to mental states from 
eyes (Baron-Cohen, Jolliffe, 
1 performance was 
TPr,nrtpri to be intact in a group of TS participants 
not screened for executive skills were 
not examined in this On a test of social prob-
lem known to be sensitive to frontal lobe 
Channon et al. found that those 
with TS-alone showed both 
of solutions, and in 
solutions. Difficulties in 
responses might be 
both to generate and 
solutions. However, 
nf'l·tolrm;~nc~ in this study did not 
inhibitory performance 
test, or with scores on other execu-
the possibility that impairment on 
task was linked not to inhibi-
to other skills such as impaired 
ability. Some tentative evi-
dence for this was provided by Channon 
and Crawford (2000), who found impairment on a 
story task involving 
skills in those with frontal lobe lesions; some of the 
group had also in an earlier 
that showed impairment associated 
with frontal lesions (Channon & 
The was designed to examine the-
ory of mind and ability in TS 
screened for comorbidity. Theory of mind was 
assessed a story comprehension task 
that has been extensively used in the literature 
performance in people with autism and 
also with focal lesions, and has also been used in 
uU"'5''''5 studies. A second story task 
& Crawford, 2000) using slightly more 
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difficult materials was 
Lr,~ .... '",r' question-
naire Non-social executive tasks 
involving both inhibitory and other skills were also 
included, It was that the TS group would 
show on the inhibitory executive 
but would be intact on the other executive tasks, 
No made theory 
in view of the limited 
literature. 
METHOD 
Participants and Procedure 
Fifteen (11 m, 4 f) who met DSM-
IVTR criteria CAP A, 2000) for TS and no other dis-
order took part in the study, In order to establish 
the and rule out any comorbid disorders 
such as ADHD and OCD, 
assessed 
with extensive PV'",PT',p.n 
related disorders 
the National 
criteria, This instrument was specifically 
for TS research, and is used in the UK. The 
study showed that it had good concurrent 
when with another used 
the Yale Schedule (Pauls & Hurst, 
1987), information on 
the characteristic symptoms of and about 
ble comorbid behaviours including obsessive-
compulsive and ADHD and also 
Those who met criteria for 
OCD or any other comorbid 
disorder were excluded from the study, as were 
those with any of 
physical illness or 
brain function, Inclusion criteria were fluency in 
age between 18 and 65 years of age, and a 
Verbal IQ score of 80 or above on the NART 
1991). 
matched control partIcI-
pants (18 m, 5 f) also took part in the study. The TS 
and control groups did not differ significantly in age, 
M = SD 12.31; control M = 
8,23), years of education M = 11 
control M SD 1,99); or 
(IS M 105,93, SD = 12,13; control 
M 106,70, SD = All 
written informed consent for the 
Social Measures 
Advanced of Mind 
671 
gave 
These stories were to study higher-
level of mind in autism by (1994) 
and later adapted Brownell, and Winner, 
1999), They consisted of eight mentalistic (theory 
of mind) and non-mentalistic control 
presented in written form one at a time in 
fixed random order, The theory of mind stories 
were concerned with double bluff, misunderstand-
ing, and white lies, After studying each 
story, were asked questions requiring 
inferences about the thoughts and and 
sometimes the intentions of the central character. 
The control stories were also about people, and 
were asked infer-
ences about rather than mentalistic issues. 
Performance was scored 0-2 for correctness of 
answers, with 2 for a correct answer, I 
point for a partially correct answer, and 0 for an 
incorrect answer. An of each type of 
is shown in Appendix 1, 
Story 
This task was by Channon and 
Crawford (2000). It consisted of twelve mentalistic 
higher-level of mind and 
comprehension, Participants 
were asked to explain the main character's speech 
or but the link between the words or 
actions and the reason behind them was not made 
explicit. The final sentence contained infor-
mation which ensured that the story could not be 
understood adequately using a literal 
so that it was necessary to invoke a non-
literal interpretation, The stories included examples 
of sarcasm, lies and 
Performance was scored 0-1 for cor-
rectness of answers. An is shown in 
npl-'''UU'A L 
Inf",,.n'PY,·tm,n! Reactivity Index (IRI; 1980) 
It_T'pn,(wt measure u~~'"'~~.u'" 
aspects of """puc,,], 
extent to which 
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the of others and to 
from their of view), 
tendency to identify emotionally with fictitious sit-
uations such as books, films and daydreams), 
concern (the extent to which 
feelings of warmth, 
concern for and 
ented of fear and the face 
of others' bad Each item was rated 
on a scale 
140, where 
0-5, a total score of 0-
scores indicated higher levels of 
Non-Social Executive Measures 
Inhibition 
& 1996) 
orally sentences 
as possible with words that make sense 
A) and 15 sentences with nonsensi-
cal words London is a .. "ba-
nana"). Straightforward completion errors consisted 
of words that made sense in completing the sentence 
London is a and these received 
an error score of 3. Related errors con-
sisted of words that were related or 111 
to the sentence London is a 
big ... "village"), and these received an error score of 
I. The maximum possible error score was therefore 
45. Patients with frontal lobe lesions have been 
found to have difficulty straightforward 
words to generate nonsensical "'v'''~,,«'''­
tion words in part B of the task, and functional 
imaging has the ventrolateral PFC and 
anterior 
The Wisconsin Card 
Grant & 1948) involved 
cards to four key cards on the basis of 
our or number, using feedback to infer the rule 
currently in The 
order: colour, 
number. There were was 
based on the number of correct rules (Le., 10 con-
secutive correct sorts) and the number of persever-
ative errors (i.e., sorts to the correct 
rule once feedback had been given that this was 
ChlannO!n, Sinclair, Waller, Healey, and Robertson 
The test has been found to be 
although other lesions may also produce 
ments (Milner, 1963). 
Multitasking 
The Six Elements test (Wilson, 
& 1996) was used to assess 
and plan responses. 
In this test, are asked to attempt each 
of a set of six tasks within a ten-minute with 
certain rule constraints the order in which 
the tasks are np'rt('lTrn 
two sets and of written arithmetic 
two sets of pictures to be 
two dictation tasks and The rules specified 
that sets A and B of anyone type of task 
or should not be carried out 
and that all six tasks should be 
the allocated time. Scores were 
based on number of tasks completed, rule breaks 
and time to an overall score ranging 
from I to 4. Tasks that 
tion in unstructured situations when environmental 
cues to guide behaviour are have been 
r"'r,nr1t""i to be sensitive to lesions """ ... ,,,,, .. 
polar Veitch, de Lacy Costello, & ...>".a"' ..... "', 
2000) and orbital PFC (Levine et ai., Lesions 
in these areas are linked to difficulties in electing to 
alter behaviour to maximise 
RESULTS 
Mean percentage scores, standard deviations 
and results of tests for the social and 
nonsocial measures are shown in Table 1. A 5% 
nificance level was adopted to compare 
the two groups. All t-tests were two-tailed. 
Social Measures 
Advanced Theory 
ANOV A with one factor (type of 
story: mentalistic or and one between-
group factor or control group) showed no sig-
nificant effect of group, F(l p = .124, 
nor group by of 
F(1.36) 0.09, p = .770. 
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Table I. Mean Percentage Scores and Standard Deviations for the Social and Non-Social Measures 
Social measure.l· 
Advanced theory of mind 
Mentalistic stories 
Non-mentalistic stories 
Story Comprehension° 
Story scores 
Interpersonal Reactivity Indexb 
Non-Social Measures 
inhibition 
Hayling errors 
Rule-Finding/Set-Shifting 
WCST N of categories 
Perseverative errors 
Multitasking 
Six Elements test 
Note: n N = 14 TS; b N 22 Control. 
M 
87.08 
82.92 
83.93 
55.38 
10.07 
SLiI 
6.51 
96.67 
TS 
(n 15) 
(1O.15) 
(12.15) 
{I 1.07) 
(5.94) 
(5.87) 
(33.85) 
(8.42) 
(S.SO) 
Group 
Control 
(n 23) 
M 
91.03 
87.77 
83.70 
56.82 
5.99 
91.30 
3.46 
97.83 
(7.73) 
(9J3) 
(t2.l7) 
(8.97) 
(5.90) 
(20.02) 
(SAl) 
(7.20) 
NS 
NS 
NS 
p < .05 
NS 
NS 
NS 
Comprehension Multitasking 
A t-test showed no significant difference between 
the two groups in the number of correct 
= 0.06, p .954. 
mT." .. npn·rm,'lI up""t"" tv Index 
A t-test showed no difference between 
the two groups on the empathy scale, 0.54, 
p .590. 
Non-Social Executive Measures 
Inhibition 
On the test, error scores were 
higher for the TS group, 2.09, 
t::::: .044. 
On the there was no differ-
ence between the groups in the number of catego-
ries completed, = 1.17, p = 
or in the number of errors, using 
transformed scores, t(36) 1.17, 
p = .249. 
On the Six Elements test, the groups did not 
differ t(36) p both 
groups approached levels on the test. 
Inhibition vs. Social and Non-Social Executive 
Measures 
A direct comparison was made of the inhibitory 
measure, where the TS group significantly 
more poorly than the control group, and the other 
measures, which did not differentiate the groups. 
The variables were each z-transformed for ease of 
A measure was calculated 
for the social measures by across the vari-
ables (Advanced Theory of Mind, Story 
sion and Interpersonal Reactivity Index). ANOV A 
was then carried out the two groups on 
the Social measure versus the 
inhibitory measure. This showed a significant group 
by task p = .024. This 
remained similar when the was 
repeated using the variables (age, educa-
tion and as there was a 
cant group by task interaction (p 
Non-Social measure was also calculated 
across the executive tests for the 
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Hayling (WCST, Six Elements test). ANOVA was 
then carried out comparing the two groups on the 
Non-Social measure versus the Hayling 
inhibitory measure. This showed a group 
by task F(l 4.67, p = .037. This 
pattern remained similar when the 
the 
tion and as there was a 
cant group by task interaction (p = .048). 
DISCUSSION 
The results showed that as the TS 
group was poorer than the control 
group on an inhibitory measure, the test, . 
with the other social or non-social execu-
tive measures. 
The IH'U"'~" for the non-social executive mea-
sures are consistent with 
circumscribed in 
U"'.Vi.";';""''''.",",,", TS. The test is thought to be 
a sensitive measure of response inhibition and strat-
egy generation, and performance has previously been 
shown to be impaired in TS (Channon et al., 2003a, 
2003b) as well as in frontal lobe lesions & 
Shallice, 1996). Recent work the fraction-
ation of functions mediated by the frontal lobes has 
linked on inhibitory tasks of this nature 
to including ventrolateral PFC and the ante-
Fletcher, & 
1997}. The Hayling task the inhibi-
tion of a oral response in favour of a non-
conformist one, and appears to share qualities with 
the everyday life coprolalic difficulties that occur in 
where social convention us to inhibit 
comments in favour of more socially 
ones. A more detailed of the 
nature of any inhibitory impairments in TS 
would be of interest in the future, to examine pre-
cisely what task characteristics are critical in deter-
mining the presence or absence of difficulties. The 
WCST was chosen in the study as 
and but might also 
have some to inhibitory difficulties in fail-
ing to suppress a learned response set, as reflected 
particularly by errors. of the 
scores showed that the number of 
errors from 0 to 27 in the control group, and 
from 0 to 32 in the TS group, but the groups did not 
differ significantly on this or on the number of cor-
rect rules identified. The lack of on the 
Channon, U"II"'~'U Waller, Healey, and Robertson 
WCST in TS in the present study is con-
sistent with previous which have for the 
most part failed to detect any in TS on 
tasks planning, rule-finding or set-shifting 
e.g., & Ozonoff, 1996}. The TS par-
U"JliJa'H~ in the present study were also found to be 
in 
The TS group performed at similar levels to the 
control group on the two tasks theory of 
mind, and on the empathy 
Both the tasks 
scenarios and 
explain the actions or words of the characters, and 
were therefore believed to test ability to take the 
"np,-o"n,prt,u .. of another. language compre-
hension skills also potentially contributed to 
mance on the story tasks, to 
",,;;a11jl111'; of the words in the 
Lhaw,p";;" of relatively r.m'nnIPY 
guage such as sarcasm were and there was 
no evidence that the TS group found the materials 
any more than did the control group. With 
respect to the empathy the groups 
did not differ on subscales concerned with either 
or emotional aspects of empathy. 
This social to be intact in 
at least on skills involved in 
and theory of and this is consistent 
""""",,,c work with a TS 
no differences in ability to 
from of eyes 
1997}. Channon et al. (2003a) report 
ment on a social solving task in TS, which 
did not correlate with performance on non-social 
executive but this does not in itself demon-
strate that reflected 
deficits in social rather than non-social 
difficulties may nevertheless have inter-
fered with problem solving. It is of course possible 
that the study failed to detect differences in 
social for reasons. The 
and it could be 
power was therefore inade-
to detect a subtle effect. H .... ,U/pvpr 
inspection of the mean scores little indication 
that size would have pro-
slglmncaIlt difference. No direct measure of 
mIICtlOn'me: was used to assess whether the 
oaJ:llcma.ms showed difficulties in everyday life. 
Failure to detect differences in mentalising/empathic 
may therefore simply reflect the fact that 
functioning group from 
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a social everyday of view. they were 
all recruited from a tertiary clinic for TS 
that typically sees more severe cases than are found 
in community ;:'<111111'10'. 
It is also possible that the measures chosen 
for the present were not sensitive 
to detect subtle differences as a result of ceiling 
effects. This issue is second-
of mind tests, since 
6 normally pass these 
Wimmer, However, the two theory of mind 
measures used in this were chosen because 
were designed to assess 
skills. The Advanced theory 
pr_",."p" mentalis-
designed for older 
found to be sensitive to 
of mind task was 
and has been 
both in adults 
with 
brain lesions 
2001). story 
task was designed as an adult-level 
been found to be sensitive to 1U11'"",IU'\,," 
with focal brain lesions (Channon & Crawford, 
2000). The test which showed intact 
et al., 1997) was also 
designed to be of adult-level difficulty. There is 
thus little reason to that failure to find dif-
ferences between the groups is attributable to the 
U'"'~V'l"~W measures. 
___ ~;·L..I_ route for further is 
the of other tasks associated with 
medial rather than lateral frontal lobe functioning. 
The present did not assess performance on 
tasks such as reversal learning Rolls, I 
or the gambling task used by Bechara and col-
leagues Bechara, Damasio, & Dama-
sio, Bechara, & 2000). 
Such processes have been linked 
to ventromedial frontal lobe areas, and are 
to be involved in 
No evidence is currently avail-
able regarding these aspects of performance in 
TS, which was assessed 
and found to be intact in the present has 
been linked to both lateral PFC and to polar 
medial/orbital frontal regions (Burgess et 2000; 
Levine et 
Overall, the most 
findings is that 
associated with difficulties in social 
ing of mind and 
involv-
and that 
any executive deficits are primarily 
reflecting inhibitory skills. This 
675 
therefore for the view that 
social cognition of mind skills can 
be dissociated from non-social executive skills. This 
is most readily in terms of distinct neuro-
anatomical underpinnings for the different domains, 
whereby associations between performance on the-
ory of mind and inhibitory tasks are attributable to 
the proximity of neuroanatomical areas 
rather than reflections of skills with a single shared 
substrate. With respect to the inhibi-
task used in the study the inhi-
bition of prepotent oral 
apparent similarities to the 
that may be involved in 
words in Closer examination of different 
inhibitory processes is needed in TS 
a range of task to determine the rele-
vant mechanism(s) Further work could 
also whether inhibitory under-
pins difficulties linked to the both 
social both those with 
and without If this is indeed 
the case, social difficulties such as 
and other difficulties 
ability to inhibit responses, combined with 
intact social and of the 
of the behaviour in the social 
context. 
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APPENDIX 1. ADVANCED THEORY OF MIND 
TASK ET 1999) 
Example of mentalistic story 
A burglar who has just robbed a shop is mak-
his getaway. As he is home, a 
man on his beat sees him drop his He doesn't 
know that man is a he just wants to tell 
him he his But when the policeman 
shouts out to the you!, the 
burglar turns round, sees the policeman and gives 
himself up. He his hands up and admits that 
he did the break-in at the local 
did the burglar do that? 
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of non-mentalistic control story 
A is about to break into a jewellers' 
the lock on the door. 
he crawls under the electronic detector 
beam. If he breaks this beam it will set off the 
alarm. he opens the door of the store-room 
and sees the gems As he reaches out, 
he steps on soft. He hears a 
screech and something small and furry runs out 
him, towards the shop door. Immediately the 
alarm sounds. 
vue.H,tUn.· Why did the alarm go off? 
Story Comprehension task (Channon & Crawford, 
2000) 
Marie dreaded her to meet her husband's 
relatives because they were so Most of the 
time, all sat in awkward and this occa-
sion was no different. On the way home, Marie's 
husband asked her how she found the visit. Marie 
said "Oh, marvellous. I could hardly get a word in 
Why did Marie say that? 
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Tourette's syndrom performance on tests of 
behavioural inhibition, working memory and 
gambling. 
Sarah Crawford,1,2 Shelley Channon,1 and Mary M. Robertson3 
of Psychology, University College London, UK; of Psychology, Institute of Psychiatry, 
"n,~n •• rtrnF"t of Psychiatry and Behavioural Sciences, University College London School of Medicine, UK 
Ba.ckground: Tourette's (TS) is a disorder associated with fronto-stri-
atal dysfunction. There is debate as to the extent to which TS is associated with ,...",.nil·i"", 
Some authors argue that any seen are attributable to comorbid pS'yctlia1:rtc SYlnprOIlna-
tology, whilst others have TS is associated with mild deficits limited 
primarily to inhibitory processes. The present was designed to examine this issue using carefully 
screened with TS and measures thought to involve different areas of the 
frontal lobes. Methods: Adolescents with TS who were screened for comorbid disorder were 
cornp;ared with a control group on a set of executive measures. Two tasks behavioural 
inhibition were used: a Sentence task in which sentences had to be first with 
strai!ifttfol-:w~rrd and then with and a Flanker task in which a central stimulus was 
surrounded by either compatible or flankers. memory was assessed an 
N-back task, and reward was assessed a Gambling task. Both accuracy and reaction 
times were measured for each task. Results: The TS group differed from the control group 
on both the Sentence Completion task and on the Flanker task. On the Sentence task, they 
were slower to make both sensible and nonsensical and they had error scores on 
the nonsensical completions. On the Flanker task, the TS participants were less accurate than the 
control group, since were poorer on the incompatible but not the compatible trials. A similar 
interaction with trta1 type was found for where the TS were slowed more the 
incompatible versus trials, overall their tended to be faster than the 
controls. The TS group did not differ from the control group on measures of 
memory or reward Conclusions: The further evidence that unco:m}:lllcat<~CI 
TS is not associated with However, it was not clear that any 
differences between the groups solely to selective inhibitory impair-
ment. Keywords: Tourette's frontal lobes, executive, memory. 
Tourette's is a 
rI''',nr,1f> .. that is characterised by the presence of a 
r~ge of both motor and vocal tics. TS is also asso-
ciated with a range of difficulties in life 
such as 
'disinhibited behaviours' (Cohen & LecK:m~m, 
and uncontrollable urges to 
appropriate acts such as others (Kurian 
et al., These characteristic behaviours may all 
reI>:re:seIlt a failure to inhibit behaviour 
social context. TS has been linked to 
of fronto-striatal (e.g., Rn,h",rt.,nn 
M .... n"'nv et 1997). Evidence has sUll&este:d 
!5i:1.ugua abnonnalities in both children and adults 
with TS Hyde et Peterson et al., 
1993). with evidence of a shortened cortical silent 
period which may result from inhibition 
of basal ganglia to motor cortex {L.lerrJ.aI:m, 
& 1997}. In addition, there is 
some evidence for frontal lobe abnonnalities in both 
children and adults with TS, 
C;eetersen et 
,--,LJ,dO'C;, Geoffrey, UlJle8:plC::, 
© Association for Child Psychology and Psychiatry, 2005. 
1986; but see also Turjanksi, & 
Brclok:s. 1996). 
studies of functioning in adults 
with TS found evidence of executive deficits (e.g., 
& 1992; 
these studies did not screen par-
tiCiP1Ul1ts adequately for comorbid symptomatology 
such as obsessive compulsive disorder (OCD) and 
attention deficit disorder (ADHD), both 
in(leJ)erlde:ntl:y with l1T11n::l,'I"-
ments on executive tasks Shallice et 2002; 
Cavedini, & 1998). Studies of 
children and adolescents with TS have reported 
mixed The most parsimonious view, 
forward some authors, is that any defi-
cits seen in TS are likely to be attributable to co-
morbid conditions Yeates & 1994; 
others have suggest:eCl 
be characterised a selective deficit 
in behavioural inhibition Channon, Pratt, & 
Robertson, 2003a; J.:Sail'OJn-\~OI:leIl, Cross, Crowson, & 
Robertson, 1994). this merits further 
since inhibition is probably not a 
Published by Blackwell Publishing, 9600 Garsington Road, Oxford OX4 2DQ, UK and 350 Main Street, Malden, MA 02148, USA 
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"1'11;t~.TV construct, and there may be many separable 
of inhibition, all with different neural sub-
strates Nigg, 2000). It is important 
therefore to take into consideration the 
tasks used to assess inhibition. 
only controlled studies that have 
with comorbid 
in studies of both 
adults Crawford, & 
2003b) and children (Channon et 2003a) on a 
sentence both inhibi-
tion and By contrast, no in-
hibitory impairment has been in children 
with uncomplicated TS using the Stroop test (Ooon-
off & 1999) or a negative priming task 
McMahon, & Filloux, 1998). With 
rf'l~nf'~t to other executive studies have 
found no deficits in children with un-
cOlnp,llc:ate:d TS on tasks ,.,'lnl''''no memory, 
such as the Wisconsin and 
Test (WCST) (CllarmolU et al., .,;,uu..::>: .... 
deficits on the 
Schuerho~,tlalurn~~(lnE:r 
1996) or Tower of Hanoi 
1999). adults with 
2003b), one 
with TS were impaired on executive 
aspects of memory, free recall 
and memory tasks et 
Most studies of executive functioning in TS have 
used traditional clinical measures such as the 
WCST. such tasks involve mul-
tiple executive and non-executive processes, often 
lack control and may be failed for many 
different reasons. The current the 
deficit of TS 
exl!>elim:ental measures linked with different 
areas within the frontal lobes. Since nonsensical 
sentence has to be sensitive in 
studies of uncomplicated this was 
included as one of the measures involving inhibition. 
To the processes in more 
inhibition of both high and low prepotent sentence 
completion was Since 
sentence is not a pure meas-
ure, the Flanker task & Eriksen, 1974) was 
also included. This assesses inhibition of inter-
trials 
same 
similarities to the Stroop task, but is not influenc-
ed by difficulties or colour blindness. Non-
memory and 
reward were also included. It was pr4~dicte:d 
that the TS group WPfe poody than 
the control group on tasks but not on 
the working memory 
consistent with the UJ.J'U""''':I 
Methods 
Participants and procedure 
Twenty cri-: 
teria 2000) for TS 
took part in the study. ofTS was established 
by a clinician with extensive in the .... c..,.,., ... ""'" 
of TS and related disorders (MMR) , an up,dal:ed 
version of the National Interview Schedule for 
Gilles de la Tourette (Robertson & 
1996). This instrument was specifically forTS 
re!learcltl. and is widely used in the UK. The 
showed that it had good inter-rater lCllctL'W'LY 
concurrent validity When with an-
other used the Yale Schedule. A 
further twenty participants made up the control group 
Exclusion criteria included a of 
UCIUHllU!¥\,;i'" disorder head injury) or psy-
chiatric illness (other than All 
screened for comorbid ps:vcrria1tric ,.u~SUIUCI, 1l1\';1IUW~lg 
OCD, depression, anxiety disorders and psy-
Structured Clinical Interview for DSM-
N (SClD; First, Spitzer, Gibbon, & 
PaJrti(~pan·ts were also excluded if their scores on the 
Raven's Standard Matrices (Raven's SPM; 
Raven, 1960) fell below the 5th percentile for their age 
group. All included in the study were be-
. tween 11 and 18 years old, and fluent in English. The 
TS and control groups were matched for age (t .20, 
df 38, P .841), and lQ, as measured by age-related 
peI'celltil4es on the Raven's SPM (t = .23, df:::: 38, p = 
mean scores and standard deviations are shown 
in Table 1. The order of of the 
mental tasks was counterbalanced within each group. 
In addition to the clinical described 
several measures of symptomatology were 
administered. The TS were given The Yale 
Global Tic et al., 1989) 
as a measure of their current TS symptomatology. 
ADHD was measured the Brown 
Attention-Deficit Disorder Scale for children (Brown 
ADD Brown, 1996), and OCD symptomatology 
was the Obsessional ImTe!1ltol'N-
Child Version (WI-CV; Rapoport, & Flament, 
Table 1 Mean scores and standard deviations for age, IQ and 
measures of symptomatology 
Age 
IQ (age-related 
percentiles) 
DEX: Self-rated 
DEX: Other-rated 
Leyton Obsessional 
Inventory 
Brown Scale 
forADHD 
Yale Tic Severity 
**p < .01; .p < .05. 
TS group Control group 
Mean (sd) Mean 
14.40 (2.44) 14.25 
55.85 (31.15) 53.70 
19.20 (12.81) 17.75 
19.20 (13.74\ 8.45 
5.55 (6.19) 4.00 
37.95 (25.85) 37.90 
21.20 (17.97) 
(sd) p 
(2.27) .841 
(28.68) .822 
Gpx rater .038* 
Rater .054 
(13.22] .727 
(5.91) .003** 
(6.25) .442 
(23.46) .995 
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1986; Whitaker, Davies, & napVI!-'''< 
1988). T-tests were carried out to compare the two 
groups on the scores. The TS and 
control groups did not differ Slg;ru.tlC!3ll1tLY 
LOI-CV scores (t= .78, df 37, P or their 
Brown ADD Scale scores (h= .01, df = p = .995); 
mean scores and standard deviations are shown in 
Table 1. 
The DEX 
Alderman, Burgess, Emslie, & Evans, 1996} provides 
information on behaviours in life, 
... ", ............ "5 emotion, motivation, behaviour 
and cognition. It is intended for use both as a self-rating 
measure, and for ratings by others who know the par-
tir:in~.nt well. completed the qU.es'tioJlUlalr·e 
themselves and a relative or teacher who 
knew them well completed an equivalent questionnaire 
(in,deIJelllde.nt-ra1in~~s). Comparison of the DEX 
was made ANOVA, which showed that the group 
rater interaction (F = 4.63, df = 1,38, P = .038) was 
the main effect of group did not reach 
df = p = Post-hoc 
Hests showed that the groups did not differ 
cantly in their (t::::: df = 38, P = 
but that the TS others to 
dy:se,cecutilve behaviours than 
parUCllpants (t 3.21, df= 38, P = .003). 
Mean scores are shown in Table 1. 
Of the twenty participants in the TS group, five (25%) 
were medication for management of 
their TS symptoms at the time of Three were 
one was taking haloperidol and one 
was taking clonidine. 
)(ut"nml"nlral measures 
Inhibition. With respect to measures inhibi-
tion, studies have indicated that the anterior 
<';U.l~LU"'L'" and ventrolateral prefrontal cortex are acti-
vated during tasks involving suppression of a pr,ep'Dte:nt 
response such as the Hayling and Tests (Taylor, 
Kornblum, Minoshima, & 
Nathaniel-James, & 1997; Par-
Janer, & Raich1e, 1990), and that an increase in 
anterior activation is associated with in-
creased amount of conflict in a task ''"', ..... ,'-
et a study the Flanker test 
(Eriksen & found that anterior cingu-
late activation was associated with snml.llUls-·reispDnlsc 
conflict Nystroom, Fissell, Carter, & Cohen, 
1999). 
(a) Flanker test. The Flanker test used in the present 
study was based on that used by Botvinick et al. (1999). 
The consisted of five arrows (one central arrow 
and two 'flankers' to either side). Participants were 
instructed to press one of two response ('left' or 
as as possible, in accordance with the 
direction of the central arrow. Thus, if the central arrow 
poin1:ed to the left, they were to press the key 
on the left, and vice versa~ The four 'flanker' arrows all 
poinl:ed in either the same direction as the central arrow 
(compatible) or in the direction (incompatible). 
Each participant received 2 practice blocks and 4 
eX];lelimiental blocks of 40 trials. Each block contained 
20 and 20 compatible trials (10 of each of 
Tourette's syndrome 1329 
the 4 Each display remained on the 
screen until the a response The 
inter-trial interval (ITI) was 1.2 seconds. The order of 
was within each 
block, such that there were never more than 4 con-
secutive identical correct responses or key), 
and never more than 2 consecutive identical trial 
For each participant the percentage of correct re-
sponses and median reaction times (RT) were recorded 
for compatible and trials. 
(bl Sentence 
the Test 
(1996, 1997). It involves sentences as 
quickly as possible with words that make sense (part A) 
and with nonsensical words (part B). The sentences 
used in the test were taken from a des-
cribed by Bloom and Fischler (1980), which gave the 
tre:qulen:C1~~s of responses for the words used 
students when asked to sentences with a 
last word. Since the Hayling test did not 
exanline the effect of prepotency on performance, the 
current task examined this two sets of 
sentences from the Bloom and Fischler set, those of 
high and low prepotency. Those with high pn~poterkcy 
were sentences for which there was one highly IlC:ULIt:IllL 
response the them ........ ·t .. ".ti<.llv 
harder responses to inhibit. For when asked 
to the last word to the sentence The children 
went outside to " 99% of the respon-
ded The low prepotent sentences were those for 
which a of responses were provided, with no 
answer than any 
other answer. For with the 
sentence The sun went before we 
could " the most frequent responses were 
'leave' and 'see' with 18% each. 
When the sentences had been selected they were 
allocated to two sets, I and n, each 15 
prepotent and 15 low prepotent sentences. Half of the 
parti<:ip:anl:s received set I for part A of the task and the 
other half received set n for part A. Within each set, two 
random orders of sentence presentation were created to 
mix high and low prepotency sentences. The sentences 
were presented orally computer. The eXl[)eIim:enter 
recorded median RT by a response key when 
the recording the word 
=, ... \J'Ul5u voice activation 
rec:on:ling is time oral responses 
ac(~r'!lt{~lv_ it was thought that vocal tics would poten-
render this problematic. 
The quality of nonsensical completions 
in part B of the test was rated similar 
pIes to those outlined by Burgess and Shallice (1996). 
Straightforward, obvious completions scored 3, while 
responses that were not obvious completions, but were 
nevertheless related to the context of the sentence, 
scored 1; scores for straightforward and related com-
pletions were added to separate error scores for the 
high and low sentences. 
Working N-back test 
(Braver et is a measure of worldng memory 
that allows cOltn,(:lartso,n across subtasks 
in which the memory gets 
Functional studies have associated perform-
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ance on this task with activation in the 
cortex et al., 2001; Callicott et 
1999), and it has been shown that activation in dorso-
lateral areas increases as the memory load increases 
,Cohen et al., 1997). 
The N-back test used in the present study <'cU':Ul'i:U ,,;u 
performance on three conditions, with 
"''''rlrina memory load. All conditions rprnwrpn 
ants to press one of two response (yes' or 'n01 as 
quic1dy as they could, in response to letters pn~sentfd 
on the computer screen. In the O-back 
condition, they were asked to press yes' to one target 
letter (B), and 'no'to any other three other letters 
were used as distracters. In the I-back par-
ticip~lnt:s were required to press the yes' key whenever 
the letter on the screen was identical to the llUUU;UliUC,IY 
<::<;';UJU~ letter. In the 2-back condition, they were 
asked to press the whenever the letter on the 
screen was the same as the letter two trials 
previously. The of the test was similar to the 
Flanker test, in that each task consisted of 2 pr;actice 
blocks and 4 blocks, with an ITI of 
1.2 seconds. The blocks consisted of 40 trials each for 
the O-back condition, 41 trials for the I-back condition 
and 42 trials for the 2-back condition. The first trial of 
each block for the I-back condition and the first two 
trials of each block for the 2-back condition were 
excluded from the since the response was 
atitorna1ticlill:y 'no'. The three tasks were matched such 
that 25% of letters within each block were 
and 75% were distracters. The order of the V-IU""-"'-. 
back and 2-back tasks was counterbalanced within 
each group. For each the percentage of 
correct responses and median RT were recorded for 
each condition. 
Reward learning: Gamblin.g test. Reward leaInl:ng 
tasks involve '''''",''''''''"''f'; responses based on achieving 
reward and/or The orbitofrontal 
cortex is be involved in controlling and 
mcldiJV:tr:lg r(~WElTa··rel,atE~a behaviour (Rolls, 1999}. Re-
cent studies have examined reward 
'Gambling' and with lesions imloj'lIin,g 
orbitofrontal and medial frontal lesions have been 
im'n»l'rPi'l relative to those with dorsolateral 
lesions et Bechara, Damasio, Tra-
nel, & Anderson, 1998). A functional has 
shown that on tasks is asso-
ciated with orbitofrontal but not dorsolateral activation 
.",u .. """,:s et al., 1999b). However, recent work has sug-
that more extensive lesions may be needed to 
Delrtolnnl~n(~ slL1b~~taJnti:ally (Manes et al., 2002). 
U"'.iUL>lllJt~ test used in the current study was 
described by Bechara, and Damasio (2000). 
were shown four decks of cards on a 
computer screen, labelled 'N, 'S', 'C' and '0'. Each of the 
4 decks contained 20 red and 20 black cards, aJ.Uc.U.'F.L' 
the colour of the cards did not affect their value. Overall, 
decks A and B were 'bad' and decks C and D were 
Decks A and B were associated with gains than 
decks C and D, but even higher long-term losses. Both 
rewards and varied within each deck. The 
first 10 cards of decks A and B totalled an overall re-
ward of £1,000, and an overall of£I,250. 
For each subsequent 10 cards in these two decks, the 
amount of reward increased overlUl £100 whilst the 
amount increased by £250. For decksC 
and D, the first 10 cards totalled an overall reward of 
£500, and an overall of £250. For each 
subsequent 10 cards in decks C and D the amount of 
reward increased by £50, while the amount of pU"'U~'"­
ment increased by £25. Decks A and C gave smlUl, 
tT",n,,,'nf pu:ru:srumenI:S, whereas Decks B and D gave 
punis~hnlerlts. P"'ri-j/j"""n'b. were asked 
to select a card on each trial, with the aim of winning as 
much money as card selection resulted 
in some money, but on some trials, 
pants also lost money; and losses were indicated 
on the screen. The task stopped automatically when the 
rt1c:lplmt had made 100 card selections. Pel:cent!lge 
of choices from the 'bad'decks and median RT for each 
block of 20 cards was calculated for each part1;c:lp,ant. 
Results 
In order to deal with possible effects of age and IQ, 
of covariance (ANCOVA) was carried out to 
compare the groups on the eX]pelmllental 
age and Raven's scores as covariates. Since 
each of the contained measures of 
both accuracy and level of 
alpha. (p = .025) was Since median 
RT was measured for each mean scores 
.... 'I"" .. ""~ ... rI for each group for refer to mean of 
median RT. The mean scores and standard deviations 
for each test are shown in Table 2 for both groups. 
Inhibition: (aJ Flanker test 
ANCOVA was used to compare the groups 
'""'u.}, ......... ,''- and one 
betw,eell-Il""'OUPIS factor TS or control) and one 
factor of trial: 
This a ' '''5~·LU''-''''U 
trial type interaction (F = 6.30, df 
The effect of group did Itpt reach (F 
df 1,36, P = .071). Post-hoc ANCOVAs for 
COllOpsLtible and trials 
showed that the TS grqup ... prtnrm 
less than . ,the 
incompatible trials (F df= 1,36, P 
but that the groups did not differ significantly on the 
cOIlnpaLtible trials (F = df = p = .509). 
Speed. transformations were carried 
out on the data for the two groups. ANCOVA using 
one between-groups factor (group: TS or control) and 
one within-groups factor (type of trial: compatible or 
in(:onlp~ltit)lel showed a group of 
df= 1,36, p= .010). 
There was no main effect of group 
1.61, df = 1,36, P = .213). Mean scores showed that 
relative on the versus com-
patible trials was for the TS group. 
tended to faster in both conditions than the 
control group, but post-hoc ANCOVAs 
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Table 2 Mean scores and standard deviations for the experimental tasks 
Fhmkertest 
Accuracy (% correct trials) 
Compatible 
IncompatibJe 
Speed (sees per item) 
Compatible 
Incompatible 
Sentence Completion test 
Accuracy (error scores) 
prepotent sentences 
prepotent sentences 
Speed (sees per item) 
Sensible completions: 
High prepotent sentences 
Low prepotent sentences 
Nonsensical completions: 
prepotent sentences 
prepotent sentences 
N·backtest 
Accuracy (% correct tria1.s) 
O-back 
I-back 
2-back 
Speed (sees per item) 
O-back 
I-back 
2-back 
Gambling teat 
Mean 
96.38 
92.94 
.47 
.49 
3.25 
3.70 
1.09 
2.32 
2.58 
3'.31 
95.47 
94.34 
83.50 
.45 
.53 
.87 
Accuracy (% cards from the 'bad'decks) 
Block 1 
Block 2 
Block 3 
Block 4 
Block 5 
Speed (sees per item) 
Block 1 
Block 2 
Block 3 
Block 4 
Block 5 
'p < .025. 
compatible and 
showed that the group 
for either 
56.25 
51.75 
47.50 
46.50 
41.75 
.94 
.75 
.76 
.77 
.71 
TSgroup 
(SD) 
(4.60) 
(5.89). 
(.10) 
(.10) 
(2.90) 
(3.63) 
(.26) 
(1.45) 
(1.91) 
(3.06) 
(3.52) 
(4.26) 
(6.62) 
(.10) 
(.12) 
(.38) 
(7.05) 
(11.15) 
(17.95) 
(20.72) 
(24.67) 
(.10) 
(.31) 
(.36) 
(.34) 
(.37) 
=:: .92, df 1,36, P = or the .... ~.'u.''''cu" ..... 
als alone (F=:: 2.01, df= 1,36, P =<164). 
Control group 
Mean 
97.00 
96.25 
.51 
.52 
1.80 
1.75 
.85 
1.49 
1.85 
1.94 
96.16 
95.31 
85.94 
.17 
.58 
1.06 
55.50 
46.00 
43.00 
44.50 
50.50 
1.10 
.96 
.95 
.78 
.81 
a 
(SD) 
(3.23) 
(2.87) 
(.10) 
(.10) 
(1.32) 
(1.65J 
(.14) 
(.50) 
(1.13) 
(1.12) 
(3.21) 
(3.13) 
(7.31) 
(.09) 
(.17) 
(.54) 
(14.59) 
(13.M) 
(16.17) 
(20.58) 
(19.53) 
(.54) 
(.67) 
(.70) 
(.34) 
(.41) 
Tourette's syndrome 1331 
p 
Gp x trial type .017* 
Gp .071 
.509 
.015" 
Gp x trial type .010* 
Gp .213 
.164 
.343 
Gp x prepotency .538 
Gp .021* 
Gp x condition x prepotency .617 
Gp x condition .936 
Gp x prepotency .074 
Gp.024" 
Gp x task .630 
Gp .1OS 
Gp x task .498 
Gp .129 
Gp x time .127 
Gp.790 
Gp x time .740 
GpA74 
trade-off In order to examine 
Pearson corre-
for each group for the 
trials. This showed 
correlation (using a strict 
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"l~HH.""ru"l"C level of .025) for the TS group for the 
trials (r p .041), such that 
faster RT was associated with lower accuracy; the 
correlation was not for trials 
.18, p = .455); nor did the control group show 
correlations for incompatible (r = 
p = .328) or compatible trials (r p 
Inhibition: (b) Sentence Completion test 
ANCOVA was used to compare the groups 
and low sentences for the 
one be1twl~erl-2:rOl 
and one W",",11U-'",".'U'",'" 
or low). This showed no 
"'1!!'.-LLU","'-'''UU group by interaction (F = .39, 
df = 1,36, P = .538); the main effect of group was 
(F= 5.82, df = 1,38, P = .021). Exam-
ination of the mean scores showed that the TS group 
had higher error scores than the control group for 
both high and low trials. 
transformations were carried 
out on the data for the two groups. ANCOVA was used 
to examine the of the two groups across both 
sensible and nonsensical 
one factor .t<"UUIJ. 
troll and two factors Ipr"ep,otencv: 
or low; condition: sensible or The group 
by condition interaction was not sig-
nificant p = nor was there 
a group by condition {F = .01, df = 1,36, 
or group by prepotency interaction (F = 
P .074). The main effect of group 
was (F df 1 P Mean 
scores showed that the TS group more 
slowly than the control group on the tasks. 
In order to examine 
tnlae:-O]tIs. Pearson corre-
lations were for each group for the non-
sensical This showed a 
correlation (using a strict level of .025) 
for the TS group (r .52, p = .018), such that slower 
RT was associated with error scores; the 
correlation was not for the control group 
(r .36, p = .119). However, Fisher's (1921) test for 
the difference between two independent correlations 
showed that the correlation for the TS group did not 
differ from the correlation for the control 
group (z = p:> .05). 
Working memory: N-back test 
Accuracy. ANCOVA using one between-groups fac-
tor TS or control) and one 
0, 1, or 2-back) showed no ""1;;~1l1'''''i:1.u 
Py task interaction df = 
npr main effect of group 
qf 
transformations were carried 
out on the data for the two groups. ANCOVA 
one factor TS or and 
0, 1, or 2-back) 
""s .......... "u .. group task interaction (F 
.498); nor was there a slg;mJI1Clmt 
main effect of group = 2.41, df = 1 p = .129). 
Reward learning: Gambling test 
ANCOVA was used to examine whether 
there were any in the of cards 
selected from 'bad' decks the two groups over 
one between groups factor (group: TS or 
control) and one factor (time: 1, 3, 4 
or The results showed that there was no sig;nJjic-
ant group by time interaction df = 4,33, 
P = .427), nor a main effect of group (F 
.07, df 1 p 
.LlJlUJ.' .... "=y transformed 
data was used to examine whether there were any 
in the of by the two 
groups over one factor 
TS or and one-within groups factor 
1,2,3,4, or 5). The results showed that there 
was no group time interaction (F= 
.49, df = p = .740), nor a main ef-
fect of group (F= .09, df = 1,36, P .474). 
Relationship to symptomatology scores and effects 
of medication 
In order to examine any correlations between per-
formance on the experimental tasks and SYlnt)tom!l-
tology scores for the Yale Global Tic ~""""'r';"", 
the Brown ADD the WI-CV and the DEX 
estlor.lI1alre for the TS group, ~n, .. "'"rrn"'n rarlk cor-
relations were C!l!culated 
were used for the other 
fiC!mt interactions were, found. The scores 
for the Sentence Completion test were total error 
score on Part B of the task, median on Part A, 
and median on Part B. For the N-back test, the 
pe:rcenuige of correct responses and RT were aver-
across the three conditions 1- and ~-I)a(:KI. 
For the test, the scores were the 
pelfcentllge of choices from the 'bad' decks and 
the median RT across all 100 card selections. For all 
lo{~aritl:lffiic transformations were carried out 
on the measures prior to carrying 
out the correlations. No correlations were 
found with symptomatology scores for the Sentence 
Completion or tasks. For the i ... "-nr"n,,,i-ikl 
trials of the Flarlker task, accuracy correlated 
tic~mtly with WI-CV, while speed correlated 
with Yale scores. For 
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Table:3 Correlations between symptomatology scores and experimental task performance for the TS group 
Experimental task 
Flanker: 
Incompatible trials: 
Accuracy 
Speed 
Compatible trials: 
Accuracy 
Speed 
Sentence Completion: 
Error score 
Speed Part A 
Speed Part B 
N-back: 
Accuracy 
Speed 
Gambling: 
Accuracy 
Speed . 
*p < .05; up < .01. 
Yale tic severity 
score 
r= -.049 
P .836 
r= .512 
p= .021* 
r -.240 
p= .309 
r= .472 
p .035* 
r= .095 
p .690 
r= -.127 
p .593 
r= .102 
p= .670 
r= -.176 
p = .457 
r= .183 
p .440 
r= .039 
p= .872 
r -.286 
p .221 
accuracy correlated sig;nilic.antly 
LOI-CV, DEX self- and indlepc~nd.enj:-I 
Brown 
ADD 
r -.440 
p .060 
r= .008 
p= .974 
r -.588 
p = .008** 
r= .083 
p .734 
r= -.074 
p= .764 
r= -.212 
p= .383 
r= -.269 
p= .266 
r= -.608 
p= .006** 
r= -.106 
p .665 
r= -.212 
p= .384 
r .104 
p .670 
correlated with Yale scores. For 
the N-back overall accuracy correlated SH!nIll-
cantly with Brown LOI-CV, DEX self- and 
siJl~iltic~mt correlations were 
in the expected direction, higher symptomatology 
correlated with poorer pe:rto:rman,ce. 
The above correlations showed some r lationships 
between cognitive perfonrumce and symptomatology, 
i:UlUUU15,U this was more for the measures 
that did not differentiate the groups. To in"estig'!lte 
this group on the eXlpelinlLental 
tasks were using ANCOVA with the symp-
tomatology scores as additional covariates. This 
made no difference to the of for any 
of the tasks. 
The effects of medication on were 
examined within the TS group for the Sentence 
Completion and Flanker measures that differenti-
ated the groups. showed no 
differences between the medicated and unmedicated 
partici{:)aIlts on these measures, nor any sig:nil!i~lI1t 
medication effects (p> .05). 
Discussion 
As pvnp,,,t"F·r! slg:mllCBtnttjl on 
memory 
test). Predictions 
LOI-CV Scale DEX Self-
score rated 
r= -,446 r= -,430 
P .049* p= .058 
r= -.186 r= -.263 
p= .432 P = .262 
r= -.597 r= -.613 
p .005** p .004-
r= -.125 r= -.152 
p= .599 p= .522 
r= -.112 r= -.208 
p= .639 p= .378 
r= -.098 r= -.135 
P .682 p .569 
r -.224 r -.273 
p= .342 p= .. 244 
r -.673 r= -.480 
p = .001** P .032* 
r= -.392 r= -.225 
p'" .087 p= .340 
r -.270 -,404 
P = .250 P .077 
r= .085 r= .180 
p= .720 p ,448 
inlilit)it()ry deficits were 
pal:1.icipants with TS nPTfnTlm 
DEX Independent-
rated 
r= -.107 
p= .654 
r .078 
p= .745 
r= -,449 
p .047* 
r= .130 
p= .584 
r -.047 
p= .845 
r= -.066 
p= .781 
-.383 
p= .096 
r= -.496 
P .026* 
r= -.108 
p= .649 
r= .082 
p= .732 
r .182 
P .442 
confirmed since the 
more poorly than a 
matched control group on an sentence 
co:mI>letion measure, and were less accurate on an-
other inhibitory measure, the Flanker test. HC.Wf·VI"T, 
Sentence Completion did not show the 
interaction with prepotency or type of task. The 
expected inhibitory interaction was found for accu-
racy on the Flanker test, but was less clear cut for 
With to inde-
naire group to have more 
dysexecutive behaviour's than the control group; this 
is similar to the of reported 
Chan non et aI. (2003b) with adult TS par'tici.PalltS. 
There was little evidence of correlations 
between DEX scores and inhibitory task np,ofnr'm-
ance. There was also little evidence that prl~c:rit)ed 
medication for the TS group influenced the findings, 
but the sizes were too small to draw firm 
conclusions about this. 
Another potentially factor in TS re-
search is the of comorbid syml>toml:ttCl.lo!;ry 
eS)JeciaIJ!y ADHD and which may contribute to 
any executive deficits. ShaIlice et aI. 
(2002) reported that children 
on a range of tasks .LU'~'ULULU5 
Sentence and the 
sent dealt with the Qu.est:lon 
both who did 
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not meet DSM criteria for comorbid and 
also by "1"''''''''''''' 
diI1ectJ[v The TS group did not differ from the controls 
on the symptomatology measures, and any sill:rultic-
ant correlations between these and tasks 
were more often with measures 
'Gambling, N-back and compatible Flanker 
than with inhibitory measures (Le., Sentence Com-
pletion, Flanker incompatible trials), affecting accu-
racy but not Taken the findings 
that comorbidity played at most a small role 
in any inhibitory difficulties shown by the TS group. 
With respect to Yale tic symptomatology, significant 
correlations were. found only with inhibitory and 
non-inhibitory Flanker measures, and no 
rellatiorls1:tips were found with task accuracy. Tics 
may affect control of muscles involved in 
task et Moll et 
2001). Since vocal responses were used for the 
Sentence task, and responses for 
the flanker task, this is a relevant 
but does not the lack of group differences on 
the other experimental which also involved 
the current TS "",..ti,.,.! ....... 
pathology. 
occurrence should be ideally measured 
to assess this adequately. 
What other factors could account for the pattern of 
findings on the experimental tasks? Age and IQ dif-
ferences do not readily explain group 
since the groups were matched on 
were also used as covariates. There was no reason to 
that poorer attention or differ-
• "'L."" ... ' .... for the TS group on the inhibitory tests, 
since the groups did not differ on the other 
mental measures and order of tasks was counter-
balanced. It is difficult to argue that the 
tasks were harder than the N-back or Gambling 
the TS did not differ from the 
control group regardless of working memory load in 
the N-back test. processes less reliant on 
executive skills such as language comprehension, 
.. ~_~'~,.,' __ ~ skills were not 
assessed but there was 
no indication that the memory or Vll:i.u,lISl=,aLlal de-
mands were any for the 
Another possible is 
overall psychomotor since the TS group was 
differentially slowed only on the Sentence Comple-
tion test. There was no evidence that the TS particip-
ants used a different from the control group 
nriinri1i§~i11'" either speed or accuracy on the Sen-
test, since they more 
on both, a trade-off 
may have contributed to the of TS perform-
ance on the Flanker test. 
Consistent with the inltlli:litc,ry defiCit nYlPotne:sls, 
the TS group was not on the N-back and 
"""uuu;u.u"" tasks for either or accuracy. With 
respect to intribiltOI'Y penonnance, the Flanker task 
was to show n.""""",,,,,.,1" on incompatible 
but not compatible trials. This for 
accuracy, but was less clear cut for 
group difference did not reach ""!5,UliJ.'-'''Ul ... C; 
and the TS mean RTs were 
SlIghtly faster than the control mean RTs. 
correlations a trade-off 
for the trials for the TS group 
the control This may indicate 
responding in some individuals with TS, since less 
accurate tended to be associated with 
faster RTs. For the Sentence Completion task, the TS 
participants were in line with expectations based on 
an inhibitory deficit in that made more errors in 
sentences with nonsensical than 
the control group. This may reflect the disruption of 
verbal or processes involved in task per-
rather than pure processes. 
u .... J,pi::l. ... <> may have failed to develop the str,ate~g1e:s 
used normal to increase 
such as objects in the room or 
words from semantic & 
1996). use was not assessed di-
but could potentially 
scores and slowed pe:rfo:rmance. Howe'lTer. 
with to were not consistent with 
ex]pe(;tatlOlnS, since they showed no:n-~Ipedflc 
across both the sensible and nonsensical completion 
conditions. and Shallice (1996) "'p.;;,... .. W1I.CU. 
that slower for sensible completions reflected 
initiation difficulties. If this in the present 
case, the concept of an inhibitory deficit may not be 
0."'''4''''''''''' to account for TS performance . 
Inhibition is not a unitary construct. 
Distinctions have been between auto-
matic (passive) and effortful inhibition (Kok, 
2000). It has also been that 
there may be a range of potentially inl1ellerldEmt 
processes within these For 
passive such as orienting re-
sponses, habituation and prepulse inhibition may be 
separable (Kok, 1999). Similarly, effortful tasks such 
as those involving interference control, 
behavioural inhibition and oculomotor 
inhibition may be 
processes with different 
strates (Nigg, 2000). It is possible 
impairments in uncomplicated TS are linked to very 
specific types of inhibition, and future studies could 
examine this further 
to relate to these poterltifilly processes. 
In summary, the £..u>u.u..AI$'" provided further evid-
ence that TS is not associated with 
wldelilPl:ea.d executive it was 
not clear that any group differences could be 
attributed to selective inlrlb,itClry 
Mild deficits in uncOl!Ilp'I1Cate~n 
by sensitive measures, 
difficulties of the nature of 
difficulties. Comorbid symptomatology 
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is common in TS, and is to be associated with 
more severe more extensive executive 
impairnlerlt than that shown by the 
of individuals with a pure disorder. A broader issue 
for future research is the extent to which neuro-
disorders have unique or shared 
terns of ('",.","1In",P deficits. 
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Tourette's Syndrome Cognitive Performance in Adults 
With Uncomplicated 
Shelley Channon, VUlllUlll!>. and M. Robertson 
School of Medicine and National 
Nellll'Ology and Neurosurgery 
Tourette's syndrome (TS) is a neurodevelopmental disorder associated with frontosmatal dysfunction. 
The extent of any cognitive impairment associated with uncomplicated TS is unclear, as comorbid 
psychiatric symptomatology is thought to contribute to cognitive deficits. Previous studies have found 
evidence of mild pelformance deficits, most commonly on tasks that involve inhibitory processes. The 
present study evaluated this in carefully screened adult participants with TS. The findings showed the TS 
group to poorly on Ollll test involving behavioral inbibition but did 
not provide strong support for an interpretation based solely on inlnbitory deficits, and there was no 
evidence of impairment on another behavioral inbibition task (Banker test). There were also no 
differences between the groups on tasks wailing memory (n-back). task switching. or object 
alternation learning. The findings provide further evidence that uncomplicated TS is associated with only 
mild. cin;umscribed impairment. The nature of any impairment is disenssed. 
Keywords: Tourette's syndrome, exeruuve functions, inbibition, obsessionality, ADHD 
Tourette's (TS) is a neurodevelopmental disorder in 
which the core symptomatology consists of motor and vocal tics. 
It has been linked to a range of including 
"disinhibited behaviors" (A. J, Cohen & Leckman, 1992), copro-
lalia, copropraxia, and social inappropriateness (KurIan et 
Dopaminergic basal ganglia circuitry is to be im-
in TS, with disruption of frontostriatal support-
ing motor and cognitive (see, e.g .• Chase, '-"" ...... J ... y. 
Gillespie, & Burrows, 1986; et al., 1997; Robertson, 
20(0), although others have alternative models 
e.g .• Weeks, & Brooks, 1996). 
With respect to functioning, the evidence to date has 
been mixed. Early studies executive deficits in adults 
with TS Bornstein, 1991; Channon, Flynn, & Robertson, 
1992) but did not carry out screeuing to differentiate 
between associated with TS and that linked to comor-
bid symptomatology. disorder (OCD) and 
attc~ntilon--deficiLtJhyplmlj:ti'.rity disorder commonly occur 
in with TS, and becanse these are known to be 
associated with executive deficits (e.g., Perri, Scarone. 
& Bellodi, 1998; Shallice et al., 2002), presence of these disorders 
may account for any deficits in TS Ozonoff, 1997; Yeates & 
Bornstein, Comparison of TS with and without 
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ADHD/OCD symptomatology has tended to suggest more exten-
sive impairment in those with cornorbid disorder, both in children 
Brand et at, 2002; Sherman, Joscbk:o, 
1998) and in adults Silverstein, Como, Palumbo, West, & 
Osborn, 1995), the view that plays arole. 
in these terms fails to the 
presence of cognitive often found in uncomplicated TS 
after out those with comorbid disorders, 
An alternative view is that TS may be charac-
terized by circutnscribed impairment. As tasks 
sensitive to TS have often contained inhibitory 
components, it has been that the central impairment in 
TS is inhibitory in nature (see, e.g., Baron-Cohen, Crowson, 
& Robertson, 1994; Channon, Pratt, & Robertson, 2003; Penning-
ton & Ozonoff, 1996). inhibition is not a con-
struct, and there may be many types, all with different 
neural substrates Kok, 1999; Moreover, multi-
cognitive factors contribute to neuropsychological 
tasks, including both inhibitory and other skills. The particular 
characteristics of the tasks used are therefore critical. The age of 
the with TS may also be a factor, as the symptoms of 
the disorder often lessen with age (see, e.g., Robertson, 
2000); be corresponding reductions in cognitive 
ment. With respect to tasks involving skills, the evi-
dence relating to TS is inconsistent for the 
test Ozonoff & Jensen, 1999), no impairment has 
been reported in children on a negative task (Ozonoff, 
McMahon, & and impaiIment 
was found in children on an Hanker test (Crawford, 
Channen, & Robertson, 2005). on a sentence 
tion measure both inhibition and strategy gellefl:ttiO!ll 
been found in both children (Channon, Pratt, & Robertson, 2003; 
Crawford et aI., and adults with TS (Chan-
nOD, Crawford, Vakili, & Robertson, Altered inhibitory 
has been reported in both children and adults with un-
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complicated TS Magulac, Filion, & Zinner, 1996). 
With respect to other executive functions, studies have generally 
found no deficits in children with TS on tasks 
memory, and set-shifting 
Channon, Pratt, & Robertson, 2003; Ozonoff & Jensen, 
Schnerholz, Baumgardner, Reiss, & Denckla, 1996). Sim.-
adults with uncomplicated TS have been to have no 
deficits on the Test (Channon, et al., 
2003), one reported on executive as-
pects of memory (Stebbins et aI., 
Studies of executive functioning in TS have often used tradi-
tional clinical measures that often lack control conditions, such as 
the Wisconsin Card Sorting Test. The current study ' .. "''''di .... t_ 
the inhibitory deficit of uncomplicated TS exper-
imental measures liDk:ed with different areas within the frontal 
lobes. Because nonsensical sentence has proved to be 
sensitive in studies of TS, this was in-
cluded as one of the measures inhibition. To study the 
inhibit.ory pr(]lCelI:ses in more detail, inhibition of both high and low 
prepotent sentence was manipulated 
As sentence completion is not a pure inhibitory measure, the 
flanker task (Eriksen & Eriksen, 1974) was also included. This 
assesses inhibition of interference by conflicting trials 
(flanker arrows pointing in different directions from central ar-
rows) with compatible trials (all arrows pointing in the same 
din~ti'm). The flanker task has similarities to the task but 
is not influenced by difficulties or color blindness. Non-
inhibitory tasks memory, task and 
reward learning were also included. It was that the TS 
group would more poorly than the control group on the 
inhibitory tasks but not on the other tasks, consistent with the 
inhibitory deficit hypothesis. Three of these tasks were previously 
studied in children with TS Crawford et aI. (2005); an 
adult group therefore examination of whether any cog-
nitive were milder in an adult group. 
Method 
Participants and Procedure 
Twenty participants (13 men, 7 women) who met Diagnosrie and Sta-
/i,frieal Manual of Mel'l1al Disorders (4th editio ) criteria (DSM-IV; Amer-
ican Psychiatric Association, 2(00) for TS took part in the sllldy. Diagnosis 
of TS was established by a clinician with extensive experience in the 
diagnosis ofTS and related disorders (MMR), using an updated version of 
the National Hospital Interview Scbedule for Gilles de III Tourette Syn-
drome (Robertson & Eapen, 1996). This instrument was designed specif-
ically for TS research and is used in the United Kingdom. The 
origiDal study showed that it had good intemlter reliability and also good 
concurrent Validity when compared with another widely used inslru.llJent, 
the Yale Schedule (pauls & Hurst, 1987). Twenty-five matched healthy 
participants made up the control group (16 men, 9 women). Exclusion 
criteria included a diagnosis of neurological disorder (e.g., head injury) or 
IIIlIjor psychiatric illness (other than TS). All participants were screened for 
comorbid psychiatric disorder including ADHD, OCD, depression, anxiety 
disorders, and psychosis using the Structmed Clinical Interview for 
DSM-N (SCID; FIrst, Spitzer, Gibbon, & Williams, 1996). Those who met 
DSM-N criteria for ADHD, OCD, or any other comorbid psychiatric 
disorder were excluded from the study, as were those with any histmy of 
learning disability, physical illness, or injury that might have affected brain 
ftmction. Inclusion criteria were fluency in English, age between 18 and 50 
years, and a Verbal IQ score of 80 or above on the NatioD.al Adult Reading 
Test (Nelson, 1991). 
In addition to the clinical ratings described abovn, several self-report 
measures of symptoIIllltoiogy were administered. The TS participants were 
given The Yale Global Tic Severity Rating Scale (Leckman et ai., 1989) as 
a measure of their current TS symptomatology. ADHD symptomatology 
was measured using the Conners Adult ADHD Rating Scales-Short 
Version (CAARS; Conners, Emardt, & Sparrow, 1998), and OCD symp-
tomatology was measured using the Ley ton Obsessional Inventory (LOI; 
Cooper, 1970) and the Mimdsley Obsessive-Compulsive Inventory 
(MOCI; Hodgson & Raclunan, 1977). T tests were carried ont to compare 
the two groups Oil the symptomatology scores. The TS and control groups 
did not differ significantly in obsessionality on the LOI, £(42) = 0.69, p 
.493, or the MOCI, 1(42) = 0.47, P = .639, but did differ significantly in 
ADHD symptomatology on the CAARS, £(41) 2.47. P = .018; mean 
scores and standard deviatious are shown in Table 1. 
Of the 20 participants in the TS grouP. 10 were taking prescribed 
medication for management of their TS symptoms at the time of testing. 
Nine of them were laking antipsychotic preparations, 3 of these in com-
bination with an SSRI and 1 in combination with a The remaining 
participant was taking an SSRI alone. 
/4~neJ'lmlP.ntal Measures 
With respect to measures involving inhibition, iIIlllging studies have 
indicated that the anterior cingulate and ventrola.teml prefrontal cortex are 
activated during I.lI.sks involving suppression of a prepotent response such 
as the Hayling and Stroop Tests (Nathaniel-James, Fletcher, & Frith, 1997; 
Pardo. Pardo, Janer. & RIDchle. 1990; Taylor, Kornblum, Lauber, 
Minoihima., & Koeppe, 1997) and that an increase in anterior cingu1ate 
activation is associated with increased amount of conflict in a Stroop task 
(Carter et at, 2000). Similarly, a stndy using the flanker test (Eriksen & 
Eriksen, 1974), found that: anterior cingu1ate activation was associated with 
stimu.lns-response conflict (Botvinick:, Nystroom, Fissel!, Carter, & Cohen, 
1999). 
Inhibition A: Sentence Completion Test 
This task was based on the Hayling test developed by Burgess and 
Shallice (1996). It involves completing selltences as quickly as possible 
Table 1 
Mean Scores and Standard Deviations for the IJpI'IWVy;",Il,ir. 
Measures 
Variables 
Demographic and IQ Il:l.IlIl.SII.rS 
Age 
Years of education 
NARTIQ 
Clinical measures 
ADHDScale" 
MOCIb 
Yale Tic Severity 
TS 
(n'" 20) 
M 
31.05 
13.25 
105.15 
25.80 
15.11 
5.11 
27.00 
SD 
11.32 
1.68 
12.75 
9.45 
10.51 
4.20 
19.43 
Note. TS = Tourette's syndrome; 
Test; ADHD 
Control 
(n 25) 
M SD 
28.88 7.97 
13.04 1.72 
105.00 6.69 
17.30 12.60 
12.68 12.24 
4.52 3.96 
ObsessioD.al Inventory; MOCI = MaOOSley Obses:siv!!-O:m1][Jiiliiive 
n 23. bTSn=19. 
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with words that make sense (part A) and with nonsensical words (Part B). 
The sentences used in the Hayling test were taken from a study described 
by Bloom and Fischler (1980), which gave the frequencies of responses for 
the words used by college students when as!red to complete sentences with 
a missing last word. As the Hayling test did not examine the effect of 
prepotency on performance, the cnrrent task examined this by selecting two 
sets of sentences from the Bloom and Fischler set-tbose of high and low 
prepotency. Those with high prepotency were sentences for which there 
was one highly frequent response given by the sample, them 
potentially harder responses to inhibit when asked to provide 
the tast word to the sentence "The children went ontside to -," 99% 
of the sample responded "play." The low prepotent sentences were those 
for which a variety of responses were provided. with no answer having a 
marJredly higher frequency than any other answer. For example, when 
presented with the sentence "The sun went down before we could----," 
the most frequent responses were "leave" and "see," with 18% each. 
When the sentences had been selected, !hey were allocated to two sets, 1 
and 2, each containing 15 high prepotent and 15 low prepotent sentences. 
Half of the participants received Set 1 for Part A of the task, and the other 
half received Set 2 for Part A. Within each set, two random orders of 
sentence presentation were created to mix high and low prepotency sen-
tences. The sentences were presented orally by computer. The experi-
menter recorded median reaction time (R1) by pressing a response key 
when the participant responded and then recording the word given on a 
response sheet voice activation recording is generally used to 
time oral responses accnrately, il was thought that vocal tics would poten-
tially render this problematic. 
The of participants' noasensical completions in Part B of the test 
waS rated following similar principles to those outlined by Burgess and 
Shallice (1996). Straightforwan:!. obvious completions scured 3. whereas 
responses that were not obvious completions, but were nevertheless related 
to the context of the sentence, scored 1; scures fur straightforwan:! and 
related completions were added to give separate error scores for the high 
and low prepotency sentences. 
Inhibition B: Flanker Test 
This task was based on Eriksen and Eriksen (1974). It consisted of five 
arrows (one central arrow and two "flanJrers" to either side). On conllict 
trials, the central arrow and OanJrer arrows pointed opposite ways, requir-
ing suppression of intederence from the flanJrer arrows when responding to 
the central arrow. were instructed to press one of two response 
!reys ("left" or "right"). as quicldy as possible. in accordance .with the 
direction of the central arrow. 'Thus, if the central arrow pointed to the left, 
!hey were to press the key on the left, and vice versa. The four 
"flanker' arrows all pointed in either the same direction as the central 
arrow (compatible) or in the opposite direction (incompatible). Each par-
ticipant received two practice blocks and four experimental blocks of 40 
trials. Each block contained 20 incompatible and 20 compatible trials (10 
of each of the 4 possible trial types). Each display remained on the screen 
until the participant pressed a key. The intertrial interval (lTI) 
was 1.2 s. The order of was pseudorandomized within each 
block. such that there were never more !han four consecntive identical 
correct responses (left or right key) and never more !han two consecutive 
identical trial types. For each participant, the number of correct responses 
and median RTs for correct responses were recorded for compatible and 
incompatible trials. 
Working Memory: N-Back Test 
The n-back test (Braver et at, 1997) is a measure of working memory 
that allows comparison of performance across subtasks in which the 
memory load gets progressively larger. Functional imaging srudies have 
associated performance on !his task with activation in the dorsolateral 
prefrontal cortex (Braver et at, 2001; Callicott et at, 1999), and it has been 
shown that activation in dorsolateral areas increases as the memory load 
increases (J. D. Cohen et at, 1997). 
The n-back test used in the 
conditions, with increasing working memory load. All conditions 
participants to press one of two response keys ("yes" or "no") as quickly 
as they could. in response to letters presented individnally on the computer 
screen. In the !hey were asked to press "yes" to one target 
letter (8), and "no" to any letter; three other letters were used as 
dislractors. In the I-back condition, participants were required to press the 
"yes" key whenever the letter on the screen was identical to the immedi-
ately preceding letter. In the 2-back condition, !hey were asked to press the 
"yes" key whenever the letter on the screen was the same as the letter 
presented two trials previously. The of the test was similar to the 
flanker test. in that each task. consisted of two practice blocks and four 
experimental blocks, with an m of 1.2 s. The blocks consisted of 40 trials 
each for the O-back condition, 41 trials for the I-back condition, and 42 
trials for the 2-back condition. The first trial of each block for the I-back 
condition and the first two trials of each block for the 2-back condition 
were excluded from the analysis, as the response was a1Jtomatically "no." 
The three tasks were mntched such that 25% of the letters within each 
block were targets and 75% were distractors. The order of the O-back. 
I-back. and 2-back tasks was counterbalanced within each group. For each 
participant, the percentage of correct responses and median RT were 
recorded for each condition. 
Task Switching 
Impairment on task those with 
left prefrontal cortex lesions and with Parkinson's disease (e.g., Rogers et 
ai, 1998), and studies have shown dorsolateral prefrontal cortex 
involvement (e.g., Dove, Poll.man, Schubert, Wiggins. & von Cramon, 
20(0). In this task. the currect response switched between letter and digit 
naming on every second trial in a predictable sequence, cued by the 
background color (e.g., blue for letters and yellow for digits). LiIre the 
flanJrer and n-back tasks, there were two practice blocks and four experi-
n:tental blocks, with an m of 1.2 s. Two stimuli were presented on each 
trial, consisting of either a letter and a digit or one letter or digit, as 
appropriate, and one irrelevant symbol Performance on switch trials was 
compared with nonswitch trials. 
Alternation Le'an'lill'll 
Object alternation has been found to be sensitive to persevera-
tive responding after o.tbitofrontal and medial lesions in both primate and 
human srudies (e.g., Freedman, Black, Ebert, & Binns, 1998; Mishkin. 
Vest, Waxler, & Rosvold. 1969). in this task. two objects (boxes) were 
presented on each trial and a reward was hidden under one of them. Either 
choice was rewarded on the first trial. After the first trial, the reward 
alternated from one object to the other after each correct response. When 
a currect choice was made, the box opened to display a coin. When an 
incorrect choice was made, the box opened to show nothing inside. Par-
ticipants were instructed to choose the box containing the coin as often as 
possible. There were 50 trials in all, with an IT! of 5 s. For each participant, 
!he number of total correct responses aad median RT for correct responses 
was recorded. 
Results 
Experinlen~lA1easures 
Because each of the experimental tasks contained measures of 
both accuracy and speed, we a level of a = 
.05/2 (p .025). As median RT was measured for each partici-
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pant. mean scores reported for each group for speed refer to mean 
of median RT, using logarithmically transformed data. The mean 
scores and standard deviations for each test are shown in Table 2 
for each group; effect sizes are also shown. 
Inhibition A: Sentence Completion Test 
An of variance was used to compare the 
groups on error scores for the and low prepotency sentences 
for the nonsensical completions, one between-groups factor 
(group: TS or control) and one factor (prepotency: 
high or This showed no Group X Prepolen.:y 
interaction, F(1, 42) = 0.68, p or main effect of prepo-
tency. = 0.00, p = .983. There was a signifieant main 
effect of group, £(1, 42) 6.27, p .016. Examination of the 
mean scores showed that the TS-alone group had bigher error 
scores than the control group for both and low prepotem:y 
trials. 
An ANOVA was also nsed to examine the speed of the two 
groups across both sensible and nonsensical completion condi-
tions, one between-groups factor (group: TS or control) and 
two factors high or low; condition: 
Table 2 
and 
sensible or The Group X Condition x rrepoltem:y 
interaction was not F(1,43) 0.18, p = .672., nor was 
there a significant X Condition, F(l, 0.12, P = .733, 
or Group X interaction,F(I,43) = .198. The 
main effect was also not significant. 43) 0.34,p 
.562. There was a main effect of prepotency, F(l, 
43) = 91.17, p .0001, and of condition, 43) = 56.63,p 
.0001. 
Inhibition B: Flanker Test 
An ANOVA was used to compare the groups on the compatible 
and incompatible using one factor (group: 
TS or control) and one within-groups factor (inhibition: compati-
ble or trials). This showed no Group X 
Inll1"bition interaction, F(2, 42) = 0.23, P or effect of 
group, F(l. = .203. There was a significant effect of 
p = .0001. For the ANDV A 
showed no X Inhibition F(1, 
43) = 0.52, p .474, or effect of group, F(l, 43) = 0.90, p = 
.766. There was a effect of inhibition, F(l, 43) 
107.98, p = .0001. 
Measures 
TS (n ~ 20) Control (n ~ 25) 
Variables 
Sentence completion accuracy (errors)"· 
prepotent nonsensical 
nm,rYlt"nt nonsensical 
Sentence speed per item in seconds 
prepotent sensible 
sensible 
Sentence speed per item in seconds 
prepotent oonsensicaL 
prepotent oonsensical 
FlanIrer accuracy 
pen:enltage accuracy 
I-back 
2-back 
per item in seconds 
Task pen=entage accuracy 
Switch 
Nonswitcb trials 
Task speed per item in seconds 
Switch 
Nonswitch trials 
alternation 
Pen:entage of trials correct 
in seconds 
Note. TS = Tourette's syndrome. 
"TS n 19. 
*p < .05. 
M 
4.16 
4..58 
0.33 
0.64 
0.76 
1.06 
98.19 
95.88 
0.43 
0.46 
98.06 
95.09 
82.28 
0.43 
0.59 
1.01 
8.5.03 
86.42 
0.87 
0.79 
63.80 
0.72 
SD M SD Effect size 
3.78 2.64 2.25 0.24 
3.50 2.24 2.62 0.35 
0.12 0.37 O.H 0.17 
0.31 0.68 0.28 0.07 
038 0.82 0.39 0.04-
0.76 0.94 0..54 0.09 
2..52 98.95 1.93 0.17 
2.90 96.95 3.00 0.18 
0.06 0.43 0.Q7 0.00 
0.Q7 0.47 0.07 0.07 
2.15 97.88 1.80 0.05 
4.80 96.93 2.63 0.23 
8.01 84.90 7.31 0.17 
0.10 0.46 0.20 0.09 
0.45 0.58 0.29 0.01 
0.49 1.12 0.48 O.ll 
17.21 87.75 8.03 0.10 
17.16 90.50 6.39 0.16 
0.24 0.96 0.32 0.16 
0.22 0.86 0.30 0.13 
18.33 67.76 14.63 0.12 
0.29 0.83 0.44 0.15 
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Working Memory: N-Back Test 
On the n-back task, an ANOV A with one factor 
TS or control) and one within-groups factor (working 
memory load: 0-,1-, or was used to compare accuracy of 
performance on the O-back, I-back, and 2-back conditions. There 
was no Group X Working Memory Load effect, 
2.00, p = .147, and the effect of group was also not 
lSlgllll.l~<Wl., F(1, 43) = 1.85, P = .181. The effect of memory load 
was F(2, 42) = 78.02, P = .0001. For the 
ANOV A showed no Group X Load interac-
F(2,42) = 0.18, p .835, nor was there a main 
effect of group, 0.58, p = .451. The effect of memory 
load was F(2,42) = p .0001. 
Task Switching 
An ANOVA with one betw~~n-:grolUIJS factor TS or 
control) and one factor (switching: switch or non-
switch trials) was used to compare accuracy of task switching 
performance. There was no significant X Condition effect, 
F(I,43) 1.02, p = .318, and the effect of group was also not 
Table 3 
= 0.83, P = .367. The effect of ~wiit,..hina 
9.55, p = .003. For speed, the ANOVA 
showed no significant Group X Switching interaction, 
43) 0.12, P = .730, nor was there a main effect of 
group, 43) = 1.21, p = .277. The effect of was 
sigIlificant, F(I, 43) 31.55, p .0001. 
Object Alternation Learning 
On the alternation leaming task, the ANOV A showed that the 
groups did not differ in the number of trials correct, 
0.81, p = .424. Nor did the groups differ in 
of 1.01, p = .316. 
Relationship to Symptomntology 
af Medication 
Age, and 
~n"",,",n!1n rank correlations were calculated for the TS group to 
exanline any correlations between perfonuance on the eXjJleriJnerl-
tal tasks and symptomatology scores on the Yale Global Tic 
Severity Scale, CAARS, LOL and MOC! (sec Table 3). 
Correlations Between ..... OJ~nlJ:we Mea.~ure.~ and Sy~nptomatoiloJ!,G' Scores for the 
Tourette's 
with 
Cognitive measures Yale Tic CAARS WI MOCI 
Sentence compleiion (errors)" 
prepotent .53* .24 30 .25 
prepotent nOlJSensical .51* .06 .14 .16 
Sentence completion speed per item in seconds 
prepotent sellliible .04 -.11 -.34 -.24 
prepotent sensible -.05 .05 -.17 -.01 
Sentence compleiion item in seconds 
High prepotent .12 .17 .(17 .14 
Low prepotent nonsensical .20 .16 .08 .20 
Flanker 
.00 -.10 .05 .16 
-.30 -.32 -.27 .(17 
per item in seconds 
lrials -.17 -.15 -.35 -.19 
lrials -.26 -.16 -.56* -.34 
percelltage l!CCUl'llCY 
Q.back -.18 -.28 -.43 -37 
I-back -.31 -.27 -.26 -.36 
2-back .00 .08 -.13 -.35 
N·back per item in seconds 
-.24 .02 -.07 .01 
I·back -.40 .01 .02 .10 
2-back -.02 -.08 -.19 -Ai 
Task switching percentage accuracy 
Switch trials -.22 -.05 -.12 -.15 
NOIJSwitch trials -30 .05 -.04 -.08 
Task speed per item in seconds 
Switch .30 .05 .19 -.15 
NOIJSwilch trials .24 .05 .02 -.41 
altemat:ion 
of lrials correct .02 -.01 -.20 -.09 
Speed per item in seconds -.34 .12 .14 -.05 
Note. CAARS = Conners Adult ADHD Scales--Short Version; LOI = Ley ton Obsessional InVeIltory; 
MOCI = Maudsley Obsessive-Compulsive 
"n = 19. 
"' P < .05. 
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This showed significant correlations (p < .05) between Yale Tic 
Severity scores and sentence completion errors for both high and 
low prepotent sentences and between LOI obsessionality scores 
and Flanker speed on incompatible trials. There were no other 
significant correlations with the symptomatology measures. All 
significant correlations were in the expected direction, that is, 
higher symptomatology correlated with poorer performance. 
Any effect of age on the results was examined by repeating the 
comparisons using age as a covariate. This did not alter the pattern 
of findings. The effects of medication on performance were ex-
amined within the TS group for the sentence completion measures 
that differentiated the groups. There was no significant difference 
between the medicated and unmed.icated participants on these 
measures, nor any sigllificant task by medication effects (p > .05). 
Discussion 
The findings showed that, as expected, the groups did not differ 
significantly in either accuracy or speed on measures of working 
memory, task switching, or object alternation learning. Predictions 
regarding inhibitory deficits were partially confirmed as the TS 
group made more errors than a matched control group on an 
inhibitory sentence completion measure. However, the interaction 
with prepotency was not significant, there were no group differ-
ences in speed of performance, and there was no difference on 
another inhibitory measure, the flanker task. There was little evi-
dence that prescribed medication for the TS group influenced the 
findings, but the sample sizes were too small to draw firm conclu-
sions about this. 
To address issues relating to the influence of comorbid symp-
tomatology, only TS participants who did not meet DSM criteria 
for comorbid disorders were included in the study. In addition, 
measures were included to assess comorbid symptomatology and 
tic severity, to examine the relationship between these and any 
executive deficits. The TS group differed significantly from the 
controls on the ADHD measure, but there were no significant 
correlations between ADHD scores and performance, suggesting 
that this was not a critical factor contributing to the pattern of 
findings. The TS group did not differ from the controls on the 
obsessionality measures, and there was a significant correlation 
between only one of these and a cognitive measure (inhibitory 
flanker speed), which did not differentiate the groups. Taken 
together, the findings suggest that comorbidity played at most a 
small role in any inhibitory difficulties shown by the TS group. 
With respect to Yale tic symptomatology, significant correlations 
were found with the one task that differentiated the two groups 
(sentence completion errors), suggesting that core TS severity was 
a relevant factor determining cognitive impairment. 
What do the present findings imply for the inhibitory deficit 
hypothesis of TS? Sample size in the present study was relatively 
small, as is typically the case when studying a rare disorder, and it 
is possible given the number of tests performed that the significant 
comparisons arise simply by chance. Nevertheless, the findings are 
consistent with a number of previous studies in suggesting that any 
cognitive deficits associated with uncomplicated TS are relatively 
mild and circumscribed in nature. 
The lack of impairment in the present TS participants on tasks 
involving working memory, task switching, and object alternation 
is in line with expectations. However, the inhibitory deficit hy-
pothesis receives at best only partial support from the measures 
involving inhibition. The flanker task was expected to show im-
pairment on incompatible but not compatible trials, but there was 
no evidence of group differences for either accuracy or speed. 
Performance on the sentence completion task was consistent with 
predictions based on an inhibitory deficit in that the TS group 
made more errors in completing sentences with nonsensical end-
ings than the control group. However, the lack of group differences 
in speed and the lack of effect of prepotency of the nonsensical 
sentence completions did not provide support for the hypothesis. 
Inhibition is not necessarily a unitary construct (see, e.g., Kok, 
1999; Nigg, 2000), and the two tasks involving inhibition, sentence 
completion, and the flanker task differ in several ways. Any 
cognitive impairments in uncomplicated TS may be linked to very 
specific types of inhibition, and tasks involving inhibition of any 
response for a proportion of trials (such as the go/no-go or the stop 
signal paradigm) merit further study. The sentence completion task 
used in the present study involves the inhibition of prepotent 
responses (sensible completion words), whereas conflict on the 
flanker task involves the inhibition of interfering, but not prepo-
tent, stimuli. Moreover, the sentence completion task also involves 
the use of strategic processes to search long-term memory stores 
for alternative responses. Crawford et al. (2005) suggested that 
higher error rates in sentence completion in children with uncom-
plicated TS might reflect the disruption of verbal or conceptual 
processes involved in task performance, rather than pure inhibitory 
processes. The TS participants may therefore have had difficulties 
developing efficient strategies such as those commonly used by 
normal participants, such as naming objects in the room or drawing 
words from semantic categories (Burgess & Shallice, 1996). 
Several of the measures used in this study (sentence completion, 
flanker, n-back) are the same as those used by Crawford et al. 
(2005) to study children with TS. The findings of the two studies 
are comparable in showing higher error rates on the sentence 
completion task. However, in contrast with the earlier findings, 
adults with TS in the present study showed no evidence of slowed 
performance on the sentence completion task and also showed no 
evidence of differences on the flanker test This suggests that any 
impairments associated with uncomplicated TS may be more pr0-
nounced. and hence easier to detect. in children than in adults. It 
may be that TS is associated with a lag in the development of 
certain cognitive skills and that maturation of these skills is slower 
but reaches normal or near-norrnallevels in adulthood. There may 
also be a direct relationship between cognitive impairments and 
the clinical picture often seen in TS, in which symptoms tend to 
diminish in frequency and/or severity with age, although other 
factors such as treatment response are also potentially relevant (for 
a discussion see, e.g., Robertsoll, 2(00). Some tentative support for 
an association between TS symptomatology and cognitive function 
is provided by the significant correlations between sentence com-
pletion impairment measures and Yale tic severity scores found in 
the present study. However, longitudinal data would provide a 
more powerful test of any change over time in the relationship 
between TS symptomatology and cognitive functioning. 
Overall, the present findings add to a growing body of evidence 
showing that uncomplicated TS is not associated with widespread 
executive impairments. The precise nature of performance deficits 
in both children and adults with TS merits further attention to 
determine whether these are essentially inhibitory in nature, and if 
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so, precisely which processes are involved. There may 
be a range of separable processes, both automatic and 
effortful, with different neural substrates. The present 
also suggest that any that does characterize 
uncomplicated TS may improve to some extent with age. 
tudinal studies are needed to address this issue more 
it is certainly that cognitive detected in 
childhood become less marked in adulthood and may disappear for 
some individuals. 
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